Dataset,Dataset code,Site (anonymized),Instrument model,Result ID,Sample,SOP-Exp,Repetition,Compensation control,Gating control,Population,Phenotype,Parent gate,Repeat times,Cell population (%),Abs. cell count (volume),Abs. cell count (TruCount),MedFI,rSD,ERF
Site01-Quanteon,1,Site01,Quanteon,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,75.6,134.6572,213.25824,190622.0,53319.0,117460.9402
Site01-Quanteon,1,Site01,Quanteon,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77,130.7164,213.81984,203531.0,57409.0,125415.4432
Site01-Quanteon,1,Site01,Quanteon,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77.8,10.57698,227.8224,192864.0,52916.0,118842.4567
Site01-Quanteon,1,Site01,Quanteon,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.79,99.39447,105.93648,57574.0,25147.0,35476.99726
Site01-Quanteon,1,Site01,Quanteon,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.64,94.44927,102.69792,58971.0,27343.0,36337.8262
Site01-Quanteon,1,Site01,Quanteon,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.69,1756.464,102.81024,57826.0,26246.0,35632.27922
Site01-Quanteon,1,Site01,Quanteon,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.8,34.76891,732.49488,110970.0,43660.0,85366.45622
Site01-Quanteon,1,Site01,Quanteon,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.6,35.95095,731.78352,110489.0,43787.0,84996.4349
Site01-Quanteon,1,Site01,Quanteon,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.6,3689.996,730.62288,161181.0,57416.0,123992.5275
Site01-Quanteon,1,Site01,Quanteon,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,36.1,79.4094,264.62592,190988.0,45969.0,10595909.59
Site01-Quanteon,1,Site01,Quanteon,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37,85.11352,270.65376,191753.0,44898.0,10638351.37
Site01-Quanteon,1,Site01,Quanteon,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.4,3.126737,273.48048,190988.0,45377.0,10595909.59
Site01-Quanteon,1,Site01,Quanteon,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.5,1125.402,1782.31248,35723.0,9908.0,5610942.408
Site01-Quanteon,1,Site01,Quanteon,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,1087.343,1778.62464,36209.0,10087.0,5687277.487
Site01-Quanteon,1,Site01,Quanteon,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.5,1150.612,1776.35952,35563.0,9908.0,5585811.518
Site01-Quanteon,1,Site01,Quanteon,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,49.7,144.3443,363.86064,114715.0,70382.0,1019429.986
Site01-Quanteon,1,Site01,Quanteon,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,49.2,147.2118,360.22896,116574.0,70910.0,1035950.235
Site01-Quanteon,1,Site01,Quanteon,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.7,5.155019,356.09184,113615.0,69857.0,1009654.691
Site01-Quanteon,1,Site01,Quanteon,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,67.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,15.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.3,487.4182,317.24784,319303.0,278819.0,6442078.07
Site01-Quanteon,1,Site01,Quanteon,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.9,457.846,308.1312,316700.0,279582.0,6389561.404
Site01-Quanteon,1,Site01,Quanteon,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.6,3132.481,302.29056,309018.0,277277.0,6234573.684
Site01-Quanteon,1,Site01,Quanteon,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85.4,168.4211,265.97376,176814.0,84569.0,108952.475
Site01-Quanteon,1,Site01,Quanteon,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86.5,161.5358,264.2328,189044.0,92339.0,116488.5794
Site01-Quanteon,1,Site01,Quanteon,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.6,180.8779,279.24624,180546.0,80774.0,111252.1268
Site01-Quanteon,1,Site01,Quanteon,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.6,63.70318,100.60128,61850.0,24088.0,38111.86092
Site01-Quanteon,1,Site01,Quanteon,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.5,59.60174,97.49376,64360.0,25554.0,39658.51849
Site01-Quanteon,1,Site01,Quanteon,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.61,64.38705,99.4032,62592.0,24773.0,38569.08001
Site01-Quanteon,1,Site01,Quanteon,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.6,456.1759,720.40176,118800.0,44807.0,91389.88014
Site01-Quanteon,1,Site01,Quanteon,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62,435.2598,711.97776,117783.0,44781.0,90607.52737
Site01-Quanteon,1,Site01,Quanteon,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,62.3,465.5269,718.69824,116774.0,44560.0,89831.32881
Site01-Quanteon,1,Site01,Quanteon,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,35.9,163.9165,258.86016,190043.0,44871.0,10543481.51
Site01-Quanteon,1,Site01,Quanteon,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,36.8,160.3456,262.28592,190828.0,44265.0,10587032.88
Site01-Quanteon,1,Site01,Quanteon,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.3,173.4206,267.73344,190828.0,44760.0,10587032.88
Site01-Quanteon,1,Site01,Quanteon,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.2,1145.721,1809.34416,36385.0,10122.0,5714921.466
Site01-Quanteon,1,Site01,Quanteon,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.1,1095.274,1791.5976,36921.0,10240.0,5799109.948
Site01-Quanteon,1,Site01,Quanteon,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.1,1167.297,1802.11824,36219.0,9995.0,5688848.168
Site01-Quanteon,1,Site01,Quanteon,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,51.6,235.5382,371.9664,110535.0,72411.0,982283.8644
Site01-Quanteon,1,Site01,Quanteon,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.6,221.9272,363.01824,112350.0,73488.0,998413.1014
Site01-Quanteon,1,Site01,Quanteon,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,50.6,235.4674,363.52368,110092.0,72154.0,978347.0865
Site01-Quanteon,1,Site01,Quanteon,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,25.2,186.854,295.08336,337005.0,277022.0,6799223.684
Site01-Quanteon,1,Site01,Quanteon,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.9,174.9828,286.2288,332476.0,276930.0,6707849.123
Site01-Quanteon,1,Site01,Quanteon,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,24.6,183.7638,283.7016,324699.0,274278.0,6550944.737
Site01-Quanteon,1,Site01,Quanteon,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,72.3,138.229,218.29392,190982.0,53455.0,117682.7716
Site01-Quanteon,1,Site01,Quanteon,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,74.3,130.705,213.80112,205200.0,56244.0,126443.8781
Site01-Quanteon,1,Site01,Quanteon,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76.6,143.725,221.88816,193981.0,51277.0,119530.7501
Site01-Quanteon,1,Site01,Quanteon,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.72,65.65908,103.69008,62708.0,23524.0,38640.55901
Site01-Quanteon,1,Site01,Quanteon,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.63,62.14237,101.6496,64933.0,24901.0,40011.60008
Site01-Quanteon,1,Site01,Quanteon,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.65,65.66024,101.3688,63553.0,24176.0,39161.24652
Site01-Quanteon,1,Site01,Quanteon,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.9,458.3807,723.88368,126335.0,45621.0,97186.3679
Site01-Quanteon,1,Site01,Quanteon,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.4,441.9089,722.85408,125969.0,45601.0,96904.81322
Site01-Quanteon,1,Site01,Quanteon,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,61.6,468.0369,722.57328,124154.0,45325.0,95508.57894
Site01-Quanteon,1,Site01,Quanteon,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,35.7,163.5254,258.2424,190403.0,44641.0,10563454.11
Site01-Quanteon,1,Site01,Quanteon,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,36.6,161.9364,264.888,190985.0,43824.0,10595743.15
Site01-Quanteon,1,Site01,Quanteon,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.1,173.5661,267.95808,190985.0,44190.0,10595743.15
Site01-Quanteon,1,Site01,Quanteon,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.4,1141.844,1803.22272,37634.0,10466.0,5911099.476
Site01-Quanteon,1,Site01,Quanteon,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.4,1106.397,1809.79344,38155.0,10794.0,5992931.937
Site01-Quanteon,1,Site01,Quanteon,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.4,1169.71,1805.84352,37377.0,10526.0,5870732.984
Site01-Quanteon,1,Site01,Quanteon,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,52,238.4305,376.53408,109349.0,71970.0,971744.3189
Site01-Quanteon,1,Site01,Quanteon,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.3,226.5049,370.50624,111667.0,72815.0,992343.5318
Site01-Quanteon,1,Site01,Quanteon,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,50.9,238.3048,367.90416,108968.0,71791.0,968358.5121
Site01-Quanteon,1,Site01,Quanteon,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,16.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26,195.7681,309.1608,326337.0,278382.0,6583992.105
Site01-Quanteon,1,Site01,Quanteon,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.7,184.7333,302.17824,322575.0,277913.0,6508092.105
Site01-Quanteon,1,Site01,Quanteon,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.3,192.3972,297.03024,312762.0,276076.0,6310110.526
Site01-Quanteon,1,Site01,Quanteon,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.1,1157.191334,2061.851031,46107.0,11847.0,7241937.173
Site01-Quanteon,1,Site01,Quanteon,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,96.4,1051.69265,1708.498492,44893.0,12138.0,7051256.545
Site01-Quanteon,1,Site01,Quanteon,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.4,16.58171,554.7631692,132719.0,27713.0,81781.21373
Site01-Quanteon,1,Site01,Quanteon,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.8,17.01137,574.3383298,135500.0,27744.0,83494.86103
Site01-Quanteon,1,Site01,Quanteon,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.7,60.99136,577.4115632,143880.0,29541.0,88658.60225
Site01-Quanteon,1,Site01,Quanteon,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.74,498.9038,117.2950749,58332.0,23165.0,35944.07552
Site01-Quanteon,1,Site01,Quanteon,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.59,480.8567,114.4,58587.0,23311.0,36101.20607
Site01-Quanteon,1,Site01,Quanteon,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.84,339.8276,118.3417559,59748.0,23981.0,36816.61223
Site01-Quanteon,1,Site01,Quanteon,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.4,2776.795,1025.391006,156188.0,55387.0,120151.537
Site01-Quanteon,1,Site01,Quanteon,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.3,2680.031,1015.302784,156891.0,54898.0,120692.3374
Site01-Quanteon,1,Site01,Quanteon,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,76.3,46.56645,1025.457816,157598.0,55151.0,121236.2149
Site01-Quanteon,1,Site01,Quanteon,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.2,10.55714,760.4813319,206056.0,42644.0,11431873.97
Site01-Quanteon,1,Site01,Quanteon,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.5,10.68302,746.5062099,206056.0,42644.0,11431873.97
Site01-Quanteon,1,Site01,Quanteon,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.7,729.216,1025.457816,206056.0,42644.0,11431873.97
Site01-Quanteon,1,Site01,Quanteon,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.3,1502.318,2150.238972,35403.0,8045.0,5560680.628
Site01-Quanteon,1,Site01,Quanteon,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,1516.045,2152.666381,36866.0,8247.0,5790471.204
Site01-Quanteon,1,Site01,Quanteon,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.4,68.01779,2170.482227,36046.0,8127.0,5661675.393
Site01-Quanteon,1,Site01,Quanteon,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.3,4.029105,249.1546039,154061.0,52778.0,1369083.407
Site01-Quanteon,1,Site01,Quanteon,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,74.9,4.23428,251.2414569,156088.0,52379.0,1387096.61
Site01-Quanteon,1,Site01,Quanteon,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,24.8,15.63734,756.2158458,158661.0,52654.0,1409961.914
Site01-Quanteon,1,Site01,Quanteon,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,61.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,61.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,29.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,30.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,29.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.2,1832.665,164.4572896,484000.0,388137.0,9684210.526
Site01-Quanteon,1,Site01,Quanteon,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.7,1786.372,168.4488223,479000.0,387272.0,9664035.088
Site01-Quanteon,1,Site01,Quanteon,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.4,21.99939,166.4890792,477000.0,398194.0,9623684.211
Site01-Quanteon,1,Site01,Quanteon,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.8,424.1792,607.1194861,130549.0,30483.0,80444.06356
Site01-Quanteon,1,Site01,Quanteon,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.3,442.8952,628.8770878,132726.0,30461.0,81785.52712
Site01-Quanteon,1,Site01,Quanteon,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,93,415.9041,633.6205567,141231.0,32487.0,87026.29312
Site01-Quanteon,1,Site01,Quanteon,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.98,81.9667,117.3173448,60635.0,23038.0,37363.18006
Site01-Quanteon,1,Site01,Quanteon,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.93,81.66562,115.9588865,61118.0,23182.0,37660.80381
Site01-Quanteon,1,Site01,Quanteon,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.39,81.23081,123.7533191,62344.0,23167.0,38416.26285
Site01-Quanteon,1,Site01,Quanteon,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.5,698.6152,999.9143469,166160.0,56119.0,127822.7482
Site01-Quanteon,1,Site01,Quanteon,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.2,696.6593,989.2025696,166160.0,55630.0,127822.7482
Site01-Quanteon,1,Site01,Quanteon,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.6,654.3049,996.8188437,166877.0,55862.0,128374.3184
Site01-Quanteon,1,Site01,Quanteon,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.5,513.4588,734.9036403,204716.0,41117.0,11357531.51
Site01-Quanteon,1,Site01,Quanteon,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.8,507.4969,720.606424,204716.0,41637.0,11357531.51
Site01-Quanteon,1,Site01,Quanteon,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73,477.6056,727.6214133,204716.0,41637.0,11357531.51
Site01-Quanteon,1,Site01,Quanteon,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.9,1511.903,2163.957173,35804.0,8053.0,5623664.921
Site01-Quanteon,1,Site01,Quanteon,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.1,1526.976,2168.188437,37349.0,8345.0,5866335.079
Site01-Quanteon,1,Site01,Quanteon,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.1,1441.5,2196.092505,36498.0,8209.0,5732670.157
Site01-Quanteon,1,Site01,Quanteon,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.7,172.5533,246.9721627,154121.0,52891.0,1369616.605
Site01-Quanteon,1,Site01,Quanteon,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.3,176.5213,250.6466809,156024.0,52579.0,1386527.866
Site01-Quanteon,1,Site01,Quanteon,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.3,165.4729,252.0942184,158599.0,53074.0,1412076.933
Site01-Quanteon,1,Site01,Quanteon,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,31,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.7,106.4105,152.303212,491000.0,374737.0,9906140.351
Site01-Quanteon,1,Site01,Quanteon,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.1,110.7591,157.269379,493000.0,374293.0,9946491.228
Site01-Quanteon,1,Site01,Quanteon,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.8,101.798,155.0869379,490000.0,377449.0,9885964.912
Site01-Quanteon,1,Site01,Quanteon,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91,390.8511,559.4175589,,,81806.47786
Site01-Quanteon,1,Site01,Quanteon,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.4,406.0069,576.4985011,135171.0,27890.0,83292.13181
Site01-Quanteon,1,Site01,Quanteon,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,91.1,385.2945,586.9875803,144003.0,29927.0,88734.39463
Site01-Quanteon,1,Site01,Quanteon,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.14,83.86494,120.0342612,61383.0,22988.0,37824.09634
Site01-Quanteon,1,Site01,Quanteon,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.03,82.92033,117.7404711,61711.0,23029.0,38026.20936
Site01-Quanteon,1,Site01,Quanteon,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.52,82.66335,125.9357602,62876.0,23012.0,38744.08031
Site01-Quanteon,1,Site01,Quanteon,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76,697.3705,998.1327623,172356.0,55925.0,132589.1766
Site01-Quanteon,1,Site01,Quanteon,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75.8,696.7064,989.269379,172356.0,55411.0,132589.1766
Site01-Quanteon,1,Site01,Quanteon,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.4,655.1235,998.0659529,173360.0,55897.0,133361.5288
Site01-Quanteon,1,Site01,Quanteon,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.6,513.4744,734.9259101,204273.0,41062.0,11332954.11
Site01-Quanteon,1,Site01,Quanteon,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73,508.3595,721.8312634,204900.0,40808.0,11367739.73
Site01-Quanteon,1,Site01,Quanteon,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.2,479.5936,730.6501071,204900.0,41192.0,11367739.73
Site01-Quanteon,1,Site01,Quanteon,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.4,1519.185,2174.379443,36615.0,8490.0,5751047.12
Site01-Quanteon,1,Site01,Quanteon,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.4,1534.159,2178.388009,38155.0,8799.0,5992931.937
Site01-Quanteon,1,Site01,Quanteon,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.5,1448.765,2207.1606,37249.0,8588.0,5850628.272
Site01-Quanteon,1,Site01,Quanteon,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.8,172.6778,247.1503212,152878.0,52434.0,1358570.522
Site01-Quanteon,1,Site01,Quanteon,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.4,176.9291,251.2256959,155070.0,52514.0,1378050.019
Site01-Quanteon,1,Site01,Quanteon,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.2,165.3852,251.9828694,157295.0,52627.0,1397822.775
Site01-Quanteon,1,Site01,Quanteon,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,29.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,112.8054,161.4561028,489000.0,379373.0,9865789.474
Site01-Quanteon,1,Site01,Quanteon,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.7,116.7033,165.709636,490000.0,379373.0,9885964.912
Site01-Quanteon,1,Site01,Quanteon,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.4,107.6889,164.0616702,487000.0,385869.0,9825438.596
Site01-Quanteon,1,Site01,Quanteon,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.6,1176.473792,2153.971558,43863.0,10804.0,6889476.44
Site01-Quanteon,1,Site01,Quanteon,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97.3,1139.725131,1805.125607,31544.0,7850.0,4954554.974
Site01-Quanteon,1,Site01,Quanteon,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.7,16.37238,481.8797639,170033.0,38434.0,104774.0347
Site01-Quanteon,1,Site01,Quanteon,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.6,15.80604,477.4152538,165370.0,37184.0,101900.7023
Site01-Quanteon,1,Site01,Quanteon,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.1,89.76875,464.5742621,215821.0,55099.0,132655.7725
Site01-Quanteon,1,Site01,Quanteon,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.21,470.28,93.02536009,64087.0,26333.0,39490.29637
Site01-Quanteon,1,Site01,Quanteon,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.21,488.8798,93.48949233,62558.0,26260.0,38548.12927
Site01-Quanteon,1,Site01,Quanteon,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.11,103.1998,85.79815821,70932.0,27504.0,43708.1733
Site01-Quanteon,1,Site01,Quanteon,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,77.2,2749.387,994.8784888,145348.0,50634.0,111812.5951
Site01-Quanteon,1,Site01,Quanteon,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,77,2858.906,998.7241558,144696.0,50407.0,111311.0277
Site01-Quanteon,1,Site01,Quanteon,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,78.5,70.56152,1085.892609,161181.0,57158.0,123992.5275
Site01-Quanteon,1,Site01,Quanteon,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.4,8.949987,620.8984179,212753.0,44529.0,11793433.56
Site01-Quanteon,1,Site01,Quanteon,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,62.6,8.652434,624.8324911,211059.0,44685.0,11709437.67
Site01-Quanteon,1,Site01,Quanteon,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.5,429.2283,669.3891854,214462.0,44208.0,11898234.25
Site01-Quanteon,1,Site01,Quanteon,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.5,1331.694,2136.798489,38388.0,9506.0,6029528.796
Site01-Quanteon,1,Site01,Quanteon,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,1366.629,2141.506116,37874.0,9552.0,5948795.812
Site01-Quanteon,1,Site01,Quanteon,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.6,99.59548,2111.337521,38910.0,9499.0,6111518.325
Site01-Quanteon,1,Site01,Quanteon,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32,5.238622,318.3284061,141543.0,74151.0,1257840.548
Site01-Quanteon,1,Site01,Quanteon,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.9,5.049484,319.0577568,141083.0,74467.0,1253752.698
Site01-Quanteon,1,Site01,Quanteon,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.1,37.61635,356.8513813,173915.0,84186.0,1545518.598
Site01-Quanteon,1,Site01,Quanteon,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.2,1471.188,170.3365289,408000.0,390813.0,8231578.947
Site01-Quanteon,1,Site01,Quanteon,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.4,1553.624,173.3865407,420000.0,383987.0,8493859.649
Site01-Quanteon,1,Site01,Quanteon,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13,78.91487,179.9948996,558000.0,410000.0,11257894.74
Site01-Quanteon,1,Site01,Quanteon,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92,332.1763,533.0006139,166782.0,44170.0,102770.7743
Site01-Quanteon,1,Site01,Quanteon,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92,337.4189,528.7350177,161988.0,42132.0,99816.71991
Site01-Quanteon,1,Site01,Quanteon,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,93.2,228.5,505.0200708,211690.0,61151.0,130443.0047
Site01-Quanteon,1,Site01,Quanteon,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.19,56.26722,90.28476978,68058.0,25034.0,41937.21957
Site01-Quanteon,1,Site01,Quanteon,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.01,56.33286,75.01260921,67516.0,25012.0,41603.24013
Site01-Quanteon,1,Site01,Quanteon,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.15,38.73,63.49770956,76151.0,26809.0,46924.1119
Site01-Quanteon,1,Site01,Quanteon,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,77.6,607.7686,975.2081228,155105.0,51688.0,119318.4121
Site01-Quanteon,1,Site01,Quanteon,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,77.6,624.2313,978.1697285,154439.0,51696.0,118806.0749
Site01-Quanteon,1,Site01,Quanteon,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,78.9,480.74,1062.509185,171981.0,57833.0,132300.6984
Site01-Quanteon,1,Site01,Quanteon,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.1,377.6171,605.9135773,211611.0,43768.0,11740062.33
Site01-Quanteon,1,Site01,Quanteon,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,62.3,388.7306,609.1404014,210736.0,43925.0,11691517.81
Site01-Quanteon,1,Site01,Quanteon,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.1,294.16,650.1387485,214258.0,43444.0,11886916.44
Site01-Quanteon,1,Site01,Quanteon,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98,1334.78,2141.749233,38810.0,9616.0,6095811.518
Site01-Quanteon,1,Site01,Quanteon,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98,1369.027,2145.263377,38366.0,9656.0,6026073.298
Site01-Quanteon,1,Site01,Quanteon,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.4,960.7,2123.294451,39562.0,9589.0,6213926.702
Site01-Quanteon,1,Site01,Quanteon,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.4,197.1625,316.3613695,141464.0,75380.0,1257138.505
Site01-Quanteon,1,Site01,Quanteon,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.5,203.1171,318.2842031,140890.0,75736.0,1252037.578
Site01-Quanteon,1,Site01,Quanteon,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.3,159.91,353.4256434,173580.0,85822.0,1542541.577
Site01-Quanteon,1,Site01,Quanteon,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,27,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.4,96.90083,155.4842975,407000.0,364872.0,8211403.509
Site01-Quanteon,1,Site01,Quanteon,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.5,100.6347,157.694451,402000.0,359309.0,8110526.316
Site01-Quanteon,1,Site01,Quanteon,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.4,76.27,168.5684061,557000.0,386629.0,11237719.3
Site01-Quanteon,1,Site01,Quanteon,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.1,305.854,490.7645809,170845.0,38888.0,105274.3877
Site01-Quanteon,1,Site01,Quanteon,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86.7,310.2821,486.2116647,166182.0,37851.0,102401.0553
Site01-Quanteon,1,Site01,Quanteon,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.1,215.32,475.8902479,216443.0,55290.0,133371.7949
Site01-Quanteon,1,Site01,Quanteon,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.27,57.47934,92.22970484,68729.0,24649.0,42350.68859
Site01-Quanteon,1,Site01,Quanteon,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.22,58.63188,91.87608028,67802.0,24910.0,41779.47282
Site01-Quanteon,1,Site01,Quanteon,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.24,40.15,88.73766234,76281.0,26456.0,47004.21767
Site01-Quanteon,1,Site01,Quanteon,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,77.5,612.7548,983.2088784,162159.0,52159.0,124744.8786
Site01-Quanteon,1,Site01,Quanteon,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,77.4,628.4062,984.7117828,161120.0,51822.0,123945.6017
Site01-Quanteon,1,Site01,Quanteon,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,78.5,485.07,1072.07915,179509.0,57884.0,138091.8013
Site01-Quanteon,1,Site01,Quanteon,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62,379.7521,609.3393152,211922.0,43937.0,11757316.44
Site01-Quanteon,1,Site01,Quanteon,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,62.1,390.1128,611.3063518,210627.0,43659.0,11685470.55
Site01-Quanteon,1,Site01,Quanteon,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61,296.57,655.4652184,213881.0,43839.0,11866000.68
Site01-Quanteon,1,Site01,Quanteon,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.5,1343.03,2154.988052,39625.0,9977.0,6223821.99
Site01-Quanteon,1,Site01,Quanteon,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,1377.01,2157.772845,39084.0,9977.0,6138848.168
Site01-Quanteon,1,Site01,Quanteon,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.5,969.5,2142.743802,40450.0,10168.0,6353403.141
Site01-Quanteon,1,Site01,Quanteon,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.7,200.2066,321.2458087,139398.0,75206.0,1238769.836
Site01-Quanteon,1,Site01,Quanteon,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.8,205.811,322.5055962,138905.0,75663.0,1234397.613
Site01-Quanteon,1,Site01,Quanteon,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.6,162.12,358.3100826,171979.0,85087.0,1528314.079
Site01-Quanteon,1,Site01,Quanteon,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.7,100.6336,161.4738135,401000.0,364463.0,8090350.877
Site01-Quanteon,1,Site01,Quanteon,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.9,104.457,163.6839669,393042.0,363706.0,7929794.737
Site01-Quanteon,1,Site01,Quanteon,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.7,78.47,173.4307438,554000.0,388495.0,11177192.98
Site01-Quanteon,1,Site01,Quanteon,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.6,1145.936159,1888.377237,47805.0,12286.0,7508638.743
Site01-Quanteon,1,Site01,Quanteon,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site01-Quanteon,1,Site01,Quanteon,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,188.055,420.7860933,51079.0,27021.0,8022879.581
Site01-Quanteon,1,Site01,Quanteon,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,295.37,445.1953623,51307.0,26291.0,8058691.099
Site01-Quanteon,1,Site01,Quanteon,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,76.6,18.24,26.74285714,157481.0,32913.0,97039.51446
Site01-Quanteon,1,Site01,Quanteon,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.7,46.26,67.7075188,111554.0,20818.0,68739.37806
Site01-Quanteon,1,Site01,Quanteon,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,78.2,45.24,67.38485041,91317.0,17482.0,56269.37435
Site01-Quanteon,1,Site01,Quanteon,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.3,15.64,22.93082707,92353.0,7779.0,56907.75572
Site01-Quanteon,1,Site01,Quanteon,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.5,32.61,47.8556391,70921.0,7876.0,43701.39512
Site01-Quanteon,1,Site01,Quanteon,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.9,31.32,46.65105029,59879.0,6411.0,36342.75578
Site01-Quanteon,1,Site01,Quanteon,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.2,77.84,114.1263158,346163.0,115583.0,266294.5714
Site01-Quanteon,1,Site01,Quanteon,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.1,155.26,227.1676692,317367.0,102902.0,244142.526
Site01-Quanteon,1,Site01,Quanteon,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.1,160.4,238.9153405,298425.0,98912.0,229570.9173
Site01-Quanteon,1,Site01,Quanteon,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.3,49.24,84.70377269,471000.0,62254.0,26130821.92
Site01-Quanteon,1,Site01,Quanteon,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.9,100.65,147.5109023,222323.0,31095.0,12334358.22
Site01-Quanteon,1,Site01,Quanteon,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.3,101.49,151.1690643,209377.0,29388.0,11616121.23
Site01-Quanteon,1,Site01,Quanteon,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,135.42,198.5481203,49382.0,25663.0,7756335.079
Site01-Quanteon,1,Site01,Quanteon,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,284.28,416.5815789,45078.0,22939.0,7080314.136
Site01-Quanteon,1,Site01,Quanteon,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,285.95,425.9217059,43736.0,21992.0,6869528.796
Site01-Quanteon,1,Site01,Quanteon,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.1,24.99,36.63947368,489000.0,33787.0,4345563.032
Site01-Quanteon,1,Site01,Quanteon,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.4,48.93,71.43157895,353302.0,27130.0,3139664.847
Site01-Quanteon,1,Site01,Quanteon,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.1,49.81,74.19185232,337129.0,25994.0,2995941.348
Site01-Quanteon,1,Site01,Quanteon,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,26.6,28.95,42.44548872,10540.0,3863.0,212649.1228
Site01-Quanteon,1,Site01,Quanteon,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,28.5,63.9,93.73195489,14768.0,5101.0,1430862.281
Site01-Quanteon,1,Site01,Quanteon,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,27.2,61.23,91.20190961,10880.0,3987.0,219508.7719
Site01-Quanteon,1,Site01,Quanteon,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.9,19.26,28.23834586,157336.0,33042.0,96950.16572
Site01-Quanteon,1,Site01,Quanteon,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.7,45.23,66.31466165,111627.0,20695.0,68784.36053
Site01-Quanteon,1,Site01,Quanteon,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.8,44.53,65.28834586,91365.0,17318.0,56298.95186
Site01-Quanteon,1,Site01,Quanteon,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.8,16.5,24.19172932,92487.0,8259.0,56990.32629
Site01-Quanteon,1,Site01,Quanteon,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.9,32.9,48.23684211,70838.0,7911.0,43650.25067
Site01-Quanteon,1,Site01,Quanteon,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.4,31.86,46.71203008,59918.0,6480.0,36921.36593
Site01-Quanteon,1,Site01,Quanteon,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.6,77.52,113.6571429,367024.0,115605.0,282342.4189
Site01-Quanteon,1,Site01,Quanteon,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,68.3,150.62,220.8338346,326711.0,101674.0,251330.6324
Site01-Quanteon,1,Site01,Quanteon,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.9,156.62,182.8737933,310248.0,96513.0,238666.0567
Site01-Quanteon,1,Site01,Quanteon,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64,49.64,72.78045113,471000.0,63380.0,26130821.92
Site01-Quanteon,1,Site01,Quanteon,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,97.23,142.5552632,221486.0,29758.0,12287921.92
Site01-Quanteon,1,Site01,Quanteon,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65,101.83,149.2996241,208134.0,28780.0,11547160.27
Site01-Quanteon,1,Site01,Quanteon,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,137.42,201.4804511,49433.0,26893.0,7764345.55
Site01-Quanteon,1,Site01,Quanteon,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,276.69,405.6733083,45253.0,22118.0,7107801.047
Site01-Quanteon,1,Site01,Quanteon,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,277.48,406.8315789,43884.0,20982.0,6892774.869
Site01-Quanteon,1,Site01,Quanteon,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.3,26.58,38.97067669,489000.0,33992.0,4345563.032
Site01-Quanteon,1,Site01,Quanteon,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.4,51.78,75.91804511,353389.0,26798.0,3140437.984
Site01-Quanteon,1,Site01,Quanteon,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34,53.2,78,337709.0,25450.0,3001095.595
Site01-Quanteon,1,Site01,Quanteon,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,81.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,20,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,26.7,29.71,43.55977444,10656.0,3939.0,214989.4737
Site01-Quanteon,1,Site01,Quanteon,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,28.3,62.48,91.60601504,14855.0,4953.0,299706.1404
Site01-Quanteon,1,Site01,Quanteon,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,27.1,59.97,87.92593985,10958.0,3916.0,221082.4561
Site01-Quanteon,1,Site01,Quanteon,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.9,19.19,28.13571429,158234.0,33256.0,57069.19966
Site01-Quanteon,1,Site01,Quanteon,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.7,46.65,68.39661654,111785.0,20609.0,68881.71985
Site01-Quanteon,1,Site01,Quanteon,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.7,46.76,68.55789474,91304.0,17627.0,56261.36377
Site01-Quanteon,1,Site01,Quanteon,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.6,16.42,24.07443609,92615.0,8040.0,57069.19966
Site01-Quanteon,1,Site01,Quanteon,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.8,33.54,49.17518797,71209.0,8090.0,43878.86021
Site01-Quanteon,1,Site01,Quanteon,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,32.47,47.60639098,60091.0,6528.0,37027.96822
Site01-Quanteon,1,Site01,Quanteon,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.1,77.57,113.7304511,374497.0,110996.0,121725.4738
Site01-Quanteon,1,Site01,Quanteon,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,68.8,156.34,229.2203008,334345.0,98199.0,257203.2784
Site01-Quanteon,1,Site01,Quanteon,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,69.9,159.25,233.4868421,317296.0,93477.0,244087.9075
Site01-Quanteon,1,Site01,Quanteon,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.1,48.95,71.76879699,472000.0,34795.0,26186301.37
Site01-Quanteon,1,Site01,Quanteon,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.1,101.17,148.3319549,472000.0,62118.0,26186301.37
Site01-Quanteon,1,Site01,Quanteon,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.7,102.89,150.8537594,221220.0,31357.0,12273164.38
Site01-Quanteon,1,Site01,Quanteon,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,137.88,202.1548872,50761.0,27141.0,7972931.937
Site01-Quanteon,1,Site01,Quanteon,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,287.21,421.0973684,46097.0,23380.0,7240366.492
Site01-Quanteon,1,Site01,Quanteon,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,288.43,422.8860902,44538.0,22327.0,6995497.382
Site01-Quanteon,1,Site01,Quanteon,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,26.71,39.1612782,487000.0,34795.0,4327789.768
Site01-Quanteon,1,Site01,Quanteon,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.5,53.89,79.01165414,352335.0,27005.0,3131071.474
Site01-Quanteon,1,Site01,Quanteon,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34,54.18,79.43684211,335974.0,26385.0,298564.1742
Site01-Quanteon,1,Site01,Quanteon,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,81.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site01-Quanteon,1,Site01,Quanteon,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,27,30.32,44.45413534,11665.0,4180.0,235346.4912
Site01-Quanteon,1,Site01,Quanteon,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,28.5,64.79,94.99285714,15778.0,5318.0,318328.0702
Site01-Quanteon,1,Site01,Quanteon,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,27.1,61.69,90.44774436,11820.0,4081.0,238473.6842
Site02-Penteon,2,Site02,Penteon,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site02-Penteon,2,Site02,Penteon,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site02-Penteon,2,Site02,Penteon,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site02-Penteon,2,Site02,Penteon,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site02-Penteon,2,Site02,Penteon,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site02-Penteon,2,Site02,Penteon,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site02-Penteon,2,Site02,Penteon,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site02-Penteon,2,Site02,Penteon,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site02-Penteon,2,Site02,Penteon,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site02-Penteon,2,Site02,Penteon,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site02-Penteon,2,Site02,Penteon,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site02-Penteon,2,Site02,Penteon,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.7,,1599,123004.0,35606.0,68786.15309
Site03-Aurora,3,Site03,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,81.3,,1463,123274.0,36531.0,68937.14217
Site03-Aurora,3,Site03,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,80.7,,1446,122195.0,38132.0,68333.74506
Site03-Aurora,3,Site03,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.34,,373,43025.0,19351.0,24060.3902
Site03-Aurora,3,Site03,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.34,,374,43393.0,18527.0,24266.18273
Site03-Aurora,3,Site03,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.17,,372,42481.0,17874.0,23756.17516
Site03-Aurora,3,Site03,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.7,,4218,45701.0,18153.0,56098.49833
Site03-Aurora,3,Site03,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.7,,4220,46199.0,18255.0,56709.799
Site03-Aurora,3,Site03,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.8,,4333,46099.0,18234.0,56587.04786
Site03-Aurora,3,Site03,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.1,,2030,236156.0,55631.0,9601947.253
Site03-Aurora,3,Site03,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.2,,1990,236156.0,56066.0,9601947.253
Site03-Aurora,3,Site03,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,47.3,,2048,234672.0,55631.0,9541608.791
Site03-Aurora,3,Site03,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.7,,11134,51003.0,15748.0,3617820.997
Site03-Aurora,3,Site03,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.9,,11134,51003.0,15678.0,3617820.997
Site03-Aurora,3,Site03,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.5,,11134,50901.0,15644.0,3610585.781
Site03-Aurora,3,Site03,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,43.5,,1835,207653.0,140502.0,747592.7657
Site03-Aurora,3,Site03,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.2,,1864,208492.0,138213.0,750613.3353
Site03-Aurora,3,Site03,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44.4,,1926,210604.0,139164.0,758216.9621
Site03-Aurora,3,Site03,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,52.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,52.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,54.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.3,,959,68273.0,157242.0,858746.3281
Site03-Aurora,3,Site03,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.4,,964,71633.0,156936.0,901008.8281
Site03-Aurora,3,Site03,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.5,,993,66946.0,155211.0,842055.1563
Site03-Aurora,3,Site03,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.3,,1590,123004.0,35330.0,68786.15309
Site03-Aurora,3,Site03,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,80.9,,1455,123546.0,36255.0,69089.2497
Site03-Aurora,3,Site03,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,80.2,,1435,122195.0,38132.0,68333.74506
Site03-Aurora,3,Site03,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.24,,366,43025.0,19038.0,24060.3902
Site03-Aurora,3,Site03,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.29,,370,43301.0,18261.0,24214.7346
Site03-Aurora,3,Site03,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.07,,366,42661.0,17777.0,23856.83455
Site03-Aurora,3,Site03,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.7,,4211,45999.0,18234.0,56464.29672
Site03-Aurora,3,Site03,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.6,,4209,46399.0,18306.0,56955.30128
Site03-Aurora,3,Site03,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.8,,4326,46299.0,18284.0,56832.55014
Site03-Aurora,3,Site03,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.2,,2029,236653.0,55755.0,9622154.945
Site03-Aurora,3,Site03,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.2,,1987,236653.0,56004.0,9622154.945
Site03-Aurora,3,Site03,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,47.3,,2048,235660.0,55755.0,9581780.22
Site03-Aurora,3,Site03,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.8,,11111,51208.0,15852.0,3632362.364
Site03-Aurora,3,Site03,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.9,,11111,51208.0,15678.0,3632362.364
Site03-Aurora,3,Site03,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.6,,11111,51003.0,15713.0,3617820.997
Site03-Aurora,3,Site03,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,43.2,,1819,208912.0,140004.0,752125.4201
Site03-Aurora,3,Site03,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.9,,1848,208912.0,137664.0,752125.4201
Site03-Aurora,3,Site03,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44.1,,1909,211029.0,138561.0,759747.048
Site03-Aurora,3,Site03,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,52.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,52.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,54.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.3,,1590,68826.0,157405.0,865702.0313
Site03-Aurora,3,Site03,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.4,,1455,71993.0,155681.0,905536.9531
Site03-Aurora,3,Site03,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.6,,998,67658.0,155433.0,851010.7813
Site03-Aurora,3,Site03,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.8,,1593,123004.0,35330.0,68786.15309
Site03-Aurora,3,Site03,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,81.2,,1456,123274.0,36255.0,7423.070763
Site03-Aurora,3,Site03,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,80.5,,1437,122195.0,38132.0,68333.74506
Site03-Aurora,3,Site03,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.27,,369,43025.0,19064.0,24060.3902
Site03-Aurora,3,Site03,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.31,,371,43393.0,18330.0,24266.18273
Site03-Aurora,3,Site03,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.09,,367,42571.0,17710.0,23806.50486
Site03-Aurora,3,Site03,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72,,4230,45800.0,18193.0,56220.02195
Site03-Aurora,3,Site03,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.9,,4229,46299.0,18296.0,56832.55014
Site03-Aurora,3,Site03,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.1,,4346,46199.0,18275.0,56709.799
Site03-Aurora,3,Site03,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.2,,2038,236653.0,55755.0,9622154.945
Site03-Aurora,3,Site03,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.2,,1996,236653.0,56004.0,9622154.945
Site03-Aurora,3,Site03,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,47.3,,2056,235660.0,55755.0,9581780.22
Site03-Aurora,3,Site03,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.4,,11094,51208.0,15677.0,3632362.364
Site03-Aurora,3,Site03,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.4,,11094,51208.0,15538.0,3632362.364
Site03-Aurora,3,Site03,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.1,,11094,51003.0,15573.0,3617820.997
Site03-Aurora,3,Site03,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,43.1,,1823,208072.0,139545.0,749101.2504
Site03-Aurora,3,Site03,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.8,,1853,208492.0,137219.0,750613.3353
Site03-Aurora,3,Site03,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44,,1911,210604.0,137911.0,758216.9621
Site03-Aurora,3,Site03,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,53,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,53,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,54.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.4,,962,69048.0,159294.0,868494.375
Site03-Aurora,3,Site03,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.4,,966,72579.0,156667.0,912907.7344
Site03-Aurora,3,Site03,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.6,,998,67630.0,155769.0,850658.5938
Site03-Aurora,3,Site03,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,10982,,,
Site03-Aurora,3,Site03,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,11285,,,
Site03-Aurora,3,Site03,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93,,1584,92113.0,23124.0,51511.32418
Site03-Aurora,3,Site03,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.1,,1422,92517.0,23407.0,51737.24859
Site03-Aurora,3,Site03,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,91.9,,1413,91512.0,23094.0,51175.23366
Site03-Aurora,3,Site03,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.88,,218,42211.0,17207.0,23605.18608
Site03-Aurora,3,Site03,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.33,,203,43209.0,17061.0,24163.28647
Site03-Aurora,3,Site03,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.69,,206,42390.0,17722.0,23705.28625
Site03-Aurora,3,Site03,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,83.1,,3080,70378.0,27085.0,86389.79706
Site03-Aurora,3,Site03,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,83.7,,3192,70998.0,27685.0,87150.85412
Site03-Aurora,3,Site03,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,83.1,,3006,70688.0,27388.0,86770.32559
Site03-Aurora,3,Site03,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.6,,2206,258006.0,55357.0,10490353.85
Site03-Aurora,3,Site03,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72,,2299,259647.0,56503.0,10557075.82
Site03-Aurora,3,Site03,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.7,,2155,258006.0,55696.0,10490353.85
Site03-Aurora,3,Site03,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.4,,6796,52249.0,12471.0,3706204.131
Site03-Aurora,3,Site03,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.1,,6796,52144.0,12431.0,3698756.114
Site03-Aurora,3,Site03,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.3,,6796,51934.0,12402.0,3683860.08
Site03-Aurora,3,Site03,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.5,,816,300064.0,104793.0,1080291.042
Site03-Aurora,3,Site03,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.2,,838,305086.0,104681.0,1098371.256
Site03-Aurora,3,Site03,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.6,,799,299442.0,105428.0,1078051.716
Site03-Aurora,3,Site03,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,56.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.86,,328,233095.0,296736.0,2931898.047
Site03-Aurora,3,Site03,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.75,,334,237815.0,307163.0,2991266.797
Site03-Aurora,3,Site03,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.83,,319,220964.0,310615.0,2779312.813
Site03-Aurora,3,Site03,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.8,,1570,92113.0,22996.0,51511.32418
Site03-Aurora,3,Site03,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.8,,1408,92517.0,23407.0,51737.24859
Site03-Aurora,3,Site03,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,91.6,,1398,91512.0,23018.0,51175.23366
Site03-Aurora,3,Site03,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.84,,216,42390.0,17121.0,130863.3579
Site03-Aurora,3,Site03,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.29,,202,43393.0,17186.0,24266.18273
Site03-Aurora,3,Site03,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.62,,203,42301.0,17323.0,23655.51577
Site03-Aurora,3,Site03,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,83.1,,3078,70688.0,27095.0,86770.32559
Site03-Aurora,3,Site03,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,83.7,,3189,71154.0,27584.0,87342.3459
Site03-Aurora,3,Site03,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,83.1,,3004,70843.0,27287.0,86960.58985
Site03-Aurora,3,Site03,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.6,,2206,258552.0,55264.0,10512553.85
Site03-Aurora,3,Site03,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72,,2297,260746.0,56412.0,10601760.44
Site03-Aurora,3,Site03,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.7,,2154,258552.0,56161.0,10512553.85
Site03-Aurora,3,Site03,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.5,,6776,52460.0,12459.0,3721171.098
Site03-Aurora,3,Site03,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.1,,6776,52354.0,12526.0,3713652.148
Site03-Aurora,3,Site03,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.4,,6776,52039.0,12457.0,3691308.097
Site03-Aurora,3,Site03,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.5,,815,298822.0,104220.0,1075819.591
Site03-Aurora,3,Site03,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.3,,837,303822.0,104624.0,1093820.601
Site03-Aurora,3,Site03,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.6,,798,298822.0,105367.0,1075819.591
Site03-Aurora,3,Site03,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,56.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.85,,328,234011.0,296622.0,2943419.609
Site03-Aurora,3,Site03,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.78,,335,237138.0,306782.0,2982751.406
Site03-Aurora,3,Site03,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.86,,320,221424.0,309642.0,2785098.75
Site03-Aurora,3,Site03,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93,,1578,91913.0,22996.0,51399.48042
Site03-Aurora,3,Site03,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.1,,1416,92517.0,23278.0,51737.24859
Site03-Aurora,3,Site03,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,91.9,,1406,91512.0,23018.0,51175.23366
Site03-Aurora,3,Site03,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.84,,217,42390.0,16939.0,23705.28625
Site03-Aurora,3,Site03,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.32,,203,43301.0,17090.0,24214.7346
Site03-Aurora,3,Site03,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.65,,204,42211.0,17351.0,23605.18608
Site03-Aurora,3,Site03,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,83.3,,3088,70533.0,27146.0,86580.06132
Site03-Aurora,3,Site03,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,83.9,,3198,70998.0,27635.0,87150.85412
Site03-Aurora,3,Site03,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,83.3,,3014,70688.0,27338.0,86770.32559
Site03-Aurora,3,Site03,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.7,,2213,258552.0,55264.0,10512553.85
Site03-Aurora,3,Site03,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72,,2304,260746.0,56412.0,10601760.44
Site03-Aurora,3,Site03,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.7,,2162,258552.0,56161.0,10512553.85
Site03-Aurora,3,Site03,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95,,6776,52354.0,12419.0,3713652.148
Site03-Aurora,3,Site03,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94.8,,6776,52249.0,12419.0,3706204.131
Site03-Aurora,3,Site03,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95,,6776,52039.0,12390.0,3691308.097
Site03-Aurora,3,Site03,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.4,,817,297586.0,103931.0,1071369.741
Site03-Aurora,3,Site03,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.2,,839,303192.0,104567.0,1091552.474
Site03-Aurora,3,Site03,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.6,,801,297586.0,105072.0,1071369.741
Site03-Aurora,3,Site03,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,56.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.86,,329,234342.0,296223.0,2947582.969
Site03-Aurora,3,Site03,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.77,,334,240042.0,306372.0,3019278.281
Site03-Aurora,3,Site03,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.89,,322,220932.0,310756.0,2778910.313
Site03-Aurora,3,Site03,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,6880,,,
Site03-Aurora,3,Site03,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,6712,,,
Site03-Aurora,3,Site03,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.3,,1953,119803.0,33058.0,66996.09361
Site03-Aurora,3,Site03,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.2,,1883,119016.0,34064.0,66555.98839
Site03-Aurora,3,Site03,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.3,,1785,118234.0,33513.0,66118.67927
Site03-Aurora,3,Site03,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.96,,211,46452.0,18138.0,25976.83314
Site03-Aurora,3,Site03,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.08,,218,45666.0,19505.0,25537.28714
Site03-Aurora,3,Site03,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.81,,207,45764.0,19959.0,25592.09058
Site03-Aurora,3,Site03,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.2,,4493,61580.0,25479.0,75590.15179
Site03-Aurora,3,Site03,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,84.1,,4497,62393.0,25750.0,76588.11855
Site03-Aurora,3,Site03,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,84.4,,4583,62120.0,25651.0,76253.00794
Site03-Aurora,3,Site03,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61,,2741,259647.0,59561.0,10557075.82
Site03-Aurora,3,Site03,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,61.3,,2755,260196.0,59561.0,10579397.8
Site03-Aurora,3,Site03,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.7,,2827,259647.0,58801.0,10557075.82
Site03-Aurora,3,Site03,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95,,10127,53528.0,14642.0,3796928.07
Site03-Aurora,3,Site03,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.1,,10127,53853.0,14855.0,3819981.455
Site03-Aurora,3,Site03,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,94.7,,10127,53636.0,14752.0,3804588.887
Site03-Aurora,3,Site03,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.4,,1500,219289.0,171868.0,789484.7173
Site03-Aurora,3,Site03,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.3,,1497,224232.0,172573.0,807280.5163
Site03-Aurora,3,Site03,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.7,,1498,226518.0,172712.0,815510.5782
Site03-Aurora,3,Site03,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,52.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,52.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.13,,487,108951.0,305850.0,1370399.297
Site03-Aurora,3,Site03,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.1,,487,101087.0,269202.0,1271484.922
Site03-Aurora,3,Site03,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.2,,500,104482.0,275816.0,1314187.656
Site03-Aurora,3,Site03,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91,,1939,119803.0,32788.0,66996.09361
Site03-Aurora,3,Site03,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.9,,1865,119016.0,33891.0,66555.98839
Site03-Aurora,3,Site03,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90,,1772,118234.0,33513.0,66118.67927
Site03-Aurora,3,Site03,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.86,,206,46650.0,17934.0,26087.55847
Site03-Aurora,3,Site03,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.03,,216,45764.0,19492.0,25592.09058
Site03-Aurora,3,Site03,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.77,,205,45764.0,19770.0,25592.09058
Site03-Aurora,3,Site03,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.2,,4489,61849.0,25495.0,75920.35236
Site03-Aurora,3,Site03,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,84.1,,4495,62529.0,25766.0,76755.0601
Site03-Aurora,3,Site03,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,84.4,,4579,62256.0,25625.0,76419.94949
Site03-Aurora,3,Site03,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.1,,2741,260746.0,59484.0,10601760.44
Site03-Aurora,3,Site03,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,61.3,,2756,260746.0,59484.0,10601760.44
Site03-Aurora,3,Site03,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.7,,2826,260196.0,59064.0,10579397.8
Site03-Aurora,3,Site03,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.1,,1018,53744.0,14745.0,3812249.704
Site03-Aurora,3,Site03,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.2,,10108,54071.0,14960.0,3835444.957
Site03-Aurora,3,Site03,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,94.7,,10108,53744.0,14855.0,3812249.704
Site03-Aurora,3,Site03,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.2,,1492,218846.0,171777.0,787889.8278
Site03-Aurora,3,Site03,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.2,,1490,223324.0,172248.0,804011.5327
Site03-Aurora,3,Site03,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.6,,1493,226518.0,172666.0,815510.5782
Site03-Aurora,3,Site03,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,52.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,52.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.18,,490,108524.0,301567.0,1365028.438
Site03-Aurora,3,Site03,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.15,,489,101897.0,268360.0,1281673.203
Site03-Aurora,3,Site03,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.24,,502,105271.0,273111.0,1324111.797
Site03-Aurora,3,Site03,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.5,,1947,119803.0,32788.0,66996.09361
Site03-Aurora,3,Site03,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.3,,1875,119016.0,33891.0,66555.98839
Site03-Aurora,3,Site03,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.4,,1781,118234.0,33513.0,66118.67927
Site03-Aurora,3,Site03,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.88,,208,46551.0,18076.0,26032.1958
Site03-Aurora,3,Site03,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.05,,205,45666.0,19448.0,25537.28714
Site03-Aurora,3,Site03,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.78,,206,45666.0,19726.0,25537.28714
Site03-Aurora,3,Site03,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.2,,4507,61714.0,25536.0,75754.63832
Site03-Aurora,3,Site03,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,84.2,,4511,62393.0,25808.0,76588.11855
Site03-Aurora,3,Site03,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,84.4,,4597,62256.0,25609.0,76419.94949
Site03-Aurora,3,Site03,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.1,,2753,260746.0,59484.0,10601760.44
Site03-Aurora,3,Site03,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,61.3,,2766,260746.0,59826.0,10601760.44
Site03-Aurora,3,Site03,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.7,,2838,260196.0,59064.0,10579397.8
Site03-Aurora,3,Site03,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,94.7,,10107,53636.0,14635.0,3804588.887
Site03-Aurora,3,Site03,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94.8,,10107,53962.0,14810.0,3827713.206
Site03-Aurora,3,Site03,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,94.3,,10107,53744.0,14745.0,3812249.704
Site03-Aurora,3,Site03,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.2,,1498,217522.0,171866.0,783123.1602
Site03-Aurora,3,Site03,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.1,,1493,222421.0,172072.0,800760.5503
Site03-Aurora,3,Site03,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.5,,1496,225601.0,172148.0,812209.1929
Site03-Aurora,3,Site03,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,52.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,53,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.19,,492,110578.0,304649.0,1390863.906
Site03-Aurora,3,Site03,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.2,,502,102874.0,268965.0,1293962.031
Site03-Aurora,3,Site03,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.28,,505,105751.0,275593.0,1330149.297
Site03-Aurora,3,Site03,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,10754,,,
Site03-Aurora,3,Site03,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,9499,,,
Site03-Aurora,3,Site03,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,2404,,,
Site03-Aurora,3,Site03,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-Aurora,3,Site03,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.7,,368,49103.0,9833.0,27459.32226
Site03-Aurora,3,Site03,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.5,,292,47150.0,4650.0,26367.16788
Site03-Aurora,3,Site03,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.2,,1319,134344.0,45222.0,164908.791
Site03-Aurora,3,Site03,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.7,,840,438000.0,80689.0,17808791.21
Site03-Aurora,3,Site03,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,2404,60948.0,29162.0,4323254.596
Site03-Aurora,3,Site03,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-Aurora,3,Site03,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-Aurora,3,Site03,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.8,,473,780000.0,55137.0,2808157.634
Site03-Aurora,3,Site03,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.4,,252,2848.0,2263.0,35822.5
Site03-Aurora,3,Site03,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.7,,368,49103.0,9855.0,27459.32226
Site03-Aurora,3,Site03,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,291,47352.0,4580.0,26480.13009
Site03-Aurora,3,Site03,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.3,,1323,134344.0,45083.0,164908.791
Site03-Aurora,3,Site03,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.7,,843,439000.0,80870.0,17849450.55
Site03-Aurora,3,Site03,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,2402,61322.0,28770.0,4349783.722
Site03-Aurora,3,Site03,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-Aurora,3,Site03,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-Aurora,3,Site03,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.9,,475,780000.0,55137.0,2808157.634
Site03-Aurora,3,Site03,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,5.09,,96,6319.0,4541.0,79481.17188
Site03-Aurora,3,Site03,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.7,,369,49103.0,9789.0,27459.32226
Site03-Aurora,3,Site03,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,291,47251.0,4570.0,26423.64898
Site03-Aurora,3,Site03,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.3,,1325,134344.0,45062.0,164908.791
Site03-Aurora,3,Site03,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.7,,845,439000.0,80870.0,17849450.55
Site03-Aurora,3,Site03,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,2407,61072.0,28770.0,4332050.349
Site03-Aurora,3,Site03,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-Aurora,3,Site03,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-Aurora,3,Site03,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.9,,475,778000.0,55014.0,2800957.23
Site03-Aurora,3,Site03,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-Aurora,3,Site03,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-Aurora,3,Site03,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,10.4,,195,3370.0,2677.0,42388.28125
Site03-Aurora,3,Site03,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-Aurora,3,Site03,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.6,,1612,10995.0,3276.0,92417.57793
Site03-SymphonyA3,4,Site03,SymphonyA3,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85.2,,1606,10864.0,3357.0,91316.46809
Site03-SymphonyA3,4,Site03,SymphonyA3,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.4,,1525,10839.0,3320.0,91106.33263
Site03-SymphonyA3,4,Site03,SymphonyA3,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.78,,531,3440.0,1302.0,28914.64012
Site03-SymphonyA3,4,Site03,SymphonyA3,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.28,,498,3424.0,1301.0,28780.15342
Site03-SymphonyA3,4,Site03,SymphonyA3,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.6,,524,3371.0,1295.0,28334.66623
Site03-SymphonyA3,4,Site03,SymphonyA3,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,69.8,,4219,14891.0,5734.0,73173.65516
Site03-SymphonyA3,4,Site03,SymphonyA3,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.2,,4222,14788.0,5770.0,72667.51813
Site03-SymphonyA3,4,Site03,SymphonyA3,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.9,,4262,14926.0,5751.0,73345.64347
Site03-SymphonyA3,4,Site03,SymphonyA3,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,46.4,,1957,18941.0,4302.0,11054283.36
Site03-SymphonyA3,4,Site03,SymphonyA3,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.2,,1993,18941.0,4229.0,11054283.36
Site03-SymphonyA3,4,Site03,SymphonyA3,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.3,,1971,19075.0,4397.0,11132487.99
Site03-SymphonyA3,4,Site03,SymphonyA3,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.1,,9384,9034.0,2595.0,73173.65516
Site03-SymphonyA3,4,Site03,SymphonyA3,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.3,,9384,9034.0,2561.0,3956496.35
Site03-SymphonyA3,4,Site03,SymphonyA3,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95,,9384,9014.0,2561.0,3947737.226
Site03-SymphonyA3,4,Site03,SymphonyA3,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,45.3,,1910,8099.0,4758.0,1069204.571
Site03-SymphonyA3,4,Site03,SymphonyA3,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.7,,1888,7974.0,4706.0,1052702.463
Site03-SymphonyA3,4,Site03,SymphonyA3,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,45.5,,1939,8171.0,4679.0,1078709.785
Site03-SymphonyA3,4,Site03,SymphonyA3,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.1,,1157,13273.0,13741.0,4471642.01
Site03-SymphonyA3,4,Site03,SymphonyA3,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19,,1145,12729.0,14158.0,4288369.709
Site03-SymphonyA3,4,Site03,SymphonyA3,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19,,1161,12636.0,13887.0,4257038.231
Site03-SymphonyA3,4,Site03,SymphonyA3,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.6,,1613,11070.0,3290.0,93047.98433
Site03-SymphonyA3,4,Site03,SymphonyA3,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85.4,,1608,10945.0,3376.0,91997.307
Site03-SymphonyA3,4,Site03,SymphonyA3,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.6,,1527,10920.0,3342.0,91787.17154
Site03-SymphonyA3,4,Site03,SymphonyA3,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.77,,529,3504.0,1299.0,29452.58691
Site03-SymphonyA3,4,Site03,SymphonyA3,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.28,,497,3483.0,1297.0,29276.07312
Site03-SymphonyA3,4,Site03,SymphonyA3,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.59,,523,3434.0,1291.0,28864.20761
Site03-SymphonyA3,4,Site03,SymphonyA3,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,69.8,,4212,14961.0,5737.0,73517.63178
Site03-SymphonyA3,4,Site03,SymphonyA3,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.2,,4219,14857.0,5773.0,73006.5808
Site03-SymphonyA3,4,Site03,SymphonyA3,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.9,,4256,14995.0,5754.0,73684.70614
Site03-SymphonyA3,4,Site03,SymphonyA3,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,46.4,,1955,19075.0,4334.0,11132487.99
Site03-SymphonyA3,4,Site03,SymphonyA3,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.2,,1990,19031.0,4261.0,11106808.86
Site03-SymphonyA3,4,Site03,SymphonyA3,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.3,,1969,19165.0,4401.0,11185013.5
Site03-SymphonyA3,4,Site03,SymphonyA3,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.1,,9378,9095.0,2621.0,3983211.679
Site03-SymphonyA3,4,Site03,SymphonyA3,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.3,,9378,9095.0,2587.0,3983211.679
Site03-SymphonyA3,4,Site03,SymphonyA3,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.1,,9378,9074.0,2601.0,3974014.599
Site03-SymphonyA3,4,Site03,SymphonyA3,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44.9,,1890,8063.0,4694.0,1064451.964
Site03-SymphonyA3,4,Site03,SymphonyA3,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.3,,1868,7939.0,4658.0,1048081.873
Site03-SymphonyA3,4,Site03,SymphonyA3,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,45.2,,1923,8117.0,4635.0,1071580.874
Site03-SymphonyA3,4,Site03,SymphonyA3,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.1,,1154,13281.0,13758.0,4474337.191
Site03-SymphonyA3,4,Site03,SymphonyA3,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19,,1141,12806.0,14131.0,4314310.825
Site03-SymphonyA3,4,Site03,SymphonyA3,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19,,1158,12682.0,13896.0,4272535.521
Site03-SymphonyA3,4,Site03,SymphonyA3,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.8,,1607,11070.0,3273.0,93047.98433
Site03-SymphonyA3,4,Site03,SymphonyA3,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85.5,,1600,10920.0,3367.0,91787.17154
Site03-SymphonyA3,4,Site03,SymphonyA3,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.6,,1522,10895.0,3316.0,91577.03607
Site03-SymphonyA3,4,Site03,SymphonyA3,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.78,,527,3497.0,1297.0,29393.74898
Site03-SymphonyA3,4,Site03,SymphonyA3,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.28,,494,3483.0,1297.0,29276.07312
Site03-SymphonyA3,4,Site03,SymphonyA3,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.62,,521,3427.0,1289.0,28805.36968
Site03-SymphonyA3,4,Site03,SymphonyA3,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.3,,4223,14899.0,5738.0,73212.96677
Site03-SymphonyA3,4,Site03,SymphonyA3,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.8,,4230,14828.0,5763.0,72864.0762
Site03-SymphonyA3,4,Site03,SymphonyA3,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,70.5,,4265,14971.0,5755.0,73566.7713
Site03-SymphonyA3,4,Site03,SymphonyA3,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,46.4,,1959,18941.0,4319.0,11054283.36
Site03-SymphonyA3,4,Site03,SymphonyA3,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.2,,1996,18897.0,4229.0,11028604.23
Site03-SymphonyA3,4,Site03,SymphonyA3,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.3,,1973,19031.0,4386.0,11106808.86
Site03-SymphonyA3,4,Site03,SymphonyA3,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,94,,9277,9156.0,2597.0,4009927.007
Site03-SymphonyA3,4,Site03,SymphonyA3,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94.1,,9277,9156.0,2563.0,4009927.007
Site03-SymphonyA3,4,Site03,SymphonyA3,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,94,,9277,9136.0,2563.0,4001167.883
Site03-SymphonyA3,4,Site03,SymphonyA3,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44.9,,1895,8045.0,4701.0,1062075.66
Site03-SymphonyA3,4,Site03,SymphonyA3,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.3,,1875,7921.0,4665.0,1045705.569
Site03-SymphonyA3,4,Site03,SymphonyA3,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,45.2,,1927,8117.0,4632.0,1071580.874
Site03-SymphonyA3,4,Site03,SymphonyA3,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.1,,1145,13510.0,13776.0,4551486.744
Site03-SymphonyA3,4,Site03,SymphonyA3,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19,,1133,13032.0,14145.0,4390449.685
Site03-SymphonyA3,4,Site03,SymphonyA3,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19,,1151,12815.0,13925.0,4317342.903
Site03-SymphonyA3,4,Site03,SymphonyA3,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,9521,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,9248,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.8,,2527,8387.0,2137.0,70496.24612
Site03-SymphonyA3,4,Site03,SymphonyA3,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.9,,2455,8387.0,2119.0,70496.24612
Site03-SymphonyA3,4,Site03,SymphonyA3,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.2,,2327,8289.0,2163.0,69672.5151
Site03-SymphonyA3,4,Site03,SymphonyA3,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.05,,437,3440.0,1214.0,28914.64012
Site03-SymphonyA3,4,Site03,SymphonyA3,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.81,,426,3371.0,1185.0,28334.66623
Site03-SymphonyA3,4,Site03,SymphonyA3,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.13,,446,3349.0,1218.0,28149.74702
Site03-SymphonyA3,4,Site03,SymphonyA3,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.3,,4306,21820.0,8224.0,107222.4267
Site03-SymphonyA3,4,Site03,SymphonyA3,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,80.1,,4368,21975.0,8234.0,107984.0892
Site03-SymphonyA3,4,Site03,SymphonyA3,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,79.7,,4378,22079.0,8333.0,108495.1402
Site03-SymphonyA3,4,Site03,SymphonyA3,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.3,,3070,19995.0,4246.0,11669415.33
Site03-SymphonyA3,4,Site03,SymphonyA3,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.1,,3104,,4197.0,5833248.624
Site03-SymphonyA3,4,Site03,SymphonyA3,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.6,,3133,19995.0,4216.0,11669415.33
Site03-SymphonyA3,4,Site03,SymphonyA3,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,93.7,,9034,9074.0,2208.0,3974014.599
Site03-SymphonyA3,4,Site03,SymphonyA3,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,93.9,,9034,9074.0,2172.0,3974014.599
Site03-SymphonyA3,4,Site03,SymphonyA3,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,93.7,,9034,9054.0,2154.0,3965255.474
Site03-SymphonyA3,4,Site03,SymphonyA3,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27,,1164,10156.0,3423.0,1340763.257
Site03-SymphonyA3,4,Site03,SymphonyA3,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.1,,1185,10248.0,3345.0,1352908.809
Site03-SymphonyA3,4,Site03,SymphonyA3,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.8,,1174,10248.0,3338.0,1352908.809
Site03-SymphonyA3,4,Site03,SymphonyA3,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.9,,593,24228.0,22328.0,8162355.354
Site03-SymphonyA3,4,Site03,SymphonyA3,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.5,,573,23637.0,21381.0,7963248.865
Site03-SymphonyA3,4,Site03,SymphonyA3,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.5,,579,24109.0,22102.0,8122264.538
Site03-SymphonyA3,4,Site03,SymphonyA3,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.9,,2532,8505.0,2151.0,71488.08552
Site03-SymphonyA3,4,Site03,SymphonyA3,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,93.1,,2460,8486.0,2133.0,71328.38257
Site03-SymphonyA3,4,Site03,SymphonyA3,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.3,,2331,8392.0,2175.0,70538.27322
Site03-SymphonyA3,4,Site03,SymphonyA3,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.02,,434,3511.0,1214.0,29511.42484
Site03-SymphonyA3,4,Site03,SymphonyA3,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.78,,424,3448.0,1196.0,28981.88347
Site03-SymphonyA3,4,Site03,SymphonyA3,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.12,,445,3434.0,1225.0,28864.20761
Site03-SymphonyA3,4,Site03,SymphonyA3,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.3,,4298,21871.0,8191.0,107473.0382
Site03-SymphonyA3,4,Site03,SymphonyA3,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,80.1,,4359,22027.0,8238.0,108239.6147
Site03-SymphonyA3,4,Site03,SymphonyA3,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,79.7,,4370,22132.0,8337.0,108755.5796
Site03-SymphonyA3,4,Site03,SymphonyA3,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.3,,3064,20137.0,4267.0,11752288.9
Site03-SymphonyA3,4,Site03,SymphonyA3,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.1,,3099,20089.0,4218.0,11724275.3
Site03-SymphonyA3,4,Site03,SymphonyA3,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.6,,3128,20089.0,4237.0,11724275.3
Site03-SymphonyA3,4,Site03,SymphonyA3,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,93.7,,9030,9136.0,2211.0,4001167.883
Site03-SymphonyA3,4,Site03,SymphonyA3,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,93.9,,9030,9136.0,2183.0,4001167.883
Site03-SymphonyA3,4,Site03,SymphonyA3,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,93.8,,9030,9115.0,2177.0,3991970.803
Site03-SymphonyA3,4,Site03,SymphonyA3,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27,,1160,10064.0,3397.0,1328617.706
Site03-SymphonyA3,4,Site03,SymphonyA3,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.1,,1182,10156.0,3335.0,1340763.257
Site03-SymphonyA3,4,Site03,SymphonyA3,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.8,,1170,10156.0,3321.0,1340763.257
Site03-SymphonyA3,4,Site03,SymphonyA3,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.9,,591,24233.0,22330.0,8164039.842
Site03-SymphonyA3,4,Site03,SymphonyA3,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.5,,572,23645.0,21400.0,7965944.046
Site03-SymphonyA3,4,Site03,SymphonyA3,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.5,,578,24174.0,22043.0,8144162.883
Site03-SymphonyA3,4,Site03,SymphonyA3,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93.1,,2518,8467.0,2133.0,71168.67961
Site03-SymphonyA3,4,Site03,SymphonyA3,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,93.1,,2449,8448.0,2128.0,71008.97666
Site03-SymphonyA3,4,Site03,SymphonyA3,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.5,,2323,8373.0,2164.0,70378.57026
Site03-SymphonyA3,4,Site03,SymphonyA3,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.02,,432,3511.0,1204.0,29511.42484
Site03-SymphonyA3,4,Site03,SymphonyA3,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.78,,421,3448.0,1194.0,28981.88347
Site03-SymphonyA3,4,Site03,SymphonyA3,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.16,,445,3420.0,1222.0,28746.53174
Site03-SymphonyA3,4,Site03,SymphonyA3,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.9,,4309,21851.0,8191.0,107374.7592
Site03-SymphonyA3,4,Site03,SymphonyA3,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,80.7,,4370,22010.0,8255.0,108156.0775
Site03-SymphonyA3,4,Site03,SymphonyA3,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.3,,4380,22117.0,8338.0,108681.8703
Site03-SymphonyA3,4,Site03,SymphonyA3,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.3,,3701,19995.0,4235.0,11669415.33
Site03-SymphonyA3,4,Site03,SymphonyA3,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.1,,3106,19948.0,4187.0,11641985.35
Site03-SymphonyA3,4,Site03,SymphonyA3,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.6,,3135,19948.0,4206.0,11641985.35
Site03-SymphonyA3,4,Site03,SymphonyA3,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,92.8,,8937,9197.0,2204.0,4027883.212
Site03-SymphonyA3,4,Site03,SymphonyA3,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,92.9,,8937,9197.0,2167.0,4027883.212
Site03-SymphonyA3,4,Site03,SymphonyA3,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92.8,,8937,9177.0,2148.0,4019124.088
Site03-SymphonyA3,4,Site03,SymphonyA3,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27,,1164,10064.0,3389.0,1328617.706
Site03-SymphonyA3,4,Site03,SymphonyA3,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.1,,1186,10133.0,3327.0,1337726.869
Site03-SymphonyA3,4,Site03,SymphonyA3,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.8,,1173,10156.0,3328.0,1340763.257
Site03-SymphonyA3,4,Site03,SymphonyA3,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,61,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.9,,585,24690.0,22218.0,8318002.051
Site03-SymphonyA3,4,Site03,SymphonyA3,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.5,,566,23920.0,21232.0,8058590.889
Site03-SymphonyA3,4,Site03,SymphonyA3,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.5,,573,24391.0,21893.0,8217269.665
Site03-SymphonyA3,4,Site03,SymphonyA3,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,10860,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,7209,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.4,,2327,10864.0,3080.0,91316.46809
Site03-SymphonyA3,4,Site03,SymphonyA3,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.5,,2299,10839.0,3108.0,91106.33263
Site03-SymphonyA3,4,Site03,SymphonyA3,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.3,,2293,10761.0,3154.0,90450.70997
Site03-SymphonyA3,4,Site03,SymphonyA3,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.92,,495,3771.0,1346.0,31696.83369
Site03-SymphonyA3,4,Site03,SymphonyA3,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.71,,482,3831.0,1262.0,32201.15881
Site03-SymphonyA3,4,Site03,SymphonyA3,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.71,,484,3805.0,1309.0,31982.61792
Site03-SymphonyA3,4,Site03,SymphonyA3,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.2,,4949,19392.0,7637.0,95291.35188
Site03-SymphonyA3,4,Site03,SymphonyA3,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,80.1,,5007,19484.0,7717.0,95743.43544
Site03-SymphonyA3,4,Site03,SymphonyA3,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80,,5021,19438.0,7716.0,95517.39366
Site03-SymphonyA3,4,Site03,SymphonyA3,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61,,3018,20184.0,4289.0,11779718.88
Site03-SymphonyA3,4,Site03,SymphonyA3,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.5,,3029,20184.0,4347.0,11779718.88
Site03-SymphonyA3,4,Site03,SymphonyA3,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.7,,3046,19995.0,4220.0,11669415.33
Site03-SymphonyA3,4,Site03,SymphonyA3,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,93.4,,9930,9136.0,2477.0,4001167.883
Site03-SymphonyA3,4,Site03,SymphonyA3,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,93.2,,9930,9177.0,2495.0,4019124.088
Site03-SymphonyA3,4,Site03,SymphonyA3,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,93.4,,9930,9136.0,2503.0,4001167.883
Site03-SymphonyA3,4,Site03,SymphonyA3,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33,,1635,9301.0,5590.0,1227888.84
Site03-SymphonyA3,4,Site03,SymphonyA3,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.7,,1685,9239.0,5719.0,1219703.794
Site03-SymphonyA3,4,Site03,SymphonyA3,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.6,,1687,9197.0,5652.0,1214159.086
Site03-SymphonyA3,4,Site03,SymphonyA3,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,91.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,90.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,90.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,687,21840.0,22000.0,7357843.855
Site03-SymphonyA3,4,Site03,SymphonyA3,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.3,,647,21840.0,23078.0,7357843.855
Site03-SymphonyA3,4,Site03,SymphonyA3,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.4,,653,22497.0,22930.0,7579185.587
Site03-SymphonyA3,4,Site03,SymphonyA3,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.7,,2330,10970.0,3093.0,92207.44247
Site03-SymphonyA3,4,Site03,SymphonyA3,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.8,,2302,10945.0,3120.0,91997.307
Site03-SymphonyA3,4,Site03,SymphonyA3,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.6,,2295,10870.0,3173.0,91366.9006
Site03-SymphonyA3,4,Site03,SymphonyA3,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.88,,492,3847.0,1339.0,32335.6455
Site03-SymphonyA3,4,Site03,SymphonyA3,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.67,,479,3910.0,1266.0,32865.18688
Site03-SymphonyA3,4,Site03,SymphonyA3,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.67,,481,3894.0,1305.0,32730.70018
Site03-SymphonyA3,4,Site03,SymphonyA3,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.2,,4942,19438.0,7641.0,95517.39366
Site03-SymphonyA3,4,Site03,SymphonyA3,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,80.1,,4999,19576.0,7703.0,96195.519
Site03-SymphonyA3,4,Site03,SymphonyA3,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.1,,5014,19484.0,7721.0,95743.43544
Site03-SymphonyA3,4,Site03,SymphonyA3,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61,,3014,20280.0,4310.0,11835746.08
Site03-SymphonyA3,4,Site03,SymphonyA3,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.5,,3025,20327.0,4369.0,11863176.07
Site03-SymphonyA3,4,Site03,SymphonyA3,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.7,,3041,20089.0,4223.0,11724275.3
Site03-SymphonyA3,4,Site03,SymphonyA3,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,93.4,,9917,9197.0,2495.0,4027883.212
Site03-SymphonyA3,4,Site03,SymphonyA3,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,93.2,,9917,9218.0,2521.0,4037080.292
Site03-SymphonyA3,4,Site03,SymphonyA3,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,93.4,,9917,9197.0,2529.0,4027883.212
Site03-SymphonyA3,4,Site03,SymphonyA3,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.8,,1623,9239.0,5526.0,1219703.794
Site03-SymphonyA3,4,Site03,SymphonyA3,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.4,,1670,9177.0,5673.0,1211518.749
Site03-SymphonyA3,4,Site03,SymphonyA3,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.4,,1675,9115.0,5624.0,1203333.703
Site03-SymphonyA3,4,Site03,SymphonyA3,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,686,21860.0,21988.0,7364581.808
Site03-SymphonyA3,4,Site03,SymphonyA3,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.4,,646,21860.0,23067.0,7364581.808
Site03-SymphonyA3,4,Site03,SymphonyA3,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.4,,653,22458.0,22979.0,7566046.58
Site03-SymphonyA3,4,Site03,SymphonyA3,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.7,,2316,10945.0,3068.0,91997.307
Site03-SymphonyA3,4,Site03,SymphonyA3,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.9,,2290,10920.0,3104.0,91787.17154
Site03-SymphonyA3,4,Site03,SymphonyA3,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.7,,2280,10846.0,3148.0,91165.17056
Site03-SymphonyA3,4,Site03,SymphonyA3,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.87,,488,3839.0,1336.0,32268.40215
Site03-SymphonyA3,4,Site03,SymphonyA3,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.67,,475,3910.0,1255.0,32865.18688
Site03-SymphonyA3,4,Site03,SymphonyA3,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.69,,478,3886.0,1299.0,32663.45683
Site03-SymphonyA3,4,Site03,SymphonyA3,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.7,,4940,19410.0,7637.0,95379.80301
Site03-SymphonyA3,4,Site03,SymphonyA3,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,80.8,,5005,19504.0,7698.0,95841.71447
Site03-SymphonyA3,4,Site03,SymphonyA3,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.6,,5017,19457.0,7719.0,95610.75874
Site03-SymphonyA3,4,Site03,SymphonyA3,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61,,3015,20137.0,4278.0,11752288.9
Site03-SymphonyA3,4,Site03,SymphonyA3,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.5,,3030,20137.0,4366.0,11752288.9
Site03-SymphonyA3,4,Site03,SymphonyA3,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.7,,3047,19948.0,4210.0,11641985.35
Site03-SymphonyA3,4,Site03,SymphonyA3,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,92.2,,9790,9280.0,2468.0,4064233.577
Site03-SymphonyA3,4,Site03,SymphonyA3,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,92,,9790,9301.0,2480.0,4073430.657
Site03-SymphonyA3,4,Site03,SymphonyA3,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92.2,,9790,9280.0,2502.0,4064233.577
Site03-SymphonyA3,4,Site03,SymphonyA3,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.9,,1624,9218.0,5541.0,1216931.44
Site03-SymphonyA3,4,Site03,SymphonyA3,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.4,,1673,9136.0,5658.0,1206106.057
Site03-SymphonyA3,4,Site03,SymphonyA3,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.4,,1677,9095.0,5615.0,1200693.366
Site03-SymphonyA3,4,Site03,SymphonyA3,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,63.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,680,22074.0,21949.0,7436677.897
Site03-SymphonyA3,4,Site03,SymphonyA3,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.4,,643,22021.0,23000.0,7418822.323
Site03-SymphonyA3,4,Site03,SymphonyA3,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.4,,649,22618.0,22918.0,7619950.198
Site03-SymphonyA3,4,Site03,SymphonyA3,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,10024,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,9248,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1922,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.9,,246,4572.0,960.0,38429.57402
Site03-SymphonyA3,4,Site03,SymphonyA3,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,16,,247,3432.0,369.0,28847.39677
Site03-SymphonyA3,4,Site03,SymphonyA3,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70,,1076,42960.0,14417.0,211103.3662
Site03-SymphonyA3,4,Site03,SymphonyA3,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.8,,686,38910.0,6006.0,22708524.66
Site03-SymphonyA3,4,Site03,SymphonyA3,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1922,10041.0,4151.0,4397518.248
Site03-SymphonyA3,4,Site03,SymphonyA3,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.5,,382,24742.0,1902.0,3266361.216
Site03-SymphonyA3,4,Site03,SymphonyA3,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,15.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,5.83,,90,285.0,200.0,96015.81954
Site03-SymphonyA3,4,Site03,SymphonyA3,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.9,,245,4594.0,961.0,38614.49323
Site03-SymphonyA3,4,Site03,SymphonyA3,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,16,,246,3554.0,377.0,29872.85784
Site03-SymphonyA3,4,Site03,SymphonyA3,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70,,1073,42960.0,14334.0,211103.3662
Site03-SymphonyA3,4,Site03,SymphonyA3,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.8,,685,39099.0,5981.0,22818828.21
Site03-SymphonyA3,4,Site03,SymphonyA3,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1917,10110.0,4151.0,4427737.226
Site03-SymphonyA3,4,Site03,SymphonyA3,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.5,,381,24624.0,1892.0,3250783.226
Site03-SymphonyA3,4,Site03,SymphonyA3,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,15.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,5.96,,91,297.0,200.0,100058.5909
Site03-SymphonyA3,4,Site03,SymphonyA3,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.9,,245,4594.0,961.0,38614.49323
Site03-SymphonyA3,4,Site03,SymphonyA3,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,16.1,,246,3532.0,375.0,29687.93863
Site03-SymphonyA3,4,Site03,SymphonyA3,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70,,1073,42919.0,14422.0,210901.8941
Site03-SymphonyA3,4,Site03,SymphonyA3,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.8,,684,38910.0,5951.0,22708524.66
Site03-SymphonyA3,4,Site03,SymphonyA3,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1916,10156.0,4161.0,4447883.212
Site03-SymphonyA3,4,Site03,SymphonyA3,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.5,,380,24624.0,1892.0,3250783.226
Site03-SymphonyA3,4,Site03,SymphonyA3,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,15.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA3,4,Site03,SymphonyA3,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,4.13,,63,339.0,251.0,114208.2906
Site03-SymphonyA3,4,Site03,SymphonyA3,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA3,4,Site03,SymphonyA3,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.7,,1018,11983.0,3774.0,94756.36252
Site03-SymphonyA5,5,Site03,SymphonyA5,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.9,,1016,11926.0,3813.0,94305.63126
Site03-SymphonyA5,5,Site03,SymphonyA5,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.7,,1001,11869.0,3776.0,93854.9
Site03-SymphonyA5,5,Site03,SymphonyA5,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.99,,471,3533.0,1410.0,27937.43042
Site03-SymphonyA5,5,Site03,SymphonyA5,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.6,,442,3613.0,1411.0,28570.0357
Site03-SymphonyA5,5,Site03,SymphonyA5,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.05,,476,3557.0,1382.0,28127.21201
Site03-SymphonyA5,5,Site03,SymphonyA5,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.3,,4867,10202.0,3885.0,72147.232
Site03-SymphonyA5,5,Site03,SymphonyA5,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.8,,4876,10179.0,3914.0,71984.57896
Site03-SymphonyA5,5,Site03,SymphonyA5,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.4,,4889,10248.0,3897.0,72472.53809
Site03-SymphonyA5,5,Site03,SymphonyA5,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,38,,1850,32958.0,7856.0,11544382.97
Site03-SymphonyA5,5,Site03,SymphonyA5,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,38,,1852,32958.0,7848.0,11544382.97
Site03-SymphonyA5,5,Site03,SymphonyA5,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.8,,1847,33037.0,7719.0,11572054.74
Site03-SymphonyA5,5,Site03,SymphonyA5,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98,,9632,6041.0,1701.0,3493755.434
Site03-SymphonyA5,5,Site03,SymphonyA5,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.1,,9632,6041.0,1710.0,3493755.434
Site03-SymphonyA5,5,Site03,SymphonyA5,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98,,9632,6054.0,1719.0,3501273.861
Site03-SymphonyA5,5,Site03,SymphonyA5,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,52.6,,2559,23706.0,14742.0,1084588.235
Site03-SymphonyA5,5,Site03,SymphonyA5,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,52.4,,2556,23316.0,14548.0,1066745.098
Site03-SymphonyA5,5,Site03,SymphonyA5,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,52.4,,2560,23427.0,14797.0,1071823.529
Site03-SymphonyA5,5,Site03,SymphonyA5,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,12.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,12.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.7,,1194,2345.0,3605.0,2164077.726
Site03-SymphonyA5,5,Site03,SymphonyA5,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.6,,1179,2373.0,3625.0,2189917.46
Site03-SymphonyA5,5,Site03,SymphonyA5,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.7,,1196,2323.0,3560.0,2143775.077
Site03-SymphonyA5,5,Site03,SymphonyA5,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.5,,1019,11926.0,3775.0,94305.63126
Site03-SymphonyA5,5,Site03,SymphonyA5,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.6,,1018,11869.0,3794.0,93854.9
Site03-SymphonyA5,5,Site03,SymphonyA5,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.4,,1002,11812.0,3767.0,93404.16875
Site03-SymphonyA5,5,Site03,SymphonyA5,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.99,,469,3502.0,1404.0,27692.29588
Site03-SymphonyA5,5,Site03,SymphonyA5,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.58,,439,3581.0,1397.0,28316.99359
Site03-SymphonyA5,5,Site03,SymphonyA5,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.02,,473,3525.0,1375.0,27874.1699
Site03-SymphonyA5,5,Site03,SymphonyA5,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.7,,4880,10248.0,3904.0,72472.53809
Site03-SymphonyA5,5,Site03,SymphonyA5,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.3,,4894,10225.0,3909.0,72309.88504
Site03-SymphonyA5,5,Site03,SymphonyA5,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.8,,4904,10294.0,3916.0,72797.84417
Site03-SymphonyA5,5,Site03,SymphonyA5,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,38,,1856,33196.0,7865.0,11627748.56
Site03-SymphonyA5,5,Site03,SymphonyA5,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,38,,1859,33116.0,7906.0,11599726.51
Site03-SymphonyA5,5,Site03,SymphonyA5,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.8,,1854,33276.0,7776.0,11655770.61
Site03-SymphonyA5,5,Site03,SymphonyA5,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.4,,9613,6107.0,1707.0,3531925.912
Site03-SymphonyA5,5,Site03,SymphonyA5,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.4,,9613,6107.0,1708.0,3531925.912
Site03-SymphonyA5,5,Site03,SymphonyA5,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.3,,9613,6107.0,1717.0,3531925.912
Site03-SymphonyA5,5,Site03,SymphonyA5,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,52.1,,2543,23700.0,14648.0,1084313.725
Site03-SymphonyA5,5,Site03,SymphonyA5,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,52,,2545,23263.0,14456.0,1064320.261
Site03-SymphonyA5,5,Site03,SymphonyA5,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,51.9,,2546,23426.0,14720.0,1071777.778
Site03-SymphonyA5,5,Site03,SymphonyA5,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,12.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,12.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.8,,1193,2373.0,3622.0,2189917.46
Site03-SymphonyA5,5,Site03,SymphonyA5,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.6,,1178,2418.0,3632.0,2231445.604
Site03-SymphonyA5,5,Site03,SymphonyA5,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.8,,1196,2346.0,3569.0,2165000.573
Site03-SymphonyA5,5,Site03,SymphonyA5,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.5,,1009,11897.0,3737.0,94076.31185
Site03-SymphonyA5,5,Site03,SymphonyA5,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.6,,1006,11812.0,3766.0,93404.16875
Site03-SymphonyA5,5,Site03,SymphonyA5,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.4,,991,11756.0,3719.0,92961.34505
Site03-SymphonyA5,5,Site03,SymphonyA5,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.98,,467,3470.0,1401.0,27439.25377
Site03-SymphonyA5,5,Site03,SymphonyA5,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.59,,438,3541.0,1390.0,28000.69095
Site03-SymphonyA5,5,Site03,SymphonyA5,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7,,470,3502.0,1375.0,27692.29588
Site03-SymphonyA5,5,Site03,SymphonyA5,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.8,,4870,27200.0,10225.0,192354.902
Site03-SymphonyA5,5,Site03,SymphonyA5,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.5,,4887,27348.0,10202.0,193401.539
Site03-SymphonyA5,5,Site03,SymphonyA5,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,73,,4895,27244.0,10271.0,192666.0644
Site03-SymphonyA5,5,Site03,SymphonyA5,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,38,,1853,33037.0,7856.0,11572054.74
Site03-SymphonyA5,5,Site03,SymphonyA5,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,38,,1857,32958.0,7897.0,11544382.97
Site03-SymphonyA5,5,Site03,SymphonyA5,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.8,,1850,33037.0,7719.0,11572054.74
Site03-SymphonyA5,5,Site03,SymphonyA5,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.2,,9549,6107.0,1698.0,3531925.912
Site03-SymphonyA5,5,Site03,SymphonyA5,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.1,,9549,6107.0,1699.0,3531925.912
Site03-SymphonyA5,5,Site03,SymphonyA5,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97,,9549,6120.0,1703.0,3539444.339
Site03-SymphonyA5,5,Site03,SymphonyA5,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,52,,2532,23601.0,14593.0,1079784.314
Site03-SymphonyA5,5,Site03,SymphonyA5,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.8,,2532,23225.0,14395.0,1062581.699
Site03-SymphonyA5,5,Site03,SymphonyA5,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,51.7,,2531,23385.0,14648.0,1069901.961
Site03-SymphonyA5,5,Site03,SymphonyA5,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,12.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,12.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.8,,1189,2375.0,3621.0,2191763.155
Site03-SymphonyA5,5,Site03,SymphonyA5,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.6,,1172,2436.0,3630.0,2248056.861
Site03-SymphonyA5,5,Site03,SymphonyA5,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.8,,1192,2343.0,3569.0,2162232.03
Site03-SymphonyA5,5,Site03,SymphonyA5,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,9721,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,9543,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93,,1689,9784.0,2623.0,77367.62504
Site03-SymphonyA5,5,Site03,SymphonyA5,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,93,,1630,9714.0,2595.0,76814.09543
Site03-SymphonyA5,5,Site03,SymphonyA5,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.7,,1628,9622.0,2584.0,76086.59936
Site03-SymphonyA5,5,Site03,SymphonyA5,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.49,,197,3486.0,1296.0,27565.77483
Site03-SymphonyA5,5,Site03,SymphonyA5,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.57,,203,3494.0,1337.0,27629.03535
Site03-SymphonyA5,5,Site03,SymphonyA5,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.48,,199,3621.0,1263.0,28633.29623
Site03-SymphonyA5,5,Site03,SymphonyA5,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.8,,3727,15455.0,5702.0,109295.7725
Site03-SymphonyA5,5,Site03,SymphonyA5,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,84.4,,3751,15455.0,5730.0,109295.7725
Site03-SymphonyA5,5,Site03,SymphonyA5,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,84.6,,3754,15527.0,5706.0,43279.85295
Site03-SymphonyA5,5,Site03,SymphonyA5,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.7,,2673,36023.0,7814.0,12617977.66
Site03-SymphonyA5,5,Site03,SymphonyA5,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.9,,2697,36197.0,7907.0,12678925.61
Site03-SymphonyA5,5,Site03,SymphonyA5,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.2,,2671,36197.0,7779.0,12678925.61
Site03-SymphonyA5,5,Site03,SymphonyA5,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.6,,6902,6133.0,1462.0,3546962.767
Site03-SymphonyA5,5,Site03,SymphonyA5,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.7,,6902,6133.0,1458.0,3546962.767
Site03-SymphonyA5,5,Site03,SymphonyA5,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.4,,6902,6120.0,1436.0,3539444.339
Site03-SymphonyA5,5,Site03,SymphonyA5,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.4,,986,32176.0,10682.0,1472104.575
Site03-SymphonyA5,5,Site03,SymphonyA5,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.4,,988,32331.0,10615.0,1479196.078
Site03-SymphonyA5,5,Site03,SymphonyA5,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.1,,1017,32176.0,10644.0,1472104.575
Site03-SymphonyA5,5,Site03,SymphonyA5,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.26,,407,7211.0,6246.0,6654654.362
Site03-SymphonyA5,5,Site03,SymphonyA5,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.37,,416,7123.0,6287.0,6573443.769
Site03-SymphonyA5,5,Site03,SymphonyA5,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.34,,414,7176.0,6215.0,6622354.694
Site03-SymphonyA5,5,Site03,SymphonyA5,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93.2,,1706,9737.0,2618.0,76995.96944
Site03-SymphonyA5,5,Site03,SymphonyA5,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,93,,1644,9691.0,2597.0,76632.22141
Site03-SymphonyA5,5,Site03,SymphonyA5,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.7,,1641,9577.0,2586.0,75730.7589
Site03-SymphonyA5,5,Site03,SymphonyA5,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.46,,196,3447.0,1281.0,27257.37976
Site03-SymphonyA5,5,Site03,SymphonyA5,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.53,,201,3463.0,1328.0,27383.90081
Site03-SymphonyA5,5,Site03,SymphonyA5,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.42,,196,3597.0,1240.0,28443.51464
Site03-SymphonyA5,5,Site03,SymphonyA5,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,85.1,,3736,15491.0,5678.0,109550.3598
Site03-SymphonyA5,5,Site03,SymphonyA5,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,84.7,,3758,15527.0,5706.0,109804.9472
Site03-SymphonyA5,5,Site03,SymphonyA5,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85,,3763,15563.0,5708.0,110059.5346
Site03-SymphonyA5,5,Site03,SymphonyA5,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.8,,2682,36197.0,7907.0,12678925.61
Site03-SymphonyA5,5,Site03,SymphonyA5,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72,,2704,36459.0,7947.0,12770697.82
Site03-SymphonyA5,5,Site03,SymphonyA5,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.2,,2680,36372.0,7837.0,12740223.84
Site03-SymphonyA5,5,Site03,SymphonyA5,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.2,,6906,6200.0,1466.0,3585711.586
Site03-SymphonyA5,5,Site03,SymphonyA5,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.2,,6906,6186.0,1462.0,3577614.818
Site03-SymphonyA5,5,Site03,SymphonyA5,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97,,6906,6173.0,1445.0,3570096.39
Site03-SymphonyA5,5,Site03,SymphonyA5,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.4,,986,31925.0,10629.0,1460620.915
Site03-SymphonyA5,5,Site03,SymphonyA5,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.3,,989,32076.0,10542.0,1467529.412
Site03-SymphonyA5,5,Site03,SymphonyA5,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27,,1017,32000.0,10571.0,1464052.288
Site03-SymphonyA5,5,Site03,SymphonyA5,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.3,,408,7217.0,6233.0,6660191.448
Site03-SymphonyA5,5,Site03,SymphonyA5,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.38,,416,7147.0,6265.0,6595592.113
Site03-SymphonyA5,5,Site03,SymphonyA5,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.37,,415,7182.0,6217.0,6627891.78
Site03-SymphonyA5,5,Site03,SymphonyA5,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93.1,,1671,9668.0,2584.0,76450.3474
Site03-SymphonyA5,5,Site03,SymphonyA5,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.9,,1609,9599.0,2563.0,75904.72535
Site03-SymphonyA5,5,Site03,SymphonyA5,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.6,,1609,9509.0,2561.0,75193.04441
Site03-SymphonyA5,5,Site03,SymphonyA5,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.45,,195,3417.0,1280.0,27020.15278
Site03-SymphonyA5,5,Site03,SymphonyA5,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.53,,200,3432.0,1315.0,27138.76627
Site03-SymphonyA5,5,Site03,SymphonyA5,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.41,,195,3565.0,1242.0,28190.47253
Site03-SymphonyA5,5,Site03,SymphonyA5,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,85.2,,3730,27440.0,15455.0,194052.1512
Site03-SymphonyA5,5,Site03,SymphonyA5,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,84.9,,3754,27579.0,15491.0,195035.1413
Site03-SymphonyA5,5,Site03,SymphonyA5,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.1,,3758,27516.0,15563.0,194589.6134
Site03-SymphonyA5,5,Site03,SymphonyA5,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.8,,2678,36023.0,7868.0,12617977.66
Site03-SymphonyA5,5,Site03,SymphonyA5,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72,,2701,36197.0,7907.0,12678925.61
Site03-SymphonyA5,5,Site03,SymphonyA5,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.2,,2677,36197.0,7799.0,12678925.61
Site03-SymphonyA5,5,Site03,SymphonyA5,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97,,6848,6213.0,1455.0,3593230.013
Site03-SymphonyA5,5,Site03,SymphonyA5,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.1,,6848,6200.0,1452.0,3585711.586
Site03-SymphonyA5,5,Site03,SymphonyA5,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.8,,6848,6186.0,1435.0,3577614.818
Site03-SymphonyA5,5,Site03,SymphonyA5,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.4,,987,31818.0,10587.0,1455725.49
Site03-SymphonyA5,5,Site03,SymphonyA5,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.3,,988,31967.0,10480.0,1462542.484
Site03-SymphonyA5,5,Site03,SymphonyA5,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.1,,1018,31818.0,10510.0,1455725.49
Site03-SymphonyA5,5,Site03,SymphonyA5,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.3,,407,7234.0,6246.0,6675879.858
Site03-SymphonyA5,5,Site03,SymphonyA5,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.38,,415,7182.0,6273.0,6627891.78
Site03-SymphonyA5,5,Site03,SymphonyA5,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.37,,414,7182.0,6213.0,6627891.78
Site03-SymphonyA5,5,Site03,SymphonyA5,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,6782,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,7022,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.3,,1699,11616.0,3374.0,91854.28582
Site03-SymphonyA5,5,Site03,SymphonyA5,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.2,,1674,11700.0,3337.0,92518.52136
Site03-SymphonyA5,5,Site03,SymphonyA5,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.1,,1668,11616.0,3301.0,91854.28582
Site03-SymphonyA5,5,Site03,SymphonyA5,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.38,,179,3883.0,1531.0,30705.0785
Site03-SymphonyA5,5,Site03,SymphonyA5,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,3.32,,176,3874.0,1547.0,30633.91041
Site03-SymphonyA5,5,Site03,SymphonyA5,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.3,,176,3857.0,1450.0,30499.48179
Site03-SymphonyA5,5,Site03,SymphonyA5,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,85.7,,4534,13956.0,5292.0,98695.03723
Site03-SymphonyA5,5,Site03,SymphonyA5,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,85.6,,4548,13924.0,5315.0,98468.73734
Site03-SymphonyA5,5,Site03,SymphonyA5,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.6,,4568,13892.0,5269.0,98242.43746
Site03-SymphonyA5,5,Site03,SymphonyA5,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,60.4,,2738,36372.0,8075.0,12740223.84
Site03-SymphonyA5,5,Site03,SymphonyA5,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.2,,2738,36459.0,7864.0,12770697.82
Site03-SymphonyA5,5,Site03,SymphonyA5,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.5,,2765,36635.0,7952.0,12832346.32
Site03-SymphonyA5,5,Site03,SymphonyA5,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.9,,8024,6432.0,1672.0,3719886.6
Site03-SymphonyA5,5,Site03,SymphonyA5,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98,,8024,6404.0,1663.0,3703693.064
Site03-SymphonyA5,5,Site03,SymphonyA5,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.9,,8024,6404.0,1653.0,3703693.064
Site03-SymphonyA5,5,Site03,SymphonyA5,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.9,,1536,27673.0,16775.0,1266084.967
Site03-SymphonyA5,5,Site03,SymphonyA5,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.1,,1551,27673.0,16653.0,1266084.967
Site03-SymphonyA5,5,Site03,SymphonyA5,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.7,,1539,27541.0,16820.0,1260045.752
Site03-SymphonyA5,5,Site03,SymphonyA5,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.47,,501,5750.0,6427.0,5306373.954
Site03-SymphonyA5,5,Site03,SymphonyA5,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.42,,500,5963.0,6612.0,5502940.502
Site03-SymphonyA5,5,Site03,SymphonyA5,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.45,,504,5949.0,6478.0,5490020.635
Site03-SymphonyA5,5,Site03,SymphonyA5,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.2,,1707,11561.0,3376.0,91419.3697
Site03-SymphonyA5,5,Site03,SymphonyA5,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.2,,1680,11644.0,3329.0,92075.69767
Site03-SymphonyA5,5,Site03,SymphonyA5,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92,,1676,11561.0,3274.0,91419.3697
Site03-SymphonyA5,5,Site03,SymphonyA5,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.33,,176,3839.0,1508.0,30357.1456
Site03-SymphonyA5,5,Site03,SymphonyA5,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,3.27,,173,3848.0,1518.0,30428.31369
Site03-SymphonyA5,5,Site03,SymphonyA5,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.23,,173,3848.0,1439.0,30428.31369
Site03-SymphonyA5,5,Site03,SymphonyA5,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,85.8,,4543,13989.0,5295.0,98928.40898
Site03-SymphonyA5,5,Site03,SymphonyA5,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,85.8,,4558,13989.0,5295.0,98928.40898
Site03-SymphonyA5,5,Site03,SymphonyA5,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.8,,4581,13956.0,5271.0,98695.03723
Site03-SymphonyA5,5,Site03,SymphonyA5,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,60.4,,2745,36635.0,8081.0,12832346.32
Site03-SymphonyA5,5,Site03,SymphonyA5,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.3,,2746,36724.0,7922.0,12863520.85
Site03-SymphonyA5,5,Site03,SymphonyA5,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.6,,2774,36812.0,7957.0,12894345.1
Site03-SymphonyA5,5,Site03,SymphonyA5,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.6,,8031,6488.0,1683.0,3752273.672
Site03-SymphonyA5,5,Site03,SymphonyA5,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.6,,8031,6474.0,1664.0,3744176.904
Site03-SymphonyA5,5,Site03,SymphonyA5,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.4,,8031,6460.0,1655.0,3736080.136
Site03-SymphonyA5,5,Site03,SymphonyA5,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.7,,1530,27588.0,16675.0,1262196.078
Site03-SymphonyA5,5,Site03,SymphonyA5,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.9,,1545,27524.0,16515.0,1259267.974
Site03-SymphonyA5,5,Site03,SymphonyA5,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.5,,1534,27459.0,16674.0,1256294.118
Site03-SymphonyA5,5,Site03,SymphonyA5,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.48,,502,5750.0,6441.0,5306373.954
Site03-SymphonyA5,5,Site03,SymphonyA5,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.44,,502,5962.0,6608.0,5502017.654
Site03-SymphonyA5,5,Site03,SymphonyA5,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.46,,505,5962.0,6474.0,5502017.654
Site03-SymphonyA5,5,Site03,SymphonyA5,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.2,,1680,11505.0,3341.0,90976.54601
Site03-SymphonyA5,5,Site03,SymphonyA5,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.1,,1651,11588.0,3294.0,91632.87398
Site03-SymphonyA5,5,Site03,SymphonyA5,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,91.9,,1647,11505.0,3258.0,90976.54601
Site03-SymphonyA5,5,Site03,SymphonyA5,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.32,,175,3805.0,1508.0,30088.28836
Site03-SymphonyA5,5,Site03,SymphonyA5,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,3.24,,172,3822.0,1515.0,30222.71698
Site03-SymphonyA5,5,Site03,SymphonyA5,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.22,,171,3814.0,1442.0,30159.45645
Site03-SymphonyA5,5,Site03,SymphonyA5,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,85.9,,4538,28904.0,13956.0,204405.3709
Site03-SymphonyA5,5,Site03,SymphonyA5,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,85.9,,4551,29019.0,13956.0,205218.6361
Site03-SymphonyA5,5,Site03,SymphonyA5,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.9,,4576,29099.0,13924.0,205784.3858
Site03-SymphonyA5,5,Site03,SymphonyA5,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,60.4,,2742,36459.0,8041.0,12770697.82
Site03-SymphonyA5,5,Site03,SymphonyA5,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.3,,2743,36459.0,7918.0,12770697.82
Site03-SymphonyA5,5,Site03,SymphonyA5,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.6,,2772,36635.0,7952.0,12832346.32
Site03-SymphonyA5,5,Site03,SymphonyA5,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.4,,7973,6502.0,1672.0,3760370.44
Site03-SymphonyA5,5,Site03,SymphonyA5,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.5,,7973,6488.0,1663.0,3752273.672
Site03-SymphonyA5,5,Site03,SymphonyA5,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.3,,7973,6474.0,1645.0,3744176.904
Site03-SymphonyA5,5,Site03,SymphonyA5,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.7,,1528,27416.0,16624.0,1254326.797
Site03-SymphonyA5,5,Site03,SymphonyA5,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.9,,1541,27353.0,16489.0,1251444.444
Site03-SymphonyA5,5,Site03,SymphonyA5,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.5,,1531,27290.0,16650.0,1248562.092
Site03-SymphonyA5,5,Site03,SymphonyA5,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.49,,501,5758.0,6441.0,5313756.735
Site03-SymphonyA5,5,Site03,SymphonyA5,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.45,,501,5969.0,6607.0,5508477.588
Site03-SymphonyA5,5,Site03,SymphonyA5,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.47,,504,5954.0,6473.0,5494634.873
Site03-SymphonyA5,5,Site03,SymphonyA5,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,6782,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,7022,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,7235,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.5,,249,5259.0,1066.0,41585.88922
Site03-SymphonyA5,5,Site03,SymphonyA5,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.8,,184,3857.0,392.0,30499.48179
Site03-SymphonyA5,5,Site03,SymphonyA5,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.7,,879,30597.0,10189.0,48873.70323
Site03-SymphonyA5,5,Site03,SymphonyA5,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.2,,573,74793.0,11483.0,26198162.37
Site03-SymphonyA5,5,Site03,SymphonyA5,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1576,6911.0,310.0,3996911.737
Site03-SymphonyA5,5,Site03,SymphonyA5,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.7,,305,72455.0,6024.0,3314934.641
Site03-SymphonyA5,5,Site03,SymphonyA5,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,1.68,,21,203.0,165.0,187338.0718
Site03-SymphonyA5,5,Site03,SymphonyA5,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.5,,249,5235.0,1068.0,41396.10764
Site03-SymphonyA5,5,Site03,SymphonyA5,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.8,,184,3788.0,388.0,29953.85974
Site03-SymphonyA5,5,Site03,SymphonyA5,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.8,,879,30597.0,10111.0,216378.0492
Site03-SymphonyA5,5,Site03,SymphonyA5,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.2,,573,74976.0,11540.0,26262262.8
Site03-SymphonyA5,5,Site03,SymphonyA5,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1577,6987.0,3204.0,4040865.621
Site03-SymphonyA5,5,Site03,SymphonyA5,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.7,,305,72125.0,6049.0,3299836.601
Site03-SymphonyA5,5,Site03,SymphonyA5,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,1.93,,24,194.0,165.0,179032.443
Site03-SymphonyA5,5,Site03,SymphonyA5,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.5,,249,5222.0,1066.0,41293.30928
Site03-SymphonyA5,5,Site03,SymphonyA5,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.8,,184,3729.0,386.0,29487.31335
Site03-SymphonyA5,5,Site03,SymphonyA5,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.8,,879,30597.0,10150.0,216378.0492
Site03-SymphonyA5,5,Site03,SymphonyA5,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.2,,573,74793.0,11590.0,26198162.37
Site03-SymphonyA5,5,Site03,SymphonyA5,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1577,6987.0,3210.0,4040865.621
Site03-SymphonyA5,5,Site03,SymphonyA5,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.7,,305,72079.0,5995.0,3297732.026
Site03-SymphonyA5,5,Site03,SymphonyA5,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site03-SymphonyA5,5,Site03,SymphonyA5,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,1.8,,249,193.0,162.0,178109.5953
Site03-SymphonyA5,5,Site03,SymphonyA5,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site03-SymphonyA5,5,Site03,SymphonyA5,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.31,,1163,5408.2,3604.6,5680.850778
Site04-Aurora,6,Site04,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.65,,1163,5122.64,3455.78,5380.894462
Site04-Aurora,6,Site04,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.39,,1249,5350.86,3567.15,5620.620021
Site04-Aurora,6,Site04,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.53,,279,24420.41,8669.88,25651.5486
Site04-Aurora,6,Site04,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.87,,258,24423.55,8897.43,25654.8469
Site04-Aurora,6,Site04,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.74,,247,24398.15,8483.18,25628.16638
Site04-Aurora,6,Site04,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.4,,2170,82234.43,28426.13,74688.49058
Site04-Aurora,6,Site04,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.66,,2184,79065.27,26999.86,71810.13686
Site04-Aurora,6,Site04,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.8,,2132,82070.31,28002.82,74539.43044
Site04-Aurora,6,Site04,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,40.44,,878,230011.47,44437.03,7539053.758
Site04-Aurora,6,Site04,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37.68,,823,217467.59,43095.16,7127904.759
Site04-Aurora,6,Site04,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,40.8,,870,219484.39,42626.26,7194009.131
Site04-Aurora,6,Site04,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,4613,88414.3,19339.76,3965141.029
Site04-Aurora,6,Site04,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,4613,85508.82,17485.59,3834838.148
Site04-Aurora,6,Site04,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,4613,86132.92,18039.89,3862827.337
Site04-Aurora,6,Site04,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.01,,1085,122921.74,78507.05,943295.4371
Site04-Aurora,6,Site04,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,52.59,,1148,124504.52,79283.45,955441.6136
Site04-Aurora,6,Site04,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,49.91,,1064,125285.63,76038.92,961435.8137
Site04-Aurora,6,Site04,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,71.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.23,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,29.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,24.59,,804,255826.52,204843.32,3173424.092
Site04-Aurora,6,Site04,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.08,,822,259489.11,205901.4,3218857.034
Site04-Aurora,6,Site04,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.03,,799,255113.68,200551.68,3164581.601
Site04-Aurora,6,Site04,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.35,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.21,,1176,5244.64,3620.24,5509.045011
Site04-Aurora,6,Site04,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.42,,1176,4972.86,3459.02,5223.563404
Site04-Aurora,6,Site04,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.47,,1263,5206.45,3582.09,5468.929687
Site04-Aurora,6,Site04,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.74,,284,24722.16,8741.51,25968.51113
Site04-Aurora,6,Site04,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.14,,265,24655.66,9028.85,25898.65858
Site04-Aurora,6,Site04,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.92,,251,24650.65,8642.02,25893.396
Site04-Aurora,6,Site04,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.5,,2160,82092.77,28400.2,74559.82948
Site04-Aurora,6,Site04,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.61,,2169,78934.39,27005.71,71691.26658
Site04-Aurora,6,Site04,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.89,,2123,82003.15,27980.95,74478.43313
Site04-Aurora,6,Site04,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,40.42,,873,229467.3,44145.97,7521217.574
Site04-Aurora,6,Site04,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37.67,,817,217130.64,43032.24,7116860.596
Site04-Aurora,6,Site04,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,40.89,,868,219120.04,42471.39,7182066.882
Site04-Aurora,6,Site04,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,4613,89761.26,19611.93,4025548.523
Site04-Aurora,6,Site04,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,4613,86793.52,17775.72,3892453.451
Site04-Aurora,6,Site04,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,4613,87440.7,18321.63,3921477.715
Site04-Aurora,6,Site04,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.2,,1084,123294.42,78927.37,946155.3653
Site04-Aurora,6,Site04,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,52.79,,1145,125165.54,79580.56,960514.2489
Site04-Aurora,6,Site04,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,49.99,,1061,126124.73,75914.07,967875.0262
Site04-Aurora,6,Site04,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,68.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,24.61,,799,255908.72,204703.28,3174443.75
Site04-Aurora,6,Site04,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.3,,824,261094.59,207942.54,3238772.361
Site04-Aurora,6,Site04,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.07,,796,255581.86,200452.08,3170389.184
Site04-Aurora,6,Site04,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.05,,1160,5532.89,3626.74,5811.826941
Site04-Aurora,6,Site04,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.27,,1159,5239.2,3458.88,5503.330757
Site04-Aurora,6,Site04,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.29,,1247,5477.57,3584.8,5753.718021
Site04-Aurora,6,Site04,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.62,,281,24387.19,8800.25,25616.65384
Site04-Aurora,6,Site04,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.96,,261,24382.55,8975.37,25611.77992
Site04-Aurora,6,Site04,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.76,,247,24338.14,8600.33,25565.13102
Site04-Aurora,6,Site04,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.32,,2165,82203.25,28411.9,74660.17169
Site04-Aurora,6,Site04,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.49,,2175,79048.14,27026.2,71794.57874
Site04-Aurora,6,Site04,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.73,,2126,82063.83,27981.45,74533.54506
Site04-Aurora,6,Site04,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,40.4,,875,228257.09,44140.2,7481550.691
Site04-Aurora,6,Site04,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37.68,,820,215903.38,42806.83,7076634.867
Site04-Aurora,6,Site04,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,40.85,,868,217895.55,42318.5,7141931.944
Site04-Aurora,6,Site04,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,4613,90082.73,19635.9,4039965.579
Site04-Aurora,6,Site04,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,4613,87098.95,17770.25,3906151.156
Site04-Aurora,6,Site04,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,4613,87767.95,18331.63,3936153.988
Site04-Aurora,6,Site04,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.03,,1083,121886.91,78089.36,935354.2022
Site04-Aurora,6,Site04,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,52.59,,1144,123759.79,78641.29,949726.5919
Site04-Aurora,6,Site04,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,49.91,,1061,124463.34,75539.0,955125.6003
Site04-Aurora,6,Site04,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.56,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.26,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,24.78,,809,255620.27,205530.56,3170865.645
Site04-Aurora,6,Site04,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.43,,832,259048.41,207499.09,3213390.329
Site04-Aurora,6,Site04,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.23,,804,254888.57,200904.36,3161789.203
Site04-Aurora,6,Site04,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,4613,100922.0,24634.0,4526077.375
Site04-Aurora,6,Site04,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,4448,99752.0,24182.0,4473606.056
Site04-Aurora,6,Site04,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.08,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,95.37,,1777,2051.73,752.44,2155.166593
Site04-Aurora,6,Site04,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,95.49,,1804,1997.54,742.97,2098.24464
Site04-Aurora,6,Site04,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,95.28,,1750,2064.97,751.6,2169.074079
Site04-Aurora,6,Site04,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.16,,268,25196.8,7997.82,26467.07979
Site04-Aurora,6,Site04,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.66,,278,25904.5,7923.25,27210.45801
Site04-Aurora,6,Site04,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.01,,293,25445.97,7863.46,26728.81152
Site04-Aurora,6,Site04,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.67,,2020,116695.61,40375.85,105987.4674
Site04-Aurora,6,Site04,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.45,,1995,113462.57,38839.16,103051.0954
Site04-Aurora,6,Site04,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,76.39,,2032,117475.6,40653.49,106695.8845
Site04-Aurora,6,Site04,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,76.89,,1554,239052.88,44330.57,7835402.788
Site04-Aurora,6,Site04,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,76.3,,1522,225922.42,41132.28,7405027.539
Site04-Aurora,6,Site04,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,77.17,,1568,233270.58,44409.73,7645877.151
Site04-Aurora,6,Site04,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,4543,87225.56,19262.72,3911829.271
Site04-Aurora,6,Site04,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,4543,84843.02,18048.12,3804978.828
Site04-Aurora,6,Site04,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,4543,86441.18,18889.63,3876651.96
Site04-Aurora,6,Site04,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,21.69,,438,161150.87,38928.14,1236663.916
Site04-Aurora,6,Site04,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.3,,445,163970.03,37196.51,1258298.012
Site04-Aurora,6,Site04,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,21.5,,437,160943.12,37625.77,1235069.653
Site04-Aurora,6,Site04,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,57.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,58.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,41.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,41.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,40.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.03,,343,483061.5,355765.9,5992181.741
Site04-Aurora,6,Site04,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.8,,334,456629.34,338571.68,5664301.53
Site04-Aurora,6,Site04,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.49,,332,476493.91,352431.02,5910713.454
Site04-Aurora,6,Site04,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,95,,1787,1896.14,752.51,1991.732627
Site04-Aurora,6,Site04,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,95.09,,1811,1849.85,743.04,1943.108948
Site04-Aurora,6,Site04,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,94.87,,1759,1912.46,750.11,2008.875389
Site04-Aurora,6,Site04,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.39,,273,25800.74,8015.11,27101.46702
Site04-Aurora,6,Site04,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.86,,283,26422.7,7997.03,27754.78271
Site04-Aurora,6,Site04,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.27,,299,26031.67,7956.64,27344.0392
Site04-Aurora,6,Site04,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.56,,2014,116529.27,40333.67,105836.391
Site04-Aurora,6,Site04,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.11,,1985,113447.52,38823.85,103037.4264
Site04-Aurora,6,Site04,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,76.21,,2025,117411.46,40665.64,106637.63
Site04-Aurora,6,Site04,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,76.95,,1550,238341.7,44024.44,7812092.541
Site04-Aurora,6,Site04,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,76.33,,1515,225259.32,40929.77,7383293.203
Site04-Aurora,6,Site04,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,77.21,,1564,232735.61,44190.77,7628342.514
Site04-Aurora,6,Site04,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,4543,88465.82,19512.61,3967451.561
Site04-Aurora,6,Site04,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,4543,85977.86,18266.8,3855873.317
Site04-Aurora,6,Site04,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,4543,87667.73,19134.92,3931659.393
Site04-Aurora,6,Site04,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,21.72,,437,161658.59,38905.28,1240560.135
Site04-Aurora,6,Site04,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.36,,444,164421.48,37477.5,1261762.418
Site04-Aurora,6,Site04,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,21.52,,436,161365.27,37587.13,1238309.211
Site04-Aurora,6,Site04,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,57.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,57.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,58.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,41.41,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,41.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,40.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.07,,344,480400.97,354274.5,5959178.947
Site04-Aurora,6,Site04,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.04,,340,466184.17,348682.94,5782825.316
Site04-Aurora,6,Site04,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.55,,334,475260.41,353496.36,5895412.388
Site04-Aurora,6,Site04,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.02,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,95.09,,1779,2157.27,752.37,2266.027321
Site04-Aurora,6,Site04,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,95.16,,1804,2103.33,745.93,2209.367972
Site04-Aurora,6,Site04,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,94.9,,1749,2175.15,754.78,2284.808729
Site04-Aurora,6,Site04,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.3,,272,25408.41,8047.55,26689.35796
Site04-Aurora,6,Site04,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.76,,281,26163.07,8039.38,27482.06364
Site04-Aurora,6,Site04,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.19,,298,25627.56,7985.01,26919.55626
Site04-Aurora,6,Site04,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.48,,2018,116367.2,40251.84,105689.1927
Site04-Aurora,6,Site04,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.23,,1992,113289.23,38604.97,102893.6613
Site04-Aurora,6,Site04,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,76.22,,2031,117481.82,40610.23,106701.5337
Site04-Aurora,6,Site04,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,76.92,,1552,236803.42,43882.06,7761672.553
Site04-Aurora,6,Site04,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,76.4,,1522,223507.27,40657.69,7325866.505
Site04-Aurora,6,Site04,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,77.24,,1569,231904.83,44202.65,7601112.154
Site04-Aurora,6,Site04,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,4543,88889.75,19460.04,3986463.669
Site04-Aurora,6,Site04,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,4543,86323.94,18155.95,3871394.065
Site04-Aurora,6,Site04,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,4543,88183.13,19103.43,3954773.682
Site04-Aurora,6,Site04,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,21.77,,439,160142.84,38540.49,1228928.343
Site04-Aurora,6,Site04,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.31,,444,162727.3,37102.64,1248761.363
Site04-Aurora,6,Site04,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,21.49,,436,159807.52,37410.4,1226355.114
Site04-Aurora,6,Site04,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,57.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,58.65,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,41.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,41.74,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,40.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.24,,349,483672.0,356414.45,5999754.746
Site04-Aurora,6,Site04,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.04,,341,458363.58,343430.52,5685814.073
Site04-Aurora,6,Site04,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.61,,336,475713.97,354543.31,5901038.615
Site04-Aurora,6,Site04,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,4543,94865.0,23061.0,4254437.389
Site04-Aurora,6,Site04,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,4617,95315.0,23220.0,4274618.666
Site04-Aurora,6,Site04,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93.85,,2384,2574.06,942.43,2703.82951
Site04-Aurora,6,Site04,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,93.74,,2353,2555.6,924.43,2684.438861
Site04-Aurora,6,Site04,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.76,,2293,2586.04,919.12,2716.413473
Site04-Aurora,6,Site04,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.86,,300,26185.1,8691.89,27505.20427
Site04-Aurora,6,Site04,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.79,,300,26820.78,8706.83,28172.93165
Site04-Aurora,6,Site04,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.15,,316,25800.22,8817.76,27100.9208
Site04-Aurora,6,Site04,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.01,,3013,101647.07,35975.34,92319.8012
Site04-Aurora,6,Site04,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,79.52,,3059,101781.51,35881.19,92441.90481
Site04-Aurora,6,Site04,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,79.27,,3076,102801.8,36464.27,93368.57166
Site04-Aurora,6,Site04,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.61,,1886,241305.72,45683.52,7909243.81
Site04-Aurora,6,Site04,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.37,,1939,229459.88,42596.86,7520974.37
Site04-Aurora,6,Site04,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.69,,1959,245319.09,46451.88,8040789.476
Site04-Aurora,6,Site04,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,6424,86265.46,17609.63,3868771.396
Site04-Aurora,6,Site04,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,6424,84966.22,16982.96,3810504.013
Site04-Aurora,6,Site04,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.99,,6424,87521.59,18384.23,3925105.412
Site04-Aurora,6,Site04,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.41,,976,136392.66,80784.55,1046670.62
Site04-Aurora,6,Site04,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.42,,961,137849.69,78980.79,1057851.797
Site04-Aurora,6,Site04,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.24,,961,133544.06,79118.93,1024810.603
Site04-Aurora,6,Site04,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.41,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,39.54,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,39.08,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,38.48,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.89,,492,359968.86,317512.48,4465267.529
Site04-Aurora,6,Site04,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.55,,483,368828.34,315662.54,4575165.78
Site04-Aurora,6,Site04,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.34,,479,359273.19,322508.4,4456638.025
Site04-Aurora,6,Site04,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.97,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,94.12,,2397,2435.52,940.23,2558.305109
Site04-Aurora,6,Site04,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,93.79,,2360,2420.34,923.22,2542.359819
Site04-Aurora,6,Site04,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,93.07,,2307,2439.21,919.89,2562.181137
Site04-Aurora,6,Site04,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.22,,313,26744.27,8852.2,28092.56445
Site04-Aurora,6,Site04,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.09,,311,27369.39,8911.81,28749.19945
Site04-Aurora,6,Site04,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.43,,327,26254.59,8968.99,27578.19756
Site04-Aurora,6,Site04,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,78.74,,2997,101723.96,35943.37,92389.63568
Site04-Aurora,6,Site04,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,79.24,,3045,101783.85,35841.86,92444.03009
Site04-Aurora,6,Site04,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,79.1,,3064,102843.27,36437.3,93406.23632
Site04-Aurora,6,Site04,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.88,,1885,240845.16,45457.91,7894148.099
Site04-Aurora,6,Site04,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.63,,1937,229045.5,42450.83,7507392.295
Site04-Aurora,6,Site04,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.9,,1958,244833.75,46233.63,8024881.555
Site04-Aurora,6,Site04,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,6424,87468.98,17808.68,3922745.996
Site04-Aurora,6,Site04,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,6424,86128.66,17188.78,3862636.287
Site04-Aurora,6,Site04,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,6424,88759.32,18586.96,3980614.238
Site04-Aurora,6,Site04,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.29,,968,137764.2,80692.13,1057195.751
Site04-Aurora,6,Site04,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.37,,955,138959.41,78629.09,1066367.734
Site04-Aurora,6,Site04,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.18,,955,135010.07,78809.43,1036060.692
Site04-Aurora,6,Site04,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,39.65,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,39.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,38.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.02,,496,360545.53,319035.64,4472420.886
Site04-Aurora,6,Site04,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.73,,489,371596.83,320592.19,4609507.775
Site04-Aurora,6,Site04,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.42,,481,357953.5,322126.17,4440267.806
Site04-Aurora,6,Site04,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93.96,,2376,2694.61,945.42,2830.456957
Site04-Aurora,6,Site04,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,93.71,,2340,2674.19,929.21,2809.007497
Site04-Aurora,6,Site04,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.86,,2285,2703.71,925.38,2840.015728
Site04-Aurora,6,Site04,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.18,,313,26308.07,8939.41,27634.37372
Site04-Aurora,6,Site04,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.98,,308,26967.37,8937.63,28326.91189
Site04-Aurora,6,Site04,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.36,,325,25924.56,9017.08,27231.52932
Site04-Aurora,6,Site04,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,78.64,,3005,101731.19,35927.63,92396.20224
Site04-Aurora,6,Site04,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,79.23,,3053,101811.57,35834.04,92469.20647
Site04-Aurora,6,Site04,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,78.96,,3068,102892.22,36425.7,93450.6946
Site04-Aurora,6,Site04,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.82,,1888,239549.4,45305.84,7851677.155
Site04-Aurora,6,Site04,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.58,,1941,227764.77,42297.14,7465413.987
Site04-Aurora,6,Site04,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.84,,1959,243581.65,46118.57,7983841.649
Site04-Aurora,6,Site04,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,6424,87896.98,17827.96,3941940.633
Site04-Aurora,6,Site04,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,6424,86553.5,17199.09,3881689.207
Site04-Aurora,6,Site04,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,6424,89188.5,18582.04,3999861.794
Site04-Aurora,6,Site04,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.33,,972,135848.98,80197.0,1042498.446
Site04-Aurora,6,Site04,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.33,,957,137297.03,78062.96,1053610.711
Site04-Aurora,6,Site04,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.16,,956,133124.73,78369.08,1021592.685
Site04-Aurora,6,Site04,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,39.37,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,38.87,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,38.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.16,,503,360737.38,319841.37,4474800.707
Site04-Aurora,6,Site04,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.82,,494,370810.03,322273.46,4599747.84
Site04-Aurora,6,Site04,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.6,,490,360187.63,326397.53,4467981.282
Site04-Aurora,6,Site04,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,6424,96693.0,22513.0,4336418.221
Site04-Aurora,6,Site04,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,6404,100235.0,23672.0,4495267.293
Site04-Aurora,6,Site04,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1117,155008.71,24616.74,6951719.301
Site04-Aurora,6,Site04,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1528,153954.41,24132.95,6904436.812
Site04-Aurora,6,Site04,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,482,262635.11,50025.95,238535.367
Site04-Aurora,6,Site04,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,401,251473.02,56232.06,228397.525
Site04-Aurora,6,Site04,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,364,246577.64,53785.48,223951.3515
Site04-Aurora,6,Site04,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.11,,362,852005.28,182968.87,27926057.81
Site04-Aurora,6,Site04,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.55,,287,680180.69,183687.28,22294187.27
Site04-Aurora,6,Site04,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.65,,261,758713.5,198924.33,24868246.19
Site04-Aurora,6,Site04,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1528,151814.02,39996.52,6808446.138
Site04-Aurora,6,Site04,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1528,152115.02,33406.28,6821945.17
Site04-Aurora,6,Site04,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1528,155471.42,38046.27,6972470.587
Site04-Aurora,6,Site04,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.62,,119,484747.91,44879.74,3719931.817
Site04-Aurora,6,Site04,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.2,,113,445409.44,41371.79,3418050.317
Site04-Aurora,6,Site04,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.07,,102,403107.81,39765.23,3093429.672
Site04-Aurora,6,Site04,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,484,261957.19,50279.44,237919.6538
Site04-Aurora,6,Site04,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,396,250499.88,55842.95,227513.6816
Site04-Aurora,6,Site04,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,360,247182.22,52759.99,224500.4545
Site04-Aurora,6,Site04,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.11,,363,848306.13,182516.4,27804811.29
Site04-Aurora,6,Site04,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.66,,284,681250.19,186816.12,22329242.13
Site04-Aurora,6,Site04,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.47,,261,748988.94,195622.12,24549505.65
Site04-Aurora,6,Site04,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1528,153985.0,40788.21,6905808.69
Site04-Aurora,6,Site04,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1528,154421.58,34101.49,6925388.117
Site04-Aurora,6,Site04,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1528,158132.38,38594.39,7091807.41
Site04-Aurora,6,Site04,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.63,,119,485563.47,45186.03,3726190.385
Site04-Aurora,6,Site04,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.17,,112,446638.44,41880.53,3427481.603
Site04-Aurora,6,Site04,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.33,,98,405088.14,41282.95,3108626.628
Site04-Aurora,6,Site04,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site04-Aurora,6,Site04,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,485,262229.53,50391.21,238167.0035
Site04-Aurora,6,Site04,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,398,250943.94,56526.21,227916.9941
Site04-Aurora,6,Site04,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,365,246484.11,54187.06,223866.404
Site04-Aurora,6,Site04,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75,,364,844627.94,181799.79,27684251.77
Site04-Aurora,6,Site04,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.31,,284,674913.78,183683.85,22121554.5
Site04-Aurora,6,Site04,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.35,,261,751788.34,196302.82,24641261.19
Site04-Aurora,6,Site04,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1528,155127.27,40372.65,6957036.395
Site04-Aurora,6,Site04,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1528,154981.64,33903.7,6950505.285
Site04-Aurora,6,Site04,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1528,158443.39,38603.26,7105755.363
Site04-Aurora,6,Site04,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.72,,120,481426.19,44873.25,3694441.1
Site04-Aurora,6,Site04,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.43,,113,442047.52,41176.97,3392251.107
Site04-Aurora,6,Site04,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.38,,104,400073.47,38747.03,3070144.295
Site04-Aurora,6,Site04,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site04-Aurora,6,Site04,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site04-Aurora,6,Site04,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site04-Aurora,6,Site04,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,79.25,149.5775,,,
Site05-Cytoflex,7,Site05,Cytoflex,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,7.1875,173.7409755,,,3706.639449
Site05-Cytoflex,7,Site05,Cytoflex,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,21.86300771,383.1635498,67617.9,21132.9,67476.62491
Site05-Cytoflex,7,Site05,Cytoflex,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,18.06741979,383.6060662,67617.9,21132.9,67476.62491
Site05-Cytoflex,7,Site05,Cytoflex,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,48.5,1172.373887,30594.4,10492.1,30530.47866
Site05-Cytoflex,7,Site05,Cytoflex,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,72.30135005,1267.128581,31116.5,10218.8,31051.48783
Site05-Cytoflex,7,Site05,Cytoflex,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,57.28091175,1216.183909,31160.5,10218.8,31095.3959
Site05-Cytoflex,7,Site05,Cytoflex,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,449.9791667,10877.19226,21494.1,7901.8,101995.7543
Site05-Cytoflex,7,Site05,Cytoflex,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,592.8491526,10390.07024,21175.3,7698.6,100482.9556
Site05-Cytoflex,7,Site05,Cytoflex,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,492.8540433,10464.23911,21175.3,7689.6,100482.9556
Site05-Cytoflex,7,Site05,Cytoflex,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,339.9375,8217.192747,169229.3,35487.3,10735782.49
Site05-Cytoflex,7,Site05,Cytoflex,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,442.2738514,7751.139329,168397.7,35860.0,10683026.4
Site05-Cytoflex,7,Site05,Cytoflex,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,369.6630044,7848.656453,168397.7,35860.0,10683026.4
Site05-Cytoflex,7,Site05,Cytoflex,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,609.3541667,14729.70955,24104.8,4905.2,3713883.026
Site05-Cytoflex,7,Site05,Cytoflex,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,840.4655232,14729.70955,23942.3,4856.8,3688846.27
Site05-Cytoflex,7,Site05,Cytoflex,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,693.7529649,14729.70955,23942.3,4856.8,3688846.27
Site05-Cytoflex,7,Site05,Cytoflex,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,100.6041667,2431.87006,238764.5,64697.1,1437474.413
Site05-Cytoflex,7,Site05,Cytoflex,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,136.6300996,2394.532109,239423.2,65997.5,1441440.096
Site05-Cytoflex,7,Site05,Cytoflex,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,111.6854184,2371.296205,239423.2,65997.5,1441440.096
Site05-Cytoflex,7,Site05,Cytoflex,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,57.0625,1379.352267,108610.7,74107.1,9361150.766
Site05-Cytoflex,7,Site05,Cytoflex,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,79.61641654,1395.329919,101171.3,74200.8,8719949.254
Site05-Cytoflex,7,Site05,Cytoflex,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,65.84271143,1397.96738,101171.3,74200.8,8719949.254
Site05-Cytoflex,7,Site05,Cytoflex,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,15.95833333,779.1021621,6811.02,19019.5,6796.789634
Site05-Cytoflex,7,Site05,Cytoflex,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,48.52053465,1634.788219,71500.9,24902.6,71351.5121
Site05-Cytoflex,7,Site05,Cytoflex,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,40.11236856,1597.650334,70888.8,23971.9,70740.69097
Site05-Cytoflex,7,Site05,Cytoflex,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,34.02083333,1660.931894,31395.3,10586.1,31329.70533
Site05-Cytoflex,7,Site05,Cytoflex,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,50.41094509,1698.481266,32167.4,10696.0,32100.19217
Site05-Cytoflex,7,Site05,Cytoflex,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,39.84270558,1586.909827,331610.7,10947.7,330917.8608
Site05-Cytoflex,7,Site05,Cytoflex,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,184.125,8989.170899,23087.9,8353.8,109558.7988
Site05-Cytoflex,7,Site05,Cytoflex,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,235.8081546,7945.015357,23022.9,8384.9,109250.3549
Site05-Cytoflex,7,Site05,Cytoflex,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,202.2247645,8054.484791,22860.8,8261.3,108481.1432
Site05-Cytoflex,7,Site05,Cytoflex,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,165.6875,8089.033284,172873.0,36782.3,8002899.346
Site05-Cytoflex,7,Site05,Cytoflex,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,212.0547364,7144.698369,171459.6,37364.3,7937468.087
Site05-Cytoflex,7,Site05,Cytoflex,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,181.4607149,7227.465794,171685.7,38066.7,7947935.052
Site05-Cytoflex,7,Site05,Cytoflex,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,301.7083333,14729.70955,24704.9,5063.2,3806341.839
Site05-Cytoflex,7,Site05,Cytoflex,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,437.1779624,14729.70955,224576.1,5790.5,34600966.02
Site05-Cytoflex,7,Site05,Cytoflex,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,369.8203078,14729.70955,24414.2,5707.9,3761553.009
Site05-Cytoflex,7,Site05,Cytoflex,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,7.791666667,380.3971392,179948.1,72832.4,1083372.065
Site05-Cytoflex,7,Site05,Cytoflex,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,9.068490666,305.5420104,1145434.2,54545.3,6896051.776
Site05-Cytoflex,7,Site05,Cytoflex,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,7.955057967,316.8449401,151154.5,54506.3,910021.0716
Site05-Cytoflex,7,Site05,Cytoflex,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,32.02083333,1563.289847,108511.9,73246.4,9352635.199
Site05-Cytoflex,7,Site05,Cytoflex,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,43.34245388,1460.324654,93458.9,69798.6,8055217.886
Site05-Cytoflex,7,Site05,Cytoflex,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,39.61798643,1577.959405,92962.4,71942.3,8012424.576
Site05-Cytoflex,7,Site05,Cytoflex,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,9.395833333,223.8165495,64482.3,17101.3,64347.57617
Site05-Cytoflex,7,Site05,Cytoflex,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,28.52054013,493.1061113,70741.4,23051.2,70593.59894
Site05-Cytoflex,7,Site05,Cytoflex,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,23.79775816,495.9230117,69689.6,22215.1,69543.99648
Site05-Cytoflex,7,Site05,Cytoflex,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,48.25,1149.355052,30583.2,10253.6,30519.30206
Site05-Cytoflex,7,Site05,Cytoflex,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,70.95888467,1226.844215,31301.0,10280.3,31235.60235
Site05-Cytoflex,7,Site05,Cytoflex,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,56.35956323,1174.48056,31385.7,10421.5,31320.12539
Site05-Cytoflex,7,Site05,Cytoflex,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,450.8541667,10739.7205,21545.8,7896.7,102241.0859
Site05-Cytoflex,7,Site05,Cytoflex,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,591.808057,10232.07023,21244.5,7814.8,100811.3297
Site05-Cytoflex,7,Site05,Cytoflex,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,492.8315714,10270.14879,21135.1,7682.3,100292.1949
Site05-Cytoflex,7,Site05,Cytoflex,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,200.2083333,4769.128693,164267.7,34270.4,7604529.735
Site05-Cytoflex,7,Site05,Cytoflex,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,260.6574628,4506.63933,164190.3,33935.6,7600946.617
Site05-Cytoflex,7,Site05,Cytoflex,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,225.1910618,4692.77101,163406.8,34333.1,7564675.645
Site05-Cytoflex,7,Site05,Cytoflex,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,618.3541667,14729.70955,23923.8,4618.4,3685995.932
Site05-Cytoflex,7,Site05,Cytoflex,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,851.9449721,14729.70955,24076.9,4972.4,3709584.407
Site05-Cytoflex,7,Site05,Cytoflex,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,706.8316195,14729.70955,23836.8,4890.7,3672591.638
Site05-Cytoflex,7,Site05,Cytoflex,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,100.2083333,2387.045683,238422.1,64259.1,1435413.004
Site05-Cytoflex,7,Site05,Cytoflex,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,135.9999627,2351.372465,236088.5,67168.5,1421363.636
Site05-Cytoflex,7,Site05,Cytoflex,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,110.719126,2307.282982,238512.4,65793.4,1435956.653
Site05-Cytoflex,7,Site05,Cytoflex,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,58.39583333,1391.037224,112369.7,73445.9,9685138.786
Site05-Cytoflex,7,Site05,Cytoflex,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,80.54792314,1392.633974,106969.1,73477.7,9219661.344
Site05-Cytoflex,7,Site05,Cytoflex,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,67.03372293,1396.92006,103026.9,74736.8,8879883.325
Site05-Cytoflex,7,Site05,Cytoflex,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,558.3655,14729.71,27880.9,5330.8,
Site05-Cytoflex,7,Site05,Cytoflex,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,6.464865564,361.9182364,74855.0,27822.7,74698.60433
Site05-Cytoflex,7,Site05,Cytoflex,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,7.96053679,316.1218162,68622.2,22310.4,68478.82661
Site05-Cytoflex,7,Site05,Cytoflex,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,12.05607702,359.4378921,67125.6,21141.9,66985.35348
Site05-Cytoflex,7,Site05,Cytoflex,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,13.63243391,763.1754114,29376.9,13380.8,29315.5224
Site05-Cytoflex,7,Site05,Cytoflex,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,19.53949939,775.9353672,31842.5,12464.5,31775.97099
Site05-Cytoflex,7,Site05,Cytoflex,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,26.67290218,795.221507,31922.1,11784.4,31855.40468
Site05-Cytoflex,7,Site05,Cytoflex,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,132.8000144,7434.454206,23652.1,8293.4,112236.0918
Site05-Cytoflex,7,Site05,Cytoflex,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,203.4739519,8080.178126,23739.1,8238.8,112648.9321
Site05-Cytoflex,7,Site05,Cytoflex,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,269.8318261,8044.721566,23719.8,8169.4,112557.348
Site05-Cytoflex,7,Site05,Cytoflex,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,52.07568131,2915.317967,204178.0,42955.5,12952902.35
Site05-Cytoflex,7,Site05,Cytoflex,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,76.93431176,3055.147537,196439.9,40413.8,12462002.97
Site05-Cytoflex,7,Site05,Cytoflex,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,109.383198,3261.132627,195009.4,41695.0,12371253.1
Site05-Cytoflex,7,Site05,Cytoflex,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,263.113542,14729.70909,19520.3,5972.6,3007538.367
Site05-Cytoflex,7,Site05,Cytoflex,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,370.9215407,14729.70909,19437.0,5286.9,2994704.141
Site05-Cytoflex,7,Site05,Cytoflex,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,494.0561671,14729.70909,19752.2,5347.5,3043267.743
Site05-Cytoflex,7,Site05,Cytoflex,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,38.68108526,2165.457274,198569.4,71891.4,1195481.036
Site05-Cytoflex,7,Site05,Cytoflex,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,61.73692334,2451.642251,201555.1,63835.5,1213456.352
Site05-Cytoflex,7,Site05,Cytoflex,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,81.17758527,2420.21514,201584.4,64289.6,1213632.751
Site05-Cytoflex,7,Site05,Cytoflex,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,51.49189746,2882.636388,117240.41,65841.1,10104945.04
Site05-Cytoflex,7,Site05,Cytoflex,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,66.42114003,2637.657733,110426.0,59019.1,9517611.381
Site05-Cytoflex,7,Site05,Cytoflex,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,85.51403468,2549.501328,110940.6,57918.1,9561964.729
Site05-Cytoflex,7,Site05,Cytoflex,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,3.459459833,425.9449583,69796.8,21339.8,69650.9725
Site05-Cytoflex,7,Site05,Cytoflex,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,17.27633852,1807.317824,69796.8,21339.8,69650.9725
Site05-Cytoflex,7,Site05,Cytoflex,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,25.45794868,1999.587739,18201.1,5881.4,18163.07217
Site05-Cytoflex,7,Site05,Cytoflex,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,7.783784625,958.3761563,31397.5,13303.1,31331.90073
Site05-Cytoflex,7,Site05,Cytoflex,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,8.526327008,891.9588348,31397.5,13303.1,31331.90073
Site05-Cytoflex,7,Site05,Cytoflex,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,11.32710492,889.6844123,30725.6,11900.2,30661.40454
Site05-Cytoflex,7,Site05,Cytoflex,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,43.01622087,5296.359341,23489.4,9198.0,111464.033
Site05-Cytoflex,7,Site05,Cytoflex,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,41.42110713,4333.158043,23489.4,9198.0,111464.033
Site05-Cytoflex,7,Site05,Cytoflex,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,52.5420659,4126.902447,23879.1,9393.4,113313.2728
Site05-Cytoflex,7,Site05,Cytoflex,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,16.56216395,2039.211488,190296.3,39224.4,8809485.199
Site05-Cytoflex,7,Site05,Cytoflex,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,17.21054896,1800.435426,190296.3,39224.4,8809485.199
Site05-Cytoflex,7,Site05,Cytoflex,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,23.62617264,1855.711382,189860.6,38957.5,8789315.113
Site05-Cytoflex,7,Site05,Cytoflex,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,119.6324454,14729.70909,18480.8,5600.6,2847380.166
Site05-Cytoflex,7,Site05,Cytoflex,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,140.8028168,14729.70909,18480.8,5600.6,2847380.166
Site05-Cytoflex,7,Site05,Cytoflex,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,187.5327453,14729.70909,18717.1,5676.8,2883787.461
Site05-Cytoflex,7,Site05,Cytoflex,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,4.378378852,539.0865879,123757.8,59145.2,745080.0722
Site05-Cytoflex,7,Site05,Cytoflex,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,3.368425485,352.3787989,123757.8,59145.2,745080.0722
Site05-Cytoflex,7,Site05,Cytoflex,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,3.757010048,295.0933447,130250.8,59052.6,784170.9813
Site05-Cytoflex,7,Site05,Cytoflex,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,37.6324365,4633.4825,111164.4,57998.8,9581254.04
Site05-Cytoflex,7,Site05,Cytoflex,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,39.05268296,4085.3917,111164.4,57998.8,9581254.04
Site05-Cytoflex,7,Site05,Cytoflex,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,50.03739253,3930.173551,110907.5,56173.7,9559111.842
Site05-Cytoflex,7,Site05,Cytoflex,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,2.378378636,141.8922848,64202.8,19939.3,64068.66013
Site05-Cytoflex,7,Site05,Cytoflex,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,10.86842248,434.8525576,68420.6,21673.7,68277.64782
Site05-Cytoflex,7,Site05,Cytoflex,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,16.26168528,489.3217347,67817.0,21564.8,67675.30893
Site05-Cytoflex,7,Site05,Cytoflex,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,12.67027164,755.898899,32320.7,11803.4,32253.17188
Site05-Cytoflex,7,Site05,Cytoflex,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,19.31579202,772.8372331,31916.2,12444.1,31849.51701
Site05-Cytoflex,7,Site05,Cytoflex,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,25.92523849,780.1025816,32056.9,11788.2,31989.92304
Site05-Cytoflex,7,Site05,Cytoflex,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,132.6054197,7911.139842,23882.3,8247.9,113328.4577
Site05-Cytoflex,7,Site05,Cytoflex,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,199.1973946,7970.015581,23518.4,8045.6,111601.6464
Site05-Cytoflex,7,Site05,Cytoflex,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,262.4673388,7897.765285,23491.4,7966.2,111473.5236
Site05-Cytoflex,7,Site05,Cytoflex,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,16.6918937,995.8258532,190624.0,38931.5,8824655.585
Site05-Cytoflex,7,Site05,Cytoflex,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,26.88158248,1075.549365,188959.0,38403.1,8747576.877
Site05-Cytoflex,7,Site05,Cytoflex,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,43.83178389,1318.918928,188404.0,39080.5,8721883.975
Site05-Cytoflex,7,Site05,Cytoflex,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,246.897324,14729.70909,19842.1,5644.1,3057118.847
Site05-Cytoflex,7,Site05,Cytoflex,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,368.1447853,14729.70909,19303.7,5430.0,2974166.297
Site05-Cytoflex,7,Site05,Cytoflex,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,489.5141102,14729.70909,19612.9,5452.3,3021805.466
Site05-Cytoflex,7,Site05,Cytoflex,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,38.60540958,2303.169768,207478.1,66833.5,1249115.593
Site05-Cytoflex,7,Site05,Cytoflex,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,62.00000816,2480.660111,200142.9,63394.6,1204954.244
Site05-Cytoflex,7,Site05,Cytoflex,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,81.47665074,2451.670622,201199.3,64565.1,1211314.269
Site05-Cytoflex,7,Site05,Cytoflex,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,52.90811383,3156.458372,115864.4,63176.1,9986346.804
Site05-Cytoflex,7,Site05,Cytoflex,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,67.7894826,2712.300698,111879.8,59319.5,9642914.33
Site05-Cytoflex,7,Site05,Cytoflex,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,86.87852091,2614.215428,111901.0,57556.1,9644741.557
Site05-Cytoflex,7,Site05,Cytoflex,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,1416.325,14729.71,20648.4,4849.9,
Site05-Cytoflex,7,Site05,Cytoflex,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-Cytoflex,7,Site05,Cytoflex,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,321.6561023,1982.439252,45293.4,9604.1,
Site05-Cytoflex,7,Site05,Cytoflex,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,257.39,1665.398169,45145.1,9670.4,
Site05-Cytoflex,7,Site05,Cytoflex,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,17.21172117,275.1548317,71473.7,13370.5,71324.36893
Site05-Cytoflex,7,Site05,Cytoflex,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,45.52957193,277.0557794,68528.6,13624.1,68385.42217
Site05-Cytoflex,7,Site05,Cytoflex,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,48.96855346,300.9077662,59305.5,12039.4,59181.59213
Site05-Cytoflex,7,Site05,Cytoflex,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,13.13131313,209.9234712,35487.9,2855.2,35413.7546
Site05-Cytoflex,7,Site05,Cytoflex,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,34.89114589,212.3190096,34699.1,3249.8,34626.60265
Site05-Cytoflex,7,Site05,Cytoflex,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,37.47169811,230.260528,33528.1,3247.9,33458.04924
Site05-Cytoflex,7,Site05,Cytoflex,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,65.63656366,1049.297595,29073.5,10449.4,137962.2112
Site05-Cytoflex,7,Site05,Cytoflex,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,172.829243,1051.69758,34712.7,14336.1,164721.8549
Site05-Cytoflex,7,Site05,Cytoflex,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,169.1572327,1039.457395,48658.5,16741.3,230898.7309
Site05-Cytoflex,7,Site05,Cytoflex,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,42.84428443,684.9292847,437838.6,56763.4,27776159.18
Site05-Cytoflex,7,Site05,Cytoflex,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,111.1311912,676.253641,417801.2,60020.7,26505001.24
Site05-Cytoflex,7,Site05,Cytoflex,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,108.8930818,669.1391041,38804.6,1859.4,1796401.451
Site05-Cytoflex,7,Site05,Cytoflex,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,114.0914091,5569.44716,34839.4,7182.1,5367788.005
Site05-Cytoflex,7,Site05,Cytoflex,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,299.7313285,1823.92,33337.9,7528.2,5136448.381
Site05-Cytoflex,7,Site05,Cytoflex,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,301.3459119,1851.746046,,,4879378.676
Site05-Cytoflex,7,Site05,Cytoflex,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,22.36223622,357.4934362,542823.9,37870.2,3268054.786
Site05-Cytoflex,7,Site05,Cytoflex,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,59.98722907,365.0332696,539099.3,43481.4,3245630.945
Site05-Cytoflex,7,Site05,Cytoflex,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,58.57861635,359.9608187,532473.8,43853.5,3205742.324
Site05-Cytoflex,7,Site05,Cytoflex,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,11.91119112,190.4180154,645.4,398.5,55626.99351
Site05-Cytoflex,7,Site05,Cytoflex,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,31.20444332,189.8847496,591.3,322.2,50964.11723
Site05-Cytoflex,7,Site05,Cytoflex,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,30.91823899,189.9900564,639.5,382.3,55118.47281
Site05-Cytoflex,7,Site05,Cytoflex,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,17.21172117,275.1548317,71466.0,13368.8,71316.68502
Site05-Cytoflex,7,Site05,Cytoflex,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,45.54161998,277.4636832,68544.0,13642.2,68400.79
Site05-Cytoflex,7,Site05,Cytoflex,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,48.98113208,296.4621814,59319.1,12042.7,59195.16372
Site05-Cytoflex,7,Site05,Cytoflex,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,13.13131313,209.9234712,71466.0,13368.8,71316.68502
Site05-Cytoflex,7,Site05,Cytoflex,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,34.87909784,212.5019478,34801.1,3266.4,34728.38954
Site05-Cytoflex,7,Site05,Cytoflex,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,37.47169811,226.8004208,33617.0,3257.6,33546.7635
Site05-Cytoflex,7,Site05,Cytoflex,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,64.73647365,1034.908324,28862.8,10458.4,136962.3784
Site05-Cytoflex,7,Site05,Cytoflex,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,158.40773,965.1038377,33337.9,13990.8,158198.0291
Site05-Cytoflex,7,Site05,Cytoflex,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,161.3710692,976.7111775,47872.1,17568.7,227167.0342
Site05-Cytoflex,7,Site05,Cytoflex,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,24.35243524,389.3097125,429470.2,54324.3,19881686.46
Site05-Cytoflex,7,Site05,Cytoflex,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,63.1317695,384.6321958,398625.6,52160.8,18453781.41
Site05-Cytoflex,7,Site05,Cytoflex,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,65.18238994,394.5215778,372427.3,50384.8,17240969.93
Site05-Cytoflex,7,Site05,Cytoflex,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,114.0914091,1823.92,34826.0,7113.9,5365723.435
Site05-Cytoflex,7,Site05,Cytoflex,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,299.7313285,1826.122093,33373.3,7471.5,5141902.542
Site05-Cytoflex,7,Site05,Cytoflex,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,301.3459119,1823.92,31766.6,7137.6,4894354.507
Site05-Cytoflex,7,Site05,Cytoflex,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,22.59225923,361.1706942,543583.8,38314.2,3272629.741
Site05-Cytoflex,7,Site05,Cytoflex,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,60.43300683,368.1899034,539658.4,43582.1,3248996.99
Site05-Cytoflex,7,Site05,Cytoflex,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,58.89308176,356.455042,533082.0,44002.8,3209403.974
Site05-Cytoflex,7,Site05,Cytoflex,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,11.83118312,189.1389691,681.9,393.5,58772.92667
Site05-Cytoflex,7,Site05,Cytoflex,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,31.13215503,189.6735866,624.6,375.4,53834.24256
Site05-Cytoflex,7,Site05,Cytoflex,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,30.8427673,186.6782919,669.5,380.9,57704.1713
Site05-Cytoflex,7,Site05,Cytoflex,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,17.2101721,275.1548317,71501.4,13374.7,71352.01106
Site05-Cytoflex,7,Site05,Cytoflex,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,45.52957193,277.0669164,8627.2,1283.5,8609.175062
Site05-Cytoflex,7,Site05,Cytoflex,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,48.98113208,296.4621814,59343.3,12046.3,59219.31316
Site05-Cytoflex,7,Site05,Cytoflex,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,13.1201312,209.7635905,35680.6,2886.4,35606.05199
Site05-Cytoflex,7,Site05,Cytoflex,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,34.89114589,212.3275443,34899.4,3281.8,34826.48416
Site05-Cytoflex,7,Site05,Cytoflex,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,37.4591195,226.7242877,33708.4,3255.8,33637.97254
Site05-Cytoflex,7,Site05,Cytoflex,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,64.16064161,1025.795119,28818.7,10618.9,136753.1111
Site05-Cytoflex,7,Site05,Cytoflex,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,155.7812556,947.9955622,33134.2,14073.8,157231.4134
Site05-Cytoflex,7,Site05,Cytoflex,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,161.2075472,975.7214476,47972.2,17464.8,227642.0378
Site05-Cytoflex,7,Site05,Cytoflex,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,21.5902159,345.1826157,427577.3,53556.5,19794057.46
Site05-Cytoflex,7,Site05,Cytoflex,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,56.60172769,344.4457193,394467.6,49876.0,18261292.96
Site05-Cytoflex,7,Site05,Cytoflex,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,60.98113208,369.0931319,369922.0,144017.2,17124990.78
Site05-Cytoflex,7,Site05,Cytoflex,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,114.0811408,1823.92,34670.9,7161.4,5341826.815
Site05-Cytoflex,7,Site05,Cytoflex,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,299.7192805,1823.92,33212.5,7502.3,5117127.709
Site05-Cytoflex,7,Site05,Cytoflex,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,301.3459119,1823.92,,,4864110.106
Site05-Cytoflex,7,Site05,Cytoflex,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,22.5602256,360.6910519,542333.9,38225.9,3265104.756
Site05-Cytoflex,7,Site05,Cytoflex,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,60.33662245,367.1741512,538672.5,43510.2,3243061.409
Site05-Cytoflex,7,Site05,Cytoflex,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,58.57861635,354.5517152,531870.8,43920.1,3202111.981
Site05-Cytoflex,7,Site05,Cytoflex,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-Cytoflex,7,Site05,Cytoflex,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,11.9501195,191.0575386,607.7,399.6,52377.63241
Site05-Cytoflex,7,Site05,Cytoflex,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,31.3008277,190.4789227,551.9,379.9,47568.23322
Site05-Cytoflex,7,Site05,Cytoflex,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,31.00628931,187.6680219,600.5,385.7,51757.06477
Site05-CytoflexLX,8,Site05,CytoflexLX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLX,8,Site05,CytoflexLX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site05-CytoflexLX,8,Site05,CytoflexLX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,1.061965699,0.361804789,81383.2,26866.5,60425.36584
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,0.590895661,0.155961072,75247.6,21699.5,55869.808
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,0.757280083,0.238268208,68216.0,25093.0,50648.98844
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,38.69095028,13.18175447,38970.7,13154.4,28934.94978
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,51.65791687,13.63459679,39689.6,13405.7,29468.71836
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,41.37856043,13.01921927,38830.8,12819.9,28831.07688
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,332.7492522,113.3655005,94573.6,33798.3,100223.1854
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,423.1494739,111.686123,95816.0,34030.2,101539.8032
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,374.3487877,117.7839175,93959.9,33693.3,99572.8245
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,261.2966601,89.02206826,109480.3,21822.5,9769732.752
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,330.9242972,87.34419878,111376.8,22118.6,9938971.401
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,293.7470024,92.42362698,111738.3,22494.5,9971230.706
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,467.3534045,159.2242574,29572.6,6103.3,3453174.181
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,603.2590168,159.2242574,29805.2,6090.3,3480334.739
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,506.0572698,159.2242574,29451.2,6062.6,3438998.378
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,91.43524664,31.15139231,38981.0,16325.4,1707471.482
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,117.8609577,31.10823535,39389.3,16225.0,1725356.108
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,101.3007742,31.87295491,39856.3,15470.7,1745811.95
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,50.39027239,17.16763722,282611.5,201188.4,9796126.65
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,59.1122929,15.60210569,272843.1,198523.9,9457525.837
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,50.11640754,15.76846782,260886.3,200114.0,9043068.792
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,23.71723393,28.76253774,83613.6,26705.4,62081.39234
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,27.56755528,26.66561152,81827.6,25853.2,60755.32378
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,18.01938249,22.09992685,77328.8,27063.6,57415.05655
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,35.62894918,43.20820035,38906.3,13274.3,28887.13409
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,47.90800209,46.34056809,39815.4,13561.6,29562.1223
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,39.04846787,47.89111302,39025.8,13140.1,28975.8604
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,29.04476185,35.22337644,71551.7,28884.3,75826.01585
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,33.24924434,32.16140945,71241.3,28720.9,75497.07335
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,31.4562496,38.57961367,71277.1,27323.9,75535.01195
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,22.4428751,27.21708795,99101.6,26289.7,8843564.982
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,25.0676121,24.24746044,101483.1,27660.1,9056083.75
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,24.64072885,30.22069738,102490.0,26452.9,9145936.846
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,131.2943592,159.2242574,27568.1,7820.9,3219109.958
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,164.6098952,159.2242574,27709.2,8292.3,3235586.117
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,129.8249906,159.2242574,27214.6,7736.4,3177831.982
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,8.814315298,10.68936104,23712.9,14119.4,1038688.092
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,9.704324902,9.386822853,23518.1,13046.8,1030155.334
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,9.669884136,11.85965902,25776.5,14842.9,1129079.261
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,9.30989929,11.29036929,89691.0,62790.3,3108947.779
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,10.09067976,9.760537111,92538.5,66537.2,3207650.311
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,9.495127194,11.64532783,90365.8,69906.6,3132338.286
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,17.68172888,5.295812797,78757.8,25780.7,58476.0599
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,20.24953978,4.843096076,78842.4,23482.7,58538.87367
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,19.94136036,5.57510185,74254.5,25752.2,55132.45151
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,46.00081417,13.77759505,39130.0,13154.4,29053.22678
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,60.97588691,14.58364397,39847.4,13605.0,29585.88164
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,50.48445661,14.1141819,55040.1,18879.9,40866.15147
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,352.2540222,105.5027691,94310.5,33684.8,99944.36845
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,403.5135565,96.50860924,94666.7,33609.6,100321.8469
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,367.2355877,102.6698163,92916.1,33132.4,98466.67056
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,272.4119011,81.5894442,111379.8,22075.6,9939239.114
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,337.4923297,80.71826794,113221.9,22390.4,10103623.25
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,303.9746801,84.98366063,113608.0,22698.7,10138077.8
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,531.6200287,159.2242574,29364.0,6151.7,3428816.088
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,665.7348697,159.2242574,29719.5,6190.2,3470327.603
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,569.5229219,159.2242574,29355.3,6169.1,3427800.195
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,98.07253226,29.37347218,39047.0,15768.3,1710362.458
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,118.1791323,28.26498271,40014.5,14934.7,1752741.531
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,105.5319314,29.5040687,40248.3,14232.5,1762982.593
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,56.56737287,16.94236006,277096.8,195733.8,9604971.302
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,51.31701552,12.27352519,224848.5,169278.5,7793895.093
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,44.36807052,12.40419448,211012.4,165591.8,7314296.11
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,22.72,159.2242574,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,43.17,5.596491228,206.994024,72253.3,23235.7,53646.60134
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,2.739393939,227.219207,69723.5,22179.6,51768.27644
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,2.000027972,120.617861,69932.2,21854.9,51923.23193
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,27.78947368,1027.832395,37599.3,12784.9,27916.71325
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,12.47272727,1034.551168,37453.8,13704.0,27808.68247
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,17.42681716,1050.978006,36889.0,13072.5,27389.32999
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,223.1578947,8253.805595,88008.9,29617.5,93266.32696
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,87.49090909,7256.939099,86785.7,29953.4,91970.05611
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,136.9669506,8260.214774,87427.8,29504.3,92650.51353
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,157.754386,5834.765716,112080.8,23282.8,10001794.5
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,62.3030303,5167.728868,112277.2,23807.2,10019320.72
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,96.22512203,5803.153032,111449.6,22878.4,9945467.881
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,436.7192982,16152.67159,19728.1,5759.2,2303638.015
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,194.7393939,16152.67159,19712.1,6223.7,2301769.705
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,267.8359138,16152.67159,19448.9,5638.2,2271036.004
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,107.4736842,3975.063921,30688.4,14928.6,1344233.545
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,42.8,3550.048761,30253.5,15264.7,1325183.769
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,65.74917132,3965.206745,30449.4,13950.5,1333764.71
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,90.29824561,3339.806399,251416.3,136111.3,8714811.381
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,49.55151515,4110.053621,265494.0,134154.1,9202784.914
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,59.37145974,3580.57916,254816.5,130963.8,8832672.083
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,31.0877193,4174.815354,72993.1,23398.3,54195.88774
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,16.5,4438.191363,72590.2,22683.9,53896.74271
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,5.846235612,1576.422304,72757.0,21989.7,54020.58831
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,20.19298246,2711.745187,36885.7,12998.0,27386.87981
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,9.025641026,2427.728609,37134.8,13505.9,27571.83148
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,13.73445782,3703.46101,36789.0,12960.8,27315.08203
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,19.85964912,2666.981366,66747.1,24557.7,70734.40132
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,8.487179487,2282.892527,68893.3,25831.7,73008.80983
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,12.43374033,3352.725904,68171.4,25486.1,72243.78536
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,12.33333333,1656.261396,100259.1,27235.6,8946857.224
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,5.205128205,1400.082124,70100.9,94485.7,6255619.126
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,8.363753339,2255.264444,101347.5,26937.1,9043983.164
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,120.2807018,16152.67159,17202.5,6805.8,2008725.268
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,60.05128205,16152.67159,17067.7,7106.4,1992984.755
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,59.90293571,16152.67159,17454.4,6315.4,2038139.475
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,12.07017544,1620.921537,17201.1,13575.4,753453.9317
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,4.679487179,1258.69452,19001.4,13750.3,832311.8602
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,6.755339236,1821.559743,19275.8,13539.6,844331.3101
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,15.14035088,2033.219893,122583.8,67594.6,4249106.742
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,7.576923077,2038.050579,127094.8,73220.6,4405470.964
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,9.832305347,2651.255692,125870.2,74416.7,4363022.809
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,26.50877193,957.1625075,72511.0,23503.1,53837.93833
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,13.43030303,1087.64267,71658.6,22008.7,53205.04872
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,15.31489951,839.92665,72145.1,22447.9,53566.26504
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,28.77192982,1038.879227,37377.8,13003.8,27752.25402
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,12.69090909,1027.763425,39847.4,13605.0,29585.88164
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,19.84643142,1088.452892,37040.6,13110.5,27501.8899
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,208.2807018,7520.472064,87278.9,29234.9,92492.71862
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,81.87878788,6630.890102,85979.4,29613.3,91115.58981
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,135.2886054,7419.735603,86704.3,29061.0,91883.79349
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,153,5524.43033,113587.7,23517.2,10136266.28
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,60.76363636,4920.895941,113695.4,24020.5,10145877.14
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,98.63075008,5409.281037,112820.0,23057.5,10067758.76
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,447.3508772,16152.67159,19796.5,5858.5,2311625.041
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,199.4545455,16152.67159,19852.4,6485.6,2318152.449
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,294.5216017,16152.67159,19577.3,5776.8,2286029.192
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,104.4561404,3771.638365,30735.8,14295.0,1346309.792
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,41.21212121,3337.531657,30457.1,14382.5,1334101.99
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,68.58837187,3761.644102,30571.7,11360.5,1339121.775
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,73.40350877,2650.408955,217748.8,120107.2,7547799.091
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,39.49090909,3198.140629,228484.6,122445.7,7919932.767
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,50.713996,2781.346149,226240.0,115324.4,7842128.481
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,1361.875,16152.67159,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,284.4831,2137.778,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,286.69385,2638.416,,,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,37.33041705,316.114867,42747.3,8486.8,31738.99824
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,39.93230834,330.976274,42490.2,8532.1,31548.10673
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,43.2653326,354.0431123,38399.7,7672.8,28510.99392
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,31.10375472,263.3873411,34377.2,3819.4,25524.36973
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,29.41317872,243.7891698,33944.7,3685.4,25203.2473
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,32.06521152,262.3917719,32852.4,3563.1,24392.23684
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,147.8241165,1251.778164,109014.4,40453.2,115526.6419
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,150.5273988,1247.636304,126495.9,50652.4,134052.4421
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,149.4286425,1222.784582,170056.1,58895.5,180214.8172
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,94.3457571,798.9221343,209983.7,27972.7,18738390.66
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,96.88368381,803.0139506,209134.1,28180.0,18662574.6
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,96.50915145,789.7408455,198665.8,26738.9,17728411.17
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,256.9680489,2176.011603,31991.2,7763.9,3735592.605
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,262.5359372,2176.011603,32323.4,8038.3,3774383.393
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,265.9163883,2176.011603,31522.0,7725.3,3680804.411
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,52.47342338,444.3462079,81595.7,9121.7,3574108.689
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,52.7398775,437.1309566,81551.2,9019.9,3572159.471
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,51.95731846,425.1702143,80757.3,8814.6,3537384.54
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,31.24168711,264.5553559,1196.2,678.0,41463.72918
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,29.03818233,240.6810372,1110.2,705.0,38482.72206
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,31.88142575,260.8878406,1313.2,661.0,45519.28537
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,37.33041705,316.1512313,42720.1,8466.9,31718.80279
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,39.93230834,330.976274,42487.5,8549.4,31546.10204
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,43.24371074,353.8805664,42548.6,8557.8,31591.46754
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,31.20227785,264.2520321,34308.5,3834.9,25473.36138
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,29.46125518,244.1876483,33891.4,3689.3,25163.67314
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,32.0976443,262.6678504,33981.8,3684.8,25230.7933
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,147.7058887,1250.920892,109193.6,40382.2,115716.5468
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,150.5370141,1247.715999,126650.9,50600.0,134216.7014
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,149.4826971,1223.276648,124724.0,51705.9,132174.6933
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,94.21767702,797.9293284,211657.7,28143.0,18887774
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,96.97983673,803.8109077,210832.2,28285.6,18814108.56
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,96.62807165,790.7461255,141792.1,22720.7,12653152.42
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,256.938492,2176.011603,31663.7,7807.3,3697350.633
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,262.5359372,2176.011603,32005.6,8060.1,3737274.084
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,265.9055774,2176.011603,32177.8,8044.5,3757381.771
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,51.89213687,439.4744089,81712.7,9073.6,3579233.601
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,52.32641994,433.7040412,81702.2,8950.8,3578773.673
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,51.94650753,425.0990303,71292.7,11885.4,3122809.885
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,31.18257323,264.0851537,1208.8,670.4,41900.48138
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,24.66322439,204.4194902,1113.4,725.2,38593.64326
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,31.75169461,259.8368059,1138.0,699.5,39446.34995
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,37.33041705,346.9383306,42770.4,8466.0,31756.14952
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,39.93268847,363.234904,42548.6,8557.8,31591.46754
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,43.26491164,388.5499536,38432.3,7679.5,28535.19876
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,31.11360703,289.1610578,34393.7,3846.9,25536.62064
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,29.43268948,267.725028,33981.8,3684.8,25230.7933
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,32.08652117,288.1599856,32846.6,3576.4,24387.93045
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,144.1393511,1339.590334,108062.1,41541.5,114517.4539
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,145.4711399,1323.231607,124724.0,51705.9,132174.6933
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,148.1407007,1330.409799,169619.6,59351.3,179752.2418
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,89.89251126,835.4355578,210678.2,27075.0,18800366.01
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,91.30768353,830.5510832,141792.1,22720.7,12653152.42
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,94.48658863,848.55737,199882.0,26182.7,17836941.64
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,256.9581966,2388.096754,31836.4,7763.7,3717516.705
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,262.5384363,2388.096754,32177.8,8044.5,3757381.771
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,265.913801,2388.096754,31400.2,7711.9,3666581.901
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,52.3453433,486.4828057,80689.7,9032.9,3534423.48
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,52.68268724,479.2111821,71292.7,11885.4,3122809.885
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,51.87032635,465.832753,79859.6,8731.8,3498062.892
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,26.65050887,247.6822867,1207.1,693.3,41841.5545
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,28.67307417,260.8154307,1138.0,699.5,39446.34995
Site05-CytoflexLXNUV,9,Site05,CytoflexLXNUV,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,27.57840819,247.673896,1319.0,666.3,45720.33003
Site06-Lyric-1,10,Site06,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,58.3,,783.2975831,22983.0,7332.0,89975.25656
Site06-Lyric-1,10,Site06,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,72.8,,983.9656863,21474.0,6979.0,84067.7309
Site06-Lyric-1,10,Site06,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.7,,903.8900041,22481.0,6853.0,88009.9962
Site06-Lyric-1,10,Site06,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.2,,354.016545,7105.0,2563.0,27815.08932
Site06-Lyric-1,10,Site06,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.2,,351.1037781,6973.0,2557.0,27298.32763
Site06-Lyric-1,10,Site06,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.6,,379.6259905,6964.0,2561.0,27263.09388
Site06-Lyric-1,10,Site06,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.7,,1883.627056,11760.0,4406.0,69822.40473
Site06-Lyric-1,10,Site06,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,57.7,,1813.726805,11590.0,4153.0,68813.06725
Site06-Lyric-1,10,Site06,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,58.2,,1897.609203,11626.0,4241.0,69026.8093
Site06-Lyric-1,10,Site06,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,34,,640.5396918,25313.0,6707.0,6290777.161
Site06-Lyric-1,10,Site06,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.1,,599.5813008,24612.0,6728.0,6178197.773
Site06-Lyric-1,10,Site06,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.6,,638.047661,24827.0,6687.0,6169996.625
Site06-Lyric-1,10,Site06,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,61.7,,4464,19192.0,5097.0,4860813.116
Site06-Lyric-1,10,Site06,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,74.5,,4325.020445,19579.0,5484.0,4960813.116
Site06-Lyric-1,10,Site06,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,82.1,,4292.1431,19738.0,4901.0,5001099.611
Site06-Lyric-1,10,Site06,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.8,,1032.548256,27885.0,18579.0,98183.71453
Site06-Lyric-1,10,Site06,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,55.3,,1002.395983,26308.0,17933.0,92631.06193
Site06-Lyric-1,10,Site06,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,55.1,,1045.273346,26027.0,17759.0,91641.65458
Site06-Lyric-1,10,Site06,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,73.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,30.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,27.1,,854.820438,29847.0,23355.0,6593227.725
Site06-Lyric-1,10,Site06,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,26.6,,838.1144189,27969.0,22195.0,6178197.773
Site06-Lyric-1,10,Site06,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.7,,836.1926395,28781.0,22614.0,6357747.417
Site06-Lyric-1,10,Site06,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,62.9,,549.9262868,22631.0,7684.0,88597.22539
Site06-Lyric-1,10,Site06,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,76.6,,955.0015672,21530.0,6945.0,84286.96313
Site06-Lyric-1,10,Site06,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.4,,904.2713925,22409.0,6925.0,87728.12619
Site06-Lyric-1,10,Site06,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,362.1917656,7005.0,2525.0,27423.60319
Site06-Lyric-1,10,Site06,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.6,,294.8427619,6628.0,2438.0,25947.70049
Site06-Lyric-1,10,Site06,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.8,,371.3634678,7058.0,2623.0,27631.09084
Site06-Lyric-1,10,Site06,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.9,,1982.328333,11774.0,4411.0,69905.52664
Site06-Lyric-1,10,Site06,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,59,,1813.766893,11585.0,4153.0,68783.38085
Site06-Lyric-1,10,Site06,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.6,,1906.170654,11641.0,4242.0,69115.86849
Site06-Lyric-1,10,Site06,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,34,,674.6709359,24612.0,6728.0,6116564.907
Site06-Lyric-1,10,Site06,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.1,,600.1815444,24860.0,6770.0,6178197.773
Site06-Lyric-1,10,Site06,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,74.4,,643.7506156,25114.0,746.0,6241321.756
Site06-Lyric-1,10,Site06,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,57.2,,4327,19178.0,6267.0,4860813.116
Site06-Lyric-1,10,Site06,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,72.5,,4436,19644.0,5418.0,4977282.438
Site06-Lyric-1,10,Site06,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,72.7,,4435.056084,19660.0,5052.0,4981336.425
Site06-Lyric-1,10,Site06,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.5,,1081.171754,27983.0,18444.0,98183.71453
Site06-Lyric-1,10,Site06,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,54.9,,996.30409,26266.0,17877.0,92483.17898
Site06-Lyric-1,10,Site06,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.9,,1042.757333,25929.0,17644.0,91296.59437
Site06-Lyric-1,10,Site06,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,74.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,72.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,27.1,,897.296906,30160.0,23119.0,6662369.691
Site06-Lyric-1,10,Site06,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,28.7,,881.1204867,27293.0,22556.0,6029046.949
Site06-Lyric-1,10,Site06,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.4,,862.3345594,28457.0,23076.0,6286175.541
Site06-Lyric-1,10,Site06,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,61.6,,506.9897182,22141.0,7515.0,86678.94337
Site06-Lyric-1,10,Site06,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,80.4,,933.5094432,21674.0,6838.0,84870.27746
Site06-Lyric-1,10,Site06,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.4,,900.709302,22456.0,7004.0,87912.12467
Site06-Lyric-1,10,Site06,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,373.2007648,7084.0,2523.0,27732.87723
Site06-Lyric-1,10,Site06,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11,,343.3894016,6938.0,2569.0,27161.30749
Site06-Lyric-1,10,Site06,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.5,,372.1077039,7054.0,2650.0,27615.43139
Site06-Lyric-1,10,Site06,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60,,2043.482232,11772.0,4410.0,69893.65208
Site06-Lyric-1,10,Site06,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,57.7,,1809.809914,11600.0,4156.0,68872.44004
Site06-Lyric-1,10,Site06,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,58.8,,1899.862626,11631.0,4248.0,69056.4957
Site06-Lyric-1,10,Site06,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,34,,694.8703777,25295.0,6730.0,6286303.808
Site06-Lyric-1,10,Site06,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.2,,600.6942118,26034.0,6746.0,6469959.807
Site06-Lyric-1,10,Site06,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.8,,641.7587215,24871.0,6696.0,6180931.488
Site06-Lyric-1,10,Site06,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,55.2,,4322.215376,18710.0,6305.0,4740630.951
Site06-Lyric-1,10,Site06,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,72.2,,4436,19837.0,5238.0,4912165.273
Site06-Lyric-1,10,Site06,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,72.7,,4435.866245,19797.0,5029.0,5016048.688
Site06-Lyric-1,10,Site06,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.2,,1108.079801,27796.0,18290.0,97870.34352
Site06-Lyric-1,10,Site06,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,54.5,,986.3802946,26068.0,17815.0,91786.01651
Site06-Lyric-1,10,Site06,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,54.3,,1032.057169,25832.0,17554.0,90955.05518
Site06-Lyric-1,10,Site06,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,76.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,72.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,27.1,,923.8799379,30091.0,23156.0,6647127.532
Site06-Lyric-1,10,Site06,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,28.2,,884.2988815,27379.0,22650.0,6048044.422
Site06-Lyric-1,10,Site06,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.6,,859.2451078,28334.0,23058.0,6259004.736
Site06-Lyric-1,10,Site06,Lyric,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,66.6,,4451,20675.0,5165.0,
Site06-Lyric-1,10,Site06,Lyric,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,67.1,,4421,20733.0,5252.0,
Site06-Lyric-1,10,Site06,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85,,960.6497522,16638.0,5204.0,65135.4618
Site06-Lyric-1,10,Site06,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.7,,941.1633365,16645.0,4903.0,65162.86583
Site06-Lyric-1,10,Site06,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.1,,941.1633365,16051.0,4731.0,62837.43824
Site06-Lyric-1,10,Site06,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.1,,522.0632676,7105.0,2405.0,27815.08932
Site06-Lyric-1,10,Site06,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.9,,471.8338813,7099.0,2469.0,27791.60015
Site06-Lyric-1,10,Site06,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.5,,471.8338813,7227.0,2499.0,28292.70239
Site06-Lyric-1,10,Site06,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.1,,2953.557935,16256.0,5823.0,96516.41252
Site06-Lyric-1,10,Site06,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.2,,2686.873565,16063.0,5597.0,98826.01418
Site06-Lyric-1,10,Site06,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,74.3,,2686.873565,15922.0,5678.0,94533.36123
Site06-Lyric-1,10,Site06,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.4,,2197.733005,25412.0,6521.0,6315380.603
Site06-Lyric-1,10,Site06,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.4,,2026.83206,25189.0,6705.0,6259960.728
Site06-Lyric-1,10,Site06,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64,,2026.83206,25127.0,6904.0,6244552.511
Site06-Lyric-1,10,Site06,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,82.1,,4954.467087,16849.0,5026.0,4269101.598
Site06-Lyric-1,10,Site06,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,81.9,,4637.946735,16872.0,4573.0,4274929.204
Site06-Lyric-1,10,Site06,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,79.1,,4637.946735,16492.0,4489.0,4178647.015
Site06-Lyric-1,10,Site06,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.9,,705.6855204,37486.0,11124.0,133256.6204
Site06-Lyric-1,10,Site06,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.2,,623.7273256,37247.0,10952.0,131147.5279
Site06-Lyric-1,10,Site06,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.1,,623.7273256,36421.0,10970.0,127605.3792
Site06-Lyric-1,10,Site06,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,74.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.4,,505.9279789,59859.0,37735.0,13163260.86
Site06-Lyric-1,10,Site06,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.5,,423.7488998,59589.0,37735.0,13163260.86
Site06-Lyric-1,10,Site06,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13,,423.7488998,57346.0,39719.0,12667780.25
Site06-Lyric-1,10,Site06,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.3,,646.2116462,16801.0,5150.0,65773.58419
Site06-Lyric-1,10,Site06,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.4,,684.7697006,16793.0,4960.0,65742.2653
Site06-Lyric-1,10,Site06,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.7,,792.2181833,16287.0,4770.0,63761.3455
Site06-Lyric-1,10,Site06,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.8,,382.1796488,7149.0,2443.0,27987.34322
Site06-Lyric-1,10,Site06,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.9,,514.0455626,7122.0,2473.0,27881.64196
Site06-Lyric-1,10,Site06,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.3,,507.913544,7254.0,2489.0,28417.97796
Site06-Lyric-1,10,Site06,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.6,,2916.220076,16288.0,5823.0,96706.40546
Site06-Lyric-1,10,Site06,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.4,,2890.937655,16060.0,5594.0,95352.70578
Site06-Lyric-1,10,Site06,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.6,,2753.52349,15923.0,5681.0,94539.29851
Site06-Lyric-1,10,Site06,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.4,,2170.663058,25892.0,6720.0,13160168.25
Site06-Lyric-1,10,Site06,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.6,,2185.295725,25428.0,6723.0,6319356.917
Site06-Lyric-1,10,Site06,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.6,,2046.06776,25374.0,6922.0,6395403.921
Site06-Lyric-1,10,Site06,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,76.3,,4949.933204,16941.0,4938.0,4292412.023
Site06-Lyric-1,10,Site06,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76,,4950.732407,16883.0,45323.0,4277716.32
Site06-Lyric-1,10,Site06,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,77.1,,4950.735531,16596.0,4481.0,4296212.636
Site06-Lyric-1,10,Site06,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.2,,696.4844053,37456.0,11222.0,131883.4216
Site06-Lyric-1,10,Site06,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.1,,666.7071938,37061.0,10929.0,130492.6177
Site06-Lyric-1,10,Site06,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23,,632.7431158,36225.0,10905.0,127654.6735
Site06-Lyric-1,10,Site06,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,81.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,80.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,77.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,15.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,18.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.4,,497.5269608,59515.0,38871.0,6434670.021
Site06-Lyric-1,10,Site06,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.7,,468.4210085,59515.0,38871.0,13146914.2
Site06-Lyric-1,10,Site06,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.4,,473.929222,57418.0,39616.0,12683685.11
Site06-Lyric-1,10,Site06,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.3,,669.0144096,16715.0,5184.0,65436.90612
Site06-Lyric-1,10,Site06,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86.5,,708.3178575,16712.0,4963.0,65425.16154
Site06-Lyric-1,10,Site06,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,85.9,,821.7284722,16188.0,4729.0,63373.77423
Site06-Lyric-1,10,Site06,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.6,,513.5289,7092.0,2421.0,27764.19612
Site06-Lyric-1,10,Site06,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.7,,508.6937088,7.0,2440.0,27732.87723
Site06-Lyric-1,10,Site06,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.1,,501.3151976,7155.0,2424.0,28010.83238
Site06-Lyric-1,10,Site06,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.1,,2930.621822,16299.0,5825.0,96771.71553
Site06-Lyric-1,10,Site06,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.3,,2896.690898,16066.0,5596.0,95388.32945
Site06-Lyric-1,10,Site06,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72,,2759.944471,15933.0,5679.0,94598.6713
Site06-Lyric-1,10,Site06,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.5,,2178.530678,25717.0,6731.0,6391179.088
Site06-Lyric-1,10,Site06,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.6,,2190.379986,25239.0,6731.0,6258469.61
Site06-Lyric-1,10,Site06,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.7,,2087.909696,25183.0,6915.0,6258469.61
Site06-Lyric-1,10,Site06,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,76.3,,4949.399806,16890.0,5003.0,4279489.94
Site06-Lyric-1,10,Site06,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76,,4950.732407,16853.0,4600.0,4270115.095
Site06-Lyric-1,10,Site06,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,7.1,,4950.735524,16549.0,4497.0,4205758.052
Site06-Lyric-1,10,Site06,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.8,,698.0845992,37156.0,11185.0,130827.1148
Site06-Lyric-1,10,Site06,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23,,667.1085829,36750.0,10876.0,129397.5797
Site06-Lyric-1,10,Site06,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23,,633.5534455,35909.0,10879.0,126436.3997
Site06-Lyric-1,10,Site06,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,82.06,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,80.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,77.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,16.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.7,,517.2626858,59931.0,38805.0,6391179.088
Site06-Lyric-1,10,Site06,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.8,,473.1038807,57418.0,39616.0,12683685.11
Site06-Lyric-1,10,Site06,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.6,,481.8761752,57384.0,39668.0,12676174.48
Site06-Lyric-1,10,Site06,Lyric,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,57.3,,5029,19053.0,3594.0,
Site06-Lyric-1,10,Site06,Lyric,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,59,,4872,18992.0,3587.0,
Site06-Lyric-1,10,Site06,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.7,,1015.497745,15782.0,4977.0,61784.34055
Site06-Lyric-1,10,Site06,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86,,1098.173138,17863.0,5880.0,69931.16686
Site06-Lyric-1,10,Site06,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87,,1128.175631,21905.0,7044.0,85755.03611
Site06-Lyric-1,10,Site06,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.4,,354.6979121,7875.0,2708.0,30829.5325
Site06-Lyric-1,10,Site06,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.4,,345.2116014,7871.0,2794.0,30813.87305
Site06-Lyric-1,10,Site06,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.2,,332.2904948,16307.0,3295.0,63839.64272
Site06-Lyric-1,10,Site06,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.9,,2822.925267,14777.0,5352.0,87735.17642
Site06-Lyric-1,10,Site06,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75,,2750.765061,14728.0,5253.0,87444.24973
Site06-Lyric-1,10,Site06,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,76.3,,2740.746561,14711.0,5309.0,87343.31598
Site06-Lyric-1,10,Site06,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64,,1806.899304,25648.0,7178.0,6374031.234
Site06-Lyric-1,10,Site06,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.7,,1751.994958,25491.0,7130.0,6335013.653
Site06-Lyric-1,10,Site06,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.1,,1757.395504,25617.0,6985.0,6366327.125
Site06-Lyric-1,10,Site06,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,79.3,,5065.735891,15869.0,483.0,4020794.899
Site06-Lyric-1,10,Site06,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,79.9,,5065.473361,15679.0,4752.0,3972653.805
Site06-Lyric-1,10,Site06,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,81,,5065.609988,17071.0,4975.0,4325350.667
Site06-Lyric-1,10,Site06,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30,,847.7887548,25863.0,16794.0,91064.20688
Site06-Lyric-1,10,Site06,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.4,,837.3553719,35836.0,1489.0,126179.365
Site06-Lyric-1,10,Site06,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.3,,830.0762164,36074.0,16496.0,127017.3684
Site06-Lyric-1,10,Site06,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,74.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,72.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.2,,497.0524724,43238.0,31904.0,9551311.031
Site06-Lyric-1,10,Site06,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.1,,480.6893809,45925.0,32595.0,10143988.02
Site06-Lyric-1,10,Site06,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.5,,447.7341408,45654.0,31785.0,10065126.41
Site06-Lyric-1,10,Site06,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,86.9,,898.7423957,15954.0,4954.0,62457.69669
Site06-Lyric-1,10,Site06,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.8,,969.4050785,18115.0,5856.0,70917.7119
Site06-Lyric-1,10,Site06,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.4,,1008.08915,22092.0,7068.0,86487.11517
Site06-Lyric-1,10,Site06,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.4,,355.0489182,7895.0,3698.0,30907.82972
Site06-Lyric-1,10,Site06,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.2,,332.8202722,7909.0,2725.0,30962.63778
Site06-Lyric-1,10,Site06,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.3,,342.244441,7904.0,2823.0,30943.06347
Site06-Lyric-1,10,Site06,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.8,,2827.947423,14779.0,5357.0,87747.05098
Site06-Lyric-1,10,Site06,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75.8,,2739.163669,14719.0,5252.0,87390.81422
Site06-Lyric-1,10,Site06,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.3,,2776.9388,14722.0,5305.0,87408.62606
Site06-Lyric-1,10,Site06,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64,,1810.32586,25895.0,7205.0,6435415.58
Site06-Lyric-1,10,Site06,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.6,,1741.231138,25663.0,7111.0,6377759.028
Site06-Lyric-1,10,Site06,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.3,,1785.147004,25935.0,7064.0,6445356.365
Site06-Lyric-1,10,Site06,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,78.6,,5065.735236,15972.0,4879.0,4046892.44
Site06-Lyric-1,10,Site06,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,79.1,,5065.603785,15739.0,4802.0,3987856.256
Site06-Lyric-1,10,Site06,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,80.2,,5065.869621,17123.0,4976.0,4338526.124
Site06-Lyric-1,10,Site06,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30,,847.3781227,35699.0,16711.0,125696.9849
Site06-Lyric-1,10,Site06,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.5,,836.5411127,35649.0,16410.0,125520.9338
Site06-Lyric-1,10,Site06,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.1,,835.9890879,35900.0,16479.0,126404.7105
Site06-Lyric-1,10,Site06,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,74.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,71.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,72.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.2,,498.8159298,43270.0,31974.0,9558379.859
Site06-Lyric-1,10,Site06,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.7,,458.6844465,45264.0,32250.0,9945839.953
Site06-Lyric-1,10,Site06,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.9,,476.7953984,46249.0,32202.0,10216443.5
Site06-Lyric-1,10,Site06,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,86.2,,934.2208111,15850.0,4978.0,62050.55112
Site06-Lyric-1,10,Site06,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.2,,1008.894468,18018.0,31.0,70537.97035
Site06-Lyric-1,10,Site06,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.9,,1047.724315,21976.0,7084.0,86032.99126
Site06-Lyric-1,10,Site06,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.1,,346.841225,7764.0,2722.0,30394.9829
Site06-Lyric-1,10,Site06,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.1,,331.2354137,7761.0,2723.0,30383.23831
Site06-Lyric-1,10,Site06,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.1,,334.4217109,7773.0,2784.0,30430.21665
Site06-Lyric-1,10,Site06,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.7,,2831.786506,14779.0,5355.0,87865.79656
Site06-Lyric-1,10,Site06,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75.3,,2755.408468,14729.0,5254.0,87450.18701
Site06-Lyric-1,10,Site06,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.8,,2771.071752,14718.0,5312.0,87384.87694
Site06-Lyric-1,10,Site06,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64,,1813.635413,25680.0,7183.0,6381983.862
Site06-Lyric-1,10,Site06,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.7,,1754.966578,25516.0,7129.0,6341226.644
Site06-Lyric-1,10,Site06,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.3,,1782.017912,25695.0,7033.0,6385711.656
Site06-Lyric-1,10,Site06,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,78.6,,5065.735236,15913.0,4891.0,4031943.363
Site06-Lyric-1,10,Site06,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,79,,5065.603785,15710.0,4786.0,3980508.404
Site06-Lyric-1,10,Site06,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,80.2,,5065.739242,,,4328897.905
Site06-Lyric-1,10,Site06,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,29.9,,845.3923905,35435.0,16614.0,124767.435
Site06-Lyric-1,10,Site06,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.3,,836.1448981,35358.0,16362.0,124496.3162
Site06-Lyric-1,10,Site06,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30,,832.0777229,35555.0,16332.0,125189.9577
Site06-Lyric-1,10,Site06,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,74.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,72.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,72.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.4,,509.1417372,43546.0,32148.0,9599467.417
Site06-Lyric-1,10,Site06,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.3,,478.3631055,45779.0,32601.0,10112620.1
Site06-Lyric-1,10,Site06,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.8,,466.6258493,46092.0,31953.0,10181762.06
Site06-Lyric-1,10,Site06,Lyric,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,58.3,,5071,19914.0,4744.0,
Site06-Lyric-1,10,Site06,Lyric,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,58.2,,5061,19648.0,4773.0,
Site06-Lyric-1,10,Site06,Lyric,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1780,31376.0,6835.0,
Site06-Lyric-1,10,Site06,Lyric,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1388,31451.0,7112.0,
Site06-Lyric-1,10,Site06,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.3,,263,8652.0,1722.0,33871.3797
Site06-Lyric-1,10,Site06,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,19.7,,252.0181208,11286.0,2175.0,44183.12429
Site06-Lyric-1,10,Site06,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,20.8,,262.5825503,9870.0,1814.0,38639.68073
Site06-Lyric-1,10,Site06,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.1,,176.8711409,8512.0,754.0,33323.29913
Site06-Lyric-1,10,Site06,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.1,,177.8013423,9839.0,847.0,38518.32003
Site06-Lyric-1,10,Site06,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,,176.738255,10417.0,937.0,40781.10984
Site06-Lyric-1,10,Site06,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.4,,893.1261745,31589.0,10564.0,187552.7162
Site06-Lyric-1,10,Site06,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.2,,899.6375839,31479.0,10894.0,186899.6155
Site06-Lyric-1,10,Site06,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.4,,886.3489933,31590.0,10177.0,187558.6535
Site06-Lyric-1,10,Site06,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.9,,579.7812081,62917.0,10929.0,15636108.98
Site06-Lyric-1,10,Site06,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.8,,574.0671141,60164.0,10127.0,15063768.29
Site06-Lyric-1,10,Site06,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.6,,581.309396,68693.0,11022.0,17071558.31
Site06-Lyric-1,10,Site06,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,21592.0,5506.0,5470855.345
Site06-Lyric-1,10,Site06,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,22182.0,5696.0,5620346.112
Site06-Lyric-1,10,Site06,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,22337.0,6250.0,5659619.111
Site06-Lyric-1,10,Site06,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.5,,308.2288591,101915.0,12729.0,358845.0158
Site06-Lyric-1,10,Site06,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.4,,318.3946309,98046.0,12779.0,345222.1795
Site06-Lyric-1,10,Site06,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.1,,302.5147651,102054.0,12985.0,359334.438
Site06-Lyric-1,10,Site06,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,49,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,49.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,11.2,,139.5302013,272.0,125.0,60085.0317
Site06-Lyric-1,10,Site06,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,11.5,,145.0449664,283.0,138.0,62514.94107
Site06-Lyric-1,10,Site06,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.3,,152.4865772,284.0,131.0,62735.84192
Site06-Lyric-1,10,Site06,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.3,,262.7154362,8655.0,1723.0,33883.12429
Site06-Lyric-1,10,Site06,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,19.7,,252.0181208,11289.0,2173.0,44194.86887
Site06-Lyric-1,10,Site06,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,20.8,,262.5161074,9876.0,1814.0,38663.1699
Site06-Lyric-1,10,Site06,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.1,,176.8711409,8532.0,756.0,33401.59635
Site06-Lyric-1,10,Site06,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.1,,177.6684564,9861.0,850.0,38604.44698
Site06-Lyric-1,10,Site06,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,,176.2067114,10439.0,935.0,40867.23679
Site06-Lyric-1,10,Site06,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.6,,894.7872483,31611.0,10531.0,187683.3364
Site06-Lyric-1,10,Site06,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.3,,901.2322148,314.0,10883.0,187683.3364
Site06-Lyric-1,10,Site06,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.4,,886.9469799,31597.0,10165.0,187600.2145
Site06-Lyric-1,10,Site06,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.6,,581.4422819,63266.0,10966.0,15722842.33
Site06-Lyric-1,10,Site06,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.9,,575.5288591,60524.0,10157.0,14974301.23
Site06-Lyric-1,10,Site06,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.7,,582.3724832,69058.0,11027.0,17162267.97
Site06-Lyric-1,10,Site06,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,21650.0,5494.0,5485551.047
Site06-Lyric-1,10,Site06,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,22236.0,5682.0,5634028.318
Site06-Lyric-1,10,Site06,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,22394.0,6249.0,5674061.439
Site06-Lyric-1,10,Site06,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.5,,308.6275168,101588.0,12731.0,357693.6414
Site06-Lyric-1,10,Site06,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.4,,318.6604027,97738.0,12743.0,344137.7045
Site06-Lyric-1,10,Site06,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.1,,302.5147651,101709.0,12934.0,358119.6852
Site06-Lyric-1,10,Site06,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,49,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,49.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,11.2,,140.3275168,271.0,125.0,59864.13085
Site06-Lyric-1,10,Site06,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,11.5,,145.5765101,282.0,135.0,62294.04022
Site06-Lyric-1,10,Site06,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.4,,153.5496644,284.0,132.0,62735.84192
Site06-Lyric-1,10,Site06,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.3,,262.7154362,8658.0,1723.0,33894.86887
Site06-Lyric-1,10,Site06,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,19.7,,252.0181208,10727.0,2907.0,41994.71684
Site06-Lyric-1,10,Site06,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,20.8,,262.5161074,9391.0,2529.0,36764.46218
Site06-Lyric-1,10,Site06,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.1,,176.8711409,8541.0,756.0,33436.8301
Site06-Lyric-1,10,Site06,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.1,,177.6684564,9870.0,852.0,38639.68073
Site06-Lyric-1,10,Site06,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,,176.2067114,10447.0,935.0,40898.55568
Site06-Lyric-1,10,Site06,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.6,,895.3187919,31616.0,10523.0,187713.0228
Site06-Lyric-1,10,Site06,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.4,,902.0295302,31493.0,10879.0,186982.7374
Site06-Lyric-1,10,Site06,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.5,,887.0134228,31601.0,10161.0,187623.9636
Site06-Lyric-1,10,Site06,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65,,582.1731544,62984.0,10939.0,3226778.756
Site06-Lyric-1,10,Site06,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.9,,576.4590604,60240.0,10141.0,14970821.96
Site06-Lyric-1,10,Site06,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.7,,582.5053691,68579.0,11009.0,17043227.07
Site06-Lyric-1,10,Site06,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,21650.0,5494.0,5485551.047
Site06-Lyric-1,10,Site06,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,22236.0,5682.0,5634028.318
Site06-Lyric-1,10,Site06,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,22934.0,6248.0,5810883.498
Site06-Lyric-1,10,Site06,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,308.2288591,101126.0,12707.0,356066.929
Site06-Lyric-1,10,Site06,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.3,,318.3281879,97257.0,12722.0,342444.0927
Site06-Lyric-1,10,Site06,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.1,,302.3154362,101261.0,12912.0,356542.2671
Site06-Lyric-1,10,Site06,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,49,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,49.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-1,10,Site06,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,11.5,,143.9154362,271.0,123.0,59864.13085
Site06-Lyric-1,10,Site06,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,11.8,,148.8986577,281.0,132.0,62073.13936
Site06-Lyric-1,10,Site06,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.6,,156.8053691,284.0,130.0,62735.84192
Site06-Lyric-2,11,Site06,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78.2,,872.874775,16167.0,28.0,77405.25656
Site06-Lyric-2,11,Site06,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,76.2,,659.280812,14892.0,4857.0,71497.7309
Site06-Lyric-2,11,Site06,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,74.8,,677.6427683,16077.0,4910.0,75439.9962
Site06-Lyric-2,11,Site06,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.2,,363.6195241,4873.0,1629.0,15245.08932
Site06-Lyric-2,11,Site06,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.5,,403.9662509,4846.0,1642.0,14728.32763
Site06-Lyric-2,11,Site06,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.6,,403.0506176,5023.0,1688.0,14693.09388
Site06-Lyric-2,11,Site06,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.5,,1905.881736,10426.0,4315.0,57252.40473
Site06-Lyric-2,11,Site06,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.6,,1983.901225,10392.0,3804.0,56243.06725
Site06-Lyric-2,11,Site06,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,59,,2051.995271,12037.0,4537.0,56456.8093
Site06-Lyric-2,11,Site06,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.9,,643.2132741,27705.0,7409.0,6278207.161
Site06-Lyric-2,11,Site06,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.3,,660.6898328,27296.0,6938.0,6165627.773
Site06-Lyric-2,11,Site06,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.3,,682.653066,28996.0,7464.0,6157426.625
Site06-Lyric-2,11,Site06,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,72.6,,4473.5,18214.0,4730.0,4848243.116
Site06-Lyric-2,11,Site06,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,67.8,,4473.5,18236.0,4984.0,4948243.116
Site06-Lyric-2,11,Site06,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,68.2,,4473.5,18339.0,4868.0,4988529.611
Site06-Lyric-2,11,Site06,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.7,,1036.765302,25955.0,17233.0,85613.71453
Site06-Lyric-2,11,Site06,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,55.5,,1100.727015,25783.0,16876.0,80061.06193
Site06-Lyric-2,11,Site06,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,5.2,,1133.440687,26711.0,17160.0,79071.65458
Site06-Lyric-2,11,Site06,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,78.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,77.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.8,,867.3714894,19537.0,16732.0,6580657.725
Site06-Lyric-2,11,Site06,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,28.9,,1012.381414,18804.0,16019.0,6165627.773
Site06-Lyric-2,11,Site06,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.1,,941.3792739,19767.0,16506.0,6345177.417
Site06-Lyric-2,11,Site06,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.4,,477.784984,16665.0,4614.0,76027.22539
Site06-Lyric-2,11,Site06,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,74.5,,986.3832379,15436.0,4445.0,71716.96313
Site06-Lyric-2,11,Site06,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,74.1,,932.3788967,16532.0,4544.0,75158.12619
Site06-Lyric-2,11,Site06,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.8,,314.6781506,4687.0,1737.0,14853.60319
Site06-Lyric-2,11,Site06,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.1,,304.5313936,4697.0,1741.0,13377.70049
Site06-Lyric-2,11,Site06,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,382.9065734,4878.0,1744.0,15061.09084
Site06-Lyric-2,11,Site06,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.6,,1722.279392,10410.0,3849.0,57335.52664
Site06-Lyric-2,11,Site06,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.7,,1873.367879,,,56213.38085
Site06-Lyric-2,11,Site06,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,59.2,,1965.420233,10747.0,3952.0,56545.86849
Site06-Lyric-2,11,Site06,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.8,,586.1651825,27872.0,7427.0,6103994.907
Site06-Lyric-2,11,Site06,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.2,,619.9037106,27494.0,6970.0,6165627.773
Site06-Lyric-2,11,Site06,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.2,,663.7603419,29173.0,7452.0,6228751.756
Site06-Lyric-2,11,Site06,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,72.6,,3758.968667,18383.0,3527.0,4848243.116
Site06-Lyric-2,11,Site06,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,67.8,,4581.768443,18377.0,3729.0,4964712.438
Site06-Lyric-2,11,Site06,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,68.3,,4572.911111,18497.0,4757.0,4968766.425
Site06-Lyric-2,11,Site06,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.8,,931.4655633,25813.0,17151.0,85613.71453
Site06-Lyric-2,11,Site06,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,55.4,,1029.042975,25755.0,16796.0,79913.17898
Site06-Lyric-2,11,Site06,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,55.3,,1075.169402,26672.0,17134.0,78726.59437
Site06-Lyric-2,11,Site06,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,78.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,77.16,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,27,,779.5862793,19595.0,16744.0,6649799.691
Site06-Lyric-2,11,Site06,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29.2,,910.0744005,18806.0,16037.0,6016476.949
Site06-Lyric-2,11,Site06,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.3,,889.1385392,19754.0,16509.0,6273605.541
Site06-Lyric-2,11,Site06,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,73,,424.9744512,16579.0,4670.0,74108.94337
Site06-Lyric-2,11,Site06,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,70.4,,969.579837,15351.0,4507.0,72300.27746
Site06-Lyric-2,11,Site06,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,69.9,,936.3301215,16493.0,4583.0,75342.12467
Site06-Lyric-2,11,Site06,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.8,,312.8284155,4729.0,1741.0,15162.87723
Site06-Lyric-2,11,Site06,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.2,,356.6578169,4721.0,1739.0,14591.30749
Site06-Lyric-2,11,Site06,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12,,386.8236409,4900.0,1735.0,15045.43139
Site06-Lyric-2,11,Site06,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.5,,1712.909965,10414.0,3850.0,57323.65208
Site06-Lyric-2,11,Site06,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.5,,1879.740172,10386.0,3799.0,56302.44004
Site06-Lyric-2,11,Site06,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,59,,1974.997482,10755.0,3956.0,56486.4957
Site06-Lyric-2,11,Site06,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.8,,582.4618268,27867.0,7430.0,6273733.808
Site06-Lyric-2,11,Site06,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.2,,623.9047716,27474.0,6955.0,6457389.807
Site06-Lyric-2,11,Site06,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.1,,667.1386877,29169.0,7451.0,6168361.488
Site06-Lyric-2,11,Site06,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,72.6,,3623.014514,18205.0,4764.0,4728060.951
Site06-Lyric-2,11,Site06,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,67.8,,4607.405086,18225.0,4984.0,4899595.273
Site06-Lyric-2,11,Site06,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,68.3,,4611.293756,18331.0,4885.0,5003478.688
Site06-Lyric-2,11,Site06,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.3,,928.8267362,25817.0,16964.0,85300.34352
Site06-Lyric-2,11,Site06,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,55.1,,1024.493595,25604.0,16657.0,79216.01651
Site06-Lyric-2,11,Site06,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,54.9,,1072.872471,26501.0,16977.0,78385.05518
Site06-Lyric-2,11,Site06,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.35,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,78.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.9,,774.4247181,19534.0,16736.0,6634557.532
Site06-Lyric-2,11,Site06,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29.1,,918.4678008,18771.0,16004.0,6035474.422
Site06-Lyric-2,11,Site06,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.2,,893.2261213,19682.0,16430.0,6246434.736
Site06-Lyric-2,11,Site06,Lyric,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,69.1,,4752,19032.0,4780.0,
Site06-Lyric-2,11,Site06,Lyric,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,69.2,,4195,19272.0,4877.0,
Site06-Lyric-2,11,Site06,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.1,,1345.350857,12848.0,3957.0,52565.4618
Site06-Lyric-2,11,Site06,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85,,1409.161637,12956.0,3808.0,52592.86583
Site06-Lyric-2,11,Site06,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.3,,1410.943658,7312.0,3749.0,50267.43824
Site06-Lyric-2,11,Site06,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.7,,731.1283458,5401.0,1747.0,15245.08932
Site06-Lyric-2,11,Site06,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.3,,706.455701,5469.0,1725.0,15221.60015
Site06-Lyric-2,11,Site06,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.7,,707.3490825,1822.0,577.0,15722.70239
Site06-Lyric-2,11,Site06,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.4,,4136.337607,15244.0,5242.0,83946.41252
Site06-Lyric-2,11,Site06,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.9,,4022.935238,15273.0,5268.0,86256.01418
Site06-Lyric-2,11,Site06,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,74,,4028.022628,7152.0,3762.0,81963.36123
Site06-Lyric-2,11,Site06,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.8,,3077.835573,31113.0,6306.0,6302810.603
Site06-Lyric-2,11,Site06,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.2,,3034.684707,30938.0,6273.0,6247390.728
Site06-Lyric-2,11,Site06,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,74.4,,3038.522359,21411.0,6556.0,6231982.511
Site06-Lyric-2,11,Site06,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,77.2,,0,15719.0,4574.0,4256531.598
Site06-Lyric-2,11,Site06,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76.4,,6944.189557,15998.0,4405.0,4262359.204
Site06-Lyric-2,11,Site06,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,82.9,,6952.971156,13374.0,4911.0,4166077.015
Site06-Lyric-2,11,Site06,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.5,,988.283833,40202.0,10147.0,120686.6204
Site06-Lyric-2,11,Site06,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.3,,933.8789402,40176.0,9938.0,118577.5279
Site06-Lyric-2,11,Site06,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.9,,935.0599204,27905.0,14877.0,115035.3792
Site06-Lyric-2,11,Site06,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,82.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,82.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,11.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.1,,708.531531,44617.0,30177.0,13150690.86
Site06-Lyric-2,11,Site06,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.3,,634.4602155,3281.0,1692.0,13150690.86
Site06-Lyric-2,11,Site06,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.3,,635.2625518,20489.0,15460.0,12655210.25
Site06-Lyric-2,11,Site06,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,70.5,,897.7600701,13064.0,3760.0,53203.58419
Site06-Lyric-2,11,Site06,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,72.7,,957.6604715,13136.0,3632.0,53172.2653
Site06-Lyric-2,11,Site06,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,46.6,,1123.69501,8719.0,2974.0,51191.3455
Site06-Lyric-2,11,Site06,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.3,,530.949311,5367.0,1780.0,15417.34322
Site06-Lyric-2,11,Site06,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.7,,718.9002601,5440.0,1755.0,15311.64196
Site06-Lyric-2,11,Site06,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.9,,720.4327383,2256.0,806.0,15847.97796
Site06-Lyric-2,11,Site06,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,73.6,,4051.406309,15231.0,5234.0,84136.40546
Site06-Lyric-2,11,Site06,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.9,,4043.01872,15248.0,5254.0,82782.70578
Site06-Lyric-2,11,Site06,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.7,,3905.641997,7124.0,3739.0,81969.29851
Site06-Lyric-2,11,Site06,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.6,,3015.629059,31250.0,6220.0,13147598.25
Site06-Lyric-2,11,Site06,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75,,3056.168128,31061.0,6178.0,6306786.917
Site06-Lyric-2,11,Site06,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,74.5,,2902.175413,21565.0,6582.0,6382833.921
Site06-Lyric-2,11,Site06,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,77.3,,6876.775444,15825.0,4933.0,4279842.023
Site06-Lyric-2,11,Site06,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76.5,,6923.671896,16117.0,4755.0,4265146.32
Site06-Lyric-2,11,Site06,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,83,,7022.202887,13594.0,4839.0,4283642.636
Site06-Lyric-2,11,Site06,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.6,,967.6023207,40060.0,10073.0,119313.4216
Site06-Lyric-2,11,Site06,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.5,,932.3997908,40058.0,9922.0,117922.6177
Site06-Lyric-2,11,Site06,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,24,,897.4930104,27810.0,14856.0,115084.6735
Site06-Lyric-2,11,Site06,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,79.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,79.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.6,,691.1974456,44960.0,29736.0,6422100.021
Site06-Lyric-2,11,Site06,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.2,,655.0936519,3259.0,1651.0,13134344.2
Site06-Lyric-2,11,Site06,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.8,,672.2288295,20293.0,15303.0,12671115.11
Site06-Lyric-2,11,Site06,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.5,,936.9274358,13123.0,3750.0,52866.90612
Site06-Lyric-2,11,Site06,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,76.7,,990.6991927,13190.0,3.0,52855.16154
Site06-Lyric-2,11,Site06,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,57.2,,1165.553082,8719.0,2942.0,50803.77423
Site06-Lyric-2,11,Site06,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.2,,719.1763116,5385.0,1786.0,15194.19612
Site06-Lyric-2,11,Site06,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.6,,711.49194,5458.0,1760.0,15162.87723
Site06-Lyric-2,11,Site06,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.8,,711.0736619,2766.0,1404.0,15440.83238
Site06-Lyric-2,11,Site06,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,73.4,,4104.216515,15238.0,5235.0,84201.71553
Site06-Lyric-2,11,Site06,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.8,,4051.499343,15266.0,5264.0,82818.32945
Site06-Lyric-2,11,Site06,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68.6,,3914.750302,7105.0,3989.0,82028.6713
Site06-Lyric-2,11,Site06,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.7,,3050.943496,31283.0,272.0,6378609.088
Site06-Lyric-2,11,Site06,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.1,,3063.607194,31121.0,6253.0,6245899.61
Site06-Lyric-2,11,Site06,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,74.5,,2961.525204,21512.0,6583.0,6245899.61
Site06-Lyric-2,11,Site06,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,77.3,,6931.432869,15793.0,4801.0,4266919.94
Site06-Lyric-2,11,Site06,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76.5,,6924.41472,16063.0,4617.0,4257545.095
Site06-Lyric-2,11,Site06,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,83,,7022.204102,13364.0,4995.0,4193188.052
Site06-Lyric-2,11,Site06,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.5,,977.6390525,39819.0,10070.0,118257.1148
Site06-Lyric-2,11,Site06,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.3,,933.0612343,39797.0,9862.0,116827.5797
Site06-Lyric-2,11,Site06,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.9,,898.6425518,27578.0,14836.0,113866.3997
Site06-Lyric-2,11,Site06,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,80.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,80.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,71.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,12,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.7,,724.4053266,45286.0,29759.0,6378609.088
Site06-Lyric-2,11,Site06,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.2,,661.7137033,3279.0,1672.0,12671115.11
Site06-Lyric-2,11,Site06,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.2,,683.501035,20276.0,12222.0,12663604.48
Site06-Lyric-2,11,Site06,Lyric,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,80.3,,,17889.0,3687.0,
Site06-Lyric-2,11,Site06,Lyric,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,80.1,,,17869.0,3676.0,
Site06-Lyric-2,11,Site06,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.8,,1508.637066,11640.0,3907.0,49214.34055
Site06-Lyric-2,11,Site06,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,61.3,,1657.691893,12531.0,4591.0,57361.16686
Site06-Lyric-2,11,Site06,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,58.3,,1683.222284,16069.0,5853.0,73185.03611
Site06-Lyric-2,11,Site06,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,0.8,,526.9439738,1653.0,597.0,18259.5325
Site06-Lyric-2,11,Site06,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,0.8,,521.0967683,1598.0,633.0,18243.87305
Site06-Lyric-2,11,Site06,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,0.5,,495.772777,1632.0,576.0,51269.64272
Site06-Lyric-2,11,Site06,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,82.5,,4193.775625,12362.0,4633.0,75165.17642
Site06-Lyric-2,11,Site06,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,83.3,,4152.278711,117.0,4629.0,74874.24973
Site06-Lyric-2,11,Site06,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.3,,4089.155589,13296.0,4744.0,74773.31598
Site06-Lyric-2,11,Site06,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.8,,2684.353832,29402.0,7027.0,6361461.234
Site06-Lyric-2,11,Site06,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63,,2644.635658,28832.0,6798.0,6322443.653
Site06-Lyric-2,11,Site06,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.1,,2622.009546,30504.0,6529.0,6353757.125
Site06-Lyric-2,11,Site06,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,79.9,,7525.72516,15099.0,4788.0,4008224.899
Site06-Lyric-2,11,Site06,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,80.1,,7646.329925,15095.0,4367.0,3960083.805
Site06-Lyric-2,11,Site06,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,80.8,,7557.819349,16480.0,4309.0,4312780.667
Site06-Lyric-2,11,Site06,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30.6,,1259.486341,39087.0,16210.0,78494.20688
Site06-Lyric-2,11,Site06,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.4,,1263.987584,37941.0,16123.0,113609.365
Site06-Lyric-2,11,Site06,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.4,,1238.462121,38463.0,16726.0,114447.3684
Site06-Lyric-2,11,Site06,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,0.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,35.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,43.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.4,,738.4278174,30208.0,20715.0,9538741.031
Site06-Lyric-2,11,Site06,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.8,,725.6004199,29522.0,21318.0,10131418.02
Site06-Lyric-2,11,Site06,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.7,,668.0130845,30620.0,22203.0,10052556.41
Site06-Lyric-2,11,Site06,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,72.5,,1329.925584,11894.0,3631.0,49887.69669
Site06-Lyric-2,11,Site06,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,74.4,,1435.83297,13821.0,4069.0,58347.7119
Site06-Lyric-2,11,Site06,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,75.2,,1497.901757,16877.0,5106.0,73917.11517
Site06-Lyric-2,11,Site06,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.8,,525.388189,5275.0,1912.0,18337.82972
Site06-Lyric-2,11,Site06,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.5,,492.9562784,5056.0,2001.0,18392.63778
Site06-Lyric-2,11,Site06,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.9,,508.5349343,5743.0,1848.0,18373.06347
Site06-Lyric-2,11,Site06,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.2,,4184.691459,12325.0,4608.0,75177.05098
Site06-Lyric-2,11,Site06,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.1,,4057.108418,12072.0,4689.0,74820.81422
Site06-Lyric-2,11,Site06,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77.3,,4126.204025,13352.0,4861.0,74838.62606
Site06-Lyric-2,11,Site06,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.5,,2678.852903,295.0,6979.0,6422845.58
Site06-Lyric-2,11,Site06,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.3,,2579.022053,29375.0,6962.0,6365189.028
Site06-Lyric-2,11,Site06,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.4,,2652.518217,31050.0,6714.0,6432786.365
Site06-Lyric-2,11,Site06,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,80,,7496.086667,15082.0,4771.0,4034322.44
Site06-Lyric-2,11,Site06,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,80.2,,7502.911928,14780.0,4683.0,3975286.256
Site06-Lyric-2,11,Site06,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,80.9,,7527.285665,16163.0,4685.0,4325956.124
Site06-Lyric-2,11,Site06,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30.7,,1253.918642,39023.0,16193.0,113126.9849
Site06-Lyric-2,11,Site06,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.1,,1239.041693,38011.0,16225.0,112950.9338
Site06-Lyric-2,11,Site06,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.1,,1242.181333,38804.0,16690.0,113834.7105
Site06-Lyric-2,11,Site06,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.71,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.1,,738.1292678,29766.0,20450.0,9545809.859
Site06-Lyric-2,11,Site06,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.3,,679.3798234,30655.0,22086.0,9933269.953
Site06-Lyric-2,11,Site06,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.3,,708.4618113,31.0,22590.0,10203873.5
Site06-Lyric-2,11,Site06,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,61.7,,1382.49631,11692.0,3652.0,49480.55112
Site06-Lyric-2,11,Site06,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,70.8,,1517.424279,13230.0,4077.0,57967.97035
Site06-Lyric-2,11,Site06,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,71.2,,1556.834528,16138.0,5128.0,73462.99126
Site06-Lyric-2,11,Site06,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.2,,513.2691418,5340.0,1914.0,17824.9829
Site06-Lyric-2,11,Site06,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.2,,498.1934929,5292.0,2042.0,17813.23831
Site06-Lyric-2,11,Site06,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.6,,496.923913,5778.0,1884.0,17860.21665
Site06-Lyric-2,11,Site06,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,65.9,,4190.587867,12232.0,4563.0,75295.79656
Site06-Lyric-2,11,Site06,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.9,,4144.262696,12043.0,4675.0,74880.18701
Site06-Lyric-2,11,Site06,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77.8,,4117.590974,13347.0,4754.0,74814.87694
Site06-Lyric-2,11,Site06,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.1,,2683.88826,29250.0,6910.0,6369413.862
Site06-Lyric-2,11,Site06,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.2,,2639.551489,29250.0,6870.0,6328656.644
Site06-Lyric-2,11,Site06,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.2,,2647.936079,30919.0,6630.0,6373141.656
Site06-Lyric-2,11,Site06,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,80,,7496.472129,15315.0,4637.0,4019373.363
Site06-Lyric-2,11,Site06,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,80.2,,7618.904075,14857.0,4695.0,3967938.404
Site06-Lyric-2,11,Site06,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,80.9,,7527.283321,16224.0,4659.0,4316327.905
Site06-Lyric-2,11,Site06,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31,,1251.044557,38615.0,16110.0,112197.435
Site06-Lyric-2,11,Site06,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.1,,1257.600879,37838.0,16121.0,111926.3162
Site06-Lyric-2,11,Site06,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.2,,1236.400941,38563.0,16601.0,112619.9577
Site06-Lyric-2,11,Site06,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,76.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,31,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.7,,753.4477554,29174.0,20075.0,9586897.417
Site06-Lyric-2,11,Site06,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13,,719.4803952,30407.0,21929.0,10100050.1
Site06-Lyric-2,11,Site06,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.1,,693.368688,31667.0,22558.0,10169192.06
Site06-Lyric-2,11,Site06,Lyric,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,80.5,,,18427.0,4555.0,
Site06-Lyric-2,11,Site06,Lyric,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,80.7,,,18778.0,4537.0,
Site06-Lyric-2,11,Site06,Lyric,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,3738,12794.0,7796.0,
Site06-Lyric-2,11,Site06,Lyric,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,4124,13090.0,7815.0,
Site06-Lyric-2,11,Site06,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.3,,650.559769,8656.0,1718.0,21301.3797
Site06-Lyric-2,11,Site06,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.5,,622.0912467,11287.0,2174.0,31613.12429
Site06-Lyric-2,11,Site06,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.6,,651.6489933,9869.0,1814.0,26069.68073
Site06-Lyric-2,11,Site06,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.2,,437.9843462,8512.0,754.0,20753.29913
Site06-Lyric-2,11,Site06,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.1,,438.8916889,9840.0,849.0,25948.32003
Site06-Lyric-2,11,Site06,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,,438.6098993,10417.0,939.0,28211.10984
Site06-Lyric-2,11,Site06,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.6,,2211.639963,31618.0,10530.0,174982.7162
Site06-Lyric-2,11,Site06,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.4,,2220.7001,31485.0,10907.0,174329.6155
Site06-Lyric-2,11,Site06,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.5,,2199.645134,31579.0,10177.0,174988.6535
Site06-Lyric-2,11,Site06,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64,,1435.706764,62894.0,11042.0,15623538.98
Site06-Lyric-2,11,Site06,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.4,,1417.049399,60095.0,10242.0,15051198.29
Site06-Lyric-2,11,Site06,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.9,,1442.630831,68692.0,11063.0,17058988.31
Site06-Lyric-2,11,Site06,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,21605.0,5519.0,5458285.345
Site06-Lyric-2,11,Site06,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,22190.0,5710.0,5607776.112
Site06-Lyric-2,11,Site06,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,22346.0,6277.0,5647049.111
Site06-Lyric-2,11,Site06,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,763.2642307,101928.0,12749.0,346275.0158
Site06-Lyric-2,11,Site06,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.3,,785.9375834,98079.0,12802.0,332652.1795
Site06-Lyric-2,11,Site06,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34,,750.748448,102048.0,13007.0,346764.438
Site06-Lyric-2,11,Site06,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,20.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.2,,345.517328,233.0,117.0,47515.0317
Site06-Lyric-2,11,Site06,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.5,,358.0345878,237.0,132.0,49944.94107
Site06-Lyric-2,11,Site06,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,15,,378.4247064,246.0,129.0,50165.84192
Site06-Lyric-2,11,Site06,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.3,,650.0661728,8660.0,1717.0,21313.12429
Site06-Lyric-2,11,Site06,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.5,,625.4313339,10725.0,2902.0,31624.86887
Site06-Lyric-2,11,Site06,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.6,,651.4841023,9874.0,1815.0,26093.1699
Site06-Lyric-2,11,Site06,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.2,,439.4651348,8532.0,757.0,20831.59635
Site06-Lyric-2,11,Site06,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14,,440.9183725,9862.0,852.0,26034.44698
Site06-Lyric-2,11,Site06,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,,437.2907718,10439.0,936.0,28297.23679
Site06-Lyric-2,11,Site06,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.6,,2224.637996,31616.0,529.0,175113.3364
Site06-Lyric-2,11,Site06,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.4,,2236.580705,31483.0,10907.0,175113.3364
Site06-Lyric-2,11,Site06,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.5,,2201.129153,31595.0,10173.0,175030.2145
Site06-Lyric-2,11,Site06,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.4,,1454.957015,63229.0,11048.0,15710272.33
Site06-Lyric-2,11,Site06,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.3,,1428.285319,60446.0,10269.0,14961731.23
Site06-Lyric-2,11,Site06,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.8,,1445.269086,69052.0,11085.0,17149697.97
Site06-Lyric-2,11,Site06,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,21660.0,5510.0,5472981.047
Site06-Lyric-2,11,Site06,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,22246.0,5701.0,5621458.318
Site06-Lyric-2,11,Site06,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,22405.0,6271.0,5661491.439
Site06-Lyric-2,11,Site06,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,765.0740834,101600.0,12743.0,345123.6414
Site06-Lyric-2,11,Site06,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.3,,790.8169463,97760.0,12760.0,331567.7045
Site06-Lyric-2,11,Site06,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.1,,750.748448,101709.0,12975.0,345549.6852
Site06-Lyric-2,11,Site06,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,20.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.8,,434,247.0,119.0,47294.13085
Site06-Lyric-2,11,Site06,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.2,,361.2760487,255.0,131.0,49724.04022
Site06-Lyric-2,11,Site06,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.8,,381.0629614,261.0,127.0,50165.84192
Site06-Lyric-2,11,Site06,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.3,,653.2666751,8657.0,1723.0,21324.86887
Site06-Lyric-2,11,Site06,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.6,,624.6191194,11292.0,2173.0,29424.71684
Site06-Lyric-2,11,Site06,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.7,,651.238249,9878.0,1815.0,24194.46218
Site06-Lyric-2,11,Site06,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.1,,439.8067499,8541.0,756.0,20866.8301
Site06-Lyric-2,11,Site06,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.1,,440.3457752,9871.0,852.0,26069.68073
Site06-Lyric-2,11,Site06,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,,437.1257495,10448.0,936.0,28328.55568
Site06-Lyric-2,11,Site06,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.6,,2226.294498,31620.0,10487.0,175143.0228
Site06-Lyric-2,11,Site06,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.4,,2235.652298,31494.0,10866.0,174412.7374
Site06-Lyric-2,11,Site06,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.5,,2200.463332,13602.0,10156.0,175053.9636
Site06-Lyric-2,11,Site06,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.4,,1447.628378,62912.0,10988.0,3214208.756
Site06-Lyric-2,11,Site06,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.3,,1428.735956,60112.0,10203.0,14958251.96
Site06-Lyric-2,11,Site06,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.8,,1445.053336,68722.0,10999.0,17030657.07
Site06-Lyric-2,11,Site06,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,21649.0,5471.0,5472981.047
Site06-Lyric-2,11,Site06,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,22232.0,5653.0,5621458.318
Site06-Lyric-2,11,Site06,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,22394.0,6216.0,5798313.498
Site06-Lyric-2,11,Site06,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,766.4400874,101121.0,12702.0,343496.929
Site06-Lyric-2,11,Site06,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.3,,788.9665703,97256.0,12699.0,329874.0927
Site06-Lyric-2,11,Site06,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.1,,749.9706487,101240.0,12890.0,343972.2671
Site06-Lyric-2,11,Site06,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,20.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site06-Lyric-2,11,Site06,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13,,357.8592863,249.0,117.0,47294.13085
Site06-Lyric-2,11,Site06,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.4,,369.0407189,256.0,130.0,49503.13936
Site06-Lyric-2,11,Site06,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.1,,388.995765,262.0,127.0,50165.84192
Site07-CantoSORP-1,12,Site07,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,94.1,,1055.584506,13067.0,4350.0,87350.7918
Site07-CantoSORP-1,12,Site07,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,95,,854.220144,12769.0,4352.0,85358.70976
Site07-CantoSORP-1,12,Site07,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,95.3,,835.8279282,11978.0,4123.0,80071.00208
Site07-CantoSORP-1,12,Site07,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.78,,149.8526153,2697.0,2022.0,18029.0109
Site07-CantoSORP-1,12,Site07,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.25,,242.0877235,3672.0,2031.0,24546.72897
Site07-CantoSORP-1,12,Site07,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.51,,218.6520141,3188.0,1920.0,21311.26687
Site07-CantoSORP-1,12,Site07,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,46,,1443.878066,4407.0,1595.0,75064.83079
Site07-CantoSORP-1,12,Site07,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,50.7,,1693.411784,4352.0,1642.0,74128.01081
Site07-CantoSORP-1,12,Site07,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,49.9,,1674.515221,4159.0,1587.0,70840.6243
Site07-CantoSORP-1,12,Site07,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,44.4,,640.7402248,15886.0,3941.0,7241226.787
Site07-CantoSORP-1,12,Site07,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,44.2,,749.0206189,16316.0,3963.0,7437231.289
Site07-CantoSORP-1,12,Site07,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,44.2,,740.4859997,15303.0,3858.0,6975481.148
Site07-CantoSORP-1,12,Site07,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,56.7,,,4246.0,1111.0,4498878.116
Site07-CantoSORP-1,12,Site07,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,21.1,,,4133.0,1100.0,4379148.199
Site07-CantoSORP-1,12,Site07,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,53.8,,,3983.0,1074.0,4220214.681
Site07-CantoSORP-1,12,Site07,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44.6,,643.3179647,3942.0,2091.0,1132539.836
Site07-CantoSORP-1,12,Site07,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,45.5,,769.9746467,3967.0,2107.0,1139722.356
Site07-CantoSORP-1,12,Site07,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44.6,,746.9195693,3612.0,2003.0,1037730.565
Site07-CantoSORP-1,12,Site07,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,42.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,16.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,31.5,,986.5870002,24570.0,13824.0,68120.39499
Site07-CantoSORP-1,12,Site07,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.7,,856.7964589,23189.0,13847.0,64291.56855
Site07-CantoSORP-1,12,Site07,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.9,,903.2910547,22700.0,13480.0,62935.81466
Site07-CantoSORP-1,12,Site07,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,95,,1062.265584,13090.0,4319.0,87504.54309
Site07-CantoSORP-1,12,Site07,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,95.9,,861.5660857,12762.0,4346.0,85311.91589
Site07-CantoSORP-1,12,Site07,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,96,,842.0493696,11940.0,4140.0,79816.97819
Site07-CantoSORP-1,12,Site07,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.95,,155.0305988,2406.0,1930.0,16083.72274
Site07-CantoSORP-1,12,Site07,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.29,,242.7269803,3515.0,1964.0,23497.20924
Site07-CantoSORP-1,12,Site07,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.54,,218.9575971,3039.0,1872.0,20315.22586
Site07-CantoSORP-1,12,Site07,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,42.2,,1322.349812,4361.0,1579.0,74281.30862
Site07-CantoSORP-1,12,Site07,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,47.5,,1580.146694,4308.0,1638.0,73378.55481
Site07-CantoSORP-1,12,Site07,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,46.6,,1560.470823,4108.0,1587.0,69971.93667
Site07-CantoSORP-1,12,Site07,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.1,,635.8464419,15819.0,3947.0,7210686.55
Site07-CantoSORP-1,12,Site07,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.2,,745.7673898,16268.0,3968.0,7415351.716
Site07-CantoSORP-1,12,Site07,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,47.3,,737.3458983,15241.0,3868.0,6947220.034
Site07-CantoSORP-1,12,Site07,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,56.9,,,4245.0,1116.0,4497818.56
Site07-CantoSORP-1,12,Site07,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,21.3,,,4124.0,1112.0,4369612.188
Site07-CantoSORP-1,12,Site07,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,54,,,3977.0,1078.0,4213857.341
Site07-CantoSORP-1,12,Site07,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,42.8,,565.9806786,4066.0,2072.0,1168165.138
Site07-CantoSORP-1,12,Site07,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.8,,692.4133319,4074.0,2106.0,1170463.544
Site07-CantoSORP-1,12,Site07,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,43.2,,674.3823244,3708.0,2015.0,1065311.444
Site07-CantoSORP-1,12,Site07,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,42.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,16.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,31.5,,986.6201707,24624.0,13850.0,68270.11014
Site07-CantoSORP-1,12,Site07,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.7,,856.6384816,23261.0,13955.0,64491.18876
Site07-CantoSORP-1,12,Site07,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27,,903.6864638,22716.0,13542.0,62980.17471
Site07-CantoSORP-1,12,Site07,CantoSORP,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,4146.421008,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,4242.060309,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.8,,891.2571854,9806.0,2794.0,65551.53167
Site07-CantoSORP-1,12,Site07,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.7,,801.3298324,9095.0,2560.0,60798.61111
Site07-CantoSORP-1,12,Site07,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,99.9,,897.068096,8653.0,2499.0,57843.91225
Site07-CantoSORP-1,12,Site07,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.92,,161.6260041,3566.0,1889.0,23838.13603
Site07-CantoSORP-1,12,Site07,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.13,,194.5770165,3622.0,1775.0,24212.48702
Site07-CantoSORP-1,12,Site07,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.42,,130.7713401,3153.0,1794.0,21077.29751
Site07-CantoSORP-1,12,Site07,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,64.1,,1309.328971,5874.0,2364.0,100052.3749
Site07-CantoSORP-1,12,Site07,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,65.5,,1397.064209,5750.0,2368.0,97940.27163
Site07-CantoSORP-1,12,Site07,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,60.3,,1227.705619,5640.0,2323.0,96066.63165
Site07-CantoSORP-1,12,Site07,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,78.8,,1032.177522,16404.0,4078.0,7477343.838
Site07-CantoSORP-1,12,Site07,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,77.1,,1077.344809,16316.0,4045.0,7437231.289
Site07-CantoSORP-1,12,Site07,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,79.6,,977.3211125,16186.0,4233.0,7377974.114
Site07-CantoSORP-1,12,Site07,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,41.4,,,3910.0,1100.0,4142867.036
Site07-CantoSORP-1,12,Site07,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,41.6,,,3816.0,1073.0,4043268.698
Site07-CantoSORP-1,12,Site07,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,29.7,,,3831.0,1078.0,4059162.05
Site07-CantoSORP-1,12,Site07,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,19,,248.7116054,4150.0,1693.0,1192298.407
Site07-CantoSORP-1,12,Site07,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,20.5,,286.9103049,4099.0,1809.0,1177646.065
Site07-CantoSORP-1,12,Site07,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,17.9,,219.5462583,3967.0,1691.0,1139722.356
Site07-CantoSORP-1,12,Site07,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,28.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,30.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,20.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.5,,459.5440192,30131.0,19444.0,83538.28333
Site07-CantoSORP-1,12,Site07,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.7,,420.8551286,28092.0,19259.0,77885.15002
Site07-CantoSORP-1,12,Site07,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.1,,552.6974361,29049.0,19151.0,80538.43524
Site07-CantoSORP-1,12,Site07,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.8,,896.6802993,9778.0,2796.0,65364.35618
Site07-CantoSORP-1,12,Site07,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.7,,804.1981057,9032.0,2560.0,60377.46625
Site07-CantoSORP-1,12,Site07,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,99.9,,900.877856,8613.0,2490.0,57576.51869
Site07-CantoSORP-1,12,Site07,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.92,,161.2388085,3438.0,1849.0,22982.47664
Site07-CantoSORP-1,12,Site07,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.09,,193.4355108,3537.0,1738.0,23644.2757
Site07-CantoSORP-1,12,Site07,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.41,,130.3351273,3001.0,1732.0,20061.20197
Site07-CantoSORP-1,12,Site07,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.7,,1297.009789,5862.0,2370.0,99847.97779
Site07-CantoSORP-1,12,Site07,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,65.1,,1386.693098,5737.0,2373.0,97718.84145
Site07-CantoSORP-1,12,Site07,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,59.9,,1216.521865,5628.0,2325.0,95862.23456
Site07-CantoSORP-1,12,Site07,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,79,,1024.227416,16306.0,4089.0,7432673.044
Site07-CantoSORP-1,12,Site07,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,77.1,,1069.366458,16230.0,4049.0,7398030.388
Site07-CantoSORP-1,12,Site07,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,79.8,,970.2321626,16154.0,4227.0,7363387.732
Site07-CantoSORP-1,12,Site07,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,41.6,,,3906.0,1112.0,4138628.809
Site07-CantoSORP-1,12,Site07,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,41.8,,,3808.0,1075.0,4034792.244
Site07-CantoSORP-1,12,Site07,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,29.9,,,3822.0,1081.0,4049626.039
Site07-CantoSORP-1,12,Site07,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,18.9,,245.4680368,4193.0,1694.0,1204652.342
Site07-CantoSORP-1,12,Site07,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,20.5,,284.5605362,4116.0,1818.0,1182530.179
Site07-CantoSORP-1,12,Site07,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,17.8,,216.8611475,4008.0,1704.0,1151501.69
Site07-CantoSORP-1,12,Site07,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,28.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,30.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,20.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.7,,461.3355163,30377.0,19755.0,84220.31903
Site07-CantoSORP-1,12,Site07,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.8,,422.4942803,28207.0,19551.0,78203.98785
Site07-CantoSORP-1,12,Site07,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.3,,553.7422586,29167.0,19422.0,80865.59058
Site07-CantoSORP-1,12,Site07,CantoSORP,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3030.220201,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,2839.714721,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.8,,600.3150742,10550.0,3382.0,70525.05192
Site07-CantoSORP-1,12,Site07,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.9,,569.6493152,10365.0,3318.0,69288.3567
Site07-CantoSORP-1,12,Site07,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,100,,508.0924584,11559.0,3837.0,77270.05452
Site07-CantoSORP-1,12,Site07,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.26,,65.18113337,2468.0,2026.0,16498.18276
Site07-CantoSORP-1,12,Site07,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.36,,68.08140259,2855.0,2057.0,19085.21547
Site07-CantoSORP-1,12,Site07,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.74,,76.90048018,2918.0,2045.0,19506.36033
Site07-CantoSORP-1,12,Site07,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,64.7,,989.8198081,4924.0,2045.0,83870.9387
Site07-CantoSORP-1,12,Site07,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,67,,1045.381208,4903.0,2002.0,83513.24379
Site07-CantoSORP-1,12,Site07,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65,,1055.1128,4731.0,1989.0,80583.55219
Site07-CantoSORP-1,12,Site07,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.6,,619.458077,16014.0,4220.0,7299572.313
Site07-CantoSORP-1,12,Site07,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,62.5,,653.7909461,15971.0,4052.0,7279971.863
Site07-CantoSORP-1,12,Site07,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.5,,648.4000115,16404.0,4362.0,7477343.838
Site07-CantoSORP-1,12,Site07,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,34.4,,,4049.0,1190.0,4290145.429
Site07-CantoSORP-1,12,Site07,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,34.9,,,3991.0,1165.0,4228691.136
Site07-CantoSORP-1,12,Site07,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,12.4,,,4041.0,1207.0,4281668.975
Site07-CantoSORP-1,12,Site07,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28.1,,278.3645732,2882.0,2067.0,828000.9657
Site07-CantoSORP-1,12,Site07,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,29,,303.6779691,3028.0,2145.0,869946.8856
Site07-CantoSORP-1,12,Site07,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.9,,304.6166537,2604.0,2061.0,748131.3375
Site07-CantoSORP-1,12,Site07,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,24.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,9.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,20.8,,317.7580252,32317.0,21960.0,89598.97455
Site07-CantoSORP-1,12,Site07,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.9,,295.0892383,31635.0,22893.0,87708.12761
Site07-CantoSORP-1,12,Site07,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.4,,314.1695083,31348.0,21417.0,86912.41929
Site07-CantoSORP-1,12,Site07,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.8,,603.0114216,10484.0,3391.0,70083.85254
Site07-CantoSORP-1,12,Site07,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.8,,573.5750079,10319.0,3294.0,68980.8541
Site07-CantoSORP-1,12,Site07,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,99.9,,511.32259,11531.0,3816.0,77082.87902
Site07-CantoSORP-1,12,Site07,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.37,,66.59509374,2266.0,1880.0,15147.84528
Site07-CantoSORP-1,12,Site07,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.27,,66.34919961,2398.0,1878.0,16030.24403
Site07-CantoSORP-1,12,Site07,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.75,,76.71614687,2506.0,1932.0,16752.20665
Site07-CantoSORP-1,12,Site07,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,62.2,,948.6224749,4872.0,2030.0,82985.21798
Site07-CantoSORP-1,12,Site07,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64.3,,999.5921604,4852.0,1981.0,82644.55616
Site07-CantoSORP-1,12,Site07,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,62.3,,1005.952315,4672.0,1969.0,79578.59983
Site07-CantoSORP-1,12,Site07,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.8,,614.8523153,15930.0,4240.0,7261283.061
Site07-CantoSORP-1,12,Site07,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.1,,650.3603837,15893.0,4057.0,7244417.558
Site07-CantoSORP-1,12,Site07,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.9,,642.3793409,16306.0,4351.0,7432673.044
Site07-CantoSORP-1,12,Site07,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,34.5,,,4050.0,1195.0,4291204.986
Site07-CantoSORP-1,12,Site07,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,35,,,3992.0,1167.0,4229750.693
Site07-CantoSORP-1,12,Site07,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,12.5,,,4035.0,1210.0,4275311.634
Site07-CantoSORP-1,12,Site07,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27.1,,256.8440847,2871.0,2069.0,824840.6567
Site07-CantoSORP-1,12,Site07,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.6,,276.2476571,3004.0,2138.0,863051.6659
Site07-CantoSORP-1,12,Site07,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.7,,278.687978,2604.0,2042.0,748131.3375
Site07-CantoSORP-1,12,Site07,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,24.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,25.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,9.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,21,,320.6577604,32800.0,22655.0,90938.09343
Site07-CantoSORP-1,12,Site07,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.3,,299.469877,32022.0,23558.0,88781.08621
Site07-CantoSORP-1,12,Site07,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.8,,319.1770555,31793.0,22016.0,88146.18306
Site07-CantoSORP-1,12,Site07,CantoSORP,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,1796.190065,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,2466.054873,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1917.620294,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1858.21118,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site07-CantoSORP-1,12,Site07,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.5,,309.198253,15859.0,3848.0,106014.8624
Site07-CantoSORP-1,12,Site07,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.8,,308.6679798,11618.0,2839.0,77664.46002
Site07-CantoSORP-1,12,Site07,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.6,,303.9365342,9806.0,2328.0,65551.53167
Site07-CantoSORP-1,12,Site07,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.6,,232.4851811,7120.0,599.0,47596.054
Site07-CantoSORP-1,12,Site07,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.6,,218.8983349,6290.0,558.0,42047.63759
Site07-CantoSORP-1,12,Site07,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15,,224.6453294,6200.0,564.0,41446.00208
Site07-CantoSORP-1,12,Site07,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.2,,1046.496111,13481.0,4495.0,229623.096
Site07-CantoSORP-1,12,Site07,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.1,,1063.702431,12934.0,4327.0,220305.9953
Site07-CantoSORP-1,12,Site07,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.6,,1059.322646,12381.0,4149.0,210886.6962
Site07-CantoSORP-1,12,Site07,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.8,,678.64872,55089.0,7424.0,25110911.65
Site07-CantoSORP-1,12,Site07,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.4,,684.6147216,54044.0,7457.0,24634575.13
Site07-CantoSORP-1,12,Site07,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.1,,689.4409515,47398.0,6680.0,21605166.01
Site07-CantoSORP-1,12,Site07,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,5604.0,2680.0,5937756.233
Site07-CantoSORP-1,12,Site07,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,5202.0,2507.0,5511814.404
Site07-CantoSORP-1,12,Site07,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,4791.0,2322.0,5076336.565
Site07-CantoSORP-1,12,Site07,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35,,366.7526066,12993.0,1195.0,3732899.565
Site07-CantoSORP-1,12,Site07,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.6,,378.3121622,12757.0,1251.0,3665096.572
Site07-CantoSORP-1,12,Site07,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.8,,368.5470903,12381.0,1218.0,3557071.463
Site07-CantoSORP-1,12,Site07,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,20,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,17.9,,267.4400671,323.0,187.0,895.5184201
Site07-CantoSORP-1,12,Site07,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.8,,206.6834588,281.0,162.0,779.0733004
Site07-CantoSORP-1,12,Site07,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14,,210.6712359,262.0,144.0,726.3957463
Site07-CantoSORP-1,12,Site07,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.3,,309.5645005,15835.0,3836.0,105854.4263
Site07-CantoSORP-1,12,Site07,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.7,,308.2914239,11604.0,2808.0,77570.87227
Site07-CantoSORP-1,12,Site07,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.6,,302.7313768,9809.0,2326.0,65571.58619
Site07-CantoSORP-1,12,Site07,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.6,,233.595826,7076.0,602.0,47301.92108
Site07-CantoSORP-1,12,Site07,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.7,,221.113201,6234.0,559.0,41673.2866
Site07-CantoSORP-1,12,Site07,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.1,,228.2104602,6155.0,570.0,41145.18432
Site07-CantoSORP-1,12,Site07,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.1,,1051.593237,13481.0,4511.0,229623.096
Site07-CantoSORP-1,12,Site07,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.1,,1067.942947,12934.0,4361.0,220305.9953
Site07-CantoSORP-1,12,Site07,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.6,,1065.467925,12410.0,4181.0,211380.6558
Site07-CantoSORP-1,12,Site07,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.7,,680.735829,55148.0,7334.0,25137805.29
Site07-CantoSORP-1,12,Site07,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.3,,686.4264798,53955.0,7402.0,24594006.75
Site07-CantoSORP-1,12,Site07,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.8,,690.2637755,47443.0,6625.0,21625678.11
Site07-CantoSORP-1,12,Site07,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,5610.0,2652.0,5944113.573
Site07-CantoSORP-1,12,Site07,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,5199.0,2476.0,5508635.734
Site07-CantoSORP-1,12,Site07,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,4784.0,2272.0,5068919.668
Site07-CantoSORP-1,12,Site07,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.8,,365.5992459,13083.0,1187.0,3758756.639
Site07-CantoSORP-1,12,Site07,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.4,,377.9018551,12845.0,1260.0,3690379.044
Site07-CantoSORP-1,12,Site07,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.5,,367.7205483,12467.0,1214.0,3581779.334
Site07-CantoSORP-1,12,Site07,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,20,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-1,12,Site07,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,17.3,,259.886638,317.0,187.0,878.883403
Site07-CantoSORP-1,12,Site07,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.3,,200.0085309,274.0,160.0,759.6657805
Site07-CantoSORP-1,12,Site07,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.4,,202.8056023,255.0,143.0,706.9882264
Site07-CantoSORP-2,13,Site07,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.9,,884.8684453,5486.0,1857.0,78160.03873
Site07-CantoSORP-2,13,Site07,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.5,,784.2243327,5393.0,1873.0,76835.05083
Site07-CantoSORP-2,13,Site07,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,93.1,,828.1737741,5313.0,1864.0,75695.2763
Site07-CantoSORP-2,13,Site07,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,2.59,,90.81354712,1677.0,745.0,23892.52369
Site07-CantoSORP-2,13,Site07,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.55,,164.7142457,1748.0,716.0,24904.07359
Site07-CantoSORP-2,13,Site07,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.82,,136.3641226,1664.0,712.0,23707.31033
Site07-CantoSORP-2,13,Site07,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.5,,1736.910544,7414.0,2839.0,70651.02221
Site07-CantoSORP-2,13,Site07,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,53.5,,1934.148663,7317.0,2848.0,69726.66975
Site07-CantoSORP-2,13,Site07,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,52,,1857.869528,7221.0,2786.0,68811.84669
Site07-CantoSORP-2,13,Site07,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41.8,,725.4261897,45239.0,11272.0,7109416.208
Site07-CantoSORP-2,13,Site07,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,42,,812.9882702,44753.0,11011.0,7033040.155
Site07-CantoSORP-2,13,Site07,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,41.9,,778.9617218,44273.0,11432.0,6957607.016
Site07-CantoSORP-2,13,Site07,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89.2,,,4682.0,1252.0,4398808.72
Site07-CantoSORP-2,13,Site07,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.7,,,4547.0,1224.0,4271974.209
Site07-CantoSORP-2,13,Site07,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,85.4,,,4481.0,1239.0,4209966.227
Site07-CantoSORP-2,13,Site07,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,46.8,,813.624451,4713.0,2838.0,971331.8324
Site07-CantoSORP-2,13,Site07,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.2,,912.0339039,4725.0,2742.0,973804.9879
Site07-CantoSORP-2,13,Site07,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,46.6,,865.6555793,4524.0,2751.0,932379.6328
Site07-CantoSORP-2,13,Site07,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,74.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,68.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.4,,997.6864666,14699.0,7334.0,64297.39042
Site07-CantoSORP-2,13,Site07,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.5,,850.6165658,14368.0,7313.0,62849.50715
Site07-CantoSORP-2,13,Site07,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,24.7,,883.6175202,14533.0,7358.0,63571.26165
Site07-CantoSORP-2,13,Site07,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.4,,959.9154409,5521.0,1881.0,78658.69009
Site07-CantoSORP-2,13,Site07,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92,,853.9836637,5427.0,1894.0,77319.45501
Site07-CantoSORP-2,13,Site07,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.6,,898.2295519,5347.0,1884.0,76179.68048
Site07-CantoSORP-2,13,Site07,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.12,,109.2274455,1582.0,776.0,22539.04143
Site07-CantoSORP-2,13,Site07,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.07,,183.1178456,1718.0,757.0,24476.65814
Site07-CantoSORP-2,13,Site07,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.42,,157.7210508,1612.0,760.0,22966.45688
Site07-CantoSORP-2,13,Site07,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.6,,1737.725599,7414.0,2861.0,70651.02221
Site07-CantoSORP-2,13,Site07,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,53.7,,1937.937591,7284.0,2856.0,69412.19932
Site07-CantoSORP-2,13,Site07,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,52.2,,1859.16638,7205.0,2796.0,68659.37618
Site07-CantoSORP-2,13,Site07,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41.7,,725.4738674,44874.0,11301.0,7052055.592
Site07-CantoSORP-2,13,Site07,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,42.1,,815.2678302,44392.0,11085.0,6976308.148
Site07-CantoSORP-2,13,Site07,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,41.9,,779.2581493,43916.0,11458.0,6901503.618
Site07-CantoSORP-2,13,Site07,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89,,,4672.0,1259.0,4389413.571
Site07-CantoSORP-2,13,Site07,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.5,,,4537.0,1234.0,4262579.06
Site07-CantoSORP-2,13,Site07,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,85.3,,,4472.0,1246.0,4201510.593
Site07-CantoSORP-2,13,Site07,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,47.1,,817.7322085,4750.0,2862.0,978957.3952
Site07-CantoSORP-2,13,Site07,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.3,,916.1257061,4750.0,2777.0,978957.3952
Site07-CantoSORP-2,13,Site07,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,46.7,,868.6455113,4559.0,2779.0,939593.0031
Site07-CantoSORP-2,13,Site07,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,73.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,68.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.3,,992.5139836,14699.0,7401.0,64297.39042
Site07-CantoSORP-2,13,Site07,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.4,,844.4164716,14409.0,7358.0,63028.8522
Site07-CantoSORP-2,13,Site07,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,24.6,,877.4481246,,,63571.26165
Site07-CantoSORP-2,13,Site07,CantoSORP,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.5,,4296.810244,5158.0,1346.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.4,,4633.940075,4913.0,1242.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,99.9,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,99.8,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,99.7,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,4.1,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,4.48,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,5.43,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,60.9,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,61.5,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,63.1,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,79.6,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,80.4,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,79.5,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,85.2,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,85.5,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,68.6,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,17.7,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,16.9,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,18,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,24,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,23.5,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,19.5,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.9,,780.8452031,3894.0,1217.0,55478.52549
Site07-CantoSORP-2,13,Site07,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.8,,757.643369,3991.0,1285.0,56860.50211
Site07-CantoSORP-2,13,Site07,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,99.7,,630.2642477,3332.0,1145.0,47471.60938
Site07-CantoSORP-2,13,Site07,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.1,,85.74520283,1558.0,757.0,22197.10907
Site07-CantoSORP-2,13,Site07,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.48,,94.6309086,1600.0,705.0,22795.4907
Site07-CantoSORP-2,13,Site07,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.43,,121.6155263,1379.0,670.0,19646.86355
Site07-CantoSORP-2,13,Site07,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.9,,1273.345427,10041.0,4110.0,95684.77394
Site07-CantoSORP-2,13,Site07,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.5,,1300.094562,9513.0,3922.0,90653.24713
Site07-CantoSORP-2,13,Site07,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.1,,1412.547903,8244.0,3425.0,78560.42987
Site07-CantoSORP-2,13,Site07,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,79.6,,1013.582182,45117.0,12146.0,7090243.619
Site07-CantoSORP-2,13,Site07,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,80.4,,1045.410746,45729.0,11929.0,7186420.871
Site07-CantoSORP-2,13,Site07,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,79.5,,1123.300165,42063.0,12780.0,6610300.271
Site07-CantoSORP-2,13,Site07,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.7,,,4228.0,1245.0,3972268.959
Site07-CantoSORP-2,13,Site07,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.1,,,4228.0,1236.0,3972268.959
Site07-CantoSORP-2,13,Site07,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.6,,,3792.0,1293.0,3562640.467
Site07-CantoSORP-2,13,Site07,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,17.7,,225.7373707,5227.0,2273.0,1077265.327
Site07-CantoSORP-2,13,Site07,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,16.9,,219.9609781,4924.0,2247.0,1014818.15
Site07-CantoSORP-2,13,Site07,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,18,,254.735224,3876.0,2086.0,429916.8687
Site07-CantoSORP-2,13,Site07,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,27.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,24,,501.2497344,18378.0,10926.0,80390.32867
Site07-CantoSORP-2,13,Site07,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.5,,496.8495264,18220.0,10771.0,79699.19406
Site07-CantoSORP-2,13,Site07,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.5,,436.3367868,17201.0,10073.0,75241.81322
Site07-CantoSORP-2,13,Site07,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.8,,778.9380546,3942.0,1236.0,56162.39021
Site07-CantoSORP-2,13,Site07,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.7,,754.3455488,4041.0,1297.0,57572.86119
Site07-CantoSORP-2,13,Site07,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,99.9,,626.5189252,3386.0,1189.0,48240.95719
Site07-CantoSORP-2,13,Site07,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.4,,91.99144641,1541.0,751.0,21954.90698
Site07-CantoSORP-2,13,Site07,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.8,,101.5207901,1588.0,716.0,22624.52452
Site07-CantoSORP-2,13,Site07,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.83,,130.7740731,1363.0,696.0,19418.90864
Site07-CantoSORP-2,13,Site07,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.2,,1280.744645,10019.0,4124.0,95475.12699
Site07-CantoSORP-2,13,Site07,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.8,,1309.216866,9470.0,3913.0,90243.48264
Site07-CantoSORP-2,13,Site07,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.3,,1419.710689,8262.0,3438.0,78731.9592
Site07-CantoSORP-2,13,Site07,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,79.4,,1017.498682,44874.0,12170.0,7052055.592
Site07-CantoSORP-2,13,Site07,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,80.3,,1051.624583,45483.0,11955.0,7147761.387
Site07-CantoSORP-2,13,Site07,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,79.7,,1131.665835,41837.0,12750.0,6574783.835
Site07-CantoSORP-2,13,Site07,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,84.7,,,4211.0,1251.0,3956297.206
Site07-CantoSORP-2,13,Site07,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,85.1,,,4219.0,1236.0,3963813.325
Site07-CantoSORP-2,13,Site07,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,68.5,,,3785.0,1287.0,3556063.862
Site07-CantoSORP-2,13,Site07,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,17.7,,227.1822303,5227.0,2319.0,1077265.327
Site07-CantoSORP-2,13,Site07,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,16.9,,221.0269618,4963.0,2266.0,1022855.906
Site07-CantoSORP-2,13,Site07,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,17.9,,254.7102861,3944.0,2086.0,812843.7825
Site07-CantoSORP-2,13,Site07,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,27.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,23.8,,498.1423608,18431.0,10972.0,80622.16496
Site07-CantoSORP-2,13,Site07,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.4,,494.6723126,18220.0,10816.0,79699.19406
Site07-CantoSORP-2,13,Site07,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.2,,431.6399144,17152.0,10073.0,75027.47401
Site07-CantoSORP-2,13,Site07,CantoSORP,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,92.5,2839.484863,4965.0,1454.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,92.4,2906.027027,4801.0,1295.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.8,,655.7711325,5235.0,1616.0,74583.99613
Site07-CantoSORP-2,13,Site07,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.8,,571.1508513,5701.0,1748.0,81223.18279
Site07-CantoSORP-2,13,Site07,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,99.8,,578.097652,5093.0,1607.0,72560.89633
Site07-CantoSORP-2,13,Site07,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,2.46,,35.97113267,1794.0,845.0,25559.44394
Site07-CantoSORP-2,13,Site07,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,3.34,,51.82353378,1906.0,808.0,27155.12829
Site07-CantoSORP-2,13,Site07,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,2.88,,44.40180151,1754.0,789.0,24989.55668
Site07-CantoSORP-2,13,Site07,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.4,,986.910593,9115.0,3694.0,86860.54322
Site07-CantoSORP-2,13,Site07,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.5,,1091.797644,9259.0,3810.0,88232.7778
Site07-CantoSORP-2,13,Site07,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68.9,,1062.238331,9095.0,3734.0,86669.95508
Site07-CantoSORP-2,13,Site07,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.5,,617.17014,46728.0,12001.0,7343416.092
Site07-CantoSORP-2,13,Site07,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,61.1,,667.3815571,46602.0,11808.0,7323614.893
Site07-CantoSORP-2,13,Site07,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.3,,650.8429869,46226.0,11790.0,7264525.6
Site07-CantoSORP-2,13,Site07,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89.6,,,4761.0,1345.0,4473030.396
Site07-CantoSORP-2,13,Site07,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,90.5,,,4721.0,1369.0,4435449.8
Site07-CantoSORP-2,13,Site07,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,87.8,,,4633.0,1334.0,4352772.49
Site07-CantoSORP-2,13,Site07,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,29.1,,287.100453,4455.0,3039.0,918158.9886
Site07-CantoSORP-2,13,Site07,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.3,,341.4711335,4310.0,3053.0,888275.026
Site07-CantoSORP-2,13,Site07,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.7,,323.5119859,4149.0,3008.0,855093.5227
Site07-CantoSORP-2,13,Site07,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,31,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.4,,283.8465587,21923.0,13539.0,95897.11478
Site07-CantoSORP-2,13,Site07,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.3,,253.2027792,20808.0,13367.0,91019.80406
Site07-CantoSORP-2,13,Site07,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.4,,268.9414817,21358.0,13632.0,93425.6524
Site07-CantoSORP-2,13,Site07,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,99.8,,656.8051368,5279.0,1643.0,75210.87212
Site07-CantoSORP-2,13,Site07,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,99.8,,571.4097402,5737.0,1773.0,81736.08133
Site07-CantoSORP-2,13,Site07,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,99.7,,578.4880854,5125.0,1626.0,73016.80614
Site07-CantoSORP-2,13,Site07,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,2.95,,43.17256807,1674.0,869.0,23849.78214
Site07-CantoSORP-2,13,Site07,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,3.85,,59.62027764,1856.0,889.0,26442.76921
Site07-CantoSORP-2,13,Site07,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.3,,50.8430554,1705.0,829.0,24291.44477
Site07-CantoSORP-2,13,Site07,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.5,,988.5151031,9095.0,3713.0,86669.95508
Site07-CantoSORP-2,13,Site07,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.6,,1094.85328,9218.0,3828.0,87842.07212
Site07-CantoSORP-2,13,Site07,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.1,,1065.330879,9074.0,3737.0,86469.83754
Site07-CantoSORP-2,13,Site07,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.3,,616.2343884,46476.0,11948.0,7303813.694
Site07-CantoSORP-2,13,Site07,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.9,,666.6221987,46226.0,11882.0,7264525.6
Site07-CantoSORP-2,13,Site07,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.1,,650.5081406,45977.0,11817.0,7225394.659
Site07-CantoSORP-2,13,Site07,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89.5,,,4751.0,1359.0,4463635.247
Site07-CantoSORP-2,13,Site07,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,90.2,,,4711.0,1376.0,4426054.652
Site07-CantoSORP-2,13,Site07,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,87.6,,,4614.0,1341.0,4334921.707
Site07-CantoSORP-2,13,Site07,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,29,,286.86165,4501.0,3056.0,927639.4181
Site07-CantoSORP-2,13,Site07,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.2,,341.4779525,4354.0,3054.0,897343.2629
Site07-CantoSORP-2,13,Site07,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.6,,326.189692,4201.0,3019.0,865810.53
Site07-CantoSORP-2,13,Site07,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,31,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.4,,284.6126194,22051.0,13807.0,96457.0213
Site07-CantoSORP-2,13,Site07,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.3,,252.9699629,20929.0,13574.0,91549.09069
Site07-CantoSORP-2,13,Site07,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.4,,269.0026647,21420.0,13757.0,93696.85712
Site07-CantoSORP-2,13,Site07,CantoSORP,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,1744.44948,5082.0,1406.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,2499.074402,4986.0,1350.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1913.886403,9014.0,3916.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1773.009126,8973.0,3909.0,
Site07-CantoSORP-2,13,Site07,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site07-CantoSORP-2,13,Site07,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.1,,287.1725955,2793.0,240.0,39792.37845
Site07-CantoSORP-2,13,Site07,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.8,,295.0709932,2911.0,249.0,41473.54589
Site07-CantoSORP-2,13,Site07,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.8,,296.5086158,2777.0,262.0,39564.42354
Site07-CantoSORP-2,13,Site07,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,221.8037592,3634.0,844.0,51774.25825
Site07-CantoSORP-2,13,Site07,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.1,,221.9282245,3366.0,772.0,47956.01356
Site07-CantoSORP-2,13,Site07,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.3,,208.2396879,3182.0,749.0,45334.53213
Site07-CantoSORP-2,13,Site07,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.2,,1053.199089,21060.0,7127.0,200689.3078
Site07-CantoSORP-2,13,Site07,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.5,,1036.498354,21310.0,7154.0,203071.6595
Site07-CantoSORP-2,13,Site07,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.8,,1049.247948,19807.0,6702.0,188748.961
Site07-CantoSORP-2,13,Site07,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.1,,685.7516994,134441.0,18963.0,2680076.571
Site07-CantoSORP-2,13,Site07,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.5,,668.1233066,133340.0,18164.0,2750166.53
Site07-CantoSORP-2,13,Site07,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64,,671.582642,126575.0,19051.0,2703177.97
Site07-CantoSORP-2,13,Site07,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,5147.0,2352.0,4835683.144
Site07-CantoSORP-2,13,Site07,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,5114.0,2432.0,4804679.153
Site07-CantoSORP-2,13,Site07,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,4934.0,2334.0,4635566.472
Site07-CantoSORP-2,13,Site07,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.8,,1053.199089,17054.0,1172.0,3514766.193
Site07-CantoSORP-2,13,Site07,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.5,,1036.498354,17500.0,1131.0,3606685.14
Site07-CantoSORP-2,13,Site07,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.7,,1049.247948,17201.0,1183.0,3545062.348
Site07-CantoSORP-2,13,Site07,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.1,,179.1820358,147.0,81.8,643.0176469
Site07-CantoSORP-2,13,Site07,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.1,,207.8964254,151.0,81.4,660.5147257
Site07-CantoSORP-2,13,Site07,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,10.6,,155.2011442,142.0,80.7,621.1462983
Site07-CantoSORP-2,13,Site07,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.1,,287.4833825,2849.0,243.0,40590.22062
Site07-CantoSORP-2,13,Site07,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.8,,295.0129521,2963.0,251.0,42214.39934
Site07-CantoSORP-2,13,Site07,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.8,,296.5705059,2826.0,262.0,40262.53545
Site07-CantoSORP-2,13,Site07,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,221.5168317,3649.0,843.0,51987.96597
Site07-CantoSORP-2,13,Site07,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.1,,222.0865893,3379.0,776.0,48141.22692
Site07-CantoSORP-2,13,Site07,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.3,,208.4950369,3195.0,753.0,45519.74549
Site07-CantoSORP-2,13,Site07,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.2,,1053.426197,21060.0,7127.0,200689.3078
Site07-CantoSORP-2,13,Site07,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.5,,1036.538535,21310.0,7141.0,203071.6595
Site07-CantoSORP-2,13,Site07,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.8,,1049.275738,19807.0,6702.0,188748.961
Site07-CantoSORP-2,13,Site07,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.1,,685.8598065,134073.0,19123.0,21069890.12
Site07-CantoSORP-2,13,Site07,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.5,,668.195866,133340.0,18114.0,20954697.43
Site07-CantoSORP-2,13,Site07,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64,,671.0985833,126229.0,18849.0,19837186.91
Site07-CantoSORP-2,13,Site07,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,5114.0,2350.0,4804679.153
Site07-CantoSORP-2,13,Site07,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,5082.0,2432.0,4774614.676
Site07-CantoSORP-2,13,Site07,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,4913.0,2334.0,4615836.66
Site07-CantoSORP-2,13,Site07,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.8,,367.0663526,17152.0,1179.0,3534963.63
Site07-CantoSORP-2,13,Site07,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.5,,367.9393148,17601.0,1137.0,3627500.866
Site07-CantoSORP-2,13,Site07,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,36,,377.5136865,17301.0,1186.0,3565671.978
Site07-CantoSORP-2,13,Site07,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site07-CantoSORP-2,13,Site07,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12,,177.5519526,123.0,81.5,538.0351739
Site07-CantoSORP-2,13,Site07,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.1,,207.848201,126.0,80.5,551.157983
Site07-CantoSORP-2,13,Site07,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,10.5,,153.3718463,120.0,81.1,524.9123648
Site08-CantoSORP,14,Site08,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,85.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,84.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,88.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.2,,906.3132214,8133.0,3086.0,72713.7711
Site08-CantoSORP,14,Site08,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77.5,,872.8362635,8096.0,2972.0,72382.96949
Site08-CantoSORP,14,Site08,CantoSORP,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76.7,,861.4854634,8021.0,2979.0,71712.42568
Site08-CantoSORP,14,Site08,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.1,,442.599302,2865.0,975.0,25614.77366
Site08-CantoSORP,14,Site08,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.2,,426.719951,2891.0,1019.0,25847.22885
Site08-CantoSORP,14,Site08,CantoSORP,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.5,,423.3044741,2904.0,1002.0,25963.45645
Site08-CantoSORP,14,Site08,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.3,,2142.152931,6155.0,2243.0,63129.6313
Site08-CantoSORP,14,Site08,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64.3,,2242.924701,6185.0,2244.0,63437.33056
Site08-CantoSORP,14,Site08,CantoSORP,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.9,,2169.604481,6185.0,2270.0,63437.33056
Site08-CantoSORP,14,Site08,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,38.9,,834.0850767,21717.0,4707.0,7536855.711
Site08-CantoSORP,14,Site08,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,39.3,,881.417684,21820.0,4742.0,7572601.722
Site08-CantoSORP,14,Site08,CantoSORP,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,38.8,,841.3120073,21820.0,4774.0,7572601.722
Site08-CantoSORP,14,Site08,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.9,,,4481.0,1226.0,2652710.389
Site08-CantoSORP,14,Site08,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.8,,,4438.0,1214.0,2627254.788
Site08-CantoSORP,14,Site08,CantoSORP,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92.4,,,4459.0,1227.0,2639686.593
Site08-CantoSORP,14,Site08,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.8,,1089.075811,20715.0,10943.0,1025153.872
Site08-CantoSORP,14,Site08,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,50.3,,1128.75068,20715.0,10905.0,1025153.872
Site08-CantoSORP,14,Site08,CantoSORP,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,50.9,,1103.341534,20617.0,10901.0,1020304.001
Site08-CantoSORP,14,Site08,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,57.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.5,,760.9338887,6901.0,5130.0,3340669.761
Site08-CantoSORP,14,Site08,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22.3,,779.2635139,7193.0,5280.0,3482022.546
Site08-CantoSORP,14,Site08,CantoSORP,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.4,,758.7022684,7299.0,5384.0,3533335.544
Site08-CantoSORP,14,Site08,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,88.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,87.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78,,948.8341737,8171.0,3187.0,73053.5133
Site08-CantoSORP,14,Site08,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,78.2,,904.2520912,8152.0,3005.0,72883.6422
Site08-CantoSORP,14,Site08,CantoSORP,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,74.2,,924.0601729,7947.0,3143.0,71050.82245
Site08-CantoSORP,14,Site08,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,434.6108818,2865.0,989.0,25614.77366
Site08-CantoSORP,14,Site08,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.2,,409.7164091,2884.0,1024.0,25784.64476
Site08-CantoSORP,14,Site08,CantoSORP,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.2,,382.2871965,2910.0,980.0,26017.09995
Site08-CantoSORP,14,Site08,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.5,,2115.636305,6185.0,2233.0,63437.33056
Site08-CantoSORP,14,Site08,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64.5,,2169.463552,6200.0,2249.0,63591.18019
Site08-CantoSORP,14,Site08,CantoSORP,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.8,,2026.753122,6215.0,2276.0,63745.02982
Site08-CantoSORP,14,Site08,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,39.8,,842.169003,22132.0,4833.0,7680880.904
Site08-CantoSORP,14,Site08,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,39.9,,864.5948682,22184.0,4845.0,7698927.434
Site08-CantoSORP,14,Site08,CantoSORP,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,39.2,,794.1652063,22079.0,4760.0,7662487.325
Site08-CantoSORP,14,Site08,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.6,,,4491.0,1259.0,2627254.788
Site08-CantoSORP,14,Site08,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,92.3,,,4438.0,1236.0,2627254.788
Site08-CantoSORP,14,Site08,CantoSORP,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92.9,,,4459.0,1260.0,2639686.593
Site08-CantoSORP,14,Site08,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.5,,1068.749676,20472.0,10943.0,1013128.171
Site08-CantoSORP,14,Site08,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,50.3,,1090.180431,20520.0,10855.0,1015503.618
Site08-CantoSORP,14,Site08,CantoSORP,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,51,,1034.481773,20520.0,10844.0,1015503.618
Site08-CantoSORP,14,Site08,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,56.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,53.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.3,,741.4664816,6868.0,5089.0,3324694.96
Site08-CantoSORP,14,Site08,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22.1,,744.9491386,7176.0,5250.0,3473793.103
Site08-CantoSORP,14,Site08,CantoSORP,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22,,687.5512471,7299.0,5250.0,3533335.544
Site08-CantoSORP,14,Site08,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,86.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,85.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.1,,903.0568716,8114.0,3074.0,72543.9
Site08-CantoSORP,14,Site08,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77.3,,865.1883036,8077.0,2954.0,72213.09839
Site08-CantoSORP,14,Site08,CantoSORP,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76.6,,856.2027172,8003.0,2973.0,71551.49516
Site08-CantoSORP,14,Site08,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.1,,440.2373736,2852.0,973.0,25498.54607
Site08-CantoSORP,14,Site08,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.3,,423.6567357,2878.0,1019.0,25731.00126
Site08-CantoSORP,14,Site08,CantoSORP,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.5,,420.7356939,2897.0,1004.0,25900.87236
Site08-CantoSORP,14,Site08,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.2,,2119.184103,6185.0,2238.0,63437.33056
Site08-CantoSORP,14,Site08,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64.2,,2217.755959,6215.0,2244.0,63745.02982
Site08-CantoSORP,14,Site08,CantoSORP,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.9,,2149.546472,6200.0,2270.0,63591.18019
Site08-CantoSORP,14,Site08,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,39.8,,843.7502824,22027.0,4789.0,7644440.795
Site08-CantoSORP,14,Site08,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,40.1,,889.7952153,22184.0,4845.0,7698927.434
Site08-CantoSORP,14,Site08,CantoSORP,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,39.6,,852.1850819,22132.0,4845.0,7680880.904
Site08-CantoSORP,14,Site08,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.8,,,4491.0,1237.0,2658630.296
Site08-CantoSORP,14,Site08,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.8,,,4438.0,1221.0,2627254.788
Site08-CantoSORP,14,Site08,CantoSORP,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92.3,,,4470.0,1238.0,2646198.491
Site08-CantoSORP,14,Site08,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.4,,1068.545066,20569.0,10855.0,1017928.554
Site08-CantoSORP,14,Site08,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,49.9,,1107.54317,20520.0,10767.0,1015503.618
Site08-CantoSORP,14,Site08,CantoSORP,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,50.5,,1085.43113,20472.0,10772.0,1013128.171
Site08-CantoSORP,14,Site08,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,57,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.5,,753.5358362,6884.0,5130.0,3332440.318
Site08-CantoSORP,14,Site08,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22.3,,770.010626,7193.0,5280.0,3482022.546
Site08-CantoSORP,14,Site08,CantoSORP,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.4,,752.8602099,7299.0,5384.0,3533335.544
Site08-CantoSORP,14,Site08,CantoSORP,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.5,,5942.001589,6533.0,1644.0,
Site08-CantoSORP,14,Site08,CantoSORP,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.8,,4967.217391,6741.0,1663.0,
Site08-CantoSORP,14,Site08,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,65.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,74.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,74.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,81.7,,754.5297209,6532.0,1720.0,58399.89584
Site08-CantoSORP,14,Site08,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.9,,772.3437306,6840.0,1785.0,53875.96024
Site08-CantoSORP,14,Site08,CantoSORP,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.8,,756.7174562,6547.0,1692.0,57470.07508
Site08-CantoSORP,14,Site08,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.7,,674.7385902,2917.0,876.0,26079.68404
Site08-CantoSORP,14,Site08,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.4,,728.8163735,2964.0,924.0,26142.26813
Site08-CantoSORP,14,Site08,CantoSORP,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.3,,706.9442508,2917.0,880.0,26142.26813
Site08-CantoSORP,14,Site08,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67,,2552.670621,8167.0,2802.0,83765.99494
Site08-CantoSORP,14,Site08,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.8,,2514.624044,8187.0,2802.0,80945.4184
Site08-CantoSORP,14,Site08,CantoSORP,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66,,2412.882624,8207.0,2809.0,81540.30363
Site08-CantoSORP,14,Site08,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70.8,,1808.082514,22502.0,4476.0,7809288.907
Site08-CantoSORP,14,Site08,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.8,,1855.309118,22878.0,4554.0,7626394.264
Site08-CantoSORP,14,Site08,CantoSORP,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73,,1760.653599,22878.0,4554.0,7608347.734
Site08-CantoSORP,14,Site08,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,86.5,,,4623.0,1054.0,2736773.07
Site08-CantoSORP,14,Site08,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,82.4,,,4645.0,1095.0,2347243.18
Site08-CantoSORP,14,Site08,CantoSORP,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,82.3,,,4634.0,1072.0,2564503.772
Site08-CantoSORP,14,Site08,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.8,,608.7624288,27345.0,6852.0,1353262.497
Site08-CantoSORP,14,Site08,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.3,,585.1879556,27085.0,6854.0,1277990.518
Site08-CantoSORP,14,Site08,CantoSORP,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.5,,565.8613353,27085.0,6761.0,1284127.09
Site08-CantoSORP,14,Site08,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,57.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,55.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.2,,539.6875827,13977.0,10012.0,6766054.377
Site08-CantoSORP,14,Site08,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13,,488.0519735,13671.0,10060.0,6101889.92
Site08-CantoSORP,14,Site08,CantoSORP,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.5,,493.3783695,13908.0,10023.0,6284389.92
Site08-CantoSORP,14,Site08,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,73.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,80.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,81,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85.9,,975.5467124,6026.0,1636.0,61153.59576
Site08-CantoSORP,14,Site08,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,83.9,,961.8386842,6252.0,1717.0,55896.53227
Site08-CantoSORP,14,Site08,CantoSORP,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.3,,944.3586248,6068.0,1632.0,59758.86463
Site08-CantoSORP,14,Site08,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,18.3,,628.9958883,2924.0,960.0,26499.8915
Site08-CantoSORP,14,Site08,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.5,,654.8159695,2917.0,962.0,26079.68404
Site08-CantoSORP,14,Site08,CantoSORP,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.6,,632.5680309,2924.0,962.0,26258.49573
Site08-CantoSORP,14,Site08,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.5,,2289.491426,7892.0,2821.0,83971.12778
Site08-CantoSORP,14,Site08,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,67.1,,2259.142131,7931.0,2822.0,81345.42744
Site08-CantoSORP,14,Site08,CantoSORP,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66,,2129.564646,7931.0,2822.0,81940.31267
Site08-CantoSORP,14,Site08,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,72.9,,1669.765186,21975.0,4526.0,7939779.203
Site08-CantoSORP,14,Site08,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,74.8,,1689.003437,22237.0,4517.0,7717321.013
Site08-CantoSORP,14,Site08,CantoSORP,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,74.2,,1580.732848,22289.0,4615.0,7698927.434
Site08-CantoSORP,14,Site08,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.6,,,3965.0,1038.0,2749796.866
Site08-CantoSORP,14,Site08,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,83.5,,,3965.0,1071.0,2347243.18
Site08-CantoSORP,14,Site08,CantoSORP,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,83.7,,,3974.0,1054.0,2564503.772
Site08-CantoSORP,14,Site08,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.2,,531.1620108,25824.0,6761.0,1340395.492
Site08-CantoSORP,14,Site08,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.9,,518.1211082,25641.0,6777.0,1268934.126
Site08-CantoSORP,14,Site08,CantoSORP,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.9,,488.5670852,25580.0,6733.0,1271952.924
Site08-CantoSORP,14,Site08,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,55.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,52.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,50,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14,,482.9151671,12605.0,10145.0,6617924.403
Site08-CantoSORP,14,Site08,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.6,,425.6574163,12299.0,10000.0,5953759.947
Site08-CantoSORP,14,Site08,CantoSORP,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.3,,429.0424652,12512.0,10150.0,6238401.857
Site08-CantoSORP,14,Site08,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,67.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,77,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,76.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.8,,797.7592787,6428.0,1752.0,58534.0046
Site08-CantoSORP,14,Site08,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,83.8,,813.8377638,6684.0,1840.0,54251.46478
Site08-CantoSORP,14,Site08,CantoSORP,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.8,,796.4447473,6472.0,1749.0,57863.46079
Site08-CantoSORP,14,Site08,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.8,,658.5562804,2924.0,964.0,26079.68404
Site08-CantoSORP,14,Site08,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.4,,714.8947654,2937.0,978.0,26142.26813
Site08-CantoSORP,14,Site08,CantoSORP,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.5,,694.0447083,2924.0,969.0,26142.26813
Site08-CantoSORP,14,Site08,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.9,,2479.816112,7950.0,2808.0,84176.26062
Site08-CantoSORP,14,Site08,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.7,,2453.694427,7989.0,2808.0,81345.42744
Site08-CantoSORP,14,Site08,CantoSORP,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.8,,2346.553781,7989.0,2808.0,81940.31267
Site08-CantoSORP,14,Site08,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.3,,1818.540057,21923.0,4568.0,7939779.203
Site08-CantoSORP,14,Site08,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,74.7,,1833.490754,22184.0,4571.0,7735367.543
Site08-CantoSORP,14,Site08,CantoSORP,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,74.1,,1738.411328,22184.0,4636.0,7698927.434
Site08-CantoSORP,14,Site08,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,86.2,,,4332.0,1110.0,2743284.968
Site08-CantoSORP,14,Site08,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,82.2,,,4332.0,1161.0,2352571.097
Site08-CantoSORP,14,Site08,CantoSORP,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,82,,,4343.0,1132.0,2571015.67
Site08-CantoSORP,14,Site08,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.5,,583.7624847,25948.0,6827.0,1340395.492
Site08-CantoSORP,14,Site08,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.1,,567.5719733,25702.0,6782.0,1265915.329
Site08-CantoSORP,14,Site08,CantoSORP,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.2,,545.3370962,25702.0,6820.0,1271952.924
Site08-CantoSORP,14,Site08,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,56,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,54.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,18,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.1,,521.8258043,12982.0,9943.0,6732652.52
Site08-CantoSORP,14,Site08,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13,,476.2134557,12887.0,9879.0,6056870.027
Site08-CantoSORP,14,Site08,CantoSORP,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.5,,480.2561826,12887.0,9995.0,6238401.857
Site08-CantoSORP,14,Site08,CantoSORP,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.5,,5596.813296,6197.0,1399.0,
Site08-CantoSORP,14,Site08,CantoSORP,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.5,,5198,6256.0,1450.0,
Site08-CantoSORP,14,Site08,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,86.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,82.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.7,,846.7417508,7213.0,2244.0,64488.43366
Site08-CantoSORP,14,Site08,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,83,,947.2015909,7330.0,2358.0,58534.0046
Site08-CantoSORP,14,Site08,CantoSORP,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84,,920.5124127,7196.0,2232.0,55512.08715
Site08-CantoSORP,14,Site08,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.8,,384.9208679,3130.0,1036.0,27984.02847
Site08-CantoSORP,14,Site08,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.7,,380.9938824,3130.0,1039.0,26920.09895
Site08-CantoSORP,14,Site08,CantoSORP,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.2,,397.9714208,3116.0,1039.0,26562.47559
Site08-CantoSORP,14,Site08,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.2,,2143.101372,7498.0,2664.0,76904.30146
Site08-CantoSORP,14,Site08,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.3,,1986.959296,7498.0,2671.0,76524.80571
Site08-CantoSORP,14,Site08,CantoSORP,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,70.2,,1971.371232,7516.0,2665.0,76719.68191
Site08-CantoSORP,14,Site08,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.5,,1360.425434,23206.0,4708.0,8053611.163
Site08-CantoSORP,14,Site08,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.7,,1285.219363,23482.0,4745.0,7921038.575
Site08-CantoSORP,14,Site08,CantoSORP,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63,,1242.439677,23482.0,4745.0,8015435.81
Site08-CantoSORP,14,Site08,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.9,,,4568.0,1259.0,2704213.581
Site08-CantoSORP,14,Site08,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,86.8,,,4579.0,1301.0,2189773.651
Site08-CantoSORP,14,Site08,CantoSORP,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,86.7,,,4579.0,1275.0,1763540.337
Site08-CantoSORP,14,Site08,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30.5,,652.8611387,25398.0,10825.0,1256908.426
Site08-CantoSORP,14,Site08,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30,,596.687219,25097.0,10762.0,1187179.157
Site08-CantoSORP,14,Site08,CantoSORP,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31,,611.2941855,25217.0,10634.0,1129525.077
Site08-CantoSORP,14,Site08,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,48.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,49.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.1,,423.0026811,11481.0,8753.0,5557778.515
Site08-CantoSORP,14,Site08,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.3,,371.240439,11313.0,8630.0,5304602.122
Site08-CantoSORP,14,Site08,CantoSORP,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.1,,395.1355199,11453.0,8793.0,5087732.095
Site08-CantoSORP,14,Site08,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,86.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,89.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,86.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85,,977.039109,6547.0,2084.0,65534.48201
Site08-CantoSORP,14,Site08,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,84.4,,1017.2513,6684.0,2138.0,59758.86463
Site08-CantoSORP,14,Site08,CantoSORP,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,85.2,,995.9218788,6547.0,2069.0,56808.47185
Site08-CantoSORP,14,Site08,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.6,,359.384221,3011.0,1005.0,27984.02847
Site08-CantoSORP,14,Site08,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.3,,358.9338219,3011.0,1005.0,26920.09895
Site08-CantoSORP,14,Site08,CantoSORP,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.6,,398.1123502,3011.0,1008.0,26678.70318
Site08-CantoSORP,14,Site08,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.6,,2035.890057,7461.0,2651.0,76904.30146
Site08-CantoSORP,14,Site08,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.9,,1939.222334,7461.0,2651.0,76524.80571
Site08-CantoSORP,14,Site08,CantoSORP,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.1,,2074.58249,7480.0,2652.0,76155.5666
Site08-CantoSORP,14,Site08,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.1,,1305.266246,22824.0,4586.0,8149396.592
Site08-CantoSORP,14,Site08,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65,,1259.96625,23096.0,4643.0,8015435.81
Site08-CantoSORP,14,Site08,CantoSORP,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,62.8,,1303.800689,23096.0,4609.0,8091786.515
Site08-CantoSORP,14,Site08,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89.8,,,3699.0,1150.0,2710725.479
Site08-CantoSORP,14,Site08,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,87.8,,,3699.0,1177.0,2189773.651
Site08-CantoSORP,14,Site08,CantoSORP,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,87.6,,,3717.0,1162.0,1767684.272
Site08-CantoSORP,14,Site08,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30.2,,615.0094752,23989.0,10115.0,1242012.393
Site08-CantoSORP,14,Site08,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.1,,583.1113815,23650.0,10165.0,1170402.562
Site08-CantoSORP,14,Site08,CantoSORP,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.5,,653.6261226,23819.0,10027.0,1092656.159
Site08-CantoSORP,14,Site08,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,51.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,47.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,51.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.9,,395.9301082,10958.0,8131.0,5476452.255
Site08-CantoSORP,14,Site08,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.2,,355.283973,10745.0,7892.0,5201492.042
Site08-CantoSORP,14,Site08,CantoSORP,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.7,,398.7040455,10958.0,8116.0,4988978.78
Site08-CantoSORP,14,Site08,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,83.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,87.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,83.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.8,,849.4851353,6209.0,1913.0,64336.44373
Site08-CantoSORP,14,Site08,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,83.2,,951.3815891,6354.0,1992.0,58534.0046
Site08-CantoSORP,14,Site08,CantoSORP,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.2,,928.362835,6209.0,1913.0,55512.08715
Site08-CantoSORP,14,Site08,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.8,,380.6645326,2971.0,1026.0,27858.86029
Site08-CantoSORP,14,Site08,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.7,,377.0683082,2984.0,1047.0,26920.09895
Site08-CantoSORP,14,Site08,CantoSORP,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.2,,393.8727998,2971.0,1031.0,26562.47559
Site08-CantoSORP,14,Site08,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.1,,2112.848534,7480.0,2620.0,77088.92102
Site08-CantoSORP,14,Site08,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.2,,1960.234556,7425.0,2639.0,76719.68191
Site08-CantoSORP,14,Site08,CantoSORP,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,70.1,,1940.249417,7498.0,2620.0,76904.30146
Site08-CantoSORP,14,Site08,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.4,,1361.349077,23096.0,4631.0,8149396.592
Site08-CantoSORP,14,Site08,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.4,,1281.191203,23316.0,4743.0,8015435.81
Site08-CantoSORP,14,Site08,CantoSORP,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.9,,1240.570265,23316.0,4643.0,8091786.515
Site08-CantoSORP,14,Site08,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.9,,,2979.0,957.0,2710725.479
Site08-CantoSORP,14,Site08,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,86.8,,,2986.0,979.0,2200429.483
Site08-CantoSORP,14,Site08,CantoSORP,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,86.6,,,2993.0,964.0,1771828.207
Site08-CantoSORP,14,Site08,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30.2,,637.1655863,22824.0,9352.0,1247951.011
Site08-CantoSORP,14,Site08,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,29.9,,586.6285761,22079.0,9439.0,1178766.115
Site08-CantoSORP,14,Site08,CantoSORP,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.9,,599.4300067,22662.0,9297.0,1121507.943
Site08-CantoSORP,14,Site08,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,53.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,48.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,48.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.1,,417.9135763,10510.0,7968.0,5544224.138
Site08-CantoSORP,14,Site08,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.3,,366.7555,10306.0,7993.0,5304602.122
Site08-CantoSORP,14,Site08,CantoSORP,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.1,,389.1236127,10510.0,7998.0,5087732.095
Site08-CantoSORP,14,Site08,CantoSORP,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.9,,4992.980885,6905.0,1771.0,
Site08-CantoSORP,14,Site08,CantoSORP,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.7,,4917.127189,6757.0,1700.0,
Site08-CantoSORP,14,Site08,CantoSORP,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1476.380977,13445.0,5861.0,
Site08-CantoSORP,14,Site08,CantoSORP,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1143.458755,13216.0,5618.0,
Site08-CantoSORP,14,Site08,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.9,,205.8631519,30197.0,6827.0,269978.8204
Site08-CantoSORP,14,Site08,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.6,,205.1538266,44085.0,7633.0,269835.771
Site08-CantoSORP,14,Site08,CantoSORP,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,82.2,,193.3230457,41242.0,7140.0,368727.5726
Site08-CantoSORP,14,Site08,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,152.6069665,9115.0,766.0,81493.42476
Site08-CantoSORP,14,Site08,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.4,,156.1819568,19134.0,1237.0,81243.08841
Site08-CantoSORP,14,Site08,CantoSORP,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.1,,156.6340006,18206.0,1169.0,162772.2755
Site08-CantoSORP,14,Site08,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71,,720.3908208,18942.0,5848.0,194281.3121
Site08-CantoSORP,14,Site08,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.1,,711.6968983,28215.0,6968.0,194599.268
Site08-CantoSORP,14,Site08,CantoSORP,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.6,,732.4201835,26911.0,6885.0,276016.492
Site08-CantoSORP,14,Site08,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65,,468.0424411,92993.0,15050.0,32273095.87
Site08-CantoSORP,14,Site08,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,66.3,,472.0660471,99846.0,14749.0,32511518.3
Site08-CantoSORP,14,Site08,CantoSORP,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.5,,479.7798216,94140.0,14830.0,32671160.68
Site08-CantoSORP,14,Site08,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,10889.0,5142.0,6446186.883
Site08-CantoSORP,14,Site08,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,11583.0,5426.0,6491178.178
Site08-CantoSORP,14,Site08,CantoSORP,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,11151.0,4782.0,6601288.45
Site08-CantoSORP,14,Site08,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,251.50201,85353.0,8792.0,435102.7198
Site08-CantoSORP,14,Site08,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.6,,239.1649455,95535.0,8359.0,427234.0514
Site08-CantoSORP,14,Site08,CantoSORP,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.4,,252.0859945,90299.0,8798.0,435399.6507
Site08-CantoSORP,14,Site08,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,77.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.8,,139.8463157,1861.0,268.0,900881.9629
Site08-CantoSORP,14,Site08,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.9,,140.8070675,5846.0,498.0,910079.5756
Site08-CantoSORP,14,Site08,CantoSORP,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.7,,152.8542226,5465.0,489.0,2645523.873
Site08-CantoSORP,14,Site08,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.8,,205.7980465,30181.0,6825.0,394145.6534
Site08-CantoSORP,14,Site08,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.7,,204.8866254,44118.0,7594.0,394440.6927
Site08-CantoSORP,14,Site08,CantoSORP,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,82.3,,193.3849548,41235.0,7130.0,368664.9885
Site08-CantoSORP,14,Site08,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,152.0210182,9108.0,751.0,171069.1376
Site08-CantoSORP,14,Site08,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.5,,156.8574367,19130.0,1236.0,171033.3753
Site08-CantoSORP,14,Site08,CantoSORP,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.2,,157.0654569,18177.0,1197.0,162512.9986
Site08-CantoSORP,14,Site08,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71,,719.4142404,18973.0,5842.0,289391.1531
Site08-CantoSORP,14,Site08,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.8,,717.3875383,28243.0,6959.0,289678.3391
Site08-CantoSORP,14,Site08,CantoSORP,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.7,,731.9814478,27013.0,6861.0,277062.6694
Site08-CantoSORP,14,Site08,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65,,467.7820197,93910.0,15064.0,34651420.33
Site08-CantoSORP,14,Site08,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.9,,472.4335057,100584.0,14752.0,34907542.24
Site08-CantoSORP,14,Site08,CantoSORP,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.5,,479.3065499,95068.0,14842.0,32993221.84
Site08-CantoSORP,14,Site08,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,10911.0,5166.0,6857028.439
Site08-CantoSORP,14,Site08,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,11627.0,5478.0,6883076.03
Site08-CantoSORP,14,Site08,CantoSORP,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,11181.0,4801.0,6619048.172
Site08-CantoSORP,14,Site08,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,250.785851,84936.0,8655.0,413674.2078
Site08-CantoSORP,14,Site08,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.1,,244.3853339,94835.0,8423.0,416841.4705
Site08-CantoSORP,14,Site08,CantoSORP,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.5,,252.1711601,89857.0,8853.0,438121.5171
Site08-CantoSORP,14,Site08,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.7,,139.1952621,1880.0,267.0,2829960.212
Site08-CantoSORP,14,Site08,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.5,,136.5393837,5891.0,481.0,2851744.032
Site08-CantoSORP,14,Site08,CantoSORP,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.2,,147.1418216,5504.0,490.0,2664403.183
Site08-CantoSORP,14,Site08,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.8,,205.7980465,30181.0,6825.0,269835.771
Site08-CantoSORP,14,Site08,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.7,,204.9189764,44118.0,7594.0,394440.6927
Site08-CantoSORP,14,Site08,CantoSORP,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,82.3,,193.3775183,41235.0,7130.0,368664.9885
Site08-CantoSORP,14,Site08,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,152.0861236,9087.0,750.0,81430.84068
Site08-CantoSORP,14,Site08,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.5,,156.8304959,19086.0,1234.0,170639.9896
Site08-CantoSORP,14,Site08,CantoSORP,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.2,,157.0594171,18177.0,1174.0,162512.9986
Site08-CantoSORP,14,Site08,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71,,719.6095565,18973.0,5855.0,194599.268
Site08-CantoSORP,14,Site08,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.7,,717.4491034,28243.0,6959.0,289678.3391
Site08-CantoSORP,14,Site08,CantoSORP,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.7,,731.9533001,26946.0,6861.0,276375.4744
Site08-CantoSORP,14,Site08,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65,,467.9122304,93680.0,14928.0,32591339.49
Site08-CantoSORP,14,Site08,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.9,,472.4563934,100584.0,14859.0,34907542.24
Site08-CantoSORP,14,Site08,CantoSORP,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.5,,479.2377467,94835.0,14941.0,32912359.5
Site08-CantoSORP,14,Site08,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,10965.0,5183.0,6459210.679
Site08-CantoSORP,14,Site08,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,11684.0,5478.0,6916819.501
Site08-CantoSORP,14,Site08,CantoSORP,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,11236.0,4819.0,6651607.661
Site08-CantoSORP,14,Site08,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,250.8509564,84729.0,8633.0,428322.798
Site08-CantoSORP,14,Site08,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.1,,244.3722135,94603.0,8403.0,415851.7009
Site08-CantoSORP,14,Site08,CantoSORP,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.5,,252.1614631,89638.0,8732.0,432133.411
Site08-CantoSORP,14,Site08,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-CantoSORP,14,Site08,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.7,,139.1301567,1880.0,267.0,910079.5756
Site08-CantoSORP,14,Site08,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.4,,136.3024026,5891.0,488.0,2851744.032
Site08-CantoSORP,14,Site08,CantoSORP,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.1,,146.5317012,5504.0,490.0,2664403.183
Site08-MQA10-1,15,Site08,MQA10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,69.7,,745.3785635,64.7,30.7,75728.40909
Site08-MQA10-1,15,Site08,MQA10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,68.9,,740.2429563,61.6,28.8,72100
Site08-MQA10-1,15,Site08,MQA10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,70.5,,711.5670876,59.9,28.4,70110.22727
Site08-MQA10-1,15,Site08,MQA10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.7,,352.4902859,20.5,7.65,23994.31818
Site08-MQA10-1,15,Site08,MQA10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.5,,342.9431935,20.3,7.42,23760.22727
Site08-MQA10-1,15,Site08,MQA10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10,,329.0270315,23.6,8.43,27622.72727
Site08-MQA10-1,15,Site08,MQA10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.4,,2302.482014,72.8,26.9,61893.63296
Site08-MQA10-1,15,Site08,MQA10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,65.9,,2258.866139,70.7,26.1,60108.2397
Site08-MQA10-1,15,Site08,MQA10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.9,,2307.589496,70.5,26.2,59938.20225
Site08-MQA10-1,15,Site08,MQA10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,49.1,,867.4883623,369.0,84.6,5362858.852
Site08-MQA10-1,15,Site08,MQA10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,49.9,,844.4263807,369.0,86.2,5362858.852
Site08-MQA10-1,15,Site08,MQA10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,49.5,,859.0472799,526.0,120.0,7644617.225
Site08-MQA10-1,15,Site08,MQA10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,60.3,,,222.0,90.2,3103507.109
Site08-MQA10-1,15,Site08,MQA10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,63.5,,,214.0,61.2,3205023.697
Site08-MQA10-1,15,Site08,MQA10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,59.6,,,221.0,60.0,3263033.175
Site08-MQA10-1,15,Site08,MQA10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,40.1,,1130.227946,216.0,105.0,1040647.773
Site08-MQA10-1,15,Site08,MQA10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41.9,,1126.437614,219.0,103.0,1055101.215
Site08-MQA10-1,15,Site08,MQA10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,39.3,,1142.79406,211.0,101.0,1016558.704
Site08-MQA10-1,15,Site08,MQA10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,67.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,67.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,37.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,37.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,37.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.3,,638.4307314,237.0,162.0,5081057.269
Site08-MQA10-1,15,Site08,MQA10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,20.1,,657.1007846,230.0,162.0,4930983.847
Site08-MQA10-1,15,Site08,MQA10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.8,,617.3160311,311.0,206.0,6667547.724
Site08-MQA10-1,15,Site08,MQA10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,93.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,93.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,69.6,,793.1299637,65.2,31.8,76313.63636
Site08-MQA10-1,15,Site08,MQA10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,68.8,,778.291962,62.2,29.7,72802.27273
Site08-MQA10-1,15,Site08,MQA10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,70.4,,744.0919758,60.7,30.7,71046.59091
Site08-MQA10-1,15,Site08,MQA10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.8,,346.5843811,20.9,7.75,24462.5
Site08-MQA10-1,15,Site08,MQA10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.6,,338.5781911,20.7,7.48,24228.40909
Site08-MQA10-1,15,Site08,MQA10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.2,,323.6553343,20.1,7.1,23526.13636
Site08-MQA10-1,15,Site08,MQA10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,64.4,,2227.538938,72.6,26.9,61723.59551
Site08-MQA10-1,15,Site08,MQA10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64.2,,2195.602588,70.6,26.1,60023.22097
Site08-MQA10-1,15,Site08,MQA10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.9,,2237.348035,71.6,26.3,60873.40824
Site08-MQA10-1,15,Site08,MQA10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.8,,840.8097924,370.0,85.0,5377392.344
Site08-MQA10-1,15,Site08,MQA10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,49.5,,820.667205,371.0,86.8,5391925.837
Site08-MQA10-1,15,Site08,MQA10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,49.2,,832.9224106,376.0,87.2,5464593.301
Site08-MQA10-1,15,Site08,MQA10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,61.1,,,222.0,62.3,3219526.066
Site08-MQA10-1,15,Site08,MQA10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,64.2,,,214.0,62.4,3205023.697
Site08-MQA10-1,15,Site08,MQA10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,60.3,,,221.0,61.5,3263033.175
Site08-MQA10-1,15,Site08,MQA10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,39.3,,1086.356015,215.0,104.0,1035829.96
Site08-MQA10-1,15,Site08,MQA10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41.2,,1087.489985,218.0,103.0,1050283.401
Site08-MQA10-1,15,Site08,MQA10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,38.5,,1100.784555,214.0,103.0,1031012.146
Site08-MQA10-1,15,Site08,MQA10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.5,,623.6560756,237.0,163.0,5081057.269
Site08-MQA10-1,15,Site08,MQA10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,20.2,,644.5274452,229.0,163.0,4909544.787
Site08-MQA10-1,15,Site08,MQA10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.9,,601.9358632,236.0,158.0,5059618.209
Site08-MQA10-1,15,Site08,MQA10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,69.7,,703.0407875,76.6,29.4,89656.81818
Site08-MQA10-1,15,Site08,MQA10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,68.9,,693.9725368,59.4,27.5,69525
Site08-MQA10-1,15,Site08,MQA10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,70.4,,676.4426092,75.6,28.9,88486.36364
Site08-MQA10-1,15,Site08,MQA10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.5,,352.8577555,19.1,7.54,22355.68182
Site08-MQA10-1,15,Site08,MQA10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.4,,344.6932447,19.0,7.32,22238.63636
Site08-MQA10-1,15,Site08,MQA10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.89,,326.9186468,18.2,6.94,21302.27273
Site08-MQA10-1,15,Site08,MQA10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.3,,2330.815792,72.8,26.9,61893.63296
Site08-MQA10-1,15,Site08,MQA10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.8,,2288.733557,70.9,26.1,60278.27715
Site08-MQA10-1,15,Site08,MQA10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.5,,2328.204437,71.7,26.2,60958.42697
Site08-MQA10-1,15,Site08,MQA10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.5,,880.0869091,365.0,84.4,5304724.88
Site08-MQA10-1,15,Site08,MQA10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,49.3,,855.667694,366.0,85.8,5319258.373
Site08-MQA10-1,15,Site08,MQA10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,48.9,,866.2986461,371.0,86.0,5391925.837
Site08-MQA10-1,15,Site08,MQA10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,60,,,221.0,60.5,3205023.697
Site08-MQA10-1,15,Site08,MQA10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,63.1,,,213.0,61.1,3190521.327
Site08-MQA10-1,15,Site08,MQA10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,59.3,,,220.0,60.1,3248530.806
Site08-MQA10-1,15,Site08,MQA10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,40.4,,1130.379305,213.0,103.0,1026194.332
Site08-MQA10-1,15,Site08,MQA10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,42.2,,1128.90736,216.0,102.0,1040647.773
Site08-MQA10-1,15,Site08,MQA10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,39.4,,1138.277792,212.0,102.0,1021376.518
Site08-MQA10-1,15,Site08,MQA10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,15,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,14.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.4,,649.0319473,236.0,162.0,5059618.209
Site08-MQA10-1,15,Site08,MQA10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,20.1,,667.9356222,229.0,162.0,4909544.787
Site08-MQA10-1,15,Site08,MQA10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.9,,623.7922538,237.0,158.0,5081057.269
Site08-MQA10-1,15,Site08,MQA10,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,5835.984667,290.0,69.2,
Site08-MQA10-1,15,Site08,MQA10,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,4108.637347,302.0,71.4,
Site08-MQA10-1,15,Site08,MQA10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,70.8,,691.1452609,50.9,19.7,59576.13636
Site08-MQA10-1,15,Site08,MQA10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,70.9,,747.2021266,47.9,18.2,56064.77273
Site08-MQA10-1,15,Site08,MQA10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,70.8,,765.046602,51.1,19.5,59810.22727
Site08-MQA10-1,15,Site08,MQA10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.9,,314.9129898,21.1,7.07,24696.59091
Site08-MQA10-1,15,Site08,MQA10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.2,,316.8819569,20.8,6.86,24345.45455
Site08-MQA10-1,15,Site08,MQA10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.6,,300.5058951,20.8,7.08,24345.45455
Site08-MQA10-1,15,Site08,MQA10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.5,,1398.923687,103.0,36.5,87569.28839
Site08-MQA10-1,15,Site08,MQA10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,49.1,,1391.420621,103.0,37.1,87569.28839
Site08-MQA10-1,15,Site08,MQA10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,48.3,,1364.465821,103.0,36.9,87569.28839
Site08-MQA10-1,15,Site08,MQA10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,22.7,,1048.634189,391.0,82.6,5682595.694
Site08-MQA10-1,15,Site08,MQA10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,23.1,,1042.093413,396.0,80.9,5755263.158
Site08-MQA10-1,15,Site08,MQA10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,22.7,,1017.897873,395.0,83.7,5740729.665
Site08-MQA10-1,15,Site08,MQA10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,26.5,,,225.0,58.6,3263033.175
Site08-MQA10-1,15,Site08,MQA10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,26.4,,,202.0,55.6,2929478.673
Site08-MQA10-1,15,Site08,MQA10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,26.4,,,222.0,60.9,3219526.066
Site08-MQA10-1,15,Site08,MQA10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,13.1,,317.2714237,289.0,77.7,1392348.178
Site08-MQA10-1,15,Site08,MQA10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,13,,321.928996,286.0,73.8,1377894.737
Site08-MQA10-1,15,Site08,MQA10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,12.8,,310.3063319,284.0,79.8,1368259.109
Site08-MQA10-1,15,Site08,MQA10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,67.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,67.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,75,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,74.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,74.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.5,,265.8823902,350.0,273.0,7503671.072
Site08-MQA10-1,15,Site08,MQA10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13,,255.5964817,343.0,270.0,7353597.651
Site08-MQA10-1,15,Site08,MQA10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.7,,263.8767623,336.0,270.0,7203524.229
Site08-MQA10-1,15,Site08,MQA10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,93.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,71.2,,827.9994061,54.6,19.8,63906.81818
Site08-MQA10-1,15,Site08,MQA10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,70.9,,854.2629482,50.4,18.3,58990.90909
Site08-MQA10-1,15,Site08,MQA10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,71,,886.9396957,54.5,20.2,63789.77273
Site08-MQA10-1,15,Site08,MQA10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.8,,283.2729698,21.5,7.06,25164.77273
Site08-MQA10-1,15,Site08,MQA10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.3,,297.4984093,21.3,6.99,24930.68182
Site08-MQA10-1,15,Site08,MQA10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.5,,272.7413013,21.5,7.04,25164.77273
Site08-MQA10-1,15,Site08,MQA10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,45,,1277.836375,103.0,36.7,87569.28839
Site08-MQA10-1,15,Site08,MQA10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,45.9,,1298.225542,103.0,37.1,87569.28839
Site08-MQA10-1,15,Site08,MQA10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,44,,1246.677474,103.0,37.1,87569.28839
Site08-MQA10-1,15,Site08,MQA10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,22.7,,957.5209923,393.0,83.3,5711662.679
Site08-MQA10-1,15,Site08,MQA10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,23.2,,971.634932,397.0,81.4,5769796.651
Site08-MQA10-1,15,Site08,MQA10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,22.5,,931.6620874,398.0,84.8,5784330.144
Site08-MQA10-1,15,Site08,MQA10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,27.9,,,225.0,58.5,3263033.175
Site08-MQA10-1,15,Site08,MQA10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,27.8,,,225.0,55.9,3234028.436
Site08-MQA10-1,15,Site08,MQA10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,27.9,,,223.0,60.9,3234028.436
Site08-MQA10-1,15,Site08,MQA10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,12.6,,289.6158486,288.0,78.0,1387530.364
Site08-MQA10-1,15,Site08,MQA10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,12.8,,300.6194117,283.0,74.3,1363441.296
Site08-MQA10-1,15,Site08,MQA10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,12.3,,280.2494401,285.0,78.1,1373076.923
Site08-MQA10-1,15,Site08,MQA10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,71.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,71.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.4,,241.1562542,349.0,279.0,7482232.012
Site08-MQA10-1,15,Site08,MQA10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.1,,239.7598645,339.0,271.0,7267841.41
Site08-MQA10-1,15,Site08,MQA10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.5,,237.4856933,339.0,271.0,7267841.41
Site08-MQA10-1,15,Site08,MQA10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,70.7,,685.5693873,49.5,19.2,57937.5
Site08-MQA10-1,15,Site08,MQA10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,70.8,,742.844944,46.7,17.9,54660.22727
Site08-MQA10-1,15,Site08,MQA10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,70.7,,759.5669794,49.7,19.1,58171.59091
Site08-MQA10-1,15,Site08,MQA10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.9,,314.7707181,19.6,7.14,22940.90909
Site08-MQA10-1,15,Site08,MQA10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.1,,315.5744194,19.6,6.88,22940.90909
Site08-MQA10-1,15,Site08,MQA10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.6,,299.8515335,19.3,7.15,22589.77273
Site08-MQA10-1,15,Site08,MQA10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.5,,1395.751495,103.0,36.5,87569.28839
Site08-MQA10-1,15,Site08,MQA10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,49.1,,1387.880973,103.0,37.1,87569.28839
Site08-MQA10-1,15,Site08,MQA10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,48.3,,1361.830796,103.0,37.0,87569.28839
Site08-MQA10-1,15,Site08,MQA10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,22.6,,1045.236675,387.0,82.1,5624461.722
Site08-MQA10-1,15,Site08,MQA10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,23.1,,1039.025184,392.0,80.7,5697129.187
Site08-MQA10-1,15,Site08,MQA10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,22.7,,1014.788313,391.0,83.3,5682595.694
Site08-MQA10-1,15,Site08,MQA10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,26.5,,,224.0,58.9,3248530.806
Site08-MQA10-1,15,Site08,MQA10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,26.4,,,201.0,56.0,2914976.303
Site08-MQA10-1,15,Site08,MQA10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,26.4,,,221.0,61.6,3205023.697
Site08-MQA10-1,15,Site08,MQA10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,13.1,,315.5128102,286.0,76.6,1377894.737
Site08-MQA10-1,15,Site08,MQA10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,13,,320.7222571,282.0,73.1,1358623.482
Site08-MQA10-1,15,Site08,MQA10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,12.8,,308.8751258,280.0,79.1,1348987.854
Site08-MQA10-1,15,Site08,MQA10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,67.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,18.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.6,,267.6478719,348.0,275.0,7460792.952
Site08-MQA10-1,15,Site08,MQA10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.1,,256.5538622,339.0,271.0,7267841.41
Site08-MQA10-1,15,Site08,MQA10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.8,,265.8301517,333.0,273.0,7139207.048
Site08-MQA10-1,15,Site08,MQA10,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,4002.855346,279.0,60.1,
Site08-MQA10-1,15,Site08,MQA10,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,3981.56056,284.0,60.6,
Site08-MQA10-1,15,Site08,MQA10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,89.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,89.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78.3,,698.898068,52.1,23.5,60980.68182
Site08-MQA10-1,15,Site08,MQA10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77.8,,667.4125712,48.1,21.3,56298.86364
Site08-MQA10-1,15,Site08,MQA10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77.1,,601.3798267,44.9,19.0,52553.40909
Site08-MQA10-1,15,Site08,MQA10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.02,,199.969058,22.0,7.65,25750
Site08-MQA10-1,15,Site08,MQA10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.89,,231.986327,21.3,7.83,24930.68182
Site08-MQA10-1,15,Site08,MQA10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.04,,243.8026324,21.1,8.37,24696.59091
Site08-MQA10-1,15,Site08,MQA10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.2,,1951.126666,90.0,31.5,76516.85393
Site08-MQA10-1,15,Site08,MQA10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62,,2030.90878,89.2,32.2,75836.70412
Site08-MQA10-1,15,Site08,MQA10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.1,,2080.325058,88.1,32.0,74901.49813
Site08-MQA10-1,15,Site08,MQA10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,34.2,,1144.04658,409.0,85.4,5944198.565
Site08-MQA10-1,15,Site08,MQA10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.7,,1198.07662,405.0,84.8,5886064.593
Site08-MQA10-1,15,Site08,MQA10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.7,,1229.063042,399.0,84.7,5798863.636
Site08-MQA10-1,15,Site08,MQA10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,55.2,,,234.0,67.1,3393554.502
Site08-MQA10-1,15,Site08,MQA10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,59.6,,,192.0,59.4,2784454.976
Site08-MQA10-1,15,Site08,MQA10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,58.2,,,154.0,50.0,2233364.929
Site08-MQA10-1,15,Site08,MQA10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.7,,667.846972,270.0,108.0,1300809.717
Site08-MQA10-1,15,Site08,MQA10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,37,,684.116584,252.0,100.0,1214089.069
Site08-MQA10-1,15,Site08,MQA10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37.3,,700.6378959,230.0,93.6,1108097.166
Site08-MQA10-1,15,Site08,MQA10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,58.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,59,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,59.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.9,,321.1925367,346.0,231.0,7417914.831
Site08-MQA10-1,15,Site08,MQA10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.8,,334.2049128,316.0,223.0,6774743.025
Site08-MQA10-1,15,Site08,MQA10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.2,,356.5846135,319.0,215.0,6839060.206
Site08-MQA10-1,15,Site08,MQA10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78.1,,783.7715257,54.1,24.6,63321.59091
Site08-MQA10-1,15,Site08,MQA10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77.7,,733.5374493,49.7,21.9,58171.59091
Site08-MQA10-1,15,Site08,MQA10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77.1,,661.9294094,46.4,19.9,54309.09091
Site08-MQA10-1,15,Site08,MQA10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.17,,193.1897228,22.5,7.83,26335.22727
Site08-MQA10-1,15,Site08,MQA10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.02,,226.2724002,21.7,7.9,25398.86364
Site08-MQA10-1,15,Site08,MQA10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.15,,237.7101127,21.4,8.34,25047.72727
Site08-MQA10-1,15,Site08,MQA10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,56.2,,1847.896603,90.0,31.5,76516.85393
Site08-MQA10-1,15,Site08,MQA10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,59.6,,1950.735134,89.2,32.2,75836.70412
Site08-MQA10-1,15,Site08,MQA10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,61.7,,2001.469255,88.1,32.0,74901.49813
Site08-MQA10-1,15,Site08,MQA10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,34.2,,1084.393011,411.0,85.7,5973265.55
Site08-MQA10-1,15,Site08,MQA10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.5,,1151.62876,406.0,84.9,5900598.086
Site08-MQA10-1,15,Site08,MQA10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.5,,1183.44235,400.0,85.0,5813397.129
Site08-MQA10-1,15,Site08,MQA10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,56.5,,,234.0,68.1,3393554.502
Site08-MQA10-1,15,Site08,MQA10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,60.6,,,192.0,60.0,2784454.976
Site08-MQA10-1,15,Site08,MQA10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,59.1,,,154.0,50.6,2233364.929
Site08-MQA10-1,15,Site08,MQA10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31.8,,631.1176695,268.0,108.0,1291174.089
Site08-MQA10-1,15,Site08,MQA10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,36.1,,653.5433605,251.0,99.3,1209271.255
Site08-MQA10-1,15,Site08,MQA10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,36.5,,671.1954707,228.0,93.1,1098461.538
Site08-MQA10-1,15,Site08,MQA10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,68.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,68.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,18.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.1,,308.7052272,345.0,232.0,7396475.771
Site08-MQA10-1,15,Site08,MQA10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.9,,323.7912745,315.0,224.0,6753303.965
Site08-MQA10-1,15,Site08,MQA10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.3,,346.6457316,319.0,217.0,6839060.206
Site08-MQA10-1,15,Site08,MQA10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,89,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,88.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78.2,,664.7035698,50.0,22.9,58522.72727
Site08-MQA10-1,15,Site08,MQA10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77.7,,634.7617268,46.5,20.7,54426.13636
Site08-MQA10-1,15,Site08,MQA10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77,,577.4088287,43.4,18.5,50797.72727
Site08-MQA10-1,15,Site08,MQA10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.99,,201.7109528,20.6,7.64,24111.36364
Site08-MQA10-1,15,Site08,MQA10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.88,,234.9287091,20.1,7.86,23526.13636
Site08-MQA10-1,15,Site08,MQA10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.11,,248.4448311,20.1,8.62,23526.13636
Site08-MQA10-1,15,Site08,MQA10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60,,1974.882189,90.2,31.5,76686.89139
Site08-MQA10-1,15,Site08,MQA10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.8,,2055.941629,89.4,32.1,76006.74157
Site08-MQA10-1,15,Site08,MQA10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.8,,2101.888352,88.3,32.0,75071.53558
Site08-MQA10-1,15,Site08,MQA10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,34.1,,1157.481542,406.0,84.6,5900598.086
Site08-MQA10-1,15,Site08,MQA10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.5,,1214.134784,402.0,84.1,5842464.115
Site08-MQA10-1,15,Site08,MQA10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.5,,1242.725052,397.0,84.6,5769796.651
Site08-MQA10-1,15,Site08,MQA10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,54.8,,,234.0,67.4,3393554.502
Site08-MQA10-1,15,Site08,MQA10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,59.3,,,192.0,59.6,2784454.976
Site08-MQA10-1,15,Site08,MQA10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,57.9,,,153.0,50.3,2218862.559
Site08-MQA10-1,15,Site08,MQA10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.9,,673.249579,265.0,107.0,1276720.648
Site08-MQA10-1,15,Site08,MQA10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,37.2,,688.1316752,249.0,98.6,1199635.628
Site08-MQA10-1,15,Site08,MQA10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37.5,,704.6366253,227.0,92.5,1093643.725
Site08-MQA10-1,15,Site08,MQA10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,16,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,14.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.9,,327.0105291,345.0,232.0,7396475.771
Site08-MQA10-1,15,Site08,MQA10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.9,,340.533075,314.0,225.0,6731864.905
Site08-MQA10-1,15,Site08,MQA10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.2,,360.896171,318.0,216.0,6817621.145
Site08-MQA10-1,15,Site08,MQA10,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,31806,315.0,81.0,
Site08-MQA10-1,15,Site08,MQA10,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,31599,314.0,78.2,
Site08-MQA10-1,15,Site08,MQA10,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,2115.909587,562.0,238.0,
Site08-MQA10-1,15,Site08,MQA10,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1679.682429,564.0,240.0,
Site08-MQA10-1,15,Site08,MQA10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.4,,275.1179504,77.1,21.1,90242.04545
Site08-MQA10-1,15,Site08,MQA10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81,,233.1837992,79.2,22.1,92700
Site08-MQA10-1,15,Site08,MQA10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.2,,276.061046,71.6,18.6,83804.54545
Site08-MQA10-1,15,Site08,MQA10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,224.7303485,23.6,4.39,27622.72727
Site08-MQA10-1,15,Site08,MQA10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,16.5,,256.3034132,24.7,4.15,28910.22727
Site08-MQA10-1,15,Site08,MQA10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.8,,236.5648569,23.0,4.0,26920.45455
Site08-MQA10-1,15,Site08,MQA10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.9,,1036.43927,238.0,87.7,202344.5693
Site08-MQA10-1,15,Site08,MQA10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.8,,1080.449654,244.0,88.6,207445.6929
Site08-MQA10-1,15,Site08,MQA10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.4,,1056.419988,242.0,87.9,205745.3184
Site08-MQA10-1,15,Site08,MQA10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.8,,671.3141024,816.0,179.0,11859330.14
Site08-MQA10-1,15,Site08,MQA10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.7,,698.8191022,822.0,177.0,11946531.1
Site08-MQA10-1,15,Site08,MQA10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.1,,688.0087717,750.0,165.0,10900119.62
Site08-MQA10-1,15,Site08,MQA10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,348.0,159.0,5046824.645
Site08-MQA10-1,15,Site08,MQA10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,360.0,132.0,5220853.081
Site08-MQA10-1,15,Site08,MQA10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,335.0,137.0,4858293.839
Site08-MQA10-1,15,Site08,MQA10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.1,,363.9743903,589.0,76.0,2837692.308
Site08-MQA10-1,15,Site08,MQA10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.2,,380.061347,588.0,73.7,2832874.494
Site08-MQA10-1,15,Site08,MQA10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.8,,367.3392951,562.0,71.1,2707611.336
Site08-MQA10-1,15,Site08,MQA10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,15.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,9.36,,136.860289,3.31,1.6,70963.28928
Site08-MQA10-1,15,Site08,MQA10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,8.94,,138.4038431,3.39,1.88,72678.4141
Site08-MQA10-1,15,Site08,MQA10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,7.71,,115.6850799,3.48,2.04,74607.92952
Site08-MQA10-1,15,Site08,MQA10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.2,,273.7975475,77.4,21.2,59810.22727
Site08-MQA10-1,15,Site08,MQA10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.6,,231.6436642,79.4,22.1,92934.09091
Site08-MQA10-1,15,Site08,MQA10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81,,275.0381459,71.8,18.5,84038.63636
Site08-MQA10-1,15,Site08,MQA10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,225.1968492,24.7,4.46,28910.22727
Site08-MQA10-1,15,Site08,MQA10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,16.6,,257.3933857,25.8,4.26,30197.72727
Site08-MQA10-1,15,Site08,MQA10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.8,,237.3167544,24.0,4.14,28090.90909
Site08-MQA10-1,15,Site08,MQA10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.9,,1037.032716,238.0,87.8,202344.5693
Site08-MQA10-1,15,Site08,MQA10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.7,,1078.892566,244.0,88.7,207445.6929
Site08-MQA10-1,15,Site08,MQA10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.4,,1055.87095,241.0,88.0,204895.1311
Site08-MQA10-1,15,Site08,MQA10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.7,,671.1797278,821.0,180.0,11931997.61
Site08-MQA10-1,15,Site08,MQA10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.7,,698.0458781,827.0,180.0,12019198.56
Site08-MQA10-1,15,Site08,MQA10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.1,,687.1853496,752.0,166.0,10929186.6
Site08-MQA10-1,15,Site08,MQA10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,349.0,159.0,5235355.45
Site08-MQA10-1,15,Site08,MQA10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,361.0,134.0,5235355.45
Site08-MQA10-1,15,Site08,MQA10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,336.0,138.0,4872796.209
Site08-MQA10-1,15,Site08,MQA10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.1,,363.8926235,587.0,76.0,2828056.68
Site08-MQA10-1,15,Site08,MQA10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.1,,379.0815858,585.0,73.9,2818421.053
Site08-MQA10-1,15,Site08,MQA10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.8,,367.209546,559.0,71.4,2693157.895
Site08-MQA10-1,15,Site08,MQA10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,15.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,10.2,,149.477778,3.18,1.6,68176.21145
Site08-MQA10-1,15,Site08,MQA10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,9.76,,150.9681254,3.25,1.78,69676.94567
Site08-MQA10-1,15,Site08,MQA10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,8.55,,128.2527311,3.35,1.92,71820.85169
Site08-MQA10-1,15,Site08,MQA10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.2,,273.7975475,76.5,21.0,89539.77273
Site08-MQA10-1,15,Site08,MQA10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.6,,231.5398346,78.5,22.1,91880.68182
Site08-MQA10-1,15,Site08,MQA10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81,,274.8622631,71.0,18.5,83102.27273
Site08-MQA10-1,15,Site08,MQA10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.2,,222.7463938,20.5,4.23,23994.31818
Site08-MQA10-1,15,Site08,MQA10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,16.6,,256.2512609,21.5,4.03,25164.77273
Site08-MQA10-1,15,Site08,MQA10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.7,,236.0765082,20.0,3.85,23409.09091
Site08-MQA10-1,15,Site08,MQA10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.9,,1037.032716,239.0,87.7,203194.7566
Site08-MQA10-1,15,Site08,MQA10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.7,,1078.996395,244.0,88.9,207445.6929
Site08-MQA10-1,15,Site08,MQA10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.3,,1055.743329,242.0,88.1,205745.3184
Site08-MQA10-1,15,Site08,MQA10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.7,,671.3430915,813.0,180.0,11815729.67
Site08-MQA10-1,15,Site08,MQA10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.7,,698.2535372,820.0,179.0,11917464.11
Site08-MQA10-1,15,Site08,MQA10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.1,,687.1556579,745.0,165.0,10827452.15
Site08-MQA10-1,15,Site08,MQA10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,349.0,160.0,5061327.014
Site08-MQA10-1,15,Site08,MQA10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,361.0,134.0,5235355.45
Site08-MQA10-1,15,Site08,MQA10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,336.0,138.0,4872796.209
Site08-MQA10-1,15,Site08,MQA10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,362.0956229,582.0,75.7,2803967.611
Site08-MQA10-1,15,Site08,MQA10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35,,377.2126544,580.0,73.1,2794331.984
Site08-MQA10-1,15,Site08,MQA10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.6,,364.9796937,556.0,70.6,2678704.453
Site08-MQA10-1,15,Site08,MQA10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,15.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-1,15,Site08,MQA10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,10.2,,149.7228236,3.3,1.6,70748.89868
Site08-MQA10-1,15,Site08,MQA10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,9.86,,152.6293977,3.36,1.79,72035.24229
Site08-MQA10-1,15,Site08,MQA10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,8.65,,129.8051798,3.42,1.95,73321.5859
Site08-MQA10-2,16,Site08,MQA10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,93.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,67.7,,952.4277207,79.7,29.0,93285.22727
Site08-MQA10-2,16,Site08,MQA10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,65.5,,911.6861343,78.5,28.4,91880.68182
Site08-MQA10-2,16,Site08,MQA10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,66,,902.6663986,78.7,28.4,92114.77273
Site08-MQA10-2,16,Site08,MQA10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,,449.2454769,23.1,8.46,26920.45455
Site08-MQA10-2,16,Site08,MQA10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12,,437.4955309,23.4,8.2,27388.63636
Site08-MQA10-2,16,Site08,MQA10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12,,436.5048509,23.6,8.43,27622.72727
Site08-MQA10-2,16,Site08,MQA10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.1,,2457.331794,69.9,26.1,59428.08989
Site08-MQA10-2,16,Site08,MQA10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,67.6,,2472.4041,71.0,26.4,60363.29588
Site08-MQA10-2,16,Site08,MQA10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68,,2474.02425,70.5,26.2,59938.20225
Site08-MQA10-2,16,Site08,MQA10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,38.1,,937.2708064,518.0,120.0,7528349.282
Site08-MQA10-2,16,Site08,MQA10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37.5,,927.6789065,526.0,120.0,7644617.225
Site08-MQA10-2,16,Site08,MQA10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.3,,922.0401203,526.0,120.0,7644617.225
Site08-MQA10-2,16,Site08,MQA10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88,,,295.0,90.2,4278199.052
Site08-MQA10-2,16,Site08,MQA10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.1,,,295.0,90.3,4278199.052
Site08-MQA10-2,16,Site08,MQA10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,90.9,,,297.0,90.9,4307203.791
Site08-MQA10-2,16,Site08,MQA10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,48,,1180.600727,208.0,102.0,1002105.263
Site08-MQA10-2,16,Site08,MQA10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,48.6,,1200.831532,212.0,102.0,1021376.518
Site08-MQA10-2,16,Site08,MQA10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,49,,1212.794973,211.0,101.0,1016558.704
Site08-MQA10-2,16,Site08,MQA10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.3,,706.3668243,310.0,203.0,6646108.664
Site08-MQA10-2,16,Site08,MQA10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.4,,708.9801987,313.0,202.0,6710425.844
Site08-MQA10-2,16,Site08,MQA10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.7,,681.6569436,311.0,206.0,6667547.724
Site08-MQA10-2,16,Site08,MQA10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,94.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,66.7,,931.9944039,78.8,28.7,92231.81818
Site08-MQA10-2,16,Site08,MQA10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,64.8,,893.8963214,77.7,28.1,90944.31818
Site08-MQA10-2,16,Site08,MQA10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,65.2,,883.4915589,77.8,28.0,91061.36364
Site08-MQA10-2,16,Site08,MQA10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.1,,438.6013624,22.5,8.39,26335.22727
Site08-MQA10-2,16,Site08,MQA10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.9,,429.8691831,22.7,8.14,26569.31818
Site08-MQA10-2,16,Site08,MQA10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.9,,427.6093285,22.9,8.41,26803.40909
Site08-MQA10-2,16,Site08,MQA10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.2,,2425.971922,522.0,26.1,443797.7528
Site08-MQA10-2,16,Site08,MQA10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,67.6,,2444.706088,530.0,26.3,78217.22846
Site08-MQA10-2,16,Site08,MQA10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68.1,,2444.800303,530.0,26.3,450599.2509
Site08-MQA10-2,16,Site08,MQA10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,38.1,,923.1527148,69.7,121.0,1012984.45
Site08-MQA10-2,16,Site08,MQA10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37.5,,917.6332056,70.9,121.0,1030424.641
Site08-MQA10-2,16,Site08,MQA10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.2,,909.4205932,70.4,121.0,1023157.895
Site08-MQA10-2,16,Site08,MQA10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88,,,295.0,92.0,4278199.052
Site08-MQA10-2,16,Site08,MQA10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91,,,295.0,91.9,4278199.052
Site08-MQA10-2,16,Site08,MQA10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,90.9,,,297.0,92.4,4307203.791
Site08-MQA10-2,16,Site08,MQA10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,47.5,,1151.830945,206.0,101.0,992469.6356
Site08-MQA10-2,16,Site08,MQA10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,48.1,,1176.712612,210.0,101.0,1011740.891
Site08-MQA10-2,16,Site08,MQA10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.6,,1188.487318,209.0,100.0,1006923.077
Site08-MQA10-2,16,Site08,MQA10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,57.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,58.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.2,,694.3405197,308.0,203.0,6603230.543
Site08-MQA10-2,16,Site08,MQA10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.4,,700.7205404,311.0,201.0,6667547.724
Site08-MQA10-2,16,Site08,MQA10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.8,,674.7408589,309.0,206.0,6624669.604
Site08-MQA10-2,16,Site08,MQA10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,67,,920.6548966,76.6,27.8,89656.81818
Site08-MQA10-2,16,Site08,MQA10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,65,,882.797782,75.6,27.1,88486.36364
Site08-MQA10-2,16,Site08,MQA10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,65.2,,866.9664272,75.6,27.0,88486.36364
Site08-MQA10-2,16,Site08,MQA10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.9,,442.0626659,20.4,8.15,23877.27273
Site08-MQA10-2,16,Site08,MQA10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.7,,433.5733721,20.7,7.96,447198.5019
Site08-MQA10-2,16,Site08,MQA10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.7,,430.6244212,20.8,8.15,24345.45455
Site08-MQA10-2,16,Site08,MQA10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67,,2483.735749,517.0,26.1,439546.8165
Site08-MQA10-2,16,Site08,MQA10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,67.5,,2504.562289,526.0,26.4,4278199.052
Site08-MQA10-2,16,Site08,MQA10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68,,2506.860056,526.0,26.2,447198.5019
Site08-MQA10-2,16,Site08,MQA10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,38,,944.9621634,69.9,120.0,1015891.148
Site08-MQA10-2,16,Site08,MQA10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37.5,,940.4490734,70.9,120.0,6688986.784
Site08-MQA10-2,16,Site08,MQA10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.3,,933.9223558,70.5,120.0,1024611.244
Site08-MQA10-2,16,Site08,MQA10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.7,,,293.0,87.7,4249194.313
Site08-MQA10-2,16,Site08,MQA10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,90.8,,,293.0,87.7,4249194.313
Site08-MQA10-2,16,Site08,MQA10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,90.7,,,295.0,87.5,4278199.052
Site08-MQA10-2,16,Site08,MQA10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,47.2,,1172.379304,204.0,99.7,982834.0081
Site08-MQA10-2,16,Site08,MQA10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.9,,1199.384599,208.0,100.0,24228.40909
Site08-MQA10-2,16,Site08,MQA10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.2,,1208.81782,208.0,99.2,1002105.263
Site08-MQA10-2,16,Site08,MQA10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,18.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,18.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.3,,714.1117933,310.0,204.0,6646108.664
Site08-MQA10-2,16,Site08,MQA10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.4,,720.3439711,312.0,202.0,1002105.263
Site08-MQA10-2,16,Site08,MQA10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.8,,692.4296248,310.0,206.0,6646108.664
Site08-MQA10-2,16,Site08,MQA10,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.4,,6067.029481,357.0,88.8,
Site08-MQA10-2,16,Site08,MQA10,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97,,5034.113004,370.0,90.0,
Site08-MQA10-2,16,Site08,MQA10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.2,,1330.090212,70.1,19.7,82048.86364
Site08-MQA10-2,16,Site08,MQA10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.6,,1305.160714,63.9,17.4,74792.04545
Site08-MQA10-2,16,Site08,MQA10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.2,,1313.658545,68.3,19.1,79942.04545
Site08-MQA10-2,16,Site08,MQA10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.1,,416.9394532,24.5,7.91,28676.13636
Site08-MQA10-2,16,Site08,MQA10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.9,,423.7895045,23.4,7.76,27388.63636
Site08-MQA10-2,16,Site08,MQA10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.8,,441.0166969,24.2,8.15,28325
Site08-MQA10-2,16,Site08,MQA10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.1,,1631.933034,95.1,34.3,80852.80899
Site08-MQA10-2,16,Site08,MQA10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,67.6,,1693.392754,92.0,33.5,78217.22846
Site08-MQA10-2,16,Site08,MQA10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.4,,1643.391857,92.3,33.3,78472.28464
Site08-MQA10-2,16,Site08,MQA10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.2,,1194.540426,543.0,114.0,7891686.603
Site08-MQA10-2,16,Site08,MQA10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.2,,1238.963306,532.0,114.0,7731818.182
Site08-MQA10-2,16,Site08,MQA10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,74,,1216.398153,529.0,111.0,7688217.703
Site08-MQA10-2,16,Site08,MQA10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,81,,,291.0,76.7,4220189.573
Site08-MQA10-2,16,Site08,MQA10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76.4,,,257.0,75.3,3727109.005
Site08-MQA10-2,16,Site08,MQA10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,75.6,,,285.0,79.3,4133175.355
Site08-MQA10-2,16,Site08,MQA10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.8,,388.8640056,277.0,73.4,1334534.413
Site08-MQA10-2,16,Site08,MQA10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.1,,408.4064877,270.0,72.9,1300809.717
Site08-MQA10-2,16,Site08,MQA10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.8,,374.7612713,274.0,74.5,1320080.972
Site08-MQA10-2,16,Site08,MQA10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,40.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,39.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,38.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.7,,357.2314877,486.0,345.0,10419383.26
Site08-MQA10-2,16,Site08,MQA10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.4,,361.1226245,475.0,328.0,10183553.6
Site08-MQA10-2,16,Site08,MQA10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,15,,370.3871267,470.0,341.0,10076358.3
Site08-MQA10-2,16,Site08,MQA10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.2,,1324.091659,69.5,19.6,81346.59091
Site08-MQA10-2,16,Site08,MQA10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.6,,1295.486393,63.2,17.5,79942.04545
Site08-MQA10-2,16,Site08,MQA10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83,,1307.197237,67.4,19.0,78888.63636
Site08-MQA10-2,16,Site08,MQA10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.6,,417.726312,23.7,7.94,27388.63636
Site08-MQA10-2,16,Site08,MQA10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.1,,422.8465544,22.7,7.81,26569.31818
Site08-MQA10-2,16,Site08,MQA10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.1,,438.2700648,23.4,8.09,27388.63636
Site08-MQA10-2,16,Site08,MQA10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,68.2,,1620.917591,547.0,34.3,78217.22846
Site08-MQA10-2,16,Site08,MQA10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,68.3,,1688.576606,535.0,33.7,454850.1873
Site08-MQA10-2,16,Site08,MQA10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,67.5,,1632.979298,533.0,33.5,453149.8127
Site08-MQA10-2,16,Site08,MQA10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.2,,1186.270393,95.0,115.0,7731818.182
Site08-MQA10-2,16,Site08,MQA10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.1,,1233.547227,91.8,115.0,1334174.641
Site08-MQA10-2,16,Site08,MQA10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.9,,1207.30999,92.0,112.0,1337081.34
Site08-MQA10-2,16,Site08,MQA10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,80.7,,,290.0,78.9,4205687.204
Site08-MQA10-2,16,Site08,MQA10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76,,,256.0,76.6,4133175.355
Site08-MQA10-2,16,Site08,MQA10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,75.2,,,284.0,81.1,4118672.986
Site08-MQA10-2,16,Site08,MQA10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.6,,382.3345342,274.0,72.9,1300809.717
Site08-MQA10-2,16,Site08,MQA10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.1,,406.499723,267.0,72.9,1286356.275
Site08-MQA10-2,16,Site08,MQA10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.7,,370.9347718,272.0,74.3,1310445.344
Site08-MQA10-2,16,Site08,MQA10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,39.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,38.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,37.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.3,,316.3301602,415.0,300.0,10183553.6
Site08-MQA10-2,16,Site08,MQA10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.7,,338.5582047,423.0,307.0,9068722.467
Site08-MQA10-2,16,Site08,MQA10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.8,,333.0012442,409.0,300.0,8768575.624
Site08-MQA10-2,16,Site08,MQA10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,93.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.5,,1295.930175,66.9,19.2,78888.63636
Site08-MQA10-2,16,Site08,MQA10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82,,1274.689369,61.2,17.0,71631.81818
Site08-MQA10-2,16,Site08,MQA10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,82.3,,1276.397718,65.1,18.5,76196.59091
Site08-MQA10-2,16,Site08,MQA10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.3,,421.8722513,21.4,7.85,460801.4981
Site08-MQA10-2,16,Site08,MQA10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.9,,425.7738236,20.8,7.77,24345.45455
Site08-MQA10-2,16,Site08,MQA10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.8,,439.6225952,21.3,8.09,24930.68182
Site08-MQA10-2,16,Site08,MQA10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.7,,1623.717618,542.0,34.4,4205687.204
Site08-MQA10-2,16,Site08,MQA10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,67.3,,1692.566887,531.0,33.7,451449.4382
Site08-MQA10-2,16,Site08,MQA10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.1,,1636.5643,528.0,33.5,448898.8764
Site08-MQA10-2,16,Site08,MQA10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.1,,1187.254675,95.1,114.0,10226431.72
Site08-MQA10-2,16,Site08,MQA10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73,,1235.709193,92.0,114.0,1337081.34
Site08-MQA10-2,16,Site08,MQA10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.9,,1209.695479,92.1,112.0,1338534.689
Site08-MQA10-2,16,Site08,MQA10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,80.6,,,290.0,78.0,4205687.204
Site08-MQA10-2,16,Site08,MQA10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,76,,,256.0,76.1,3712606.635
Site08-MQA10-2,16,Site08,MQA10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,75.3,,,285.0,80.3,4133175.355
Site08-MQA10-2,16,Site08,MQA10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.7,,384.5150484,272.0,72.1,25047.72727
Site08-MQA10-2,16,Site08,MQA10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.1,,407.7251246,265.0,72.8,1337081.34
Site08-MQA10-2,16,Site08,MQA10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.7,,371.9000545,269.0,74.1,1295991.903
Site08-MQA10-2,16,Site08,MQA10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,40.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,39.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,38.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.8,,360.4907192,477.0,350.0,1310445.344
Site08-MQA10-2,16,Site08,MQA10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.5,,365.235479,468.0,336.0,10033480.18
Site08-MQA10-2,16,Site08,MQA10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.1,,374.0681961,466.0,344.0,9990602.056
Site08-MQA10-2,16,Site08,MQA10,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,90,,5121.81703,347.0,78.8,
Site08-MQA10-2,16,Site08,MQA10,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,88.9,,4544.013329,351.0,79.7,
Site08-MQA10-2,16,Site08,MQA10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,93.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,93.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,93.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.4,,1146.885045,72.8,22.9,85209.09091
Site08-MQA10-2,16,Site08,MQA10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,79.5,,1154.078588,67.4,21.5,78888.63636
Site08-MQA10-2,16,Site08,MQA10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.4,,1161.599317,63.1,19.5,73855.68182
Site08-MQA10-2,16,Site08,MQA10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,325.1551409,24.9,8.35,29144.31818
Site08-MQA10-2,16,Site08,MQA10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.6,,322.2202337,24.7,8.36,28910.22727
Site08-MQA10-2,16,Site08,MQA10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.4,,315.522298,24.1,8.46,28207.95455
Site08-MQA10-2,16,Site08,MQA10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74,,2178.887963,85.4,30.7,72605.99251
Site08-MQA10-2,16,Site08,MQA10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.3,,2260.869792,87.3,32.1,74221.34831
Site08-MQA10-2,16,Site08,MQA10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,74.7,,2269.77196,87.7,32.2,74561.42322
Site08-MQA10-2,16,Site08,MQA10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,57.3,,1249.504472,554.0,116.0,8051555.024
Site08-MQA10-2,16,Site08,MQA10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,57.4,,1297.805596,559.0,117.0,8124222.488
Site08-MQA10-2,16,Site08,MQA10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.7,,1310.478116,557.0,117.0,8095155.502
Site08-MQA10-2,16,Site08,MQA10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.8,,,304.0,92.9,4408720.379
Site08-MQA10-2,16,Site08,MQA10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.6,,,248.0,80.3,3596587.678
Site08-MQA10-2,16,Site08,MQA10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,89.4,,,198.0,68.7,2871469.194
Site08-MQA10-2,16,Site08,MQA10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.6,,753.0587901,254.0,103.0,1223724.696
Site08-MQA10-2,16,Site08,MQA10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34,,768.1868904,240.0,97.3,1156275.304
Site08-MQA10-2,16,Site08,MQA10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.1,,775.0182161,222.0,90.7,1069554.656
Site08-MQA10-2,16,Site08,MQA10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,54,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,55.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,56.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.6,,398.9894961,433.0,273.0,9283113.069
Site08-MQA10-2,16,Site08,MQA10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.7,,415.7293714,411.0,268.0,8811453.744
Site08-MQA10-2,16,Site08,MQA10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.6,,414.1561593,414.0,254.0,8875770.925
Site08-MQA10-2,16,Site08,MQA10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,94,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.1,,1133.846278,71.9,22.5,84155.68182
Site08-MQA10-2,16,Site08,MQA10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,79.3,,1142.024528,66.7,21.3,78069.31818
Site08-MQA10-2,16,Site08,MQA10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.2,,1147.312057,62.6,19.4,73270.45455
Site08-MQA10-2,16,Site08,MQA10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,322.7826045,24.2,8.17,28325
Site08-MQA10-2,16,Site08,MQA10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.6,,321.5724225,24.1,8.28,28207.95455
Site08-MQA10-2,16,Site08,MQA10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.3,,311.4084459,23.7,8.36,27739.77273
Site08-MQA10-2,16,Site08,MQA10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.5,,2179.35489,558.0,30.6,474404.4944
Site08-MQA10-2,16,Site08,MQA10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.5,,2259.07147,561.0,31.9,476955.0562
Site08-MQA10-2,16,Site08,MQA10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75,,2271.761216,560.0,32.2,476104.8689
Site08-MQA10-2,16,Site08,MQA10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,57.4,,1250.462772,85.2,116.0,1238253.589
Site08-MQA10-2,16,Site08,MQA10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,57.5,,1298.050437,87.0,116.0,1264413.876
Site08-MQA10-2,16,Site08,MQA10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.8,,1312.307852,87.5,116.0,1271680.622
Site08-MQA10-2,16,Site08,MQA10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.6,,,303.0,93.8,4394218.009
Site08-MQA10-2,16,Site08,MQA10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.6,,,248.0,80.7,3596587.678
Site08-MQA10-2,16,Site08,MQA10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,89.1,,,198.0,68.9,2871469.194
Site08-MQA10-2,16,Site08,MQA10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,749.1195781,251.0,102.0,1209271.255
Site08-MQA10-2,16,Site08,MQA10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.8,,764.6725631,236.0,98.5,1137004.049
Site08-MQA10-2,16,Site08,MQA10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.9,,770.9189193,222.0,89.7,1069554.656
Site08-MQA10-2,16,Site08,MQA10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,53.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,55.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,55.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.2,,385.1306837,418.0,260.0,8961527.166
Site08-MQA10-2,16,Site08,MQA10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.4,,407.4818785,407.0,259.0,8725697.504
Site08-MQA10-2,16,Site08,MQA10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.4,,406.9145443,412.0,253.0,8832892.805
Site08-MQA10-2,16,Site08,MQA10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,94.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.1,,1121.388489,69.8,22.2,81697.72727
Site08-MQA10-2,16,Site08,MQA10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,78.5,,1133.566304,65.1,20.9,76196.59091
Site08-MQA10-2,16,Site08,MQA10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,78.4,,1140.549913,61.2,19.1,71631.81818
Site08-MQA10-2,16,Site08,MQA10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.9,,318.7774433,22.0,8.14,25750
Site08-MQA10-2,16,Site08,MQA10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.5,,316.7298255,22.2,8.21,25984.09091
Site08-MQA10-2,16,Site08,MQA10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.3,,311.4286093,22.2,8.29,25984.09091
Site08-MQA10-2,16,Site08,MQA10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74,,2161.267764,553.0,30.7,470153.5581
Site08-MQA10-2,16,Site08,MQA10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.2,,2245.411735,559.0,32.1,475254.6816
Site08-MQA10-2,16,Site08,MQA10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,74.6,,2253.169597,557.0,32.2,473554.3071
Site08-MQA10-2,16,Site08,MQA10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,57.3,,1237.666478,85.4,116.0,1241160.287
Site08-MQA10-2,16,Site08,MQA10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,57.3,,1286.665551,87.3,116.0,1268773.923
Site08-MQA10-2,16,Site08,MQA10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.7,,1299.345722,87.7,116.0,1274587.321
Site08-MQA10-2,16,Site08,MQA10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.6,,,303.0,93.6,4394218.009
Site08-MQA10-2,16,Site08,MQA10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.5,,,248.0,80.7,3596587.678
Site08-MQA10-2,16,Site08,MQA10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,89.2,,,198.0,69.1,2871469.194
Site08-MQA10-2,16,Site08,MQA10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.3,,741.8612095,249.0,101.0,1199635.628
Site08-MQA10-2,16,Site08,MQA10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.8,,758.5192247,235.0,96.6,1132186.235
Site08-MQA10-2,16,Site08,MQA10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.9,,763.9507695,219.0,89.7,1055101.215
Site08-MQA10-2,16,Site08,MQA10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,53.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,55.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,55.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.6,,396.5932715,432.0,274.0,9261674.009
Site08-MQA10-2,16,Site08,MQA10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.7,,413.881368,410.0,268.0,8790014.684
Site08-MQA10-2,16,Site08,MQA10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.6,,411.4791477,413.0,254.0,8854331.865
Site08-MQA10-2,16,Site08,MQA10,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,95.7,,5174.327837,386.0,102.0,
Site08-MQA10-2,16,Site08,MQA10,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,95.2,,4501.070632,385.0,97.9,
Site08-MQA10-2,16,Site08,MQA10,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,2170.660239,,,
Site08-MQA10-2,16,Site08,MQA10,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1819.272502,,,
Site08-MQA10-2,16,Site08,MQA10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.5,,278.2639196,97.1,25.8,113651.1364
Site08-MQA10-2,16,Site08,MQA10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.5,,278.2639196,97.1,25.8,113651.1364
Site08-MQA10-2,16,Site08,MQA10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.5,,278.2639196,97.1,25.8,113651.1364
Site08-MQA10-2,16,Site08,MQA10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,236.6276278,24.9,4.64,29144.31818
Site08-MQA10-2,16,Site08,MQA10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.4,,236.6276278,24.9,4.64,29144.31818
Site08-MQA10-2,16,Site08,MQA10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.4,,236.6276278,24.9,4.64,29144.31818
Site08-MQA10-2,16,Site08,MQA10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.6,,1083.576548,245.0,84.1,208295.8801
Site08-MQA10-2,16,Site08,MQA10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.6,,1083.576548,245.0,84.1,208295.8801
Site08-MQA10-2,16,Site08,MQA10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.6,,1083.576548,245.0,84.1,208295.8801
Site08-MQA10-2,16,Site08,MQA10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.7,,711.5515134,1249.0,208.0,18152332.54
Site08-MQA10-2,16,Site08,MQA10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.7,,711.5515134,1249.0,208.0,18152332.54
Site08-MQA10-2,16,Site08,MQA10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.7,,711.5515134,1249.0,208.0,18152332.54
Site08-MQA10-2,16,Site08,MQA10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,467.0,219.0,6772606.635
Site08-MQA10-2,16,Site08,MQA10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,467.0,219.0,6772606.635
Site08-MQA10-2,16,Site08,MQA10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,467.0,219.0,6772606.635
Site08-MQA10-2,16,Site08,MQA10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.1,,369.4029018,564.0,82.9,2717246.964
Site08-MQA10-2,16,Site08,MQA10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.1,,369.4029018,564.0,82.9,2717246.964
Site08-MQA10-2,16,Site08,MQA10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.1,,369.4029018,564.0,82.9,2717246.964
Site08-MQA10-2,16,Site08,MQA10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,77,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,77,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,17.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.2,,212.3133047,4.62,2.42,99048.45815
Site08-MQA10-2,16,Site08,MQA10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.2,,212.3133047,4.62,2.42,99048.45815
Site08-MQA10-2,16,Site08,MQA10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.2,,212.3133047,4.62,2.42,99048.45815
Site08-MQA10-2,16,Site08,MQA10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.6,,236.8899236,99.7,26.4,116694.3182
Site08-MQA10-2,16,Site08,MQA10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.6,,236.8899236,99.7,26.4,116694.3182
Site08-MQA10-2,16,Site08,MQA10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.6,,236.8899236,99.7,26.4,116694.3182
Site08-MQA10-2,16,Site08,MQA10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,16.6,,273.9872211,25.7,4.65,30080.68182
Site08-MQA10-2,16,Site08,MQA10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,16.6,,273.9872211,25.7,4.65,30080.68182
Site08-MQA10-2,16,Site08,MQA10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,16.6,,273.9872211,25.7,4.65,30080.68182
Site08-MQA10-2,16,Site08,MQA10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.6,,1147.253657,244.0,85.1,207445.6929
Site08-MQA10-2,16,Site08,MQA10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.6,,1147.253657,244.0,85.1,207445.6929
Site08-MQA10-2,16,Site08,MQA10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,69.6,,1147.253657,244.0,85.1,207445.6929
Site08-MQA10-2,16,Site08,MQA10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.6,,740.7619935,1229.0,216.0,17861662.68
Site08-MQA10-2,16,Site08,MQA10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,740.7619935,1229.0,216.0,17861662.68
Site08-MQA10-2,16,Site08,MQA10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.6,,740.7619935,1229.0,216.0,17861662.68
Site08-MQA10-2,16,Site08,MQA10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,478.0,179.0,6932132.701
Site08-MQA10-2,16,Site08,MQA10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,478.0,179.0,6932132.701
Site08-MQA10-2,16,Site08,MQA10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,478.0,179.0,6932132.701
Site08-MQA10-2,16,Site08,MQA10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.3,,405.1103816,556.0,81.2,2678704.453
Site08-MQA10-2,16,Site08,MQA10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.3,,405.1103816,556.0,81.2,2678704.453
Site08-MQA10-2,16,Site08,MQA10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.3,,405.1103816,556.0,81.2,2678704.453
Site08-MQA10-2,16,Site08,MQA10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,82.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,82.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,82.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,14.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,14.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,14.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.6,,216.3680144,4.27,2.31,91544.78708
Site08-MQA10-2,16,Site08,MQA10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.6,,216.3680144,4.27,2.31,91544.78708
Site08-MQA10-2,16,Site08,MQA10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.6,,216.3680144,4.27,2.31,91544.78708
Site08-MQA10-2,16,Site08,MQA10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.9,,287.4486056,88.1,22.9,103117.0455
Site08-MQA10-2,16,Site08,MQA10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.9,,287.4486056,88.1,22.9,103117.0455
Site08-MQA10-2,16,Site08,MQA10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.9,,287.4486056,88.1,22.9,103117.0455
Site08-MQA10-2,16,Site08,MQA10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.5,,245.2521761,24.2,4.29,28325
Site08-MQA10-2,16,Site08,MQA10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.5,,245.2521761,24.2,4.29,28325
Site08-MQA10-2,16,Site08,MQA10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.5,,245.2521761,24.2,4.29,28325
Site08-MQA10-2,16,Site08,MQA10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.6,,1117.622559,245.0,84.9,208295.8801
Site08-MQA10-2,16,Site08,MQA10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.6,,1117.622559,245.0,84.9,208295.8801
Site08-MQA10-2,16,Site08,MQA10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.6,,1117.622559,245.0,84.9,208295.8801
Site08-MQA10-2,16,Site08,MQA10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.7,,722.6235696,1128.0,193.0,16393779.9
Site08-MQA10-2,16,Site08,MQA10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.7,,722.6235696,1128.0,193.0,16393779.9
Site08-MQA10-2,16,Site08,MQA10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.7,,722.6235696,1128.0,193.0,16393779.9
Site08-MQA10-2,16,Site08,MQA10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,439.0,192.0,6366540.284
Site08-MQA10-2,16,Site08,MQA10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,439.0,192.0,6366540.284
Site08-MQA10-2,16,Site08,MQA10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,439.0,192.0,6366540.284
Site08-MQA10-2,16,Site08,MQA10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.1,,392.9008246,537.0,79.1,2587165.992
Site08-MQA10-2,16,Site08,MQA10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.1,,392.9008246,537.0,79.1,2587165.992
Site08-MQA10-2,16,Site08,MQA10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.1,,392.9008246,537.0,79.1,2587165.992
Site08-MQA10-2,16,Site08,MQA10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18,Not reportable,Not reportable,Not reportable,Not reportable,
Site08-MQA10-2,16,Site08,MQA10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.2,,201.0352914,4.0,1.98,85756.24082
Site08-MQA10-2,16,Site08,MQA10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.2,,201.0352914,4.0,1.98,85756.24082
Site08-MQA10-2,16,Site08,MQA10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.2,,201.0352914,4.0,1.98,85756.24082
Site09-CellStream,17,Site09,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site09-CellStream,17,Site09,CellStream,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site09-CellStream,17,Site09,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site09-CellStream,17,Site09,CellStream,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site09-CellStream,17,Site09,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site09-CellStream,17,Site09,CellStream,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site09-CellStream,17,Site09,CellStream,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site09-CellStream,17,Site09,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CellStream,17,Site09,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CellStream,17,Site09,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site09-CellStream,17,Site09,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site09-CellStream,17,Site09,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site09-CytoflexS,18,Site09,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site09-CytoflexS,18,Site09,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site10-AriaIII,19,Site10,AriaIII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,85.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,84.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,85.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,70.3,,764.9216668,12993.0,6904.0,80823.71059
Site10-AriaIII,19,Site10,AriaIII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,61.5,,708.4068081,11693.0,6188.0,72736.98514
Site10-AriaIII,19,Site10,AriaIII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,69.1,,773.2452598,12381.0,6985.0,77016.72907
Site10-AriaIII,19,Site10,AriaIII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.1,,461.5585727,3870.0,1736.0,24073.55961
Site10-AriaIII,19,Site10,AriaIII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.85,,401.2653948,4008.0,1643.0,24931.99662
Site10-AriaIII,19,Site10,AriaIII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.7,,437.9484629,3831.0,1703.0,23830.95785
Site10-AriaIII,19,Site10,AriaIII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.7,,2532.523499,15930.0,6385.0,71562.20934
Site10-AriaIII,19,Site10,AriaIII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,59.2,,2413.537041,15819.0,6530.0,71063.56494
Site10-AriaIII,19,Site10,AriaIII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,60.1,,2466.038387,15672.0,6678.0,70403.19804
Site10-AriaIII,19,Site10,AriaIII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,27.2,,688.1503316,40540.0,11210.0,8600967.144
Site10-AriaIII,19,Site10,AriaIII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,25.4,,612.7966585,38817.0,10551.0,8235415.432
Site10-AriaIII,19,Site10,AriaIII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,25.3,,624.5442483,38910.0,11476.0,8255146.314
Site10-AriaIII,19,Site10,AriaIII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,24.1,,5672.703748,18458.0,5657.0,4317165.788
Site10-AriaIII,19,Site10,AriaIII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,22.8,,5672.703748,18897.0,5932.0,4419844.072
Site10-AriaIII,19,Site10,AriaIII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,22.7,,5672.703748,19120.0,6474.0,4472001.834
Site10-AriaIII,19,Site10,AriaIII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,57.7,,1461.912334,16382.0,9687.0,1096494.741
Site10-AriaIII,19,Site10,AriaIII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,60.8,,1467.343333,15241.0,9495.0,1020124.304
Site10-AriaIII,19,Site10,AriaIII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,59,,1455.830871,15277.0,9817.0,1022533.888
Site10-AriaIII,19,Site10,AriaIII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,71.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,72.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.4,,1098.993295,31039.0,29348.0,3924698.223
Site10-AriaIII,19,Site10,AriaIII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29,,1182.989831,29236.0,29096.0,3696719.522
Site10-AriaIII,19,Site10,AriaIII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.3,,1120.054393,28614.0,29282.0,3618071.296
Site10-AriaIII,19,Site10,AriaIII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,87.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,86.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,87.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.6,,857.9399158,12129.0,6193.0,75449.14845
Site10-AriaIII,19,Site10,AriaIII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,74.8,,804.2810798,11070.0,5416.0,68861.57749
Site10-AriaIII,19,Site10,AriaIII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,74.6,,856.1452502,11613.0,6308.0,72239.3405
Site10-AriaIII,19,Site10,AriaIII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.8,,628.0672883,3227.0,1620.0,20073.74079
Site10-AriaIII,19,Site10,AriaIII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.9,,588.498351,3246.0,1502.0,20191.93139
Site10-AriaIII,19,Site10,AriaIII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.5,,614.2627969,3034.0,1530.0,18873.17309
Site10-AriaIII,19,Site10,AriaIII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.5,,3450.601682,15206.0,6251.0,68309.79003
Site10-AriaIII,19,Site10,AriaIII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.9,,3477.745017,15171.0,6398.0,68152.55981
Site10-AriaIII,19,Site10,AriaIII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.2,,3434.467205,14961.0,6483.0,67209.17852
Site10-AriaIII,19,Site10,AriaIII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,27.3,,942.7289998,40757.0,11289.0,8647005.868
Site10-AriaIII,19,Site10,AriaIII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,25.7,,895.3582055,39110.0,10778.0,8297578.318
Site10-AriaIII,19,Site10,AriaIII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,25.7,,881.8493801,39211.0,11774.0,8319006.479
Site10-AriaIII,19,Site10,AriaIII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,19,,5672.703748,17205.0,5121.0,4024099.977
Site10-AriaIII,19,Site10,AriaIII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,17.3,,5672.703748,17613.0,5373.0,4119527.631
Site10-AriaIII,19,Site10,AriaIII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,17.6,,5672.703748,17862.0,5884.0,4177766.567
Site10-AriaIII,19,Site10,AriaIII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,58.1,,2004.790784,16419.0,10180.0,1098971.258
Site10-AriaIII,19,Site10,AriaIII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,60,,2087.067366,15448.0,9872.0,1033979.414
Site10-AriaIII,19,Site10,AriaIII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,59.5,,2043.148788,15176.0,10320.0,1015773.666
Site10-AriaIII,19,Site10,AriaIII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,79.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,75,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,78.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,0.89,,37.6840373,2854.0,1775.0,360871.4433
Site10-AriaIII,19,Site10,AriaIII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,1.06,,44.8379696,2755.0,1748.0,348353.478
Site10-AriaIII,19,Site10,AriaIII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,1.45,,61.29446364,2519.0,1567.0,318512.6719
Site10-AriaIII,19,Site10,AriaIII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,85.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,84.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,85.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,70.6,,768.9665081,3886.0,1766.0,77551.69706
Site10-AriaIII,19,Site10,AriaIII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,63.2,,684.0452508,4041.0,1641.0,70447.81978
Site10-AriaIII,19,Site10,AriaIII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,69.5,,758.2541291,3823.0,1720.0,74248.58075
Site10-AriaIII,19,Site10,AriaIII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.3,,477.6276489,3886.0,1766.0,24173.08854
Site10-AriaIII,19,Site10,AriaIII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.8,,416.0943859,4041.0,1641.0,25137.27503
Site10-AriaIII,19,Site10,AriaIII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.9,,460.2482206,3823.0,1720.0,23781.19338
Site10-AriaIII,19,Site10,AriaIII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.4,,2564.155472,15856.0,6365.0,71229.77974
Site10-AriaIII,19,Site10,AriaIII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,58.1,,2466.738761,15746.0,6514.0,70735.62763
Site10-AriaIII,19,Site10,AriaIII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,59.3,,2512.589397,15636.0,6650.0,70241.47553
Site10-AriaIII,19,Site10,AriaIII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,27.4,,702.668242,40835.0,11358.0,8663554.349
Site10-AriaIII,19,Site10,AriaIII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,25.8,,637.3154154,39193.0,10788.0,8315187.599
Site10-AriaIII,19,Site10,AriaIII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,25.7,,645.1177987,39288.0,11846.0,8335342.801
Site10-AriaIII,19,Site10,AriaIII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,24,,5672.703748,17654.0,5274.0,4129117.175
Site10-AriaIII,19,Site10,AriaIII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,22.8,,5672.703748,18115.0,5533.0,4236941.069
Site10-AriaIII,19,Site10,AriaIII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,22.6,,5672.703748,18415.0,6077.0,4307108.461
Site10-AriaIII,19,Site10,AriaIII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.8,,1404.402706,17343.0,9554.0,1160214.86
Site10-AriaIII,19,Site10,AriaIII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,55.7,,1374.553138,16563.0,9368.0,1107605.602
Site10-AriaIII,19,Site10,AriaIII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,55.7,,1400.483341,16340.0,9876.0,1091474.774
Site10-AriaIII,19,Site10,AriaIII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,74.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,74.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.3,,1116.332071,30232.0,28715.0,3822657.839
Site10-AriaIII,19,Site10,AriaIII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29.4,,1249.774535,28410.0,28136.0,3592276.701
Site10-AriaIII,19,Site10,AriaIII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.4,,1160.730607,27607.0,28650.0,3490742.093
Site10-AriaIII,19,Site10,AriaIII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,9.12,,5788.199509,21768.0,6030.0,
Site10-AriaIII,19,Site10,AriaIII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,8.5,,5557.207987,20472.0,5861.0,
Site10-AriaIII,19,Site10,AriaIII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,89.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,89.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.8,,1183.461957,9974.0,3676.0,62043.84588
Site10-AriaIII,19,Site10,AriaIII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,78.2,,1211.387942,10110.0,3692.0,62889.84177
Site10-AriaIII,19,Site10,AriaIII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,78.8,,1073.039025,9839.0,3571.0,61204.07054
Site10-AriaIII,19,Site10,AriaIII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.9,,412.6519001,3777.0,1671.0,23495.04771
Site10-AriaIII,19,Site10,AriaIII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.6,,432.6702809,3575.0,1711.0,22238.49499
Site10-AriaIII,19,Site10,AriaIII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.3,,442.8415025,3701.0,1734.0,23022.2853
Site10-AriaIII,19,Site10,AriaIII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,48.8,,1348.522717,20327.0,8073.0,91314.81665
Site10-AriaIII,19,Site10,AriaIII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,48.5,,1341.988623,19995.0,8339.0,89823.37575
Site10-AriaIII,19,Site10,AriaIII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,50.6,,1562.047203,19995.0,7953.0,89823.37575
Site10-AriaIII,19,Site10,AriaIII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.2,,987.2055027,41431.0,9028.0,8790001.72
Site10-AriaIII,19,Site10,AriaIII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.4,,917.7585219,40442.0,9274.0,8580175.462
Site10-AriaIII,19,Site10,AriaIII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,68.3,,1066.315723,39957.0,8758.0,8477277.853
Site10-AriaIII,19,Site10,AriaIII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,12.5,,4877.97983,17367.0,5704.0,4061990.369
Site10-AriaIII,19,Site10,AriaIII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,11.5,,4877.97983,17904.0,6137.0,4187590.002
Site10-AriaIII,19,Site10,AriaIII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,4.7,,4877.97983,17737.0,5730.0,4148530.154
Site10-AriaIII,19,Site10,AriaIII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.5,,329.7266379,18073.0,6137.0,1209678.272
Site10-AriaIII,19,Site10,AriaIII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,29.1,,390.0251608,18158.0,6206.0,1215367.568
Site10-AriaIII,19,Site10,AriaIII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,29,,452.2541256,17820.0,6237.0,1192744.249
Site10-AriaIII,19,Site10,AriaIII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,56.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,56.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,31.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,34.3,,946.9275182,32721.0,39944.0,4137377.188
Site10-AriaIII,19,Site10,AriaIII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,33.7,,933.3062219,31489.0,38717.0,3981598.065
Site10-AriaIII,19,Site10,AriaIII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,32.8,,1011.184645,32409.0,39195.0,4097926.631
Site10-AriaIII,19,Site10,AriaIII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,56,,1561.48137,8600.0,3319.0,53496.79913
Site10-AriaIII,19,Site10,AriaIII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,56.4,,1586.494636,8620.0,3362.0,53621.21029
Site10-AriaIII,19,Site10,AriaIII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,61.4,,1388.640169,8430.0,3240.0,52439.30426
Site10-AriaIII,19,Site10,AriaIII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.2,,604.7991223,2987.0,1541.0,18580.80686
Site10-AriaIII,19,Site10,AriaIII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.2,,637.2993157,2782.0,1570.0,17305.59246
Site10-AriaIII,19,Site10,AriaIII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.2,,635.5004985,2987.0,1595.0,18580.80686
Site10-AriaIII,19,Site10,AriaIII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,73.6,,2008.482903,19484.0,7797.0,87527.81461
Site10-AriaIII,19,Site10,AriaIII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.4,,1992.327822,19256.0,8017.0,86503.57206
Site10-AriaIII,19,Site10,AriaIII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,74.2,,2220.828382,19165.0,7707.0,86094.77351
Site10-AriaIII,19,Site10,AriaIII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.5,,1476.259676,41607.0,9213.0,8827341.883
Site10-AriaIII,19,Site10,AriaIII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.7,,1367.921845,40757.0,9455.0,8647005.868
Site10-AriaIII,19,Site10,AriaIII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,68.6,,1524.329795,40235.0,8861.0,8536258.338
Site10-AriaIII,19,Site10,AriaIII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,9.28,,4877.97983,16117.0,5073.0,3769626.233
Site10-AriaIII,19,Site10,AriaIII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,8.57,,4877.97983,16691.0,5539.0,3903879.844
Site10-AriaIII,19,Site10,AriaIII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,3.43,,4877.97983,16574.0,4996.0,3876514.561
Site10-AriaIII,19,Site10,AriaIII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.2,,486.5883848,18370.0,6523.0,1229557.343
Site10-AriaIII,19,Site10,AriaIII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.9,,575.9024645,18370.0,6640.0,1229557.343
Site10-AriaIII,19,Site10,AriaIII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.8,,638.6126459,18229.0,6612.0,1220119.804
Site10-AriaIII,19,Site10,AriaIII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,91.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,91.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,92.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,35.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,35.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,1.33,,36.28794734,2438.0,1270.0,308270.7003
Site10-AriaIII,19,Site10,AriaIII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,1.34,,36.83811074,2998.0,1512.0,379079.3928
Site10-AriaIII,19,Site10,AriaIII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,1.18,,35.47848033,2614.0,1415.0,330524.8608
Site10-AriaIII,19,Site10,AriaIII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.7,Not reportable,Not reportable,Not reportable,Not reportable,60115.47288
Site10-AriaIII,19,Site10,AriaIII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78.6,,1245.811007,3761.0,1677.0,8600967.144
Site10-AriaIII,19,Site10,AriaIII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,79.7,,1273.817065,3547.0,1752.0,60115.47288
Site10-AriaIII,19,Site10,AriaIII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.2,,1115.741976,3708.0,1776.0,59176.16862
Site10-AriaIII,19,Site10,AriaIII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,15,,431.3985342,3761.0,1677.0,23395.51878
Site10-AriaIII,19,Site10,AriaIII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.7,,452.4418733,3547.0,1752.0,22064.31936
Site10-AriaIII,19,Site10,AriaIII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.5,,454.8598555,3708.0,1776.0,23065.82921
Site10-AriaIII,19,Site10,AriaIII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,48.4,,1392.072839,20042.0,8086.0,22064.31936
Site10-AriaIII,19,Site10,AriaIII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,48.2,,1389.731925,19761.0,8280.0,88772.17945
Site10-AriaIII,19,Site10,AriaIII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,49.4,,1550.253953,19714.0,7967.0,88561.04174
Site10-AriaIII,19,Site10,AriaIII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.6,,1024.202171,41431.0,9370.0,3915341.36
Site10-AriaIII,19,Site10,AriaIII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.5,,951.4158769,40540.0,9528.0,8600967.144
Site10-AriaIII,19,Site10,AriaIII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,68.6,,1063.176624,40150.0,8937.0,8518224.737
Site10-AriaIII,19,Site10,AriaIII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,13.2,,4877.97983,16458.0,5297.0,
Site10-AriaIII,19,Site10,AriaIII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,12.1,,4877.97983,17045.0,5730.0,3986677.368
Site10-AriaIII,19,Site10,AriaIII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,4.94,,4877.97983,16847.0,5266.0,3940366.888
Site10-AriaIII,19,Site10,AriaIII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.8,,331.674558,18212.0,6521.0,1218446.482
Site10-AriaIII,19,Site10,AriaIII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.8,,400.0932268,18113.0,6659.0,1212489.454
Site10-AriaIII,19,Site10,AriaIII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.8,,445.9576589,17917.0,6574.0,1197764.216
Site10-AriaIII,19,Site10,AriaIII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.9,Not reportable,Not reportable,Not reportable,Not reportable,1212489.454
Site10-AriaIII,19,Site10,AriaIII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,32.5,Not reportable,Not reportable,Not reportable,Not reportable,88772.17945
Site10-AriaIII,19,Site10,AriaIII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,32.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,33.9,,973.9708345,32022.0,38924.0,4048992.767
Site10-AriaIII,19,Site10,AriaIII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,33.7,,970.942753,30965.0,38256.0,3915341.36
Site10-AriaIII,19,Site10,AriaIII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,33.2,,1041.13309,31565.0,38143.0,3991207.816
Site10-AriaIII,19,Site10,AriaIII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,8.82,,5687.359133,19120.0,5414.0,
Site10-AriaIII,19,Site10,AriaIII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,6,,4068.600527,18329.0,5264.0,
Site10-AriaIII,19,Site10,AriaIII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83,,975.8785429,12296.0,4944.0,76487.98164
Site10-AriaIII,19,Site10,AriaIII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82,,927.9309631,12212.0,4841.0,75965.45477
Site10-AriaIII,19,Site10,AriaIII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.2,,936.6874931,11827.0,4813.0,73570.53992
Site10-AriaIII,19,Site10,AriaIII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.2,,382.0383777,4334.0,1782.0,26959.89854
Site10-AriaIII,19,Site10,AriaIII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.5,,307.948266,4290.0,1768.0,26686.19398
Site10-AriaIII,19,Site10,AriaIII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.3,,305.7854105,4246.0,1785.0,26412.48943
Site10-AriaIII,19,Site10,AriaIII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.6,,1657.909213,18589.0,7925.0,83507.21339
Site10-AriaIII,19,Site10,AriaIII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.9,,1690.557972,18720.0,7767.0,84095.70363
Site10-AriaIII,19,Site10,AriaIII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.3,,1763.714011,18502.0,7788.0,83116.384
Site10-AriaIII,19,Site10,AriaIII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.6,,888.049474,41231.0,10540.0,8747569.717
Site10-AriaIII,19,Site10,AriaIII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,50.1,,847.6935379,40736.0,10437.0,8642550.507
Site10-AriaIII,19,Site10,AriaIII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,53.6,,944.7714752,40638.0,10602.0,8621758.826
Site10-AriaIII,19,Site10,AriaIII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,6.63,,4362.538523,18073.0,5905.0,4227117.634
Site10-AriaIII,19,Site10,AriaIII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,6.23,,4362.538523,19211.0,6186.0,4493285.944
Site10-AriaIII,19,Site10,AriaIII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,6.59,,4362.538523,19438.0,6263.0,4546379.271
Site10-AriaIII,19,Site10,AriaIII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,36.6,,607.2133156,14382.0,8742.0,962628.9443
Site10-AriaIII,19,Site10,AriaIII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,40.4,,683.1325225,14720.0,9034.0,985252.2639
Site10-AriaIII,19,Site10,AriaIII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37.7,,664.2924435,14788.0,9078.0,989803.701
Site10-AriaIII,19,Site10,AriaIII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,61.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,61.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,26.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.3,,600.7074586,39004.0,38120.0,4931825.429
Site10-AriaIII,19,Site10,AriaIII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24,,644.8711577,38352.0,38508.0,4849383.88
Site10-AriaIII,19,Site10,AriaIII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.8,,588.7247846,38630.0,37424.0,4884535.338
Site10-AriaIII,19,Site10,AriaIII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,60.5,,1101.362185,10846.0,4509.0,67468.17248
Site10-AriaIII,19,Site10,AriaIII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,60.8,,1087.578315,10870.0,4260.0,67617.46588
Site10-AriaIII,19,Site10,AriaIII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,60.5,,1063.037381,10341.0,4378.0,64326.79068
Site10-AriaIII,19,Site10,AriaIII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,18.5,,489.4446396,3547.0,1665.0,22064.31936
Site10-AriaIII,19,Site10,AriaIII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.3,,404.8443273,3511.0,1622.0,21840.37927
Site10-AriaIII,19,Site10,AriaIII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.7,,388.9691152,3462.0,1616.0,21535.57193
Site10-AriaIII,19,Site10,AriaIII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,77.6,,2047.621821,17904.0,7838.0,80429.99347
Site10-AriaIII,19,Site10,AriaIII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.5,,2163.401568,17946.0,7575.0,80618.66973
Site10-AriaIII,19,Site10,AriaIII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,82.5,,2176.923238,17779.0,7651.0,79868.45699
Site10-AriaIII,19,Site10,AriaIII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.6,,1098.233315,41287.0,10512.0,
Site10-AriaIII,19,Site10,AriaIII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,50.4,,1089.929327,40968.0,10468.0,8691771.632
Site10-AriaIII,19,Site10,AriaIII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,53.8,,1172.122574,40757.0,10578.0,8647005.868
Site10-AriaIII,19,Site10,AriaIII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,5.43,,4362.538523,16966.0,5429.0,3968199.954
Site10-AriaIII,19,Site10,AriaIII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,4.98,,4362.538523,18030.0,5715.0,4217060.307
Site10-AriaIII,19,Site10,AriaIII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,5.4,,4362.538523,18286.0,5888.0,4276936.482
Site10-AriaIII,19,Site10,AriaIII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,36.9,,754.9515948,14354.0,9092.0,960754.8231
Site10-AriaIII,19,Site10,AriaIII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,40.3,,872.2255831,14648.0,9351.0,980433.0952
Site10-AriaIII,19,Site10,AriaIII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37.8,,822.2676714,14685.0,9378.0,982909.6125
Site10-AriaIII,19,Site10,AriaIII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,92.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,93.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,92.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,27.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,26.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,1.41,,37.0994567,3292.0,1783.0,416253.9563
Site10-AriaIII,19,Site10,AriaIII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,1.08,,28.68235071,3052.0,1738.0,385907.3738
Site10-AriaIII,19,Site10,AriaIII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,1.07,,28.24915362,2718.0,1361.0,343675.0465
Site10-AriaIII,19,Site10,AriaIII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.4,,984.6686353,4316.0,1834.0,73066.67472
Site10-AriaIII,19,Site10,AriaIII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,81.4,,901.5169122,4316.0,1827.0,74416.53581
Site10-AriaIII,19,Site10,AriaIII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.9,,884.8213214,4254.0,1815.0,71747.91642
Site10-AriaIII,19,Site10,AriaIII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.5,,386.1109148,4316.0,1834.0,26847.92849
Site10-AriaIII,19,Site10,AriaIII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.7,,319.4731962,4316.0,1827.0,26847.92849
Site10-AriaIII,19,Site10,AriaIII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.7,,318.7467663,4254.0,1815.0,26462.2539
Site10-AriaIII,19,Site10,AriaIII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61,,1625.784359,18329.0,7957.0,82339.21751
Site10-AriaIII,19,Site10,AriaIII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.6,,1710.055595,18633.0,7755.0,83704.87424
Site10-AriaIII,19,Site10,AriaIII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.7,,1759.439932,18415.0,7789.0,82725.55461
Site10-AriaIII,19,Site10,AriaIII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.1,,862.829191,41231.0,10640.0,8747569.717
Site10-AriaIII,19,Site10,AriaIII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,50.5,,863.2098817,40933.0,10452.0,8684346.031
Site10-AriaIII,19,Site10,AriaIII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,54,,949.9075816,40835.0,10654.0,8663554.349
Site10-AriaIII,19,Site10,AriaIII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,6.94,,4362.538523,17327.0,5607.0,4052634.717
Site10-AriaIII,19,Site10,AriaIII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,6.22,,4362.538523,18415.0,5828.0,4307108.461
Site10-AriaIII,19,Site10,AriaIII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,6.59,,4362.538523,18633.0,5990.0,4358096.767
Site10-AriaIII,19,Site10,AriaIII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.7,,579.6811868,14436.0,8886.0,966577.9853
Site10-AriaIII,19,Site10,AriaIII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,38.7,,662.0049933,15524.0,9238.0,1039601.777
Site10-AriaIII,19,Site10,AriaIII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,36.3,,639.2526207,15233.0,9265.0,1019588.841
Site10-AriaIII,19,Site10,AriaIII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,27.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.5,,599.2441398,36459.0,37727.0,4610025.21
Site10-AriaIII,19,Site10,AriaIII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.9,,653.4509962,37258.0,38319.0,4711054.041
Site10-AriaIII,19,Site10,AriaIII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.9,,595.9790531,37710.0,37330.0,4768206.771
Site10-AriaIII,19,Site10,AriaIII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,6.16,,4293.596968,19807.0,6058.0,
Site10-AriaIII,19,Site10,AriaIII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,6.37,,4431.480078,20472.0,6273.0,
Site10-AriaIII,19,Site10,AriaIII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,862.3622705,34998.0,16127.0,
Site10-AriaIII,19,Site10,AriaIII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1039.399835,34746.0,16534.0,
Site10-AriaIII,19,Site10,AriaIII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.4,,146.7647803,8171.0,1546.0,50828.17973
Site10-AriaIII,19,Site10,AriaIII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.2,,135.5677751,7817.0,1430.0,48626.10219
Site10-AriaIII,19,Site10,AriaIII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.3,,141.6714484,5676.0,1131.0,35307.88743
Site10-AriaIII,19,Site10,AriaIII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.6,,118.665616,6602.0,881.0,41068.12417
Site10-AriaIII,19,Site10,AriaIII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.4,,119.3285702,6418.0,925.0,39923.54149
Site10-AriaIII,19,Site10,AriaIII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15,,114.045516,4944.0,734.0,30754.43894
Site10-AriaIII,19,Site10,AriaIII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.9,,532.0612315,41431.0,15460.0,186120.1441
Site10-AriaIII,19,Site10,AriaIII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.8,,539.509778,37801.0,15105.0,169813.1246
Site10-AriaIII,19,Site10,AriaIII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.7,,537.3775127,37892.0,14447.0,170221.9232
Site10-AriaIII,19,Site10,AriaIII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.5,,343.1921656,82883.0,15461.0,17584458.8
Site10-AriaIII,19,Site10,AriaIII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.7,,348.8470488,82075.0,16049.0,17413033.51
Site10-AriaIII,19,Site10,AriaIII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.7,,347.8919505,71750.0,13145.0,15222481.32
Site10-AriaIII,19,Site10,AriaIII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,950.8810528,23371.0,12140.0,5466273.79
Site10-AriaIII,19,Site10,AriaIII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,950.8810528,23041.0,10646.0,5389089.658
Site10-AriaIII,19,Site10,AriaIII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,950.8810528,22395.0,11359.0,5237995.873
Site10-AriaIII,19,Site10,AriaIII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35,,185.9791202,47214.0,6811.0,3160169.863
Site10-AriaIII,19,Site10,AriaIII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.8,,187.8356612,47214.0,7790.0,3160169.863
Site10-AriaIII,19,Site10,AriaIII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.5,,185.1468741,45309.0,6669.0,3032662.692
Site10-AriaIII,19,Site10,AriaIII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,17.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29.6,,225.5491458,4272.0,887.0,540169.1681
Site10-AriaIII,19,Site10,AriaIII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.7,,229.3212412,3983.0,890.0,503626.825
Site10-AriaIII,19,Site10,AriaIII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,28.6,,217.554218,2843.0,698.0,359480.5582
Site10-AriaIII,19,Site10,AriaIII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82,,146.234654,7731.0,1491.0,48091.13419
Site10-AriaIII,19,Site10,AriaIII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.4,,135.0909286,7237.0,1390.0,45018.17852
Site10-AriaIII,19,Site10,AriaIII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.2,,139.6894611,5313.0,1060.0,33049.82486
Site10-AriaIII,19,Site10,AriaIII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,116.9254578,4862.0,804.0,30244.35318
Site10-AriaIII,19,Site10,AriaIII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.4,,119.0076346,4537.0,832.0,28222.67182
Site10-AriaIII,19,Site10,AriaIII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.6,,110.8829416,3372.0,619.0,20975.72171
Site10-AriaIII,19,Site10,AriaIII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.9,,532.1909578,38630.0,14456.0,173537.2346
Site10-AriaIII,19,Site10,AriaIII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.7,,538.222189,35937.0,14100.0,161439.4926
Site10-AriaIII,19,Site10,AriaIII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.5,,535.535358,35850.0,13538.0,161048.6632
Site10-AriaIII,19,Site10,AriaIII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.2,,341.5255194,83079.0,15374.0,17626042.16
Site10-AriaIII,19,Site10,AriaIII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.1,,350.3360996,82000.0,15575.0,17397121.5
Site10-AriaIII,19,Site10,AriaIII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.4,,344.7918806,71961.0,13063.0,15267247.08
Site10-AriaIII,19,Site10,AriaIII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,950.8810528,23206.0,12101.0,5427681.724
Site10-AriaIII,19,Site10,AriaIII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,950.8810528,22878.0,10619.0,5350965.375
Site10-AriaIII,19,Site10,AriaIII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,950.8810528,22237.0,11360.0,5201041.046
Site10-AriaIII,19,Site10,AriaIII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,185.8621104,,,3251399.404
Site10-AriaIII,19,Site10,AriaIII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.2,,184.1711981,48577.0,7809.0,3251399.404
Site10-AriaIII,19,Site10,AriaIII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.4,,184.2730899,46688.0,6746.0,3124963.159
Site10-AriaIII,19,Site10,AriaIII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,17.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29.4,,223.8884574,4416.0,895.0,558377.1175
Site10-AriaIII,19,Site10,AriaIII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.4,,227.0454139,3894.0,946.0,492373.3007
Site10-AriaIII,19,Site10,AriaIII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,28.4,,215.6500374,2975.0,708.0,376171.1786
Site10-AriaIII,19,Site10,AriaIII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.4,,146.7647803,6674.0,875.0,50716.20969
Site10-AriaIII,19,Site10,AriaIII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.2,,136.5180036,6432.0,936.0,48302.63317
Site10-AriaIII,19,Site10,AriaIII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,78.5,,137.3507909,5114.0,723.0,35768.20872
Site10-AriaIII,19,Site10,AriaIII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.6,,118.8434588,6674.0,875.0,41516.00435
Site10-AriaIII,19,Site10,AriaIII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.7,,120.3965308,6432.0,936.0,40010.6293
Site10-AriaIII,19,Site10,AriaIII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15,,114.0869273,5114.0,723.0,31811.93381
Site10-AriaIII,19,Site10,AriaIII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.8,,531.7944673,41231.0,15384.0,185221.6857
Site10-AriaIII,19,Site10,AriaIII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.7,,537.7254363,37529.0,15002.0,168591.2212
Site10-AriaIII,19,Site10,AriaIII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.6,,538.3587031,38167.0,14457.0,171457.3034
Site10-AriaIII,19,Site10,AriaIII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.4,,342.2584909,83086.0,15414.0,17627527.28
Site10-AriaIII,19,Site10,AriaIII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65,,349.2414087,82276.0,15967.0,17455677.67
Site10-AriaIII,19,Site10,AriaIII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.3,,345.5506211,71926.0,12957.0,15259821.48
Site10-AriaIII,19,Site10,AriaIII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,950.8810528,23316.0,12150.0,5453409.768
Site10-AriaIII,19,Site10,AriaIII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,950.8810528,22932.0,10670.0,5363595.506
Site10-AriaIII,19,Site10,AriaIII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,950.8810528,22395.0,11322.0,5237995.873
Site10-AriaIII,19,Site10,AriaIII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35,,185.8901988,48686.0,7084.0,3258695.09
Site10-AriaIII,19,Site10,AriaIII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.3,,184.7109169,48686.0,8121.0,3258695.09
Site10-AriaIII,19,Site10,AriaIII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.6,,186.933369,46809.0,6736.0,3133062.039
Site10-AriaIII,19,Site10,AriaIII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,17.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-AriaIII,19,Site10,AriaIII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29.6,,225.4157637,4263.0,885.0,539031.1712
Site10-AriaIII,19,Site10,AriaIII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.6,,228.3875312,3902.0,908.0,493384.8534
Site10-AriaIII,19,Site10,AriaIII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,27.4,,209.1397843,2957.0,628.0,373895.1849
Site10-Canto10,20,Site10,Canto10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,55.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,51.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,54.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,67.4,,878.6767843,7800.0,3543.0,64787.71017
Site10-Canto10,20,Site10,Canto10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,68.8,,848.8874884,7612.0,3678.0,63226.16024
Site10-Canto10,20,Site10,Canto10,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,69.5,,851.9492663,7731.0,3853.0,64214.58812
Site10-Canto10,20,Site10,Canto10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.7,,493.6613091,3372.0,1373.0,27842.10314
Site10-Canto10,20,Site10,Canto10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.9,,504.1038382,3663.0,1427.0,30367.16261
Site10-Canto10,20,Site10,Canto10,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.7,,495.7178335,3656.0,1449.0,30367.16261
Site10-Canto10,20,Site10,Canto10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,57.3,,2645.540466,17988.0,7176.0,53931.6885
Site10-Canto10,20,Site10,Canto10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.9,,2640.778252,18676.0,7575.0,55994.45266
Site10-Canto10,20,Site10,Canto10,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,58,,2695.634817,18545.0,7830.0,55601.68798
Site10-Canto10,20,Site10,Canto10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,27.3,,721.904016,43906.0,11489.0,8780250.784
Site10-Canto10,20,Site10,Canto10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,25.8,,682.493238,45861.0,11677.0,9171208.518
Site10-Canto10,20,Site10,Canto10,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,25.6,,689.0147207,45090.0,12291.0,9017025.186
Site10-Canto10,20,Site10,Canto10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.3,,6278.691735,28958.0,8802.0,1479457.139
Site10-Canto10,20,Site10,Canto10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.2,,6278.691735,29873.0,9067.0,1503666.204
Site10-Canto10,20,Site10,Canto10,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.5,,6278.691735,30450.0,10057.0,1582731.978
Site10-Canto10,20,Site10,Canto10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,48.1,,1271.761446,23989.0,11619.0,995290.0774
Site10-Canto10,20,Site10,Canto10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,49.7,,1312.699928,24161.0,12066.0,1002426.26
Site10-Canto10,20,Site10,Canto10,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,50.1,,1351.274507,24276.0,12574.0,1007197.545
Site10-Canto10,20,Site10,Canto10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,74,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,29.5,,1361.67524,20813.0,20565.0,3042256.117
Site10-Canto10,20,Site10,Canto10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,30,,1391.437318,19256.0,19805.0,2814667.938
Site10-Canto10,20,Site10,Canto10,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.9,,1344.36031,20424.0,20806.0,2985395.615
Site10-Canto10,20,Site10,Canto10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,55.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,51.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,54.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,67.2,,863.5389748,8010.0,3464.0,66531.99468
Site10-Canto10,20,Site10,Canto10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,60.9,,848.8092206,7886.0,3469.0,65502.03621
Site10-Canto10,20,Site10,Canto10,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,62.9,,888.9539219,7852.0,3681.0,65219.62824
Site10-Canto10,20,Site10,Canto10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.8,,500.0541995,3462.0,1320.0,28755.77598
Site10-Canto10,20,Site10,Canto10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.1,,491.888064,3708.0,1373.0,30799.08068
Site10-Canto10,20,Site10,Canto10,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.7,,476.4851218,3708.0,1413.0,30799.08068
Site10-Canto10,20,Site10,Canto10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,57.4,,2651.898076,17946.0,7198.0,53805.76395
Site10-Canto10,20,Site10,Canto10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,58.2,,2588.556061,18502.0,7588.0,55472.76522
Site10-Canto10,20,Site10,Canto10,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,60.1,,2668.316682,18589.0,7797.0,55733.60894
Site10-Canto10,20,Site10,Canto10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,27.1,,718.2151003,43906.0,11461.0,6407210.031
Site10-Canto10,20,Site10,Canto10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,25.3,,653.7703372,45750.0,11733.0,6676305.264
Site10-Canto10,20,Site10,Canto10,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,25.1,,668.897816,44872.0,12006.0,6548178.575
Site10-Canto10,20,Site10,Canto10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.3,,6278.691735,28889.0,8756.0,3720083.323
Site10-Canto10,20,Site10,Canto10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95,,6278.691735,29873.0,9091.0,3846794.597
Site10-Canto10,20,Site10,Canto10,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.1,,6278.691735,30597.0,9986.0,3940025.249
Site10-Canto10,20,Site10,Canto10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,53.7,,1422.773258,22027.0,12564.0,913887.8042
Site10-Canto10,20,Site10,Canto10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,57.8,,1495.16808,21411.0,13217.0,888330.3117
Site10-Canto10,20,Site10,Canto10,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,58.1,,1550.940885,21210.0,13934.0,879990.9351
Site10-Canto10,20,Site10,Canto10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,29.9,,1379.351185,20089.0,20666.0,2662848.064
Site10-Canto10,20,Site10,Canto10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29.6,,1313.781919,19165.0,20169.0,2540369.513
Site10-Canto10,20,Site10,Canto10,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.2,,1251.591835,20764.0,20884.0,2752321.031
Site10-Canto10,20,Site10,Canto10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,55.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,51.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,54.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,68.3,,875.4574714,7765.0,3558.0,64496.99609
Site10-Canto10,20,Site10,Canto10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,66.2,,801.4518439,7817.0,3550.0,64928.91416
Site10-Canto10,20,Site10,Canto10,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,67.7,,818.8408412,7886.0,3764.0,65502.03621
Site10-Canto10,20,Site10,Canto10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.7,,493.1066438,3393.0,1368.0,28182.65393
Site10-Canto10,20,Site10,Canto10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.8,,501.0218956,3693.0,1423.0,30674.48893
Site10-Canto10,20,Site10,Canto10,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.7,,493.6338112,3663.0,1447.0,30425.30543
Site10-Canto10,20,Site10,Canto10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,57.5,,2642.399096,17946.0,7216.0,53805.76395
Site10-Canto10,20,Site10,Canto10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,57,,2635.784293,18633.0,7616.0,55865.5299
Site10-Canto10,20,Site10,Canto10,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,58.1,,2691.842211,18545.0,7871.0,55601.68798
Site10-Canto10,20,Site10,Canto10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,27.2,,718.3387556,43906.0,11489.0,6407210.031
Site10-Canto10,20,Site10,Canto10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,25.7,,677.4939587,45861.0,11706.0,6692503.513
Site10-Canto10,20,Site10,Canto10,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,25.6,,688.9372066,45199.0,12332.0,6595897.741
Site10-Canto10,20,Site10,Canto10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.2,,6232.089538,28958.0,8756.0,3728968.565
Site10-Canto10,20,Site10,Canto10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.1,,6232.089538,29801.0,9091.0,3837523.04
Site10-Canto10,20,Site10,Canto10,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.4,,6232.089538,30450.0,10057.0,3921095.821
Site10-Canto10,20,Site10,Canto10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,53.3,,1408.344628,22186.0,12555.0,920484.6245
Site10-Canto10,20,Site10,Canto10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,57,,1502.760372,21391.0,13343.0,887500.523
Site10-Canto10,20,Site10,Canto10,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,57.8,,1555.260066,21245.0,13850.0,881443.0653
Site10-Canto10,20,Site10,Canto10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,74.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,29.7,,1362.8403,20617.0,20730.0,2732835.807
Site10-Canto10,20,Site10,Canto10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,30.1,,1391.320401,19120.0,19778.0,2534404.648
Site10-Canto10,20,Site10,Canto10,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,29.1,,1347.115622,20232.0,20793.0,2681803.078
Site10-Canto10,20,Site10,Canto10,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.3,,5877.345734,34830.0,9474.0,
Site10-Canto10,20,Site10,Canto10,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97.8,,6680.037736,35678.0,9650.0,
Site10-Canto10,20,Site10,Canto10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,56.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,50.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,51.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83,,1190.757201,7189.0,2303.0,59712.67288
Site10-Canto10,20,Site10,Canto10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85.6,,1357.377014,7512.0,2275.0,62395.54857
Site10-Canto10,20,Site10,Canto10,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84,,1323.711383,7173.0,2189.0,59579.77501
Site10-Canto10,20,Site10,Canto10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.4,,519.2642287,3345.0,1572.0,27842.10314
Site10-Canto10,20,Site10,Canto10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.1,,500.073373,3612.0,1581.0,30001.69348
Site10-Canto10,20,Site10,Canto10,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.6,,520.9366015,3590.0,1580.0,29818.95891
Site10-Canto10,20,Site10,Canto10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.5,,1921.499554,22237.0,9097.0,66671.05611
Site10-Canto10,20,Site10,Canto10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,50.1,,1911.843474,23151.0,9574.0,69411.41431
Site10-Canto10,20,Site10,Canto10,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,49.9,,1912.298917,23427.0,9363.0,70238.91853
Site10-Canto10,20,Site10,Canto10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.4,,1333.000095,48021.0,10735.0,7007712.68
Site10-Canto10,20,Site10,Canto10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,67.7,,1294.408442,50043.0,11039.0,7302783.483
Site10-Canto10,20,Site10,Canto10,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.3,,1324.688292,50286.0,10563.0,7338244.514
Site10-Canto10,20,Site10,Canto10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,92.6,,5856.812302,26892.0,8756.0,1382363.338
Site10-Canto10,20,Site10,Canto10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,92.2,,5856.812302,28889.0,9242.0,1421509.91
Site10-Canto10,20,Site10,Canto10,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92,,5856.812302,29027.0,8807.0,1360214.619
Site10-Canto10,20,Site10,Canto10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.5,,509.7221937,25217.0,9362.0,1046239.105
Site10-Canto10,20,Site10,Canto10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.8,,550.0562089,27607.0,9576.0,1145398.856
Site10-Canto10,20,Site10,Canto10,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.3,,522.1577375,28005.0,9901.0,1161911.652
Site10-Canto10,20,Site10,Canto10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,26.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,33.8,,1310.587408,18372.0,25105.0,2435255.345
Site10-Canto10,20,Site10,Canto10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,34,,1298.818692,19948.0,25834.0,2644158.155
Site10-Canto10,20,Site10,Canto10,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,33.7,,1291.473394,20232.0,26493.0,2681803.078
Site10-Canto10,20,Site10,Canto10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,56.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,50.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,51.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,72,,1259.987061,7095.0,2261.0,58931.89791
Site10-Canto10,20,Site10,Canto10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,73.5,,1440.79713,7365.0,2322.0,61174.54941
Site10-Canto10,20,Site10,Canto10,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,71.7,,1399.262723,7064.0,2215.0,58674.40829
Site10-Canto10,20,Site10,Canto10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.5,,510.8788149,3325.0,1561.0,27617.83799
Site10-Canto10,20,Site10,Canto10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.4,,486.0587983,3656.0,1539.0,30367.16261
Site10-Canto10,20,Site10,Canto10,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.7,,491.329536,3561.0,1518.0,29578.08153
Site10-Canto10,20,Site10,Canto10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,51.8,,1821.547223,22395.0,9221.0,67144.7723
Site10-Canto10,20,Site10,Canto10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,53.5,,1811.367909,23151.0,9533.0,69411.41431
Site10-Canto10,20,Site10,Canto10,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,53.6,,1793.968679,23594.0,9292.0,70739.61855
Site10-Canto10,20,Site10,Canto10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.6,,1267.033666,47789.0,10467.0,6973856.88
Site10-Canto10,20,Site10,Canto10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,67.9,,1229.723153,49800.0,10864.0,7267322.452
Site10-Canto10,20,Site10,Canto10,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.3,,1242.967924,50043.0,10289.0,7302783.483
Site10-Canto10,20,Site10,Canto10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,92.3,,5856.812302,26956.0,8777.0,3471167.782
Site10-Canto10,20,Site10,Canto10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,92.4,,5856.812302,28889.0,9242.0,3720083.323
Site10-Canto10,20,Site10,Canto10,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92,,5856.812302,28958.0,8807.0,3728968.565
Site10-Canto10,20,Site10,Canto10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.5,,482.4213743,24624.0,9771.0,1021635.869
Site10-Canto10,20,Site10,Canto10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,29.2,,528.9463393,27345.0,9879.0,1134528.624
Site10-Canto10,20,Site10,Canto10,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.8,,497.8988446,27806.0,9912.0,1153655.254
Site10-Canto10,20,Site10,Canto10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,57.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,57.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,29.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,33.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,33.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,32.3,,1136.129439,16458.0,23817.0,2181549.775
Site10-Canto10,20,Site10,Canto10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,31.1,,1053.127396,18764.0,24652.0,2487215.943
Site10-Canto10,20,Site10,Canto10,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,30.8,,1030.834001,19031.0,25470.0,2522607.472
Site10-Canto10,20,Site10,Canto10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,56.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,51,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,51.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.9,,1177.904953,7158.0,2307.0,59455.18326
Site10-Canto10,20,Site10,Canto10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,84.7,,1326.58638,7529.0,2247.0,62536.75255
Site10-Canto10,20,Site10,Canto10,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.5,,1266.39784,7221.0,2135.0,59978.46861
Site10-Canto10,20,Site10,Canto10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.4,,517.1773337,3345.0,1572.0,27783.96032
Site10-Canto10,20,Site10,Canto10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.2,,503.1879373,3590.0,1586.0,29818.95891
Site10-Canto10,20,Site10,Canto10,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.7,,521.4865363,3590.0,1569.0,29818.95891
Site10-Canto10,20,Site10,Canto10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.7,,1918.774144,22184.0,9147.0,66512.15131
Site10-Canto10,20,Site10,Canto10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,50.2,,1910.313586,23151.0,9551.0,69411.41431
Site10-Canto10,20,Site10,Canto10,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,50,,1910.172362,23427.0,9399.0,70238.91853
Site10-Canto10,20,Site10,Canto10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.1,,1326.51913,48021.0,10780.0,7007712.68
Site10-Canto10,20,Site10,Canto10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,67.6,,1291.061506,50043.0,11113.0,7302783.483
Site10-Canto10,20,Site10,Canto10,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.2,,1322.314812,50286.0,10637.0,7338244.514
Site10-Canto10,20,Site10,Canto10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,92.4,,5805.640321,26892.0,8778.0,3462926.398
Site10-Canto10,20,Site10,Canto10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.9,,5805.640321,28820.0,9266.0,3711198.081
Site10-Canto10,20,Site10,Canto10,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,91.5,,5805.640321,28958.0,8785.0,3728968.565
Site10-Canto10,20,Site10,Canto10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27.1,,520.7000401,24825.0,9702.0,1029975.246
Site10-Canto10,20,Site10,Canto10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,29.4,,560.8550268,27290.0,9973.0,1132246.705
Site10-Canto10,20,Site10,Canto10,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.7,,529.9956407,27672.0,10014.0,1148095.67
Site10-Canto10,20,Site10,Canto10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,26.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,34,,1311.767797,17988.0,24888.0,2384355.168
Site10-Canto10,20,Site10,Canto10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,34.3,,1304.444164,19622.0,25731.0,2600946.026
Site10-Canto10,20,Site10,Canto10,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,34,,1299.948023,19622.0,26456.0,2600946.026
Site10-Canto10,20,Site10,Canto10,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,96.4,,5170.972411,31945.0,8420.0,
Site10-Canto10,20,Site10,Canto10,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,96.8,,6542.652193,31338.0,8081.0,
Site10-Canto10,20,Site10,Canto10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,48.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,52.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,49.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,80.5,,880.9369051,8262.0,3157.0,68625.13608
Site10-Canto10,20,Site10,Canto10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.6,,737.5911775,8854.0,3359.0,73542.35716
Site10-Canto10,20,Site10,Canto10,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,80.7,,880.952368,8355.0,3119.0,69397.60494
Site10-Canto10,20,Site10,Canto10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13,,440.9126971,4380.0,1441.0,36380.7911
Site10-Canto10,20,Site10,Canto10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.2,,388.1618061,4254.0,1612.0,35334.22039
Site10-Canto10,20,Site10,Canto10,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.2,,373.8974902,4108.0,1549.0,34121.52736
Site10-Canto10,20,Site10,Canto10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.1,,2077.953794,22289.0,9900.0,66826.9627
Site10-Canto10,20,Site10,Canto10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63.4,,2199.583568,21563.0,9588.0,64650.2668
Site10-Canto10,20,Site10,Canto10,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.5,,2122.697848,22289.0,9892.0,66826.9627
Site10-Canto10,20,Site10,Canto10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,52.1,,1082.4018,50043.0,12561.0,7302783.483
Site10-Canto10,20,Site10,Canto10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,52.7,,1159.879399,50531.0,12561.0,7373997.406
Site10-Canto10,20,Site10,Canto10,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,51,,1082.379337,51521.0,12955.0,7518468.274
Site10-Canto10,20,Site10,Canto10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,93.4,,4942.886775,29730.0,9490.0,1617500.316
Site10-Canto10,20,Site10,Canto10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94,,4942.886775,30597.0,10031.0,1617500.316
Site10-Canto10,20,Site10,Canto10,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,93.4,,4942.886775,31338.0,10129.0,1668236.334
Site10-Canto10,20,Site10,Canto10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.4,,693.6878353,22132.0,12102.0,918244.195
Site10-Canto10,20,Site10,Canto10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.8,,742.6159257,21717.0,12221.0,901026.0791
Site10-Canto10,20,Site10,Canto10,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.7,,735.7474072,22448.0,11968.0,931354.8567
Site10-Canto10,20,Site10,Canto10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,23.5,,797.6410555,25337.0,28359.0,3358483.817
Site10-Canto10,20,Site10,Canto10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23,,797.050699,23763.0,28401.0,3149846.112
Site10-Canto10,20,Site10,Canto10,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,23,,770.1992392,23932.0,27279.0,3172247.492
Site10-Canto10,20,Site10,Canto10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,48.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,52.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,50,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,67.2,,936.2427284,8081.0,3062.0,67121.72896
Site10-Canto10,20,Site10,Canto10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,58.9,,762.4475129,8775.0,3265.0,72886.17394
Site10-Canto10,20,Site10,Canto10,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,66.4,,933.7896026,8208.0,3041.0,68176.60578
Site10-Canto10,20,Site10,Canto10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.4,,396.8967244,4325.0,1427.0,35923.95468
Site10-Canto10,20,Site10,Canto10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.7,,348.8478122,4193.0,1564.0,34827.54728
Site10-Canto10,20,Site10,Canto10,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.9,,343.8372568,4116.0,1474.0,34187.97629
Site10-Canto10,20,Site10,Canto10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.1,,1870.679035,22132.0,9915.0,66356.24472
Site10-Canto10,20,Site10,Canto10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,65.1,,1943.990274,21462.0,9594.0,64347.44822
Site10-Canto10,20,Site10,Canto10,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.1,,1883.866233,22079.0,9955.0,66197.33992
Site10-Canto10,20,Site10,Canto10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,51.5,,963.3390587,49319.0,12478.0,7197130.04
Site10-Canto10,20,Site10,Canto10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,52,,1011.180782,49800.0,12434.0,7267322.452
Site10-Canto10,20,Site10,Canto10,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,50,,941.4806992,50900.0,12686.0,7427845.638
Site10-Canto10,20,Site10,Canto10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,93.4,,4942.886775,29730.0,9418.0,3828380.255
Site10-Canto10,20,Site10,Canto10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94,,4942.886775,30670.0,10031.0,3949425.578
Site10-Canto10,20,Site10,Canto10,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,93.6,,4942.886775,31338.0,10051.0,4035445.02
Site10-Canto10,20,Site10,Canto10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,37.1,,694.1821773,19761.0,12496.0,819872.7425
Site10-Canto10,20,Site10,Canto10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,37.9,,737.120206,18941.0,12555.0,785851.4051
Site10-Canto10,20,Site10,Canto10,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,39.4,,743.0956504,19854.0,12763.0,823731.26
Site10-Canto10,20,Site10,Canto10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,58.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.6,,671.2148116,24801.0,27491.0,3287435.653
Site10-Canto10,20,Site10,Canto10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22.3,,665.9170224,23650.0,28157.0,3134867.674
Site10-Canto10,20,Site10,Canto10,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22,,637.6823861,23261.0,26677.0,3083304.735
Site10-Canto10,20,Site10,Canto10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,48.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,52.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,49.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.4,,813.5445897,8355.0,2946.0,69397.60494
Site10-Canto10,20,Site10,Canto10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,71.1,,690.3029905,9034.0,3125.0,75037.45817
Site10-Canto10,20,Site10,Canto10,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76.8,,830.2951263,8467.0,2966.0,70327.89
Site10-Canto10,20,Site10,Canto10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.9,,441.4600337,4380.0,1447.0,36380.7911
Site10-Canto10,20,Site10,Canto10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.3,,393.8564405,4254.0,1605.0,35334.22039
Site10-Canto10,20,Site10,Canto10,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.3,,379.8430061,4108.0,1550.0,34121.52736
Site10-Canto10,20,Site10,Canto10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.3,,2094.871742,22237.0,9892.0,66671.05611
Site10-Canto10,20,Site10,Canto10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63.6,,2225.457564,21563.0,9580.0,64650.2668
Site10-Canto10,20,Site10,Canto10,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.7,,2145.921574,22237.0,9924.0,66671.05611
Site10-Canto10,20,Site10,Canto10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,52,,1090.377284,50043.0,12561.0,7302783.483
Site10-Canto10,20,Site10,Canto10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,52.6,,1171.659657,50531.0,12561.0,7373997.406
Site10-Canto10,20,Site10,Canto10,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,50.9,,1092.101812,51521.0,13033.0,7518468.274
Site10-Canto10,20,Site10,Canto10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,92.9,,4938.597113,29730.0,9442.0,3828380.255
Site10-Canto10,20,Site10,Canto10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,93.1,,4938.597113,30597.0,10006.0,3940025.249
Site10-Canto10,20,Site10,Canto10,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,92.8,,4938.597113,31338.0,10077.0,4035445.02
Site10-Canto10,20,Site10,Canto10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,36.6,,766.0301949,20393.0,12670.0,846094.066
Site10-Canto10,20,Site10,Canto10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,37.4,,832.200948,19666.0,12763.0,815931.2461
Site10-Canto10,20,Site10,Canto10,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,38.8,,833.4852972,20393.0,12755.0,846094.066
Site10-Canto10,20,Site10,Canto10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,68.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,23.5,,804.6216986,24978.0,28343.0,3310897.453
Site10-Canto10,20,Site10,Canto10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23,,806.6888338,23482.0,28359.0,3112598.847
Site10-Canto10,20,Site10,Canto10,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,23.1,,778.4016809,23763.0,27357.0,3149846.112
Site10-Canto10,20,Site10,Canto10,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,95.4,,4265.29582,33276.0,9742.0,
Site10-Canto10,20,Site10,Canto10,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,96.4,,5620.47773,34003.0,9912.0,
Site10-Canto10,20,Site10,Canto10,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1421.763025,64603.0,31543.0,
Site10-Canto10,20,Site10,Canto10,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1391.672321,60490.0,29547.0,
Site10-Canto10,20,Site10,Canto10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.8,,222.0118356,8486.0,1827.0,70485.70622
Site10-Canto10,20,Site10,Canto10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.5,,210.347723,8318.0,1800.0,69090.27862
Site10-Canto10,20,Site10,Canto10,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.6,,224.7197151,6957.0,1543.0,57785.6538
Site10-Canto10,20,Site10,Canto10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.1,,169.1256415,6054.0,601.0,50285.23043
Site10-Canto10,20,Site10,Canto10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.5,,175.3819057,6107.0,579.0,50725.45462
Site10-Canto10,20,Site10,Canto10,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.5,,171.5915355,5533.0,502.0,45957.74364
Site10-Canto10,20,Site10,Canto10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.6,,788.6102797,72632.0,23659.0,217765.5325
Site10-Canto10,20,Site10,Canto10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.9,,788.5275516,71575.0,23214.0,214596.4312
Site10-Canto10,20,Site10,Canto10,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,69.9,,776.1846702,70019.0,22982.0,209931.2262
Site10-Canto10,20,Site10,Canto10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.3,,515.0206323,123021.0,15618.0,17952475.41
Site10-Canto10,20,Site10,Canto10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.9,,511.7724167,125464.0,16423.0,18308982.81
Site10-Canto10,20,Site10,Canto10,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.5,,508.0468867,115975.0,15005.0,16924251.43
Site10-Canto10,20,Site10,Canto10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1406.717673,46645.0,23592.0,6006552.203
Site10-Canto10,20,Site10,Canto10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1406.717673,46532.0,23603.0,5992001.01
Site10-Canto10,20,Site10,Canto10,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1406.717673,44981.0,23201.0,5792276.228
Site10-Canto10,20,Site10,Canto10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.2,,269.4579134,76269.0,5698.0,3164357.785
Site10-Canto10,20,Site10,Canto10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.6,,272.7471954,77396.0,5682.0,3211116.38
Site10-Canto10,20,Site10,Canto10,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.9,,263.2827279,74246.0,5629.0,3080424.657
Site10-Canto10,20,Site10,Canto10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,80.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,28.8,,321.0357251,1585.0,359.0,210095.7828
Site10-Canto10,20,Site10,Canto10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.6,,333.48821,1549.0,344.0,205323.8912
Site10-Canto10,20,Site10,Canto10,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,29.5,,327.4388194,1302.0,307.0,1749958.691
Site10-Canto10,20,Site10,Canto10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.8,,222.116944,8486.0,1827.0,70518.93069
Site10-Canto10,20,Site10,Canto10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.4,,210.599325,8318.0,1800.0,69123.50308
Site10-Canto10,20,Site10,Canto10,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.6,,225.0748277,6957.0,1543.0,57735.8171
Site10-Canto10,20,Site10,Canto10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.2,,169.4649597,6054.0,600.0,50343.37325
Site10-Canto10,20,Site10,Canto10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.6,,175.5109721,6107.0,579.0,50733.76074
Site10-Canto10,20,Site10,Canto10,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.5,,171.4458873,5533.0,494.0,45966.04976
Site10-Canto10,20,Site10,Canto10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.8,,790.6756743,72632.0,23659.0,217765.5325
Site10-Canto10,20,Site10,Canto10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.1,,790.629868,71575.0,23214.0,214596.4312
Site10-Canto10,20,Site10,Canto10,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.3,,779.4952598,70019.0,23028.0,209931.2262
Site10-Canto10,20,Site10,Canto10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.7,,511.6339411,123021.0,15618.0,17952475.41
Site10-Canto10,20,Site10,Canto10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.4,,509.4385906,125156.0,16245.0,18264036.32
Site10-Canto10,20,Site10,Canto10,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.1,,507.2519728,115975.0,15005.0,16924251.43
Site10-Canto10,20,Site10,Canto10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1406.717673,46645.0,23534.0,6006552.203
Site10-Canto10,20,Site10,Canto10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1406.717673,46532.0,23565.0,5992001.01
Site10-Canto10,20,Site10,Canto10,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1406.717673,44981.0,23054.0,5792276.228
Site10-Canto10,20,Site10,Canto10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.2,,270.6339556,76269.0,5698.0,3165478
Site10-Canto10,20,Site10,Canto10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.6,,273.7168354,77396.0,5682.0,3207963.182
Site10-Canto10,20,Site10,Canto10,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34,,265.0881304,74246.0,5629.0,3082250.192
Site10-Canto10,20,Site10,Canto10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,80.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,28.7,,319.9090456,1585.0,353.0,210095.7828
Site10-Canto10,20,Site10,Canto10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.4,,331.4361378,1547.0,341.0,205058.7861
Site10-Canto10,20,Site10,Canto10,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,29.3,,325.3859546,1297.0,298.0,171920.6501
Site10-Canto10,20,Site10,Canto10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,76.9,,196.3774292,8373.0,1912.0,69547.11504
Site10-Canto10,20,Site10,Canto10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,76.9,,183.3407993,8226.0,1920.0,68326.11588
Site10-Canto10,20,Site10,Canto10,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,75.7,,194.2141267,6881.0,1614.0,57154.38894
Site10-Canto10,20,Site10,Canto10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,19.2,,165.8848947,6041.0,591.0,50177.25092
Site10-Canto10,20,Site10,Canto10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,19.7,,170.9109146,6093.0,554.0,50609.16899
Site10-Canto10,20,Site10,Canto10,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,20.8,,166.6871691,5521.0,486.0,45858.07024
Site10-Canto10,20,Site10,Canto10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,63.6,,550.9994115,74428.0,22931.0,223150.3064
Site10-Canto10,20,Site10,Canto10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,62.3,,539.1117213,72987.0,22396.0,218829.8949
Site10-Canto10,20,Site10,Canto10,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,59.9,,479.8843166,71401.0,22247.0,214074.7438
Site10-Canto10,20,Site10,Canto10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.2,,403.0796445,123627.0,16315.0,18040909.09
Site10-Canto10,20,Site10,Canto10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73,,393.4058507,125773.0,17231.0,25151880.88
Site10-Canto10,20,Site10,Canto10,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.3,,351.7487557,116546.0,16288.0,23306680.36
Site10-Canto10,20,Site10,Canto10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1406.717673,46645.0,23627.0,6006552.203
Site10-Canto10,20,Site10,Canto10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1406.717673,46532.0,23682.0,5992001.01
Site10-Canto10,20,Site10,Canto10,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1406.717673,44981.0,23218.0,5792276.228
Site10-Canto10,20,Site10,Canto10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26,,143.2391974,74735.0,6071.0,3100712.991
Site10-Canto10,20,Site10,Canto10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.4,,142.115015,75642.0,6146.0,3138343.909
Site10-Canto10,20,Site10,Canto10,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.8,,124.0446529,72253.0,6069.0,2997736.211
Site10-Canto10,20,Site10,Canto10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,61.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,61.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,56.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,16.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Canto10,20,Site10,Canto10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,36.1,,312.841015,1588.0,359.0,210493.4405
Site10-Canto10,20,Site10,Canto10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,37.2,,322.2792882,1549.0,343.0,226418.8116
Site10-Canto10,20,Site10,Canto10,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,39.5,,316.7333562,1297.0,303.0,189583.7305
Site10-CantoII,21,Site10,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,59.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,62.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,70.7,,911.7216057,16004.0,7888.0,72411.51793
Site10-CantoII,21,Site10,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,65.7,,952.2497412,13732.0,7397.0,62131.65235
Site10-CantoII,21,Site10,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,69.5,,988.8472895,14483.0,7619.0,65529.61848
Site10-CantoII,21,Site10,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.2,,552.6448092,5125.0,2189.0,23188.51721
Site10-CantoII,21,Site10,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12,,566.0368633,5039.0,2296.0,22799.40258
Site10-CantoII,21,Site10,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.1,,571.5789269,4924.0,2241.0,22279.07488
Site10-CantoII,21,Site10,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.5,,2989.324498,10087.0,4011.0,59848.63692
Site10-CantoII,21,Site10,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.3,,2647.499495,9974.0,3902.0,59178.1803
Site10-CantoII,21,Site10,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,59.9,,2842.542308,9773.0,4010.0,57985.59816
Site10-CantoII,21,Site10,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,26.9,,803.5512457,31869.0,8846.0,5286156.902
Site10-CantoII,21,Site10,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,26.4,,699.2700889,31489.0,9095.0,5223125.755
Site10-CantoII,21,Site10,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,27.6,,784.5432516,29377.0,8906.0,4872805.275
Site10-CantoII,21,Site10,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.3,,6695.582622,27739.0,7552.0,1395872.525
Site10-CantoII,21,Site10,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,90.2,,6695.582622,27476.0,7919.0,1435163.985
Site10-CantoII,21,Site10,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,88.1,,6695.582622,27739.0,8361.0,1405340.347
Site10-CantoII,21,Site10,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,58.6,,1751.871845,19438.0,11244.0,985061.7494
Site10-CantoII,21,Site10,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,58.4,,1546.894966,17737.0,10901.0,898859.9779
Site10-CantoII,21,Site10,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,57.2,,1625.378367,17572.0,11076.0,890498.254
Site10-CantoII,21,Site10,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26,,1284.218033,30232.0,27306.0,3441025.321
Site10-CantoII,21,Site10,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29.1,,1370.749198,27673.0,27395.0,3149758.326
Site10-CantoII,21,Site10,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.8,,1223.068682,28614.0,27089.0,3256863.54
Site10-CantoII,21,Site10,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,58.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,58.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,61.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,70.9,,890.6673476,16004.0,7798.0,72411.51793
Site10-CantoII,21,Site10,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,65.8,,930.2015323,13732.0,7397.0,62131.65235
Site10-CantoII,21,Site10,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,70.2,,961.1777144,14652.0,7536.0,66294.27398
Site10-CantoII,21,Site10,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.1,,548.4201723,5082.0,2257.0,22993.95989
Site10-CantoII,21,Site10,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12,,564.971758,4976.0,2362.0,22514.35349
Site10-CantoII,21,Site10,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12,,573.4829081,4862.0,2265.0,21998.55037
Site10-CantoII,21,Site10,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.2,,3028.910409,10064.0,4037.0,59712.1723
Site10-CantoII,21,Site10,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,57,,2691.400895,9929.0,3919.0,58911.1843
Site10-CantoII,21,Site10,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,60.1,,2869.535409,9795.0,4057.0,58116.12954
Site10-CantoII,21,Site10,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,26.9,,814.6124197,31893.0,8860.0,5290137.817
Site10-CantoII,21,Site10,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,26.1,,701.9885308,31461.0,9099.0,5218481.355
Site10-CantoII,21,Site10,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,27.6,,791.9323887,29456.0,8893.0,4885909.119
Site10-CantoII,21,Site10,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,93.5,,6695.582622,27739.0,7534.0,4377131.807
Site10-CantoII,21,Site10,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94.1,,6695.582622,27410.0,7877.0,4325216.584
Site10-CantoII,21,Site10,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,91.6,,6695.582622,27673.0,8318.0,4366717.203
Site10-CantoII,21,Site10,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,55.9,,1692.451225,20042.0,10720.0,1015670.727
Site10-CantoII,21,Site10,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,55.8,,1501.846185,18545.0,10382.0,939807.0863
Site10-CantoII,21,Site10,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,53.7,,1540.174881,18897.0,10375.0,957645.4305
Site10-CantoII,21,Site10,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,71.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.4,,1307.136802,29944.0,27650.0,3408244.979
Site10-CantoII,21,Site10,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29.6,,1399.083606,27410.0,27042.0,3119823.5
Site10-CantoII,21,Site10,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.1,,1247.494995,28410.0,27490.0,3233644.131
Site10-CantoII,21,Site10,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,59.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,62.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,73.3,,945.5935142,15856.0,8259.0,71741.8788
Site10-CantoII,21,Site10,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,68.6,,995.0408108,13512.0,7632.0,61136.24283
Site10-CantoII,21,Site10,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,72.2,,1027.275016,14250.0,7877.0,64475.38931
Site10-CantoII,21,Site10,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.1,,549.6313118,5235.0,2185.0,23686.22197
Site10-CantoII,21,Site10,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.9,,561.0640793,5136.0,2303.0,23238.28768
Site10-CantoII,21,Site10,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12,,566.5553517,5039.0,2256.0,22799.40258
Site10-CantoII,21,Site10,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.1,,3017.280766,10041.0,4044.0,59575.70768
Site10-CantoII,21,Site10,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,57.1,,2685.179946,9906.0,3940.0,58774.71967
Site10-CantoII,21,Site10,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,60.1,,2850.875055,9773.0,4031.0,57985.59816
Site10-CantoII,21,Site10,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,26.6,,802.9007698,31469.0,8796.0,5219808.326
Site10-CantoII,21,Site10,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,26,,699.184734,31072.0,9033.0,5153957.365
Site10-CantoII,21,Site10,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,27.4,,782.1611384,28983.0,8774.0,4807451.928
Site10-CantoII,21,Site10,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.3,,6695.582622,27739.0,7552.0,4377131.807
Site10-CantoII,21,Site10,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,90.2,,6695.582622,27476.0,7962.0,4335631.188
Site10-CantoII,21,Site10,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,88.1,,6695.582622,27739.0,8361.0,4377131.807
Site10-CantoII,21,Site10,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,57.1,,1724.102362,19481.0,11210.0,987240.8653
Site10-CantoII,21,Site10,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,57.1,,1532.812354,17780.0,10939.0,901039.0938
Site10-CantoII,21,Site10,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,55.2,,1574.94519,18002.0,10923.0,912289.4132
Site10-CantoII,21,Site10,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.2,,1294.804533,30088.0,27411.0,3424635.15
Site10-CantoII,21,Site10,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,29.5,,1386.518879,27410.0,27398.0,3119823.5
Site10-CantoII,21,Site10,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.1,,1238.946391,28274.0,27287.0,3218164.525
Site10-CantoII,21,Site10,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.7,,7192.099644,31945.0,8431.0,
Site10-CantoII,21,Site10,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.5,,6199.0656,31716.0,8527.0,
Site10-CantoII,21,Site10,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,58.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,60.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,58.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83,,1900.124526,11854.0,4159.0,53634.47473
Site10-CantoII,21,Site10,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,84.6,,1928.598043,12073.0,4148.0,54625.35966
Site10-CantoII,21,Site10,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,82.5,,1904.705729,11908.0,4068.0,53878.80252
Site10-CantoII,21,Site10,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.8,,546.7821023,4731.0,2144.0,22184.05851
Site10-CantoII,21,Site10,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.2,,568.2184245,4566.0,2092.0,21138.87852
Site10-CantoII,21,Site10,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.5,,620.9687123,4643.0,2256.0,21138.87852
Site10-CantoII,21,Site10,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,53.5,,2120.19865,12582.0,4951.0,74652.08186
Site10-CantoII,21,Site10,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56,,2245.607939,12524.0,4941.0,74307.95368
Site10-CantoII,21,Site10,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,53.4,,2140.440364,12410.0,4817.0,73631.56382
Site10-CantoII,21,Site10,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70.8,,1500.43664,33116.0,8117.0,5492998.587
Site10-CantoII,21,Site10,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71,,1595.228693,32409.0,8077.0,5375727.479
Site10-CantoII,21,Site10,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.5,,1488.592674,33276.0,7934.0,5519538.017
Site10-CantoII,21,Site10,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,83.4,,6840.070158,25519.0,7265.0,1280838.49
Site10-CantoII,21,Site10,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,84.8,,6840.070158,26259.0,7560.0,1274526.609
Site10-CantoII,21,Site10,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,84.8,,6840.070158,26196.0,7328.0,1251961.634
Site10-CantoII,21,Site10,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.9,,570.2264248,21512.0,7470.0,1090166.085
Site10-CantoII,21,Site10,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.9,,604.5727703,21360.0,7594.0,1082463.163
Site10-CantoII,21,Site10,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28,,598.7509112,22132.0,7637.0,1121585.896
Site10-CantoII,21,Site10,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,57.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,58.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,33.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,33.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,30.5,,1207.760743,29167.0,34465.0,3319806.349
Site10-CantoII,21,Site10,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,27.7,,1109.534633,28958.0,33764.0,3296017.837
Site10-CantoII,21,Site10,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,29.4,,1176.41374,27939.0,33410.0,3180034.614
Site10-CantoII,21,Site10,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,57.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,57.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.5,,1854.017869,11827.0,4141.0,53512.31083
Site10-CantoII,21,Site10,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85.2,,1882.504012,12101.0,4094.0,54752.04815
Site10-CantoII,21,Site10,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.1,,1868.846287,11936.0,4004.0,54005.49101
Site10-CantoII,21,Site10,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.8,,597.3669992,4852.0,2249.0,21953.30449
Site10-CantoII,21,Site10,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.9,,609.432275,4633.0,2204.0,20962.41956
Site10-CantoII,21,Site10,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.7,,639.5307507,4643.0,2268.0,21007.66544
Site10-CantoII,21,Site10,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,53.1,,2144.416717,12582.0,4960.0,74652.08186
Site10-CantoII,21,Site10,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56,,2293.840904,12553.0,4984.0,74480.01777
Site10-CantoII,21,Site10,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,53.8,,2184.185115,12438.0,4807.0,73797.69466
Site10-CantoII,21,Site10,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70.4,,1509.986802,33003.0,8057.0,5474255.114
Site10-CantoII,21,Site10,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,70.9,,1627.411366,32406.0,8130.0,5375229.865
Site10-CantoII,21,Site10,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.3,,1513.036166,33306.0,7973.0,5524514.161
Site10-CantoII,21,Site10,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,90.1,,6840.070158,25458.0,7207.0,4017196.782
Site10-CantoII,21,Site10,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,90.8,,6840.070158,26196.0,7501.0,4133650.99
Site10-CantoII,21,Site10,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,91.2,,6840.070158,26134.0,7287.0,4123867.574
Site10-CantoII,21,Site10,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27,,578.1814897,21563.0,7411.0,1092750.617
Site10-CantoII,21,Site10,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.7,,613.0195153,21411.0,7517.0,1085047.696
Site10-CantoII,21,Site10,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.1,,614.2361923,22132.0,7739.0,1121585.896
Site10-CantoII,21,Site10,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,32.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,32.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,32.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,30.7,,1241.389669,28546.0,34400.0,3249123.737
Site10-CantoII,21,Site10,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,27.7,,1135.95944,28342.0,33528.0,3225904.328
Site10-CantoII,21,Site10,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,29.2,,1187.157939,27150.0,32663.0,3090230.136
Site10-CantoII,21,Site10,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,58.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,60.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,58.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84,,1923.710714,11908.0,4266.0,53878.80252
Site10-CantoII,21,Site10,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85.6,,1951.867546,12129.0,4258.0,54878.73663
Site10-CantoII,21,Site10,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.6,,1930.919893,11963.0,4150.0,54127.6549
Site10-CantoII,21,Site10,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.7,,542.7787739,4831.0,2163.0,21858.28812
Site10-CantoII,21,Site10,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.1,,565.0429585,4672.0,2119.0,21138.87852
Site10-CantoII,21,Site10,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.4,,617.1718232,4771.0,2262.0,21586.8128
Site10-CantoII,21,Site10,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,53.7,,2125.411385,12524.0,4926.0,74307.95368
Site10-CantoII,21,Site10,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.2,,2252.182795,12496.0,4957.0,74141.82284
Site10-CantoII,21,Site10,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,53.5,,2143.166789,12381.0,4817.0,73459.49973
Site10-CantoII,21,Site10,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70.6,,1500.668106,32622.0,8048.0,5411058.096
Site10-CantoII,21,Site10,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,70.8,,1594.902747,31938.0,8010.0,5297602.031
Site10-CantoII,21,Site10,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.4,,1486.85724,32761.0,7882.0,5434114.226
Site10-CantoII,21,Site10,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,83.4,,6840.070158,25519.0,7265.0,4026822.401
Site10-CantoII,21,Site10,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,84.9,,6840.070158,26259.0,7560.0,4143592.203
Site10-CantoII,21,Site10,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,84.8,,6840.070158,26196.0,7328.0,4133650.99
Site10-CantoII,21,Site10,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.8,,569.5966535,21405.0,7630.0,1084743.633
Site10-CantoII,21,Site10,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.9,,604.9881548,21181.0,7697.0,1073391.96
Site10-CantoII,21,Site10,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.1,,601.7425276,21952.0,7755.0,1112464.015
Site10-CantoII,21,Site10,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,57.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,58.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,33.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,33.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,31,,1226.823561,28478.0,34435.0,3241383.934
Site10-CantoII,21,Site10,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,28.1,,1125.001983,28478.0,33789.0,3241383.934
Site10-CantoII,21,Site10,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,29.6,,1185.797814,27410.0,33312.0,3119823.5
Site10-CantoII,21,Site10,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,93.3,,6539.950566,28478.0,7580.0,
Site10-CantoII,21,Site10,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.7,,7140.189749,26700.0,7227.0,
Site10-CantoII,21,Site10,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,57.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,61.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,79.7,,1350.707819,14449.0,5618.0,65375.78247
Site10-CantoII,21,Site10,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,80.8,,1398.545176,14961.0,5856.0,65375.78247
Site10-CantoII,21,Site10,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.1,,1348.607953,14550.0,5575.0,65375.78247
Site10-CantoII,21,Site10,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.7,,523.6405341,5701.0,2280.0,25794.68031
Site10-CantoII,21,Site10,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.2,,471.6370433,5604.0,2244.0,25794.68031
Site10-CantoII,21,Site10,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.2,,433.2603918,5713.0,2235.0,25794.68031
Site10-CantoII,21,Site10,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.5,,2158.791156,11639.0,5046.0,69057.03233
Site10-CantoII,21,Site10,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.7,,2231.125899,11827.0,5030.0,69057.03233
Site10-CantoII,21,Site10,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.8,,2274.462542,11827.0,5070.0,69057.03233
Site10-CantoII,21,Site10,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.6,,1158.020758,32643.0,9267.0,5414541.396
Site10-CantoII,21,Site10,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,52.2,,1165.553501,33436.0,9168.0,5414541.396
Site10-CantoII,21,Site10,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,53.5,,1216.343012,33037.0,9336.0,5414541.396
Site10-CantoII,21,Site10,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,86.2,,5917.929033,27476.0,8253.0,1462305.074
Site10-CantoII,21,Site10,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88,,5917.929033,28207.0,8592.0,1462305.074
Site10-CantoII,21,Site10,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,87.3,,5917.929033,28682.0,8511.0,1462305.074
Site10-CantoII,21,Site10,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,37.4,,806.5013422,16344.0,10845.0,828266.7575
Site10-CantoII,21,Site10,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,39.1,,872.4541394,16966.0,11149.0,828266.7575
Site10-CantoII,21,Site10,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37.6,,855.0866649,16458.0,11035.0,828266.7575
Site10-CantoII,21,Site10,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.7,,808.0833378,36284.0,35528.0,4129867.781
Site10-CantoII,21,Site10,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22.2,,789.1365544,35678.0,35480.0,4129867.781
Site10-CantoII,21,Site10,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22,,782.7735895,37710.0,35179.0,4129867.781
Site10-CantoII,21,Site10,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,56.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,60.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,58.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,79.8,,1305.576495,14516.0,5578.0,65678.92991
Site10-CantoII,21,Site10,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,81.7,,1364.713991,15030.0,5804.0,68004.56852
Site10-CantoII,21,Site10,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.3,,1298.386977,14652.0,5490.0,66294.27398
Site10-CantoII,21,Site10,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.5,,522.8678101,5676.0,2378.0,25681.5656
Site10-CantoII,21,Site10,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.5,,483.4253322,5604.0,2294.0,25355.79521
Site10-CantoII,21,Site10,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.2,,439.5846104,5701.0,2276.0,25794.68031
Site10-CantoII,21,Site10,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.4,,2209.709459,11613.0,5106.0,68902.76798
Site10-CantoII,21,Site10,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63,,2262.127797,11827.0,5030.0,70172.48229
Site10-CantoII,21,Site10,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.1,,2308.922409,11800.0,5058.0,70012.28469
Site10-CantoII,21,Site10,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,54,,1192.29437,32554.0,9167.0,5399778.838
Site10-CantoII,21,Site10,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,52.4,,1185.362864,33306.0,9077.0,5524514.161
Site10-CantoII,21,Site10,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,53.7,,1238.983651,33079.0,9467.0,5486861.344
Site10-CantoII,21,Site10,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,92.2,,5917.929033,27345.0,8121.0,4314959.777
Site10-CantoII,21,Site10,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,93.4,,5917.929033,28072.0,8525.0,4429678.218
Site10-CantoII,21,Site10,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,93.1,,5917.929033,28614.0,8490.0,4515204.208
Site10-CantoII,21,Site10,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.5,,785.1867317,17045.0,10535.0,863791.4147
Site10-CantoII,21,Site10,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,37.6,,851.0128721,17737.0,10826.0,898859.9779
Site10-CantoII,21,Site10,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,36.3,,837.417169,17045.0,10877.0,863791.4147
Site10-CantoII,21,Site10,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,27.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,23,,826.6055088,35507.0,35383.0,4041429.151
Site10-CantoII,21,Site10,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22.3,,801.9792611,34830.0,35843.0,3964372.583
Site10-CantoII,21,Site10,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.3,,802.4540687,36990.0,35372.0,4210225.147
Site10-CantoII,21,Site10,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,57.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,61.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,81.4,,1380.070407,14449.0,5854.0,65375.78247
Site10-CantoII,21,Site10,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.4,,1426.404661,14961.0,6019.0,67692.37189
Site10-CantoII,21,Site10,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,80.8,,1376.794052,14550.0,5782.0,65832.76593
Site10-CantoII,21,Site10,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.6,,518.7117585,5799.0,2289.0,26238.09001
Site10-CantoII,21,Site10,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.2,,469.5211508,5725.0,2245.0,25903.27044
Site10-CantoII,21,Site10,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.1,,431.1360468,5824.0,2246.0,26351.20473
Site10-CantoII,21,Site10,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.9,,2170.939889,11586.0,5094.0,68742.57038
Site10-CantoII,21,Site10,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.9,,2240.261146,11800.0,5042.0,70012.28469
Site10-CantoII,21,Site10,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.1,,2283.229795,11800.0,5066.0,70012.28469
Site10-CantoII,21,Site10,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.4,,1158.48787,32142.0,9187.0,5331439.805
Site10-CantoII,21,Site10,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,52.1,,1166.517717,32900.0,9039.0,5457170.356
Site10-CantoII,21,Site10,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,53.2,,1215.272453,32553.0,9300.0,5399612.967
Site10-CantoII,21,Site10,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,86.2,,5917.929033,27410.0,8232.0,4325216.584
Site10-CantoII,21,Site10,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88,,5917.929033,28207.0,8616.0,4450980.817
Site10-CantoII,21,Site10,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,87.3,,5917.929033,28682.0,8511.0,4525934.406
Site10-CantoII,21,Site10,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,36.5,,793.3982412,16239.0,10929.0,822945.6605
Site10-CantoII,21,Site10,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,38.4,,859.9462749,16921.0,11251.0,857507.4525
Site10-CantoII,21,Site10,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37.3,,850.8451354,16173.0,11182.0,819600.971
Site10-CantoII,21,Site10,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,60.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,22.9,,817.7375498,35678.0,35587.0,4060892.478
Site10-CantoII,21,Site10,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22.5,,799.5835177,34830.0,35401.0,3964372.583
Site10-CantoII,21,Site10,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.3,,793.4015074,36812.0,35453.0,1840821.068
Site10-CantoII,21,Site10,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.5,,5399.344874,28751.0,9164.0,
Site10-CantoII,21,Site10,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.7,,6436.513192,29659.0,8965.0,
Site10-CantoII,21,Site10,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1877.003675,60934.0,27266.0,
Site10-CantoII,21,Site10,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1441.212713,62133.0,28371.0,
Site10-CantoII,21,Site10,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.5,,237.1951424,17045.0,3986.0,77121.61479
Site10-CantoII,21,Site10,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.6,,255.4179137,13512.0,3032.0,61136.24283
Site10-CantoII,21,Site10,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.7,,252.3410575,17572.0,3943.0,61136.24283
Site10-CantoII,21,Site10,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.3,,201.9766619,7529.0,730.0,34065.6285
Site10-CantoII,21,Site10,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.1,,195.8986296,6545.0,675.0,29613.4332
Site10-CantoII,21,Site10,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.1,,196.2217636,7663.0,770.0,29613.4332
Site10-CantoII,21,Site10,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.1,,938.5857463,36110.0,11726.0,214249.4576
Site10-CantoII,21,Site10,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.9,,920.6257727,35336.0,11606.0,209657.1264
Site10-CantoII,21,Site10,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71,,924.2717192,36812.0,11858.0,209657.1264
Site10-CantoII,21,Site10,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.6,,606.1285861,106424.0,14174.0,17652702.07
Site10-CantoII,21,Site10,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,594.9320777,96476.0,13246.0,16002612.99
Site10-CantoII,21,Site10,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.4,,604.1959791,103082.0,14129.0,16002612.99
Site10-CantoII,21,Site10,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1659.108194,43906.0,19635.0,6928236.386
Site10-CantoII,21,Site10,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1659.108194,41732.0,20871.0,6585185.644
Site10-CantoII,21,Site10,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1659.108194,44012.0,21240.0,6585185.644
Site10-CantoII,21,Site10,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.1,,329.4119533,61381.0,4846.0,3110611.958
Site10-CantoII,21,Site10,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.1,,322.7601049,58748.0,4658.0,2977179.116
Site10-CantoII,21,Site10,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.4,,317.7265603,60196.0,4763.0,2977179.116
Site10-CantoII,21,Site10,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,78.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,28.9,,382.1072738,1853.0,487.0,210909.6295
Site10-CantoII,21,Site10,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29,,376.7381632,1594.0,438.0,181430.0861
Site10-CantoII,21,Site10,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,28.9,,375.607739,2068.0,509.0,181430.0861
Site10-CantoII,21,Site10,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.9,,237.7534096,17045.0,3986.0,77121.61479
Site10-CantoII,21,Site10,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.7,,256.9980895,13481.0,3025.0,60995.98058
Site10-CantoII,21,Site10,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.7,,252.6375227,17613.0,3926.0,79691.58119
Site10-CantoII,21,Site10,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.3,,202.8520038,7529.0,737.0,34065.6285
Site10-CantoII,21,Site10,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.2,,197.3948787,6545.0,681.0,29613.4332
Site10-CantoII,21,Site10,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.1,,196.5900971,7663.0,778.0,34671.92339
Site10-CantoII,21,Site10,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71,,941.9405973,36110.0,11726.0,214249.4576
Site10-CantoII,21,Site10,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.9,,922.4151169,35336.0,11555.0,209657.1264
Site10-CantoII,21,Site10,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71,,926.6420706,36812.0,11858.0,218414.5953
Site10-CantoII,21,Site10,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.6,,608.3573316,106455.0,14188.0,17657844.08
Site10-CantoII,21,Site10,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.7,,596.7494334,96449.0,13222.0,15998134.46
Site10-CantoII,21,Site10,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.4,,605.8863729,102924.0,14101.0,17072152.03
Site10-CantoII,21,Site10,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1659.108194,43906.0,19612.0,6928236.386
Site10-CantoII,21,Site10,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1659.108194,41732.0,20871.0,6585185.644
Site10-CantoII,21,Site10,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1659.108194,44012.0,21278.0,6944962.871
Site10-CantoII,21,Site10,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.2,,331.199109,61381.0,4996.0,3110611.958
Site10-CantoII,21,Site10,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35,,323.1224393,58748.0,4658.0,2977179.116
Site10-CantoII,21,Site10,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.4,,318.9940208,60050.0,4763.0,3043160.719
Site10-CantoII,21,Site10,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,78.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,78.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29,,384.1141436,1856.0,487.0,211251.0914
Site10-CantoII,21,Site10,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.1,,378.4216984,1594.0,440.0,181430.0861
Site10-CantoII,21,Site10,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,28.9,,377.84708,2068.0,510.0,235381.0652
Site10-CantoII,21,Site10,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.2,,240.4953231,17125.0,3952.0,77483.58189
Site10-CantoII,21,Site10,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.1,,260.768267,13544.0,3040.0,61281.02967
Site10-CantoII,21,Site10,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.2,,255.9922304,17654.0,3935.0,79877.08933
Site10-CantoII,21,Site10,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.3,,206.0427194,7731.0,761.0,34979.59542
Site10-CantoII,21,Site10,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.1,,200.7596673,6747.0,706.0,30527.40012
Site10-CantoII,21,Site10,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.2,,201.3451844,7869.0,820.0,35603.98867
Site10-CantoII,21,Site10,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71,,957.9438778,36110.0,11726.0,214249.4576
Site10-CantoII,21,Site10,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.9,,941.6631863,35336.0,11606.0,209657.1264
Site10-CantoII,21,Site10,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.9,,942.1309911,36812.0,11858.0,218414.5953
Site10-CantoII,21,Site10,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.5,,617.4552558,105703.0,14148.0,17533108.76
Site10-CantoII,21,Site10,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.5,,607.7947425,95665.0,13266.0,15868091.25
Site10-CantoII,21,Site10,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.2,,614.5803107,102243.0,14037.0,16959193.58
Site10-CantoII,21,Site10,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1659.108194,44119.0,17932.0,6961847.153
Site10-CantoII,21,Site10,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1659.108194,41934.0,19100.0,6617060.644
Site10-CantoII,21,Site10,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1659.108194,44333.0,19258.0,6995615.718
Site10-CantoII,21,Site10,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.1,,336.4512074,61702.0,5025.0,3126879.312
Site10-CantoII,21,Site10,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35,,329.6817973,59200.0,4761.0,3000085.172
Site10-CantoII,21,Site10,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.3,,323.1736111,60511.0,4858.0,3066522.869
Site10-CantoII,21,Site10,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,81.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,80.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-CantoII,21,Site10,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29,,391.0908835,1902.0,495.0,216486.8405
Site10-CantoII,21,Site10,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.1,,386.0353881,1642.0,447.0,186893.4764
Site10-CantoII,21,Site10,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,29,,384.8504957,2115.0,522.0,240730.6349
Site10-Fortessa,22,Site10,Fortessa,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,61.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77,,1122.97437,10056.0,5822.0,93157.17048
Site10-Fortessa,22,Site10,Fortessa,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,76.6,,1116.398713,10260.0,5531.0,95046.99375
Site10-Fortessa,22,Site10,Fortessa,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76.4,,1155.719163,9732.0,5173.0,90155.68647
Site10-Fortessa,22,Site10,Fortessa,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,,564.9518971,3860.0,1735.0,35758.42065
Site10-Fortessa,22,Site10,Fortessa,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.4,,513.9419562,3748.0,1747.0,34720.87062
Site10-Fortessa,22,Site10,Fortessa,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.3,,455.5722238,3680.0,1606.0,34090.92953
Site10-Fortessa,22,Site10,Fortessa,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,56.4,,2590.381895,7800.0,3063.0,66789.89061
Site10-Fortessa,22,Site10,Fortessa,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.5,,2540.050371,7748.0,2945.0,66344.62467
Site10-Fortessa,22,Site10,Fortessa,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,58.6,,2596.637315,7731.0,2943.0,66199.05696
Site10-Fortessa,22,Site10,Fortessa,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,25.4,,658.2953202,29323.0,7901.0,8035483.632
Site10-Fortessa,22,Site10,Fortessa,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,23,,584.3830539,28558.0,7711.0,7825848.023
Site10-Fortessa,22,Site10,Fortessa,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,23.3,,605.6333202,29151.0,8249.0,7988349.874
Site10-Fortessa,22,Site10,Fortessa,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,84,,6714.612266,18458.0,5658.0,4065755.831
Site10-Fortessa,22,Site10,Fortessa,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,74.5,,6714.612266,18941.0,5723.0,4172146.559
Site10-Fortessa,22,Site10,Fortessa,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,77.8,,6714.612266,18676.0,5876.0,4113774.834
Site10-Fortessa,22,Site10,Fortessa,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,60.8,,1573.79457,27329.0,16355.0,1462495.391
Site10-Fortessa,22,Site10,Fortessa,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,63.5,,1612.266966,26028.0,15559.0,1392873.139
Site10-Fortessa,22,Site10,Fortessa,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,62.1,,1611.70592,26028.0,15754.0,1392873.139
Site10-Fortessa,22,Site10,Fortessa,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.3,,1301.101339,14349.0,13526.0,3593443.668
Site10-Fortessa,22,Site10,Fortessa,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,30.1,,1354.137417,13638.0,13532.0,3415386.769
Site10-Fortessa,22,Site10,Fortessa,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.3,,1253.134515,13144.0,13800.0,3291673.537
Site10-Fortessa,22,Site10,Fortessa,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,61.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.7,,1104.387774,10110.0,5808.0,93657.41782
Site10-Fortessa,22,Site10,Fortessa,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77.4,,1100.409486,10271.0,5523.0,95148.89598
Site10-Fortessa,22,Site10,Fortessa,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77.5,,1151.267351,9795.0,5142.0,90739.30836
Site10-Fortessa,22,Site10,Fortessa,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,,588.5708341,3863.0,1724.0,35786.21217
Site10-Fortessa,22,Site10,Fortessa,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.5,,542.3906403,3746.0,1717.0,34702.34294
Site10-Fortessa,22,Site10,Fortessa,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.6,,497.9356614,3708.0,1618.0,34350.31704
Site10-Fortessa,22,Site10,Fortessa,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,56.6,,2698.025053,7748.0,3081.0,66344.62467
Site10-Fortessa,22,Site10,Fortessa,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.3,,2666.907199,7697.0,3008.0,65907.92154
Site10-Fortessa,22,Site10,Fortessa,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,57.9,,2721.101425,7714.0,2976.0,66053.48925
Site10-Fortessa,22,Site10,Fortessa,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,25,,673.1778916,29377.0,7991.0,8050281.44
Site10-Fortessa,22,Site10,Fortessa,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,22.8,,606.7420722,28342.0,7713.0,7766656.792
Site10-Fortessa,22,Site10,Fortessa,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,22.8,,619.9131892,29097.0,8264.0,7973552.066
Site10-Fortessa,22,Site10,Fortessa,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,83.9,,6714.612266,18458.0,5628.0,4065755.831
Site10-Fortessa,22,Site10,Fortessa,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,75.2,,6714.612266,18853.0,5785.0,4152762.741
Site10-Fortessa,22,Site10,Fortessa,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,77.3,,6714.612266,18720.0,5787.0,4123466.743
Site10-Fortessa,22,Site10,Fortessa,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,60.9,,1643.093579,27021.0,16325.0,1446012.951
Site10-Fortessa,22,Site10,Fortessa,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,63,,1681.410985,25398.0,15545.0,1359159.059
Site10-Fortessa,22,Site10,Fortessa,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,62.3,,1693.900258,25580.0,15667.0,1368898.682
Site10-Fortessa,22,Site10,Fortessa,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,71,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.6,,1362.704973,14054.0,13367.0,3519566.333
Site10-Fortessa,22,Site10,Fortessa,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,30.4,,1437.79485,12845.0,13306.0,3216794.475
Site10-Fortessa,22,Site10,Fortessa,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,29,,1363.892562,12669.0,13682.0,3172718.505
Site10-Fortessa,22,Site10,Fortessa,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,61.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.3,,1135.973613,9929.0,5821.0,91980.66286
Site10-Fortessa,22,Site10,Fortessa,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.5,,1102.12011,10087.0,5495.0,93444.34951
Site10-Fortessa,22,Site10,Fortessa,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76,,1176.419031,9620.0,5230.0,89118.13644
Site10-Fortessa,22,Site10,Fortessa,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,,585.334589,3863.0,1726.0,35786.21217
Site10-Fortessa,22,Site10,Fortessa,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.3,,533.4848656,3723.0,1697.0,34489.27463
Site10-Fortessa,22,Site10,Fortessa,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.4,,484.4567592,3701.0,1609.0,34285.47016
Site10-Fortessa,22,Site10,Fortessa,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,57.1,,2705.845879,7765.0,3088.0,66490.19238
Site10-Fortessa,22,Site10,Fortessa,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.5,,2672.763626,7646.0,3030.0,65471.21841
Site10-Fortessa,22,Site10,Fortessa,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,58.4,,2725.848975,7697.0,2974.0,65907.92154
Site10-Fortessa,22,Site10,Fortessa,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,24.8,,671.8694097,29306.0,7972.0,8030825.063
Site10-Fortessa,22,Site10,Fortessa,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,22.8,,608.6799801,27806.0,7945.0,7619774.848
Site10-Fortessa,22,Site10,Fortessa,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,22.7,,619.6056405,29097.0,8288.0,7973552.066
Site10-Fortessa,22,Site10,Fortessa,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,84,,6714.612266,18458.0,5658.0,4065755.831
Site10-Fortessa,22,Site10,Fortessa,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,77.7,,6714.612266,18589.0,6078.0,4094611.287
Site10-Fortessa,22,Site10,Fortessa,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,77.7,,6714.612266,18676.0,5846.0,4113774.834
Site10-Fortessa,22,Site10,Fortessa,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,61,,1650.28434,27021.0,16325.0,1446012.951
Site10-Fortessa,22,Site10,Fortessa,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,62.6,,1674.314887,24860.0,15827.0,1330368.305
Site10-Fortessa,22,Site10,Fortessa,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,62.2,,1695.806578,25458.0,15746.0,1362369.924
Site10-Fortessa,22,Site10,Fortessa,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.6,,1357.617045,14119.0,13339.0,3535844.39
Site10-Fortessa,22,Site10,Fortessa,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,30,,1418.028579,12410.0,13247.0,3107856.71
Site10-Fortessa,22,Site10,Fortessa,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.7,,1341.092745,12815.0,13661.0,3209281.526
Site10-Fortessa,22,Site10,Fortessa,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,94.8,,6936.209607,21060.0,6137.0,
Site10-Fortessa,22,Site10,Fortessa,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,93.8,,6493.014925,20764.0,6311.0,
Site10-Fortessa,22,Site10,Fortessa,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,58.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.5,,2672.225842,8960.0,3103.0,83004.00234
Site10-Fortessa,22,Site10,Fortessa,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86.5,,2529.078452,9141.0,3258.0,84680.7573
Site10-Fortessa,22,Site10,Fortessa,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.5,,2328.541027,8915.0,3152.0,82587.12956
Site10-Fortessa,22,Site10,Fortessa,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,16,,818.0072139,3825.0,1552.0,35434.18627
Site10-Fortessa,22,Site10,Fortessa,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.8,,807.3617592,3816.0,1680.0,35350.81171
Site10-Fortessa,22,Site10,Fortessa,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.5,,897.7712303,3851.0,1588.0,35675.04609
Site10-Fortessa,22,Site10,Fortessa,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,51.8,,2646.372264,10364.0,3942.0,88744.92644
Site10-Fortessa,22,Site10,Fortessa,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,48.8,,2491.958371,9974.0,3936.0,85405.43191
Site10-Fortessa,22,Site10,Fortessa,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,51.2,,2782.241188,10435.0,4077.0,89352.8857
Site10-Fortessa,22,Site10,Fortessa,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70,,1853.184485,32218.0,7259.0,8828810.547
Site10-Fortessa,22,Site10,Fortessa,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,66.7,,1662.76127,31008.0,7564.0,8497230.04
Site10-Fortessa,22,Site10,Fortessa,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.8,,2054.395112,31747.0,7280.0,8699740.779
Site10-Fortessa,22,Site10,Fortessa,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,77.1,,9140.274033,18073.0,5625.0,3980951.627
Site10-Fortessa,22,Site10,Fortessa,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,75.1,,9140.274033,18200.0,6051.0,4008926.001
Site10-Fortessa,22,Site10,Fortessa,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,73.9,,9140.274033,18073.0,5760.0,3980951.627
Site10-Fortessa,22,Site10,Fortessa,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28.1,,742.5147656,31380.0,10358.0,1679282.277
Site10-Fortessa,22,Site10,Fortessa,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.8,,766.4204935,30488.0,10621.0,1631547.421
Site10-Fortessa,22,Site10,Fortessa,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.7,,658.1767631,30400.0,11417.0,1626838.153
Site10-Fortessa,22,Site10,Fortessa,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,55.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,55.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,32,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,29.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,29.6,,1509.848966,14857.0,19211.0,3720662.944
Site10-Fortessa,22,Site10,Fortessa,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,32.8,,1674.770708,14686.0,18320.0,3677839.133
Site10-Fortessa,22,Site10,Fortessa,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,30,,1628.449392,14857.0,18764.0,3720662.944
Site10-Fortessa,22,Site10,Fortessa,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,58.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.9,,2660.488367,8993.0,3094.0,83309.70904
Site10-Fortessa,22,Site10,Fortessa,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.1,,2537.165731,9156.0,3259.0,84819.71489
Site10-Fortessa,22,Site10,Fortessa,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.1,,2335.904768,8933.0,3145.0,82753.87867
Site10-Fortessa,22,Site10,Fortessa,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,16,,864.1789081,3831.0,1528.0,35489.7693
Site10-Fortessa,22,Site10,Fortessa,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.8,,855.2367392,3808.0,1653.0,35276.70099
Site10-Fortessa,22,Site10,Fortessa,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.4,,941.5387909,3839.0,1586.0,35563.88002
Site10-Fortessa,22,Site10,Fortessa,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,50.9,,2746.076314,10294.0,3940.0,88145.52999
Site10-Fortessa,22,Site10,Fortessa,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,47.8,,2593.156839,9974.0,3933.0,85405.43191
Site10-Fortessa,22,Site10,Fortessa,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,50.3,,2885.562925,10412.0,4075.0,89155.94115
Site10-Fortessa,22,Site10,Fortessa,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.8,,1916.132585,32176.0,7411.0,8817301.141
Site10-Fortessa,22,Site10,Fortessa,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,66.5,,1724.196789,31039.0,7527.0,8505725.078
Site10-Fortessa,22,Site10,Fortessa,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.7,,2127.433384,31793.0,7332.0,8712346.319
Site10-Fortessa,22,Site10,Fortessa,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,77,,9140.274033,18115.0,5595.0,3990202.995
Site10-Fortessa,22,Site10,Fortessa,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,74.8,,9140.274033,18200.0,5993.0,4008926.001
Site10-Fortessa,22,Site10,Fortessa,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,73.6,,9140.274033,18115.0,5701.0,3990202.995
Site10-Fortessa,22,Site10,Fortessa,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28,,768.7353792,31263.0,10373.0,1673021.091
Site10-Fortessa,22,Site10,Fortessa,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.7,,797.0499007,30305.0,10683.0,1621754.283
Site10-Fortessa,22,Site10,Fortessa,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.6,,682.373546,30450.0,11487.0,1629513.873
Site10-Fortessa,22,Site10,Fortessa,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,32.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,29,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,30.4,,1638.62015,14788.0,19065.0,3703383.16
Site10-Fortessa,22,Site10,Fortessa,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,33.8,,1832.33648,14483.0,18340.0,3627001.509
Site10-Fortessa,22,Site10,Fortessa,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,31.1,,1783.398641,14995.0,18670.0,3755222.511
Site10-Fortessa,22,Site10,Fortessa,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,58.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.1,,2688.315892,8933.0,3118.0,82753.87867
Site10-Fortessa,22,Site10,Fortessa,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86,,2552.861734,9095.0,3282.0,84254.62068
Site10-Fortessa,22,Site10,Fortessa,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.9,,2357.387098,8873.0,3153.0,82198.0483
Site10-Fortessa,22,Site10,Fortessa,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,16,,857.2568018,3839.0,1517.0,35563.88002
Site10-Fortessa,22,Site10,Fortessa,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.7,,847.8522353,3808.0,1653.0,35276.70099
Site10-Fortessa,22,Site10,Fortessa,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.3,,933.7480717,3839.0,1578.0,35563.88002
Site10-Fortessa,22,Site10,Fortessa,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,51.2,,2742.185806,10271.0,3954.0,87948.58544
Site10-Fortessa,22,Site10,Fortessa,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,47.9,,2592.818618,9929.0,3931.0,85020.10562
Site10-Fortessa,22,Site10,Fortessa,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,50.4,,2884.787104,10388.0,4089.0,88950.4338
Site10-Fortessa,22,Site10,Fortessa,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.8,,1914.971841,32099.0,7345.0,8796200.563
Site10-Fortessa,22,Site10,Fortessa,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,66.5,,1723.619554,30965.0,7490.0,8485446.601
Site10-Fortessa,22,Site10,Fortessa,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.7,,2125.512957,31716.0,7343.0,8691245.741
Site10-Fortessa,22,Site10,Fortessa,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,77.1,,9140.274033,18073.0,5610.0,3980951.627
Site10-Fortessa,22,Site10,Fortessa,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,75,,9140.274033,18200.0,5993.0,4008926.001
Site10-Fortessa,22,Site10,Fortessa,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,73.8,,9140.274033,18073.0,5730.0,3980951.627
Site10-Fortessa,22,Site10,Fortessa,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27.9,,765.5743523,31263.0,10394.0,1673021.091
Site10-Fortessa,22,Site10,Fortessa,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.7,,796.9482599,30160.0,10720.0,1613994.694
Site10-Fortessa,22,Site10,Fortessa,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.7,,683.1194048,30305.0,11528.0,1621754.283
Site10-Fortessa,22,Site10,Fortessa,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,32.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,29.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,30.7,,1645.622272,14857.0,19086.0,3720662.944
Site10-Fortessa,22,Site10,Fortessa,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,33.8,,1831.448405,14584.0,18205.0,3652295.105
Site10-Fortessa,22,Site10,Fortessa,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,31.2,,1783.953254,15030.0,18643.0,3763987.618
Site10-Fortessa,22,Site10,Fortessa,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,94.5,,10080.45694,20666.0,6056.0,
Site10-Fortessa,22,Site10,Fortessa,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,93.4,,8200.091131,20280.0,6109.0,
Site10-Fortessa,22,Site10,Fortessa,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,68.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.9,,2028.416724,10005.0,4024.0,92684.71466
Site10-Fortessa,22,Site10,Fortessa,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,83.6,,1909.521918,9683.0,4338.0,89701.75833
Site10-Fortessa,22,Site10,Fortessa,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,85.2,,1977.797166,10005.0,4277.0,92684.71466
Site10-Fortessa,22,Site10,Fortessa,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.1,,683.4939544,4260.0,1741.0,39463.95647
Site10-Fortessa,22,Site10,Fortessa,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.4,,846.1239977,4310.0,1645.0,39927.14845
Site10-Fortessa,22,Site10,Fortessa,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,17,,890.8805829,4290.0,1707.0,39741.87166
Site10-Fortessa,22,Site10,Fortessa,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.6,,3057.597859,9136.0,3894.0,78229.80008
Site10-Fortessa,22,Site10,Fortessa,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56,,2889.647454,8873.0,3888.0,75977.78197
Site10-Fortessa,22,Site10,Fortessa,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,57.8,,3029.83942,8814.0,3819.0,75472.57639
Site10-Fortessa,22,Site10,Fortessa,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,47.3,,1445.266617,31008.0,9007.0,8497230.04
Site10-Fortessa,22,Site10,Fortessa,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,45.1,,1302.686381,29932.0,8746.0,8202370.019
Site10-Fortessa,22,Site10,Fortessa,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.6,,1411.353521,28895.0,8967.0,7918197.304
Site10-Fortessa,22,Site10,Fortessa,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,60.8,,8496.654669,19256.0,6141.0,4241531.817
Site10-Fortessa,22,Site10,Fortessa,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,69.3,,8496.654669,18458.0,6199.0,4065755.831
Site10-Fortessa,22,Site10,Fortessa,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,67.6,,8496.654669,18243.0,6537.0,4018397.639
Site10-Fortessa,22,Site10,Fortessa,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,42.1,,1286.607759,23015.0,15606.0,1231634.213
Site10-Fortessa,22,Site10,Fortessa,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.1,,1273.493189,22819.0,15005.0,1221145.388
Site10-Fortessa,22,Site10,Fortessa,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,42.5,,1288.764971,23614.0,15541.0,1263689.347
Site10-Fortessa,22,Site10,Fortessa,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,25.2,,1316.027945,23206.0,22412.0,5811516.745
Site10-Fortessa,22,Site10,Fortessa,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.2,,1248.128612,23371.0,22372.0,5852837.966
Site10-Fortessa,22,Site10,Fortessa,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22,,1155.608443,20617.0,20825.0,5163149.217
Site10-Fortessa,22,Site10,Fortessa,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,68.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.6,,2013.405304,10041.0,4016.0,93018.21289
Site10-Fortessa,22,Site10,Fortessa,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,83.9,,1874.219689,9773.0,4269.0,90535.50389
Site10-Fortessa,22,Site10,Fortessa,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.2,,1962.974394,10064.0,4257.0,93231.2812
Site10-Fortessa,22,Site10,Fortessa,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.2,,727.5020211,4254.0,1739.0,39408.37343
Site10-Fortessa,22,Site10,Fortessa,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.3,,898.933963,4308.0,1645.0,39908.62077
Site10-Fortessa,22,Site10,Fortessa,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.1,,950.9236912,4263.0,1713.0,39491.74799
Site10-Fortessa,22,Site10,Fortessa,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.5,,3231.352207,9074.0,3915.0,77698.90607
Site10-Fortessa,22,Site10,Fortessa,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.3,,3112.654887,8736.0,3906.0,74804.67748
Site10-Fortessa,22,Site10,Fortessa,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,57.5,,3196.145419,8775.0,3847.0,75138.62693
Site10-Fortessa,22,Site10,Fortessa,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,47.2,,1524.540803,30965.0,9088.0,8485446.601
Site10-Fortessa,22,Site10,Fortessa,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,45.1,,1404.584317,29730.0,8862.0,8147015.257
Site10-Fortessa,22,Site10,Fortessa,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.6,,1490.967554,28820.0,9012.0,7897644.793
Site10-Fortessa,22,Site10,Fortessa,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,60.8,,8496.654669,19301.0,6110.0,4251443.997
Site10-Fortessa,22,Site10,Fortessa,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,69.1,,8496.654669,18502.0,6170.0,4075447.74
Site10-Fortessa,22,Site10,Fortessa,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,67.3,,8496.654669,18243.0,6512.0,4018397.639
Site10-Fortessa,22,Site10,Fortessa,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,41.8,,1350.172107,22662.0,15556.0,1212743.625
Site10-Fortessa,22,Site10,Fortessa,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.8,,1364.247537,21975.0,14904.0,1175979.224
Site10-Fortessa,22,Site10,Fortessa,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,42.3,,1350.641196,23371.0,15385.0,1250685.344
Site10-Fortessa,22,Site10,Fortessa,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,28,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,26.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,25.5,,1410.226583,22395.0,22213.0,5608416.681
Site10-Fortessa,22,Site10,Fortessa,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.4,,1348.881144,22342.0,22304.0,5595143.804
Site10-Fortessa,22,Site10,Fortessa,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.6,,1256.558751,19901.0,20676.0,4983840.159
Site10-Fortessa,22,Site10,Fortessa,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,68.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.3,,2052.74884,9929.0,4056.0,91980.66286
Site10-Fortessa,22,Site10,Fortessa,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.9,,1928.791431,9642.0,4338.0,89321.94091
Site10-Fortessa,22,Site10,Fortessa,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.6,,1999.399846,9974.0,4290.0,92397.53564
Site10-Fortessa,22,Site10,Fortessa,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.9,,700.7333304,4263.0,1732.0,39491.74799
Site10-Fortessa,22,Site10,Fortessa,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.9,,874.5005144,4308.0,1638.0,39908.62077
Site10-Fortessa,22,Site10,Fortessa,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.7,,923.4112164,4272.0,1698.0,39575.12254
Site10-Fortessa,22,Site10,Fortessa,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.3,,3230.63317,9074.0,3921.0,77698.90607
Site10-Fortessa,22,Site10,Fortessa,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,56.9,,3130.750197,8736.0,3906.0,74804.67748
Site10-Fortessa,22,Site10,Fortessa,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,58.3,,3218.429799,8736.0,3864.0,74804.67748
Site10-Fortessa,22,Site10,Fortessa,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,47.1,,1521.938082,30817.0,9091.0,8444889.646
Site10-Fortessa,22,Site10,Fortessa,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,45.1,,1410.515632,29659.0,8840.0,8127558.88
Site10-Fortessa,22,Site10,Fortessa,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.7,,1502.993472,28751.0,9014.0,7878736.483
Site10-Fortessa,22,Site10,Fortessa,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,60.9,,8496.654669,19301.0,6141.0,4251443.997
Site10-Fortessa,22,Site10,Fortessa,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,69.2,,8496.654669,18458.0,6184.0,4065755.831
Site10-Fortessa,22,Site10,Fortessa,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,67.5,,8496.654669,18243.0,6510.0,4018397.639
Site10-Fortessa,22,Site10,Fortessa,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,41.8,,1350.437282,22662.0,15545.0,1212743.625
Site10-Fortessa,22,Site10,Fortessa,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.8,,1371.201465,21975.0,14856.0,1175979.224
Site10-Fortessa,22,Site10,Fortessa,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,42.1,,1355.713886,23261.0,15385.0,1244798.759
Site10-Fortessa,22,Site10,Fortessa,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,29,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,25.6,,1392.523368,22662.0,22129.0,5675281.93
Site10-Fortessa,22,Site10,Fortessa,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.3,,1337.161148,22555.0,22262.0,5648485.744
Site10-Fortessa,22,Site10,Fortessa,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.3,,1229.625607,20089.0,20734.0,5030921.308
Site10-Fortessa,22,Site10,Fortessa,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,94.4,,9259.148709,21820.0,6775.0,
Site10-Fortessa,22,Site10,Fortessa,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,94.1,,7734.16063,21512.0,6709.0,
Site10-Fortessa,22,Site10,Fortessa,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,3566.367405,37892.0,17542.0,
Site10-Fortessa,22,Site10,Fortessa,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,4768.673684,35421.0,16105.0,
Site10-Fortessa,22,Site10,Fortessa,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.9,,677.1706243,8873.0,2027.0,82198.0483
Site10-Fortessa,22,Site10,Fortessa,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.7,,634.4618784,8755.0,2024.0,81104.91523
Site10-Fortessa,22,Site10,Fortessa,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.3,,644.8561062,7126.0,1695.0,66014.12061
Site10-Fortessa,22,Site10,Fortessa,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,509.5444275,4142.0,454.0,38370.8234
Site10-Fortessa,22,Site10,Fortessa,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.6,,525.3706678,4074.0,476.0,37740.88231
Site10-Fortessa,22,Site10,Fortessa,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.9,,530.5478722,3532.0,441.0,32719.88128
Site10-Fortessa,22,Site10,Fortessa,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.5,,2336.375892,26134.0,8579.0,223780.3848
Site10-Fortessa,22,Site10,Fortessa,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.1,,2368.500147,26072.0,8596.0,223249.4908
Site10-Fortessa,22,Site10,Fortessa,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.1,,2346.472127,25458.0,8366.0,217991.9276
Site10-Fortessa,22,Site10,Fortessa,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.8,,1513.733176,97427.0,13239.0,26698259.52
Site10-Fortessa,22,Site10,Fortessa,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,1531.21526,101078.0,13640.0,27698755.74
Site10-Fortessa,22,Site10,Fortessa,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.5,,1513.007435,92993.0,12863.0,25483195.08
Site10-Fortessa,22,Site10,Fortessa,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,4167.520545,26072.0,13238.0,6052156.637
Site10-Fortessa,22,Site10,Fortessa,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,4167.520545,26259.0,12605.0,6095549.957
Site10-Fortessa,22,Site10,Fortessa,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,4167.520545,25398.0,12262.0,5881226.605
Site10-Fortessa,22,Site10,Fortessa,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.8,,813.6242302,61231.0,5363.0,3276741.017
Site10-Fortessa,22,Site10,Fortessa,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.2,,832.9527454,62436.0,5248.0,3341225.885
Site10-Fortessa,22,Site10,Fortessa,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.1,,822.8222016,59904.0,5404.0,3205727.391
Site10-Fortessa,22,Site10,Fortessa,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29.2,,967.1345367,1093.0,258.0,273721.7876
Site10-Fortessa,22,Site10,Fortessa,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.4,,992.454335,976.0,236.0,244421.2851
Site10-Fortessa,22,Site10,Fortessa,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,29.6,,989.1603903,837.0,215.0,209611.2865
Site10-Fortessa,22,Site10,Fortessa,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.7,,674.8497231,8873.0,2032.0,82198.0483
Site10-Fortessa,22,Site10,Fortessa,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.5,,632.492723,8775.0,2024.0,81290.19202
Site10-Fortessa,22,Site10,Fortessa,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.1,,644.6590231,7126.0,1695.0,66014.12061
Site10-Fortessa,22,Site10,Fortessa,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,508.9802095,4142.0,454.0,38370.8234
Site10-Fortessa,22,Site10,Fortessa,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.6,,526.9459921,4074.0,480.0,37740.88231
Site10-Fortessa,22,Site10,Fortessa,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.8,,529.7595396,3532.0,441.0,32719.88128
Site10-Fortessa,22,Site10,Fortessa,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.5,,2332.36848,26134.0,8579.0,223780.3848
Site10-Fortessa,22,Site10,Fortessa,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.1,,2366.137161,26072.0,8579.0,223249.4908
Site10-Fortessa,22,Site10,Fortessa,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.1,,2342.530464,25458.0,8366.0,217991.9276
Site10-Fortessa,22,Site10,Fortessa,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.7,,1508.902809,97427.0,13239.0,26698259.52
Site10-Fortessa,22,Site10,Fortessa,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,1529.639935,101078.0,13530.0,27698755.74
Site10-Fortessa,22,Site10,Fortessa,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.5,,1511.233687,92766.0,12863.0,25420989.48
Site10-Fortessa,22,Site10,Fortessa,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,4167.520545,26072.0,13228.0,5742896.631
Site10-Fortessa,22,Site10,Fortessa,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,4167.520545,26259.0,12605.0,5784087.244
Site10-Fortessa,22,Site10,Fortessa,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,4167.520545,25398.0,12262.0,5594434.207
Site10-Fortessa,22,Site10,Fortessa,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,813.0743178,61196.0,5329.0,3274868.013
Site10-Fortessa,22,Site10,Fortessa,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.1,,831.3774211,62428.0,5211.0,3340797.769
Site10-Fortessa,22,Site10,Fortessa,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.1,,821.2455363,59839.0,5454.0,3202248.954
Site10-Fortessa,22,Site10,Fortessa,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29.2,,965.2194035,1093.0,257.0,273721.7876
Site10-Fortessa,22,Site10,Fortessa,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.4,,992.454335,976.0,236.0,244421.2851
Site10-Fortessa,22,Site10,Fortessa,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,29.6,,988.5691409,837.0,214.0,209611.2865
Site10-Fortessa,22,Site10,Fortessa,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82,,675.2418496,8873.0,2032.0,82198.0483
Site10-Fortessa,22,Site10,Fortessa,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.9,,632.492723,8775.0,2024.0,81104.91523
Site10-Fortessa,22,Site10,Fortessa,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.4,,643.8706904,7126.0,1695.0,66014.12061
Site10-Fortessa,22,Site10,Fortessa,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.4,,509.3723361,4142.0,454.0,38370.8234
Site10-Fortessa,22,Site10,Fortessa,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.6,,526.9459921,4074.0,480.0,37740.88231
Site10-Fortessa,22,Site10,Fortessa,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.8,,530.1537059,3532.0,441.0,32719.88128
Site10-Fortessa,22,Site10,Fortessa,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.5,,2335.897618,26134.0,8579.0,223780.3848
Site10-Fortessa,22,Site10,Fortessa,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.2,,2371.650796,26072.0,8596.0,223249.4908
Site10-Fortessa,22,Site10,Fortessa,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.1,,2347.26046,25458.0,8366.0,217991.9276
Site10-Fortessa,22,Site10,Fortessa,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.9,,1515.176833,97427.0,13207.0,26698259.52
Site10-Fortessa,22,Site10,Fortessa,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,1532.790584,100831.0,13640.0,27631069.47
Site10-Fortessa,22,Site10,Fortessa,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.6,,1516.357849,92766.0,12964.0,25420989.48
Site10-Fortessa,22,Site10,Fortessa,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,4167.520545,26072.0,13228.0,5742896.631
Site10-Fortessa,22,Site10,Fortessa,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,4167.520545,26259.0,12605.0,5784087.244
Site10-Fortessa,22,Site10,Fortessa,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,4167.520545,25398.0,12262.0,5594434.207
Site10-Fortessa,22,Site10,Fortessa,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,814.4467606,61231.0,5363.0,3276741.017
Site10-Fortessa,22,Site10,Fortessa,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.2,,835.709563,62284.0,5318.0,3333091.694
Site10-Fortessa,22,Site10,Fortessa,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.1,,824.2017837,59904.0,5404.0,3205727.391
Site10-Fortessa,22,Site10,Fortessa,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,18.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site10-Fortessa,22,Site10,Fortessa,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,29.2,,966.7879096,1093.0,257.0,273721.7876
Site10-Fortessa,22,Site10,Fortessa,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,29.4,,992.454335,976.0,236.0,244421.2851
Site10-Fortessa,22,Site10,Fortessa,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,29.6,,989.948723,837.0,215.0,209611.2865
Site11-BRZE5,23,Site11,BRZE5,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,79.87,,443.6514741,26053.39,8112.01,110625.5455
Site11-BRZE5,23,Site11,BRZE5,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,81.58,,438.1571492,26012.5,7954.84,110451.9221
Site11-BRZE5,23,Site11,BRZE5,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.44,,429.3997256,25670.75,8235.44,109000.8142
Site11-BRZE5,23,Site11,BRZE5,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.1,,433.7258009,6500.9,2496.36,27603.53293
Site11-BRZE5,23,Site11,BRZE5,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.5,,453.4969705,6685.55,2506.32,28387.57704
Site11-BRZE5,23,Site11,BRZE5,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.83,,425.7240985,6570.21,2485.16,27897.83077
Site11-BRZE5,23,Site11,BRZE5,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,62.53,,2444.131738,6056.08,2494.68,64429.40245
Site11-BRZE5,23,Site11,BRZE5,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.62,,2430.029344,6059.51,2509.15,64465.89352
Site11-BRZE5,23,Site11,BRZE5,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,62.31,,2450.273896,6033.61,2505.33,64190.34869
Site11-BRZE5,23,Site11,BRZE5,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.51,,818.9986442,35430.54,11341.86,8459856.607
Site11-BRZE5,23,Site11,BRZE5,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,32.94,,800.3353714,35597.45,11145.38,8499710.21
Site11-BRZE5,23,Site11,BRZE5,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,32.65,,800.1335605,35127.28,10901.36,8387446.305
Site11-BRZE5,23,Site11,BRZE5,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.09,,4684.983075,6428.0,1963.3,4093585.848
Site11-BRZE5,23,Site11,BRZE5,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.84,,4684.983075,6399.67,1937.27,4075544.266
Site11-BRZE5,23,Site11,BRZE5,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.71,,4684.983075,6401.94,1948.46,4076989.886
Site11-BRZE5,23,Site11,BRZE5,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.9,,1244.170082,10211.33,7757.29,861685.0589
Site11-BRZE5,23,Site11,BRZE5,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.23,,1244.974135,10135.24,7536.92,855264.1895
Site11-BRZE5,23,Site11,BRZE5,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,51.49,,1261.749076,10314.65,7669.44,870403.7371
Site11-BRZE5,23,Site11,BRZE5,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,78.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,78.85,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,11.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,11.54,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.04,,744.033691,37621.12,44488.64,4719054.101
Site11-BRZE5,23,Site11,BRZE5,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.53,,770.3038902,35681.08,42644.87,4475702.661
Site11-BRZE5,23,Site11,BRZE5,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.67,,773.4672465,36496.73,43098.15,4578014.78
Site11-BRZE5,23,Site11,BRZE5,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.47,,632.6679576,26054.36,8321.39,110629.6642
Site11-BRZE5,23,Site11,BRZE5,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.61,,616.8655126,26082.94,8226.29,110751.018
Site11-BRZE5,23,Site11,BRZE5,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,72.9,,609.6672269,25639.17,8484.45,108866.722
Site11-BRZE5,23,Site11,BRZE5,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.61,,660.0012438,6864.5,2722.93,29147.41832
Site11-BRZE5,23,Site11,BRZE5,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.98,,687.4537221,7050.46,2658.73,29937.02484
Site11-BRZE5,23,Site11,BRZE5,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.15,,637.9735911,6962.81,2660.14,29564.85334
Site11-BRZE5,23,Site11,BRZE5,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,62.01,,3524.920117,6073.62,2468.36,64616.00694
Site11-BRZE5,23,Site11,BRZE5,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.15,,3510.012185,6076.17,2474.55,64643.13587
Site11-BRZE5,23,Site11,BRZE5,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,61.93,,3544.777904,6052.11,2486.37,64387.16642
Site11-BRZE5,23,Site11,BRZE5,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.43,,1178.455112,35790.65,11246.12,8545841.155
Site11-BRZE5,23,Site11,BRZE5,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,32.95,,1156.568952,35892.54,11003.85,8570169.737
Site11-BRZE5,23,Site11,BRZE5,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,32.68,,1158.400143,35372.4,10815.66,8445974.344
Site11-BRZE5,23,Site11,BRZE5,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,90.85,,6909.561905,6406.96,1937.41,4080186.805
Site11-BRZE5,23,Site11,BRZE5,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.81,,6909.561905,6385.44,1910.27,4066482.081
Site11-BRZE5,23,Site11,BRZE5,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,91.46,,6909.561905,6387.09,1921.6,4067532.862
Site11-BRZE5,23,Site11,BRZE5,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.81,,1790.915962,10517.67,7695.71,887535.6191
Site11-BRZE5,23,Site11,BRZE5,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.23,,1798.113396,10472.12,7479.24,883691.8735
Site11-BRZE5,23,Site11,BRZE5,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,51.48,,1824.680098,10618.7,7632.06,896061.0552
Site11-BRZE5,23,Site11,BRZE5,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.87,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,74.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.06,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,12.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,18.36,,1043.741059,40982.06,46033.86,5140637.98
Site11-BRZE5,23,Site11,BRZE5,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.67,,1071.539796,39530.87,44749.06,4958606.075
Site11-BRZE5,23,Site11,BRZE5,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.61,,1065.270044,39992.76,44677.3,5016543.848
Site11-BRZE5,23,Site11,BRZE5,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.49,,629.9469028,25924.25,8302.78,110077.2029
Site11-BRZE5,23,Site11,BRZE5,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.75,,614.8278607,25938.64,8203.82,110138.3044
Site11-BRZE5,23,Site11,BRZE5,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,72.96,,607.5763045,25523.05,8458.37,108373.6638
Site11-BRZE5,23,Site11,BRZE5,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.55,,651.652428,6790.28,2702.46,28832.27208
Site11-BRZE5,23,Site11,BRZE5,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.96,,681.170776,6973.06,2641.65,29608.37597
Site11-BRZE5,23,Site11,BRZE5,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.12,,631.5212609,6885.03,2629.93,29234.59095
Site11-BRZE5,23,Site11,BRZE5,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.89,,3490.598861,40768.7,45603.3,433729.9011
Site11-BRZE5,23,Site11,BRZE5,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.03,,3474.88492,6106.75,2473.76,64968.47026
Site11-BRZE5,23,Site11,BRZE5,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,61.82,,3511.171923,6085.83,2484.43,64745.90664
Site11-BRZE5,23,Site11,BRZE5,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.79,,1179.301093,45603.3,11258.2,10888837.11
Site11-BRZE5,23,Site11,BRZE5,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.3,,1157.183882,35855.79,11036.29,8561394.829
Site11-BRZE5,23,Site11,BRZE5,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.07,,1161.222527,35354.0,10844.38,8441580.921
Site11-BRZE5,23,Site11,BRZE5,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,90.84,,6851.061905,6485.16,1961.88,4129987.43
Site11-BRZE5,23,Site11,BRZE5,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.82,,6851.061905,6462.08,1932.41,4115289.24
Site11-BRZE5,23,Site11,BRZE5,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,91.44,,6851.061905,6467.32,1946.31,4118626.264
Site11-BRZE5,23,Site11,BRZE5,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,50.52,,1763.306256,10477.52,7597.83,884147.5535
Site11-BRZE5,23,Site11,BRZE5,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,50.97,,1771.044018,10420.1,7396.18,879302.1557
Site11-BRZE5,23,Site11,BRZE5,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,51.26,,1799.754699,10581.92,7550.99,892957.3677
Site11-BRZE5,23,Site11,BRZE5,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,74.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.85,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,12.16,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.81,,1004.586215,40768.7,45603.3,5113874.891
Site11-BRZE5,23,Site11,BRZE5,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.04,,1026.971126,39528.56,44632.98,4958316.318
Site11-BRZE5,23,Site11,BRZE5,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.97,,1020.465013,39805.3,44341.47,4993029.559
Site11-BRZE5,23,Site11,BRZE5,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,38.23,,4489.093069,,,
Site11-BRZE5,23,Site11,BRZE5,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,32.54,,4898.607309,,,
Site11-BRZE5,23,Site11,BRZE5,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.64,,831.5394552,18202.19,4585.7,77288.49098
Site11-BRZE5,23,Site11,BRZE5,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,83.72,,736.5286396,20800.3,5459.58,88320.35041
Site11-BRZE5,23,Site11,BRZE5,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.63,,710.7470383,20463.93,5305.05,86892.08657
Site11-BRZE5,23,Site11,BRZE5,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.07,,297.5496149,6443.63,2233.03,27360.35824
Site11-BRZE5,23,Site11,BRZE5,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.02,,334.5520854,6791.26,2332.2,28836.43327
Site11-BRZE5,23,Site11,BRZE5,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.44,,322.0891693,6747.22,2355.63,28649.43461
Site11-BRZE5,23,Site11,BRZE5,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.82,,1957.026673,8072.86,2983.67,85885.51436
Site11-BRZE5,23,Site11,BRZE5,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.07,,1978.800569,9136.74,3400.75,97203.91714
Site11-BRZE5,23,Site11,BRZE5,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.25,,2005.231881,9023.25,3340.73,95996.52013
Site11-BRZE5,23,Site11,BRZE5,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.07,,1390.803309,41342.78,11057.71,9871539.935
Site11-BRZE5,23,Site11,BRZE5,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.38,,1412.566532,41900.56,10958.7,10004722.74
Site11-BRZE5,23,Site11,BRZE5,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,70.91,,1421.914637,41337.43,10950.99,9870262.5
Site11-BRZE5,23,Site11,BRZE5,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.19,,3806.852459,6546.78,1482.51,4169229.303
Site11-BRZE5,23,Site11,BRZE5,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.17,,3806.852459,6773.95,1513.65,4313899.48
Site11-BRZE5,23,Site11,BRZE5,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.92,,3806.852459,6718.0,1495.57,4278268.47
Site11-BRZE5,23,Site11,BRZE5,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.73,,483.9302005,15649.54,5244.99,1320589.462
Site11-BRZE5,23,Site11,BRZE5,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.25,,499.5866231,16992.87,5485.8,1433946.625
Site11-BRZE5,23,Site11,BRZE5,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.62,,513.6844614,16735.98,5447.73,1412268.912
Site11-BRZE5,23,Site11,BRZE5,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,67.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.48,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.91,,293.1541343,67590.94,61467.63,8478357.439
Site11-BRZE5,23,Site11,BRZE5,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.26,,313.4520521,84161.35,66838.3,10556888.36
Site11-BRZE5,23,Site11,BRZE5,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.07,,311.6953199,79286.3,68055.39,9945380.127
Site11-BRZE5,23,Site11,BRZE5,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.71,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.72,,778.9995784,18450.11,4673.37,78341.18644
Site11-BRZE5,23,Site11,BRZE5,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,84.72,,695.659563,18450.11,4673.37,78341.18644
Site11-BRZE5,23,Site11,BRZE5,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.8,,664.8609946,20750.92,5390.74,88110.67752
Site11-BRZE5,23,Site11,BRZE5,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.8,,307.7307766,6686.53,2273.06,28391.73823
Site11-BRZE5,23,Site11,BRZE5,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.8,,346.3202128,6686.53,2273.06,28391.73823
Site11-BRZE5,23,Site11,BRZE5,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.19,,333.9790375,7078.66,2418.73,30056.76512
Site11-BRZE5,23,Site11,BRZE5,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.12,,1998.008046,8090.22,2979.54,86070.20387
Site11-BRZE5,23,Site11,BRZE5,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.12,,2016.657948,8090.22,2979.54,86070.20387
Site11-BRZE5,23,Site11,BRZE5,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68.65,,2048.434259,9034.82,3341.32,96119.611
Site11-BRZE5,23,Site11,BRZE5,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.06,,1419.763725,41490.8,10922.5,9906883.116
Site11-BRZE5,23,Site11,BRZE5,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.06,,1437.549667,41490.8,10922.5,9906883.116
Site11-BRZE5,23,Site11,BRZE5,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,70.75,,1449.307216,41455.83,10778.67,9898533.224
Site11-BRZE5,23,Site11,BRZE5,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.69,,3975.197503,6522.52,1475.74,4153779.646
Site11-BRZE5,23,Site11,BRZE5,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.69,,3975.197503,6522.52,1475.74,4153779.646
Site11-BRZE5,23,Site11,BRZE5,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.83,,3975.197503,6689.59,1482.19,4260175.942
Site11-BRZE5,23,Site11,BRZE5,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.43,,488.0517875,15797.08,5182.86,1333039.654
Site11-BRZE5,23,Site11,BRZE5,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.43,,506.4602895,15797.08,5182.56,1333039.654
Site11-BRZE5,23,Site11,BRZE5,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.43,,520.8783588,16856.08,5391.79,1422403.574
Site11-BRZE5,23,Site11,BRZE5,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.35,,294.9193371,74185.05,59142.3,9305498.2
Site11-BRZE5,23,Site11,BRZE5,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.35,,317.5126107,74185.05,59142.3,9305498.2
Site11-BRZE5,23,Site11,BRZE5,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.53,,314.0692349,86588.82,64830.18,10861381.22
Site11-BRZE5,23,Site11,BRZE5,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.35,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.66,,773.4632598,18309.69,4644.38,77744.94775
Site11-BRZE5,23,Site11,BRZE5,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,84.66,,692.9819521,18309.69,4644.38,77744.94775
Site11-BRZE5,23,Site11,BRZE5,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.86,,662.3244177,20616.99,5358.5,87541.99608
Site11-BRZE5,23,Site11,BRZE5,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.69,,303.4090648,6605.53,2250.02,28047.80336
Site11-BRZE5,23,Site11,BRZE5,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.69,,342.4685885,6605.53,2250.02,28047.80336
Site11-BRZE5,23,Site11,BRZE5,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.12,,330.5623345,7008.3,2394.18,29758.00886
Site11-BRZE5,23,Site11,BRZE5,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.12,,1991.058139,8132.83,2985.79,86523.52299
Site11-BRZE5,23,Site11,BRZE5,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.12,,2006.165782,8132.83,2985.79,86523.52299
Site11-BRZE5,23,Site11,BRZE5,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68.57,,2038.499302,9075.49,3340.13,96552.29086
Site11-BRZE5,23,Site11,BRZE5,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70.12,,1418.718312,41480.04,10947.35,9904313.918
Site11-BRZE5,23,Site11,BRZE5,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.25,,503.2383902,41480.04,10947.35,9904313.918
Site11-BRZE5,23,Site11,BRZE5,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.24,,1452.327353,41439.14,10808.75,9894548.102
Site11-BRZE5,23,Site11,BRZE5,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,95.7,,3957.023735,6581.32,1497.98,4191225.64
Site11-BRZE5,23,Site11,BRZE5,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,95.7,,3957.023735,6581.32,1497.98,4191225.64
Site11-BRZE5,23,Site11,BRZE5,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.84,,3957.023735,6758.29,1504.55,4303926.618
Site11-BRZE5,23,Site11,BRZE5,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.33,,484.4201546,15642.02,5141.21,1319954.886
Site11-BRZE5,23,Site11,BRZE5,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.33,,342.4685885,15642.02,5141.21,1319954.886
Site11-BRZE5,23,Site11,BRZE5,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.39,,517.533695,16689.42,5342.76,1408339.938
Site11-BRZE5,23,Site11,BRZE5,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.63,,273.3363229,72561.25,58196.14,9101814.736
Site11-BRZE5,23,Site11,BRZE5,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.63,,320.7854057,72561.25,58196.14,9101814.736
Site11-BRZE5,23,Site11,BRZE5,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.7,,317.9965457,84784.11,64724.04,10635005.07
Site11-BRZE5,23,Site11,BRZE5,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,27.84,,3779.669275,,,
Site11-BRZE5,23,Site11,BRZE5,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,38.11,,3834.627883,,,
Site11-BRZE5,23,Site11,BRZE5,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,83.13,,553.7695889,23731.83,6710.1,100767.9476
Site11-BRZE5,23,Site11,BRZE5,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,84.93,,626.2754285,23782.02,6507.28,100981.0599
Site11-BRZE5,23,Site11,BRZE5,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.02,,602.129326,23532.71,6632.03,99922.46233
Site11-BRZE5,23,Site11,BRZE5,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.89,,200.9472669,7374.25,2716.55,31311.87262
Site11-BRZE5,23,Site11,BRZE5,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.76,,192.201224,7300.22,2697.76,30997.53313
Site11-BRZE5,23,Site11,BRZE5,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.87,,196.2452445,7349.35,2685.05,31206.14449
Site11-BRZE5,23,Site11,BRZE5,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,73.74,,1879.142803,8094.58,2997.19,86116.58902
Site11-BRZE5,23,Site11,BRZE5,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.6,,1823.934249,8031.59,2923.22,85446.45123
Site11-BRZE5,23,Site11,BRZE5,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,74.3,,1852.444995,8078.37,2949.38,85944.13413
Site11-BRZE5,23,Site11,BRZE5,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,57.06,,1072.177541,41315.05,11744.66,9864918.76
Site11-BRZE5,23,Site11,BRZE5,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,57.65,,1051.490976,41380.29,11830.79,9880496.311
Site11-BRZE5,23,Site11,BRZE5,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.99,,1074.240222,41515.96,11930.43,9912890.645
Site11-BRZE5,23,Site11,BRZE5,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.11,,3339.133747,6940.84,1814.07,4420181.145
Site11-BRZE5,23,Site11,BRZE5,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.23,,3339.133747,6863.38,1779.56,4370851.779
Site11-BRZE5,23,Site11,BRZE5,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.2,,3339.133747,6861.78,1775.76,4369832.841
Site11-BRZE5,23,Site11,BRZE5,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.74,,652.760998,15882.2,7135.49,1340222.522
Site11-BRZE5,23,Site11,BRZE5,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.03,,620.6860377,15826.43,7095.81,1335516.359
Site11-BRZE5,23,Site11,BRZE5,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.23,,634.0516034,16182.68,7074.39,1365578.585
Site11-BRZE5,23,Site11,BRZE5,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,68.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.08,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.06,,256.4777419,82693.48,58331.25,
Site11-BRZE5,23,Site11,BRZE5,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.23,,253.4208731,81441.2,57613.14,10215682.81
Site11-BRZE5,23,Site11,BRZE5,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.36,,258.3957482,85332.22,57507.68,10703757.96
Site11-BRZE5,23,Site11,BRZE5,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,80.36,,637.8803908,23870.52,6718.12,101356.8406
Site11-BRZE5,23,Site11,BRZE5,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.2,,725.927865,23893.35,6545.41,101453.7792
Site11-BRZE5,23,Site11,BRZE5,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.93,,694.5460059,23763.35,6670.6,100901.785
Site11-BRZE5,23,Site11,BRZE5,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.02,,260.6256291,7476.48,2794.99,31745.95239
Site11-BRZE5,23,Site11,BRZE5,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.86,,247.7542199,7427.54,2742.01,31538.14779
Site11-BRZE5,23,Site11,BRZE5,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.08,,255.9733787,7483.94,2738.06,31777.62836
Site11-BRZE5,23,Site11,BRZE5,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.92,,2335.79447,8098.14,2994.95,86154.46314
Site11-BRZE5,23,Site11,BRZE5,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.73,,2262.324055,8042.45,2920.69,85561.98856
Site11-BRZE5,23,Site11,BRZE5,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.46,,2296.001613,8068.72,2951.96,85841.46975
Site11-BRZE5,23,Site11,BRZE5,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,56.98,,1331.030812,41522.1,11706.61,9914356.711
Site11-BRZE5,23,Site11,BRZE5,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,57.71,,1305.510059,41537.12,11774.4,9917943.082
Site11-BRZE5,23,Site11,BRZE5,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.82,,1327.556734,41654.25,11886.82,9945910.564
Site11-BRZE5,23,Site11,BRZE5,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,94.34,,4190.819968,6916.96,1807.47,4404973.486
Site11-BRZE5,23,Site11,BRZE5,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94.74,,4190.819968,6843.56,1773.01,4358229.677
Site11-BRZE5,23,Site11,BRZE5,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,94.49,,4190.819968,6838.46,1768.01,4354981.811
Site11-BRZE5,23,Site11,BRZE5,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.37,,802.8875285,16116.4,7028.98,1359985.534
Site11-BRZE5,23,Site11,BRZE5,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.72,,762.9309845,16050.5,7027.72,1354424.55
Site11-BRZE5,23,Site11,BRZE5,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.01,,780.9629396,16402.5,6993.51,1384128.138
Site11-BRZE5,23,Site11,BRZE5,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.24,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.23,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.74,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.33,,335.6349565,85108.68,59651.88,10675717.93
Site11-BRZE5,23,Site11,BRZE5,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.42,,328.7610491,83491.87,58991.03,10472911.27
Site11-BRZE5,23,Site11,BRZE5,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.67,,338.0427113,87645.26,58231.83,10993897.14
Site11-BRZE5,23,Site11,BRZE5,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,80.36,,635.7221398,23739.16,6708.15,100799.0716
Site11-BRZE5,23,Site11,BRZE5,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.26,,723.9206938,23771.24,6523.98,100935.2868
Site11-BRZE5,23,Site11,BRZE5,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.91,,691.8126538,23617.35,6640.68,100281.853
Site11-BRZE5,23,Site11,BRZE5,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.94,,256.7905403,7411.54,2735.39,31470.21004
Site11-BRZE5,23,Site11,BRZE5,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.77,,243.882733,7399.15,2700.72,31417.60074
Site11-BRZE5,23,Site11,BRZE5,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.98,,251.7869293,7421.96,2710.95,31514.4545
Site11-BRZE5,23,Site11,BRZE5,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.84,,2323.221944,8137.81,2998.24,86576.50419
Site11-BRZE5,23,Site11,BRZE5,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.65,,2250.302847,8082.05,2919.39,85983.2849
Site11-BRZE5,23,Site11,BRZE5,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.39,,2283.790309,8111.36,2949.8,86295.10803
Site11-BRZE5,23,Site11,BRZE5,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,56.95,,1323.083325,41607.28,11668.69,9934695.396
Site11-BRZE5,23,Site11,BRZE5,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,57.69,,758.9609335,41606.82,11738.56,9934585.56
Site11-BRZE5,23,Site11,BRZE5,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.89,,1322.081846,41700.59,11860.17,9956975.305
Site11-BRZE5,23,Site11,BRZE5,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,94.33,,4170.388073,6996.36,1823.22,4455538.314
Site11-BRZE5,23,Site11,BRZE5,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,94.73,,4170.388073,6926.46,1789.93,4411023.434
Site11-BRZE5,23,Site11,BRZE5,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,94.48,,4170.388073,6919.82,1783.24,4406794.839
Site11-BRZE5,23,Site11,BRZE5,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.39,,798.9336319,15963.78,6941.82,1347106.666
Site11-BRZE5,23,Site11,BRZE5,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.73,,243.882733,15917.0,6951.37,1343159.126
Site11-BRZE5,23,Site11,BRZE5,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.99,,776.2762097,16268.4,6887.33,1372812.083
Site11-BRZE5,23,Site11,BRZE5,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,6.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.26,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.21,,330.2357117,84911.52,58970.11,10650986.91
Site11-BRZE5,23,Site11,BRZE5,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.32,,324.1555255,83242.79,58401.24,10441667.59
Site11-BRZE5,23,Site11,BRZE5,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.58,,333.7112328,87179.24,57265.8,10935441.32
Site11-BRZE5,23,Site11,BRZE5,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,29.74,,3546.468769,,,
Site11-BRZE5,23,Site11,BRZE5,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,36.65,,3153.226307,,,
Site11-BRZE5,23,Site11,BRZE5,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1917.853908,,,
Site11-BRZE5,23,Site11,BRZE5,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-BRZE5,23,Site11,BRZE5,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,16.14,,309.5525984,14511.76,3050.22,61618.52128
Site11-BRZE5,23,Site11,BRZE5,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.12,,117.4107042,7739.87,957.05,32864.33515
Site11-BRZE5,23,Site11,BRZE5,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,53.44,,1024.980985,17695.51,7398.5,188258.9291
Site11-BRZE5,23,Site11,BRZE5,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.45,,660.6075769,114628.75,26256.61,27370251.43
Site11-BRZE5,23,Site11,BRZE5,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1917.853908,8146.36,2736.14,5187900.437
Site11-BRZE5,23,Site11,BRZE5,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-BRZE5,23,Site11,BRZE5,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-BRZE5,23,Site11,BRZE5,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.91,,357.8487231,39233.86,4431.02,3310756.871
Site11-BRZE5,23,Site11,BRZE5,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,21.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,10.07,,193.1508662,392.52,187.32,49236.25654
Site11-BRZE5,23,Site11,BRZE5,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,16.4,,295.4679908,14628.95,3023.16,62116.12285
Site11-BRZE5,23,Site11,BRZE5,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.47,,115.402303,7997.69,967.3,33959.06709
Site11-BRZE5,23,Site11,BRZE5,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,54.89,,988.9983932,17759.46,7273.11,188939.2801
Site11-BRZE5,23,Site11,BRZE5,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.97,,632.6437007,115607.52,25571.03,27603955.29
Site11-BRZE5,23,Site11,BRZE5,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1801.806304,8190.36,2484.86,5215921.249
Site11-BRZE5,23,Site11,BRZE5,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-BRZE5,23,Site11,BRZE5,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-BRZE5,23,Site11,BRZE5,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.14,,347.5533785,39439.06,4423.05,3328072.713
Site11-BRZE5,23,Site11,BRZE5,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.24,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,10.68,,192.4466407,371.57,183.09,46608.36606
Site11-BRZE5,23,Site11,BRZE5,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,16.4,,295.6137815,14584.92,3017.0,61929.16665
Site11-BRZE5,23,Site11,BRZE5,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.46,,115.5064626,7810.64,950.82,33164.83232
Site11-BRZE5,23,Site11,BRZE5,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,54.86,,988.5211875,17840.71,7311.16,189803.6823
Site11-BRZE5,23,Site11,BRZE5,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.04,,633.0030024,115572.08,25605.96,27595493.17
Site11-BRZE5,23,Site11,BRZE5,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1802.058459,8273.17,2490.43,5268657.69
Site11-BRZE5,23,Site11,BRZE5,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-BRZE5,23,Site11,BRZE5,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-BRZE5,23,Site11,BRZE5,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.17,,347.6360268,39214.17,4400.19,3309095.327
Site11-BRZE5,23,Site11,BRZE5,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-BRZE5,23,Site11,BRZE5,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,20.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-BRZE5,23,Site11,BRZE5,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,22,,396.4068817,126.08,165.82,15815.00873
Site11-BRZE5,23,Site11,BRZE5,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-BRZE5,23,Site11,BRZE5,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,80.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.36,,457.5680359,8710.55,2809.61,108824.4252
Site11-CantoII,24,Site11,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.5,,488.6226611,8548.71,2668.65,106802.4926
Site11-CantoII,24,Site11,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,74.75,,521.4026598,8486.53,2542.65,106025.6527
Site11-CantoII,24,Site11,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.27,,478.8148076,2020.1,38.66,25237.92658
Site11-CantoII,24,Site11,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.79,,495.8366783,2063.65,37.63,25782.01435
Site11-CantoII,24,Site11,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.55,,488.5991812,2018.25,38.6,25214.81378
Site11-CantoII,24,Site11,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.61,,2483.127493,9202.13,3625.26,59817.12835
Site11-CantoII,24,Site11,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63.9,,2464.958569,9199.7,3603.46,59801.33249
Site11-CantoII,24,Site11,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.26,,2539.984519,9188.98,3579.04,59731.64866
Site11-CantoII,24,Site11,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,31.5,,782.1658449,16035.7,4302.58,5801303.31
Site11-CantoII,24,Site11,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,31.43,,784.6005799,15993.23,4195.39,5785938.758
Site11-CantoII,24,Site11,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,34.35,,872.389725,16054.59,4166.83,5808137.226
Site11-CantoII,24,Site11,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.78,,5036.908126,33401.02,10066.85,4606098.789
Site11-CantoII,24,Site11,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.24,,5037.54512,33482.05,10088.19,4617273.064
Site11-CantoII,24,Site11,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.76,,5036.908126,32930.74,9558.97,4541245.795
Site11-CantoII,24,Site11,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,54.86,,1362.131551,9262.62,6750.55,90782.02795
Site11-CantoII,24,Site11,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,54.58,,1345.261808,9342.16,6658.36,91561.59167
Site11-CantoII,24,Site11,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,52.43,,1331.638425,9348.99,6592.19,91628.53182
Site11-CantoII,24,Site11,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,70.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,61.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.22,Not reportable,Not reportable,Not reportable,Not reportable,3847546.477
Site11-CantoII,24,Site11,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,12.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.85,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.64,,766.7136473,18435.15,20828.97,3847546.477
Site11-CantoII,24,Site11,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.1,,740.1988118,18479.0,21060.71,3856698.282
Site11-CantoII,24,Site11,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.06,,702.7866003,18477.42,20506.27,3856368.525
Site11-CantoII,24,Site11,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,89.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,80.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,82.23,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,73.96,,459.4995955,8920.19,2822.21,111443.5425
Site11-CantoII,24,Site11,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.29,,495.4556809,8735.09,2682.18,109131.0134
Site11-CantoII,24,Site11,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,75.74,,525.5969687,8676.4,2559.61,108397.7754
Site11-CantoII,24,Site11,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.67,,488.3970145,2063.65,37.63,25782.01435
Site11-CantoII,24,Site11,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.12,,506.3833343,2201.65,36.38,27506.10418
Site11-CantoII,24,Site11,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.86,,498.4481525,2153.34,36.83,26902.54781
Site11-CantoII,24,Site11,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.59,,2463.428387,9265.09,3621.32,60226.39082
Site11-CantoII,24,Site11,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64,,2470.989849,9261.44,3603.01,60202.66452
Site11-CantoII,24,Site11,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.66,,2544.481667,9254.19,3579.86,60155.53693
Site11-CantoII,24,Site11,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,31.83,,774.2057628,21920.02,5303.17,7930098.754
Site11-CantoII,24,Site11,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,31.82,,786.3786796,21932.26,21932.26,7934526.871
Site11-CantoII,24,Site11,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,34.28,,872.2585578,21857.9,5110.92,7907625.338
Site11-CantoII,24,Site11,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.75,,5037.54512,35141.59,10643.31,4846128.506
Site11-CantoII,24,Site11,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.28,,5037.54512,35290.56,10593.81,4866671.906
Site11-CantoII,24,Site11,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.42,,5037.54512,34718.07,10024.29,4787723.853
Site11-CantoII,24,Site11,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,51.89,,1278.225764,10988.72,6465.82,107699.3643
Site11-CantoII,24,Site11,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.38,,1269.669614,11099.28,6314.45,108782.952
Site11-CantoII,24,Site11,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,49.27,,1253.576022,11030.26,6277.75,108106.4938
Site11-CantoII,24,Site11,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,61.16,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,13.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,13.06,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.78,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.1,,736.322574,18716.81,20690.45,3906330.915
Site11-CantoII,24,Site11,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.53,,715.4520237,18892.55,20981.21,3943009.099
Site11-CantoII,24,Site11,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.54,,679.6459336,18752.07,20391.05,3913689.927
Site11-CantoII,24,Site11,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,80.87,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,80.35,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,82.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,75.57,,463.4443093,8921.93,2830.83,111465.2811
Site11-CantoII,24,Site11,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.31,,495.5432124,8744.66,2685.36,109250.5752
Site11-CantoII,24,Site11,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,75.79,,525.9100974,8685.03,2563.31,108505.5935
Site11-CantoII,24,Site11,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.68,,492.4610267,2018.25,38.6,25214.81378
Site11-CantoII,24,Site11,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.13,,506.9859618,2207.38,36.41,27577.69139
Site11-CantoII,24,Site11,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.87,,498.5553681,2160.46,36.83,26991.50085
Site11-CantoII,24,Site11,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63.9,,2482.472781,9264.13,3621.39,60220.15048
Site11-CantoII,24,Site11,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64.01,,2470.809177,9260.4,3602.58,60195.90415
Site11-CantoII,24,Site11,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.67,,2544.606854,9253.66,3580.67,60152.09174
Site11-CantoII,24,Site11,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,31.22,,774.9109887,21970.39,5287.03,7948321.323
Site11-CantoII,24,Site11,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,31.65,,782.1273876,21967.43,5208.65,7947250.471
Site11-CantoII,24,Site11,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,34.08,,867.2271904,21915.51,5118.33,7928467.152
Site11-CantoII,24,Site11,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.26,,5036.046809,35185.22,10655.67,4852145.211
Site11-CantoII,24,Site11,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.28,,5036.046809,35337.64,10604.09,4873164.377
Site11-CantoII,24,Site11,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.43,,5036.046809,34766.29,10039.21,4794373.533
Site11-CantoII,24,Site11,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,51.73,,1284.14409,10958.19,6437.7,107400.1428
Site11-CantoII,24,Site11,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.21,,1265.403148,11073.28,6291.24,108528.1286
Site11-CantoII,24,Site11,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,49.09,,1249.062191,10998.57,6235.32,107795.9032
Site11-CantoII,24,Site11,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,61.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,13.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.78,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.16,,744.453725,18828.28,20801.99,3929595.494
Site11-CantoII,24,Site11,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.62,,718.9345461,19004.92,21081.33,3966461.514
Site11-CantoII,24,Site11,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.63,,683.2512099,18917.27,20552.98,3948168.338
Site11-CantoII,24,Site11,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,77.84,,4815.535411,,,
Site11-CantoII,24,Site11,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,78.09,,5405.247281,,,
Site11-CantoII,24,Site11,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.14,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85.92,,715.9602194,6662.25,1786.15,83234.18462
Site11-CantoII,24,Site11,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86.82,,756.6256788,6422.68,1681.99,80241.13969
Site11-CantoII,24,Site11,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.74,,792.240724,6349.63,1604.77,79328.49649
Site11-CantoII,24,Site11,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.94,,129.900266,2010.76,35.86,25121.23818
Site11-CantoII,24,Site11,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.9,,258.6905553,2047.24,34.76,25576.99758
Site11-CantoII,24,Site11,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.62,,246.3096219,2039.13,35.84,25475.67607
Site11-CantoII,24,Site11,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.73,,2149.058224,13555.33,4771.85,88114.48159
Site11-CantoII,24,Site11,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,77.5,,2025.181699,13392.97,4750.86,87059.08366
Site11-CantoII,24,Site11,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77.6,,1987.633968,13378.57,4767.89,86965.47852
Site11-CantoII,24,Site11,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.96,,1589.346313,18755.56,3836.6,6785278.617
Site11-CantoII,24,Site11,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.04,,1479.22088,18719.68,3921.49,6772298.157
Site11-CantoII,24,Site11,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.25,,1455.914452,18796.88,3824.65,6800227.129
Site11-CantoII,24,Site11,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.87,,3634.337129,35016.25,7286.96,4828843.751
Site11-CantoII,24,Site11,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.78,,3634.337129,34856.67,7202.77,4806837.201
Site11-CantoII,24,Site11,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.79,,3634.337129,34697.58,7219.5,4784898.222
Site11-CantoII,24,Site11,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.4,,524.4585242,14882.4,4478.18,145860.9392
Site11-CantoII,24,Site11,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.3,,512.4459547,15040.9,4481.21,147414.3821
Site11-CantoII,24,Site11,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.05,,497.9946107,14915.0,4476.02,146180.4486
Site11-CantoII,24,Site11,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,68.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.98,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.93,,287.3261407,44618.48,35289.54,9312193.04
Site11-CantoII,24,Site11,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.09,,2613.201831,43485.68,34876.64,9075769.65
Site11-CantoII,24,Site11,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.3,,263.8347908,43938.43,33383.72,9170261.784
Site11-CantoII,24,Site11,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.29,,738.6842886,6830.27,1836.46,85333.32646
Site11-CantoII,24,Site11,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.24,,783.0597485,6601.28,1728.67,82472.46175
Site11-CantoII,24,Site11,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.38,,821.534221,6513.72,1664.39,81771.08201
Site11-CantoII,24,Site11,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.04,,133.2604683,2150.81,34.43,26870.93949
Site11-CantoII,24,Site11,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.12,,265.7263428,2196.14,32.59,27437.26552
Site11-CantoII,24,Site11,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.81,,252.6992938,2188.36,33.72,27472.37199
Site11-CantoII,24,Site11,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.48,,2154.502066,13629.12,4762.25,88594.14292
Site11-CantoII,24,Site11,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,77.17,,2025.406974,13462.33,4745.71,87509.94841
Site11-CantoII,24,Site11,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77.42,,1993.94836,13449.84,4771.7,87335.08881
Site11-CantoII,24,Site11,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.47,,1604.354449,25116.29,4658.01,9086426.93
Site11-CantoII,24,Site11,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.57,,1490.069619,25070.05,4751.26,9069698.489
Site11-CantoII,24,Site11,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.68,,1469.048142,25093.93,4689.79,9085591.231
Site11-CantoII,24,Site11,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.74,,3664.961668,36814.41,7851.23,5076815.298
Site11-CantoII,24,Site11,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.77,,3664.961668,36553.19,7729.18,5040792.293
Site11-CantoII,24,Site11,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.74,,3664.961668,36400.04,7729.41,5019672.458
Site11-CantoII,24,Site11,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.02,,517.5047782,16047.28,5599.9,157277.8136
Site11-CantoII,24,Site11,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.9,,504.3347035,16197.59,4537.26,158750.9871
Site11-CantoII,24,Site11,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,24.79,,494.3401915,16045.03,4538.31,156653.3001
Site11-CantoII,24,Site11,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.51,,277.8749675,44116.79,35141.87,9207486.781
Site11-CantoII,24,Site11,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.75,,255.9399636,44112.79,35141.87,9206651.952
Site11-CantoII,24,Site11,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.92,,255.4638928,43599.76,33207.78,7607335.797
Site11-CantoII,24,Site11,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,86.43,,742.3603423,6863.32,1813.8,85746.23348
Site11-CantoII,24,Site11,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.41,,787.2229347,6628.7,1707.07,82815.0309
Site11-CantoII,24,Site11,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.37,,824.153632,6545.14,1640.27,81771.08201
Site11-CantoII,24,Site11,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.04,,135.3399255,2161.09,34.36,26999.37169
Site11-CantoII,24,Site11,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.14,,270.0415057,2208.59,35.55,27592.80841
Site11-CantoII,24,Site11,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.83,,6323.566716,2198.95,33.8,27472.37199
Site11-CantoII,24,Site11,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,82.07,,2202.363483,13613.92,4764.62,88495.3375
Site11-CantoII,24,Site11,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,77.82,,2073.275699,13452.75,4752.65,87447.67499
Site11-CantoII,24,Site11,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77.94,,2037.027499,13435.43,4775.63,87335.08881
Site11-CantoII,24,Site11,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.92,,1628.021782,25148.18,4659.27,9097963.911
Site11-CantoII,24,Site11,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.89,,522.5655758,25097.87,4756.02,9079763.048
Site11-CantoII,24,Site11,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.06,,1488.29952,25113.98,4697.85,9085591.231
Site11-CantoII,24,Site11,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.74,,3719.232139,36865.11,7861.59,5083806.977
Site11-CantoII,24,Site11,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.77,,3719.232139,36608.39,7731.94,5048404.535
Site11-CantoII,24,Site11,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.75,,3719.232139,36449.82,7734.56,5026537.266
Site11-CantoII,24,Site11,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.27,,534.5358404,15982.34,4543.83,156641.343
Site11-CantoII,24,Site11,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.2,,270.0415057,16154.16,4569.01,158325.3339
Site11-CantoII,24,Site11,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.01,,509.3706244,15983.56,4564.98,156653.3001
Site11-CantoII,24,Site11,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.74,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.64,,285.6165263,44654.64,35206.63,9319739.888
Site11-CantoII,24,Site11,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.85,,262.5340333,43279.56,34445.58,9032750.945
Site11-CantoII,24,Site11,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.05,,262.6098664,36449.82,7734.56,7607335.797
Site11-CantoII,24,Site11,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,83.43,,3653.563389,,,
Site11-CantoII,24,Site11,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,84.29,,3615.422844,,,
Site11-CantoII,24,Site11,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.74,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85.33,,629.4953528,6979.66,1889.27,87199.71617
Site11-CantoII,24,Site11,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,85.33,,623.1280972,6192.85,1560.35,77369.78052
Site11-CantoII,24,Site11,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,85.11,,651.8382875,6717.77,1800.91,83927.81845
Site11-CantoII,24,Site11,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.66,,159.6042229,2163.96,35.32,27035.22776
Site11-CantoII,24,Site11,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.66,,145.6204061,2069.27,36.36,25852.22728
Site11-CantoII,24,Site11,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6,,150.1031846,2166.55,37.47,27067.58568
Site11-CantoII,24,Site11,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,80.98,,1941.66405,12162.38,4209.7,79059.80958
Site11-CantoII,24,Site11,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.76,,2104.07349,11540.16,3949.88,75015.15757
Site11-CantoII,24,Site11,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.92,,2024.907522,11845.6,4086.37,77000.62655
Site11-CantoII,24,Site11,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.63,,1157.903348,18977.48,4238.86,6865563.558
Site11-CantoII,24,Site11,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.2,,1266.756154,18744.25,4245.33,6781186.95
Site11-CantoII,24,Site11,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.11,,1217.165644,19155.78,4173.55,6930067.906
Site11-CantoII,24,Site11,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.75,,3500.544909,35631.72,9103.6,4913718.873
Site11-CantoII,24,Site11,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.81,,3500.544909,30003.2,7864.74,4137529.428
Site11-CantoII,24,Site11,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.81,,3500.544909,34457.87,8661.18,4751841.509
Site11-CantoII,24,Site11,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.92,,658.5781646,14322.97,5876.1,140378.0208
Site11-CantoII,24,Site11,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,33.44,,703.5020786,12647.53,5266.97,123957.1981
Site11-CantoII,24,Site11,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.53,,679.0011635,14009.89,5823.45,137309.5545
Site11-CantoII,24,Site11,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.78,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.79,,234.8401925,41651.03,28264.16,8692865.191
Site11-CantoII,24,Site11,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.13,,260.5615617,39216.68,26891.83,8184799.091
Site11-CantoII,24,Site11,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.63,,266.1113009,40029.49,29829.15,8354438.299
Site11-CantoII,24,Site11,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85.94,,643.326488,7158.9,1899.2,89439.03401
Site11-CantoII,24,Site11,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86.23,,619.6419685,6348.37,1573.31,79312.7548
Site11-CantoII,24,Site11,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,85.68,,662.293096,6893.06,1829.54,86117.78733
Site11-CantoII,24,Site11,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.83,,164.3267927,2318.2,33.54,28962.21048
Site11-CantoII,24,Site11,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.7,,149.1663553,2204.98,34.69,27547.70722
Site11-CantoII,24,Site11,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.11,,154.5038574,2316.04,35.69,28935.22473
Site11-CantoII,24,Site11,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.04,,1948.763766,12255.21,4183.23,79663.2377
Site11-CantoII,24,Site11,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.97,,2146.603876,11587.73,3951.76,75324.37955
Site11-CantoII,24,Site11,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.03,,2048.868021,11905.1,4086.58,77387.39778
Site11-CantoII,24,Site11,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.71,,1163.694665,25416.51,5204.59,9195038.795
Site11-CantoII,24,Site11,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.06,,1289.223499,24381.1,5101.24,8820454.12
Site11-CantoII,24,Site11,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.16,,1232.647037,25367.34,5131.64,9177250.355
Site11-CantoII,24,Site11,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.51,,3539.765448,37569.91,9717.85,5181000.968
Site11-CantoII,24,Site11,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.32,,3539.765448,31988.61,8259.39,4411323.3
Site11-CantoII,24,Site11,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.51,,3539.765448,36475.78,9252.69,5030117.227
Site11-CantoII,24,Site11,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.27,,648.3451946,15829.07,5738.17,155139.1588
Site11-CantoII,24,Site11,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.72,,702.2705618,13989.85,5201.09,137113.1444
Site11-CantoII,24,Site11,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33,,676.0443713,15432.82,5812.69,151255.5515
Site11-CantoII,24,Site11,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,67.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.59,,230.5737195,41708.58,27694.1,9195038.795
Site11-CantoII,24,Site11,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.9,,259.2653318,38865.11,26696.81,8111423.94
Site11-CantoII,24,Site11,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.39,,262.6421583,39669.04,29531.45,8279209.829
Site11-CantoII,24,Site11,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.86,,669.0573451,7165.53,1906.05,89521.86528
Site11-CantoII,24,Site11,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,84.93,,622.8607739,6352.66,1577.28,79366.3515
Site11-CantoII,24,Site11,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.25,,665.9563575,6897.33,1833.88,133295.1318
Site11-CantoII,24,Site11,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.64,,166.7265088,2302.78,33.28,28769.56219
Site11-CantoII,24,Site11,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.64,,151.2206209,2203.39,34.62,27527.8427
Site11-CantoII,24,Site11,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6,,155.7594725,2307.8,35.5,37512.82151
Site11-CantoII,24,Site11,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.21,,2039.871944,12176.04,4206.67,79148.60446
Site11-CantoII,24,Site11,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.94,,2195.961192,11542.36,3966.94,75029.45836
Site11-CantoII,24,Site11,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.09,,2103.941057,11842.54,4114.15,192140.6016
Site11-CantoII,24,Site11,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,58.68,,1196.917058,25404.09,5256.3,9190545.559
Site11-CantoII,24,Site11,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,58.69,,720.0740302,24419.36,5101.96,8834295.603
Site11-CantoII,24,Site11,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,59.19,,1245.28366,25364.32,5155.32,20221990.23
Site11-CantoII,24,Site11,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.51,,3539.693421,37622.26,9732.77,5188220.187
Site11-CantoII,24,Site11,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.33,,3539.693421,32036.13,8270.51,4417876.448
Site11-CantoII,24,Site11,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.51,,3539.693421,36530.14,9266.21,5037613.63
Site11-CantoII,24,Site11,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.4,,681.2481006,15589.73,5881.61,152793.411
Site11-CantoII,24,Site11,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.79,,151.2206209,13812.83,5256.69,135378.1888
Site11-CantoII,24,Site11,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,33.2,,698.4332517,15213.39,5894.75,358517.5716
Site11-CantoII,24,Site11,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,68.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.59,,240.803276,40995.68,28240.08,8556089.001
Site11-CantoII,24,Site11,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.99,,267.6445504,38667.65,27064.01,8070212.638
Site11-CantoII,24,Site11,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.51,,272.7771066,39265.65,29869.75,127138.0969
Site11-CantoII,24,Site11,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,87.37,,3457.576882,,,
Site11-CantoII,24,Site11,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,88.51,,3544.564039,,,
Site11-CantoII,24,Site11,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1928.253756,,,
Site11-CantoII,24,Site11,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-CantoII,24,Site11,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.72,,293.0781968,10669.24,2178.7,133295.1318
Site11-CantoII,24,Site11,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.19,,231.0252807,3002.61,328.07,37512.82151
Site11-CantoII,24,Site11,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.56,,1073.450471,29558.47,10169.07,192140.6016
Site11-CantoII,24,Site11,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.49,,660.035101,55896.71,7479.76,20221990.23
Site11-CantoII,24,Site11,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1928.253756,97.67,14666.33,13468.97995
Site11-CantoII,24,Site11,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-CantoII,24,Site11,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-CantoII,24,Site11,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.51,,370.433167,36580.06,3050.05,358517.5716
Site11-CantoII,24,Site11,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,28.74,,437.229395,609.17,294.44,127138.0969
Site11-CantoII,24,Site11,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.79,,291.2720386,10740.47,2188.01,134185.037
Site11-CantoII,24,Site11,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.03,,226.8207651,3324.35,341.14,41532.4495
Site11-CantoII,24,Site11,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.52,,1049.308003,29633.76,10113.11,192630.0134
Site11-CantoII,24,Site11,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.75,,679.4628008,66797.19,8283.68,24165503.19
Site11-CantoII,24,Site11,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1914.322119,97.68,14710.06,13470.35898
Site11-CantoII,24,Site11,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-CantoII,24,Site11,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-CantoII,24,Site11,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.83,,365.460323,38253.09,3116.19,374914.7742
Site11-CantoII,24,Site11,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,27.48,,414.6934869,538.12,294.88,112309.4583
Site11-CantoII,24,Site11,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.78,,291.2720386,10744.18,2188.4,134231.3876
Site11-CantoII,24,Site11,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.06,,228.0137101,3338.8,344.13,41712.97919
Site11-CantoII,24,Site11,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,68.98,,1044.278289,29593.33,10191.16,192367.204
Site11-CantoII,24,Site11,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.54,,674.0139437,66798.57,8277.89,24166002.44
Site11-CantoII,24,Site11,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1914.322119,97.69,14716.41,13471.73801
Site11-CantoII,24,Site11,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-CantoII,24,Site11,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-CantoII,24,Site11,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.99,,365.3635977,38114.98,3110.99,373561.1716
Site11-CantoII,24,Site11,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-CantoII,24,Site11,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.08,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,49.97,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-CantoII,24,Site11,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,27.4,,414.8224539,537.6,294.64,112200.9306
Site11-CantoII,24,Site11,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-CantoII,24,Site11,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.89,,309.7099834,472.73,32.27,2233.125956
Site11-Lyric,25,Site11,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,80.61,,784.5277751,449.51,28.85,2123.43716
Site11-Lyric,25,Site11,Lyric,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83.56,,716.5740367,445.39,28.5,2103.97472
Site11-Lyric,25,Site11,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.53,,471.2691302,5563.46,37.74,26281.18996
Site11-Lyric,25,Site11,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.39,,460.2112508,56122.55,42.12,265116.9232
Site11-Lyric,25,Site11,Lyric,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.55,,518.8383657,5581.45,40.64,26366.1728
Site11-Lyric,25,Site11,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.98,,2259.080451,12481.44,4704.78,54208.78928
Site11-Lyric,25,Site11,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.72,,2275.991469,12323.42,4703.27,53522.48442
Site11-Lyric,25,Site11,Lyric,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.38,,2475.942413,12294.01,4661.88,53394.75232
Site11-Lyric,25,Site11,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.82,,731.3024236,23710.96,848.52,5674044.258
Site11-Lyric,25,Site11,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.66,,769.7068587,24262.47,876.82,5806020.869
Site11-Lyric,25,Site11,Lyric,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,35.61,,885.3462228,24261.82,934.11,5805865.324
Site11-Lyric,25,Site11,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.55,,5414.429501,15619.04,5031.48,3924030.71
Site11-Lyric,25,Site11,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.55,,5414.429501,16273.84,4791.62,4088538.599
Site11-Lyric,25,Site11,Lyric,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.34,,5414.429501,15782.9,4604.77,3965197.879
Site11-Lyric,25,Site11,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,49,,847.1414309,13369.17,6879.72,990813.3927
Site11-Lyric,25,Site11,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,49.07,,1115.164984,12433.8,7346.32,921491.4286
Site11-Lyric,25,Site11,Lyric,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,47.53,,1176.069924,12067.94,7347.42,894376.8816
Site11-Lyric,25,Site11,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,14.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,10.48,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,21.75,,608.4295487,19587.53,18839.43,4346569.578
Site11-Lyric,25,Site11,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,21.73,,798.6948276,24370.06,19444.88,5407836.588
Site11-Lyric,25,Site11,Lyric,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.44,,618.1417423,20561.21,19251.44,4562633.975
Site11-Lyric,25,Site11,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.24,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,74.89,,402.7697932,441.38,30.78,2085.031909
Site11-Lyric,25,Site11,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,76.16,,771.1471357,567.44,30.62,2680.525866
Site11-Lyric,25,Site11,Lyric,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,78.94,,703.3657182,558.56,29.89,2638.577695
Site11-Lyric,25,Site11,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.53,,457.9181033,5460.93,39.88,25796.84921
Site11-Lyric,25,Site11,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.94,,441.0765146,5504.9,38.62,26004.55879
Site11-Lyric,25,Site11,Lyric,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.21,,497.8318263,5480.73,37.16,25890.38229
Site11-Lyric,25,Site11,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.98,,2248.642071,1201.44,4703.95,5218.036363
Site11-Lyric,25,Site11,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.27,,2263.996304,12399.98,4691.88,53854.99613
Site11-Lyric,25,Site11,Lyric,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.35,,2462.052172,12357.47,4655.36,53670.36874
Site11-Lyric,25,Site11,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,33.82,,731.7883535,24137.0,878.61,5775995.837
Site11-Lyric,25,Site11,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.91,,767.6543249,24204.58,862.98,5792167.764
Site11-Lyric,25,Site11,Lyric,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,35.82,,881.7926509,24236.03,924.36,5799693.764
Site11-Lyric,25,Site11,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.55,,5422.807077,16273.84,4791.62,4088538.599
Site11-Lyric,25,Site11,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.77,,5422.807077,16326.04,4791.58,4101653.003
Site11-Lyric,25,Site11,Lyric,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.7,,5422.807077,15809.5,4609.39,3971880.698
Site11-Lyric,25,Site11,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,49,,1128.83417,12301.44,4703.95,911681.9893
Site11-Lyric,25,Site11,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,49.7,,1125.121681,12314.16,7406.6,912624.6916
Site11-Lyric,25,Site11,Lyric,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.2,,1186.718727,11966.01,7389.96,886822.6648
Site11-Lyric,25,Site11,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,63.26,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,14.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,14.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,12.97,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,21.75,,637.2326682,24321.81,19206.44,5397129.675
Site11-Lyric,25,Site11,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,21.95,,811.2053096,24874.39,19249.56,5519749.904
Site11-Lyric,25,Site11,Lyric,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.47,,620.6296177,21026.87,19265.43,4665966.227
Site11-Lyric,25,Site11,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.44,,313.2640419,433.59,29.9,2048.232782
Site11-Lyric,25,Site11,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.57,,607.547028,569.71,28.87,2691.249103
Site11-Lyric,25,Site11,Lyric,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,84.92,,562.270716,559.3,28.7,2642.073376
Site11-Lyric,25,Site11,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.81,,491.2425669,5444.95,38.38,25721.3614
Site11-Lyric,25,Site11,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.35,,503.8088889,5602.01,41.88,26463.29604
Site11-Lyric,25,Site11,Lyric,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.51,,557.4863587,5577.31,40.14,26346.61588
Site11-Lyric,25,Site11,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,65.92,,2237.28833,12279.76,4661.14,53332.86241
Site11-Lyric,25,Site11,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,60.01,,2264.207089,12340.02,4717.59,53594.58074
Site11-Lyric,25,Site11,Lyric,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,64.24,,2467.858474,12313.84,4675.82,53480.87703
Site11-Lyric,25,Site11,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,35.76,,721.3043781,24153.37,935.75,5779913.186
Site11-Lyric,25,Site11,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,33.84,,766.1414605,24082.91,853.03,5763052.074
Site11-Lyric,25,Site11,Lyric,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,35.74,,881.9527707,24107.42,908.67,5768917.329
Site11-Lyric,25,Site11,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.34,,5414.696353,15782.9,4604.77,3965197.879
Site11-Lyric,25,Site11,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.42,,5414.696353,16293.92,4791.02,4093583.374
Site11-Lyric,25,Site11,Lyric,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.24,,5414.696353,15794.35,4607.31,3968074.506
Site11-Lyric,25,Site11,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,47.5,,1008.472182,12041.7,7334.13,892432.1877
Site11-Lyric,25,Site11,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,45.07,,1020.54431,12664.65,7150.52,938600.14
Site11-Lyric,25,Site11,Lyric,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,43.06,,1062.562258,12344.93,758.37,914905.112
Site11-Lyric,25,Site11,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,63.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,13.23,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,10.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.46,,632.861062,20404.54,19047.62,4527868.129
Site11-Lyric,25,Site11,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,21.7,,818.6079748,24951.04,19603.9,5536758.917
Site11-Lyric,25,Site11,Lyric,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.37,,628.8167763,21085.27,19615.18,4678925.476
Site11-Lyric,25,Site11,Lyric,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.02,,5475.731427,,,
Site11-Lyric,25,Site11,Lyric,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97.85,,5359.620178,,,
Site11-Lyric,25,Site11,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.87,,739.7088506,369.08,25.09,1743.494443
Site11-Lyric,25,Site11,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.6,,748.9448145,371.31,24.9,1754.028724
Site11-Lyric,25,Site11,Lyric,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.88,,705.1271792,374.42,25.38,1768.720031
Site11-Lyric,25,Site11,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.69,,198.9627427,5555.36,36.73,26242.92643
Site11-Lyric,25,Site11,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.69,,218.5375977,5634.57,35.86,26617.106
Site11-Lyric,25,Site11,Lyric,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.8,,204.8526107,5567.09,35.88,26298.33769
Site11-Lyric,25,Site11,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,77,,1433.304962,17370.4,6332.67,75442.28496
Site11-Lyric,25,Site11,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.32,,1427.053304,17663.77,6302.24,76716.43542
Site11-Lyric,25,Site11,Lyric,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77.12,,1463.471504,17566.62,6289.24,76294.49822
Site11-Lyric,25,Site11,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.55,,1054.149547,27780.4,9130.84,6647863.229
Site11-Lyric,25,Site11,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.72,,1037.704711,27953.95,9553.75,6689393.828
Site11-Lyric,25,Site11,Lyric,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.21,,1071.46822,28085.25,9525.58,6720813.982
Site11-Lyric,25,Site11,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.25,,2762.225922,17013.31,3616.4,4274318.454
Site11-Lyric,25,Site11,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.18,,2762.225922,16996.14,3534.46,4270004.77
Site11-Lyric,25,Site11,Lyric,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.18,,2762.225922,16923.07,3580.9,4251647.117
Site11-Lyric,25,Site11,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.87,,342.0635156,17430.23,5212.71,1291785.902
Site11-Lyric,25,Site11,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.67,,352.0604416,17645.52,5261.33,1307741.433
Site11-Lyric,25,Site11,Lyric,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,24.32,,355.931411,17824.78,5181.92,1321026.716
Site11-Lyric,25,Site11,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.68,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.78,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.03,,186.6921595,38172.36,26808.97,8470635.077
Site11-Lyric,25,Site11,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.58,,179.184084,39099.37,26718.96,8676343.171
Site11-Lyric,25,Site11,Lyric,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.78,,185.6476784,37848.9,27379.52,8398857.706
Site11-Lyric,25,Site11,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,90.68,,784.0586053,477.64,24.95,2256.320271
Site11-Lyric,25,Site11,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.75,,788.8979378,477.16,24.73,2254.052802
Site11-Lyric,25,Site11,Lyric,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.01,,742.609474,480.13,25.15,2268.082764
Site11-Lyric,25,Site11,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,224.5848268,5650.7,38.02,26693.30239
Site11-Lyric,25,Site11,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.99,,245.6943932,5722.53,36.62,2254.052802
Site11-Lyric,25,Site11,Lyric,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.15,,231.6212617,5648.29,36.85,26681.91781
Site11-Lyric,25,Site11,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.72,,1566.098333,17484.37,6364.96,75937.27398
Site11-Lyric,25,Site11,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75.94,,1555.719869,17771.46,6336.19,77184.14945
Site11-Lyric,25,Site11,Lyric,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,76.84,,1596.747046,17675.93,6320.54,76769.24815
Site11-Lyric,25,Site11,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.58,,1152.289625,27831.11,9136.95,6659998.156
Site11-Lyric,25,Site11,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.74,,1131.653779,28001.83,9548.7,6700851.536
Site11-Lyric,25,Site11,Lyric,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.22,,1169.161926,28133.71,9533.91,6732410.484
Site11-Lyric,25,Site11,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.27,,2995.647134,17022.51,3605.92,4276629.805
Site11-Lyric,25,Site11,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.21,,2995.647134,17001.8,3525.69,4271426.753
Site11-Lyric,25,Site11,Lyric,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.2,,2995.647134,16928.68,3567.13,4253056.538
Site11-Lyric,25,Site11,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.91,,374.4100081,17408.12,5225.28,1290147.289
Site11-Lyric,25,Site11,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.72,,384.5360515,17622.24,5276.32,1306016.11
Site11-Lyric,25,Site11,Lyric,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,24.4,,389.6194001,17795.99,5181.42,1318893.037
Site11-Lyric,25,Site11,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.15,,207.2102447,37207.37,27136.08,8256499.033
Site11-Lyric,25,Site11,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.7,,198.7448705,37904.92,27335.41,8411288.821
Site11-Lyric,25,Site11,Lyric,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.93,,206.2905336,36509.67,27519.83,8101675.96
Site11-Lyric,25,Site11,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.68,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,90.3,,783.054222,469.0,24.9,2215.505835
Site11-Lyric,25,Site11,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.45,,787.2137931,468.49,24.69,2213.096649
Site11-Lyric,25,Site11,Lyric,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.71,,741.3453227,471.52,25.1,2227.410045
Site11-Lyric,25,Site11,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.99,,223.8691298,5634.04,38.12,26614.60233
Site11-Lyric,25,Site11,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.99,,245.6092448,5713.56,36.66,26990.24631
Site11-Lyric,25,Site11,Lyric,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.13,,230.9019013,5636.76,36.87,26627.45132
Site11-Lyric,25,Site11,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.62,,1560.621456,37592.03,27738.36,163267.8948
Site11-Lyric,25,Site11,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75.84,,1554.005734,17740.21,6316.75,77048.42595
Site11-Lyric,25,Site11,Lyric,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,76.73,,1592.084358,17641.98,6302.57,76621.79815
Site11-Lyric,25,Site11,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.54,,1147.695089,27665.33,9104.48,6620326.922
Site11-Lyric,25,Site11,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.79,,364.5543801,27834.19,9513.48,6660735.202
Site11-Lyric,25,Site11,Lyric,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.19,,1165.170245,27960.56,9507.38,6690975.604
Site11-Lyric,25,Site11,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.26,,2988.701656,17014.49,3608.87,4274614.91
Site11-Lyric,25,Site11,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.18,,2988.701656,16994.88,3519.61,4269688.216
Site11-Lyric,25,Site11,Lyric,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.19,,2988.701656,16923.38,3566.68,4251724.999
Site11-Lyric,25,Site11,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.88,,357.0810167,17324.23,5136.33,1283930.05
Site11-Lyric,25,Site11,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.46,,245.6092448,17559.55,5174.26,1301370.041
Site11-Lyric,25,Site11,Lyric,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.21,,369.4915,17755.33,5102.16,1315879.651
Site11-Lyric,25,Site11,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.16,,206.9813986,37592.03,27738.36,8341856.986
Site11-Lyric,25,Site11,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.71,,198.9307246,38329.49,27830.34,8505502.999
Site11-Lyric,25,Site11,Lyric,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.93,,206.0672267,36929.73,28080.25,8194889.347
Site11-Lyric,25,Site11,Lyric,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.44,,2560.125042,,,
Site11-Lyric,25,Site11,Lyric,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97.18,,2997.944726,,,
Site11-Lyric,25,Site11,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,86.9,,804.148079,413.28,27.69,1952.290515
Site11-Lyric,25,Site11,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.33,,671.160606,458.59,25.97,2166.330108
Site11-Lyric,25,Site11,Lyric,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.43,,637.1628683,426.22,26.44,2013.417691
Site11-Lyric,25,Site11,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7,,140.5909073,6034.55,37.51,28506.56873
Site11-Lyric,25,Site11,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.75,,122.5649924,5730.14,38.84,27068.56845
Site11-Lyric,25,Site11,Lyric,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.62,,140.3897698,6059.96,38.25,28626.60286
Site11-Lyric,25,Site11,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.7,,1599.643466,15941.86,5648.54,69237.91882
Site11-Lyric,25,Site11,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,82.03,,1749.046945,15031.95,5309.03,65286.04151
Site11-Lyric,25,Site11,Lyric,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.11,,1719.306311,15488.84,5539.56,67270.38416
Site11-Lyric,25,Site11,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.72,,955.3554101,28673.22,17916.17,6861515.489
Site11-Lyric,25,Site11,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,59.98,,1049.019216,27911.82,17248.61,6679312.099
Site11-Lyric,25,Site11,Lyric,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,59.89,,1029.686138,28181.47,17614.32,6743839.475
Site11-Lyric,25,Site11,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.33,,3032.431115,17445.5,4362.88,4382899.189
Site11-Lyric,25,Site11,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.65,,3032.431115,14519.56,3838.8,3647804.176
Site11-Lyric,25,Site11,Lyric,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.75,,3032.431115,16726.03,4267.26,4202144.01
Site11-Lyric,25,Site11,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31.5,,503.8198816,17321.44,6646.36,1283723.278
Site11-Lyric,25,Site11,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,29.77,,1749.046945,15387.23,6071.1,1140375.473
Site11-Lyric,25,Site11,Lyric,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.99,,532.7317352,16818.85,6634.66,1246475.423
Site11-Lyric,25,Site11,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.82,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,67.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,26.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.06,,221.9016677,40740.03,26105.67,9040413.722
Site11-Lyric,25,Site11,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.93,,211.6320943,36513.06,22950.21,8102428.218
Site11-Lyric,25,Site11,Lyric,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.96,,211.0379148,38862.95,26261.14,8623880.406
Site11-Lyric,25,Site11,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.28,,819.4878634,530.42,27.6,2505.647345
Site11-Lyric,25,Site11,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.65,,686.3942547,558.52,25.89,3653137.869
Site11-Lyric,25,Site11,Lyric,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.86,,647.9942835,535.6,26.32,2530.117111
Site11-Lyric,25,Site11,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.21,,154.6942442,6149.02,38.14,29047.31277
Site11-Lyric,25,Site11,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.98,,135.8116513,5859.2,39.28,27678.23409
Site11-Lyric,25,Site11,Lyric,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.77,,152.5973686,6121.74,38.72,28918.44497
Site11-Lyric,25,Site11,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.4,,1702.876851,16030.56,5650.8,69623.15638
Site11-Lyric,25,Site11,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.71,,1856.645426,15121.12,5322.4,65673.32036
Site11-Lyric,25,Site11,Lyric,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.87,,1824.057463,15578.53,5546.16,67659.92145
Site11-Lyric,25,Site11,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.75,,1017.522605,28723.15,17912.86,6873463.762
Site11-Lyric,25,Site11,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,59.96,,1113.285551,27949.99,17270.5,6688446.198
Site11-Lyric,25,Site11,Lyric,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,59.89,,1092.397283,28233.75,17659.67,6756350.104
Site11-Lyric,25,Site11,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.34,,3191.98845,17465.77,4348.28,4387991.698
Site11-Lyric,25,Site11,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.67,,3191.98845,14540.79,3814.94,3653137.869
Site11-Lyric,25,Site11,Lyric,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.75,,3191.98845,16739.44,4251.0,4205513.055
Site11-Lyric,25,Site11,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31.75,,540.7118646,17270.18,6689.69,1279924.306
Site11-Lyric,25,Site11,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,30.19,,560.5340443,15288.33,6148.61,1133045.815
Site11-Lyric,25,Site11,Lyric,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.4,,572.7846652,16739.05,6717.05,1240561.3
Site11-Lyric,25,Site11,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,68.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.16,,239.4170835,39730.55,26168.61,8816405.128
Site11-Lyric,25,Site11,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.14,,230.3503396,35407.53,23567.21,7857105.654
Site11-Lyric,25,Site11,Lyric,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.14,,228.639802,37898.74,26650.95,8409917.448
Site11-Lyric,25,Site11,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.54,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.42,,822.8286539,521.38,27.6,2462.943352
Site11-Lyric,25,Site11,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.07,,687.6677435,551.07,25.92,2603.195737
Site11-Lyric,25,Site11,Lyric,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.17,,651.4316327,527.26,26.36,2490.719843
Site11-Lyric,25,Site11,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.23,,154.6748684,6131.73,38.39,28965.63666
Site11-Lyric,25,Site11,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.98,,135.7113216,5844.75,39.37,27609.97384
Site11-Lyric,25,Site11,Lyric,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.77,,152.8294751,6106.09,38.83,28844.51604
Site11-Lyric,25,Site11,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,79.32,,1697.32405,16005.06,5646.35,69512.40601
Site11-Lyric,25,Site11,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.66,,1854.084252,15094.34,5315.11,65557.01076
Site11-Lyric,25,Site11,Lyric,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.79,,1823.893228,15550.91,5544.52,67539.9636
Site11-Lyric,25,Site11,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.71,,1013.488041,28565.36,17838.72,6835704.539
Site11-Lyric,25,Site11,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,59.92,,480.9150494,27806.64,17210.13,6654142.474
Site11-Lyric,25,Site11,Lyric,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,59.87,,1092.041893,28079.85,17590.45,6719521.759
Site11-Lyric,25,Site11,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.34,,3186.094059,17464.58,4355.26,4387692.73
Site11-Lyric,25,Site11,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.67,,3186.094059,14536.52,3819.3,3652065.101
Site11-Lyric,25,Site11,Lyric,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.75,,3186.094059,16741.35,4252.61,4205992.911
Site11-Lyric,25,Site11,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28.63,,485.9536882,17435.42,6405.29,1292170.542
Site11-Lyric,25,Site11,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.94,,135.7113216,15488.18,5884.54,1147857.06
Site11-Lyric,25,Site11,Lyric,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.09,,512.3151587,16943.86,6349.24,1255740.14
Site11-Lyric,25,Site11,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,68.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.19,,239.3328422,40207.68,26544.39,8922282.63
Site11-Lyric,25,Site11,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.13,,230.0083901,35693.65,23840.47,7920597.095
Site11-Lyric,25,Site11,Lyric,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.18,,229.8529674,38254.64,27038.98,8488893.415
Site11-Lyric,25,Site11,Lyric,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.42,,2861.791793,,,
Site11-Lyric,25,Site11,Lyric,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.85,,3224.649019,,,
Site11-Lyric,25,Site11,Lyric,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1586.346292,,,
Site11-Lyric,25,Site11,Lyric,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-Lyric,25,Site11,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,78.55,,243.3793167,7058.63,1729.9,33344.21312
Site11-Lyric,25,Site11,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.37,,178.9707021,5910.59,1033.7,27920.99495
Site11-Lyric,25,Site11,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.4,,889.1703972,26784.33,11924.71,116328.4125
Site11-Lyric,25,Site11,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,52.76,,469.0936237,51940.58,10754.37,12429406.05
Site11-Lyric,25,Site11,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1586.346292,19334.22,6358.44,4857409.484
Site11-Lyric,25,Site11,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-Lyric,25,Site11,Lyric,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-Lyric,25,Site11,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.51,,306.8407459,44332.45,5846.53,3285558.13
Site11-Lyric,25,Site11,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.51,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,10.91,,135.8264021,213.09,97.67,47285.72267
Site11-Lyric,25,Site11,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,77.37,,242.6731763,7108.47,1696.09,33579.65195
Site11-Lyric,25,Site11,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.25,,179.5771937,6001.25,1016.66,28349.2631
Site11-Lyric,25,Site11,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.56,,901.7128668,27118.36,12065.44,117779.1555
Site11-Lyric,25,Site11,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.11,,433.8267368,51632.01,10944.82,12355565.1
Site11-Lyric,25,Site11,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1590.554526,19429.52,6231.8,4881352.065
Site11-Lyric,25,Site11,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-Lyric,25,Site11,Lyric,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-Lyric,25,Site11,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.59,,311.8921959,44348.05,5847.05,3286714.275
Site11-Lyric,25,Site11,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,27.59,,347.6258569,89.98,100.16,19967.00608
Site11-Lyric,25,Site11,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,77.35,,242.6253401,7104.3,1695.26,33559.95331
Site11-Lyric,25,Site11,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.25,,179.62503,5975.9,1017.97,28229.51241
Site11-Lyric,25,Site11,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.56,,901.7128668,27038.4,12020.13,117431.8771
Site11-Lyric,25,Site11,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,30.49,,274.9147929,49209.95,11429.95,11775964.96
Site11-Lyric,25,Site11,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1590.554526,19407.06,6237.76,4875709.354
Site11-Lyric,25,Site11,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site11-Lyric,25,Site11,Lyric,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site11-Lyric,25,Site11,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.51,,311.2224887,44196.25,5818.13,3275464.102
Site11-Lyric,25,Site11,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site11-Lyric,25,Site11,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site11-Lyric,25,Site11,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,27.63,,348.1520554,92.13,100.67,20444.10169
Site11-Lyric,25,Site11,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site11-Lyric,25,Site11,Lyric,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site12-CytoflexS,26,Site12,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76,,2020.48,156319.0,60139.0,16844.71377
Site12-CytoflexS,26,Site12,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,71.3,,996.19,138365.0,58383.0,14910.01619
Site12-CytoflexS,26,Site12,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,49.3,,374.03,113009.0,51444.0,12177.68959
Site12-CytoflexS,26,Site12,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.69,,1235,50304.0,16977.0,5420.687706
Site12-CytoflexS,26,Site12,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.2,,1433,54266.0,16649.0,5847.627207
Site12-CytoflexS,26,Site12,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.72,,1579,49852.0,15724.0,5371.980827
Site12-CytoflexS,26,Site12,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.7,,11674.99,47384.0,17729.0,9960.199249
Site12-CytoflexS,26,Site12,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.9,,14320.37,59474.0,22677.0,12501.53829
Site12-CytoflexS,26,Site12,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,79.1,,14325.05,66655.0,24552.0,14010.99698
Site12-CytoflexS,26,Site12,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,40.8,,4766.33,371104.0,88583.0,89917.77318
Site12-CytoflexS,26,Site12,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,66.4,,9513.46,399315.0,89825.0,96753.24328
Site12-CytoflexS,26,Site12,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.5,,10382,393778.0,88816.0,95411.63902
Site12-CytoflexS,26,Site12,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89.2,,,189868.0,47261.0,12596.33776
Site12-CytoflexS,26,Site12,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,89,,,191858.0,47825.0,12728.35954
Site12-CytoflexS,26,Site12,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,89.5,,,183385.0,38765.0,12166.23865
Site12-CytoflexS,26,Site12,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,48.9,,5706,161834.0,82441.0,27336.9224
Site12-CytoflexS,26,Site12,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.2,,4042,191858.0,83349.0,32408.56221
Site12-CytoflexS,26,Site12,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.7,,3676,198643.0,56880.0,33554.68119
Site12-CytoflexS,26,Site12,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,83.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,90.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,94.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,13.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,7.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,3.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.6,,2829,476000.0,325218.0,25530.6519
Site12-CytoflexS,26,Site12,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.78,,1535,591000.0,436000.0,31698.77158
Site12-CytoflexS,26,Site12,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.2,,2024,623000.0,457000.0,33415.11793
Site12-CytoflexS,26,Site12,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,62.6,,557,156858.0,69668.0,16902.79564
Site12-CytoflexS,26,Site12,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,49.1,,125,102441.0,73262.0,11038.89689
Site12-CytoflexS,26,Site12,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,30.2,,88,127838.0,55035.0,13775.6416
Site12-CytoflexS,26,Site12,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.2,,1821,50784.0,17164.0,5472.411825
Site12-CytoflexS,26,Site12,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.39,,1748,54754.0,16606.0,5900.213395
Site12-CytoflexS,26,Site12,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.1,,2257,51132.0,15976.0,5509.911811
Site12-CytoflexS,26,Site12,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,83.1,,14797,47591.0,17597.0,10003.71101
Site12-CytoflexS,26,Site12,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,87.8,,16360,59448.0,22508.0,12496.07304
Site12-CytoflexS,26,Site12,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.1,,15822,66579.0,24662.0,13995.02165
Site12-CytoflexS,26,Site12,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41,,6062,371104.0,89893.0,89917.77318
Site12-CytoflexS,26,Site12,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.9,,10788,399315.0,90367.0,96753.24328
Site12-CytoflexS,26,Site12,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.6,,11494,395155.0,88816.0,95745.28342
Site12-CytoflexS,26,Site12,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.3,,,189210.0,45013.0,12552.68432
Site12-CytoflexS,26,Site12,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.2,,,193196.0,46677.0,12817.12595
Site12-CytoflexS,26,Site12,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,88.6,,,184023.0,37074.0,12208.56523
Site12-CytoflexS,26,Site12,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,49.1,,7259,161834.0,83311.0,27336.9224
Site12-CytoflexS,26,Site12,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.7,,4698,189868.0,84799.0,32072.41236
Site12-CytoflexS,26,Site12,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.7,,4062,200726.0,57719.0,33906.54056
Site12-CytoflexS,26,Site12,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,92.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,96.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,96.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,4.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,1.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,1.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.07,,902,131371.0,69251.0,7046.191745
Site12-CytoflexS,26,Site12,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,2.19,,408,141254.0,89814.0,7576.274587
Site12-CytoflexS,26,Site12,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,1.96,,364,154690.0,71283.0,8296.925509
Site12-CytoflexS,26,Site12,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,45.9,,408,116025.0,70735.0,12502.68947
Site12-CytoflexS,26,Site12,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,41,,156,85604.0,54293.0,9224.565648
Site12-CytoflexS,26,Site12,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,34.8,,186,84723.0,54817.0,9129.630337
Site12-CytoflexS,26,Site12,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.1,,1789,50265.0,17783.0,5416.485121
Site12-CytoflexS,26,Site12,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.23,,1701,54754.0,16999.0,5900.213395
Site12-CytoflexS,26,Site12,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.1,,2205,51483.0,16150.0,5547.735074
Site12-CytoflexS,26,Site12,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.5,,12496,47918.0,17721.0,10072.44698
Site12-CytoflexS,26,Site12,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,80.6,,14859,59652.0,22802.0,12538.9542
Site12-CytoflexS,26,Site12,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.7,,13834,67039.0,24630.0,14091.71445
Site12-CytoflexS,26,Site12,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,40.9,,5109,370054.0,89383.0,89663.36023
Site12-CytoflexS,26,Site12,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.3,,9708,397985.0,90661.0,96430.98689
Site12-CytoflexS,26,Site12,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.3,,9996,393861.0,88106.0,95431.74975
Site12-CytoflexS,26,Site12,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.1,,,186598.0,46442.0,12379.39744
Site12-CytoflexS,26,Site12,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,86.5,,,191858.0,47399.0,12728.35954
Site12-CytoflexS,26,Site12,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,87.8,,,184023.0,39158.0,12208.56523
Site12-CytoflexS,26,Site12,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,49,,6118,157254.0,82912.0,26563.27097
Site12-CytoflexS,26,Site12,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.9,,4299,183604.0,84934.0,31014.30045
Site12-CytoflexS,26,Site12,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.8,,3574,196990.0,57360.0,33275.45721
Site12-CytoflexS,26,Site12,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,92.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,95.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,95.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,4.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,1.98,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,2.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.2,,3055,450000.0,325649.0,24136.12049
Site12-CytoflexS,26,Site12,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.63,,1589,551000.0,434000.0,29553.33865
Site12-CytoflexS,26,Site12,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.9,,1994,602000.0,461000.0,32288.76564
Site12-CytoflexS,26,Site12,CytoflexS,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,91.7,,18023.26,188554.0,44699.0,12509.16357
Site12-CytoflexS,26,Site12,CytoflexS,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,91.1,,20412,183385.0,37724.0,12166.23865
Site12-CytoflexS,26,Site12,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,48.1,,237.5,116124.0,55294.0,12513.35757
Site12-CytoflexS,26,Site12,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,76.4,,1249.43,156319.0,60447.0,16844.71377
Site12-CytoflexS,26,Site12,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,69.3,,637.42,138846.0,56951.0,14961.84807
Site12-CytoflexS,26,Site12,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.96,,1035,48962.0,15300.0,5276.075689
Site12-CytoflexS,26,Site12,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.34,,761,50304.0,17220.0,5420.687706
Site12-CytoflexS,26,Site12,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.4,,937,54432.0,17495.0,5865.515132
Site12-CytoflexS,26,Site12,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,78.8,,9097.19,66394.0,24542.0,13956.13433
Site12-CytoflexS,26,Site12,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.5,,6899.08,47015.0,17518.0,9882.634807
Site12-CytoflexS,26,Site12,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.3,,9075.25,59241.0,22253.0,12452.56128
Site12-CytoflexS,26,Site12,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.7,,6520,396537.0,88816.0,96080.13932
Site12-CytoflexS,26,Site12,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,40.9,,2819,382937.0,89281.0,92784.88593
Site12-CytoflexS,26,Site12,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,66.1,,6001,409000.0,91209.0,99099.89984
Site12-CytoflexS,26,Site12,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,89.5,,,185306.0,38777.0,12293.68279
Site12-CytoflexS,26,Site12,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.7,,,189868.0,46433.0,12596.33776
Site12-CytoflexS,26,Site12,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,90,,,192526.0,47303.0,12772.6764
Site12-CytoflexS,26,Site12,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.2,,2380,197954.0,57153.0,33438.29564
Site12-CytoflexS,26,Site12,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,48,,3308,157403.0,82453.0,26588.43998
Site12-CytoflexS,26,Site12,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.6,,2599,191858.0,83516.0,32408.56221
Site12-CytoflexS,26,Site12,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,94.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,84.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,90.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,4.02,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,13.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,7.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.3,,1302,619000.0,470000.0,33200.57464
Site12-CytoflexS,26,Site12,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.8,,2474,94943.0,51960.0,5092.345974
Site12-CytoflexS,26,Site12,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.23,,1029,619000.0,453000.0,33200.57464
Site12-CytoflexS,26,Site12,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,30.6,,63,117643.0,67749.0,1267.671958
Site12-CytoflexS,26,Site12,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,57.1,,277,147874.0,81649.0,15934.69254
Site12-CytoflexS,26,Site12,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,47.3,,84,95601.0,71606.0,10301.82819
Site12-CytoflexS,26,Site12,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,,1460,50265.0,15572.0,5416.485121
Site12-CytoflexS,26,Site12,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.7,,1002,50438.0,17228.0,5435.127356
Site12-CytoflexS,26,Site12,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.63,,1146,54942.0,17581.0,5920.472009
Site12-CytoflexS,26,Site12,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.8,,10048,66579.0,24690.0,13995.02165
Site12-CytoflexS,26,Site12,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,68.1,,7855,47268.0,17414.0,9935.815847
Site12-CytoflexS,26,Site12,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,87.6,,10430,59245.0,22206.0,12453.40209
Site12-CytoflexS,26,Site12,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,72,,7231,397923.0,89687.0,96415.96441
Site12-CytoflexS,26,Site12,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,41.4,,3255,381603.0,89281.0,92461.66034
Site12-CytoflexS,26,Site12,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.6,,6841,409000.0,91765.0,99099.89984
Site12-CytoflexS,26,Site12,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.6,,,185951.0,37465.0,12336.47377
Site12-CytoflexS,26,Site12,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.1,,,189868.0,44348.0,12596.33776
Site12-CytoflexS,26,Site12,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,89.3,,,194544.0,46573.0,12906.55578
Site12-CytoflexS,26,Site12,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.2,,2633,200029.0,57554.0,33788.80365
Site12-CytoflexS,26,Site12,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,48,,3769,158499.0,82995.0,26773.57578
Site12-CytoflexS,26,Site12,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,29.2,,3047,191193.0,84141.0,32296.23073
Site12-CytoflexS,26,Site12,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,96.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,93.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,1.68,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,3.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,1.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,2.18,,258,138713.0,79836.0,7439.98596
Site12-CytoflexS,26,Site12,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,22,,2536,88096.0,43116.0,4725.101491
Site12-CytoflexS,26,Site12,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,2.13,,253,135727.0,80718.0,7279.829392
Site12-CytoflexS,26,Site12,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,34.8,,121,80731.0,53726.0,8699.458078
Site12-CytoflexS,26,Site12,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,43.2,,226,106780.0,72596.0,11506.46138
Site12-CytoflexS,26,Site12,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,42.3,,115,82134.0,52682.0,8850.643369
Site12-CytoflexS,26,Site12,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.2,,1428,50784.0,15798.0,5472.411825
Site12-CytoflexS,26,Site12,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.62,,1098,50438.0,17579.0,5435.127356
Site12-CytoflexS,26,Site12,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.41,,1106,54942.0,17581.0,5920.472009
Site12-CytoflexS,26,Site12,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.4,,8800,67039.0,24699.0,14091.71445
Site12-CytoflexS,26,Site12,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,64.9,,7415,47591.0,17421.0,10003.71101
Site12-CytoflexS,26,Site12,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.1,,9424,59448.0,22430.0,12496.07304
Site12-CytoflexS,26,Site12,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.7,,6314,396605.0,89520.0,96096.61559
Site12-CytoflexS,26,Site12,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,41.3,,3065,380440.0,90227.0,92179.86771
Site12-CytoflexS,26,Site12,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.9,,6116,408000.0,92494.0,98857.60179
Site12-CytoflexS,26,Site12,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88,,,185951.0,39173.0,12336.47377
Site12-CytoflexS,26,Site12,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,89.6,,,186598.0,45628.0,12379.39744
Site12-CytoflexS,26,Site12,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,87.5,,,193196.0,47303.0,12817.12595
Site12-CytoflexS,26,Site12,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.3,,2311,195535.0,57628.0,33029.67931
Site12-CytoflexS,26,Site12,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.9,,3549,153824.0,82598.0,25983.877
Site12-CytoflexS,26,Site12,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,29.5,,2783,184285.0,84457.0,31129.33465
Site12-CytoflexS,26,Site12,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,95.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,93.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,95.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,2.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,4.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,2.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,1277,604000.0,471000.0,32396.03729
Site12-CytoflexS,26,Site12,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23,,2624,94615.0,51590.0,5074.753423
Site12-CytoflexS,26,Site12,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.03,,1062,587000.0,456000.0,31484.22829
Site12-CytoflexS,26,Site12,CytoflexS,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,93.2,,14453.95,187248.0,44637.0,12422.52013
Site12-CytoflexS,26,Site12,CytoflexS,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,90.7,,10088.58,195901.0,47004.0,12996.58269
Site12-CytoflexS,26,Site12,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,75.5,,953.92,150417.0,62370.0,16208.72262
Site12-CytoflexS,26,Site12,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,45.9,,168.49,118929.0,59086.0,12815.62039
Site12-CytoflexS,26,Site12,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,72.7,,483.95,132282.0,51213.0,14254.52074
Site12-CytoflexS,26,Site12,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.34,,557,49702.0,16788.0,5355.817039
Site12-CytoflexS,26,Site12,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.82,,752,48816.0,15404.0,5260.342936
Site12-CytoflexS,26,Site12,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.06,,665,53936.0,17001.0,5812.066875
Site12-CytoflexS,26,Site12,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.6,,5666.66,46467.0,17309.0,9767.444253
Site12-CytoflexS,26,Site12,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,79.2,,6754.19,67447.0,24848.0,14177.47676
Site12-CytoflexS,26,Site12,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.5,,6732.16,58090.0,21888.0,12210.61908
Site12-CytoflexS,26,Site12,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41,,2320,381603.0,90630.0,92461.66034
Site12-CytoflexS,26,Site12,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.1,,4803,411000.0,90308.0,99584.49592
Site12-CytoflexS,26,Site12,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,66.9,,4502,401000.0,91232.0,97161.51549
Site12-CytoflexS,26,Site12,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,90.1,,,187248.0,45948.0,12422.52013
Site12-CytoflexS,26,Site12,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,89.7,,,187900.0,40533.0,12465.77551
Site12-CytoflexS,26,Site12,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,90.8,,,189210.0,47417.0,12552.68432
Site12-CytoflexS,26,Site12,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,48.3,,2736,159603.0,82307.0,26960.06294
Site12-CytoflexS,26,Site12,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.4,,1781,198643.0,58057.0,33554.68119
Site12-CytoflexS,26,Site12,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.2,,1898,187248.0,82394.0,31629.8432
Site12-CytoflexS,26,Site12,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,83.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,94,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,91,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,13.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,4.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,7.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.3,,1237,468000.0,331634.0,25101.56531
Site12-CytoflexS,26,Site12,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11,,942,619000.0,466000.0,33200.57464
Site12-CytoflexS,26,Site12,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.3,,768,625000.0,446000.0,33522.38958
Site12-CytoflexS,26,Site12,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,59.1,,222,150461.0,77261.0,16213.464
Site12-CytoflexS,26,Site12,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,28.6,,50,112467.0,69221.0,12119.28443
Site12-CytoflexS,26,Site12,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,43.2,,51,102087.0,61560.0,11000.75035
Site12-CytoflexS,26,Site12,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.5,,805,49923.0,16875.0,5379.631686
Site12-CytoflexS,26,Site12,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.2,,1061,50784.0,15743.0,5472.411825
Site12-CytoflexS,26,Site12,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.16,,807,54567.0,17152.0,5880.06254
Site12-CytoflexS,26,Site12,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.2,,7139,46627.0,17279.0,9801.076532
Site12-CytoflexS,26,Site12,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,85,,7422,67501.0,24803.0,14188.82765
Site12-CytoflexS,26,Site12,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,88.1,,7763,58038.0,21812.0,12199.68859
Site12-CytoflexS,26,Site12,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41.3,,2949,380275.0,91142.0,92139.88853
Site12-CytoflexS,26,Site12,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.6,,5314,412000.0,90308.0,99826.79397
Site12-CytoflexS,26,Site12,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,66.3,,5150,401000.0,91773.0,97161.51549
Site12-CytoflexS,26,Site12,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.5,,,186598.0,43885.0,12379.39744
Site12-CytoflexS,26,Site12,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,89,,,188554.0,38930.0,12509.16357
Site12-CytoflexS,26,Site12,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,90,,,191193.0,46713.0,12684.24171
Site12-CytoflexS,26,Site12,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,48.5,,3460,160158.0,83104.0,27053.81327
Site12-CytoflexS,26,Site12,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.5,,1966,200029.0,58905.0,33788.80365
Site12-CytoflexS,26,Site12,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.8,,2237,186598.0,83460.0,31520.04551
Site12-CytoflexS,26,Site12,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,93.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,96.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,4.16,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,1.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,1.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.95,,419,129951.0,70050.0,6970.028876
Site12-CytoflexS,26,Site12,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,2.11,,183,140742.0,71752.0,7548.813046
Site12-CytoflexS,26,Site12,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,2.07,,182,134259.0,85475.0,7201.092003
Site12-CytoflexS,26,Site12,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,99.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,99.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,42.6,,169,106044.0,69351.0,11427.15106
Site12-CytoflexS,26,Site12,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,31.5,,86,80453.0,54954.0,8669.501192
Site12-CytoflexS,26,Site12,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,42.5,,79,80453.0,54434.0,8669.501192
Site12-CytoflexS,26,Site12,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.58,,806,49753.0,17106.0,5361.312727
Site12-CytoflexS,26,Site12,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.1,,1039,51132.0,16038.0,5509.911811
Site12-CytoflexS,26,Site12,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.01,,785,54567.0,17340.0,5880.06254
Site12-CytoflexS,26,Site12,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.4,,6095,46946.0,17293.0,9868.130887
Site12-CytoflexS,26,Site12,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75.8,,6522,67967.0,24977.0,14286.78166
Site12-CytoflexS,26,Site12,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,80.3,,6994,58437.0,21822.0,12283.55908
Site12-CytoflexS,26,Site12,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41.2,,2512,379125.0,91226.0,91861.24578
Site12-CytoflexS,26,Site12,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.4,,4657,411000.0,90627.0,99584.49592
Site12-CytoflexS,26,Site12,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.7,,4593,399370.0,91864.0,96766.56968
Site12-CytoflexS,26,Site12,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88,,,184023.0,44994.0,12208.56523
Site12-CytoflexS,26,Site12,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88,,,188554.0,41203.0,12509.16357
Site12-CytoflexS,26,Site12,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,88.4,,,189868.0,47161.0,12596.33776
Site12-CytoflexS,26,Site12,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,48.4,,2947,154959.0,82914.0,26175.60066
Site12-CytoflexS,26,Site12,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.6,,1735,196261.0,58815.0,33152.31488
Site12-CytoflexS,26,Site12,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,29.1,,2038,180240.0,83800.0,30446.05517
Site12-CytoflexS,26,Site12,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,92.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,94.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,96,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,4.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,3.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,2.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16,,1347,438000.0,334099.0,23492.49061
Site12-CytoflexS,26,Site12,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.8,,929,595000.0,468000.0,31913.31488
Site12-CytoflexS,26,Site12,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.2,,801,599000.0,454000.0,32127.85817
Site12-CytoflexS,26,Site12,CytoflexS,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,90.4,,8279.73,197267.0,47334.0,13087.20669
Site12-CytoflexS,26,Site12,CytoflexS,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,79.7,,9871.54,196583.0,46900.0,13041.82835
Site12-CytoflexS,26,Site12,CytoflexS,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1743.36,300545.0,75471.0,19938.93827
Site12-CytoflexS,26,Site12,CytoflexS,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1963.71,262380.0,70130.0,17406.97274
Site12-CytoflexS,26,Site12,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.6,,202,73536.0,17351.0,7924.135081
Site12-CytoflexS,26,Site12,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80,,145,116918.0,32463.0,12598.91788
Site12-CytoflexS,26,Site12,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.4,,165,98434.0,25016.0,10607.10825
Site12-CytoflexS,26,Site12,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.3,,240,48962.0,5196.0,5276.075689
Site12-CytoflexS,26,Site12,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.4,,252,56645.0,5473.0,6103.984874
Site12-CytoflexS,26,Site12,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.4,,249,53445.0,5805.0,5759.157411
Site12-CytoflexS,26,Site12,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.6,,1110,122972.0,44740.0,25848.92837
Site12-CytoflexS,26,Site12,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.5,,1155,148185.0,50155.0,31148.74484
Site12-CytoflexS,26,Site12,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.4,,1140,130509.0,46654.0,27433.21889
Site12-CytoflexS,26,Site12,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.1,,722,693000.0,111435.0,167912.5442
Site12-CytoflexS,26,Site12,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,747,1000000.0,130542.0,242298.0436
Site12-CytoflexS,26,Site12,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.9,,739,800000.0,111262.0,193838.4349
Site12-CytoflexS,26,Site12,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,205670.0,64564.0,13644.6836
Site12-CytoflexS,26,Site12,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,243040.0,52815.0,16123.90676
Site12-CytoflexS,26,Site12,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,220482.0,54835.0,14627.35027
Site12-CytoflexS,26,Site12,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.8,,386,410000.0,34996.0,69257.00522
Site12-CytoflexS,26,Site12,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.9,,403,439000.0,35167.0,74155.67144
Site12-CytoflexS,26,Site12,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35,,398,427000.0,38122.0,72128.63714
Site12-CytoflexS,26,Site12,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,84.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,88.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,87.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,13.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,9.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,11,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.3,,208,3556.0,2552.0,190.7289877
Site12-CytoflexS,26,Site12,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.6,,239,4983.0,3264.0,267.2673076
Site12-CytoflexS,26,Site12,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.7,,221,3977.0,2673.0,213.3096693
Site12-CytoflexS,26,Site12,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.2,,316,73816.0,17386.0,7954.307484
Site12-CytoflexS,26,Site12,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.9,,138,117643.0,31947.0,12677.04285
Site12-CytoflexS,26,Site12,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.7,,162,98961.0,24939.0,10663.89703
Site12-CytoflexS,26,Site12,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.3,,375,49414.0,5227.0,5324.782568
Site12-CytoflexS,26,Site12,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.5,,239,57052.0,5572.0,6147.842616
Site12-CytoflexS,26,Site12,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.5,,250,54009.0,5846.0,5819.933252
Site12-CytoflexS,26,Site12,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.8,,1734,123059.0,44953.0,25867.21592
Site12-CytoflexS,26,Site12,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,70.5,,1085,147874.0,50097.0,31083.3721
Site12-CytoflexS,26,Site12,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.5,,1137,131887.0,46868.0,27722.87689
Site12-CytoflexS,26,Site12,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.8,,1124,693000.0,109990.0,167912.5442
Site12-CytoflexS,26,Site12,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.9,,704,1000000.0,130542.0,242298.0436
Site12-CytoflexS,26,Site12,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.4,,732,803000.0,111262.0,194565.329
Site12-CytoflexS,26,Site12,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,206386.0,65473.0,13692.18491
Site12-CytoflexS,26,Site12,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,243040.0,53338.0,16123.90676
Site12-CytoflexS,26,Site12,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,222795.0,55122.0,14780.80072
Site12-CytoflexS,26,Site12,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,,605,413000.0,35241.0,69763.76379
Site12-CytoflexS,26,Site12,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.8,,378,443000.0,35538.0,74831.34954
Site12-CytoflexS,26,Site12,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35,,398,432000.0,37701.0,72973.23477
Site12-CytoflexS,26,Site12,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,84.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,88.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,87.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,13.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,9.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,10.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.3,,325,3737.0,2520.0,200.4370717
Site12-CytoflexS,26,Site12,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.8,,228,5119.0,3105.0,274.5617796
Site12-CytoflexS,26,Site12,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.7,,221,4171.0,2642.0,223.7150191
Site12-CytoflexS,26,Site12,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.3,,202,73816.0,17386.0,7954.307484
Site12-CytoflexS,26,Site12,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.9,,147,117643.0,31947.0,12677.04285
Site12-CytoflexS,26,Site12,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.9,,164,98961.0,24939.0,10663.89703
Site12-CytoflexS,26,Site12,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.3,,241,49753.0,5263.0,5361.312727
Site12-CytoflexS,26,Site12,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.5,,255,57444.0,5611.0,6190.083981
Site12-CytoflexS,26,Site12,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,15.5,,251,54380.0,5804.0,5859.911686
Site12-CytoflexS,26,Site12,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.4,,1105,123486.0,45387.0,25956.97207
Site12-CytoflexS,26,Site12,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.9,,1145,148903.0,50132.0,31299.66969
Site12-CytoflexS,26,Site12,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,69.7,,1131,132345.0,47324.0,27819.14928
Site12-CytoflexS,26,Site12,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.7,,716,692000.0,107638.0,167670.2462
Site12-CytoflexS,26,Site12,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.4,,738,996000.0,129473.0,241328.8514
Site12-CytoflexS,26,Site12,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.3,,728,802000.0,108613.0,194323.031
Site12-CytoflexS,26,Site12,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,207826.0,65475.0,13787.71826
Site12-CytoflexS,26,Site12,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,245590.0,53186.0,16293.0804
Site12-CytoflexS,26,Site12,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,224350.0,55022.0,14883.96347
Site12-CytoflexS,26,Site12,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.1,,388,407000.0,35428.0,68750.24664
Site12-CytoflexS,26,Site12,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.2,,403,438000.0,34791.0,73986.75192
Site12-CytoflexS,26,Site12,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.5,,401,426000.0,37243.0,71959.71762
Site12-CytoflexS,26,Site12,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,84.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,88.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,87.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,13.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,9.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,10.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site12-CytoflexS,26,Site12,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.2,,207,3798.0,2587.0,203.708857
Site12-CytoflexS,26,Site12,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.8,,242,5196.0,3283.0,278.691738
Site12-CytoflexS,26,Site12,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.8,,224,4227.0,2761.0,226.7186252
Site13-CellStream-1,27,Site13,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,87.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,86.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,87.14,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.14,277.2,1692.814955,19974.2,5470.3,119890.71
Site13-CellStream-1,27,Site13,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.85,261.6,1667.172004,19614.3,5389.6,117730.49
Site13-CellStream-1,27,Site13,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76.54,247.2,1673.078239,19548.0,5491.4,117332.54
Site13-CellStream-1,27,Site13,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.85,121.1,739.2708815,8371.3,2065.6,50246.87
Site13-CellStream-1,27,Site13,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.73,115,733.1895639,8253.2,2009.8,49538.01
Site13-CellStream-1,27,Site13,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.32,105,710.5479924,8349.7,2099.4,50117.23
Site13-CellStream-1,27,Site13,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.51,505.9,3089.467669,10191.9,3641.9,77320
Site13-CellStream-1,27,Site13,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,48.59,476.7,3038.589259,10130.5,3600.1,76854.19
Site13-CellStream-1,27,Site13,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,48.34,448.3,3033.896864,10028.6,3646.0,76081.14
Site13-CellStream-1,27,Site13,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.48,270.6,1652.343231,51869.5,11417.5,11681126.84
Site13-CellStream-1,27,Site13,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,51.66,246.3,1569.731207,51292.1,11260.7,11551095.07
Site13-CellStream-1,27,Site13,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,51.49,230.8,1562.061076,51343.2,11678.9,11562602.9
Site13-CellStream-1,27,Site13,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.36,1474.2,,23778.2,10633.3,5295697.29
Site13-CellStream-1,27,Site13,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.33,1412.4,,23648.8,10470.4,5266878.32
Site13-CellStream-1,27,Site13,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.94,1330.4,,23694.1,10532.2,5276967.18
Site13-CellStream-1,27,Site13,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,40.56,205.2,1253.110479,9026.1,2500.9,1521525.77
Site13-CellStream-1,27,Site13,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41.43,197.5,1258.912224,8974.6,2518.2,1512844.43
Site13-CellStream-1,27,Site13,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,41.67,186.8,1264.107797,8877.8,2487.3,1496526.9
Site13-CellStream-1,27,Site13,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,47.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,47.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,47.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.41,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17,173.7,1060.58611,118997.6,65964.4,8799677.38
Site13-CellStream-1,27,Site13,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.5,171.7,1094.349781,116476.3,64956.6,8613231.38
Site13-CellStream-1,27,Site13,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.94,166.3,1125.622471,114338.7,65168.8,8455159.37
Site13-CellStream-1,27,Site13,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,87.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,87.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,87.56,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.57,278,1691.100243,20088.9,5475.8,120579.17
Site13-CellStream-1,27,Site13,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,75.15,261.6,1661.169941,19706.9,5380.1,118286.3
Site13-CellStream-1,27,Site13,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,75.7,247.7,1667.80441,19643.3,5468.3,117904.56
Site13-CellStream-1,27,Site13,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.7,119.7,728.2015525,8410.1,2056.9,50479.76
Site13-CellStream-1,27,Site13,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.63,114.2,724.9570557,8284.1,2024.2,49723.48
Site13-CellStream-1,27,Site13,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.19,103.9,699.5365334,8390.7,2098.6,50363.32
Site13-CellStream-1,27,Site13,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.38,505.2,3072.347523,10194.7,3640.7,
Site13-CellStream-1,27,Site13,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,48.42,475.4,3018.754616,10132.0,3596.6,76865.57
Site13-CellStream-1,27,Site13,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,48.14,447.1,3010.132652,10032.3,3648.3,76109.21
Site13-CellStream-1,27,Site13,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.66,271,1648.719138,51868.6,11429.7,11680924.15
Site13-CellStream-1,27,Site13,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,51.87,246.6,1565.800853,51292.1,11267.6,11551095.07
Site13-CellStream-1,27,Site13,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,51.69,231.1,1555.833017,51355.4,11672.1,11565350.37
Site13-CellStream-1,27,Site13,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.38,1480.2,,23789.3,10576.1,5298169.39
Site13-CellStream-1,27,Site13,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.34,1417.6,,23655.5,10392.3,5268370.49
Site13-CellStream-1,27,Site13,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.96,1337.1,,23702.4,10435.1,5278815.69
Site13-CellStream-1,27,Site13,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,40.31,203.6,1238.470049,9049.7,2464.6,1525504.01
Site13-CellStream-1,27,Site13,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41.23,196,1244.737586,8991.5,2483.2,1515693.26
Site13-CellStream-1,27,Site13,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,41.42,185.2,1246.678103,8897.7,2453.0,1499881.43
Site13-CellStream-1,27,Site13,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,47.95,Not reportable,Not reportable,Not reportable,Not reportable,77341.24
Site13-CellStream-1,27,Site13,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,47.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,47.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.99,173.8,1057.078922,118949.7,65995.2,8796135.26
Site13-CellStream-1,27,Site13,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.94,171.8,1091.235149,116358.1,65025.5,8604490.69
Site13-CellStream-1,27,Site13,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.94,166.7,1121.991315,114257.4,166649.75,8449147.37
Site13-CellStream-1,27,Site13,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,87.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,86.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,87.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,75.19,269.6,1647.518814,14156.5,5018.8,84971.26
Site13-CellStream-1,27,Site13,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,74.16,255.5,1629.637938,13789.4,4962.7,82767.82
Site13-CellStream-1,27,Site13,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,74.72,241.4,1633.696601,13797.6,4988.8,82817.04
Site13-CellStream-1,27,Site13,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.68,119.3,729.1396725,4102.8,1688.7,24626.15
Site13-CellStream-1,27,Site13,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.58,113.5,724.0079575,4030.5,1628.2,24192.18
Site13-CellStream-1,27,Site13,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.16,103.4,699.9104191,4069.0,1676.7,24423.27
Site13-CellStream-1,27,Site13,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,50,510.7,3120.558837,9485.6,3602.2,71961.71
Site13-CellStream-1,27,Site13,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,48.95,479.8,3060.102145,9427.0,3570.6,71517.15
Site13-CellStream-1,27,Site13,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,48.76,452,3058.888954,9322.2,3610.1,70722.09
Site13-CellStream-1,27,Site13,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.03,270.8,1654.709913,48617.1,11052.2,10948679.12
Site13-CellStream-1,27,Site13,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,51.3,246.2,1569.923974,48106.8,10900.6,10833758.42
Site13-CellStream-1,27,Site13,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,51.08,230.9,1562.541903,48196.1,11263.0,10853868.98
Site13-CellStream-1,27,Site13,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.37,1473.3,,21906.1,7656.2,4878757.61
Site13-CellStream-1,27,Site13,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.33,1411.7,,21742.8,7611.2,4842388.7
Site13-CellStream-1,27,Site13,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.95,1330.2,,21796.3,7672.1,4854303.81
Site13-CellStream-1,27,Site13,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,41.06,209.7,1281.340442,7633.0,2445.0,1286691.5
Site13-CellStream-1,27,Site13,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41.93,201.2,1282.991703,7601.9,2475.8,1281448.99
Site13-CellStream-1,27,Site13,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,42.1,190.2,1287.842802,7511.5,2422.3,1266210.3
Site13-CellStream-1,27,Site13,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,47.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,47.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,47.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.41,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.97,173.4,1059.362545,118415.3,65944.3,8756617.25
Site13-CellStream-1,27,Site13,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.49,171.4,1093.356945,115969.0,64975.8,8575717.38
Site13-CellStream-1,27,Site13,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.95,166.3,1125.694027,113634.9,65184.2,8403114.51
Site13-CellStream-1,27,Site13,CellStream,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.33,1626.5,9002.5,25508.0,7122.9,5680945
Site13-CellStream-1,27,Site13,CellStream,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.48,1701.3,8784.1,25857.0,7038.1,5758671.59
Site13-CellStream-1,27,Site13,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,57.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,59.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,42.61,46,223.0838703,16123.5,4557.1,96777.74
Site13-CellStream-1,27,Site13,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,40.55,42.6,233.5566958,15339.7,4489.6,92073.15
Site13-CellStream-1,27,Site13,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,44.92,46.2,250.8818012,15261.4,4282.5,91603.17
Site13-CellStream-1,27,Site13,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.56,121.9,590.2925195,8443.1,2006.5,50677.84
Site13-CellStream-1,27,Site13,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.38,97.6,534.5105607,8324.5,1967.7,49965.97
Site13-CellStream-1,27,Site13,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.84,103.3,561.0668511,8283.6,1947.6,49720.47
Site13-CellStream-1,27,Site13,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.59,652.9,3160.535845,13824.3,4963.4,104876.9
Site13-CellStream-1,27,Site13,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.59,579.8,3176.892007,13637.2,4925.8,103457.48
Site13-CellStream-1,27,Site13,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,73.14,588,3195.056693,13584.9,4911.4,103060.71
Site13-CellStream-1,27,Site13,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.58,493.5,2388.865495,52022.1,11109.0,11715492.7
Site13-CellStream-1,27,Site13,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.94,440.3,2412.406242,52061.7,10978.0,11724410.7
Site13-CellStream-1,27,Site13,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.51,444,2412.598222,51833.6,10987.1,11673042.08
Site13-CellStream-1,27,Site13,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.95,1073.1,,21524.2,8453.4,4793703.79
Site13-CellStream-1,27,Site13,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.77,948.2,,21601.9,8357.5,4811008.54
Site13-CellStream-1,27,Site13,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.95,956,,21415.8,8369.3,4769561.78
Site13-CellStream-1,27,Site13,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.88,149.4,723.1219126,9352.0,2363.8,1576462.59
Site13-CellStream-1,27,Site13,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.46,130.2,713.4766348,9283.1,2346.8,1564848.146
Site13-CellStream-1,27,Site13,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23,135.2,734.6714608,9202.4,2284.1,1551244.58
Site13-CellStream-1,27,Site13,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,39.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,40.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,41.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,10.08,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,10.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.87,97.8,473.4287199,151749.6,96602.8,11221634.08
Site13-CellStream-1,27,Site13,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.14,87.8,480.8967096,144459.2,95556.5,10682520.95
Site13-CellStream-1,27,Site13,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.04,88.8,482.282862,147442.1,95498.9,10903101.51
Site13-CellStream-1,27,Site13,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,58.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,59.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,43.75,50.2,240.7007243,16210.8,4436.1,97301.74
Site13-CellStream-1,27,Site13,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,41.34,45.8,248.5999379,15427.6,4336.6,92600.75
Site13-CellStream-1,27,Site13,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,45.49,49.4,265.7979838,15404.7,4172.1,92463.3
Site13-CellStream-1,27,Site13,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.46,121.5,582.0248867,8465.0,2003.9,50809.29
Site13-CellStream-1,27,Site13,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.32,97.3,528.274868,8345.1,1968.5,50089.61
Site13-CellStream-1,27,Site13,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.73,102.6,552.714748,8301.1,1958.3,49825.51
Site13-CellStream-1,27,Site13,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.54,654.6,3136.419666,13826.9,4963.0,104896.62
Site13-CellStream-1,27,Site13,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.56,581.1,3154.380527,13637.2,4925.8,103457.48
Site13-CellStream-1,27,Site13,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,73.11,589.2,3173.043427,13585.9,4914.1,103068.3
Site13-CellStream-1,27,Site13,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.63,495,2372.068549,52038.4,11116.3,11719163.49
Site13-CellStream-1,27,Site13,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.96,441.4,2396.107706,52065.1,10992.6,11725176.39
Site13-CellStream-1,27,Site13,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.55,445.2,2397.301558,51837.7,11001.7,11673965.41
Site13-CellStream-1,27,Site13,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.98,1084.2,,21542.0,8569.5,4797668.07
Site13-CellStream-1,27,Site13,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.79,957,,21622.7,8450.2,4815640.95
Site13-CellStream-1,27,Site13,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.93,964.7,,21433.8,8472.1,4773570.6
Site13-CellStream-1,27,Site13,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.91,150,718.5545517,9348.4,2349.3,1575855.74
Site13-CellStream-1,27,Site13,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.49,130.7,709.5635771,9286.7,2329.3,1565455
Site13-CellStream-1,27,Site13,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.05,135.8,731.3710974,9206.8,2280.1,1551986.29
Site13-CellStream-1,27,Site13,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,39.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,40.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,41.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,10.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,11.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.88,98.2,470.4360739,151707.1,96386.1,11218491.27
Site13-CellStream-1,27,Site13,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.15,88.1,478.2753131,144455.9,95543.1,10682276.92
Site13-CellStream-1,27,Site13,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.05,89.1,479.7589611,146983.7,95159.3,10869203.59
Site13-CellStream-1,27,Site13,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,57.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,59.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,59.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,40.5,43.9,212.2537631,10304.1,3668.8,61848.08
Site13-CellStream-1,27,Site13,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,38.75,41.1,224.7199136,9705.5,3596.1,58255.11
Site13-CellStream-1,27,Site13,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,43.04,44.4,240.8780144,9711.1,3414.6,58288.73
Site13-CellStream-1,27,Site13,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.42,120.7,583.5893343,3963.9,1528.7,23792.43
Site13-CellStream-1,27,Site13,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.27,96.7,529.2246108,3873.0,1494.5,23246.82
Site13-CellStream-1,27,Site13,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.71,102.1,554.5571074,3866.9,1492.8,23210.21
Site13-CellStream-1,27,Site13,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,72.66,653.2,3159.499267,13087.9,4927.0,99290.26
Site13-CellStream-1,27,Site13,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.63,440.4,3174.697246,12896.2,4891.7,97835.95
Site13-CellStream-1,27,Site13,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,73.22,588.6,3195.720015,12846.8,4880.6,97461.18
Site13-CellStream-1,27,Site13,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.56,493.6,2387.312264,48870.9,10732.2,11005835.44
Site13-CellStream-1,27,Site13,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.92,580.1,2410.129204,48900.4,10638.7,11012478.91
Site13-CellStream-1,27,Site13,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.51,444.5,2413.081538,48710.8,10649.7,10969780.57
Site13-CellStream-1,27,Site13,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.96,1074.1,,19865.5,5493.6,4424290.92
Site13-CellStream-1,27,Site13,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.79,949.3,,19926.9,5495.8,4437965.46
Site13-CellStream-1,27,Site13,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.92,956.9,,19753.1,5471.3,4399258.06
Site13-CellStream-1,27,Site13,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.99,150.2,726.2854991,7964.0,2259.6,1342488.03
Site13-CellStream-1,27,Site13,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.58,131,716.8706168,7890.5,2239.2,1330098.17
Site13-CellStream-1,27,Site13,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,23.13,136.1,739.086872,7844.4,2190.6,1322327.11
Site13-CellStream-1,27,Site13,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,39.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,40.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,41.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,10.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.16,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,10.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.85,97.5,471.7112005,151167.5,95776.3,11178588.73
Site13-CellStream-1,27,Site13,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.14,87.8,480.4431535,144044.0,95466.6,10651817.59
Site13-CellStream-1,27,Site13,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.03,88.6,481.2183548,146256.6,94743.2,10815435.73
Site13-CellStream-1,27,Site13,CellStream,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.45,985.5,5194.9,23067.8,5577.9,5137482.48
Site13-CellStream-1,27,Site13,CellStream,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97.81,1060.3,5789.2,23093.0,5629.2,5143094.83
Site13-CellStream-1,27,Site13,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,71.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,71.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,70.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,62.71,167.2,666.0291904,17479.8,5438.2,104918.63
Site13-CellStream-1,27,Site13,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,60.88,159.6,657.7099522,17332.1,5576.6,104032.09
Site13-CellStream-1,27,Site13,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,61.43,168.1,716.7878287,17053.3,5416.6,102358.66
Site13-CellStream-1,27,Site13,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.05,110.5,439.9380501,9166.6,2142.6,55020.49
Site13-CellStream-1,27,Site13,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.76,100.8,415.5093051,9154.6,2085.1,54948.46
Site13-CellStream-1,27,Site13,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.03,99.8,425.6682527,9031.6,2085.2,54210.18
Site13-CellStream-1,27,Site13,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.02,960.6,3825.752539,12878.3,4695.6,97700.15
Site13-CellStream-1,27,Site13,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,69.68,905.4,3731.098093,12933.1,4669.9,98115.89
Site13-CellStream-1,27,Site13,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.07,859.1,3663.78746,12922.6,4688.8,98036.23
Site13-CellStream-1,27,Site13,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.61,668.7,2662.977764,55194.8,11544.5,12429991.8
Site13-CellStream-1,27,Site13,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,69.69,631,2600.061342,55335.3,11676.1,12461632.71
Site13-CellStream-1,27,Site13,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.84,600,2558.698118,55460.2,11632.1,12489760.47
Site13-CellStream-1,27,Site13,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.04,1716.4,,23636.7,9644.9,5264183.5
Site13-CellStream-1,27,Site13,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.97,1658.9,,23695.6,10084.7,5277301.25
Site13-CellStream-1,27,Site13,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.99,1602.9,,23601.7,10084.3,5256388.57
Site13-CellStream-1,27,Site13,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.55,255,1015.701634,10232.6,3041.9,1724904.95
Site13-CellStream-1,27,Site13,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.29,238,980.8838562,10450.3,3092.3,1761602.54
Site13-CellStream-1,27,Site13,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.18,224.9,959.3164359,10208.2,3092.1,1720791.85
Site13-CellStream-1,27,Site13,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,46.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,43.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,15.54,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.99,109.7,436.8058051,156442.1,94890.3,11568636.76
Site13-CellStream-1,27,Site13,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.36,108.6,447.438369,154245.9,93966.5,11406231.37
Site13-CellStream-1,27,Site13,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.51,105.8,451.3845256,153417.8,92899.2,11344994.73
Site13-CellStream-1,27,Site13,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,72.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,72.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,71.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,62.64,174.4,687.9994981,17565.4,5391.8,105432.42
Site13-CellStream-1,27,Site13,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,60.96,167.7,683.4986338,17296.2,5578.1,103816.61
Site13-CellStream-1,27,Site13,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,61.53,176.7,744.7531321,17121.7,5367.7,102769.21
Site13-CellStream-1,27,Site13,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.98,109.6,432.6623869,9201.9,2121.3,55232.37
Site13-CellStream-1,27,Site13,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.7,100.2,408.6194996,9201.3,2084.9,55228.77
Site13-CellStream-1,27,Site13,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.96,99.2,418.1341087,9065.9,2104.5,54416.06
Site13-CellStream-1,27,Site13,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,69.82,960,3787.876671,12880.6,4693.3,97717.6
Site13-CellStream-1,27,Site13,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,69.46,904.4,3686.823501,12938.2,4666.4,98154.58
Site13-CellStream-1,27,Site13,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68.91,859,3615.407308,12923.8,4685.9,98045.33
Site13-CellStream-1,27,Site13,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.81,670.1,2644.220339,55194.4,11557.3,12429901.72
Site13-CellStream-1,27,Site13,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,69.89,632.1,2576.63619,55339.8,11678.1,12462646.12
Site13-CellStream-1,27,Site13,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,70.02,601.5,2534.069553,55460.3,11652.8,12489782.99
Site13-CellStream-1,27,Site13,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.05,1732.3,,23647.7,9561.3,5266633.33
Site13-CellStream-1,27,Site13,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.98,1676.9,,23703.4,9934.1,5279038.41
Site13-CellStream-1,27,Site13,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.01,1622.5,,23606.5,10019.0,5257457.59
Site13-CellStream-1,27,Site13,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.38,253.2,999.0593491,10242.8,3016.7,1726624.36
Site13-CellStream-1,27,Site13,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.15,236.5,964.0688474,10458.6,3069.4,1763001.67
Site13-CellStream-1,27,Site13,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.02,223.5,941.678998,10214.7,3070.3,1721887.55
Site13-CellStream-1,27,Site13,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,46.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,43.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,16.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.71,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.02,110.2,434.9195105,156327.0,94598.3,11560125.3
Site13-CellStream-1,27,Site13,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.37,109,444.4732998,153947.8,93609.6,11384187.36
Site13-CellStream-1,27,Site13,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.53,106.3,447.7501869,153384.7,92550.9,11342547.04
Site13-CellStream-1,27,Site13,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,71.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,71.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,70.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,59.74,156.1,623.3609892,12314.9,4717.3,73917.46
Site13-CellStream-1,27,Site13,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,58.17,150.6,621.3353012,12027.3,4801.9,72191.2
Site13-CellStream-1,27,Site13,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,58.8,158.3,676.3144026,11810.5,4611.7,70889.91
Site13-CellStream-1,27,Site13,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.95,109,435.4674798,4475.7,1725.0,26864.4
Site13-CellStream-1,27,Site13,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.67,99.6,411.008407,4436.4,1650.2,26628.51
Site13-CellStream-1,27,Site13,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.95,98.9,422.5186739,4356.4,1671.4,26148.33
Site13-CellStream-1,27,Site13,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.45,965.9,3857.52799,12102.1,4676.6,91811.57
Site13-CellStream-1,27,Site13,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.18,911.6,3760.259051,12160.4,4661.1,92253.86
Site13-CellStream-1,27,Site13,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.5,864.6,3692.272614,12142.4,4676.7,92117.31
Site13-CellStream-1,27,Site13,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.24,668.8,2670.914802,51882.2,11206.8,11683986.9
Site13-CellStream-1,27,Site13,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,69.28,631.6,2605.260645,51996.9,11304.8,11709817.6
Site13-CellStream-1,27,Site13,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.52,601.1,2566.694247,52105.9,11297.7,11734364.64
Site13-CellStream-1,27,Site13,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.04,1711.6,,21770.6,6652.8,4848580.1
Site13-CellStream-1,27,Site13,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.97,1657.3,,21804.7,7119.6,4856174.59
Site13-CellStream-1,27,Site13,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.99,1600.8,,21721.8,7059.0,4837711.74
Site13-CellStream-1,27,Site13,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.98,260.6,1040.695889,8737.4,2950.4,1472859.73
Site13-CellStream-1,27,Site13,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.7,243.4,1003.983408,8900.7,2998.9,1500387.14
Site13-CellStream-1,27,Site13,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.53,229.4,979.6173699,8704.7,2990.2,1467347.51
Site13-CellStream-1,27,Site13,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,46.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,43.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,15.26,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15.62,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8,109.8,438.1802281,155473.9,93793.4,11497039.95
Site13-CellStream-1,27,Site13,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.34,108.3,446.8546744,153468.7,93241.2,11348758.7
Site13-CellStream-1,27,Site13,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.5,105.7,451.5401586,152244.8,92126.2,11258253.3
Site13-CellStream-1,27,Site13,CellStream,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.25,1299.1,6835.84,25306.4,6550.9,5636046.2
Site13-CellStream-1,27,Site13,CellStream,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.25,1289.3,6717.88,25341.2,6582.9,5643796.59
Site13-CellStream-1,27,Site13,CellStream,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,480.6,2451.366618,41433.5,22184.6,9227749.51
Site13-CellStream-1,27,Site13,CellStream,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,520.8,2702.063694,41495.9,23456.8,9241646.76
Site13-CellStream-1,27,Site13,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.1,121.6,398.3969464,10325.2,2652.1,61974.73
Site13-CellStream-1,27,Site13,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.29,121.3,347.7857343,9058.2,2333.6,54369.84
Site13-CellStream-1,27,Site13,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.77,118.8,389.5496469,9051.7,2329.0,54330.82
Site13-CellStream-1,27,Site13,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.47,86.1,282.074779,5092.1,554.9,30564.2
Site13-CellStream-1,27,Site13,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.44,93.4,267.9720872,4846.6,538.4,29090.64
Site13-CellStream-1,27,Site13,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.53,86.8,284.5257803,4792.1,544.6,28763.52
Site13-CellStream-1,27,Site13,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.5,425.5,1393.638011,25822.6,7762.2,195901
Site13-CellStream-1,27,Site13,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,72.43,503.4,1443.791571,25822.6,7762.2,195901
Site13-CellStream-1,27,Site13,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.36,426.1,1397.406634,25805.1,7757.5,195768.24
Site13-CellStream-1,27,Site13,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.21,273.2,894.8775732,109699.3,22470.2,24704526.5
Site13-CellStream-1,27,Site13,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.26,323.5,927.8139441,106671.6,22262.1,24022681.72
Site13-CellStream-1,27,Site13,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.33,274.1,898.9050629,108204.7,23432.7,24367939.25
Site13-CellStream-1,27,Site13,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,748.4,,25701.2,11806.8,5723973.01
Site13-CellStream-1,27,Site13,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,854.7,,25320.5,10902.7,5639186.45
Site13-CellStream-1,27,Site13,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,747.5,,25252.3,11300.2,5623997.47
Site13-CellStream-1,27,Site13,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.77,152.2,498.4495544,18741.1,1644.3,3159179.11
Site13-CellStream-1,27,Site13,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.69,179.7,515.3471041,18871.4,1701.3,3181143.72
Site13-CellStream-1,27,Site13,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.64,151.9,498.0364067,18564.2,1704.1,3129359.15
Site13-CellStream-1,27,Site13,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,17.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.01,83.4,273.0591634,822.6,1735.4,60829.92
Site13-CellStream-1,27,Site13,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.03,97.5,279.7418416,807.8,1586.0,59735.49
Site13-CellStream-1,27,Site13,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.03,83.8,274.8090053,799.9,1509.5,59151.29
Site13-CellStream-1,27,Site13,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.11,121.6,398.4656048,11757.4,2839.3,70571.19
Site13-CellStream-1,27,Site13,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.28,121.3,347.9959085,10450.3,2538.4,62725.61
Site13-CellStream-1,27,Site13,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.76,118.8,389.5849038,10464.8,2510.6,62812.64
Site13-CellStream-1,27,Site13,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.47,86.1,282.0348877,11328.5,1379.4,67996.81
Site13-CellStream-1,27,Site13,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.44,93.4,267.9195436,10929.0,1215.9,65598.9
Site13-CellStream-1,27,Site13,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.52,86.7,284.4104173,10855.7,1287.2,65158.94
Site13-CellStream-1,27,Site13,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.5,425.5,1393.645111,26382.4,7908.9,200147.88
Site13-CellStream-1,27,Site13,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,72.44,503.4,1443.844114,26249.2,7846.6,199137.37
Site13-CellStream-1,27,Site13,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.37,426.1,1397.451076,26359.1,7901.2,199971.11
Site13-CellStream-1,27,Site13,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.22,273.2,895.0190366,113803.4,21868.9,25628778.95
Site13-CellStream-1,27,Site13,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.27,323.6,928.0241183,110751.9,21906.3,24941574.36
Site13-CellStream-1,27,Site13,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.33,274.1,899.0222076,112265.3,22730.2,25282395.41
Site13-CellStream-1,27,Site13,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,748.4,,27951.8,11935.7,6225209.28
Site13-CellStream-1,27,Site13,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,854.7,,27515.9,11027.5,6128129
Site13-CellStream-1,27,Site13,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,747.6,,27443.3,11443.6,6111960.09
Site13-CellStream-1,27,Site13,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.75,152.1,498.2633622,19864.0,1756.4,3348465.88
Site13-CellStream-1,27,Site13,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.68,179.6,515.1894734,19971.4,1786.5,3366570.25
Site13-CellStream-1,27,Site13,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.63,151.9,497.9637235,19674.2,1800.2,3316471.37
Site13-CellStream-1,27,Site13,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.87,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,17.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.19,84.4,276.542384,1223.4,1837.0,90468.42
Site13-CellStream-1,27,Site13,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.02,97.4,279.4265803,1208.0,1698.5,89329.62
Site13-CellStream-1,27,Site13,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.05,83.9,275.1075143,1200.2,1540.7,88752.82
Site13-CellStream-1,27,Site13,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.07,121.6,398.4390549,11755.1,2824.2,70557.38
Site13-CellStream-1,27,Site13,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.23,121.1,347.4928179,10450.9,2535.9,62729.21
Site13-CellStream-1,27,Site13,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.73,118.7,389.1361671,10464.8,2510.6,62812.64
Site13-CellStream-1,27,Site13,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.47,86.2,282.260051,11328.3,2824.2,67995.61
Site13-CellStream-1,27,Site13,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.43,93.4,267.9367728,10928.0,1210.8,65592.9
Site13-CellStream-1,27,Site13,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.52,86.8,284.5257803,10855.8,1307.5,65159.53
Site13-CellStream-1,27,Site13,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.5,425.8,1394.71806,26382.9,7908.3,200151.67
Site13-CellStream-1,27,Site13,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,72.41,503.5,1444.304793,26249.9,7844.4,199142.68
Site13-CellStream-1,27,Site13,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.35,426.3,1397.871799,26359.1,7900.6,199971.11
Site13-CellStream-1,27,Site13,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.19,273.3,895.2830733,113589.1,19861.4,25580518.11
Site13-CellStream-1,27,Site13,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.27,323.6,928.2939847,110565.8,20011.1,24899664.23
Site13-CellStream-1,27,Site13,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.34,274.3,899.3702277,112033.6,20802.4,25230216.05
Site13-CellStream-1,27,Site13,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,748.3,,27951.2,11887.9,6225075.66
Site13-CellStream-1,27,Site13,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,854.6,,27516.1,11045.2,6128173.54
Site13-CellStream-1,27,Site13,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,747.5,,27443.3,11443.6,6111960.09
Site13-CellStream-1,27,Site13,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.79,152.4,499.227709,19862.9,1734.3,3348280.45
Site13-CellStream-1,27,Site13,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.69,179.7,515.4853385,19971.4,1782.3,3366570.25
Site13-CellStream-1,27,Site13,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.64,151.9,498.1397767,19674.0,1796.0,3316437.66
Site13-CellStream-1,27,Site13,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,81.37,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,17.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-1,27,Site13,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.06,83.7,274.331689,1227.0,1843.3,90734.64
Site13-CellStream-1,27,Site13,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.98,97.2,278.8139864,1209.7,1700.9,89455.33
Site13-CellStream-1,27,Site13,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.97,83.5,273.7753058,1202.8,1518.7,88945.09
Site13-CellStream-2,28,Site13,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,87.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,86.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,87.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.1,284.6,1067.146244,13228.0,4691.8,89252.79
Site13-CellStream-2,28,Site13,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,77.43,248.1,998.2267846,12934.2,4647.8,87270.44
Site13-CellStream-2,28,Site13,CellStream,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77.01,257.8,1026.142538,12917.2,4584.7,87155.74
Site13-CellStream-2,28,Site13,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.48,111.8,419.2268164,3960.5,1532.8,26722.53
Site13-CellStream-2,28,Site13,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.65,105.6,425.0226656,4051.2,1513.1,27334.51
Site13-CellStream-2,28,Site13,CellStream,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.19,102.6,408.5387496,3967.4,1517.1,26769.09
Site13-CellStream-2,28,Site13,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,48.18,469.1,1759.154101,10405.4,3945.3,75072.17
Site13-CellStream-2,28,Site13,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,46.72,423.4,1704.021205,10279.8,3974.7,74166
Site13-CellStream-2,28,Site13,CellStream,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,47.27,433.6,1726.179907,10371.4,4028.6,74826.87
Site13-CellStream-2,28,Site13,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,54.3,254.7,955.2492956,49096.5,11401.8,10826173.11
Site13-CellStream-2,28,Site13,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,53.37,226,909.3965234,48717.6,11432.9,10742622.62
Site13-CellStream-2,28,Site13,CellStream,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,52.32,226.9,903.1402307,48835.6,11824.7,10768642.56
Site13-CellStream-2,28,Site13,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.65,1478.9,,23717.1,8226.8,4939414.68
Site13-CellStream-2,28,Site13,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.7,1378.1,,23388.1,8075.0,4870895.87
Site13-CellStream-2,28,Site13,CellStream,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.59,1393,,23503.1,8309.0,4894846.22
Site13-CellStream-2,28,Site13,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,39.49,185.3,694.715041,6447.7,2097.3,1324557.29
Site13-CellStream-2,28,Site13,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,40.16,170,684.3074545,6450.8,2084.8,1325194.12
Site13-CellStream-2,28,Site13,CellStream,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,40.59,176,700.6854316,6460.7,2097.6,1327227.89
Site13-CellStream-2,28,Site13,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,42.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,40.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,41.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.9,174.3,653.5916233,142821.7,80167.7,9345078.15
Site13-CellStream-2,28,Site13,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.78,161.2,648.6705356,139833.7,79701.7,9149567.99
Site13-CellStream-2,28,Site13,CellStream,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.92,164.3,654.2841396,140030.2,79368.8,9162425.33
Site13-CellStream-2,28,Site13,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,88.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,87.64,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,87.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78.69,282.2,1053.628533,17987.3,4893.7,121365.04
Site13-CellStream-2,28,Site13,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,78.33,243.9,976.4201452,17662.2,4842.3,119171.5
Site13-CellStream-2,28,Site13,CellStream,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,78.04,254.6,1007.56514,17680.6,4879.4,119295.65
Site13-CellStream-2,28,Site13,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.6,117.7,439.4182822,7363.2,1937.0,49681.44
Site13-CellStream-2,28,Site13,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.73,111.4,445.9836809,7389.2,1900.5,49856.87
Site13-CellStream-2,28,Site13,CellStream,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.32,108.6,429.9545874,7340.1,1906.1,49525.58
Site13-CellStream-2,28,Site13,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,48.65,493.7,1842.887422,10882.4,3976.1,78513.6
Site13-CellStream-2,28,Site13,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,47.05,446.8,1788.626545,10727.8,4006.1,77398.2
Site13-CellStream-2,28,Site13,CellStream,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,47.57,456.7,1807.17502,10818.9,4061.3,78055.46
Site13-CellStream-2,28,Site13,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,53.27,263,981.632722,53253.8,12044.1,11742891.2
Site13-CellStream-2,28,Site13,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,52.46,234.4,938.2339329,52858.0,12192.4,11655614.11
Site13-CellStream-2,28,Site13,CellStream,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,51.33,234.4,927.6814591,53067.2,12445.3,11701744.4
Site13-CellStream-2,28,Site13,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.95,1485.6,,25963.3,12920.1,5407216.96
Site13-CellStream-2,28,Site13,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.95,1385.4,,25611.6,12575.0,5333970.56
Site13-CellStream-2,28,Site13,CellStream,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.76,1401.3,,25734.8,12842.1,5359628.66
Site13-CellStream-2,28,Site13,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,39.34,194.2,724.9631647,7358.4,2082.6,1511643.28
Site13-CellStream-2,28,Site13,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,39.63,177.1,708.8560024,7347.5,2057.8,1509404.08
Site13-CellStream-2,28,Site13,CellStream,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,40.48,184.9,731.5799062,7341.4,2087.2,1508150.95
Site13-CellStream-2,28,Site13,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,44.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,42.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.62,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.14,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.48,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,18.42,186.9,697.6278568,142675.5,82779.2,9335512.02
Site13-CellStream-2,28,Site13,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.37,174.4,698.2994044,139144.1,82316.9,9104446.23
Site13-CellStream-2,28,Site13,CellStream,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.44,177,700.6571909,140684.0,81567.3,9205204.63
Site13-CellStream-2,28,Site13,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,86.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,86.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,86.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.81,268.1,1021.448055,12917.3,4622.3,87156.42
Site13-CellStream-2,28,Site13,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,76.91,234.6,956.8846222,12606.5,4590.8,85059.37
Site13-CellStream-2,28,Site13,CellStream,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76.53,245.1,986.732612,12593.1,4521.6,84968.95
Site13-CellStream-2,28,Site13,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.36,114.2,435.3498315,3775.8,1565.1,25476.31
Site13-CellStream-2,28,Site13,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.52,108.3,441.5982036,3836.4,1515.5,25885.2
Site13-CellStream-2,28,Site13,CellStream,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.04,105.1,423.035225,3752.0,1508.3,25315.73
Site13-CellStream-2,28,Site13,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,47.56,478.4,1822.732733,10331.5,3943.5,74539
Site13-CellStream-2,28,Site13,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,46.07,433,1765.9945,10181.2,3981.8,73454.63
Site13-CellStream-2,28,Site13,CellStream,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,46.69,444.4,1789.28038,10287.8,4028.9,74223.72
Site13-CellStream-2,28,Site13,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,54.6,261.2,995.1227495,49481.8,11561.5,10911134.86
Site13-CellStream-2,28,Site13,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,53.7,232.5,948.2544709,49082.6,11658.4,10823108.05
Site13-CellStream-2,28,Site13,CellStream,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,52.53,233.4,939.9326196,49230.4,11935.5,10855699.14
Site13-CellStream-2,28,Site13,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.97,1455.7,,24060.4,9522.7,5010911.67
Site13-CellStream-2,28,Site13,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.95,1359.9,,23735.2,9322.3,4943184.26
Site13-CellStream-2,28,Site13,CellStream,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.76,1377.3,,23865.2,9596.1,4970258.56
Site13-CellStream-2,28,Site13,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,38.71,185.2,705.5443869,6495.1,2012.8,1334294.72
Site13-CellStream-2,28,Site13,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,39.34,170.2,693.9969363,6489.7,1999.1,1333185.39
Site13-CellStream-2,28,Site13,CellStream,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,39.94,177.5,714.7158497,6476.8,2017.4,1330535.33
Site13-CellStream-2,28,Site13,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,43.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,42.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.24,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.98,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,22.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.98,180.8,688.9109848,143877.9,81131.9,9414187.2
Site13-CellStream-2,28,Site13,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.8,167.3,682.4458107,141244.6,80220.4,9241885.69
Site13-CellStream-2,28,Site13,CellStream,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.91,170.4,686.3998879,142377.4,79536.6,9316006.81
Site13-CellStream-2,28,Site13,CellStream,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.89,1432.2,5545.602456,33657.0,19502.9,7009536.58
Site13-CellStream-2,28,Site13,CellStream,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.05,1523.3,5893.474369,33343.5,19404.9,6944245.86
Site13-CellStream-2,28,Site13,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,56.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,56.23,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,55.71,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,52.01,61.2,200.3435971,9932.5,3417.4,67017.19
Site13-CellStream-2,28,Site13,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,49.27,55.7,190.2374181,9525.9,3292.2,64273.75
Site13-CellStream-2,28,Site13,CellStream,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,53.43,66.5,210.2979027,9547.1,3348.3,64416.79
Site13-CellStream-2,28,Site13,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.3,132.2,432.5581024,3964.2,1421.9,26747.5
Site13-CellStream-2,28,Site13,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12,106.2,362.7329262,3809.6,1389.5,25704.37
Site13-CellStream-2,28,Site13,CellStream,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.14,135.2,427.4739053,3847.6,1412.3,25960.77
Site13-CellStream-2,28,Site13,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.22,658.5,2154.354095,14220.7,5349.8,102598.54
Site13-CellStream-2,28,Site13,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.18,647.7,2212.984941,14054.4,5253.6,101398.73
Site13-CellStream-2,28,Site13,CellStream,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.57,684.6,2163.936187,14133.4,5289.1,101968.69
Site13-CellStream-2,28,Site13,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.7,498.5,1630.78495,49611.7,11073.7,10939778.86
Site13-CellStream-2,28,Site13,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.53,489.2,1671.559572,49641.4,11113.4,10946327.95
Site13-CellStream-2,28,Site13,CellStream,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.71,518.3,1638.277407,49474.8,11107.7,10909591.31
Site13-CellStream-2,28,Site13,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.78,1143.5,,21685.5,6176.0,4516305.83
Site13-CellStream-2,28,Site13,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.53,1094.8,,21670.2,6182.9,4513119.4
Site13-CellStream-2,28,Site13,CellStream,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.63,1183.5,,21487.4,6223.9,4475048.77
Site13-CellStream-2,28,Site13,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.9,150.8,493.3173473,6792.0,1899.6,1395287.17
Site13-CellStream-2,28,Site13,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.74,147.3,503.2250846,6730.2,1886.5,1382591.54
Site13-CellStream-2,28,Site13,CellStream,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.71,155.5,491.3542576,6749.2,1929.6,1386494.73
Site13-CellStream-2,28,Site13,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,35.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,35.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,34.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,10.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,10.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,10.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.2,103.6,338.9053533,184011.9,115316.2,12040226.28
Site13-CellStream-2,28,Site13,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.53,102,348.6412656,182017.9,113345.8,11909755.31
Site13-CellStream-2,28,Site13,CellStream,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.08,106,335.1354149,179962.3,113294.1,11775253.74
Site13-CellStream-2,28,Site13,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,56.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,57.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,56.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,57.03,62.9,205.749722,14527.7,3954.9,98022.21
Site13-CellStream-2,28,Site13,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,54.35,57.2,195.3239445,14104.3,3996.6,95165.42
Site13-CellStream-2,28,Site13,CellStream,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,57.9,68.2,215.2505719,14040.8,4073.4,94736.96
Site13-CellStream-2,28,Site13,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.81,134.6,440.3078143,7527.8,1860.0,50792.04
Site13-CellStream-2,28,Site13,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.66,108.8,371.3189571,7343.2,1883.4,49546.5
Site13-CellStream-2,28,Site13,CellStream,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.73,138,435.5668733,7374.8,1920.3,49759.71
Site13-CellStream-2,28,Site13,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.42,695.9,2276.969272,14711.3,5410.1,106138.09
Site13-CellStream-2,28,Site13,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.15,682.6,2329.221083,14559.2,5324.7,105040.73
Site13-CellStream-2,28,Site13,CellStream,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.74,720.8,2275.199404,14619.0,5348.2,105472.17
Site13-CellStream-2,28,Site13,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.68,526.6,1723.132614,53787.2,12034.4,11860510.19
Site13-CellStream-2,28,Site13,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.56,515.8,1760.034901,53806.6,12080.9,11864788.04
Site13-CellStream-2,28,Site13,CellStream,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.73,545.9,1723.034893,53591.3,12033.2,11817312.66
Site13-CellStream-2,28,Site13,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.07,1143.3,,23404.9,9803.6,4874394.71
Site13-CellStream-2,28,Site13,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.88,1096.3,,23399.9,9722.9,4873353.39
Site13-CellStream-2,28,Site13,CellStream,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.95,1185.1,,23185.9,9742.3,4828784.92
Site13-CellStream-2,28,Site13,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.67,157.8,516.1641741,7673.5,1974.3,1576374.57
Site13-CellStream-2,28,Site13,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.43,153.1,522.5593725,7597.5,1962.3,1560761.82
Site13-CellStream-2,28,Site13,CellStream,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.48,162,511.3810954,7620.7,2000.8,1565527.82
Site13-CellStream-2,28,Site13,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,37.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,37.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,36.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,9.64,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,9.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,9.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.39,110.9,363.0025128,184651.1,116578.9,12082050.27
Site13-CellStream-2,28,Site13,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.74,109.6,373.9470136,182710.7,115199.9,11955086.45
Site13-CellStream-2,28,Site13,CellStream,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11.22,112.7,355.8889591,179833.1,114903.8,11766799.96
Site13-CellStream-2,28,Site13,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,54.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,55.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,54.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,45.44,41.3,139.736938,9580.4,3408.6,64641.47
Site13-CellStream-2,28,Site13,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,43.09,37.3,131.6198899,9221.1,3290.7,62217.18
Site13-CellStream-2,28,Site13,CellStream,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,47.6,46.1,150.7155792,9228.6,3329.3,62267.79
Site13-CellStream-2,28,Site13,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.72,132.2,447.0524737,3746.2,1414.4,25276.6
Site13-CellStream-2,28,Site13,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.49,106,373.7408992,3604.8,1374.5,24322.53
Site13-CellStream-2,28,Site13,CellStream,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.46,133.7,437.4579776,3634.2,1383.1,24520.9
Site13-CellStream-2,28,Site13,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.58,689.4,2331.650899,14140.4,5368.8,102019.2
Site13-CellStream-2,28,Site13,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.33,676.3,2385.457153,13993.5,5273.2,100959.35
Site13-CellStream-2,28,Site13,CellStream,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72.01,714.8,2339.429832,14048.6,5306.2,101356.88
Site13-CellStream-2,28,Site13,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.76,522.3,1766.535691,50053.6,11537.3,11037221.36
Site13-CellStream-2,28,Site13,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.73,512.1,1806.399741,50089.9,11559.3,11045225.8
Site13-CellStream-2,28,Site13,CellStream,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.87,542.4,6.754158886,49949.9,11557.6,11014354.68
Site13-CellStream-2,28,Site13,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.07,1106,,21813.9,6249.3,4543046.91
Site13-CellStream-2,28,Site13,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.87,1060.1,,21789.3,6295.2,4537923.62
Site13-CellStream-2,28,Site13,CellStream,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.96,1143,,21628.1,6339.7,4504351.49
Site13-CellStream-2,28,Site13,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.79,157.1,531.4585182,6792.6,1888.3,1395410.43
Site13-CellStream-2,28,Site13,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,22.56,152.6,538.134317,6729.4,1873.4,1382427.19
Site13-CellStream-2,28,Site13,CellStream,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.65,161.9,529.7746083,6748.9,1910.7,1386433.1
Site13-CellStream-2,28,Site13,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,37,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,87.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,36.06,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,8.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,8.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,8.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.16,107.5,363.4393878,186684.2,115417.3,12215079.63
Site13-CellStream-2,28,Site13,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.49,105.9,373.6532695,184636.2,113935.9,12081075.34
Site13-CellStream-2,28,Site13,CellStream,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,11,109.2,357.5155145,182961.5,113408.7,11971496.74
Site13-CellStream-2,28,Site13,CellStream,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.52,934.6,3740.826552,53821.0,30986.1,11208968.96
Site13-CellStream-2,28,Site13,CellStream,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.6,1002.7,3863.531353,53882.0,31046.7,11221673.05
Site13-CellStream-2,28,Site13,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,75.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,74.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,70.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,62.9,130.9,371.6930434,11113.5,3969.5,74985.7
Site13-CellStream-2,28,Site13,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,63.21,143.6,418.6356757,10930.1,4082.3,73748.26
Site13-CellStream-2,28,Site13,CellStream,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,65.35,198.8,523.4446249,11230.6,4198.4,75775.81
Site13-CellStream-2,28,Site13,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.03,72.7,206.3942122,4183.2,1535.9,28225.15
Site13-CellStream-2,28,Site13,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.99,70.5,205.3849349,4162.0,1531.1,28082.11
Site13-CellStream-2,28,Site13,CellStream,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.15,107.7,283.4406139,4378.7,1499.7,29544.24
Site13-CellStream-2,28,Site13,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,69.95,843.7,2394.998438,12947.2,4893.0,93410.58
Site13-CellStream-2,28,Site13,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,69.97,823,2399.070835,178574.3,106342.4,1288365.72
Site13-CellStream-2,28,Site13,CellStream,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.46,918,2416.628482,13251.1,4906.7,95603.14
Site13-CellStream-2,28,Site13,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.21,584,1657.666581,52119.1,11546.1,11492680.72
Site13-CellStream-2,28,Site13,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,69.18,569.4,1659.685069,52211.6,11516.5,11513077.72
Site13-CellStream-2,28,Site13,CellStream,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.94,642.1,1690.19205,52405.3,11258.2,11555790.12
Site13-CellStream-2,28,Site13,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.39,1602.3,,23625.4,7854.9,4920316.89
Site13-CellStream-2,28,Site13,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.36,1560.4,,23801.9,7613.1,4957075.46
Site13-CellStream-2,28,Site13,CellStream,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.57,1727.8,,23845.8,7322.7,4966218.24
Site13-CellStream-2,28,Site13,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.8,226.1,641.7484037,7168.3,2490.8,1472590.85
Site13-CellStream-2,28,Site13,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.84,220.9,643.8307887,7290.0,2457.8,1497591.8
Site13-CellStream-2,28,Site13,CellStream,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.22,240.7,633.61826,7320.0,2427.5,1503754.73
Site13-CellStream-2,28,Site13,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,46.02,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,46.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,43.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,14.56,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.32,100.4,285.0074743,168000.6,107195.5,10992578.41
Site13-CellStream-2,28,Site13,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.05,106.5,310.3594571,178574.3,106342.4,11684434.43
Site13-CellStream-2,28,Site13,CellStream,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.18,108.1,284.4953658,184054.1,106871.6,12042987.5
Site13-CellStream-2,28,Site13,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,76.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,75.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,71.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,65.35,129.8,370.0946895,10758.5,5532.3,72590.42
Site13-CellStream-2,28,Site13,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,35.87,143.1,417.2494286,14974.5,4546.8,101036.88
Site13-CellStream-2,28,Site13,CellStream,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,68.39,199.9,520.3672944,15334.4,4708.8,103465.22
Site13-CellStream-2,28,Site13,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.23,79.3,226.0922002,7798.0,2074.6,52615.15
Site13-CellStream-2,28,Site13,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.14,76.3,222.3647176,7785.3,2051.2,52529.46
Site13-CellStream-2,28,Site13,CellStream,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.14,113.2,294.6978045,8163.5,1933.6,55081.28
Site13-CellStream-2,28,Site13,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.02,891.7,2542.293468,13276.1,4905.6,95783.5
Site13-CellStream-2,28,Site13,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.17,872.3,2542.628878,13566.6,4964.5,97879.38
Site13-CellStream-2,28,Site13,CellStream,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.7,969.6,2523.895161,13702.4,4952.3,98859.14
Site13-CellStream-2,28,Site13,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,68.12,607.4,1731.899421,30407.0,5886.6,6704988.05
Site13-CellStream-2,28,Site13,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.07,593.8,1730.852005,56376.3,12115.8,12431427.56
Site13-CellStream-2,28,Site13,CellStream,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,68.9,668,1738.887721,56571.3,11769.9,12474426.63
Site13-CellStream-2,28,Site13,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.45,1595.3,,25709.3,8794.2,5354317.94
Site13-CellStream-2,28,Site13,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.47,1560.5,,25950.0,11438.4,5404447.05
Site13-CellStream-2,28,Site13,CellStream,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.66,1747.3,,25835.2,11510.4,5380538.36
Site13-CellStream-2,28,Site13,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.96,240.4,685.370773,8263.6,2512.7,1697599.39
Site13-CellStream-2,28,Site13,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.24,237.7,692.729212,8303.2,2487.5,1705734.46
Site13-CellStream-2,28,Site13,CellStream,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.49,256.9,668.6643878,8288.1,2448.0,1702632.45
Site13-CellStream-2,28,Site13,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,48.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,49.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,45.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,12.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,13.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,16.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.75,111.5,317.7636505,30028.1,12011.0,1964792.05
Site13-CellStream-2,28,Site13,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.54,118.6,345.781991,182859.8,114402.4,11964842.33
Site13-CellStream-2,28,Site13,CellStream,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.63,120,312.3341596,188721.6,115548.4,12348390.34
Site13-CellStream-2,28,Site13,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,72.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,71.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,67.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,54.27,83.4,248.9565379,10788.8,4081.4,72794.87
Site13-CellStream-2,28,Site13,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,55.49,94.9,289.631765,10495.2,4211.3,70813.87
Site13-CellStream-2,28,Site13,CellStream,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,57.87,130.5,358.6900551,10745.2,4216.0,72500.69
Site13-CellStream-2,28,Site13,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.91,74.3,221.7450094,3973.2,1567.6,26808.22
Site13-CellStream-2,28,Site13,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.9,72.5,221.1899891,3937.3,1556.2,26566
Site13-CellStream-2,28,Site13,CellStream,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.98,109.7,301.5438438,4131.5,1529.3,27876.32
Site13-CellStream-2,28,Site13,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,69.35,870.9,2600.727368,12828.5,4894.9,92554.19
Site13-CellStream-2,28,Site13,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,69.42,852,2600.685789,12999.6,4919.6,93788.63
Site13-CellStream-2,28,Site13,CellStream,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.09,950.2,2610.711155,13132.8,4910.6,94749.63
Site13-CellStream-2,28,Site13,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.09,601.8,1796.925833,52348.9,11637.9,11543353.47
Site13-CellStream-2,28,Site13,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,69.1,588.7,1797.079677,52455.9,11630.8,11566947.83
Site13-CellStream-2,28,Site13,CellStream,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,69.79,663.2,1822.073422,52648.6,11326.1,11609439.73
Site13-CellStream-2,28,Site13,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.45,1523.2,,23997.5,8148.8,4997811.869
Site13-CellStream-2,28,Site13,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.46,1490,,24135.4,7966.1,5026531.45
Site13-CellStream-2,28,Site13,CellStream,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.65,1655.4,,24141.9,8006.6,5027885.17
Site13-CellStream-2,28,Site13,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.69,232.4,694.086968,7166.6,2429.6,1472241.61
Site13-CellStream-2,28,Site13,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.76,228,696.0111656,7296.2,2403.7,1498865.47
Site13-CellStream-2,28,Site13,CellStream,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.13,248.3,682.2517037,7311.9,2380.6,1502090.73
Site13-CellStream-2,28,Site13,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,47.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,48.54,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,44.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,10.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,11.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.53,107.2,320.0731924,169845.5,110130.0,11113293.5
Site13-CellStream-2,28,Site13,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.28,113.9,347.7004932,185012.2,111240.8,12105677.69
Site13-CellStream-2,28,Site13,CellStream,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.38,115.3,316.7561452,189880.6,112188.3,12424225.77
Site13-CellStream-2,28,Site13,CellStream,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.95,1259.2,4548.378051,40379.0,23373.2,8409486.21
Site13-CellStream-2,28,Site13,CellStream,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.84,1202.1,4661.127413,40832.0,23498.0,8503829.74
Site13-CellStream-2,28,Site13,CellStream,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,471,1702.239729,57502.0,35184.0,11975588.21
Site13-CellStream-2,28,Site13,CellStream,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,942.5,3475.723724,56051.5,32708.1,11673501.49
Site13-CellStream-2,28,Site13,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.82,23.2,255.1918689,7634.9,2078.4,51514.68
Site13-CellStream-2,28,Site13,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.11,168.4,275.6943914,7495.4,1927.8,50573.43
Site13-CellStream-2,28,Site13,CellStream,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.61,224.4,270.0709941,6986.4,1771.8,47139.08
Site13-CellStream-2,28,Site13,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.23,16.6,182.3503265,3861.4,541.1,26053.88
Site13-CellStream-2,28,Site13,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.45,119.6,195.7562795,4035.0,528.7,27225.2
Site13-CellStream-2,28,Site13,CellStream,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.04,158.8,191.1220136,4047.1,518.5,27306.85
Site13-CellStream-2,28,Site13,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,72.67,91,1001.77028,26626.2,7943.8,192100.9
Site13-CellStream-2,28,Site13,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.24,589.5,965.0777214,27452.0,8102.7,198058.82
Site13-CellStream-2,28,Site13,CellStream,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,72.04,814.8,980.4257939,27421.1,8129.1,197835.89
Site13-CellStream-2,28,Site13,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.47,58.7,645.8288129,107691.5,23519.6,23746841.87
Site13-CellStream-2,28,Site13,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.02,383.3,627.5325973,110888.3,22619.3,24451761.98
Site13-CellStream-2,28,Site13,CellStream,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.73,527.4,634.605448,110848.5,22584.6,24442985.76
Site13-CellStream-2,28,Site13,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,154.6,,27322.7,11668.4,5690330.84
Site13-CellStream-2,28,Site13,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,1039.8,,27158.8,11891.8,5656196.39
Site13-CellStream-2,28,Site13,CellStream,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,1414.7,,27007.0,11626.6,5624581.94
Site13-CellStream-2,28,Site13,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.52,32.3,355.8277114,14958.2,1249.8,3072877.59
Site13-CellStream-2,28,Site13,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.95,206,337.2504214,15148.9,1326.3,3112053.27
Site13-CellStream-2,28,Site13,CellStream,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.24,287.2,345.522706,15579.0,1356.0,3200409.14
Site13-CellStream-2,28,Site13,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.8,17.3,190.1994672,1010.0,1447.7,66086.1
Site13-CellStream-2,28,Site13,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.26,118,193.1407929,1034.1,1422.1,67663
Site13-CellStream-2,28,Site13,CellStream,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.74,155.4,186.9550552,1034.4,1423.7,67682.63
Site13-CellStream-2,28,Site13,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.82,23.1,255.2259809,8918.8,2258.6,60177.49
Site13-CellStream-2,28,Site13,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.12,168.4,275.7063245,8760.2,2096.3,59107.37
Site13-CellStream-2,28,Site13,CellStream,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.61,224.4,270.0709941,8236.4,1957.7,55573.15
Site13-CellStream-2,28,Site13,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.22,16.6,182.2230072,9363.6,1053.1,63178.67
Site13-CellStream-2,28,Site13,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.44,119.5,195.6173948,9563.4,1045.1,64526.77
Site13-CellStream-2,28,Site13,CellStream,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.04,158.8,191.1220136,9532.9,1019.7,64320.98
Site13-CellStream-2,28,Site13,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,72.67,91,1001.866265,27139.4,8094.4,195803.5
Site13-CellStream-2,28,Site13,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.24,589.4,964.8984567,27979.6,8255.7,201865.32
Site13-CellStream-2,28,Site13,CellStream,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,72.04,814.7,980.3513839,27955.5,8280.0,201691.44
Site13-CellStream-2,28,Site13,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.46,58.7,645.8392949,111495.0,23840.1,24585544.21
Site13-CellStream-2,28,Site13,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.03,383.2,627.4492408,114680.1,22902.7,25287884.37
Site13-CellStream-2,28,Site13,CellStream,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.72,527.3,634.4938331,114583.8,22757.8,25266649.45
Site13-CellStream-2,28,Site13,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,154.6,,29786.8,12122.8,6203513.81
Site13-CellStream-2,28,Site13,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,1039.7,,29811.2,12122.8,6208595.44
Site13-CellStream-2,28,Site13,CellStream,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,1414.7,,29647.9,11871.9,6174398.52
Site13-CellStream-2,28,Site13,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.53,32.3,355.9131992,15785.0,1314.4,3242727.92
Site13-CellStream-2,28,Site13,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.95,206,337.2281793,15983.1,1389.7,3283423.79
Site13-CellStream-2,28,Site13,CellStream,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.24,287.2,345.522706,16403.9,1418.2,3369869.15
Site13-CellStream-2,28,Site13,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.23,16.6,182.4126253,1298.8,1485.5,84982.8
Site13-CellStream-2,28,Site13,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.78,114,186.6285729,1323.6,1476.4,86605.5
Site13-CellStream-2,28,Site13,CellStream,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.13,148.5,178.7327533,1321.6,1461.4,86474.64
Site13-CellStream-2,28,Site13,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.73,23.2,255.4099418,8918.4,2257.5,60174.79
Site13-CellStream-2,28,Site13,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,82.09,168.4,275.8625668,8760.2,2096.3,59107.37
Site13-CellStream-2,28,Site13,CellStream,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,81.58,224.4,270.1087531,8237.0,1959.4,55577.2
Site13-CellStream-2,28,Site13,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.23,16.6,182.3760532,9364.0,1042.3,63181.37
Site13-CellStream-2,28,Site13,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.45,119.5,195.7021015,9563.4,1045.1,64526.77
Site13-CellStream-2,28,Site13,CellStream,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.04,158.7,191.0153123,9532.9,1019.7,64320.98
Site13-CellStream-2,28,Site13,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,72.66,90.9,1001.607615,27139.7,8093.3,195805.66
Site13-CellStream-2,28,Site13,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.23,588.8,964.4686054,27981.9,8256.3,201881.91
Site13-CellStream-2,28,Site13,CellStream,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,72.03,814.3,980.1631397,27956.2,8282.2,201696.49
Site13-CellStream-2,28,Site13,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.48,58.6,645.8472132,111473.8,23730.3,24580869.44
Site13-CellStream-2,28,Site13,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.03,382.9,627.2049649,114680.1,22902.7,25287884.37
Site13-CellStream-2,28,Site13,CellStream,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.73,527,634.4224469,114586.9,22857.4,25267333.02
Site13-CellStream-2,28,Site13,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,154.5,,29780.2,11815.0,6202139.26
Site13-CellStream-2,28,Site13,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,1309.3,,29811.2,12122.8,6208595.44
Site13-CellStream-2,28,Site13,CellStream,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,1414.4,,29647.9,11873.0,6174585.96
Site13-CellStream-2,28,Site13,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.51,32.3,355.6465826,15782.7,1304.6,3242255.42
Site13-CellStream-2,28,Site13,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.93,205.7,336.931942,15983.1,1389.7,3283423.79
Site13-CellStream-2,28,Site13,CellStream,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.24,286.9,345.3684884,16403.9,1418.3,3369869.15
Site13-CellStream-2,28,Site13,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.98,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,79.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.74,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-CellStream-2,28,Site13,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.12,17.7,194.6685103,1262.2,1429.6,84982.8
Site13-CellStream-2,28,Site13,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.58,120.5,197.4343047,1288.0,1417.8,84276.13
Site13-CellStream-2,28,Site13,CellStream,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.96,157.8,189.9359194,1286.0,1413.9,84145.27
Site13-ImageStreamX,29,Site13,ImageStreamX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,80.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,84.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,87.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,48.5,202.1,698.1967918,82174.85,32427.51,88661.48
Site13-ImageStreamX,29,Site13,ImageStreamX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,36.91,192.1,596.3983419,67975.23,29419.73,73340.98
Site13-ImageStreamX,29,Site13,ImageStreamX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,30.16,155.9,474.3766277,56566.46,26971.97,61031.64
Site13-ImageStreamX,29,Site13,ImageStreamX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.2,117.2,404.8101308,26349.82,9314.21,28429.79
Site13-ImageStreamX,29,Site13,ImageStreamX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.63,109.5,339.8957544,23957.16,8909.95,25848.26
Site13-ImageStreamX,29,Site13,ImageStreamX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.83,80.4,244.7581536,22939.02,8767.95,24749.76
Site13-ImageStreamX,29,Site13,ImageStreamX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.6,959.7,3314.756697,40055.66,15638.61,67637.35
Site13-ImageStreamX,29,Site13,ImageStreamX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.57,945.4,2935.582637,38648.0,15247.25,65260.4
Site13-ImageStreamX,29,Site13,ImageStreamX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,74.99,882.7,2686.812505,37229.38,14940.35,62864.94
Site13-ImageStreamX,29,Site13,ImageStreamX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,42.5,408.3,1410.184221,20928.54,4789.69,6714158.36
Site13-ImageStreamX,29,Site13,ImageStreamX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,41.61,393.4,1221.429531,20481.32,4700.72,6570684.14
Site13-ImageStreamX,29,Site13,ImageStreamX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,42.93,379,1153.499399,20383.32,4733.38,6539244.42
Site13-ImageStreamX,29,Site13,ImageStreamX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.6,1995.7,,40096.13,13016.17,4281406.78
Site13-ImageStreamX,29,Site13,ImageStreamX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.84,2219.9,,39820.25,12963.47,4251948.71
Site13-ImageStreamX,29,Site13,ImageStreamX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.55,2264.6,,38370.25,13049.85,4097119.81
Site13-ImageStreamX,29,Site13,ImageStreamX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,45.4,435.5,1504.277863,15361.1,8387.92,991721.54
Site13-ImageStreamX,29,Site13,ImageStreamX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,46.22,436.9,1356.719733,14499.71,8080.73,936109.7
Site13-ImageStreamX,29,Site13,ImageStreamX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44.77,395.2,1202.763435,13675.38,7879.89,882890.48
Site13-ImageStreamX,29,Site13,ImageStreamX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,40.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,37.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,34.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.82,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.7,161.5,557.8495954,160216.02,116425.35,6373880.28
Site13-ImageStreamX,29,Site13,ImageStreamX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.6,185,574.5657961,150763.57,111746.9,5997833.08
Site13-ImageStreamX,29,Site13,ImageStreamX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.09,177.7,540.8229993,126050.9,109110.5,5014687.95
Site13-ImageStreamX,29,Site13,ImageStreamX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,80.37,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,84.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,86.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,48.91,202.5,700.7924087,78351.77,32930.54,84536.62
Site13-ImageStreamX,29,Site13,ImageStreamX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,38.08,197.4,614.065609,63527.22,29813.23,68541.86
Site13-ImageStreamX,29,Site13,ImageStreamX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,32.47,166.6,507.6911944,51219.62,27362.47,55262.74
Site13-ImageStreamX,29,Site13,ImageStreamX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.71,123.3,426.9307556,24161.64,9630.85,26068.89
Site13-ImageStreamX,29,Site13,ImageStreamX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.18,116.5,362.3680277,21723.7,9302.13,23438.5
Site13-ImageStreamX,29,Site13,ImageStreamX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.44,87.6,267.0222234,20466.16,9287.34,22081.7
Site13-ImageStreamX,29,Site13,ImageStreamX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.67,961,3325.34067,40029.41,15652.28,67593.02
Site13-ImageStreamX,29,Site13,ImageStreamX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.58,946.6,2944.35974,38634.12,15250.44,65236.96
Site13-ImageStreamX,29,Site13,ImageStreamX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.06,883.6,2693.326455,37185.02,14960.7,62790.03
Site13-ImageStreamX,29,Site13,ImageStreamX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,42.53,408.7,1414.177563,20962.88,4804.19,6725175.09
Site13-ImageStreamX,29,Site13,ImageStreamX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,41.61,393.8,1225.02384,20514.6,4715.81,6581360.81
Site13-ImageStreamX,29,Site13,ImageStreamX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,42.88,378.9,1154.850058,20419.15,4737.81,6550739.16
Site13-ImageStreamX,29,Site13,ImageStreamX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.59,1992.1,,40045.34,12987.15,4275983.49
Site13-ImageStreamX,29,Site13,ImageStreamX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.85,2216,,39784.27,12905.96,4248106.82
Site13-ImageStreamX,29,Site13,ImageStreamX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.51,2261.3,,38348.51,13028.78,4094798.44
Site13-ImageStreamX,29,Site13,ImageStreamX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,45.06,433,1498.292214,15322.91,8374.68,989255.97
Site13-ImageStreamX,29,Site13,ImageStreamX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,45.96,435.1,1353.262922,14419.68,8053.05,930942.92
Site13-ImageStreamX,29,Site13,ImageStreamX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44.54,393.5,1199.494152,13584.58,7866.72,877028.38
Site13-ImageStreamX,29,Site13,ImageStreamX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,40.26,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,37.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,34.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.68,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.73,161.8,559.7047535,159425.19,116798.77,6342418.66
Site13-ImageStreamX,29,Site13,ImageStreamX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.61,185.4,576.6575639,150073.04,112734.1,5970361.7
Site13-ImageStreamX,29,Site13,ImageStreamX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.22,179.2,546.1982298,125490.57,109354.93,4992396.32
Site13-ImageStreamX,29,Site13,ImageStreamX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,82.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,86.51,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,47.92,212.8,720.4284425,82185.51,33385.61,88672.98
Site13-ImageStreamX,29,Site13,ImageStreamX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,36.89,203.8,620.6379097,67410.76,30360.5,72731.96
Site13-ImageStreamX,29,Site13,ImageStreamX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,29.47,160.2,477.3552225,55534.1,37946.48,59917.79
Site13-ImageStreamX,29,Site13,ImageStreamX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.53,121.7,411.8955708,26309.18,9587.32,28385.95
Site13-ImageStreamX,29,Site13,ImageStreamX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.9,113.2,344.7728407,24016.95,9139.08,25912.77
Site13-ImageStreamX,29,Site13,ImageStreamX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.21,84.9,253.091221,22665.0,9071.06,24454.11
Site13-ImageStreamX,29,Site13,ImageStreamX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.65,965.8,3270.041688,37861.99,15576.61,63933.15
Site13-ImageStreamX,29,Site13,ImageStreamX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.5,948,2886.521988,36477.49,15153.0,61595.31
Site13-ImageStreamX,29,Site13,ImageStreamX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.13,884.9,2637.631753,35174.29,7906.04,59394.74
Site13-ImageStreamX,29,Site13,ImageStreamX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,42.51,410.5,1390.012965,20666.36,4776.24,6630047.47
Site13-ImageStreamX,29,Site13,ImageStreamX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,41.61,394.4,1201.030873,20226.97,4685.94,6489085.22
Site13-ImageStreamX,29,Site13,ImageStreamX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,42.93,379.9,1132.380247,20146.33,4703.82,6463214.82
Site13-ImageStreamX,29,Site13,ImageStreamX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.64,2035.8,,39993.18,13183.46,4270413.92
Site13-ImageStreamX,29,Site13,ImageStreamX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.9,2263.8,,39719.71,13138.79,4241213.19
Site13-ImageStreamX,29,Site13,ImageStreamX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.57,2312.6,,38223.38,13123.24,4081437.24
Site13-ImageStreamX,29,Site13,ImageStreamX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,45.2,436.5,1477.943039,15334.16,8403.23,989982.28
Site13-ImageStreamX,29,Site13,ImageStreamX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,46.5,440.9,1342.35615,14404.74,8087.14,929978.39
Site13-ImageStreamX,29,Site13,ImageStreamX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,45.01,398.4,1187.328457,13593.43,7906.04,877599.74
Site13-ImageStreamX,29,Site13,ImageStreamX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,40.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,37.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,34.94,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.41,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.86,164.2,555.8137735,157151.98,117035.51,6251983.45
Site13-ImageStreamX,29,Site13,ImageStreamX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.88,189.3,576.5322561,147342.25,113342.99,5861722.57
Site13-ImageStreamX,29,Site13,ImageStreamX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.39,181.2,540.1867948,123221.58,109646.51,4902129
Site13-ImageStreamX,29,Site13,ImageStreamX,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.6,3088.8,6893,63052.91,17031.06,6732698.55
Site13-ImageStreamX,29,Site13,ImageStreamX,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.6,2976.6,7239,63002.02,17128.26,6727264.58
Site13-ImageStreamX,29,Site13,ImageStreamX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,68.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,67.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,70.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,47.4,309.5,360.1668547,57829.92,17275.09,62394.84
Site13-ImageStreamX,29,Site13,ImageStreamX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,49.4,207.2,354.3738282,59142.1,18398.53,63810.59
Site13-ImageStreamX,29,Site13,ImageStreamX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,48.67,188.4,358.4671703,596989.64,17727.6,644114.16
Site13-ImageStreamX,29,Site13,ImageStreamX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.62,222.2,258.6150103,26355.55,8611.02,28435.98
Site13-ImageStreamX,29,Site13,ImageStreamX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.84,151.2,258.6645004,26807.84,8725.17,28923.97
Site13-ImageStreamX,29,Site13,ImageStreamX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.1,125.6,238.955126,25706.71,8674.11,27735.92
Site13-ImageStreamX,29,Site13,ImageStreamX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.83,1890.6,2200.05953,54638.35,19522.95,92261.45
Site13-ImageStreamX,29,Site13,ImageStreamX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.41,1250.9,2139.401271,56476.14,2358.4,95364.71
Site13-ImageStreamX,29,Site13,ImageStreamX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.63,1126.5,2143.217145,55538.22,20071.48,93780.95
Site13-ImageStreamX,29,Site13,ImageStreamX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.22,1422.2,1654.970154,21878.38,4846.85,7018879.86
Site13-ImageStreamX,29,Site13,ImageStreamX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.19,940.6,1608.706206,21923.65,4872.38,7033403.09
Site13-ImageStreamX,29,Site13,ImageStreamX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.19,847,1611.447166,21490.59,4822.47,6894471.59
Site13-ImageStreamX,29,Site13,ImageStreamX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.29,3475.2,,39410.05,10726.19,4208148.15
Site13-ImageStreamX,29,Site13,ImageStreamX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.93,2364.5,,39334.54,10814.5,4200085.3
Site13-ImageStreamX,29,Site13,ImageStreamX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.29,2125.7,,39315.58,10581.7,4198060.78
Site13-ImageStreamX,29,Site13,ImageStreamX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.1,436.7,508.2431316,20733.98,6507.75,1338597.8
Site13-ImageStreamX,29,Site13,ImageStreamX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.05,288.3,493.159279,21567.61,6670.71,1392417.44
Site13-ImageStreamX,29,Site13,ImageStreamX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.85,257.4,489.7718052,21267.61,6818.49,1373049.26
Site13-ImageStreamX,29,Site13,ImageStreamX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,39.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,37.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,39.65,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.79,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.74,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,18.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.31,168.9,196.536347,240074.63,160850.33,9550898.52
Site13-ImageStreamX,29,Site13,ImageStreamX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.35,113,193.2192653,248336.52,165835.74,9879581.62
Site13-ImageStreamX,29,Site13,ImageStreamX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.92,109.3,207.9219928,233626.86,159171.6,9294386.63
Site13-ImageStreamX,29,Site13,ImageStreamX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,67.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,67.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,70.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,46.47,293.1,343.8199259,54382.68,17468.32,58675.48
Site13-ImageStreamX,29,Site13,ImageStreamX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,48.19,194.4,335.5696452,55595.97,18594.41,59984.54
Site13-ImageStreamX,29,Site13,ImageStreamX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,47.87,179.5,344.2245626,53558.4,17889.84,57786.13
Site13-ImageStreamX,29,Site13,ImageStreamX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.97,230.6,270.5125562,24122.02,8954.58,26026.14
Site13-ImageStreamX,29,Site13,ImageStreamX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.22,157.1,271.1956308,24553.17,8994.73,26491.32
Site13-ImageStreamX,29,Site13,ImageStreamX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.52,131.3,251.6529661,23438.47,9059.68,25288.63
Site13-ImageStreamX,29,Site13,ImageStreamX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.86,1892.5,2219.986867,54661.66,19688.97,92300.81
Site13-ImageStreamX,29,Site13,ImageStreamX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.43,1252.1,2161.317344,56520.8,20512.53,95440.12
Site13-ImageStreamX,29,Site13,ImageStreamX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.65,1126.1,2159.030943,55566.49,20295.24,93828.69
Site13-ImageStreamX,29,Site13,ImageStreamX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.25,1424.1,1670.530013,21911.12,4854.45,7029383.3
Site13-ImageStreamX,29,Site13,ImageStreamX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.21,941.6,1625.42639,21948.12,4881.72,7041253.4
Site13-ImageStreamX,29,Site13,ImageStreamX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.18,846.6,1623.199856,21523.73,4829.9,6905103.35
Site13-ImageStreamX,29,Site13,ImageStreamX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.27,3447.6,,39346.11,10661.28,4201320.73
Site13-ImageStreamX,29,Site13,ImageStreamX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.87,2342.8,,39267.58,10728.64,4192935.41
Site13-ImageStreamX,29,Site13,ImageStreamX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.26,2109.3,,39249.11,10531.18,4190963.21
Site13-ImageStreamX,29,Site13,ImageStreamX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.08,436.9,512.4547497,20656.43,6507.24,1333591.13
Site13-ImageStreamX,29,Site13,ImageStreamX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.05,288.6,498.2171278,21494.84,6704.44,1387719.36
Site13-ImageStreamX,29,Site13,ImageStreamX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.86,257.5,493.6456831,21167.33,6849.73,1366575.13
Site13-ImageStreamX,29,Site13,ImageStreamX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,39.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,37.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,39.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.78,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.3,168.9,198.1110761,239917.37,161559.19,9544642.24
Site13-ImageStreamX,29,Site13,ImageStreamX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.36,113.1,195.2888125,245268.94,165930.58,9757543.97
Site13-ImageStreamX,29,Site13,ImageStreamX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.97,109.9,210.7880272,232572.19,159275.32,9252428.66
Site13-ImageStreamX,29,Site13,ImageStreamX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,72.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,72.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,74.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,55.65,464.3,508.0396968,59626.98,17288.74,64333.75
Site13-ImageStreamX,29,Site13,ImageStreamX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,57.02,307.5,494.4836395,61328.39,18316.14,66169.46
Site13-ImageStreamX,29,Site13,ImageStreamX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,55.87,270.2,486.4537976,59245.53,18009.98,63922.19
Site13-ImageStreamX,29,Site13,ImageStreamX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.91,229.2,250.8019386,26467.34,8929.56,28556.59
Site13-ImageStreamX,29,Site13,ImageStreamX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.17,156.4,251.5394126,26943.35,8971.22,29070.17
Site13-ImageStreamX,29,Site13,ImageStreamX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.43,130.3,234.5786862,25754.9,9014.69,27787.91
Site13-ImageStreamX,29,Site13,ImageStreamX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,81.81,1892.4,2070.838713,52526.16,19644.48,88694.84
Site13-ImageStreamX,29,Site13,ImageStreamX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,81.37,1251.2,2012.054841,54300.79,20441.83,91691.45
Site13-ImageStreamX,29,Site13,ImageStreamX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,81.61,1126.9,2029.164379,53387.89,20256.5,90149.94
Site13-ImageStreamX,29,Site13,ImageStreamX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.18,1422.7,1556.883263,21608.51,4827.56,6932301.92
Site13-ImageStreamX,29,Site13,ImageStreamX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,75.13,940.1,1511.710847,21651.43,4854.44,6946071.24
Site13-ImageStreamX,29,Site13,ImageStreamX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,75.13,846.6,1524.435113,21220.94,4803.95,6807964.23
Site13-ImageStreamX,29,Site13,ImageStreamX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.35,3695.6,,39626.65,11086.69,4231276.38
Site13-ImageStreamX,29,Site13,ImageStreamX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.05,2514.8,,39539.1,11156.56,4221927.92
Site13-ImageStreamX,29,Site13,ImageStreamX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.4,2246,,39518.45,10827.09,4219722.94
Site13-ImageStreamX,29,Site13,ImageStreamX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.09,437,478.200897,20747.27,6551.49,1339455.81
Site13-ImageStreamX,29,Site13,ImageStreamX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,23.09,288.9,464.5307196,21611.96,6704.05,1395280.7
Site13-ImageStreamX,29,Site13,ImageStreamX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,22.92,258.3,465.1759312,21274.55,6864.59,1373497.31
Site13-ImageStreamX,29,Site13,ImageStreamX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,39.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,37.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,39.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,21.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.38,170.7,186.7687843,239345.0,162753.34,9521871.63
Site13-ImageStreamX,29,Site13,ImageStreamX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.43,114.3,183.7546525,243107.69,167427.59,9671562.87
Site13-ImageStreamX,29,Site13,ImageStreamX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.05,111.1,200.1163751,232120.67,161357.92,9234465.82
Site13-ImageStreamX,29,Site13,ImageStreamX,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.5,1850.2,4044.1,54774.17,13151.72,5848706.66
Site13-ImageStreamX,29,Site13,ImageStreamX,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.3,1730,3830.9,54301.2,13411.76,5798203.61
Site13-ImageStreamX,29,Site13,ImageStreamX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,68.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,70.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,69.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,40.86,186.9,279.7195589,64248.91,27362.54,69320.52
Site13-ImageStreamX,29,Site13,ImageStreamX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,37.36,144.5,256.2812717,60954.4,26176.99,65765.95
Site13-ImageStreamX,29,Site13,ImageStreamX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,33.77,204,285.086469,60019.53,25616.82,64757.29
Site13-ImageStreamX,29,Site13,ImageStreamX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.85,157.8,236.2480253,28519.88,9551.09,30771.15
Site13-ImageStreamX,29,Site13,ImageStreamX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.46,109.7,194.5750243,27828.32,9291.1,30025
Site13-ImageStreamX,29,Site13,ImageStreamX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.99,143.2,200.1534569,27723.89,9432.98,29912.33
Site13-ImageStreamX,29,Site13,ImageStreamX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.19,1940,2903.898444,54902.98,20396.71,92708.3
Site13-ImageStreamX,29,Site13,ImageStreamX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,86.19,1731.3,3069.925877,56397.38,20980.4,95231.72
Site13-ImageStreamX,29,Site13,ImageStreamX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.16,2035.3,2844.214275,56539.32,21323.79,95471.39
Site13-ImageStreamX,29,Site13,ImageStreamX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.07,1184.8,1773.401453,22692.09,4828.6,7279929.02
Site13-ImageStreamX,29,Site13,ImageStreamX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.64,1049.9,1861.60536,22654.2,4808.96,7267773.4
Site13-ImageStreamX,29,Site13,ImageStreamX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.04,1242.3,1736.078843,22315.56,4894.1,7159133.11
Site13-ImageStreamX,29,Site13,ImageStreamX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.62,3088.5,,45580.69,13046.67,4867040.16
Site13-ImageStreamX,29,Site13,ImageStreamX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.59,2607.1,,45036.36,12736.86,4808917.39
Site13-ImageStreamX,29,Site13,ImageStreamX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.63,3308.1,,44105.84,12809.82,4709557.81
Site13-ImageStreamX,29,Site13,ImageStreamX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31.86,618,925.0742349,23299.28,9423.41,1504215.06
Site13-ImageStreamX,29,Site13,ImageStreamX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.39,560.8,994.4322389,22967.81,9265.84,1482815.16
Site13-ImageStreamX,29,Site13,ImageStreamX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.02,651.6,910.6261157,22667.63,9274.79,1463435.37
Site13-ImageStreamX,29,Site13,ImageStreamX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,45.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,49.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,44.68,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,14.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,14.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,18.26,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.38,170.1,254.5851086,285412.51,173732.81,11354577.2
Site13-ImageStreamX,29,Site13,ImageStreamX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.93,139.2,246.9051276,282815.7,171658.16,11251268.21
Site13-ImageStreamX,29,Site13,ImageStreamX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.23,172.8,241.4180807,280190.6,173643.98,11146833.75
Site13-ImageStreamX,29,Site13,ImageStreamX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,68.22,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,70.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,69.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,39.17,172.9,260.1127705,60035.3,27422.51,64774.3
Site13-ImageStreamX,29,Site13,ImageStreamX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,35.89,134,238.6583994,56893.9,26153.52,61384.93
Site13-ImageStreamX,29,Site13,ImageStreamX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,32.61,191,268.2940746,55760.52,25496.64,60162.08
Site13-ImageStreamX,29,Site13,ImageStreamX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.07,163.1,245.4148894,25969.47,9900.32,28019.45
Site13-ImageStreamX,29,Site13,ImageStreamX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.67,114,203.149508,25349.4,9612.27,27350.4
Site13-ImageStreamX,29,Site13,ImageStreamX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.23,149,209.272599,25170.82,9752.73,27157.73
Site13-ImageStreamX,29,Site13,ImageStreamX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.19,1941.9,2921.779855,54875.14,20471.85,92661.29
Site13-ImageStreamX,29,Site13,ImageStreamX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,86.21,1733.3,3088.146286,56404.2,21080.38,95243.23
Site13-ImageStreamX,29,Site13,ImageStreamX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.17,2038.1,2862.179225,56564.74,51401.61,95514.32
Site13-ImageStreamX,29,Site13,ImageStreamX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.31,1190.6,1791.314183,22750.13,4846.39,7298549.04
Site13-ImageStreamX,29,Site13,ImageStreamX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.87,1055.1,1879.87775,22697.64,4819.62,7281709.54
Site13-ImageStreamX,29,Site13,ImageStreamX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.17,1246.7,1750.836242,22358.12,4915.7,7172786.93
Site13-ImageStreamX,29,Site13,ImageStreamX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.62,3072.6,,45576.86,13130.5,4866631.2
Site13-ImageStreamX,29,Site13,ImageStreamX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.59,2594.8,,45027.42,12698.65,4807962.79
Site13-ImageStreamX,29,Site13,ImageStreamX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.62,3291.9,,44087.74,12773.34,4707625.12
Site13-ImageStreamX,29,Site13,ImageStreamX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31.78,617.2,928.5882899,23160.74,9389.01,1495270.83
Site13-ImageStreamX,29,Site13,ImageStreamX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.26,559.1,996.100897,22840.54,9224.48,1474598.54
Site13-ImageStreamX,29,Site13,ImageStreamX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31.95,651.2,914.5510503,22527.8,9243.46,1454407.86
Site13-ImageStreamX,29,Site13,ImageStreamX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,45.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,49.16,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,44.74,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,14.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,14.38,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,17.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.55,174.2,262.0989706,290867.38,182089.22,11571588.51
Site13-ImageStreamX,29,Site13,ImageStreamX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.03,141.3,251.7024819,284679.22,179362.2,11325404.7
Site13-ImageStreamX,29,Site13,ImageStreamX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.33,175.4,246.3119971,281327.85,180565.9,11192077.01
Site13-ImageStreamX,29,Site13,ImageStreamX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,71.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,73.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,72.67,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,48.55,277.2,397.655425,66498.32,26685.42,71747.49
Site13-ImageStreamX,29,Site13,ImageStreamX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,45.36,217,370.8594387,63460.1,25740.07,68469.44
Site13-ImageStreamX,29,Site13,ImageStreamX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,41.22,292.4,391.9633688,62696.63,25924.54,67645.71
Site13-ImageStreamX,29,Site13,ImageStreamX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,7,162.1,232.502286,28531.88,9715.46,30784.1
Site13-ImageStreamX,29,Site13,ImageStreamX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.66,113.9,194.6201136,27915.77,9503.53,30119.35
Site13-ImageStreamX,29,Site13,ImageStreamX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.17,149.2,200.0173928,27701.06,9703.88,29887.7
Site13-ImageStreamX,29,Site13,ImageStreamX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,84.11,1946.8,2793.057765,52301.67,50452.93,88315.77
Site13-ImageStreamX,29,Site13,ImageStreamX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,86.14,1734.5,2964.095222,53936.55,21063.64,91076.4
Site13-ImageStreamX,29,Site13,ImageStreamX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,85.12,2058.4,2759.655803,54028.69,21407.08,91231.98
Site13-ImageStreamX,29,Site13,ImageStreamX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.16,1190.7,1708.35013,22406.02,4820.02,7188153.9
Site13-ImageStreamX,29,Site13,ImageStreamX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,60.79,1054.5,1801.935115,22371.56,4781.66,7177098.67
Site13-ImageStreamX,29,Site13,ImageStreamX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,60.97,1255,1682.544463,22033.97,4870.36,7068795.24
Site13-ImageStreamX,29,Site13,ImageStreamX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.62,3222.2,,45405.7,13075.5,4848354.98
Site13-ImageStreamX,29,Site13,ImageStreamX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.61,2705.3,,44892.62,12757.45,4793569.04
Site13-ImageStreamX,29,Site13,ImageStreamX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.64,3448.2,,43952.63,12882.59,4693198.27
Site13-ImageStreamX,29,Site13,ImageStreamX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.02,623.4,894.4027334,23109.87,9437.81,1491986.64
Site13-ImageStreamX,29,Site13,ImageStreamX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.49,563.5,962.9061811,22850.4,9272.78,1475235.1
Site13-ImageStreamX,29,Site13,ImageStreamX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.21,663,888.8551546,22499.41,9277.34,1452574.99
Site13-ImageStreamX,29,Site13,ImageStreamX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,45.35,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,49.24,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,45.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.62,176.4,253.0327909,286460.94,178824.31,11396286.93
Site13-ImageStreamX,29,Site13,ImageStreamX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.11,143.1,244.5880555,281861.27,178065.34,11213298.08
Site13-ImageStreamX,29,Site13,ImageStreamX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.41,179.3,240.3744762,276178.92,179270.49,10987236.93
Site13-ImageStreamX,29,Site13,ImageStreamX,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.7,2102.3,4623,59996.15,15529.42,6406302.13
Site13-ImageStreamX,29,Site13,ImageStreamX,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.8,2215.2,4916.1,59910.2,15704.77,6397124.52
Site13-ImageStreamX,29,Site13,ImageStreamX,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,3229.3,6333.9,31324.17,37151.6,3344749.57
Site13-ImageStreamX,29,Site13,ImageStreamX,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,3299.7,6408.8,30295.33,38156.95,3234891.53
Site13-ImageStreamX,29,Site13,ImageStreamX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,14.4,134.7,519.791743,39117.06,10500.12,42204.84
Site13-ImageStreamX,29,Site13,ImageStreamX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,14.07,245.8,516.5832802,51249.64,13042.13,55295.13
Site13-ImageStreamX,29,Site13,ImageStreamX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,13.99,198.6,507.5378598,46318.62,17186.44,49974.89
Site13-ImageStreamX,29,Site13,ImageStreamX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13,82.5,318.3755204,26743.16,5116.84,28854.18
Site13-ImageStreamX,29,Site13,ImageStreamX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.29,157.1,330.1143342,37328.21,3546.53,40274.78
Site13-ImageStreamX,29,Site13,ImageStreamX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.4,132.4,338.1843412,27991.96,4189.31,30201.56
Site13-ImageStreamX,29,Site13,ImageStreamX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,67.9,430.4,1660.82203,46800.84,22900.51,79027.15
Site13-ImageStreamX,29,Site13,ImageStreamX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.82,824.9,1733.904,78900.21,24645.87,133229.64
Site13-ImageStreamX,29,Site13,ImageStreamX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,69.65,687.8,1757.434777,93393.0,29547.97,157701.93
Site13-ImageStreamX,29,Site13,ImageStreamX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.8,266,1026.410176,31049.18,11655.36,9960996.39
Site13-ImageStreamX,29,Site13,ImageStreamX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.53,532.3,1118.942276,45300.51,9988.11,14533015.58
Site13-ImageStreamX,29,Site13,ImageStreamX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.28,449,1147.187145,47879.14,10502.74,15360274.92
Site13-ImageStreamX,29,Site13,ImageStreamX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,1641.6,,17956.11,18256.35,1917327.46
Site13-ImageStreamX,29,Site13,ImageStreamX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,3013.3,,23218.85,21987.15,2479275.22
Site13-ImageStreamX,29,Site13,ImageStreamX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,2478.9,,24080.19,23536.05,2571247.86
Site13-ImageStreamX,29,Site13,ImageStreamX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.1,142.3,549.093125,40413.49,14770.76,2609118.4
Site13-ImageStreamX,29,Site13,ImageStreamX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.2,290.4,610.3321503,53305.25,6859.24,3441417.92
Site13-ImageStreamX,29,Site13,ImageStreamX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.45,236.9,605.4126942,54900.44,4993.5,3544404.31
Site13-ImageStreamX,29,Site13,ImageStreamX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,38.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,39.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,39.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,57.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,57.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,57.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.6,86.1,332.5337512,1256.45,2261.73,49985.4
Site13-ImageStreamX,29,Site13,ImageStreamX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.17,155.6,327.1565509,1364.87,2177.41,54298.68
Site13-ImageStreamX,29,Site13,ImageStreamX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.1,119.5,305.2544903,1379.82,2486.51,54893.43
Site13-ImageStreamX,29,Site13,ImageStreamX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,13.92,135.6,523.5432565,38513.32,10676.45,41553.44
Site13-ImageStreamX,29,Site13,ImageStreamX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,14.05,245.6,516.3232794,50539.18,12935.39,54528.59
Site13-ImageStreamX,29,Site13,ImageStreamX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,13.67,197.4,505.538522,45608.31,12158.33,49208.49
Site13-ImageStreamX,29,Site13,ImageStreamX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.3,80.2,309.7641202,24094.21,4130.81,25996.13
Site13-ImageStreamX,29,Site13,ImageStreamX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.29,156.9,458.4395037,23725.41,3305.97,25598.22
Site13-ImageStreamX,29,Site13,ImageStreamX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.74,131.2,335.9342769,24239.95,3591.4,26153.38
Site13-ImageStreamX,29,Site13,ImageStreamX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,67.95,410,1583.074549,49887.79,22115.04,84239.73
Site13-ImageStreamX,29,Site13,ImageStreamX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.81,823.9,2481.54178,78940.51,24848.8,133297.69
Site13-ImageStreamX,29,Site13,ImageStreamX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,70.48,673.1,1723.807779,94041.66,29733.46,158797.25
Site13-ImageStreamX,29,Site13,ImageStreamX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,61.96,254,980.919714,31548.96,11056.22,10121332.57
Site13-ImageStreamX,29,Site13,ImageStreamX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,532.3,1119.08633,45320.95,9991.82,14539573.01
Site13-ImageStreamX,29,Site13,ImageStreamX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.42,440.4,1127.770003,48029.63,10533.53,15408554.14
Site13-ImageStreamX,29,Site13,ImageStreamX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,1640.2,,17902.57,18244.99,1911610.53
Site13-ImageStreamX,29,Site13,ImageStreamX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,3012.6,,23183.0,21987.0,2475447.21
Site13-ImageStreamX,29,Site13,ImageStreamX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,2473.3,,24053.14,23537.79,2568359.5
Site13-ImageStreamX,29,Site13,ImageStreamX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.33,136.6,527.6093726,41339.07,13970.4,2668874.38
Site13-ImageStreamX,29,Site13,ImageStreamX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.15,289.6,608.8086899,53402.52,6801.63,3447697.73
Site13-ImageStreamX,29,Site13,ImageStreamX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.37,231.4,592.5016252,55047.47,4846.78,3553896.65
Site13-ImageStreamX,29,Site13,ImageStreamX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,36.78,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,39.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,38.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,59.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,58.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,58.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.45,75.1,290.0496177,1508.31,2480.69,60005.16
Site13-ImageStreamX,29,Site13,ImageStreamX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14.69,173.4,364.5391564,1394.43,2127.15,55474.66
Site13-ImageStreamX,29,Site13,ImageStreamX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,13.96,133.3,341.3039866,1401.86,2683.02,55770.25
Site13-ImageStreamX,29,Site13,ImageStreamX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,13.99,137.1,529.5301133,38917.81,10903.46,41989.86
Site13-ImageStreamX,29,Site13,ImageStreamX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,14.03,245.3,515.6726154,51288.8,13005.66,55337.38
Site13-ImageStreamX,29,Site13,ImageStreamX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,13.95,198.3,506.9055053,46295.85,12165.72,49950.3
Site13-ImageStreamX,29,Site13,ImageStreamX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.29,81,312.7136633,27019.88,4739.99,29152.75
Site13-ImageStreamX,29,Site13,ImageStreamX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.29,156.9,329.8504385,27656.75,3540.48,29839.89
Site13-ImageStreamX,29,Site13,ImageStreamX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.43,132.5,338.63432,28325.68,3949.04,30561.62
Site13-ImageStreamX,29,Site13,ImageStreamX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,68.08,417.4,1612.503012,46773.06,22301.73,78980.24
Site13-ImageStreamX,29,Site13,ImageStreamX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,69.81,824.6,1733.225813,76064.78,25224.32,128441.77
Site13-ImageStreamX,29,Site13,ImageStreamX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,69.62,686.7,1755.537844,90401.71,30180.42,152650.88
Site13-ImageStreamX,29,Site13,ImageStreamX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,60.94,254.4,982.6382828,31248.25,10937.52,10024860.74
Site13-ImageStreamX,29,Site13,ImageStreamX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.53,532.1,1118.533768,45008.08,9938.23,14439200.08
Site13-ImageStreamX,29,Site13,ImageStreamX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.32,448.5,1146.649802,47560.31,10478.8,15257989.95
Site13-ImageStreamX,29,Site13,ImageStreamX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,1639.6,,17921.16,18229.17,1913595.55
Site13-ImageStreamX,29,Site13,ImageStreamX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,3013.4,,23157.55,21938.46,2472729.7
Site13-ImageStreamX,29,Site13,ImageStreamX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,2477.5,,24026.7,23511.53,2565536.28
Site13-ImageStreamX,29,Site13,ImageStreamX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.11,138.2,533.9675164,41072.05,14328.51,2651635.42
Site13-ImageStreamX,29,Site13,ImageStreamX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.24,290.6,610.8341455,53506.88,6927.97,3454435.27
Site13-ImageStreamX,29,Site13,ImageStreamX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.51,236.9,605.7501177,55085.28,5061.29,3556337.69
Site13-ImageStreamX,29,Site13,ImageStreamX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,37.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,39.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,39.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,59.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,58.04,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,57.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site13-ImageStreamX,29,Site13,ImageStreamX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.25,75.1,290.1568637,1550.87,2392.09,61698.32
Site13-ImageStreamX,29,Site13,ImageStreamX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.64,161.1,338.7236082,1549.06,2169.58,61626.32
Site13-ImageStreamX,29,Site13,ImageStreamX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.89,127.1,324.9059017,1527.13,2457.2,60753.87
Site14-Aurora,30,Site14,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,80.4,,573.0115883,192328.0,64871.0,101488.9685
Site14-Aurora,30,Site14,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,79.9,,495.1196891,183607.0,60327.0,96887.01096
Site14-Aurora,30,Site14,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,80.7,,607.5996283,178015.0,60243.0,93936.18575
Site14-Aurora,30,Site14,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.73,,249.3030084,51874.0,18658.0,27373.2309
Site14-Aurora,30,Site14,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.46,,212.7883136,49164.0,18704.0,25943.19937
Site14-Aurora,30,Site14,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.05,,222.9720601,49732.0,18539.0,26242.92554
Site14-Aurora,30,Site14,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.6,,2017.849742,71747.0,27337.0,54356.14614
Site14-Aurora,30,Site14,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.5,,2068.279166,66779.0,26049.0,50592.34648
Site14-Aurora,30,Site14,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,70,,1938.551079,66595.0,25902.0,50452.9465
Site14-Aurora,30,Site14,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,40.9,,825.3727788,470000.0,107675.0,9152631.579
Site14-Aurora,30,Site14,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,39.3,,812.5284138,452000.0,112738.0,8802105.263
Site14-Aurora,30,Site14,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,40.6,,787.7265566,462000.0,105196.0,8996842.105
Site14-Aurora,30,Site14,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,3669.635082,91288.0,22497.0,3969381.874
Site14-Aurora,30,Site14,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,3567.675289,89279.0,21780.0,3882026.601
Site14-Aurora,30,Site14,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,3623.303622,90421.0,22284.0,3931683.008
Site14-Aurora,30,Site14,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,47.4,,955.5290108,217874.0,130115.0,879114.003
Site14-Aurora,30,Site14,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,46.3,,958.3425384,206205.0,126913.0,832029.9944
Site14-Aurora,30,Site14,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,47.8,,925.6811531,217874.0,126140.0,879114.003
Site14-Aurora,30,Site14,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,77.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,76.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,20,,572.6446064,670000.0,619000.0,3922545.455
Site14-Aurora,30,Site14,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.4,,554.4790045,717000.0,646000.0,4197709.091
Site14-Aurora,30,Site14,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.4,,591.0548629,827000.0,659000.0,4841709.091
Site14-Aurora,30,Site14,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,97.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,80.7,,578.7915525,193385.0,62421.0,102046.7336
Site14-Aurora,30,Site14,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,79.9,,494.0799072,185138.0,58731.0,97694.89962
Site14-Aurora,30,Site14,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,80.9,,612.9820289,179035.0,58345.0,94474.4264
Site14-Aurora,30,Site14,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.96,,257.4683547,51858.0,18968.0,27364.78791
Site14-Aurora,30,Site14,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.69,,220.1891144,49192.0,18913.0,25957.9746
Site14-Aurora,30,Site14,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.26,,229.9447154,500009.0,18734.0,263848.2055
Site14-Aurora,30,Site14,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.4,,2021.060833,72904.0,27337.0,55232.69932
Site14-Aurora,30,Site14,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.3,,2070.572802,67993.0,25893.0,51512.08336
Site14-Aurora,30,Site14,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.8,,1943.26068,67787.0,25734.0,51356.01598
Site14-Aurora,30,Site14,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41.1,,829.960052,474000.0,108270.0,9230526.316
Site14-Aurora,30,Site14,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,39.4,,815.066705,455000.0,113585.0,8860526.316
Site14-Aurora,30,Site14,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,40.8,,793.1089572,465000.0,106397.0,9055263.158
Site14-Aurora,30,Site14,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,3680.399883,91661.0,22731.0,3985600.648
Site14-Aurora,30,Site14,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,4393.323304,89871.0,21925.0,3907767.926
Site14-Aurora,30,Site14,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,3631.132568,90889.0,22538.0,3952032.569
Site14-Aurora,30,Site14,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,47.8,,966.6607938,217650.0,131755.0,878210.1708
Site14-Aurora,30,Site14,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,48.6,,1007.089962,207804.0,127854.0,838481.9037
Site14-Aurora,30,Site14,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.2,,937.2410816,217650.0,127774.0,878210.1708
Site14-Aurora,30,Site14,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,78.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,80.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,76.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,17.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,20.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,20.1,,577.4765342,675000.0,624000.0,3951818.182
Site14-Aurora,30,Site14,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.5,,557.1702048,719000.0,647000.0,4209418.182
Site14-Aurora,30,Site14,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.4,,594.2047905,830000.0,661000.0,4859272.727
Site14-Aurora,30,Site14,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,80,,542.8579124,194035.0,60037.0,102389.7301
Site14-Aurora,30,Site14,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,80.1,,469.0639772,183285.0,58941.0,96717.09578
Site14-Aurora,30,Site14,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,81.9,,589.5869355,177839.0,59483.0,93843.31285
Site14-Aurora,30,Site14,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.15,,262.0250461,51858.0,19255.0,27364.78791
Site14-Aurora,30,Site14,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.87,,225.1127876,49192.0,19235.0,25957.9746
Site14-Aurora,30,Site14,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.9,,720.0795676,49681.0,18947.0,26216.0135
Site14-Aurora,30,Site14,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,70.2,,2014.45516,72543.0,27305.0,54959.20261
Site14-Aurora,30,Site14,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.2,,2063.416656,67537.0,25866.0,51166.61382
Site14-Aurora,30,Site14,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,69.7,,1937.419552,67537.0,25767.0,51166.61382
Site14-Aurora,30,Site14,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,41.1,,827.6664154,473000.0,108910.0,9211052.632
Site14-Aurora,30,Site14,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,39.6,,818.1248871,454000.0,114186.0,8841052.632
Site14-Aurora,30,Site14,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,40.8,,791.3657934,465000.0,105953.0,9055263.158
Site14-Aurora,30,Site14,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,100,,3663.793954,91815.0,22696.0,3992296.871
Site14-Aurora,30,Site14,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,100,,3561.406016,89829.0,22010.0,3905941.683
Site14-Aurora,30,Site14,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,100,,3615.627585,90817.0,22509.0,3948901.867
Site14-Aurora,30,Site14,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,47.5,,956.1406473,215958.0,130936.0,871383.0097
Site14-Aurora,30,Site14,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,48.2,,995.5911969,206284.0,126792.0,832348.7566
Site14-Aurora,30,Site14,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,47.8,,927.0267533,216480.0,126740.0,873489.2616
Site14-Aurora,30,Site14,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,78.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,80.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,76.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,16.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,20.3,,581.7274074,678000.0,629000.0,3969381.818
Site14-Aurora,30,Site14,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.6,,559.8002414,721000.0,650000.0,4221127.273
Site14-Aurora,30,Site14,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.5,,597.8134455,833000.0,665000.0,4876836.364
Site14-Aurora,30,Site14,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,100,,2592,99786.0,29098.0,4338891.636
Site14-Aurora,30,Site14,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,100,,3670,98212.0,28611.0,4270451.019
Site14-Aurora,30,Site14,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1175.223785,144484.0,33576.0,76242.31588
Site14-Aurora,30,Site14,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,1316.167345,140087.0,32676.0,73922.07652
Site14-Aurora,30,Site14,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,1321.756864,140087.0,32885.0,73922.07652
Site14-Aurora,30,Site14,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,344.0294192,51675.0,17368.0,27268.22121
Site14-Aurora,30,Site14,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,264.8445656,49732.0,17761.0,26242.92554
Site14-Aurora,30,Site14,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,238.2669504,49164.0,17890.0,25943.19937
Site14-Aurora,30,Site14,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2534.24411,104926.0,37281.0,79492.84277
Site14-Aurora,30,Site14,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2817.062815,99520.0,35230.0,75397.21053
Site14-Aurora,30,Site14,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2827.693861,99797.0,35526.0,75607.06812
Site14-Aurora,30,Site14,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1854.405152,497000.0,110147.0,9678421.053
Site14-Aurora,30,Site14,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,2048.942336,504000.0,108628.0,9814736.842
Site14-Aurora,30,Site14,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,2065.2177,506000.0,109932.0,9853684.211
Site14-Aurora,30,Site14,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,4626.642216,85664.0,17943.0,3724839.287
Site14-Aurora,30,Site14,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5013.360218,85121.0,17436.0,3701228.579
Site14-Aurora,30,Site14,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,4961.355771,85392.0,17436.0,3713012.192
Site14-Aurora,30,Site14,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,635.0680056,308633.0,85582.0,1245323.408
Site14-Aurora,30,Site14,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,722.2535434,305334.0,85340.0,1232012.057
Site14-Aurora,30,Site14,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,714.3076584,304515.0,85138.0,1228707.421
Site14-Aurora,30,Site14,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,308.4647341,1310000.0,988000.0,7669454.545
Site14-Aurora,30,Site14,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,324.1373072,1490000.0,1050000.0,8723272.727
Site14-Aurora,30,Site14,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,305.2315809,1440000.0,1030000.0,8430545.455
Site14-Aurora,30,Site14,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1289.808926,144979.0,33965.0,76503.5209
Site14-Aurora,30,Site14,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,1445.986665,140678.0,33061.0,74233.93949
Site14-Aurora,30,Site14,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,1430.040096,141150.0,33242.0,74483.00771
Site14-Aurora,30,Site14,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,348.1941589,51687.0,17453.0,27274.55345
Site14-Aurora,30,Site14,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,266.4337426,49681.0,17495.0,26216.0135
Site14-Aurora,30,Site14,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,245.3908473,49191.0,17606.0,25957.44692
Site14-Aurora,30,Site14,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2550.355077,105683.0,37068.0,80066.3525
Site14-Aurora,30,Site14,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2834.488963,100648.0,34956.0,76251.79306
Site14-Aurora,30,Site14,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2856.518244,100648.0,35173.0,76251.79306
Site14-Aurora,30,Site14,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1867.885757,500000.0,110917.0,9736842.105
Site14-Aurora,30,Site14,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,2064.56011,508000.0,109413.0,9892631.579
Site14-Aurora,30,Site14,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,2087.904572,510000.0,110747.0,9931578.947
Site14-Aurora,30,Site14,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,4702.37472,86154.0,18091.0,3746145.451
Site14-Aurora,30,Site14,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5099.997763,85670.0,17639.0,3725100.179
Site14-Aurora,30,Site14,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5058.953158,85911.0,17639.0,3735579.333
Site14-Aurora,30,Site14,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,640.4383279,310460.0,86328.0,1252695.289
Site14-Aurora,30,Site14,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,726.2538855,308008.0,86086.0,1242801.554
Site14-Aurora,30,Site14,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,721.8699489,306385.0,85365.0,1236252.806
Site14-Aurora,30,Site14,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,311.7526865,1320000.0,988000.0,7728000
Site14-Aurora,30,Site14,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,326.5484723,1490000.0,1050000.0,8723272.727
Site14-Aurora,30,Site14,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,314.547446,1450000.0,1030000.0,8489090.909
Site14-Aurora,30,Site14,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1261.422937,144495.0,33851.0,76248.12044
Site14-Aurora,30,Site14,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,1416.943086,140208.0,33019.0,73985.92664
Site14-Aurora,30,Site14,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,1397.98256,140208.0,33310.0,73985.92664
Site14-Aurora,30,Site14,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,353.4000835,51687.0,17453.0,27274.55345
Site14-Aurora,30,Site14,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,269.5572974,49681.0,17780.0,26216.0135
Site14-Aurora,30,Site14,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,248.8979965,49354.0,17951.0,26043.45988
Site14-Aurora,30,Site14,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2528.490193,105344.0,36969.0,79809.52317
Site14-Aurora,30,Site14,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2811.856891,100162.0,34874.0,75883.59527
Site14-Aurora,30,Site14,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2835.639746,100478.0,35210.0,76122.9996
Site14-Aurora,30,Site14,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1852.267983,500000.0,109917.0,9736842.105
Site14-Aurora,30,Site14,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,2047.024364,507000.0,109529.0,9873157.895
Site14-Aurora,30,Site14,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,2073.437581,510000.0,110872.0,9931578.947
Site14-Aurora,30,Site14,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,4661.384913,86222.0,17894.0,3749102.225
Site14-Aurora,30,Site14,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5048.979702,85752.0,17554.0,3728665.7
Site14-Aurora,30,Site14,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5007.880297,85752.0,17699.0,3728665.7
Site14-Aurora,30,Site14,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,634.0816199,307809.0,85167.0,1241998.596
Site14-Aurora,30,Site14,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,720.8835632,304746.0,84937.0,1229639.498
Site14-Aurora,30,Site14,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,716.1160322,303985.0,84996.0,1226568.889
Site14-Aurora,30,Site14,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,312.5746746,1310000.0,9920000.0,7669454.545
Site14-Aurora,30,Site14,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,327.534858,1490000.0,1060000.0,8723272.727
Site14-Aurora,30,Site14,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,316.2462215,1450000.0,1040000.0,8489090.909
Site14-Aurora,30,Site14,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,4626.642216,94236.0,27034.0,4097566.715
Site14-Aurora,30,Site14,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,5588.704739,94536.0,26793.0,4110611.305
Site14-Aurora,30,Site14,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1176.301458,167985.0,45087.0,88643.48601
Site14-Aurora,30,Site14,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,1101.837271,166048.0,44330.0,87621.35646
Site14-Aurora,30,Site14,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,1067.971025,163501.0,44050.0,86277.3379
Site14-Aurora,30,Site14,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,179.1794506,53696.0,19332.0,28334.67646
Site14-Aurora,30,Site14,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,139.8281195,54317.0,20179.0,28662.37003
Site14-Aurora,30,Site14,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,150.8398436,53490.0,19802.0,28225.97295
Site14-Aurora,30,Site14,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2292.765623,87092.0,33226.0,65981.65052
Site14-Aurora,30,Site14,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2341.466531,87577.0,33083.0,66349.0907
Site14-Aurora,30,Site14,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2309.761076,86851.0,32803.0,65799.06684
Site14-Aurora,30,Site14,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1394.666025,509000.0,110434.0,9912105.263
Site14-Aurora,30,Site14,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1440.125747,509000.0,109555.0,9912105.263
Site14-Aurora,30,Site14,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1411.661479,510000.0,110721.0,9931578.947
Site14-Aurora,30,Site14,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,4214.540027,87871.0,20595.0,3820803.99
Site14-Aurora,30,Site14,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,4125.282731,87871.0,20306.0,3820803.99
Site14-Aurora,30,Site14,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,4068.229534,87037.0,20177.0,3784540.029
Site14-Aurora,30,Site14,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,750.9164777,278011.0,143528.0,1121764.704
Site14-Aurora,30,Site14,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,746.8857711,271413.0,143258.0,1095142.004
Site14-Aurora,30,Site14,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,748.2985961,269250.0,145175.0,1086414.374
Site14-Aurora,30,Site14,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,249.5713776,112000.0,961000.0,655709.0909
Site14-Aurora,30,Site14,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,239.6816027,1100000.0,974000.0,6440000
Site14-Aurora,30,Site14,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,246.953496,1030000.0,951000.0,6030181.818
Site14-Aurora,30,Site14,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1218.93553,167992.0,45447.0,88647.17982
Site14-Aurora,30,Site14,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,1141.313263,165756.0,44584.0,87467.27188
Site14-Aurora,30,Site14,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,1109.441594,163003.0,44187.0,86014.54981
Site14-Aurora,30,Site14,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,178.0159477,53246.0,18955.0,28097.21735
Site14-Aurora,30,Site14,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,139.0801533,53777.0,19609.0,28377.4191
Site14-Aurora,30,Site14,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,150.7982899,53422.0,19355.0,28190.09024
Site14-Aurora,30,Site14,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2316.742094,88021.0,33168.0,66685.46893
Site14-Aurora,30,Site14,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2362.617352,88289.0,33006.0,66888.50805
Site14-Aurora,30,Site14,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2330.330146,87753.0,32891.0,66482.42982
Site14-Aurora,30,Site14,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1411.162834,510000.0,110917.0,9931578.947
Site14-Aurora,30,Site14,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1454.337104,512000.0,110033.0,9970526.316
Site14-Aurora,30,Site14,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1425.831282,512000.0,111654.0,9970526.316
Site14-Aurora,30,Site14,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,4207.060365,88116.0,20868.0,3831457.072
Site14-Aurora,30,Site14,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,4119.548324,88116.0,20452.0,3831457.072
Site14-Aurora,30,Site14,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,4063.035325,87375.0,20435.0,3799236.934
Site14-Aurora,30,Site14,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,762.5930606,278673.0,144513.0,1124435.851
Site14-Aurora,30,Site14,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,757.024868,271459.0,144088.0,1095327.612
Site14-Aurora,30,Site14,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,759.3934276,269334.0,146443.0,1086753.311
Site14-Aurora,30,Site14,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,243.6707556,1120000.0,954000.0,6557090.909
Site14-Aurora,30,Site14,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,234.3211785,1090000.0,957000.0,6381454.545
Site14-Aurora,30,Site14,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,242.465699,1030000.0,942000.0,6030181.818
Site14-Aurora,30,Site14,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1149.748659,167992.0,44209.0,88647.17982
Site14-Aurora,30,Site14,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,1081.642184,165756.0,43822.0,87467.27188
Site14-Aurora,30,Site14,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,1063.27546,162458.0,44038.0,85726.96045
Site14-Aurora,30,Site14,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,184.9969652,53246.0,19501.0,28097.21735
Site14-Aurora,30,Site14,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,144.1081481,53955.0,20039.0,28471.34737
Site14-Aurora,30,Site14,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,155.4523016,53422.0,19781.0,28190.09024
Site14-Aurora,30,Site14,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2309.387093,87501.0,33243.0,66291.51245
Site14-Aurora,30,Site14,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2355.428566,88052.0,32886.0,66708.9548
Site14-Aurora,30,Site14,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2324.097095,87501.0,32701.0,66291.51245
Site14-Aurora,30,Site14,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1405.927071,512000.0,111413.0,9970526.316
Site14-Aurora,30,Site14,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1450.264843,512000.0,110501.0,9970526.316
Site14-Aurora,30,Site14,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1421.5097,512000.0,111413.0,9970526.316
Site14-Aurora,30,Site14,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,4186.98994,88127.0,20733.0,3831935.374
Site14-Aurora,30,Site14,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,4097.69109,88127.0,20483.0,3831935.374
Site14-Aurora,30,Site14,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,4045.375012,87408.0,20315.0,3800671.839
Site14-Aurora,30,Site14,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,757.6481732,276556.0,143956.0,1115893.83
Site14-Aurora,30,Site14,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,793.4674418,269794.0,143105.0,1088609.395
Site14-Aurora,30,Site14,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,753.4928056,267801.0,145001.0,1080567.709
Site14-Aurora,30,Site14,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,250.028468,1120000.0,964000.0,6557090.909
Site14-Aurora,30,Site14,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,240.5126763,1100000.0,969000.0,6440000
Site14-Aurora,30,Site14,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,247.4936938,1040000.0,954000.0,6088727.273
Site14-Aurora,30,Site14,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,4251,103996.0,30066.0,4521950.72
Site14-Aurora,30,Site14,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,4085,103009.0,29999.0,4479034.018
Site14-Aurora,30,Site14,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1905,109422.0,53586.0,4757883.878
Site14-Aurora,30,Site14,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1952,105662.0,49642.0,4594391.679
Site14-Aurora,30,Site14,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,294.7317434,101298.0,24805.0,53453.62887
Site14-Aurora,30,Site14,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,305.9919065,132714.0,32888.0,70031.44092
Site14-Aurora,30,Site14,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,290.6151246,125730.0,31555.0,66346.07552
Site14-Aurora,30,Site14,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,234.7380785,50307.0,5969.0,26546.34551
Site14-Aurora,30,Site14,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,244.5150481,53696.0,6647.0,28334.67646
Site14-Aurora,30,Site14,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,238.5822739,53285.0,6685.0,28117.79714
Site14-Aurora,30,Site14,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,1072.379193,335420.0,118183.0,254117.0856
Site14-Aurora,30,Site14,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,1092.84121,351910.0,124904.0,266610.0518
Site14-Aurora,30,Site14,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,1055.155987,346977.0,124006.0,262872.7685
Site14-Aurora,30,Site14,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,688.8374535,1130000.0,185428.0,22005263.16
Site14-Aurora,30,Site14,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,698.5236153,1190000.0,195652.0,23173684.21
Site14-Aurora,30,Site14,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,674.6714418,1130000.0,191496.0,22005263.16
Site14-Aurora,30,Site14,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1905.146958,76159.0,35970.0,3311543.184
Site14-Aurora,30,Site14,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1976.673209,77872.0,36987.0,3386027.794
Site14-Aurora,30,Site14,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1903.330803,77133.0,36192.0,3353894.62
Site14-Aurora,30,Site14,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,377.8208505,710000.0,64828.0,2864825.276
Site14-Aurora,30,Site14,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,389.4139754,720000.0,68662.0,2905174.928
Site14-Aurora,30,Site14,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,375.9138874,720000.0,69561.0,2905174.928
Site14-Aurora,30,Site14,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,210.6740201,9983.0,6012.0,58445.92727
Site14-Aurora,30,Site14,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,211.2188667,9654.0,6319.0,56519.78182
Site14-Aurora,30,Site14,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,194.6313146,9569.0,6226.0,56022.14545
Site14-Aurora,30,Site14,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,295.0949745,101403.0,24935.0,53509.036
Site14-Aurora,30,Site14,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,307.354023,132902.0,33067.0,70130.64606
Site14-Aurora,30,Site14,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,291.8258948,125560.0,31575.0,66256.36875
Site14-Aurora,30,Site14,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,235.2829251,50507.0,5900.0,26651.88289
Site14-Aurora,30,Site14,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,245.9074338,53954.0,6701.0,28470.81968
Site14-Aurora,30,Site14,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,239.6719672,53422.0,6733.0,28190.09024
Site14-Aurora,30,Site14,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,1074.55858,336022.0,115424.0,254573.166
Site14-Aurora,30,Site14,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,1094.263865,351913.0,122537.0,266612.3247
Site14-Aurora,30,Site14,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,1057.002411,347603.0,121981.0,263347.0315
Site14-Aurora,30,Site14,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,690.5930703,1130000.0,187157.0,22005263.16
Site14-Aurora,30,Site14,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,700.2186936,1190000.0,197306.0,23173684.21
Site14-Aurora,30,Site14,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,676.2454431,1170000.0,191743.0,22784210.53
Site14-Aurora,30,Site14,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1906.539344,77415.0,36129.0,3366156.535
Site14-Aurora,30,Site14,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1978.459095,78954.0,37163.0,3433075.283
Site14-Aurora,30,Site14,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1905.086419,78291.0,36464.0,3404246.739
Site14-Aurora,30,Site14,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,379.3343133,713000.0,65161.0,2876930.171
Site14-Aurora,30,Site14,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,390.6550149,721000.0,68960.0,2909209.893
Site14-Aurora,30,Site14,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,376.8522343,723000.0,70937.0,2917279.823
Site14-Aurora,30,Site14,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,213.2771761,10655.0,6001.0,62380.18182
Site14-Aurora,30,Site14,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,213.8825612,10371.0,6289.0,60717.49091
Site14-Aurora,30,Site14,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,196.3263929,10278.0,6170.0,60173.01818
Site14-Aurora,30,Site14,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,294.9436282,101403.0,24935.0,53509.036
Site14-Aurora,30,Site14,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,307.2632153,132902.0,33067.0,70130.64606
Site14-Aurora,30,Site14,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,291.8258948,125560.0,31575.0,66256.36875
Site14-Aurora,30,Site14,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,234.5261937,50507.0,5900.0,26651.88289
Site14-Aurora,30,Site14,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,244.4847788,53777.0,6624.0,28377.4191
Site14-Aurora,30,Site14,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,238.4006584,53422.0,6733.0,28190.09024
Site14-Aurora,30,Site14,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,1071.350039,335996.0,115581.0,254553.4681
Site14-Aurora,30,Site14,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,1091.63044,351516.0,122682.0,266311.554
Site14-Aurora,30,Site14,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,1053.521447,347010.0,121392.0,262897.7696
Site14-Aurora,30,Site14,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,688.3531454,1130000.0,185693.0,22005263.16
Site14-Aurora,30,Site14,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,698.4328075,1190000.0,198573.0,23173684.21
Site14-Aurora,30,Site14,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,674.0357874,1170000.0,191327.0,22784210.53
Site14-Aurora,30,Site14,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1908.779269,77299.0,36111.0,3361112.627
Site14-Aurora,30,Site14,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1980.214712,78791.0,37156.0,3425987.723
Site14-Aurora,30,Site14,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1906.29719,78148.0,36337.0,3398028.817
Site14-Aurora,30,Site14,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,378.2143508,710000.0,64920.0,2864825.276
Site14-Aurora,30,Site14,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,389.595591,718000.0,69589.0,2897104.997
Site14-Aurora,30,Site14,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,375.8836181,719000.0,70436.0,2901139.962
Site14-Aurora,30,Site14,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site14-Aurora,30,Site14,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,204.3477457,10655.0,6001.0,62380.18182
Site14-Aurora,30,Site14,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,206.1033625,9699.0,6314.0,56783.23636
Site14-Aurora,30,Site14,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,188.3958479,9678.0,6378.0,56660.29091
Site15-AriaIII,31,Site15,AriaIII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,77.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,74.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,78,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,44.1,,275.5649663,13512.0,8657.0,77269.30017
Site15-AriaIII,31,Site15,AriaIII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,41.5,,168.9624639,13265.0,8594.0,75856.8137
Site15-AriaIII,31,Site15,AriaIII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,42.9,,268.1578441,13265.0,8660.0,75856.8137
Site15-AriaIII,31,Site15,AriaIII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.16,,125.8209817,4193.0,1704.0,23977.95853
Site15-AriaIII,31,Site15,AriaIII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.48,,72.87006737,4361.0,1632.0,24938.67807
Site15-AriaIII,31,Site15,AriaIII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.94,,119.2146295,4361.0,1751.0,24938.67807
Site15-AriaIII,31,Site15,AriaIII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.4,,1197.551492,9620.0,4166.0,56803.14223
Site15-AriaIII,31,Site15,AriaIII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,38,,590.4677575,9884.0,4204.0,58361.98106
Site15-AriaIII,31,Site15,AriaIII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,41.4,,1206.059673,9599.0,4080.0,56679.14369
Site15-AriaIII,31,Site15,AriaIII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,31,,371.6573628,11936.0,4072.0,8418452.154
Site15-AriaIII,31,Site15,AriaIII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,32.1,,189.7824832,12524.0,4036.0,8833168.128
Site15-AriaIII,31,Site15,AriaIII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,30.1,,363.2492782,12046.0,4082.0,8496035.074
Site15-AriaIII,31,Site15,AriaIII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.7,,4675.295476,8854.0,3421.0,3443034.693
Site15-AriaIII,31,Site15,AriaIII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.5,,2716.912416,9115.0,3521.0,3544529.165
Site15-AriaIII,31,Site15,AriaIII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99,,4667.888354,9406.0,3587.0,3657689.668
Site15-AriaIII,31,Site15,AriaIII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,53.6,,641.5168431,25458.0,15613.0,934771.8226
Site15-AriaIII,31,Site15,AriaIII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,52.2,,307.9961501,24392.0,16009.0,895630.2262
Site15-AriaIII,31,Site15,AriaIII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,55.1,,664.5389798,25702.0,15693.0,943731.0624
Site15-AriaIII,31,Site15,AriaIII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,13.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,36.2,,1048.608277,12438.0,16284.0,3631170.668
Site15-AriaIII,31,Site15,AriaIII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,41,,638.213667,10087.0,15891.0,2944815.768
Site15-AriaIII,31,Site15,AriaIII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,35.4,,1031.491819,12467.0,16216.0,3639636.977
Site15-AriaIII,31,Site15,AriaIII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,77.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,74.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,78.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,44,,275.3647738,13575.0,8661.0,77629.57
Site15-AriaIII,31,Site15,AriaIII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,41.4,,168.7622714,13265.0,8556.0,75856.8137
Site15-AriaIII,31,Site15,AriaIII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,42.8,,268.0577478,13235.0,8643.0,75685.25664
Site15-AriaIII,31,Site15,AriaIII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.13,,124.9201155,4185.0,1695.0,23932.20998
Site15-AriaIII,31,Site15,AriaIII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.46,,72.66987488,4325.0,1628.0,24732.80959
Site15-AriaIII,31,Site15,AriaIII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.91,,118.614052,4334.0,1739.0,24784.27671
Site15-AriaIII,31,Site15,AriaIII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.4,,1199.953802,9599.0,4156.0,56679.14369
Site15-AriaIII,31,Site15,AriaIII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,38,,590.5678537,9862.0,4200.0,58232.07783
Site15-AriaIII,31,Site15,AriaIII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,41.5,,1208.26179,9599.0,4077.0,56679.14369
Site15-AriaIII,31,Site15,AriaIII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,30.9,,371.3570741,12046.0,4092.0,8496035.074
Site15-AriaIII,31,Site15,AriaIII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,32,,189.0818094,12640.0,4076.0,8914982.844
Site15-AriaIII,31,Site15,AriaIII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,30,,362.2483157,12156.0,4112.0,8573617.995
Site15-AriaIII,31,Site15,AriaIII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.7,,4682.001925,8873.0,3429.0,3450423.18
Site15-AriaIII,31,Site15,AriaIII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.5,,2721.616939,9136.0,3536.0,3552695.387
Site15-AriaIII,31,Site15,AriaIII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99,,4674.995188,9406.0,3601.0,3657689.668
Site15-AriaIII,31,Site15,AriaIII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,53.2,,638.614052,25157.0,15460.0,923719.6458
Site15-AriaIII,31,Site15,AriaIII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.7,,305.5938402,24276.0,15885.0,887699.0959
Site15-AriaIII,31,Site15,AriaIII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,54.6,,660.0346487,25458.0,15524.0,934771.8226
Site15-AriaIII,31,Site15,AriaIII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,13.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,36.2,,1049.809432,12410.0,16286.0,3622996.301
Site15-AriaIII,31,Site15,AriaIII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,41.1,,639.4148219,10064.0,15895.0,2938101.11
Site15-AriaIII,31,Site15,AriaIII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,35.5,,1032.492782,12438.0,16216.0,3631170.668
Site15-AriaIII,31,Site15,AriaIII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,74.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,78.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,44,,276.4658325,13512.0,8652.0,77269.30017
Site15-AriaIII,31,Site15,AriaIII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,41.3,,168.7622714,13204.0,8546.0,75507.98101
Site15-AriaIII,31,Site15,AriaIII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,42.7,,267.9576516,13174.0,8590.0,75336.42395
Site15-AriaIII,31,Site15,AriaIII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.1,,123.919153,4435.0,1891.0,25361.85215
Site15-AriaIII,31,Site15,AriaIII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.43,,72.16939365,4308.0,1619.0,24635.59393
Site15-AriaIII,31,Site15,AriaIII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.89,,117.7131858,4290.0,1727.0,24532.65969
Site15-AriaIII,31,Site15,AriaIII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.5,,1201.255053,9599.0,4156.0,56679.14369
Site15-AriaIII,31,Site15,AriaIII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,38.1,,592.7699711,9839.0,4184.0,58096.2699
Site15-AriaIII,31,Site15,AriaIII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,41.5,,1209.86333,9577.0,4071.0,56549.24045
Site15-AriaIII,31,Site15,AriaIII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,31,,372.6583253,12184.0,4133.0,8593366.374
Site15-AriaIII,31,Site15,AriaIII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,32.2,,190.9836381,12757.0,4136.0,8997502.859
Site15-AriaIII,31,Site15,AriaIII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,30,,363.3493744,12296.0,4163.0,8672359.893
Site15-AriaIII,31,Site15,AriaIII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.7,,4691.110683,8873.0,3435.0,3450423.18
Site15-AriaIII,31,Site15,AriaIII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.5,,2727.522618,9136.0,3536.0,3552695.387
Site15-AriaIII,31,Site15,AriaIII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99,,4680.200192,9406.0,3587.0,3657689.668
Site15-AriaIII,31,Site15,AriaIII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,53.7,,645.120308,25398.0,15723.0,932568.7309
Site15-AriaIII,31,Site15,AriaIII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,52.3,,310.0981713,24392.0,16042.0,895630.2262
Site15-AriaIII,31,Site15,AriaIII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,55.3,,668.8431184,25641.0,15741.0,483725.5083
Site15-AriaIII,31,Site15,AriaIII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,13.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,15,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,36.2,,1049.008662,12438.0,16284.0,3631170.668
Site15-AriaIII,31,Site15,AriaIII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,41,,638.8142445,10064.0,15893.0,2938101.11
Site15-AriaIII,31,Site15,AriaIII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,35.4,,1031.892204,12438.0,16216.0,3631170.668
Site15-AriaIII,31,Site15,AriaIII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.4,,6681.929232,11273.0,3622.0,4383705.681
Site15-AriaIII,31,Site15,AriaIII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.1,,6466.853403,10388.0,3326.0,4039557.758
Site15-AriaIII,31,Site15,AriaIII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,81.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,81.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,71.5,,784.5414639,14416.0,5881.0,82438.88627
Site15-AriaIII,31,Site15,AriaIII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,64.5,,555.0327854,13512.0,6062.0,77269.30017
Site15-AriaIII,31,Site15,AriaIII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,63.2,,587.5250253,13701.0,6077.0,78350.10965
Site15-AriaIII,31,Site15,AriaIII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.05,,95.32776196,4547.0,1759.0,26002.33184
Site15-AriaIII,31,Site15,AriaIII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.65,,131.6021673,4308.0,1641.0,24635.59393
Site15-AriaIII,31,Site15,AriaIII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.02,,134.6107081,4281.0,1704.0,24481.19257
Site15-AriaIII,31,Site15,AriaIII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.1,,874.7117274,14618.0,6086.0,86314.79555
Site15-AriaIII,31,Site15,AriaIII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63,,1001.242355,14686.0,6127.0,86716.31464
Site15-AriaIII,31,Site15,AriaIII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.6,,1400.088897,14961.0,6108.0,88340.10509
Site15-AriaIII,31,Site15,AriaIII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75.1,,656.9793369,14054.0,3984.0,9912276.02
Site15-AriaIII,31,Site15,AriaIII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,74,,740.7027275,13860.0,3914.0,9775447.96
Site15-AriaIII,31,Site15,AriaIII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73,,1022.560015,13924.0,3908.0,9820587.114
Site15-AriaIII,31,Site15,AriaIII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.8,,3155.873267,9906.0,3458.0,3852123.523
Site15-AriaIII,31,Site15,AriaIII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.5,,3101.89145,9513.0,3317.0,3699298.513
Site15-AriaIII,31,Site15,AriaIII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.8,,3766.34916,9599.0,3272.0,3732741.136
Site15-AriaIII,31,Site15,AriaIII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.8,,199.7671044,30891.0,13069.0,1134261.779
Site15-AriaIII,31,Site15,AriaIII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.2,,242.4883828,30743.0,13121.0,1128827.486
Site15-AriaIII,31,Site15,AriaIII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.2,,352.1711819,32643.0,13161.0,1208909.871
Site15-AriaIII,31,Site15,AriaIII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,49.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,55.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,34.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,34.9,,516.2655891,27939.0,26310.0,8156558.715
Site15-AriaIII,31,Site15,AriaIII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,31.4,,499.1598861,26637.0,26314.0,7776450.642
Site15-AriaIII,31,Site15,AriaIII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.9,,585.5479842,26573.0,25457.0,7757766.374
Site15-AriaIII,31,Site15,AriaIII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,81.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,81.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,71.5,,784.5414639,14383.0,5876.0,82250.1735
Site15-AriaIII,31,Site15,AriaIII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,64.4,,554.5170355,13481.0,6047.0,77092.02454
Site15-AriaIII,31,Site15,AriaIII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,63.2,,588.2126917,13669.0,6070.0,78167.11545
Site15-AriaIII,31,Site15,AriaIII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.03,,94.89797043,4509.0,1741.0,25785.02623
Site15-AriaIII,31,Site15,AriaIII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.59,,130.656626,4272.0,1628.0,24429.72545
Site15-AriaIII,31,Site15,AriaIII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.98,,133.8370833,4263.0,1696.0,24378.25833
Site15-AriaIII,31,Site15,AriaIII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.2,,876.0870603,14584.0,6071.0,86108.13131
Site15-AriaIII,31,Site15,AriaIII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63.1,,1003.047479,14652.0,6112.0,86515.55509
Site15-AriaIII,31,Site15,AriaIII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.6,,1401.722105,14926.0,6079.0,88133.44085
Site15-AriaIII,31,Site15,AriaIII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,75,,657.4091285,14184.0,4002.0,10003964.93
Site15-AriaIII,31,Site15,AriaIII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,74,,741.8201855,13989.0,3920.0,9866431.567
Site15-AriaIII,31,Site15,AriaIII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73,,1022.903848,14054.0,3925.0,9912276.02
Site15-AriaIII,31,Site15,AriaIII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.7,,3158.366057,9884.0,3474.0,3843568.433
Site15-AriaIII,31,Site15,AriaIII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.5,,3104.298283,9513.0,3325.0,3699298.513
Site15-AriaIII,31,Site15,AriaIII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.8,,3770.90495,9555.0,3293.0,3715630.957
Site15-AriaIII,31,Site15,AriaIII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,22.7,,198.9075214,30450.0,12935.0,1118069.055
Site15-AriaIII,31,Site15,AriaIII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.1,,242.0585912,30450.0,13031.0,1118069.055
Site15-AriaIII,31,Site15,AriaIII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.1,,351.5694738,32253.0,13061.0,1184271.961
Site15-AriaIII,31,Site15,AriaIII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,49.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,55.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,34.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,24.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,34.9,,516.781339,27939.0,26310.0,8156558.715
Site15-AriaIII,31,Site15,AriaIII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,31.4,,500.2773441,26637.0,26314.0,7776450.642
Site15-AriaIII,31,Site15,AriaIII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.9,,586.4075673,26573.0,25457.0,7757766.374
Site15-AriaIII,31,Site15,AriaIII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,81.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,80.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,71.4,,787.378088,14316.0,5838.0,81867.0294
Site15-AriaIII,31,Site15,AriaIII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,64.3,,556.8379098,13450.0,6040.0,76914.74891
Site15-AriaIII,31,Site15,AriaIII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,63.1,,589.7599412,13606.0,6047.0,77806.84563
Site15-AriaIII,31,Site15,AriaIII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.99,,93.2647626,4490.0,1727.0,25676.37343
Site15-AriaIII,31,Site15,AriaIII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.62,,129.1953347,4254.0,1609.0,24326.79122
Site15-AriaIII,31,Site15,AriaIII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.97,,131.7740839,4228.0,1674.0,24178.10843
Site15-AriaIII,31,Site15,AriaIII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.6,,857.1762329,14349.0,5849.0,84726.43325
Site15-AriaIII,31,Site15,AriaIII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.5,,978.893195,14449.0,5865.0,85316.90251
Site15-AriaIII,31,Site15,AriaIII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.1,,1370.51924,14686.0,5869.0,86716.31464
Site15-AriaIII,31,Site15,AriaIII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,74.6,,639.7876756,14316.0,4087.0,10097064.43
Site15-AriaIII,31,Site15,AriaIII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.5,,719.0412343,14119.0,4025.0,9958120.473
Site15-AriaIII,31,Site15,AriaIII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.5,,993.9358986,14217.0,4010.0,10027239.8
Site15-AriaIII,31,Site15,AriaIII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.7,,3145.386353,9884.0,3472.0,3843568.433
Site15-AriaIII,31,Site15,AriaIII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.5,,3083.668289,9491.0,3345.0,3690743.424
Site15-AriaIII,31,Site15,AriaIII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.8,,3740.991459,9577.0,3285.0,3724186.047
Site15-AriaIII,31,Site15,AriaIII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.3,,199.5951878,30817.0,13017.0,1131544.633
Site15-AriaIII,31,Site15,AriaIII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.7,,241.9726329,30817.0,13121.0,1131544.633
Site15-AriaIII,31,Site15,AriaIII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.7,,352.0852236,32564.0,13182.0,1195691.32
Site15-AriaIII,31,Site15,AriaIII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,49.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,55,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,35,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,35.5,,516.6094224,28005.0,26310.0,8175826.866
Site15-AriaIII,31,Site15,AriaIII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,31.9,,499.8475526,26700.0,26314.0,7794842.968
Site15-AriaIII,31,Site15,AriaIII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.3,,586.2356507,26573.0,25457.0,7757766.374
Site15-AriaIII,31,Site15,AriaIII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.8,,6766.640115,11070.0,3262.0,4304765.536
Site15-AriaIII,31,Site15,AriaIII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97.8,,6819.284148,10970.0,3025.0,4265878.765
Site15-AriaIII,31,Site15,AriaIII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,85,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,84.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,53.8,,439.0232186,17045.0,7423.0,97473.00336
Site15-AriaIII,31,Site15,AriaIII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,55.4,,596.6469175,16739.0,7656.0,95723.12134
Site15-AriaIII,31,Site15,AriaIII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,56.8,,472.4963971,16808.0,7799.0,96117.70258
Site15-AriaIII,31,Site15,AriaIII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.6,,101.7934347,5180.0,2000.0,29622.18583
Site15-AriaIII,31,Site15,AriaIII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.78,,168.9895917,5007.0,1785.0,28632.87344
Site15-AriaIII,31,Site15,AriaIII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.12,,121.4027222,5125.0,1900.0,29307.66455
Site15-AriaIII,31,Site15,AriaIII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.1,,868.1793435,13357.0,5726.0,78868.97825
Site15-AriaIII,31,Site15,AriaIII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,47.7,,1604.714171,13481.0,5601.0,79601.16013
Site15-AriaIII,31,Site15,AriaIII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,50,,1124.848679,13575.0,5708.0,80156.20123
Site15-AriaIII,31,Site15,AriaIII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.2,,513.7133707,13828.0,4647.0,9752878.384
Site15-AriaIII,31,Site15,AriaIII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,56.7,,910.1457166,14021.0,4783.0,9889001.144
Site15-AriaIII,31,Site15,AriaIII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,62.4,,701.4379504,13989.0,4507.0,9866431.567
Site15-AriaIII,31,Site15,AriaIII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.8,,3553.028022,10650.0,3626.0,4141441.098
Site15-AriaIII,31,Site15,AriaIII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.1,,5314.366693,10895.0,3643.0,4236713.687
Site15-AriaIII,31,Site15,AriaIII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.1,,3741.377102,10772.0,3616.0,4188882.958
Site15-AriaIII,31,Site15,AriaIII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31.8,,276.4035228,33597.0,18327.0,1233621.216
Site15-AriaIII,31,Site15,AriaIII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,36.4,,583.7822258,35421.0,17362.0,1300595.205
Site15-AriaIII,31,Site15,AriaIII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.5,,343.1000801,34085.0,17541.0,1251539.696
Site15-AriaIII,31,Site15,AriaIII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,40.5,,855.3146517,37529.0,27806.0,10956279.47
Site15-AriaIII,31,Site15,AriaIII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,32.4,,1091.5004,36110.0,26824.0,10542014.22
Site15-AriaIII,31,Site15,AriaIII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,32.3,,725.9183347,34746.0,26655.0,10143805.76
Site15-AriaIII,31,Site15,AriaIII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,85.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,84.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,53.7,,438.7734187,17006.0,7385.0,97249.97918
Site15-AriaIII,31,Site15,AriaIII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,55.4,,596.8967174,16691.0,7638.0,95448.63004
Site15-AriaIII,31,Site15,AriaIII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,56.7,,471.7469976,16808.0,7722.0,96117.70258
Site15-AriaIII,31,Site15,AriaIII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.59,,101.5436349,5158.0,1985.0,29496.37731
Site15-AriaIII,31,Site15,AriaIII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.76,,168.2401922,4976.0,1777.0,28455.59781
Site15-AriaIII,31,Site15,AriaIII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.09,,120.6533227,5103.0,1889.0,29181.85604
Site15-AriaIII,31,Site15,AriaIII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.4,,872.9255404,13296.0,5689.0,78508.79201
Site15-AriaIII,31,Site15,AriaIII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,47.9,,1611.333867,13450.0,5597.0,79418.11466
Site15-AriaIII,31,Site15,AriaIII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,50.1,,1128.595677,13544.0,5694.0,79973.15576
Site15-AriaIII,31,Site15,AriaIII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.2,,517.0856685,13956.0,4671.0,9843156.691
Site15-AriaIII,31,Site15,AriaIII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,56.7,,913.7678143,14184.0,4797.0,10003964.93
Site15-AriaIII,31,Site15,AriaIII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,62.2,,702.4371497,14119.0,4562.0,9958120.473
Site15-AriaIII,31,Site15,AriaIII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.8,,3555.775821,10772.0,3644.0,4188882.958
Site15-AriaIII,31,Site15,AriaIII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.1,,5319.86229,10995.0,3652.0,4275600.457
Site15-AriaIII,31,Site15,AriaIII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.1,,3744.2498,10846.0,3625.0,4217659.169
Site15-AriaIII,31,Site15,AriaIII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,31.5,,275.2794235,33276.0,18177.0,1221834.676
Site15-AriaIII,31,Site15,AriaIII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,36,,580.4099279,34914.0,17106.0,1281979.08
Site15-AriaIII,31,Site15,AriaIII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,30.2,,340.3522818,33597.0,17250.0,1233621.216
Site15-AriaIII,31,Site15,AriaIII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,40.5,,855.9391513,37529.0,27806.0,10956279.47
Site15-AriaIII,31,Site15,AriaIII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,32.5,,1093.248999,36110.0,26824.0,10542014.22
Site15-AriaIII,31,Site15,AriaIII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,32.3,,726.2930344,34746.0,26655.0,10143805.76
Site15-AriaIII,31,Site15,AriaIII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,84.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,83.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,53.8,,440.8967174,16926.0,7336.0,96792.49368
Site15-AriaIII,31,Site15,AriaIII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,55.5,,599.7694155,16613.0,7609.0,95002.58168
Site15-AriaIII,31,Site15,AriaIII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,56.7,,473.3706966,16769.0,7713.0,95894.6784
Site15-AriaIII,31,Site15,AriaIII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.62,,100.7942354,5103.0,1946.0,29181.85604
Site15-AriaIII,31,Site15,AriaIII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.78,,166.991193,4934.0,1771.0,28215.41793
Site15-AriaIII,31,Site15,AriaIII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.15,,120.2786229,5039.0,1867.0,28815.86764
Site15-AriaIII,31,Site15,AriaIII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.2,,856.5636509,13144.0,5475.0,77611.27874
Site15-AriaIII,31,Site15,AriaIII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,47.8,,1590.97518,13357.0,5456.0,78868.97825
Site15-AriaIII,31,Site15,AriaIII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,50,,1108.486789,13388.0,5456.0,79052.02372
Site15-AriaIII,31,Site15,AriaIII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.2,,507.3434748,14119.0,4762.0,9958120.473
Site15-AriaIII,31,Site15,AriaIII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,56.7,,902.6517214,14316.0,4912.0,10097064.43
Site15-AriaIII,31,Site15,AriaIII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,62.2,,689.572458,14283.0,4675.0,10073789.55
Site15-AriaIII,31,Site15,AriaIII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.7,,3529.297038,10699.0,3634.0,4160495.616
Site15-AriaIII,31,Site15,AriaIII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.8,,5279.519616,10920.0,3651.0,4246435.379
Site15-AriaIII,31,Site15,AriaIII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99,,3709.902322,10796.0,3624.0,4198215.783
Site15-AriaIII,31,Site15,AriaIII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.3,,277.0280224,33597.0,18296.0,1233621.216
Site15-AriaIII,31,Site15,AriaIII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,36.7,,584.0320256,35421.0,17319.0,1300595.205
Site15-AriaIII,31,Site15,AriaIII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31,,343.4747798,34085.0,17481.0,1251539.696
Site15-AriaIII,31,Site15,AriaIII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.1,,855.9391513,37529.0,27796.0,10956279.47
Site15-AriaIII,31,Site15,AriaIII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,32.9,,1093.248999,36110.0,26813.0,10542014.22
Site15-AriaIII,31,Site15,AriaIII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,32.8,,726.6677342,34746.0,26655.0,10143805.76
Site15-AriaIII,31,Site15,AriaIII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,97.7,,6885.69493,11095.0,3263.0,4314487.228
Site15-AriaIII,31,Site15,AriaIII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,97.5,,6832.107873,11881.0,3455.0,4620137.247
Site15-AriaIII,31,Site15,AriaIII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1333.437991,20520.0,10057.0,7979565.383
Site15-AriaIII,31,Site15,AriaIII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1312.365039,20280.0,9682.0,7886237.133
Site15-AriaIII,31,Site15,AriaIII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.4,,189.4609221,12611.0,3689.0,72116.86978
Site15-AriaIII,31,Site15,AriaIII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.3,,191.2000929,10772.0,3065.0,61600.42195
Site15-AriaIII,31,Site15,AriaIII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.4,,194.4066891,10294.0,2738.0,58866.94612
Site15-AriaIII,31,Site15,AriaIII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,141.0358843,4965.0,1297.0,28392.69356
Site15-AriaIII,31,Site15,AriaIII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.9,,141.6880734,4841.0,1220.0,27683.59104
Site15-AriaIII,31,Site15,AriaIII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.8,,145.1664151,4701.0,1116.0,26882.99142
Site15-AriaIII,31,Site15,AriaIII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.5,,671.9721287,32331.0,13237.0,190904.6145
Site15-AriaIII,31,Site15,AriaIII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.5,,681.2114737,32099.0,13082.0,189534.7258
Site15-AriaIII,31,Site15,AriaIII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71,,696.9183602,30965.0,12593.0,182838.8045
Site15-AriaIII,31,Site15,AriaIII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.3,,438.9232377,42753.0,6720.0,30153659.93
Site15-AriaIII,31,Site15,AriaIII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,439.7928231,41833.0,6615.0,29504784.6
Site15-AriaIII,31,Site15,AriaIII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.7,,451.1517826,40638.0,6537.0,28661951.96
Site15-AriaIII,31,Site15,AriaIII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1233.724306,14584.0,7465.0,5671246.664
Site15-AriaIII,31,Site15,AriaIII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1251.224713,14283.0,7370.0,5554197.484
Site15-AriaIII,31,Site15,AriaIII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1283.345024,14119.0,7285.0,5490423.18
Site15-AriaIII,31,Site15,AriaIII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.6,,232.6140982,97189.0,34381.0,3568604.709
Site15-AriaIII,31,Site15,AriaIII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.4,,240.9295088,100091.0,32321.0,3675160.912
Site15-AriaIII,31,Site15,AriaIII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.2,,245.4404831,95769.0,30308.0,3516464.871
Site15-AriaIII,31,Site15,AriaIII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,76.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,76.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,76.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,0.76,,7.119730577,1055.0,571.0,307998.4768
Site15-AriaIII,31,Site15,AriaIII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,0.9,,8.587155963,1022.0,470.0,298364.4012
Site15-AriaIII,31,Site15,AriaIII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,0.81,,7.934966903,1057.0,543.0,308582.3602
Site15-AriaIII,31,Site15,AriaIII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.4,,189.406573,12611.0,3699.0,72116.86978
Site15-AriaIII,31,Site15,AriaIII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.3,,191.2000929,10772.0,3065.0,61600.42195
Site15-AriaIII,31,Site15,AriaIII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.4,,194.4066891,10271.0,2747.0,58735.41904
Site15-AriaIII,31,Site15,AriaIII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,141.0358843,4893.0,1298.0,27980.95661
Site15-AriaIII,31,Site15,AriaIII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.9,,141.6880734,4771.0,1219.0,27283.29123
Site15-AriaIII,31,Site15,AriaIII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.8,,145.1664151,4623.0,1108.0,26436.94306
Site15-AriaIII,31,Site15,AriaIII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.5,,671.4286378,32099.0,13204.0,189534.7258
Site15-AriaIII,31,Site15,AriaIII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.5,,680.5592846,31869.0,12972.0,188176.6466
Site15-AriaIII,31,Site15,AriaIII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71,,696.2661712,30743.0,12509.0,181527.9628
Site15-AriaIII,31,Site15,AriaIII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.3,,438.6514923,43064.0,6709.0,30373008.01
Site15-AriaIII,31,Site15,AriaIII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.5,,439.2493322,42138.0,6648.0,29719900.88
Site15-AriaIII,31,Site15,AriaIII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.7,,450.771339,40933.0,6628.0,28870015.25
Site15-AriaIII,31,Site15,AriaIII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1233.724306,14383.0,7447.0,410255.4327
Site15-AriaIII,31,Site15,AriaIII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1251.224713,14054.0,7371.0,5465146.778
Site15-AriaIII,31,Site15,AriaIII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1283.345024,13892.0,7277.0,5402150.21
Site15-AriaIII,31,Site15,AriaIII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.6,,232.5597492,96713.0,34543.0,3551126.847
Site15-AriaIII,31,Site15,AriaIII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.4,,240.8208106,99358.0,32363.0,3648246.475
Site15-AriaIII,31,Site15,AriaIII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.2,,245.2774358,95068.0,30362.0,3490725.416
Site15-AriaIII,31,Site15,AriaIII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,76.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,76.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,76.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,0.75,,7.065381489,1055.0,569.0,307998.4768
Site15-AriaIII,31,Site15,AriaIII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,0.9,,8.587155963,1018.0,468.0,297196.6345
Site15-AriaIII,31,Site15,AriaIII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,0.8,,7.826268726,1059.0,557.0,309166.2436
Site15-AriaIII,31,Site15,AriaIII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.4,,189.3522239,12582.0,3690.0,71951.03129
Site15-AriaIII,31,Site15,AriaIII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.3,,191.2000929,10747.0,3067.0,61457.45774
Site15-AriaIII,31,Site15,AriaIII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,80.4,,194.4066891,10248.0,2740.0,58603.89196
Site15-AriaIII,31,Site15,AriaIII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15,,141.0358843,4771.0,1300.0,27283.29123
Site15-AriaIII,31,Site15,AriaIII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.9,,141.6337243,4652.0,1212.0,26602.78156
Site15-AriaIII,31,Site15,AriaIII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.8,,145.112066,4509.0,1104.0,25785.02623
Site15-AriaIII,31,Site15,AriaIII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.5,,671.5916851,32022.0,13072.0,189080.0645
Site15-AriaIII,31,Site15,AriaIII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.5,,680.8853792,31793.0,12917.0,187727.8899
Site15-AriaIII,31,Site15,AriaIII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71,,696.7009639,30670.0,12456.0,181096.9202
Site15-AriaIII,31,Site15,AriaIII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.3,,438.7601905,43273.0,6759.0,30520415.55
Site15-AriaIII,31,Site15,AriaIII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.6,,439.5754268,42342.0,6698.0,29863781.93
Site15-AriaIII,31,Site15,AriaIII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,64.7,,451.0430844,41231.0,6619.0,29080194.43
Site15-AriaIII,31,Site15,AriaIII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1233.724306,14483.0,7456.0,5631971.026
Site15-AriaIII,31,Site15,AriaIII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1251.224713,14184.0,7379.0,5515699.581
Site15-AriaIII,31,Site15,AriaIII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,1283.345024,14021.0,7290.0,5452314.144
Site15-AriaIII,31,Site15,AriaIII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.6,,232.6140982,97189.0,34653.0,3568604.709
Site15-AriaIII,31,Site15,AriaIII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.4,,240.8208106,100091.0,32456.0,3675160.912
Site15-AriaIII,31,Site15,AriaIII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.2,,245.3317849,95769.0,30445.0,3516464.871
Site15-AriaIII,31,Site15,AriaIII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,76.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,76.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,76.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-AriaIII,31,Site15,AriaIII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,0.74,,6.956683312,1053.0,566.0,307414.5935
Site15-AriaIII,31,Site15,AriaIII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,0.89,,8.478457787,1018.0,470.0,297196.6345
Site15-AriaIII,31,Site15,AriaIII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,0.79,,7.717570549,1063.0,553.0,310334.0103
Site15-CantoII-1,32,Site15,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,80.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,81.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,82.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,32.1,751,74.30394,20443.0,9261.0,88764.58065
Site15-CantoII-1,32,Site15,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,34.8,1215,120.2121,21833.0,8305.0,94800.03372
Site15-CantoII-1,32,Site15,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,34.5,1514,149.79516,21613.0,8681.0,93844.78216
Site15-CantoII-1,32,Site15,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,2.26,485,47.9859,6353.0,2655.0,27585.05997
Site15-CantoII-1,32,Site15,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,3.28,993,98.24742,6615.0,2942.0,28722.67774
Site15-CantoII-1,32,Site15,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,3.14,1345,133.0743,6226.0,3050.0,27033.61929
Site15-CantoII-1,32,Site15,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,25.9,5559,550.00746,13698.0,6194.0,84864.79258
Site15-CantoII-1,32,Site15,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.5,7727,764.50938,13013.0,5761.0,80620.93341
Site15-CantoII-1,32,Site15,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.7,11448,1132.66512,12860.0,5731.0,79673.03493
Site15-CantoII-1,32,Site15,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,9.98,555,54.9117,7628.0,2898.0,6087369.458
Site15-CantoII-1,32,Site15,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,13.5,1041,102.99654,7218.0,2634.0,5760177.34
Site15-CantoII-1,32,Site15,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,13,1487,147.12378,7413.0,2683.0,5915793.103
Site15-CantoII-1,32,Site15,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.2,255889,25317.65766,14605.0,4376.0,5372842.029
Site15-CantoII-1,32,Site15,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.3,37817,3741.61398,14499.0,4342.0,5333847.079
Site15-CantoII-1,32,Site15,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.4,53394,5282.80236,14605.0,4399.0,5372842.029
Site15-CantoII-1,32,Site15,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,58.2,3234,319.97196,16737.0,8315.0,1328244.748
Site15-CantoII-1,32,Site15,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,56,4324,427.81656,17039.0,8059.0,1352211.404
Site15-CantoII-1,32,Site15,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,57,6522,645.28668,16625.0,7896.0,1319356.452
Site15-CantoII-1,32,Site15,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,82.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,80.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,80.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,9.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,9.23,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,8.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.7,3803,376.26882,29727.0,18219.0,10896939.42
Site15-CantoII-1,32,Site15,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.5,4397,435.03918,29229.0,17798.0,10714389.01
Site15-CantoII-1,32,Site15,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.8,5921,585.82374,29066.0,17599.0,10654638.58
Site15-CantoII-1,32,Site15,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,81.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,83,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,84,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,58.7,1435,141.9789,22392.0,9064.0,97227.24111
Site15-CantoII-1,32,Site15,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,60.8,2233,220.93302,22506.0,8230.0,29165.5671
Site15-CantoII-1,32,Site15,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,61.9,2894,286.33236,22620.0,8649.0,98217.2291
Site15-CantoII-1,32,Site15,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.86,834,82.51596,6483.0,2652.0,28149.5268
Site15-CantoII-1,32,Site15,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.03,1538,152.16972,6717.0,2842.0,97722.2351
Site15-CantoII-1,32,Site15,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.74,2053,203.12382,6418.0,3044.0,27867.29338
Site15-CantoII-1,32,Site15,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,49.4,10677,1056.38238,13807.0,5866.0,85540.09279
Site15-CantoII-1,32,Site15,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,49.9,15272,1511.01168,13431.0,5507.0,83210.61681
Site15-CantoII-1,32,Site15,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,51.5,22302,2206.55988,13272.0,5946.0,82225.54585
Site15-CantoII-1,32,Site15,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,34.2,3650,361.131,8745.0,2749.0,6978768.473
Site15-CantoII-1,32,Site15,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37.9,5789,572.76366,8319.0,2578.0,6638807.882
Site15-CantoII-1,32,Site15,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,37.3,8319,823.08186,8267.0,2572.0,6597310.345
Site15-CantoII-1,32,Site15,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.2,26314,2603.50716,14676.0,4409.0,5398961.289
Site15-CantoII-1,32,Site15,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.4,38501,3809.28894,14570.0,4376.0,5359966.338
Site15-CantoII-1,32,Site15,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.4,54352,5377.58688,14676.0,4445.0,5398961.289
Site15-CantoII-1,32,Site15,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44.3,4725,467.4915,17347.0,8219.0,1376654.218
Site15-CantoII-1,32,Site15,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41.9,6398,633.01812,17661.0,7727.0,1401573.191
Site15-CantoII-1,32,Site15,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,42.8,9539,943.78866,17154.0,7616.0,1361337.779
Site15-CantoII-1,32,Site15,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,82.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,79.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,79.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,9.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,9.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,8.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,20.9,4520,447.2088,27787.0,17487.0,10185799.29
Site15-CantoII-1,32,Site15,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.7,5116,506.17704,27477.0,17251.0,10072163.5
Site15-CantoII-1,32,Site15,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.3,7056,698.12064,27170.0,16799.0,9959627.407
Site15-CantoII-1,32,Site15,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,77.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,78.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,79.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,41.9,570,56.3958,20034.0,8035.0,86988.68115
Site15-CantoII-1,32,Site15,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,47.2,952,94.19088,21180.0,7738.0,91964.6734
Site15-CantoII-1,32,Site15,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,47.1,1166,115.36404,20547.0,8088.0,89216.15412
Site15-CantoII-1,32,Site15,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,3.68,792,78.36048,6418.0,2605.0,27867.29338
Site15-CantoII-1,32,Site15,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,4.63,1406,139.10964,6582.0,2656.0,28579.39
Site15-CantoII-1,32,Site15,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,4.37,1874,185.41356,6257.0,2731.0,27168.22292
Site15-CantoII-1,32,Site15,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,43.6,9381,928.15614,13753.0,5900.0,85205.54039
Site15-CantoII-1,32,Site15,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,44.2,13404,1326.19176,13325.0,5557.0,82553.90284
Site15-CantoII-1,32,Site15,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,45.9,19712,1950.30528,13168.0,5524.0,81581.22271
Site15-CantoII-1,32,Site15,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,30,2813,278.31822,8233.0,2594.0,6570177.34
Site15-CantoII-1,32,Site15,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,34.7,4654,460.46676,7965.0,2505.0,6356305.419
Site15-CantoII-1,32,Site15,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,33.8,6666,659.53404,7916.0,2522.0,6317201.97
Site15-CantoII-1,32,Site15,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.2,24896,2463.21024,14711.0,4432.0,5411836.98
Site15-CantoII-1,32,Site15,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.3,36291,3590.63154,14570.0,4399.0,5359966.338
Site15-CantoII-1,32,Site15,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.4,51302,5075.81988,14676.0,4445.0,5398961.289
Site15-CantoII-1,32,Site15,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,43.4,4068,402.48792,16295.0,7998.0,1293167.723
Site15-CantoII-1,32,Site15,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41,5490,543.1806,17115.0,7551.0,1358242.748
Site15-CantoII-1,32,Site15,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,41.7,8226,813.88044,16699.0,7451.0,1325229.076
Site15-CantoII-1,32,Site15,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,86.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,83.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,83.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,5.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,5.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,4.82,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,20,4296,425.04624,27787.0,17355.0,10185799.29
Site15-CantoII-1,32,Site15,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.2,4902,485.00388,27477.0,17286.0,10072163.5
Site15-CantoII-1,32,Site15,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.7,6717,664.57998,27017.0,16799.0,9903542.645
Site15-CantoII-1,32,Site15,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.5,,2720.590682,14854.0,3973.0,5464443.376
Site15-CantoII-1,32,Site15,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.7,,2733.904189,15144.0,4092.0,5571127.675
Site15-CantoII-1,32,Site15,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,77.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,80.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,80.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,48.8,1473,137.97591,13298.0,6998.0,57740.61505
Site15-CantoII-1,32,Site15,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,58.5,4097,383.76599,17039.0,6683.0,73984.23371
Site15-CantoII-1,32,Site15,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,57.2,3280,307.2376,17387.0,6625.0,75495.26801
Site15-CantoII-1,32,Site15,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,4.31,999,93.57633,5268.0,2392.0,22873.93293
Site15-CantoII-1,32,Site15,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.1,1166,109.21922,10431.0,4278.0,45291.95034
Site15-CantoII-1,32,Site15,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.3,943,88.33081,10917.0,6184.0,47402.18789
Site15-CantoII-1,32,Site15,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,7.66,1775,166.26425,9989.0,4186.0,61885.99891
Site15-CantoII-1,32,Site15,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,6.3,519,48.61473,9755.0,4808.0,60436.27183
Site15-CantoII-1,32,Site15,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,6.69,440,41.2148,10473.0,5086.0,64884.57969
Site15-CantoII-1,32,Site15,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.3,857,80.27519,6987.0,2048.0,5575832.512
Site15-CantoII-1,32,Site15,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,50.9,264,24.72888,7307.0,5086.0,5831201.97
Site15-CantoII-1,32,Site15,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,53.2,234,21.91878,7691.0,2317.0,6137645.32
Site15-CantoII-1,32,Site15,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.5,35193,3296.52831,12973.0,3578.0,4772466.939
Site15-CantoII-1,32,Site15,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.5,16291,1525.97797,14051.0,3949.0,5169038.23
Site15-CantoII-1,32,Site15,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,91,13204,1236.81868,14291.0,3988.0,5257328.685
Site15-CantoII-1,32,Site15,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,37.4,664,62.19688,13298.0,6300.0,1055326.442
Site15-CantoII-1,32,Site15,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.8,170,15.9239,14141.0,4380.0,1122226.742
Site15-CantoII-1,32,Site15,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35,154,14.42518,14616.0,9127.0,1159922.641
Site15-CantoII-1,32,Site15,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,50.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,49.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,8.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,43,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,43.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.4,2875,269.30125,27017.0,52.0,9903542.645
Site15-CantoII-1,32,Site15,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.9,1644,153.99348,27632.0,4064.0,10128981.4
Site15-CantoII-1,32,Site15,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,18.2,1198,112.21666,25255.0,17592.0,9257651.46
Site15-CantoII-1,32,Site15,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,79.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,83.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,84.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,61.5,1970,184.5299,13847.0,7341.0,60124.40191
Site15-CantoII-1,32,Site15,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,78,5867,549.56189,17564.0,6548.0,76263.81131
Site15-CantoII-1,32,Site15,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77.2,4755,445.40085,17743.0,6535.0,77041.03872
Site15-CantoII-1,32,Site15,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.75,1580,147.9986,5403.0,2392.0,23460.11003
Site15-CantoII-1,32,Site15,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.3,1614,151.18338,11253.0,6599.0,48861.11755
Site15-CantoII-1,32,Site15,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.7,1327,124.30009,11600.0,6566.0,50367.80979
Site15-CantoII-1,32,Site15,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.5,9704,908.97368,13484.0,5545.0,83538.9738
Site15-CantoII-1,32,Site15,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.7,2154,201.76518,13220.0,6193.0,81903.38428
Site15-CantoII-1,32,Site15,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.2,1837,172.07179,13644.0,6033.0,84530.24017
Site15-CantoII-1,32,Site15,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.7,6960,651.9432,8031.0,2181.0,6408975.369
Site15-CantoII-1,32,Site15,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,70.4,1516,142.00372,9234.0,3114.0,7369004.926
Site15-CantoII-1,32,Site15,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.7,1335,125.04945,9176.0,3058.0,7322719.212
Site15-CantoII-1,32,Site15,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.5,36090,3380.5503,13036.0,3618.0,4795643.183
Site15-CantoII-1,32,Site15,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,91.6,17002,1592.57734,14119.0,3989.0,5194053.859
Site15-CantoII-1,32,Site15,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,91.1,13829,1295.36243,14395.0,4075.0,5295587.882
Site15-CantoII-1,32,Site15,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,23.8,2308,216.19036,15243.0,5902.0,1209681.227
Site15-CantoII-1,32,Site15,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,21.5,464,43.46288,14681.0,6933.0,1165081.027
Site15-CantoII-1,32,Site15,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,21,386,36.15662,14877.0,7787.0,1180635.545
Site15-CantoII-1,32,Site15,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,49.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,48.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,8.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,44.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,44.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.6,3420,320.3514,25397.0,15949.0,9309703.985
Site15-CantoII-1,32,Site15,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.9,2007,187.99569,24972.0,16845.0,9153912.978
Site15-CantoII-1,32,Site15,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.1,1492,139.75564,22824.0,16683.0,8366526.903
Site15-CantoII-1,32,Site15,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,69.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,62.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,63.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,46.5,938,87.86246,12578.0,6812.0,54614.3372
Site15-CantoII-1,32,Site15,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,66.3,2443,228.83581,15954.0,6194.0,69273.10668
Site15-CantoII-1,32,Site15,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,65.9,2047,191.74249,16198.0,6271.0,70332.5675
Site15-CantoII-1,32,Site15,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.38,1479,138.53793,5349.0,2340.0,23225.63919
Site15-CantoII-1,32,Site15,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.2,1094,102.47498,9379.0,6099.0,40724.11104
Site15-CantoII-1,32,Site15,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14,854,79.99418,9866.0,5967.0,42838.69064
Site15-CantoII-1,32,Site15,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,33.3,7726,723.69442,13220.0,5564.0,81903.38428
Site15-CantoII-1,32,Site15,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,23.1,1781,166.82627,13065.0,6245.0,80943.09498
Site15-CantoII-1,32,Site15,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,24.7,1512,141.62904,13325.0,5947.0,82553.90284
Site15-CantoII-1,32,Site15,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.7,5382,504.13194,7707.0,2136.0,6150413.793
Site15-CantoII-1,32,Site15,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.1,1142,106.97114,8618.0,2864.0,6877418.719
Site15-CantoII-1,32,Site15,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.7,994,93.10798,8529.0,2844.0,6806394.089
Site15-CantoII-1,32,Site15,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.2,31721,2971.30607,12848.0,3498.0,4726482.327
Site15-CantoII-1,32,Site15,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,89.1,12438,1165.06746,13583.0,3971.0,4996871.844
Site15-CantoII-1,32,Site15,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,88.3,10098,945.87966,13882.0,4035.0,5106867.035
Site15-CantoII-1,32,Site15,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,21.8,1682,157.55294,14552.0,5907.0,1154843.615
Site15-CantoII-1,32,Site15,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,19.2,342,32.03514,14424.0,7026.0,1144685.562
Site15-CantoII-1,32,Site15,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,19.3,292,27.35164,15142.0,7893.0,1201665.889
Site15-CantoII-1,32,Site15,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,73.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,6.36,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.1,3275,306.76925,25540.0,16039.0,9362123.076
Site15-CantoII-1,32,Site15,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.4,1879,176.00593,24832.0,16789.0,9102593.588
Site15-CantoII-1,32,Site15,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,22.8,1393,130.48231,22593.0,16803.0,8281849.908
Site15-CantoII-1,32,Site15,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.9,,2505.230408,14464.0,3680.0,5320971.387
Site15-CantoII-1,32,Site15,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.4,,2733.012876,14085.0,3254.0,5181546.045
Site15-CantoII-1,32,Site15,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,79.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,77.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,77.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,37.1,666,67.6989,21613.0,8264.0,93844.78216
Site15-CantoII-1,32,Site15,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,31.4,654,66.4791,21073.0,9063.0,91500.07377
Site15-CantoII-1,32,Site15,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,32.7,603,61.29495,20967.0,9312.0,91039.8162
Site15-CantoII-1,32,Site15,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.3,516,52.4514,8962.0,7989.0,38913.47512
Site15-CantoII-1,32,Site15,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.36,477,48.48705,7897.0,6782.0,34289.18913
Site15-CantoII-1,32,Site15,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.58,394,40.0501,7320.0,6379.0,31783.8248
Site15-CantoII-1,32,Site15,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,19.1,953,96.87245,10228.0,4380.0,63366.70306
Site15-CantoII-1,32,Site15,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.9,1079,109.68035,10148.0,4278.0,62871.06987
Site15-CantoII-1,32,Site15,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,20,918,93.3147,10188.0,4064.0,63118.88646
Site15-CantoII-1,32,Site15,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,9.65,92,9.3518,6806.0,2062.0,5431389.163
Site15-CantoII-1,32,Site15,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,9.18,99,10.06335,6419.0,2072.0,5122551.724
Site15-CantoII-1,32,Site15,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,8.17,75,7.62375,6788.0,2123.0,5417024.631
Site15-CantoII-1,32,Site15,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,86.9,7553,767.76245,13388.0,3815.0,4925135.85
Site15-CantoII-1,32,Site15,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,84.5,8691,883.44015,13882.0,3991.0,5106867.035
Site15-CantoII-1,32,Site15,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,83.9,7206,732.4899,14017.0,4210.0,5156530.416
Site15-CantoII-1,32,Site15,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,42.3,403,40.96495,11927.0,7052.0,946524.1747
Site15-CantoII-1,32,Site15,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.8,473,48.08045,11498.0,6576.0,912478.8263
Site15-CantoII-1,32,Site15,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,45.9,421,42.79465,11774.0,6596.0,934382.1274
Site15-CantoII-1,32,Site15,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,25.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,20.1,1005,102.15825,17823.0,11241.0,6533324.964
Site15-CantoII-1,32,Site15,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,21.9,1248,126.8592,17232.0,11462.0,6316683.823
Site15-CantoII-1,32,Site15,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.2,884,89.8586,15661.0,11864.0,5740806.95
Site15-CantoII-1,32,Site15,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,82.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,80.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,80.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,47.7,925,94.02625,215104.0,8793.0,933992.8757
Site15-CantoII-1,32,Site15,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,43.3,980,99.617,20651.0,8824.0,89667.72759
Site15-CantoII-1,32,Site15,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,42.9,857,87.11405,20756.0,9247.0,90123.64311
Site15-CantoII-1,32,Site15,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.5,638,64.8527,8872.0,8254.0,38522.69039
Site15-CantoII-1,32,Site15,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.5,611,62.10815,8018.0,6897.0,34814.57749
Site15-CantoII-1,32,Site15,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.5,495,50.31675,7584.0,6531.0,32930.12668
Site15-CantoII-1,32,Site15,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.2,1432,145.5628,10515.0,4524.0,65144.78712
Site15-CantoII-1,32,Site15,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,27.9,1618,164.4697,10473.0,4308.0,64884.57969
Site15-CantoII-1,32,Site15,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,29.4,1380,140.277,10515.0,4108.0,65144.78712
Site15-CantoII-1,32,Site15,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,24.6,352,35.7808,7988.0,2750.0,6374660.099
Site15-CantoII-1,32,Site15,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,23.4,378,38.4237,7965.0,3032.0,6356305.419
Site15-CantoII-1,32,Site15,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,23.8,329,33.44285,8081.0,2815.0,6448876.847
Site15-CantoII-1,32,Site15,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.1,7830,795.9195,13452.0,3865.0,4948679.971
Site15-CantoII-1,32,Site15,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,84.7,9018,916.6797,13882.0,4043.0,5106867.035
Site15-CantoII-1,32,Site15,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,84.1,7501,762.47665,14017.0,4298.0,5156530.416
Site15-CantoII-1,32,Site15,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,37.6,539,54.78935,12215.0,6681.0,969379.7933
Site15-CantoII-1,32,Site15,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,39.4,637,64.75105,11953.0,6451.0,948587.5292
Site15-CantoII-1,32,Site15,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,39.9,550,55.9075,11902.0,6404.0,944540.1801
Site15-CantoII-1,32,Site15,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,62.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,26.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,25,1273,129.40045,16944.0,10991.0,6211112.506
Site15-CantoII-1,32,Site15,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,27.2,1580,160.607,16290.0,11294.0,5971377.639
Site15-CantoII-1,32,Site15,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.3,1188,120.7602,15057.0,11302.0,5519400.437
Site15-CantoII-1,32,Site15,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,72,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,71.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,70.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,36.9,437,44.42105,27123.0,7736.0,117769.4918
Site15-CantoII-1,32,Site15,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,32.9,461,46.86065,21073.0,8271.0,91500.07377
Site15-CantoII-1,32,Site15,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,34.7,432,43.9128,21180.0,8677.0,91964.6734
Site15-CantoII-1,32,Site15,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.3,497,50.52005,8099.0,7768.0,35166.28375
Site15-CantoII-1,32,Site15,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.63,476,48.3854,7246.0,6045.0,31462.51291
Site15-CantoII-1,32,Site15,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.65,384,39.0336,6785.0,6283.0,29460.82668
Site15-CantoII-1,32,Site15,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,27.2,1305,132.65325,10473.0,4524.0,64884.57969
Site15-CantoII-1,32,Site15,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,26.7,1471,149.52715,10350.0,4244.0,64122.54367
Site15-CantoII-1,32,Site15,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.4,1260,128.079,10391.0,4089.0,64376.55568
Site15-CantoII-1,32,Site15,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,22.7,296,30.0884,7597.0,2694.0,6062630.542
Site15-CantoII-1,32,Site15,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,21,309,31.40985,7322.0,2762.0,5843172.414
Site15-CantoII-1,32,Site15,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,22,277,28.15705,7535.0,2674.0,6013152.709
Site15-CantoII-1,32,Site15,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,85.6,6736,684.7144,13291.0,3800.0,4889451.791
Site15-CantoII-1,32,Site15,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,82.9,7802,793.0733,13782.0,3920.0,5070079.346
Site15-CantoII-1,32,Site15,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,82.2,6436,654.2194,13882.0,4171.0,5106867.035
Site15-CantoII-1,32,Site15,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.1,458,46.5557,12510.0,6713.0,992790.9303
Site15-CantoII-1,32,Site15,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.8,527,53.56955,11927.0,6268.0,946524.1747
Site15-CantoII-1,32,Site15,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37,466,47.3689,11825.0,6330.0,938429.4765
Site15-CantoII-1,32,Site15,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,71.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,68.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,17.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,18,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,24.9,1197,121.67505,16944.0,10798.0,6211112.506
Site15-CantoII-1,32,Site15,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,27.2,1501,152.57665,16108.0,11230.0,5904662.432
Site15-CantoII-1,32,Site15,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.2,1118,113.6447,14889.0,11155.0,5457817.168
Site15-CantoII-1,32,Site15,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.2,,2540.397397,14999.0,3902.0,5517785.525
Site15-CantoII-1,32,Site15,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.2,,2608.708134,13131.0,3534.0,4830591.488
Site15-CantoII-1,32,Site15,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,11725,1192.891304,26029.0,5546.0,9575467.66
Site15-CantoII-1,32,Site15,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,11037,1054.361298,26029.0,5778.0,9575467.66
Site15-CantoII-1,32,Site15,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,4.32,18,1.77534,11897.0,13537.0,51657.39941
Site15-CantoII-1,32,Site15,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,2.46,7,0.69041,17300.0,9633.0,75117.50943
Site15-CantoII-1,32,Site15,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,2.94,6,0.59178,12140.0,4886.0,52712.51818
Site15-CantoII-1,32,Site15,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,3.21,675,66.57525,6321.0,740.0,27446.11428
Site15-CantoII-1,32,Site15,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,4.18,637,62.82731,6194.0,805.0,26894.67361
Site15-CantoII-1,32,Site15,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,3.92,464,45.76432,6257.0,725.0,27168.22292
Site15-CantoII-1,32,Site15,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,1.9,399,39.35337,16297.0,2547.0,100966.6758
Site15-CantoII-1,32,Site15,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,1.91,291,28.70133,16426.0,2389.0,101765.8843
Site15-CantoII-1,32,Site15,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,1.84,218,21.50134,16042.0,2333.0,99386.84498
Site15-CantoII-1,32,Site15,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,3.26,13,1.28219,21259.0,2823.0,16965310.34
Site15-CantoII-1,32,Site15,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,3.44,10,0.9863,18185.0,4209.0,14512167.49
Site15-CantoII-1,32,Site15,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,0.46,1,0.09863,19903.0,,15883182.27
Site15-CantoII-1,32,Site15,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,21439,2114.529,18243.0,2675.0,6711178.168
Site15-CantoII-1,32,Site15,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,15555,1534.19,17808.0,2599.0,6551151.719
Site15-CantoII-1,32,Site15,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,12045,1187.998,17636.0,2599.0,6487876.893
Site15-CantoII-1,32,Site15,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,94.2,376,37.08488,41324.0,3876.0,3279463.821
Site15-CantoII-1,32,Site15,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,94.8,276,27.22188,43020.0,4062.0,3414058.019
Site15-CantoII-1,32,Site15,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,99.1,216,21.30408,42716.0,4235.0,3389932.644
Site15-CantoII-1,32,Site15,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,1.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,1.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,1.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,4.38,919,90.64097,91.9,98.4,33687.51412
Site15-CantoII-1,32,Site15,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,5.54,845,83.34235,88.9,90.8,32587.8129
Site15-CantoII-1,32,Site15,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,5.01,592,58.38896,90.4,85.5,33137.66351
Site15-CantoII-1,32,Site15,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,9.79,86,8.48218,31747.0,12741.0,137847.1429
Site15-CantoII-1,32,Site15,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,8.92,53,5.22739,27975.0,8826.0,121468.9206
Site15-CantoII-1,32,Site15,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,11.4,50,4.9315,27415.0,8041.0,119037.3712
Site15-CantoII-1,32,Site15,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.5,3585,353.58855,6353.0,687.0,27585.05997
Site15-CantoII-1,32,Site15,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.9,2670,263.3421,6226.0,750.0,27033.61929
Site15-CantoII-1,32,Site15,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.3,2162,213.23806,6257.0,677.0,27168.22292
Site15-CantoII-1,32,Site15,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,52.8,14042,1384.96246,31262.0,10607.0,193681.059
Site15-CantoII-1,32,Site15,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,54,10357,1021.51091,31385.0,10581.0,194443.095
Site15-CantoII-1,32,Site15,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,53,8030,791.9989,31262.0,10506.0,193681.059
Site15-CantoII-1,32,Site15,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,62.1,8725,860.54675,21650.0,3431.0,17277339.9
Site15-CantoII-1,32,Site15,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,62.4,6467,637.84021,21307.0,3311.0,17003615.76
Site15-CantoII-1,32,Site15,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,61.3,4920,485.2596,21405.0,3134.0,17081822.66
Site15-CantoII-1,32,Site15,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,27539,2716.172,19055.0,4492.0,7009894.205
Site15-CantoII-1,32,Site15,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,19835,1956.326,18600.0,4516.0,6842510.219
Site15-CantoII-1,32,Site15,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,15605,1539.12115,18510.0,4513.0,6809401.298
Site15-CantoII-1,32,Site15,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,37.1,5204,513.27052,41618.0,3905.0,3302795.599
Site15-CantoII-1,32,Site15,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,36.8,3811,375.87893,42716.0,3773.0,3389932.644
Site15-CantoII-1,32,Site15,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,37.8,3035,299.34205,43327.0,3524.0,3438421.474
Site15-CantoII-1,32,Site15,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,96.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,96.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,97,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,3.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,2.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,2.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,22.8,6073,598.97999,117.0,111.0,42888.34769
Site15-CantoII-1,32,Site15,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,23.6,4528,446.59664,115.0,109.0,42155.21354
Site15-CantoII-1,32,Site15,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,24.4,3693,364.24059,117.0,104.0,42888.34769
Site15-CantoII-1,32,Site15,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,9.87,83,8.18629,31587.0,11884.0,137152.4145
Site15-CantoII-1,32,Site15,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,8.33,47,4.63561,27975.0,8826.0,121468.9206
Site15-CantoII-1,32,Site15,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,10.8,45,4.43835,27415.0,8041.0,119037.3712
Site15-CantoII-1,32,Site15,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,12.7,3291,324.59133,6321.0,716.0,27446.11428
Site15-CantoII-1,32,Site15,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.2,2490,245.5887,6194.0,746.0,26894.67361
Site15-CantoII-1,32,Site15,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.5,2004,197.65452,6226.0,673.0,27033.61929
Site15-CantoII-1,32,Site15,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,33.8,8793,867.25359,31634.0,10464.0,195985.7533
Site15-CantoII-1,32,Site15,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,34.7,6522,643.26486,31364.0,10437.0,194312.9913
Site15-CantoII-1,32,Site15,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,33.9,5012,494.33356,31510.0,10396.0,195217.5218
Site15-CantoII-1,32,Site15,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,57.7,5075,500.54725,21066.0,3178.0,16811290.64
Site15-CantoII-1,32,Site15,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,58.6,3825,377.25975,20781.0,3071.0,16583852.22
Site15-CantoII-1,32,Site15,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,56.6,2836,279.71468,20923.0,2948.0,16697172.41
Site15-CantoII-1,32,Site15,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,26883,2651.47,19147.0,4300.0,7043738.88
Site15-CantoII-1,32,Site15,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,19426,1915.986,18735.0,4337.0,6892173.599
Site15-CantoII-1,32,Site15,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,12536,1502.727,18600.0,4385.0,6842510.219
Site15-CantoII-1,32,Site15,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.1,2825,278.62975,41032.0,3901.0,3256290.764
Site15-CantoII-1,32,Site15,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.2,2100,207.123,42113.0,3764.0,3342078.693
Site15-CantoII-1,32,Site15,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34,1703,167.96689,42615.0,3619.0,3381917.306
Site15-CantoII-1,32,Site15,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,96.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,96.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,3.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,2.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,2.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-1,32,Site15,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,20.4,5296,522.34448,108.0,109.0,39589.24402
Site15-CantoII-1,32,Site15,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,21.4,4019,396.39397,106.0,107.0,38856.10987
Site15-CantoII-1,32,Site15,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,22,3254,320.94202,108.0,102.0,39589.24402
Site15-CantoII-2,33,Site15,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,197.97096,17531.0,8192.0,94849.27118
Site15-CantoII-2,33,Site15,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,221.154,17988.0,8547.0,97321.81221
Site15-CantoII-2,33,Site15,CantoII,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,189.73488,17737.0,8444.0,95963.80827
Site15-CantoII-2,33,Site15,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,220.03552,4472.0,1964.0,24195.1937
Site15-CantoII-2,33,Site15,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,223.39096,4518.0,2102.0,24444.07091
Site15-CantoII-2,33,Site15,CantoII,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,224.40776,4594.0,2008.0,24855.25936
Site15-CantoII-2,33,Site15,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2343.82568,7080.0,3092.0,57528.00945
Site15-CantoII-2,33,Site15,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2446.01408,7173.0,3056.0,58283.67398
Site15-CantoII-2,33,Site15,CantoII,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2402.6984,7173.0,3030.0,58283.67398
Site15-CantoII-2,33,Site15,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,548.76696,12073.0,3769.0,5819986.907
Site15-CantoII-2,33,Site15,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,538.70064,11963.0,3797.0,5766959.61
Site15-CantoII-2,33,Site15,CantoII,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,520.39824,12156.0,3815.0,5859998.413
Site15-CantoII-2,33,Site15,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5492.14352,21939.0,7030.0,4243842.215
Site15-CantoII-2,33,Site15,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5643.64672,23193.0,7412.0,4486413.806
Site15-CantoII-2,33,Site15,CantoII,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5530.57856,23193.0,7517.0,4486413.806
Site15-CantoII-2,33,Site15,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,1300.58888,10041.0,6538.0,978446.6099
Site15-CantoII-2,33,Site15,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,1411.62344,10626.0,6537.0,1035452.014
Site15-CantoII-2,33,Site15,CantoII,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,1381.42448,10271.0,6555.0,1000858.991
Site15-CantoII-2,33,Site15,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,994.9388,16382.0,12050.0,5691172.132
Site15-CantoII-2,33,Site15,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,1113.59936,17205.0,11960.0,5977085.614
Site15-CantoII-2,33,Site15,CantoII,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,988.12624,16004.0,11985.0,5559853.424
Site15-CantoII-2,33,Site15,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,195.09,17622.0,8047.0,95341.61523
Site15-CantoII-2,33,Site15,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,219.03,18190.0,8333.0,98414.70781
Site15-CantoII-2,33,Site15,CantoII,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,182.385,17981.0,8295.0,97283.93959
Site15-CantoII-2,33,Site15,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,228.9,4440.0,1965.0,24022.06172
Site15-CantoII-2,33,Site15,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,233.835,4486.0,2106.0,24270.93894
Site15-CantoII-2,33,Site15,CantoII,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,229.74,4520.0,1992.0,24454.89166
Site15-CantoII-2,33,Site15,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2410.8,7111.0,3111.0,57779.89763
Site15-CantoII-2,33,Site15,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2533.02,7221.0,3071.0,58673.69438
Site15-CantoII-2,33,Site15,CantoII,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2443.875,7221.0,3040.0,58673.69438
Site15-CantoII-2,33,Site15,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,551.985,11990.0,3778.0,5779975.401
Site15-CantoII-2,33,Site15,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,546.105,11881.0,3806.0,5727430.17
Site15-CantoII-2,33,Site15,CantoII,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,520.065,12101.0,3796.0,5833484.764
Site15-CantoII-2,33,Site15,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5668.005,21768.0,7031.0,4210764.271
Site15-CantoII-2,33,Site15,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5833.59,23041.0,7351.0,4457011.189
Site15-CantoII-2,33,Site15,CantoII,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5599.23,23041.0,7440.0,4457011.189
Site15-CantoII-2,33,Site15,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,1312.395,9929.0,6475.0,967532.7547
Site15-CantoII-2,33,Site15,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,1437.135,10483.0,6482.0,1021517.36
Site15-CantoII-2,33,Site15,CantoII,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,1384.215,10133.0,6500.0,987411.5624
Site15-CantoII-2,33,Site15,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1029.945,16230.0,12040.0,5638366.725
Site15-CantoII-2,33,Site15,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,1153.32,17006.0,11847.0,5907952.22
Site15-CantoII-2,33,Site15,CantoII,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,1012.305,15782.0,11811.0,5482729.739
Site15-CantoII-2,33,Site15,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,203.65317,17531.0,8221.0,94849.27118
Site15-CantoII-2,33,Site15,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,229.28049,17946.0,8566.0,97094.57649
Site15-CantoII-2,33,Site15,CantoII,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,192.41496,17737.0,8502.0,95963.80827
Site15-CantoII-2,33,Site15,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,230.85594,4435.0,1985.0,23995.00985
Site15-CantoII-2,33,Site15,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,236.73762,4481.0,2104.0,24243.88707
Site15-CantoII-2,33,Site15,CantoII,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,230.33079,4537.0,1992.0,24546.86802
Site15-CantoII-2,33,Site15,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2410.01838,7049.0,3093.0,57276.12127
Site15-CantoII-2,33,Site15,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2535.63426,7173.0,3065.0,58283.67398
Site15-CantoII-2,33,Site15,CantoII,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2438.27145,7158.0,3027.0,58161.7926
Site15-CantoII-2,33,Site15,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,562.43565,11963.0,3723.0,5766959.61
Site15-CantoII-2,33,Site15,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,558.02439,11854.0,3797.0,5714414.379
Site15-CantoII-2,33,Site15,CantoII,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,525.99024,12046.0,3787.0,5806971.116
Site15-CantoII-2,33,Site15,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5699.87307,21717.0,7047.0,4200898.919
Site15-CantoII-2,33,Site15,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5896.80432,22932.0,7421.0,4435926.418
Site15-CantoII-2,33,Site15,CantoII,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5659.54155,22932.0,7509.0,4435926.418
Site15-CantoII-2,33,Site15,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,1296.0702,9864.0,6432.0,961198.8208
Site15-CantoII-2,33,Site15,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,1422.52632,10393.0,6427.0,1012747.298
Site15-CantoII-2,33,Site15,CantoII,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,1366.96545,10064.0,6451.0,980687.848
Site15-CantoII-2,33,Site15,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1027.61352,16344.0,12015.0,5677970.78
Site15-CantoII-2,33,Site15,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,1158.4809,17165.0,11960.0,5963189.454
Site15-CantoII-2,33,Site15,CantoII,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,1010.91375,15967.0,11944.0,5546999.477
Site15-CantoII-2,33,Site15,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3569.384874,25703.0,6396.0,4971943.865
Site15-CantoII-2,33,Site15,CantoII,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,3829.721212,22620.0,5534.0,4375573.677
Site15-CantoII-2,33,Site15,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1136.01992,16652.0,5704.0,90093.5522
Site15-CantoII-2,33,Site15,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,971.91451,15455.0,5619.0,83617.33421
Site15-CantoII-2,33,Site15,CantoII,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,954.72335,15746.0,5784.0,85191.75312
Site15-CantoII-2,33,Site15,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,270.49764,4662.0,2084.0,25223.16481
Site15-CantoII-2,33,Site15,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,361.54062,4633.0,2080.0,25066.26395
Site15-CantoII-2,33,Site15,CantoII,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,311.63363,4500.0,2072.0,24346.68418
Site15-CantoII-2,33,Site15,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1845.15527,10179.0,4154.0,82708.70172
Site15-CantoII-2,33,Site15,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2119.0736,10041.0,4131.0,81587.39306
Site15-CantoII-2,33,Site15,CantoII,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2148.45645,10294.0,4180.0,83643.1256
Site15-CantoII-2,33,Site15,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1342.66468,14382.0,3587.0,6933078.083
Site15-CantoII-2,33,Site15,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1517.99697,14119.0,3595.0,6806294.636
Site15-CantoII-2,33,Site15,CantoII,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1545.62562,14119.0,3547.0,6806294.636
Site15-CantoII-2,33,Site15,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5287.94819,23979.0,7059.0,4638456.287
Site15-CantoII-2,33,Site15,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5624.40375,22495.0,6749.0,4351393.893
Site15-CantoII-2,33,Site15,CantoII,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5591.24937,23064.0,6898.0,4461460.269
Site15-CantoII-2,33,Site15,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,445.91764,13450.0,5415.0,1310637.078
Site15-CantoII-2,33,Site15,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,541.08299,13235.0,5418.0,1289686.374
Site15-CantoII-2,33,Site15,CantoII,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,542.13551,13235.0,5381.0,1289686.374
Site15-CantoII-2,33,Site15,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,782.63633,28958.0,19408.0,10060124.68
Site15-CantoII-2,33,Site15,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,797.89787,25097.0,18178.0,8718797.887
Site15-CantoII-2,33,Site15,CantoII,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,801.93253,25337.0,18099.0,8802174.844
Site15-CantoII-2,33,Site15,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1152.305,16782.0,5671.0,90796.90085
Site15-CantoII-2,33,Site15,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,999.867,15489.0,5572.0,83801.28693
Site15-CantoII-2,33,Site15,CantoII,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,968.4774,15802.0,5728.0,85494.73408
Site15-CantoII-2,33,Site15,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,277.1846,4590.0,2099.0,24833.61786
Site15-CantoII-2,33,Site15,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,380.5538,4567.0,2105.0,24709.17925
Site15-CantoII-2,33,Site15,CantoII,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,329.0496,4406.0,2067.0,23838.109
Site15-CantoII-2,33,Site15,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1841.433,10202.0,4174.0,82895.5865
Site15-CantoII-2,33,Site15,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2184.5538,10064.0,4141.0,81774.27784
Site15-CantoII-2,33,Site15,CantoII,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2210.6216,10318.0,4191.0,83838.13581
Site15-CantoII-2,33,Site15,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1270.016,14283.0,3561.0,6885353.515
Site15-CantoII-2,33,Site15,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1502.8222,14021.0,3589.0,6759052.135
Site15-CantoII-2,33,Site15,CantoII,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1536.0158,14054.0,3521.0,6774960.324
Site15-CantoII-2,33,Site15,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5329.2866,23819.0,7065.0,4607506.163
Site15-CantoII-2,33,Site15,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5844.1482,22289.0,6754.0,4311545.61
Site15-CantoII-2,33,Site15,CantoII,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5770.7254,22878.0,6903.0,4425480.751
Site15-CantoII-2,33,Site15,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,441.7094,13296.0,5378.0,1295630.527
Site15-CantoII-2,33,Site15,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,552.024,13053.0,5389.0,1271951.359
Site15-CantoII-2,33,Site15,CantoII,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,553.7378,13053.0,5360.0,1271951.359
Site15-CantoII-2,33,Site15,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,779.779,28274.0,19154.0,9822500.357
Site15-CantoII-2,33,Site15,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,825.33,24860.0,18191.0,8636463.142
Site15-CantoII-2,33,Site15,CantoII,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,833.448,25038.0,18096.0,8698301.052
Site15-CantoII-2,33,Site15,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,1151.37216,16691.0,5690.0,90304.5568
Site15-CantoII-2,33,Site15,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,933.62304,15455.0,5609.0,83617.33421
Site15-CantoII-2,33,Site15,CantoII,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,955.00992,15746.0,5749.0,85191.75312
Site15-CantoII-2,33,Site15,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,283.8048,4614.0,2091.0,24963.46684
Site15-CantoII-2,33,Site15,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,355.18464,4566.0,2109.0,24703.76888
Site15-CantoII-2,33,Site15,CantoII,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,323.32992,4425.0,2068.0,23940.90611
Site15-CantoII-2,33,Site15,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1891.97184,10156.0,4168.0,82521.81695
Site15-CantoII-2,33,Site15,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2033.28768,9996.0,4135.0,81221.74894
Site15-CantoII-2,33,Site15,CantoII,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2159.71392,10271.0,4195.0,83456.24083
Site15-CantoII-2,33,Site15,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,1370.02368,14250.0,3573.0,6869445.326
Site15-CantoII-2,33,Site15,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1450.24704,13989.0,3551.0,6743626.012
Site15-CantoII-2,33,Site15,CantoII,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1545.8112,13989.0,3512.0,6743626.012
Site15-CantoII-2,33,Site15,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5439.12576,23706.0,7050.0,4585647.639
Site15-CantoII-2,33,Site15,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5452.84224,22289.0,6789.0,4311545.61
Site15-CantoII-2,33,Site15,CantoII,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5658.40896,22824.0,6922.0,4415035.084
Site15-CantoII-2,33,Site15,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,452.19264,13228.0,5369.0,12982420.57
Site15-CantoII-2,33,Site15,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,511.93152,12961.0,5355.0,1262986.407
Site15-CantoII-2,33,Site15,CantoII,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,537.01824,12961.0,5330.0,1262986.407
Site15-CantoII-2,33,Site15,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,811.7088,28614.0,19439.0,9940617.713
Site15-CantoII-2,33,Site15,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,782.832,25038.0,18187.0,8698301.052
Site15-CantoII-2,33,Site15,CantoII,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,815.3184,25217.0,18142.0,8760486.366
Site15-CantoII-2,33,Site15,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3422.037736,25138.0,5811.0,4862651.242
Site15-CantoII-2,33,Site15,CantoII,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,3685.522631,24586.0,5226.0,4755873.317
Site15-CantoII-2,33,Site15,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,546.1533,19529.0,7339.0,105659.1989
Site15-CantoII-2,33,Site15,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,599.73345,20184.0,7386.0,109202.9941
Site15-CantoII-2,33,Site15,CantoII,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,538.58115,19807.0,7445.0,107163.283
Site15-CantoII-2,33,Site15,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,202.33935,5664.0,2164.0,30644.35982
Site15-CantoII-2,33,Site15,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,227.7396,5713.0,2165.0,30909.46815
Site15-CantoII-2,33,Site15,CantoII,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,211.34925,5544.0,2147.0,29995.1149
Site15-CantoII-2,33,Site15,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2391.8409,9577.0,4135.0,77817.19583
Site15-CantoII-2,33,Site15,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2598.01425,9817.0,4092.0,79767.29785
Site15-CantoII-2,33,Site15,CantoII,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2643.83055,9817.0,4092.0,79767.29785
Site15-CantoII-2,33,Site15,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,919.48905,13892.0,4526.0,6696865.577
Site15-CantoII-2,33,Site15,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1127.5794,14516.0,4507.0,6997674.972
Site15-CantoII-2,33,Site15,CantoII,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1192.66155,14316.0,4463.0,6901261.704
Site15-CantoII-2,33,Site15,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5277.98025,25775.0,8015.0,4985871.42
Site15-CantoII-2,33,Site15,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5464.12095,26281.0,7992.0,5083751.185
Site15-CantoII-2,33,Site15,CantoII,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5311.8153,26354.0,8117.0,5097872.179
Site15-CantoII-2,33,Site15,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,1111.18905,13512.0,7723.0,1316678.677
Site15-CantoII-2,33,Site15,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,1126.52505,14416.0,7800.0,1404769.08
Site15-CantoII-2,33,Site15,CantoII,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,1109.84715,14086.0,7674.0,1372612.185
Site15-CantoII-2,33,Site15,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1122.69105,31338.0,18963.0,10886946.18
Site15-CantoII-2,33,Site15,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,1040.26005,31793.0,19482.0,11045014.99
Site15-CantoII-2,33,Site15,CantoII,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,988.88445,31263.0,19305.0,10860890.88
Site15-CantoII-2,33,Site15,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,575.0046,19607.0,7337.0,106081.2081
Site15-CantoII-2,33,Site15,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,605.5647,20300.0,7294.0,109830.5975
Site15-CantoII-2,33,Site15,CantoII,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,575.0046,19893.0,7454.0,107628.5752
Site15-CantoII-2,33,Site15,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,211.8438,5637.0,2180.0,30498.27971
Site15-CantoII-2,33,Site15,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,236.6677,5712.0,2177.0,30904.05778
Site15-CantoII-2,33,Site15,CantoII,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,211.8438,5505.0,2124.0,29784.11031
Site15-CantoII-2,33,Site15,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2477.0494,9620.0,4155.0,78166.58911
Site15-CantoII-2,33,Site15,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2671.4868,9862.0,4111.0,80132.94198
Site15-CantoII-2,33,Site15,CantoII,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2477.0494,9862.0,4111.0,80132.94198
Site15-CantoII-2,33,Site15,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,909.3855,13796.0,4535.0,6650587.208
Site15-CantoII-2,33,Site15,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1110.3503,14382.0,4485.0,6933078.083
Site15-CantoII-2,33,Site15,CantoII,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,909.3855,14217.0,4441.0,6853537.137
Site15-CantoII-2,33,Site15,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5500.7191,25580.0,8013.0,4948150.958
Site15-CantoII-2,33,Site15,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5612.1794,26134.0,7980.0,5055315.76
Site15-CantoII-2,33,Site15,CantoII,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5500.7191,26134.0,8065.0,5055315.76
Site15-CantoII-2,33,Site15,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,1128.0534,13296.0,7635.0,1295630.527
Site15-CantoII-2,33,Site15,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,1139.5258,14184.0,7742.0,1382161.808
Site15-CantoII-2,33,Site15,CantoII,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,1128.0534,13892.0,7617.0,1353707.828
Site15-CantoII-2,33,Site15,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1167.9101,31263.0,18978.0,10860890.88
Site15-CantoII-2,33,Site15,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,1070.3947,31640.0,19464.0,10991862.18
Site15-CantoII-2,33,Site15,CantoII,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,1167.9101,31263.0,19364.0,10860890.88
Site15-CantoII-2,33,Site15,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,560.77748,19529.0,7305.0,105659.1989
Site15-CantoII-2,33,Site15,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,605.58824,20232.0,7344.0,109462.6921
Site15-CantoII-2,33,Site15,CantoII,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,544.25784,19807.0,7432.0,107163.283
Site15-CantoII-2,33,Site15,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,211.09528,5664.0,2171.0,30644.35982
Site15-CantoII-2,33,Site15,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,233.15444,5713.0,2165.0,30909.46815
Site15-CantoII-2,33,Site15,CantoII,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,217.92076,5509.0,2137.0,29805.75181
Site15-CantoII-2,33,Site15,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,2477.4514,9555.0,4141.0,77638.43648
Site15-CantoII-2,33,Site15,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,2638.49316,9795.0,4121.0,79588.5385
Site15-CantoII-2,33,Site15,CantoII,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,2693.88836,9817.0,4115.0,79767.29785
Site15-CantoII-2,33,Site15,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,947.35684,13764.0,4502.0,6635161.086
Site15-CantoII-2,33,Site15,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,1140.84436,14382.0,4463.0,6933078.083
Site15-CantoII-2,33,Site15,CantoII,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,1207.71428,14184.0,4419.0,6837628.948
Site15-CantoII-2,33,Site15,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,5484.81724,25519.0,8013.0,4936351.223
Site15-CantoII-2,33,Site15,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,5566.92084,26072.0,7981.0,5043322.587
Site15-CantoII-2,33,Site15,CantoII,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,5432.09288,26072.0,8108.0,5043322.587
Site15-CantoII-2,33,Site15,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,1113.64136,13147.0,7610.0,1281111.202
Site15-CantoII-2,33,Site15,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,1112.65216,14066.0,7712.0,1370663.282
Site15-CantoII-2,33,Site15,CantoII,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,1095.539,13753.0,7564.0,1340162.954
Site15-CantoII-2,33,Site15,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,1174.77392,31114.0,19036.0,105659.1989
Site15-CantoII-2,33,Site15,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,1065.863,31565.0,19493.0,10965806.88
Site15-CantoII-2,33,Site15,CantoII,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,1016.30408,31189.0,19393.0,10835182.98
Site15-CantoII-2,33,Site15,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3931.030571,26135.0,7002.0,5055509.198
Site15-CantoII-2,33,Site15,CantoII,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,3980.146789,26575.0,7008.0,5140622.037
Site15-CantoII-2,33,Site15,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,23152.46281,44333.0,22190.0,8575698.843
Site15-CantoII-2,33,Site15,CantoII,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,19444.96033,44548.0,22247.0,8617288.071
Site15-CantoII-2,33,Site15,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,3374.59599,15563.0,3795.0,84201.65463
Site15-CantoII-2,33,Site15,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,2458.46319,12874.0,3168.0,69653.15824
Site15-CantoII-2,33,Site15,CantoII,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,2398.08171,12101.0,3010.0,65470.93894
Site15-CantoII-2,33,Site15,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,2606.81424,5750.0,616.0,31109.652
Site15-CantoII-2,33,Site15,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,1876.51065,5556.0,669.0,30060.0394
Site15-CantoII-2,33,Site15,CantoII,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,1947.82326,5451.0,622.0,29491.9501
Site15-CantoII-2,33,Site15,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,12310.5345,23706.0,7919.0,192621.3266
Site15-CantoII-2,33,Site15,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,8792.27223,23427.0,7841.0,190354.333
Site15-CantoII-2,33,Site15,CantoII,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,9042.64716,23096.0,7722.0,187664.8173
Site15-CantoII-2,33,Site15,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,7930.79508,36812.0,5546.0,17745826.06
Site15-CantoII-2,33,Site15,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,5652.43527,35167.0,5472.0,16952826.93
Site15-CantoII-2,33,Site15,CantoII,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,5815.88169,34331.0,5506.0,16549819.47
Site15-CantoII-2,33,Site15,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,21708.70365,33373.0,15492.0,6455615.399
Site15-CantoII-2,33,Site15,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,15557.08011,32100.0,15406.0,6209368.481
Site15-CantoII-2,33,Site15,CantoII,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,15968.29881,31394.0,14583.0,6072801.062
Site15-CantoII-2,33,Site15,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,4291.76985,36812.0,3309.0,3587150.344
Site15-CantoII-2,33,Site15,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,3079.97601,36901.0,3583.0,3595822.961
Site15-CantoII-2,33,Site15,CantoII,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,3137.75484,36724.0,3821.0,3578575.172
Site15-CantoII-2,33,Site15,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,4990.84164,88.7,117.0,30814.73374
Site15-CantoII-2,33,Site15,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,3581.76693,89.9,112.0,31231.61852
Site15-CantoII-2,33,Site15,CantoII,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,3732.2001,89.9,111.0,31231.61852
Site15-CantoII-2,33,Site15,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,3487.9428,15578.0,3773.0,84282.81024
Site15-CantoII-2,33,Site15,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,2662.974,12876.0,3172.0,69663.97899
Site15-CantoII-2,33,Site15,CantoII,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,2603.9724,12101.0,3001.0,65470.93894
Site15-CantoII-2,33,Site15,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,2689.314,5727.0,613.0,30985.21339
Site15-CantoII-2,33,Site15,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,2039.7696,5534.0,661.0,29941.01116
Site15-CantoII-2,33,Site15,CantoII,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,2127.2184,5419.0,619.0,29318.81812
Site15-CantoII-2,33,Site15,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,12786.4896,23763.0,7879.0,193084.4758
Site15-CantoII-2,33,Site15,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,9611.466,23482.0,7821.0,190801.2313
Site15-CantoII-2,33,Site15,CantoII,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,9941.2428,23151.0,7683.0,188111.7156
Site15-CantoII-2,33,Site15,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,8253.3756,36812.0,5636.0,17745826.06
Site15-CantoII-2,33,Site15,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,6204.6504,35082.0,5508.0,16911851.29
Site15-CantoII-2,33,Site15,CantoII,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,6413.79,34331.0,5540.0,16549819.47
Site15-CantoII-2,33,Site15,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,22508.0568,33037.0,15396.0,6390620.14
Site15-CantoII-2,33,Site15,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,17012.4792,31716.0,15425.0,6135088.185
Site15-CantoII-2,33,Site15,CantoII,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,17568.2532,31039.0,14633.0,6004130.476
Site15-CantoII-2,33,Site15,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,4443.0312,36724.0,3293.0,3578575.172
Site15-CantoII-2,33,Site15,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,3339.3852,36724.0,3614.0,3578575.172
Site15-CantoII-2,33,Site15,CantoII,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,3441.0576,36547.0,3754.0,3561327.383
Site15-CantoII-2,33,Site15,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,5173.7028,118.0,120.0,40993.67058
Site15-CantoII-2,33,Site15,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,3914.6508,118.0,115.0,40993.67058
Site15-CantoII-2,33,Site15,CantoII,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,4098.504,117.0,115.0,40646.2666
Site15-CantoII-2,33,Site15,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,3402.93702,15563.0,3795.0,84201.65463
Site15-CantoII-2,33,Site15,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,2736.1779,12845.0,3192.0,69496.25739
Site15-CantoII-2,33,Site15,CantoII,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,2690.08362,12073.0,3026.0,65319.44846
Site15-CantoII-2,33,Site15,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,2630.05386,5750.0,616.0,31109.652
Site15-CantoII-2,33,Site15,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,2084.9622,5556.0,664.0,30060.0394
Site15-CantoII-2,33,Site15,CantoII,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,2170.18302,5439.0,627.0,29427.02561
Site15-CantoII-2,33,Site15,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,12429.3762,23650.0,7899.0,192166.3028
Site15-CantoII-2,33,Site15,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,9778.9551,23427.0,7827.0,190354.333
Site15-CantoII-2,33,Site15,CantoII,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,10114.47858,23041.0,7722.0,187217.9189
Site15-CantoII-2,33,Site15,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,8005.39728,36724.0,5660.0,17703404.22
Site15-CantoII-2,33,Site15,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,6327.2439,34998.0,5481.0,16871357.72
Site15-CantoII-2,33,Site15,CantoII,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,6537.88404,34167.0,5548.0,16470760.59
Site15-CantoII-2,33,Site15,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,21895.85496,33037.0,15471.0,6390620.14
Site15-CantoII-2,33,Site15,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,17308.93812,31716.0,15425.0,6135088.185
Site15-CantoII-2,33,Site15,CantoII,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,17874.933,31039.0,14633.0,6004130.476
Site15-CantoII-2,33,Site15,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,4317.85488,36552.0,3262.0,3561814.609
Site15-CantoII-2,33,Site15,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,3394.36134,36630.0,3547.0,3569415.329
Site15-CantoII-2,33,Site15,CantoII,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,3495.66156,36396.0,3749.0,3546613.167
Site15-CantoII-2,33,Site15,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site15-CantoII-2,33,Site15,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,5033.92416,91.2,116.0,31683.24371
Site15-CantoII-2,33,Site15,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,3984.47532,92.5,113.0,32134.86889
Site15-CantoII-2,33,Site15,CantoII,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,4171.53234,92.5,112.0,32134.86889
Site16-AttuneNXT,34,Site16,AttuneNXT,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.3,,922,10872.0,3285.9,75900
Site16-AttuneNXT,34,Site16,AttuneNXT,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.8,,911,11152.9,3435.8,77900
Site16-AttuneNXT,34,Site16,AttuneNXT,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.9,,834,10976.5,3449.9,76600
Site16-AttuneNXT,34,Site16,AttuneNXT,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.6,,172,4678.2,1722.3,32700
Site16-AttuneNXT,34,Site16,AttuneNXT,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.4,,169,4720.5,1663.6,33000
Site16-AttuneNXT,34,Site16,AttuneNXT,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.7,,161,4692.2,1669.0,32800
Site16-AttuneNXT,34,Site16,AttuneNXT,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.3,,1482,12421.1,4619.3,94900
Site16-AttuneNXT,34,Site16,AttuneNXT,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.8,,1494,12583.1,4695.5,96200
Site16-AttuneNXT,34,Site16,AttuneNXT,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.4,,1569,12583.1,4650.5,96200
Site16-AttuneNXT,34,Site16,AttuneNXT,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.3,,880,65499.3,13827.1,11300000
Site16-AttuneNXT,34,Site16,AttuneNXT,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,58.8,,879,65499.3,13827.1,11300000
Site16-AttuneNXT,34,Site16,AttuneNXT,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,59.7,,937,65074.1,13817.5,11300000
Site16-AttuneNXT,34,Site16,AttuneNXT,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.9,,3102,16990.4,4365.9,4180000
Site16-AttuneNXT,34,Site16,AttuneNXT,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.9,,3102,17160.1,4388.5,4220000
Site16-AttuneNXT,34,Site16,AttuneNXT,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.9,,3102,17046.8,4344.3,4190000
Site16-AttuneNXT,34,Site16,AttuneNXT,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.6,,483,20769.4,10013.1,1490000
Site16-AttuneNXT,34,Site16,AttuneNXT,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.9,,492,20952.4,10003.8,1500000
Site16-AttuneNXT,34,Site16,AttuneNXT,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.6,,512,20528.3,9887.5,1470000
Site16-AttuneNXT,34,Site16,AttuneNXT,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,33.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.2,,302,72203.6,50004.2,9510000
Site16-AttuneNXT,34,Site16,AttuneNXT,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.9,,298,73177.2,49459.1,9640000
Site16-AttuneNXT,34,Site16,AttuneNXT,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.7,,307,72203.6,48758.0,9510000
Site16-AttuneNXT,34,Site16,AttuneNXT,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.7,,926,11027.5,3307.2,77000
Site16-AttuneNXT,34,Site16,AttuneNXT,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.4,,917,11309.1,3468.7,79000
Site16-AttuneNXT,34,Site16,AttuneNXT,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.5,,833,11132.2,3494.1,77700
Site16-AttuneNXT,34,Site16,AttuneNXT,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.7,,173,4780.1,1737.4,33400
Site16-AttuneNXT,34,Site16,AttuneNXT,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.5,,169,4822.5,1693.1,33700
Site16-AttuneNXT,34,Site16,AttuneNXT,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.8,,162,4794.2,1699.7,33500
Site16-AttuneNXT,34,Site16,AttuneNXT,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.2,,1480,12388.2,4624.4,94700
Site16-AttuneNXT,34,Site16,AttuneNXT,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,74.8,,1493,12505.1,4699.3,95600
Site16-AttuneNXT,34,Site16,AttuneNXT,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.4,,1573,12505.1,4655.3,95600
Site16-AttuneNXT,34,Site16,AttuneNXT,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.5,,881,65868.8,13817.9,11400000
Site16-AttuneNXT,34,Site16,AttuneNXT,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,58.9,,880,65868.8,13895.4,11400000
Site16-AttuneNXT,34,Site16,AttuneNXT,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,59.7,,939,65471.1,13880.4,11300000
Site16-AttuneNXT,34,Site16,AttuneNXT,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.9,,3102,17087.7,4354.1,4200000
Site16-AttuneNXT,34,Site16,AttuneNXT,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.9,,3102,17257.3,4390.4,4240000
Site16-AttuneNXT,34,Site16,AttuneNXT,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.9,,3102,17129.9,4338.5,4210000
Site16-AttuneNXT,34,Site16,AttuneNXT,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.5,,480,20594.3,9922.2,1480000
Site16-AttuneNXT,34,Site16,AttuneNXT,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.8,,490,20717.7,9911.4,1490000
Site16-AttuneNXT,34,Site16,AttuneNXT,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.6,,512,20289.3,9865.0,1450000
Site16-AttuneNXT,34,Site16,AttuneNXT,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,33.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.3,,305,72436.0,50054.7,9540000
Site16-AttuneNXT,34,Site16,AttuneNXT,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.9,,297,73403.9,49142.9,9670000
Site16-AttuneNXT,34,Site16,AttuneNXT,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.8,,308,72436.0,48771.9,9540000
Site16-AttuneNXT,34,Site16,AttuneNXT,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.8,,929,10994.8,3303.3,76800
Site16-AttuneNXT,34,Site16,AttuneNXT,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.2,,918,11288.7,3468.8,78800
Site16-AttuneNXT,34,Site16,AttuneNXT,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.4,,841,11104.1,3498.1,77500
Site16-AttuneNXT,34,Site16,AttuneNXT,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.7,,173,4778.8,1751.9,33400
Site16-AttuneNXT,34,Site16,AttuneNXT,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.4,,167,4809.5,1689.6,33600
Site16-AttuneNXT,34,Site16,AttuneNXT,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,7.7,,161,4778.8,1695.2,33400
Site16-AttuneNXT,34,Site16,AttuneNXT,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.2,,1477,12388.2,4624.4,94700
Site16-AttuneNXT,34,Site16,AttuneNXT,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75,,1493,12505.1,4699.3,95600
Site16-AttuneNXT,34,Site16,AttuneNXT,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,75.4,,1565,12505.1,4655.3,95600
Site16-AttuneNXT,34,Site16,AttuneNXT,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,59.6,,880,66064.6,13843.5,11400000
Site16-AttuneNXT,34,Site16,AttuneNXT,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,59,,881,66064.6,13843.5,11400000
Site16-AttuneNXT,34,Site16,AttuneNXT,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,59.7,,934,65427.1,13834.1,11300000
Site16-AttuneNXT,34,Site16,AttuneNXT,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.9,,3102,16961.7,4343.8,4170000
Site16-AttuneNXT,34,Site16,AttuneNXT,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.9,,3102,17172.2,4380.0,4220000
Site16-AttuneNXT,34,Site16,AttuneNXT,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.9,,3102,17045.6,4328.4,4190000
Site16-AttuneNXT,34,Site16,AttuneNXT,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.3,,477,20377.6,9812.8,1460000
Site16-AttuneNXT,34,Site16,AttuneNXT,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,32.7,,488,20564.6,9858.6,1470000
Site16-AttuneNXT,34,Site16,AttuneNXT,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.4,,508,20070.0,9755.1,1440000
Site16-AttuneNXT,34,Site16,AttuneNXT,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,33.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.3,,304,72157.8,49890.5,9500000
Site16-AttuneNXT,34,Site16,AttuneNXT,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.8,,295,73373.0,49477.6,9660000
Site16-AttuneNXT,34,Site16,AttuneNXT,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.8,,307,72399.2,48772.4,9540000
Site16-AttuneNXT,34,Site16,AttuneNXT,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3289,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,2915,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,89.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,71.2,,394,10872.0,4328.2,75900
Site16-AttuneNXT,34,Site16,AttuneNXT,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,73.5,,462,10976.5,4244.6,76600
Site16-AttuneNXT,34,Site16,AttuneNXT,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,75.1,,491,10941.5,4107.9,76400
Site16-AttuneNXT,34,Site16,AttuneNXT,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.3,,189,4290.0,1608.8,30000
Site16-AttuneNXT,34,Site16,AttuneNXT,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.7,,213,4277.2,1553.4,29900
Site16-AttuneNXT,34,Site16,AttuneNXT,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10,,216,4341.3,1619.1,30300
Site16-AttuneNXT,34,Site16,AttuneNXT,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.5,,1401,9944.0,3803.6,76000
Site16-AttuneNXT,34,Site16,AttuneNXT,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,60.3,,1326,9880.4,3691.2,75500
Site16-AttuneNXT,34,Site16,AttuneNXT,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,61.7,,1340,9817.3,3645.8,75000
Site16-AttuneNXT,34,Site16,AttuneNXT,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,37.8,,530,60778.6,14190.0,10500000
Site16-AttuneNXT,34,Site16,AttuneNXT,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37,,491,60778.6,14008.2,10500000
Site16-AttuneNXT,34,Site16,AttuneNXT,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,36.8,,493,60976.3,13961.1,10600000
Site16-AttuneNXT,34,Site16,AttuneNXT,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.6,,2902,16167.6,4026.6,3970000
Site16-AttuneNXT,34,Site16,AttuneNXT,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,,2902,15902.5,3992.5,3910000
Site16-AttuneNXT,34,Site16,AttuneNXT,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.6,,2902,15902.5,3979.1,3910000
Site16-AttuneNXT,34,Site16,AttuneNXT,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,46.3,,649,15415.4,8936.3,1110000
Site16-AttuneNXT,34,Site16,AttuneNXT,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.7,,633,16264.0,8753.1,1170000
Site16-AttuneNXT,34,Site16,AttuneNXT,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.8,,653,16779.5,8741.9,1200000
Site16-AttuneNXT,34,Site16,AttuneNXT,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,78.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,75.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.1,,640,57903.4,39317.3,7630000
Site16-AttuneNXT,34,Site16,AttuneNXT,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,28,,615,58097.1,38506.8,7650000
Site16-AttuneNXT,34,Site16,AttuneNXT,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.3,,571,57517.9,39075.6,7580000
Site16-AttuneNXT,34,Site16,AttuneNXT,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,72.6,,404,11027.5,4428.8,77000
Site16-AttuneNXT,34,Site16,AttuneNXT,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,74.6,,470,11097.2,4318.0,77500
Site16-AttuneNXT,34,Site16,AttuneNXT,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,76,,497,11027.5,4178.5,77000
Site16-AttuneNXT,34,Site16,AttuneNXT,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.4,,190,4391.4,1625.3,30700
Site16-AttuneNXT,34,Site16,AttuneNXT,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.7,,213,4378.7,1560.6,30600
Site16-AttuneNXT,34,Site16,AttuneNXT,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.1,,218,4455.9,1653.1,31100
Site16-AttuneNXT,34,Site16,AttuneNXT,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.5,,1397,9876.7,3804.0,75500
Site16-AttuneNXT,34,Site16,AttuneNXT,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,60.3,,1326,9816.1,3696.0,75000
Site16-AttuneNXT,34,Site16,AttuneNXT,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,61.6,,1338,9726.0,3630.3,74300
Site16-AttuneNXT,34,Site16,AttuneNXT,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,37.7,,527,61265.6,14392.0,10600000
Site16-AttuneNXT,34,Site16,AttuneNXT,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37,,490,61081.6,13995.7,10600000
Site16-AttuneNXT,34,Site16,AttuneNXT,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,36.9,,493,61265.6,13995.7,10600000
Site16-AttuneNXT,34,Site16,AttuneNXT,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.6,,2902,16268.8,4006.9,4000000
Site16-AttuneNXT,34,Site16,AttuneNXT,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,,2902,15993.4,3951.6,3930000
Site16-AttuneNXT,34,Site16,AttuneNXT,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.6,,2902,16032.4,3979.9,3940000
Site16-AttuneNXT,34,Site16,AttuneNXT,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,46.2,,645,15350.7,8869.5,1100000
Site16-AttuneNXT,34,Site16,AttuneNXT,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.4,,629,16172.6,8664.4,1160000
Site16-AttuneNXT,34,Site16,AttuneNXT,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.4,,647,16650.5,8651.1,1190000
Site16-AttuneNXT,34,Site16,AttuneNXT,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,78.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,75.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.1,,638,58217.0,39173.1,7670000
Site16-AttuneNXT,34,Site16,AttuneNXT,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,27.9,,612,58217.0,38424.1,7670000
Site16-AttuneNXT,34,Site16,AttuneNXT,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.3,,571,57833.7,38933.0,7620000
Site16-AttuneNXT,34,Site16,AttuneNXT,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,90.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,91.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,72.7,,406,11031.1,4417.7,77000
Site16-AttuneNXT,34,Site16,AttuneNXT,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,74.7,,472,11104.1,4307.2,77500
Site16-AttuneNXT,34,Site16,AttuneNXT,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,75.9,,496,11031.1,4183.4,77000
Site16-AttuneNXT,34,Site16,AttuneNXT,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.4,,190,4369.6,1624.6,30500
Site16-AttuneNXT,34,Site16,AttuneNXT,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.7,,213,4355.7,1568.2,30400
Site16-AttuneNXT,34,Site16,AttuneNXT,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10,,218,4439.9,1642.9,31000
Site16-AttuneNXT,34,Site16,AttuneNXT,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.5,,1396,9876.7,3804.0,75500
Site16-AttuneNXT,34,Site16,AttuneNXT,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,60.4,,1325,9816.1,3696.0,75000
Site16-AttuneNXT,34,Site16,AttuneNXT,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,61.6,,1340,9755.9,3630.3,74600
Site16-AttuneNXT,34,Site16,AttuneNXT,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,37.7,,527,61338.0,14359.9,10600000
Site16-AttuneNXT,34,Site16,AttuneNXT,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37,,490,61338.0,14055.7,10600000
Site16-AttuneNXT,34,Site16,AttuneNXT,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,36.9,,494,61338.0,14055.7,10600000
Site16-AttuneNXT,34,Site16,AttuneNXT,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.6,,2902,16189.6,4012.3,3980000
Site16-AttuneNXT,34,Site16,AttuneNXT,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,,2902,15915.8,3942.7,3910000
Site16-AttuneNXT,34,Site16,AttuneNXT,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.6,,2902,15915.8,3970.8,3910000
Site16-AttuneNXT,34,Site16,AttuneNXT,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,45.8,,640,15320.3,8768.7,1100000
Site16-AttuneNXT,34,Site16,AttuneNXT,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.1,,625,16065.2,8599.1,1150000
Site16-AttuneNXT,34,Site16,AttuneNXT,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,48.1,,645,16501.7,8574.0,1180000
Site16-AttuneNXT,34,Site16,AttuneNXT,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,78.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,75.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,74.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,28.1,,637,58289.0,39224.6,7680000
Site16-AttuneNXT,34,Site16,AttuneNXT,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,27.8,,611,58289.0,38308.1,7680000
Site16-AttuneNXT,34,Site16,AttuneNXT,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,26.2,,570,57709.6,39092.3,7600000
Site16-AttuneNXT,34,Site16,AttuneNXT,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3055,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,2750,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,93.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.2,,1106,8574.3,2428.9,59900
Site16-AttuneNXT,34,Site16,AttuneNXT,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.5,,1086,8547.4,2420.8,59700
Site16-AttuneNXT,34,Site16,AttuneNXT,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89,,1111,8904.3,2459.6,62200
Site16-AttuneNXT,34,Site16,AttuneNXT,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,,234,4201.6,1474.9,29300
Site16-AttuneNXT,34,Site16,AttuneNXT,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.9,,236,4201.6,1412.1,29300
Site16-AttuneNXT,34,Site16,AttuneNXT,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.3,,197,4164.4,1492.7,29100
Site16-AttuneNXT,34,Site16,AttuneNXT,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.8,,1443,13514.1,5114.2,103000
Site16-AttuneNXT,34,Site16,AttuneNXT,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,68.6,,1480,13426.6,5065.6,103000
Site16-AttuneNXT,34,Site16,AttuneNXT,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.9,,1415,13514.1,5099.8,103000
Site16-AttuneNXT,34,Site16,AttuneNXT,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,72.4,,1044,62786.2,14005.6,10900000
Site16-AttuneNXT,34,Site16,AttuneNXT,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.8,,1078,62786.2,14039.3,10900000
Site16-AttuneNXT,34,Site16,AttuneNXT,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.9,,1017,63608.4,14490.0,11000000
Site16-AttuneNXT,34,Site16,AttuneNXT,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.6,,3448,15641.8,3583.7,3850000
Site16-AttuneNXT,34,Site16,AttuneNXT,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.6,,3448,15487.5,3515.6,3810000
Site16-AttuneNXT,34,Site16,AttuneNXT,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.6,,3448,15797.7,3660.8,3880000
Site16-AttuneNXT,34,Site16,AttuneNXT,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25.3,,364,22951.6,7144.9,1650000
Site16-AttuneNXT,34,Site16,AttuneNXT,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25,,370,22749.1,7260.4,1630000
Site16-AttuneNXT,34,Site16,AttuneNXT,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.8,,364,23293.5,7304.6,1670000
Site16-AttuneNXT,34,Site16,AttuneNXT,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,61.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,35.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,35.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,36.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19,,405,75416.5,57768.1,9930000
Site16-AttuneNXT,34,Site16,AttuneNXT,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.4,,398,75669.5,56328.2,9970000
Site16-AttuneNXT,34,Site16,AttuneNXT,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.6,,456,73177.2,56684.3,9640000
Site16-AttuneNXT,34,Site16,AttuneNXT,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,93.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.6,,1108,8723.3,2446.8,60900
Site16-AttuneNXT,34,Site16,AttuneNXT,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.9,,1091,8669.4,2438.6,60500
Site16-AttuneNXT,34,Site16,AttuneNXT,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.3,,1116,9054.4,2477.7,63200
Site16-AttuneNXT,34,Site16,AttuneNXT,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.1,,237,4315.5,1486.8,30100
Site16-AttuneNXT,34,Site16,AttuneNXT,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11,,237,4328.0,1419.9,30200
Site16-AttuneNXT,34,Site16,AttuneNXT,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.3,,196,4290.5,1513.9,30000
Site16-AttuneNXT,34,Site16,AttuneNXT,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.8,,1442,13440.9,5102.0,103000
Site16-AttuneNXT,34,Site16,AttuneNXT,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,68.5,,1478,13398.7,5037.5,102000
Site16-AttuneNXT,34,Site16,AttuneNXT,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,67,,1413,13483.3,5088.2,103000
Site16-AttuneNXT,34,Site16,AttuneNXT,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,72.4,,1045,63139.2,14119.3,10900000
Site16-AttuneNXT,34,Site16,AttuneNXT,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.8,,1076,63139.2,14146.9,10900000
Site16-AttuneNXT,34,Site16,AttuneNXT,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72,,1017,63906.2,14506.2,11100000
Site16-AttuneNXT,34,Site16,AttuneNXT,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.6,,3448,15761.8,3591.5,3870000
Site16-AttuneNXT,34,Site16,AttuneNXT,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,,3448,15571.8,3525.6,3830000
Site16-AttuneNXT,34,Site16,AttuneNXT,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.5,,3448,15877.1,3662.5,3900000
Site16-AttuneNXT,34,Site16,AttuneNXT,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25.3,,364,22738.5,7110.0,1630000
Site16-AttuneNXT,34,Site16,AttuneNXT,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.1,,371,22533.8,7230.4,1620000
Site16-AttuneNXT,34,Site16,AttuneNXT,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.8,,364,23084.3,7228.1,1660000
Site16-AttuneNXT,34,Site16,AttuneNXT,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,61.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,35.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,35.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,36.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19,,405,75630.1,57712.8,9960000
Site16-AttuneNXT,34,Site16,AttuneNXT,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.4,,397,75630.1,56358.6,9960000
Site16-AttuneNXT,34,Site16,AttuneNXT,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.5,,454,73647.9,56518.8,9700000
Site16-AttuneNXT,34,Site16,AttuneNXT,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,93.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,92.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.5,,1108,8706.5,2444.4,60800
Site16-AttuneNXT,34,Site16,AttuneNXT,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.9,,1090,8649.6,2425.9,60400
Site16-AttuneNXT,34,Site16,AttuneNXT,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.3,,1117,9026.1,2474.7,63000
Site16-AttuneNXT,34,Site16,AttuneNXT,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.1,,236,4300.5,1492.2,30000
Site16-AttuneNXT,34,Site16,AttuneNXT,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11,,237,4314.3,1416.1,30100
Site16-AttuneNXT,34,Site16,AttuneNXT,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.3,,197,4273.2,1504.5,29800
Site16-AttuneNXT,34,Site16,AttuneNXT,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.7,,1442,13440.9,5115.7,103000
Site16-AttuneNXT,34,Site16,AttuneNXT,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,68.6,,1478,13398.7,5051.1,102000
Site16-AttuneNXT,34,Site16,AttuneNXT,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.9,,1410,13483.3,5088.2,103000
Site16-AttuneNXT,34,Site16,AttuneNXT,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,72.4,,1044,63348.2,14103.9,11000000
Site16-AttuneNXT,34,Site16,AttuneNXT,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.9,,1077,63144.1,14137.2,10900000
Site16-AttuneNXT,34,Site16,AttuneNXT,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72,,1015,64171.4,14589.1,11100000
Site16-AttuneNXT,34,Site16,AttuneNXT,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.5,,3448,15647.5,3585.0,3850000
Site16-AttuneNXT,34,Site16,AttuneNXT,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.5,,3448,15459.2,3519.3,3800000
Site16-AttuneNXT,34,Site16,AttuneNXT,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,99.5,,3448,15800.1,3655.6,3880000
Site16-AttuneNXT,34,Site16,AttuneNXT,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25.3,,364,22540.5,7062.2,1620000
Site16-AttuneNXT,34,Site16,AttuneNXT,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25,,370,22334.0,7205.4,1600000
Site16-AttuneNXT,34,Site16,AttuneNXT,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.8,,363,22959.9,7180.2,1650000
Site16-AttuneNXT,34,Site16,AttuneNXT,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,61.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,35.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,35.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,36.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,19,,405,75612.8,57784.0,9960000
Site16-AttuneNXT,34,Site16,AttuneNXT,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.4,,396,75865.9,56303.3,9990000
Site16-AttuneNXT,34,Site16,AttuneNXT,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,21.5,,454,73618.5,56469.7,9700000
Site16-AttuneNXT,34,Site16,AttuneNXT,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3476,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,3419,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,975,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1555,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.3,,196,15836.7,3843.9,111000
Site16-AttuneNXT,34,Site16,AttuneNXT,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.1,,200,12799.0,3096.0,89400
Site16-AttuneNXT,34,Site16,AttuneNXT,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.5,,156,8682.8,723.7,60600
Site16-AttuneNXT,34,Site16,AttuneNXT,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15,,152,7707.9,696.7,53800
Site16-AttuneNXT,34,Site16,AttuneNXT,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.5,,713,34998.2,11565.7,267000
Site16-AttuneNXT,34,Site16,AttuneNXT,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.1,,719,33629.0,11233.7,257000
Site16-AttuneNXT,34,Site16,AttuneNXT,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.4,,467,201392.9,26473.2,31900000
Site16-AttuneNXT,34,Site16,AttuneNXT,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.4,,463,184045.4,24516.6,31900000
Site16-AttuneNXT,34,Site16,AttuneNXT,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1265,29613.5,13395.8,7280000
Site16-AttuneNXT,34,Site16,AttuneNXT,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1265,27060.9,12233.7,6650000
Site16-AttuneNXT,34,Site16,AttuneNXT,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,245,65046.2,4569.1,4450000
Site16-AttuneNXT,34,Site16,AttuneNXT,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.5,,255,62000.6,4466.1,4450000
Site16-AttuneNXT,34,Site16,AttuneNXT,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.9,,141,1363.3,471.6,180000
Site16-AttuneNXT,34,Site16,AttuneNXT,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,17.1,,174,526.1,481.2,69300
Site16-AttuneNXT,34,Site16,AttuneNXT,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.1,,197,15915.8,3877.3,111000
Site16-AttuneNXT,34,Site16,AttuneNXT,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81.1,,200,12874.7,3098.6,89900
Site16-AttuneNXT,34,Site16,AttuneNXT,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.5,,156,8971.6,742.1,62600
Site16-AttuneNXT,34,Site16,AttuneNXT,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15,,152,7993.2,718.8,55800
Site16-AttuneNXT,34,Site16,AttuneNXT,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.6,,712,34927.9,11426.2,267000
Site16-AttuneNXT,34,Site16,AttuneNXT,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.1,,719,33586.1,11138.0,257000
Site16-AttuneNXT,34,Site16,AttuneNXT,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.4,,466,202295.4,26237.8,35000000
Site16-AttuneNXT,34,Site16,AttuneNXT,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.4,,463,185345.6,24568.5,32100000
Site16-AttuneNXT,34,Site16,AttuneNXT,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1265,29822.7,13662.6,7330000
Site16-AttuneNXT,34,Site16,AttuneNXT,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1265,27191.6,12494.6,6680000
Site16-AttuneNXT,34,Site16,AttuneNXT,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,245,64683.5,4593.7,4640000
Site16-AttuneNXT,34,Site16,AttuneNXT,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.5,,255,61635.4,4457.0,4420000
Site16-AttuneNXT,34,Site16,AttuneNXT,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,15.9,,160,487.9,1407.5,185000
Site16-AttuneNXT,34,Site16,AttuneNXT,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,26.8,,271,418.1,442.7,58300
Site16-AttuneNXT,34,Site16,AttuneNXT,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,82.1,,196,15915.8,3845.4,111000
Site16-AttuneNXT,34,Site16,AttuneNXT,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,81,,200,12874.7,3098.6,89900
Site16-AttuneNXT,34,Site16,AttuneNXT,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.5,,157,8931.7,738.6,62400
Site16-AttuneNXT,34,Site16,AttuneNXT,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,15.1,,152,7957.8,706.0,55600
Site16-AttuneNXT,34,Site16,AttuneNXT,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.5,,713,34830.0,11498.5,266000
Site16-AttuneNXT,34,Site16,AttuneNXT,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.1,,719,33492.6,11229.1,256000
Site16-AttuneNXT,34,Site16,AttuneNXT,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.5,,467,202953.2,26616.7,35100000
Site16-AttuneNXT,34,Site16,AttuneNXT,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.4,,463,185345.6,24568.5,32100000
Site16-AttuneNXT,34,Site16,AttuneNXT,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,1265,29578.9,13427.2,7270000
Site16-AttuneNXT,34,Site16,AttuneNXT,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,1265,26972.8,12279.6,6630000
Site16-AttuneNXT,34,Site16,AttuneNXT,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.4,,245,64293.6,4548.3,4610000
Site16-AttuneNXT,34,Site16,AttuneNXT,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.5,,255,61265.6,4427.6,4390000
Site16-AttuneNXT,34,Site16,AttuneNXT,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site16-AttuneNXT,34,Site16,AttuneNXT,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,80,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-AttuneNXT,34,Site16,AttuneNXT,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.4,,146,1451.9,471.5,191000
Site16-AttuneNXT,34,Site16,AttuneNXT,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,24.3,,246,468.8,140.0,61800
Site16-AttuneNXT,34,Site16,AttuneNXT,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,94.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,94.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.8,,961,70344.3,24820.1,69000
Site16-CytoflexLX,35,Site16,CytoflexLX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.6,,973,69862.1,23734.8,68500
Site16-CytoflexLX,35,Site16,CytoflexLX,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.2,,989,70829.9,23422.1,69500
Site16-CytoflexLX,35,Site16,CytoflexLX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.8,,118,30095.0,10485.2,29500
Site16-CytoflexLX,35,Site16,CytoflexLX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.5,,113,29892.7,10582.0,29300
Site16-CytoflexLX,35,Site16,CytoflexLX,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.5,,111,29993.7,11137.4,29400
Site16-CytoflexLX,35,Site16,CytoflexLX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.8,,1554,49752.6,18292.9,87700
Site16-CytoflexLX,35,Site16,CytoflexLX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.9,,1577,49245.1,18165.7,86800
Site16-CytoflexLX,35,Site16,CytoflexLX,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77.1,,1564,49922.9,18421.0,88000
Site16-CytoflexLX,35,Site16,CytoflexLX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,56.2,,874,80642.6,19704.2,9710000
Site16-CytoflexLX,35,Site16,CytoflexLX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,56.5,,891,80162.3,19204.9,9660000
Site16-CytoflexLX,35,Site16,CytoflexLX,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.3,,897,81369.1,19883.6,9800000
Site16-CytoflexLX,35,Site16,CytoflexLX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.7,,3168,44452.2,11241.9,4060000
Site16-CytoflexLX,35,Site16,CytoflexLX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.8,,3168,44300.9,11163.7,4040000
Site16-CytoflexLX,35,Site16,CytoflexLX,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.6,,3168,44452.2,11026.8,4060000
Site16-CytoflexLX,35,Site16,CytoflexLX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.8,,557,37598.2,17231.0,1840000
Site16-CytoflexLX,35,Site16,CytoflexLX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,36,,569,37598.2,17643.1,1840000
Site16-CytoflexLX,35,Site16,CytoflexLX,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.4,,553,38205.9,17017.3,1870000
Site16-CytoflexLX,35,Site16,CytoflexLX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,33.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,34.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.8,,364,158499.1,93423.9,9970000
Site16-CytoflexLX,35,Site16,CytoflexLX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17,,348,155233.0,92278.7,9760000
Site16-CytoflexLX,35,Site16,CytoflexLX,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.9,,343,156857.5,93696.5,9860000
Site16-CytoflexLX,35,Site16,CytoflexLX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,86.9,,937,71318.8,23103.8,70000
Site16-CytoflexLX,35,Site16,CytoflexLX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.6,,950,70586.6,22531.7,69200
Site16-CytoflexLX,35,Site16,CytoflexLX,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.6,,967,71811.3,21858.6,70400
Site16-CytoflexLX,35,Site16,CytoflexLX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.8,,119,29691.8,10676.2,29100
Site16-CytoflexLX,35,Site16,CytoflexLX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.6,,114,29393.1,10639.1,28800
Site16-CytoflexLX,35,Site16,CytoflexLX,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.5,,111,29591.9,11213.5,29000
Site16-CytoflexLX,35,Site16,CytoflexLX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.8,,1549,48909.7,18207.4,86200
Site16-CytoflexLX,35,Site16,CytoflexLX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.8,,1570,48246.0,18080.8,85100
Site16-CytoflexLX,35,Site16,CytoflexLX,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77,,1557,49245.1,18399.1,86800
Site16-CytoflexLX,35,Site16,CytoflexLX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,56,,867,80838.7,20010.5,9740000
Site16-CytoflexLX,35,Site16,CytoflexLX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,56.3,,884,80325.6,19479.5,9680000
Site16-CytoflexLX,35,Site16,CytoflexLX,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.2,,890,81875.8,20271.8,9860000
Site16-CytoflexLX,35,Site16,CytoflexLX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.6,,3168,44150.2,11066.8,4030000
Site16-CytoflexLX,35,Site16,CytoflexLX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.6,,3168,43850.3,10932.1,4000000
Site16-CytoflexLX,35,Site16,CytoflexLX,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.5,,3168,44300.9,10988.4,4040000
Site16-CytoflexLX,35,Site16,CytoflexLX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.3,,546,36433.7,16562.2,1780000
Site16-CytoflexLX,35,Site16,CytoflexLX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.3,,554,36548.1,16736.9,1790000
Site16-CytoflexLX,35,Site16,CytoflexLX,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.9,,543,37242.9,16732.4,1820000
Site16-CytoflexLX,35,Site16,CytoflexLX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,34,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,34.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,34.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.8,,364,155233.0,91287.3,9760000
Site16-CytoflexLX,35,Site16,CytoflexLX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17,,348,152034.8,90477.3,9560000
Site16-CytoflexLX,35,Site16,CytoflexLX,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,16.9,,342,153625.5,93313.7,9660000
Site16-CytoflexLX,35,Site16,CytoflexLX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,86.3,,880,71318.8,23021.6,70000
Site16-CytoflexLX,35,Site16,CytoflexLX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.4,,907,70586.6,22531.7,69200
Site16-CytoflexLX,35,Site16,CytoflexLX,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.1,,921,71811.3,21858.6,70400
Site16-CytoflexLX,35,Site16,CytoflexLX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.8,,119,29792.1,10713.4,29200
Site16-CytoflexLX,35,Site16,CytoflexLX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,5.6,,114,29591.9,10676.2,29000
Site16-CytoflexLX,35,Site16,CytoflexLX,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,5.5,,111,29591.9,11181.8,29000
Site16-CytoflexLX,35,Site16,CytoflexLX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.7,,1547,49245.1,18278.7,86800
Site16-CytoflexLX,35,Site16,CytoflexLX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.8,,1569,48576.7,18151.6,85700
Site16-CytoflexLX,35,Site16,CytoflexLX,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,77,,1556,49582.8,18471.1,87400
Site16-CytoflexLX,35,Site16,CytoflexLX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,56.1,,867,80581.7,19845.7,9710000
Site16-CytoflexLX,35,Site16,CytoflexLX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,56.4,,884,80325.6,19479.5,9680000
Site16-CytoflexLX,35,Site16,CytoflexLX,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,57.2,,890,81615.2,20106.5,9830000
Site16-CytoflexLX,35,Site16,CytoflexLX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.6,,3168,44452.2,11183.3,4060000
Site16-CytoflexLX,35,Site16,CytoflexLX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.6,,3168,44150.2,11008.6,4030000
Site16-CytoflexLX,35,Site16,CytoflexLX,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.6,,3168,44604.0,11065.4,4070000
Site16-CytoflexLX,35,Site16,CytoflexLX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35,,541,35542.7,16044.0,1740000
Site16-CytoflexLX,35,Site16,CytoflexLX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.1,,550,35649.1,16308.3,1740000
Site16-CytoflexLX,35,Site16,CytoflexLX,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,34.7,,539,36295.0,16175.0,1770000
Site16-CytoflexLX,35,Site16,CytoflexLX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,64.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,63.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,34.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,34.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,34.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.9,,366,154695.3,92092.6,9730000
Site16-CytoflexLX,35,Site16,CytoflexLX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,17.1,,349,151508.2,90817.5,9530000
Site16-CytoflexLX,35,Site16,CytoflexLX,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17,,344,153625.5,93539.3,9660000
Site16-CytoflexLX,35,Site16,CytoflexLX,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3170,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,3166,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,88.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,89,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,88.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.1,,296,72307.1,31711.3,70900
Site16-CytoflexLX,35,Site16,CytoflexLX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,82.1,,290,73562.0,32470.3,72200
Site16-CytoflexLX,35,Site16,CytoflexLX,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,83,,285,72058.8,32137.8,70700
Site16-CytoflexLX,35,Site16,CytoflexLX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.1,,93,27112.5,10532.1,26600
Site16-CytoflexLX,35,Site16,CytoflexLX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.2,,95,26482.4,10286.3,26000
Site16-CytoflexLX,35,Site16,CytoflexLX,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.3,,97,26750.6,9709.8,26200
Site16-CytoflexLX,35,Site16,CytoflexLX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.2,,763,38140.9,14299.8,67300
Site16-CytoflexLX,35,Site16,CytoflexLX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.2,,766,37754.4,14193.7,66600
Site16-CytoflexLX,35,Site16,CytoflexLX,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.7,,767,37626.4,13881.5,66400
Site16-CytoflexLX,35,Site16,CytoflexLX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,36.7,,280,72462.5,19626.8,8730000
Site16-CytoflexLX,35,Site16,CytoflexLX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,37,,283,70981.1,19181.5,8550000
Site16-CytoflexLX,35,Site16,CytoflexLX,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,36.7,,281,70564.1,18404.0,8500000
Site16-CytoflexLX,35,Site16,CytoflexLX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97,,1538,39728.3,9675.7,3630000
Site16-CytoflexLX,35,Site16,CytoflexLX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.1,,1538,39863.6,9658.0,3640000
Site16-CytoflexLX,35,Site16,CytoflexLX,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.1,,1538,39593.5,9590.9,3610000
Site16-CytoflexLX,35,Site16,CytoflexLX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,51.3,,392,27614.6,14442.1,1350000
Site16-CytoflexLX,35,Site16,CytoflexLX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,51.5,,395,27614.6,14812.1,1350000
Site16-CytoflexLX,35,Site16,CytoflexLX,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,52,,399,27284.5,14556.1,1330000
Site16-CytoflexLX,35,Site16,CytoflexLX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,75,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,75.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,75.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,24.9,,287,116024.9,72680.2,7300000
Site16-CytoflexLX,35,Site16,CytoflexLX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.7,,286,114429.8,72055.9,7190000
Site16-CytoflexLX,35,Site16,CytoflexLX,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25,,292,113640.6,72922.5,7150000
Site16-CytoflexLX,35,Site16,CytoflexLX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,89.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78,,284,74070.2,27714.5,72700
Site16-CytoflexLX,35,Site16,CytoflexLX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,78.2,,280,75097.2,28867.5,73700
Site16-CytoflexLX,35,Site16,CytoflexLX,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.2,,275,73057.4,28243.3,71700
Site16-CytoflexLX,35,Site16,CytoflexLX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8,,92,26840.6,10572.7,26300
Site16-CytoflexLX,35,Site16,CytoflexLX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.2,,95,26129.2,10227.4,25600
Site16-CytoflexLX,35,Site16,CytoflexLX,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.2,,96,26305.2,9695.2,25800
Site16-CytoflexLX,35,Site16,CytoflexLX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.1,,761,37754.4,14278.7,66600
Site16-CytoflexLX,35,Site16,CytoflexLX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.1,,765,37245.2,14122.7,65700
Site16-CytoflexLX,35,Site16,CytoflexLX,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.5,,764,36867.9,13858.1,65000
Site16-CytoflexLX,35,Site16,CytoflexLX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,36.4,,277,73267.8,20056.0,8830000
Site16-CytoflexLX,35,Site16,CytoflexLX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,36.6,,280,71441.4,19647.3,8610000
Site16-CytoflexLX,35,Site16,CytoflexLX,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,36.2,,277,70769.3,18746.5,8520000
Site16-CytoflexLX,35,Site16,CytoflexLX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.7,,1538,39728.3,9642.1,3630000
Site16-CytoflexLX,35,Site16,CytoflexLX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.7,,1538,39728.3,9624.4,3630000
Site16-CytoflexLX,35,Site16,CytoflexLX,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.7,,1538,39325.2,9473.2,3590000
Site16-CytoflexLX,35,Site16,CytoflexLX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,49.8,,379,27166.9,13930.5,1330000
Site16-CytoflexLX,35,Site16,CytoflexLX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,49.8,,381,27332.7,14100.4,1340000
Site16-CytoflexLX,35,Site16,CytoflexLX,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,50.2,,384,26920.3,13866.3,1320000
Site16-CytoflexLX,35,Site16,CytoflexLX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,74.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,75.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,75.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,24.9,,287,113640.6,72810.2,7150000
Site16-CytoflexLX,35,Site16,CytoflexLX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.6,,285,112078.5,71860.5,7050000
Site16-CytoflexLX,35,Site16,CytoflexLX,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.1,,292,110538.2,72837.3,6950000
Site16-CytoflexLX,35,Site16,CytoflexLX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,89.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,90,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,78.1,,263,74325.6,27579.8,72900
Site16-CytoflexLX,35,Site16,CytoflexLX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,78.4,,258,75097.2,28792.4,73700
Site16-CytoflexLX,35,Site16,CytoflexLX,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,79.3,,254,73309.3,28121.5,71900
Site16-CytoflexLX,35,Site16,CytoflexLX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,8,,92,27021.5,10609.5,26500
Site16-CytoflexLX,35,Site16,CytoflexLX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.2,,95,26217.0,10263.1,25700
Site16-CytoflexLX,35,Site16,CytoflexLX,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.2,,96,26393.6,9729.0,25900
Site16-CytoflexLX,35,Site16,CytoflexLX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66,,762,38011.6,14335.9,67000
Site16-CytoflexLX,35,Site16,CytoflexLX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66,,765,37498.9,14137.4,66100
Site16-CytoflexLX,35,Site16,CytoflexLX,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.4,,764,37245.2,13870.3,65700
Site16-CytoflexLX,35,Site16,CytoflexLX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,36.4,,277,73267.8,20056.0,8830000
Site16-CytoflexLX,35,Site16,CytoflexLX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,36.7,,281,71216.6,19580.0,8580000
Site16-CytoflexLX,35,Site16,CytoflexLX,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,36.3,,277,70769.3,18600.5,8520000
Site16-CytoflexLX,35,Site16,CytoflexLX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,96.8,,1538,39999.4,9572.8,3650000
Site16-CytoflexLX,35,Site16,CytoflexLX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,96.8,,1538,39999.4,9554.4,3650000
Site16-CytoflexLX,35,Site16,CytoflexLX,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.8,,1538,39593.5,9454.9,3610000
Site16-CytoflexLX,35,Site16,CytoflexLX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,49.2,,375,26442.9,13479.6,1290000
Site16-CytoflexLX,35,Site16,CytoflexLX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,49.2,,376,26748.0,13664.8,1310000
Site16-CytoflexLX,35,Site16,CytoflexLX,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,49.6,,379,26216.7,13414.6,1280000
Site16-CytoflexLX,35,Site16,CytoflexLX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,75,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,75.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,76,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,22.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,25.1,,290,113248.0,73238.3,7120000
Site16-CytoflexLX,35,Site16,CytoflexLX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,24.9,,288,111691.4,72264.0,7020000
Site16-CytoflexLX,35,Site16,CytoflexLX,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,25.3,,296,109397.0,73080.7,6880000
Site16-CytoflexLX,35,Site16,CytoflexLX,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,1552,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,1524,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.7,,1327,59041.7,16878.5,57900
Site16-CytoflexLX,35,Site16,CytoflexLX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.8,,1320,59652.3,17056.3,58500
Site16-CytoflexLX,35,Site16,CytoflexLX,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,92.4,,1300,62159.7,18151.4,61000
Site16-CytoflexLX,35,Site16,CytoflexLX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.7,,209,27945.5,9649.5,27400
Site16-CytoflexLX,35,Site16,CytoflexLX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.9,,215,27572.0,10001.2,27000
Site16-CytoflexLX,35,Site16,CytoflexLX,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.9,,216,28324.1,9748.5,27800
Site16-CytoflexLX,35,Site16,CytoflexLX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.1,,1539,53274.9,19676.7,93900
Site16-CytoflexLX,35,Site16,CytoflexLX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.4,,1552,53457.5,19875.9,94300
Site16-CytoflexLX,35,Site16,CytoflexLX,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72,,1576,53640.8,19822.0,94600
Site16-CytoflexLX,35,Site16,CytoflexLX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71,,1092,78975.3,20018.3,9510000
Site16-CytoflexLX,35,Site16,CytoflexLX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.5,,1109,78975.3,19864.7,9510000
Site16-CytoflexLX,35,Site16,CytoflexLX,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.6,,1128,79211.2,19599.5,9540000
Site16-CytoflexLX,35,Site16,CytoflexLX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.5,,3653,41666.2,9145.4,3800000
Site16-CytoflexLX,35,Site16,CytoflexLX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.3,,3653,41808.3,9177.4,3820000
Site16-CytoflexLX,35,Site16,CytoflexLX,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.6,,3653,42671.2,9281.4,3890000
Site16-CytoflexLX,35,Site16,CytoflexLX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.8,,413,40899.8,12849.2,2000000
Site16-CytoflexLX,35,Site16,CytoflexLX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.5,,411,41394.6,12682.0,2020000
Site16-CytoflexLX,35,Site16,CytoflexLX,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.4,,416,41727.8,12449.4,2040000
Site16-CytoflexLX,35,Site16,CytoflexLX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,39.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,38.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,38.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,18.7,,404,197267.2,110886.7,12400000
Site16-CytoflexLX,35,Site16,CytoflexLX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.1,,395,202125.9,112378.9,12700000
Site16-CytoflexLX,35,Site16,CytoflexLX,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.7,,387,202125.9,113650.2,12700000
Site16-CytoflexLX,35,Site16,CytoflexLX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91,,1325,59448.0,16498.5,58300
Site16-CytoflexLX,35,Site16,CytoflexLX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.4,,1326,59857.2,16821.2,58700
Site16-CytoflexLX,35,Site16,CytoflexLX,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.7,,1300,62587.9,17695.2,61400
Site16-CytoflexLX,35,Site16,CytoflexLX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.7,,208,27479.5,9547.0,27000
Site16-CytoflexLX,35,Site16,CytoflexLX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.9,,213,27203.8,9893.3,26700
Site16-CytoflexLX,35,Site16,CytoflexLX,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.9,,215,28039.6,9549.3,27500
Site16-CytoflexLX,35,Site16,CytoflexLX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.2,,1528,52550.6,19720.7,92700
Site16-CytoflexLX,35,Site16,CytoflexLX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.4,,1533,52911.5,19919.1,93300
Site16-CytoflexLX,35,Site16,CytoflexLX,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,72,,1560,53092.9,19737.6,93600
Site16-CytoflexLX,35,Site16,CytoflexLX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70.8,,1082,79309.7,20511.0,9550000
Site16-CytoflexLX,35,Site16,CytoflexLX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.3,,1094,79309.7,20252.7,9550000
Site16-CytoflexLX,35,Site16,CytoflexLX,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.6,,1117,79562.4,20132.8,9580000
Site16-CytoflexLX,35,Site16,CytoflexLX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.3,,3653,41666.2,9201.5,3800000
Site16-CytoflexLX,35,Site16,CytoflexLX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.2,,3653,41808.3,9233.6,3820000
Site16-CytoflexLX,35,Site16,CytoflexLX,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.5,,3653,42671.2,9428.9,3890000
Site16-CytoflexLX,35,Site16,CytoflexLX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.8,,409,40042.6,12871.1,1960000
Site16-CytoflexLX,35,Site16,CytoflexLX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.4,,404,40681.0,12639.1,1990000
Site16-CytoflexLX,35,Site16,CytoflexLX,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.2,,410,40810.1,12478.1,1990000
Site16-CytoflexLX,35,Site16,CytoflexLX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,39.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,39.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,39.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,18.5,,396,193196.2,108964.9,12100000
Site16-CytoflexLX,35,Site16,CytoflexLX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18,,387,198643.3,111372.6,12500000
Site16-CytoflexLX,35,Site16,CytoflexLX,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.6,,382,198643.3,111675.0,12500000
Site16-CytoflexLX,35,Site16,CytoflexLX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91,,1276,59448.0,16498.5,58300
Site16-CytoflexLX,35,Site16,CytoflexLX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.4,,1282,60062.9,16746.8,58900
Site16-CytoflexLX,35,Site16,CytoflexLX,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,90.7,,1255,62587.9,17757.1,61400
Site16-CytoflexLX,35,Site16,CytoflexLX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.7,,208,27572.0,9549.3,27000
Site16-CytoflexLX,35,Site16,CytoflexLX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.9,,213,27387.2,9927.8,26900
Site16-CytoflexLX,35,Site16,CytoflexLX,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.9,,216,28134.1,9647.2,27600
Site16-CytoflexLX,35,Site16,CytoflexLX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,71.1,,1531,52911.5,19798.3,93300
Site16-CytoflexLX,35,Site16,CytoflexLX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.2,,1538,53274.9,19806.6,93900
Site16-CytoflexLX,35,Site16,CytoflexLX,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,71.8,,1564,53457.5,19752.9,94300
Site16-CytoflexLX,35,Site16,CytoflexLX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,70.9,,1085,79058.0,20511.0,9520000
Site16-CytoflexLX,35,Site16,CytoflexLX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.4,,1098,79058.0,20252.7,9520000
Site16-CytoflexLX,35,Site16,CytoflexLX,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.7,,1121,79562.4,20132.8,9580000
Site16-CytoflexLX,35,Site16,CytoflexLX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.4,,3653,41808.3,9177.4,3820000
Site16-CytoflexLX,35,Site16,CytoflexLX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.2,,3653,41950.8,9152.8,3830000
Site16-CytoflexLX,35,Site16,CytoflexLX,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.5,,3653,42962.9,9346.4,3920000
Site16-CytoflexLX,35,Site16,CytoflexLX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.7,,409,39013.9,12530.6,1910000
Site16-CytoflexLX,35,Site16,CytoflexLX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.3,,405,39608.6,12285.0,1940000
Site16-CytoflexLX,35,Site16,CytoflexLX,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.2,,410,39728.8,12182.0,1940000
Site16-CytoflexLX,35,Site16,CytoflexLX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,58.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,59.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,39.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,39.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,38.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,18.7,,403,193868.8,110678.2,12200000
Site16-CytoflexLX,35,Site16,CytoflexLX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.3,,395,199335.0,113509.0,12500000
Site16-CytoflexLX,35,Site16,CytoflexLX,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,17.9,,390,199335.0,113916.1,12500000
Site16-CytoflexLX,35,Site16,CytoflexLX,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,3674,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,3632,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,9873,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,856,,,
Site16-CytoflexLX,35,Site16,CytoflexLX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,78.7,,507,75876.9,18724.9,74400
Site16-CytoflexLX,35,Site16,CytoflexLX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.7,,573,56856.8,13946.6,55800
Site16-CytoflexLX,35,Site16,CytoflexLX,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79,,543,44000.0,10795.8,43200
Site16-CytoflexLX,35,Site16,CytoflexLX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.6,,26,24190.9,7824.0,23700
Site16-CytoflexLX,35,Site16,CytoflexLX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.4,,17,22626.9,7631.8,55800
Site16-CytoflexLX,35,Site16,CytoflexLX,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.9,,20,22327.0,7739.6,21900
Site16-CytoflexLX,35,Site16,CytoflexLX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.2,,129,77996.5,40806.7,138000
Site16-CytoflexLX,35,Site16,CytoflexLX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.1,,83,78535.8,39433.9,138000
Site16-CytoflexLX,35,Site16,CytoflexLX,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71,,100,80176.3,38662.0,141000
Site16-CytoflexLX,35,Site16,CytoflexLX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,66.9,,86,167402.2,115111.3,20200000
Site16-CytoflexLX,35,Site16,CytoflexLX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.3,,53,181204.2,107773.2,21800000
Site16-CytoflexLX,35,Site16,CytoflexLX,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,67.2,,67,160162.2,98982.9,19300000
Site16-CytoflexLX,35,Site16,CytoflexLX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,856,15619.9,14953.8,1430000
Site16-CytoflexLX,35,Site16,CytoflexLX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,856,14630.5,10225.6,1340000
Site16-CytoflexLX,35,Site16,CytoflexLX,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,856,14068.9,10670.4,1280000
Site16-CytoflexLX,35,Site16,CytoflexLX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,32.8,,42,60335.3,20803.4,2950000
Site16-CytoflexLX,35,Site16,CytoflexLX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.9,,29,63817.8,21741.2,3120000
Site16-CytoflexLX,35,Site16,CytoflexLX,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.7,,33,65371.2,20957.8,3190000
Site16-CytoflexLX,35,Site16,CytoflexLX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,21.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,13.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,16.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,75.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,84,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,80.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.9,,25,1463.3,857.3,92000
Site16-CytoflexLX,35,Site16,CytoflexLX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,14,,16,1213.4,627.6,76300
Site16-CytoflexLX,35,Site16,CytoflexLX,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.6,,21,1447.8,616.2,91000
Site16-CytoflexLX,35,Site16,CytoflexLX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,77.6,,523,81289.2,20010.2,79700
Site16-CytoflexLX,35,Site16,CytoflexLX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.2,,585,60892.8,15093.8,59700
Site16-CytoflexLX,35,Site16,CytoflexLX,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,78.2,,559,47267.5,11682.7,46400
Site16-CytoflexLX,35,Site16,CytoflexLX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.6,,26,26930.9,7729.0,26400
Site16-CytoflexLX,35,Site16,CytoflexLX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.5,,17,25522.8,7701.4,25000
Site16-CytoflexLX,35,Site16,CytoflexLX,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,14.2,,20,25098.6,8418.9,24600
Site16-CytoflexLX,35,Site16,CytoflexLX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.3,,128,100685.7,47877.7,178000
Site16-CytoflexLX,35,Site16,CytoflexLX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.2,,82,96930.7,47005.5,171000
Site16-CytoflexLX,35,Site16,CytoflexLX,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.7,,100,101384.0,46106.4,179000
Site16-CytoflexLX,35,Site16,CytoflexLX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,66.2,,84,204956.2,126500.0,24700000
Site16-CytoflexLX,35,Site16,CytoflexLX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.9,,53,215179.8,115942.0,25900000
Site16-CytoflexLX,35,Site16,CytoflexLX,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,67.2,,67,190529.3,111313.3,23000000
Site16-CytoflexLX,35,Site16,CytoflexLX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,856,17699.4,17211.1,1620000
Site16-CytoflexLX,35,Site16,CytoflexLX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,856,16680.2,12031.8,1520000
Site16-CytoflexLX,35,Site16,CytoflexLX,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,856,16087.9,12369.1,1470000
Site16-CytoflexLX,35,Site16,CytoflexLX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.5,,43,74839.1,23925.0,3660000
Site16-CytoflexLX,35,Site16,CytoflexLX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.9,,29,78535.8,26320.6,3840000
Site16-CytoflexLX,35,Site16,CytoflexLX,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,32.3,,32,80730.8,26821.4,3940000
Site16-CytoflexLX,35,Site16,CytoflexLX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,20.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,13.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,16.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,78.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,86.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,83.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14.5,,26,1882.5,990.0,118000
Site16-CytoflexLX,35,Site16,CytoflexLX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,15.7,,18,1467.1,750.1,92200
Site16-CytoflexLX,35,Site16,CytoflexLX,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,14.7,,20,1804.1,723.3,113000
Site16-CytoflexLX,35,Site16,CytoflexLX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.9,,620,81289.2,19894.0,79700
Site16-CytoflexLX,35,Site16,CytoflexLX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,79.9,,648,60892.8,14955.5,59700
Site16-CytoflexLX,35,Site16,CytoflexLX,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,79.8,,644,47267.5,11682.7,46400
Site16-CytoflexLX,35,Site16,CytoflexLX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.5,,12,26840.6,6268.1,26300
Site16-CytoflexLX,35,Site16,CytoflexLX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.4,,6,24930.9,4894.0,24500
Site16-CytoflexLX,35,Site16,CytoflexLX,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,17.4,,8,23631.1,7531.5,23200
Site16-CytoflexLX,35,Site16,CytoflexLX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,68.9,,53,119282.9,44290.4,210000
Site16-CytoflexLX,35,Site16,CytoflexLX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,72.4,,31,113640.6,45671.2,200000
Site16-CytoflexLX,35,Site16,CytoflexLX,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,66.2,,32,115624.1,46806.5,204000
Site16-CytoflexLX,35,Site16,CytoflexLX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.5,,35,197954.0,46321.2,23800000
Site16-CytoflexLX,35,Site16,CytoflexLX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,65.8,,21,177740.2,53729.3,21400000
Site16-CytoflexLX,35,Site16,CytoflexLX,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,68.3,,22,164097.1,43955.3,19800000
Site16-CytoflexLX,35,Site16,CytoflexLX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,856,17181.8,10787.2,1570000
Site16-CytoflexLX,35,Site16,CytoflexLX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,856,16354.4,9924.8,1490000
Site16-CytoflexLX,35,Site16,CytoflexLX,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,856,15722.6,9376.5,1430000
Site16-CytoflexLX,35,Site16,CytoflexLX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34,,18,69862.1,11950.5,3410000
Site16-CytoflexLX,35,Site16,CytoflexLX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,31.2,,10,66123.4,14471.5,3230000
Site16-CytoflexLX,35,Site16,CytoflexLX,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,31,,10,66579.4,13779.5,3250000
Site16-CytoflexLX,35,Site16,CytoflexLX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,9.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,5.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,5.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,90.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,94.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,94.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site16-CytoflexLX,35,Site16,CytoflexLX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,15.2,,12,1943.6,722.3,122000
Site16-CytoflexLX,35,Site16,CytoflexLX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,13.1,,6,1605.5,831.7,101000
Site16-CytoflexLX,35,Site16,CytoflexLX,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,16.2,,8,1729.1,630.1,109000
Site17-Aurora-1,36,Site17,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,85.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.73,98.98,,104198.0,57997.0,59700
Site17-Aurora-1,36,Site17,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,72.93,164.79,,153482.0,67107.0,30600
Site17-Aurora-1,36,Site17,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,74.73,70.38,,141160.0,67144.0,80896.45829
Site17-Aurora-1,36,Site17,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.07,54.43,,43829.0,21290.0,25100
Site17-Aurora-1,36,Site17,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.81,96.44,,49049.0,20772.0,28100
Site17-Aurora-1,36,Site17,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.98,40.72,,53620.0,19919.0,30728.73401
Site17-Aurora-1,36,Site17,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,43.44,213.58,,72584.0,27909.0,60100
Site17-Aurora-1,36,Site17,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,44.78,399.45,,76768.0,32435.0,63500
Site17-Aurora-1,36,Site17,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,40.78,118.8,,83587.0,34111.0,69186.46262
Site17-Aurora-1,36,Site17,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,49.28,103.19,,224896.0,56952.0,7690000
Site17-Aurora-1,36,Site17,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.09,181.42,,248166.0,74722.0,8480000
Site17-Aurora-1,36,Site17,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.9,54.41,,270282.0,70355.0,9239253.008
Site17-Aurora-1,36,Site17,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.33,648.94,,80709.0,26748.0,3580000
Site17-Aurora-1,36,Site17,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.73,1168.81,,83719.0,23561.0,3710000
Site17-Aurora-1,36,Site17,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.56,404.1,,89960.0,25809.0,3989125.741
Site17-Aurora-1,36,Site17,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,43.68,93.3,,188125.0,90119.0,768000
Site17-Aurora-1,36,Site17,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,45.64,399.45,,200938.0,127496.0,820000
Site17-Aurora-1,36,Site17,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,45.15,53.64,,244903.0,131563.0,999888.7353
Site17-Aurora-1,36,Site17,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,75.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,76.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,72.08,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.07,128.18,,288400.0,268437.0,3110000
Site17-Aurora-1,36,Site17,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.39,226.45,,417924.0,417616.0,4500000
Site17-Aurora-1,36,Site17,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.02,78.72,,428860.0,406172.0,4621218.672
Site17-Aurora-1,36,Site17,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,85.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,77.11,99.39,,103835.0,58121.0,59500
Site17-Aurora-1,36,Site17,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,73.58,166.55,,152382.0,67833.0,87327.60064
Site17-Aurora-1,36,Site17,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,75.74,71.45,,140303.0,67468.0,80405.32578
Site17-Aurora-1,36,Site17,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.07,54.39,,43965.0,21321.0,25200
Site17-Aurora-1,36,Site17,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.94,98.09,,49425.0,20717.0,28324.64899
Site17-Aurora-1,36,Site17,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.12,41.37,,53851.0,19820.0,30861.11629
Site17-Aurora-1,36,Site17,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,40.53,199.13,,72898.0,27787.0,60300
Site17-Aurora-1,36,Site17,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,42.11,377.69,,76778.0,32766.0,63550.53091
Site17-Aurora-1,36,Site17,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,38.05,111.52,,84074.0,34640.0,69589.56127
Site17-Aurora-1,36,Site17,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,52.42,104.39,,226097.0,55982.0,7730000
Site17-Aurora-1,36,Site17,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,50,188.86,,248918.0,74718.0,8508951.318
Site17-Aurora-1,36,Site17,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,50.12,55.9,,271425.0,70485.0,32695182.78
Site17-Aurora-1,36,Site17,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.09,648.49,,82721.0,27530.0,3670000
Site17-Aurora-1,36,Site17,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.72,1172.4,,85838.0,27312.0,3806342.545
Site17-Aurora-1,36,Site17,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.22,405.42,,92218.0,26441.0,4039011.984
Site17-Aurora-1,36,Site17,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,40.59,80.82,,181963.0,82541.0,743000
Site17-Aurora-1,36,Site17,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,42.89,161.98,,189402.0,117657.0,773289.5319
Site17-Aurora-1,36,Site17,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,42.22,47.08,,239309.0,129881.0,977049.5802
Site17-Aurora-1,36,Site17,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,75.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,76.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,72.29,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.28,129.11,,295468.0,274458.0,3180000
Site17-Aurora-1,36,Site17,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.73,230.76,,426782.0,427268.0,4598827
Site17-Aurora-1,36,Site17,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.44,80.42,,435148.0,414803.0,4688975.57
Site17-Aurora-1,36,Site17,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,83.85,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,89.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,76.01,95.82,,103743.0,58611.0,59500
Site17-Aurora-1,36,Site17,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,71.73,162.21,,151965.0,65396.0,87088.62485
Site17-Aurora-1,36,Site17,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,73.83,69.73,,139692.0,65944.0,80055.1718
Site17-Aurora-1,36,Site17,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.88,52.5,,42284.0,20878.0,24200
Site17-Aurora-1,36,Site17,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.73,94.99,,47159.0,20198.0,27026.04191
Site17-Aurora-1,36,Site17,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.9,40.22,,51415.0,19637.0,29465.08503
Site17-Aurora-1,36,Site17,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.47,200.05,,72838.0,27598.0,60300
Site17-Aurora-1,36,Site17,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,43.04,381.02,,76924.0,32154.0,63671.37773
Site17-Aurora-1,36,Site17,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,39.19,113.43,,83841.0,33627.0,69396.70298
Site17-Aurora-1,36,Site17,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,51.48,102.98,,225799.0,56144.0,7720000
Site17-Aurora-1,36,Site17,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,48.84,186.08,,247384.0,73389.0,8456513.442
Site17-Aurora-1,36,Site17,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,48.74,55.29,,269307.0,69004.0,9205923.849
Site17-Aurora-1,36,Site17,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.15,635.51,,81912.0,26961.0,3630000
Site17-Aurora-1,36,Site17,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.72,1161.23,,84732.0,26690.0,3757298.825
Site17-Aurora-1,36,Site17,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.34,402,,91085.0,25998.0,4039011.984
Site17-Aurora-1,36,Site17,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,41.82,83.65,,188280.0,90319.0,769000
Site17-Aurora-1,36,Site17,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.22,168.49,,200665.0,125643.0,819274.0516
Site17-Aurora-1,36,Site17,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,43.72,49.59,,246340.0,129572.0,1005755.712
Site17-Aurora-1,36,Site17,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,75.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,76.24,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,71.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.84,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,19.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,23.49,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.64,128.52,,294789.0,273506.0,3160000
Site17-Aurora-1,36,Site17,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,25.83,228.7,,428137.0,426711.0,4613427.922
Site17-Aurora-1,36,Site17,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.48,79.52,,438916.0,411553.0,4729577.985
Site17-Aurora-1,36,Site17,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.34,1467.16,,90863.0,23938.0,4029167.766
Site17-Aurora-1,36,Site17,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.59,757.69,,90785.0,25715.0,4025708.986
Site17-Aurora-1,36,Site17,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.87,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,93.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,90.11,319.36,,127039.0,34499.0,72803.94704
Site17-Aurora-1,36,Site17,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.76,263.58,,120100.0,39199.0,68827.32106
Site17-Aurora-1,36,Site17,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.62,287.79,,128564.0,34323.0,73677.89929
Site17-Aurora-1,36,Site17,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.36,98.99,,5246.0,18533.0,3006.395722
Site17-Aurora-1,36,Site17,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.41,98.39,,50475.0,20668.0,28926.3866
Site17-Aurora-1,36,Site17,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.95,102.13,,53976.0,18352.0,30932.75172
Site17-Aurora-1,36,Site17,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,68.77,477.39,,122431.0,53600.0,101338.3398
Site17-Aurora-1,36,Site17,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,68.34,436.64,,117038.0,50725.0,96874.4567
Site17-Aurora-1,36,Site17,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,68.79,470.05,,122717.0,50489.0,101575.0671
Site17-Aurora-1,36,Site17,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,72.47,315.19,,299167.0,66405.0,10226650.7
Site17-Aurora-1,36,Site17,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.84,292.1,,289327.0,74643.0,9890282.575
Site17-Aurora-1,36,Site17,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.03,338.59,,299746.0,63621.0,10246443.09
Site17-Aurora-1,36,Site17,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.3,1105.73,,87209.0,21202.0,3867137.247
Site17-Aurora-1,36,Site17,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.1,980.18,,85329.0,22104.0,3783771.791
Site17-Aurora-1,36,Site17,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.31,1047.4,,87156.0,20540.0,3864787.051
Site17-Aurora-1,36,Site17,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25.73,123.15,,257852.0,154162.0,1052756.847
Site17-Aurora-1,36,Site17,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.28,115.41,,274519.0,142685.0,1120804.791
Site17-Aurora-1,36,Site17,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.72,120.88,,286810.0,149747.0,1170986.424
Site17-Aurora-1,36,Site17,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.24,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.77,87.31,,901818.0,761060.0,9717619.224
Site17-Aurora-1,36,Site17,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.81,76.78,,805844.0,781984.0,8683442.941
Site17-Aurora-1,36,Site17,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.32,84.15,,898813.0,788912.0,9685238.582
Site17-Aurora-1,36,Site17,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.46,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.51,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.97,331.32,,126760.0,34387.0,72644.05676
Site17-Aurora-1,36,Site17,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.93,275.28,,119799.0,39015.0,68654.82294
Site17-Aurora-1,36,Site17,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.76,290.53,,128459.0,34267.0,73617.72553
Site17-Aurora-1,36,Site17,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.44,100.25,,53177.0,18595.0,30474.85805
Site17-Aurora-1,36,Site17,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.43,99.28,,50624.0,20816.0,29011.77603
Site17-Aurora-1,36,Site17,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.05,104.11,,54178.0,18337.0,31048.51457
Site17-Aurora-1,36,Site17,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.11,466.03,,123864.0,54368.0,102524.4596
Site17-Aurora-1,36,Site17,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.58,428.52,,118359.0,51517.0,97967.87214
Site17-Aurora-1,36,Site17,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.95,463.04,,124218.0,51035.0,102817.4718
Site17-Aurora-1,36,Site17,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,72.59,338.3,,300376.0,66510.0,10267978.86
Site17-Aurora-1,36,Site17,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.86,312.21,,290400.0,74563.0,9926961.742
Site17-Aurora-1,36,Site17,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,73.2,338.92,,300677.0,63538.0,10278268.17
Site17-Aurora-1,36,Site17,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.79,1109.57,,89215.0,21664.0,3956089.962
Site17-Aurora-1,36,Site17,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.97,988.12,,87482.0,22745.0,3879242.975
Site17-Aurora-1,36,Site17,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.19,1057.11,,89264.0,21137.0,3958262.785
Site17-Aurora-1,36,Site17,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25.45,118.62,,248382.0,149895.0,1014092.779
Site17-Aurora-1,36,Site17,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.25,108.19,,268744.0,139924.0,1097226.65
Site17-Aurora-1,36,Site17,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,24.77,114.69,,280016.0,149581.0,1143247.915
Site17-Aurora-1,36,Site17,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.13,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.96,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.43,93.26,,959819.0,797007.0,10342614.1
Site17-Aurora-1,36,Site17,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.28,85.48,,887358.0,852444.0,9561804.222
Site17-Aurora-1,36,Site17,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.34,92.28,,977531.0,839914.0,10533471.32
Site17-Aurora-1,36,Site17,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,95.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,93.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.61,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.78,327.36,,124384.0,33881.0,71282.41051
Site17-Aurora-1,36,Site17,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.34,269.6,,117371.0,38388.0,67263.37635
Site17-Aurora-1,36,Site17,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.01,285,,125917.0,33882.0,72160.94742
Site17-Aurora-1,36,Site17,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.27,98.13,,50641.0,18218.0,29021.51845
Site17-Aurora-1,36,Site17,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.19,96.4,,48404.0,20153.0,27739.53079
Site17-Aurora-1,36,Site17,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.83,101.56,,51590.0,18181.0,29565.37463
Site17-Aurora-1,36,Site17,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,66.62,458.08,,120216.0,51273.0,99504.94443
Site17-Aurora-1,36,Site17,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,65.89,418.12,,115264.0,48683.0,95406.085
Site17-Aurora-1,36,Site17,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,66.26,453.8,,120814.0,48318.0,99999.91978
Site17-Aurora-1,36,Site17,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.83,329.03,,294844.0,63401.0,10078874.34
Site17-Aurora-1,36,Site17,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.23,297.81,,284625.0,70660.0,9729550.571
Site17-Aurora-1,36,Site17,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,71.78,325.74,,295708.0,60575.0,10108409.1
Site17-Aurora-1,36,Site17,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.83,1103.54,,87910.0,21318.0,3898221.92
Site17-Aurora-1,36,Site17,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,99.03,974.45,,86139.0,22225.0,3819689.887
Site17-Aurora-1,36,Site17,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.24,1047.76,,87776.0,20728.0,3892279.914
Site17-Aurora-1,36,Site17,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.03,119.24,,257789.0,150935.0,1052499.631
Site17-Aurora-1,36,Site17,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.62,111.32,,275685.0,140967.0,1125565.33
Site17-Aurora-1,36,Site17,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,26.09,118.4,,283753.0,145595.0,1158505.32
Site17-Aurora-1,36,Site17,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,65.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.37,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,33.41,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.32,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.32,91.59,,949247.0,784559.0,10228694.59
Site17-Aurora-1,36,Site17,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.04,82.75,,891718.0,842688.0,9608785.785
Site17-Aurora-1,36,Site17,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.29,91.05,,984892.0,824267.0,10612790.42
Site17-Aurora-1,36,Site17,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.91,1209.24,,91146.0,20272.0,4041716.927
Site17-Aurora-1,36,Site17,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.03,791.47,,91392.0,21821.0,4052625.386
Site17-Aurora-1,36,Site17,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.56,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.71,194.74,,153439.0,49261.0,87933.34984
Site17-Aurora-1,36,Site17,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.95,247.42,,155438.0,53759.0,89078.94363
Site17-Aurora-1,36,Site17,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.65,298,,157247.0,47732.0,90115.65158
Site17-Aurora-1,36,Site17,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.16,48.43,,58805.0,20764.0,33700.17165
Site17-Aurora-1,36,Site17,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.43,70.91,,55436.0,20992.0,31769.45354
Site17-Aurora-1,36,Site17,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.17,71.76,,57042.0,20781.0,32689.82554
Site17-Aurora-1,36,Site17,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,65.6,294.38,,106693.0,46570.0,88311.71421
Site17-Aurora-1,36,Site17,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63.97,481.02,,101645.0,45366.0,84133.39386
Site17-Aurora-1,36,Site17,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,63.61,497.95,,106630.0,47499.0,88259.56798
Site17-Aurora-1,36,Site17,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,67.38,198.34,,295275.0,78155.0,10093607.54
Site17-Aurora-1,36,Site17,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.07,327.42,,282370.0,79819.0,9652466.209
Site17-Aurora-1,36,Site17,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,66.85,332.87,,294210.0,79405.0,10057201.84
Site17-Aurora-1,36,Site17,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.56,726.65,,93698.0,25556.0,4154881.099
Site17-Aurora-1,36,Site17,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.87,1073.83,,88394.0,26606.0,3919684.09
Site17-Aurora-1,36,Site17,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.32,1168.16,,92250.0,25703.0,4090671.961
Site17-Aurora-1,36,Site17,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28.27,83.21,,255071.0,158503.0,1041402.594
Site17-Aurora-1,36,Site17,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.76,133.53,,220118.0,142523.0,898696.6621
Site17-Aurora-1,36,Site17,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.33,141.07,,238745.0,152934.0,974746.8839
Site17-Aurora-1,36,Site17,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,67.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,29.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.87,66.1,,695757.0,563967.0,7497190.784
Site17-Aurora-1,36,Site17,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.8,96.21,,575310.0,547759.0,6199303.536
Site17-Aurora-1,36,Site17,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.34,104.42,,733869.0,589012.0,7907869.994
Site17-Aurora-1,36,Site17,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.35,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.43,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.8,192.47,,153196.0,48912.0,87794.09056
Site17-Aurora-1,36,Site17,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.09,228.53,,155128.0,53086.0,88901.28777
Site17-Aurora-1,36,Site17,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.29,274.7,,156791.0,47662.0,89854.32553
Site17-Aurora-1,36,Site17,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.99,47.56,,58953.0,20434.0,33784.988
Site17-Aurora-1,36,Site17,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,9.14,64.83,,55635.0,20656.0,31883.49714
Site17-Aurora-1,36,Site17,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.93,66.53,,57007.0,20458.0,32669.76762
Site17-Aurora-1,36,Site17,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.15,276.89,,108316.0,47797.0,89655.10049
Site17-Aurora-1,36,Site17,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,60.78,431.33,,102778.0,46331.0,85071.19833
Site17-Aurora-1,36,Site17,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,60.37,449.96,,107586.0,48866.0,89050.86637
Site17-Aurora-1,36,Site17,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.63,198.34,,296400.0,78123.0,10132064.26
Site17-Aurora-1,36,Site17,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.06,310.83,,283560.0,79690.0,9693144.874
Site17-Aurora-1,36,Site17,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,70.62,317.75,,295028.0,79810.0,10085164.15
Site17-Aurora-1,36,Site17,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.38,727.88,,95918.0,26221.0,4253323.286
Site17-Aurora-1,36,Site17,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.74,1013.68,,90431.0,27269.0,4010011.448
Site17-Aurora-1,36,Site17,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.72,1113.28,,94181.0,26487.0,4176298.926
Site17-Aurora-1,36,Site17,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.38,67.51,,236814.0,149917.0,966863.0068
Site17-Aurora-1,36,Site17,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.38,105.16,,201499.0,127405.0,822679.1026
Site17-Aurora-1,36,Site17,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.06,112.78,,219040.0,139262.0,894295.4091
Site17-Aurora-1,36,Site17,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.41,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,70.01,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,29.78,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.14,67.32,,708287.0,580214.0,7632208.902
Site17-Aurora-1,36,Site17,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.05,92.64,,583548.0,563428.0,6288072.83
Site17-Aurora-1,36,Site17,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.49,100.58,,748583.0,607744.0,8066421.996
Site17-Aurora-1,36,Site17,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,94.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.97,188.14,,151362.0,48026.0,86743.05554
Site17-Aurora-1,36,Site17,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.39,223.73,,153758.0,52430.0,88116.16346
Site17-Aurora-1,36,Site17,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.77,270.47,,154889.0,46990.0,88764.32083
Site17-Aurora-1,36,Site17,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,9.8,46.16,,56351.0,20181.0,32293.82489
Site17-Aurora-1,36,Site17,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.94,62.59,,53249.0,20242.0,30516.12006
Site17-Aurora-1,36,Site17,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,8.77,64.76,,54255.0,20150.0,31092.642
Site17-Aurora-1,36,Site17,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,60.5,285,,105932.0,45623.0,87681.82083
Site17-Aurora-1,36,Site17,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.98,441.12,,232867.0,142575.0,192748.2024
Site17-Aurora-1,36,Site17,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,62.06,458.16,,105353.0,46544.0,87202.57212
Site17-Aurora-1,36,Site17,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,68.01,193.82,,282899.0,76383.0,9670549.414
Site17-Aurora-1,36,Site17,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.86,303.74,,280301.0,77859.0,9581740.025
Site17-Aurora-1,36,Site17,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,67.37,308.65,,290613.0,77545.0,9934242.881
Site17-Aurora-1,36,Site17,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.4,719.53,,94452.0,25757.0,4188315.968
Site17-Aurora-1,36,Site17,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.77,1000.84,,89076.0,26715.0,3949926.239
Site17-Aurora-1,36,Site17,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.72,1103.47,,92694.0,25999.0,4110360.398
Site17-Aurora-1,36,Site17,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27.82,79.27,,254678.0,156765.0,1039798.056
Site17-Aurora-1,36,Site17,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.31,120.45,,218521.0,141633.0,892176.4385
Site17-Aurora-1,36,Site17,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.16,129.03,,234345.0,152706.0,956782.586
Site17-Aurora-1,36,Site17,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.98,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,29.72,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.25,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.15,66.68,,710413.0,575703.0,7655117.802
Site17-Aurora-1,36,Site17,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.93,90.59,,599914.0,558905.0,6464426.103
Site17-Aurora-1,36,Site17,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.48,99.5,,752743.0,603237.0,8111248.442
Site17-Aurora-1,36,Site17,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.48,922.54,,92847.0,26506.0,4117144.927
Site17-Aurora-1,36,Site17,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.24,1036.24,,95188.0,25041.0,4220952.657
Site17-Aurora-1,36,Site17,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,312.06,,172676.0,33748.0,7657028.417
Site17-Aurora-1,36,Site17,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,311.59,,170917.0,35506.0,7579028.504
Site17-Aurora-1,36,Site17,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.13,44.08,,249159.0,46749.0,142788.8966
Site17-Aurora-1,36,Site17,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,77.61,37.72,,238157.0,44439.0,136483.8326
Site17-Aurora-1,36,Site17,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,77.57,40.3,,237653.0,42083.0,136194.9986
Site17-Aurora-1,36,Site17,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.91,33.9,,77836.0,6271.0,44606.52258
Site17-Aurora-1,36,Site17,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.81,27.34,,70333.0,6027.0,7193.916413
Site17-Aurora-1,36,Site17,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.89,30.66,,72168.0,5919.0,41358.28565
Site17-Aurora-1,36,Site17,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.06,161.54,,176509.0,85633.0,146099.6726
Site17-Aurora-1,36,Site17,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,72.32,143.2,,188351.0,88508.0,155901.5089
Site17-Aurora-1,36,Site17,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,72.41,159.83,,177146.0,84552.0,146626.9289
Site17-Aurora-1,36,Site17,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.05,101.86,,880798.0,111222.0,30108980.88
Site17-Aurora-1,36,Site17,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.13,90.41,,888272.0,112188.0,30364470.25
Site17-Aurora-1,36,Site17,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.99,102.28,,856004.0,108893.0,29261428.92
Site17-Aurora-1,36,Site17,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,285.33,,108499.0,24079.0,4811206.689
Site17-Aurora-1,36,Site17,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,248.81,,108700.0,24187.0,4820119.698
Site17-Aurora-1,36,Site17,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,273.67,,105927.0,22518.0,4697155.651
Site17-Aurora-1,36,Site17,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,36.1,58.31,,753095.0,59883.0,3074732.474
Site17-Aurora-1,36,Site17,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.82,51.3,,737873.0,58246.0,3012584.169
Site17-Aurora-1,36,Site17,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.23,56.31,,735303.0,57780.0,3002091.386
Site17-Aurora-1,36,Site17,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.68,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.58,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.54,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.98,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.94,29.41,,11508.0,3001.0,124005.4668
Site17-Aurora-1,36,Site17,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,12.99,25.73,,12553.0,2929.0,135265.9562
Site17-Aurora-1,36,Site17,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.44,27.46,,10470.0,3000.0,112820.4064
Site17-Aurora-1,36,Site17,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.08,44.08,,247910.0,46538.0,142073.1154
Site17-Aurora-1,36,Site17,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,77.48,37.71,,236941.0,44166.0,135786.9632
Site17-Aurora-1,36,Site17,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,77.48,40.28,,236445.0,41804.0,135502.7138
Site17-Aurora-1,36,Site17,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.93,33.94,,78371.0,6305.0,44913.12222
Site17-Aurora-1,36,Site17,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.83,27.39,,70848.0,6053.0,40601.81551
Site17-Aurora-1,36,Site17,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.89,30.67,,72734.0,6002.0,41682.65087
Site17-Aurora-1,36,Site17,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.38,160,,177489.0,85890.0,146910.8362
Site17-Aurora-1,36,Site17,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,72.19,142.98,,189940.0,88941.0,157216.7527
Site17-Aurora-1,36,Site17,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,71.47,157.76,,178039.0,85100.0,147366.0811
Site17-Aurora-1,36,Site17,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,63.01,100.82,,877327.0,109967.0,29990329.08
Site17-Aurora-1,36,Site17,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.31,90.53,,886073.0,111517.0,30289300.18
Site17-Aurora-1,36,Site17,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.67,100.45,,852138.0,107184.0,29334377.05
Site17-Aurora-1,36,Site17,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,285.41,,111199.0,24152.0,4930933.673
Site17-Aurora-1,36,Site17,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,248.9,,111341.0,24294.0,4937230.426
Site17-Aurora-1,36,Site17,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,273.72,,108540.0,22715.0,4813024.766
Site17-Aurora-1,36,Site17,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,36.36,58.18,,755617.0,60240.0,3085029.283
Site17-Aurora-1,36,Site17,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.87,51.29,,739995.0,58298.0,3021247.86
Site17-Aurora-1,36,Site17,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.56,56.1,,737615.0,57763.0,3011530.808
Site17-Aurora-1,36,Site17,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.57,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.64,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,11.48,26.1,,13770.0,3320.0,148379.8468
Site17-Aurora-1,36,Site17,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,11.15,22.08,,15074.0,3312.0,162431.2136
Site17-Aurora-1,36,Site17,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,11.06,24.41,,12720.0,3208.0,137065.4794
Site17-Aurora-1,36,Site17,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.13,44.07,,248279.0,46643.0,142284.5832
Site17-Aurora-1,36,Site17,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,77.56,37.7,,237188.0,44287.0,135928.5148
Site17-Aurora-1,36,Site17,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,77.5,40.28,,236757.0,42046.0,135681.5158
Site17-Aurora-1,36,Site17,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.9,33.87,,74222.0,6032.0,42535.39903
Site17-Aurora-1,36,Site17,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,13.8,27.33,,66755.0,5771.0,38256.18499
Site17-Aurora-1,36,Site17,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.88,30.65,,68577.0,5743.0,39300.34302
Site17-Aurora-1,36,Site17,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,68.91,119.93,,146408.0,75051.0,121184.5337
Site17-Aurora-1,36,Site17,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,63.22,125.21,,173540.0,86070.0,143642.1779
Site17-Aurora-1,36,Site17,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,50.6,111.7,,141074.0,70705.0,116769.486
Site17-Aurora-1,36,Site17,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,50.76,60.87,,836494.0,99381.0,28594503.91
Site17-Aurora-1,36,Site17,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,58.1,72.75,,860825.0,99250.0,29426228.79
Site17-Aurora-1,36,Site17,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,48.84,54.55,,810426.0,95535.0,27703401.85
Site17-Aurora-1,36,Site17,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,285.33,,108937.0,24128.0,4830629.067
Site17-Aurora-1,36,Site17,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,248.42,,109100.0,24209.0,4837857.029
Site17-Aurora-1,36,Site17,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,273.67,,106313.0,22665.0,4714272.175
Site17-Aurora-1,36,Site17,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,48.76,58.48,,745280.0,56874.0,3042825.431
Site17-Aurora-1,36,Site17,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,41.12,51.48,,729979.0,57637.0,2980354.586
Site17-Aurora-1,36,Site17,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,50.55,56.47,,727673.0,57202.0,2970939.66
Site17-Aurora-1,36,Site17,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.68,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,19.52,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.53,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,18.99,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-1,36,Site17,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,10.83,24.62,,11878.0,3511.0,127992.4343
Site17-Aurora-1,36,Site17,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,9.94,19.69,,13556.0,3825.0,146073.871
Site17-Aurora-1,36,Site17,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,10.69,23.6,,10676.0,3150.0,115040.1775
Site17-Aurora-2,37,Site17,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,86.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.85,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,73.34,112.89,,,,60335.09574
Site17-Aurora-2,37,Site17,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,68.56,186.62,,,,60757.22099
Site17-Aurora-2,37,Site17,Aurora,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,73.31,37.18,,,,79993.4539
Site17-Aurora-2,37,Site17,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.56,63.25,,,,25985.19435
Site17-Aurora-2,37,Site17,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.55,111.36,,,,24957.25456
Site17-Aurora-2,37,Site17,Aurora,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.97,65.47,,,,33035.98254
Site17-Aurora-2,37,Site17,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,42.32,231.62,,,,65041.63115
Site17-Aurora-2,37,Site17,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,43.36,457.83,,,,67428.21559
Site17-Aurora-2,37,Site17,Aurora,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,35.22,115.48,,,,70215.53762
Site17-Aurora-2,37,Site17,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,48.73,112.87,,,,7734209.387
Site17-Aurora-2,37,Site17,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.22,216.21,,,,7841517.87
Site17-Aurora-2,37,Site17,Aurora,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.18,53.32,,,,7843339.342
Site17-Aurora-2,37,Site17,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.05,706.76,,,,3614428.858
Site17-Aurora-2,37,Site17,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,88.26,1327.47,,,,3726757.515
Site17-Aurora-2,37,Site17,Aurora,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.65,395.37,,,,3684264.529
Site17-Aurora-2,37,Site17,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44.2,102.38,,,,779906.6463
Site17-Aurora-2,37,Site17,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.96,205.86,,,,779385.7361
Site17-Aurora-2,37,Site17,Aurora,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,45.4,52.43,,,,873878.8337
Site17-Aurora-2,37,Site17,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,77.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,77.55,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,82.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.56,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,30.08,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.06,142.66,,,,3151096.517
Site17-Aurora-2,37,Site17,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,26.2,276.61,,,,3182115.718
Site17-Aurora-2,37,Site17,Aurora,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.39,93.11,,,,44050530.79
Site17-Aurora-2,37,Site17,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,85.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,73.8,110.41,,,,59732.16259
Site17-Aurora-2,37,Site17,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,70.14,192.44,,,,88124.04711
Site17-Aurora-2,37,Site17,Aurora,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,77.72,36.87,,,,79792.47619
Site17-Aurora-2,37,Site17,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.95,65.41,,,,25213.69924
Site17-Aurora-2,37,Site17,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.86,114.64,,,,27135.59369
Site17-Aurora-2,37,Site17,Aurora,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,20.82,68.91,,,,32292.58109
Site17-Aurora-2,37,Site17,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,41.39,226.69,,,,65565.88374
Site17-Aurora-2,37,Site17,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,42.7,450.85,,,,67428.21559
Site17-Aurora-2,37,Site17,Aurora,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,34.68,114.78,,,,70583.33787
Site17-Aurora-2,37,Site17,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,49.5,112.21,,,,7836726.606
Site17-Aurora-2,37,Site17,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,48.02,216.52,,,,8488298.96
Site17-Aurora-2,37,Site17,Aurora,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,46.64,53.53,,,,7937422.351
Site17-Aurora-2,37,Site17,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.06,690.03,,,,3644585.17
Site17-Aurora-2,37,Site17,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,87.34,1312.72,,,,3791615.23
Site17-Aurora-2,37,Site17,Aurora,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.58,397.89,,,,3653242.485
Site17-Aurora-2,37,Site17,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,42.98,97.43,,,,766039.4703
Site17-Aurora-2,37,Site17,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.7,197.04,,,,819704.1802
Site17-Aurora-2,37,Site17,Aurora,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44.45,51.02,,,,852779.2318
Site17-Aurora-2,37,Site17,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,77.54,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,77.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,83,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.48,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,21.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,11.92,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.42,144.66,,,,3143933.071
Site17-Aurora-2,37,Site17,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,26.36,278.29,,,,4682286.513
Site17-Aurora-2,37,Site17,Aurora,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,28.26,93.55,,,,4434455.464
Site17-Aurora-2,37,Site17,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,82.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,93.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,90.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,73.36,106.6,,,,60757.22099
Site17-Aurora-2,37,Site17,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,68.11,187.03,,,,88124.04711
Site17-Aurora-2,37,Site17,Aurora,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,73.91,39.77,,,,79904.85082
Site17-Aurora-2,37,Site17,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.41,59.16,,,,24957.25456
Site17-Aurora-2,37,Site17,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.77,108.4,,,,27135.59369
Site17-Aurora-2,37,Site17,Aurora,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,19.76,62.65,,,,30621.36853
Site17-Aurora-2,37,Site17,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,42.11,218.32,,,,65247.4895
Site17-Aurora-2,37,Site17,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,43.17,434.61,,,,68360.06771
Site17-Aurora-2,37,Site17,Aurora,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,35.26,111.79,,,,70562.75203
Site17-Aurora-2,37,Site17,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,49.37,107.79,,,,7841517.87
Site17-Aurora-2,37,Site17,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.33,205.68,,,,8656468.379
Site17-Aurora-2,37,Site17,Aurora,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,47.4,52.99,,,,7920553.933
Site17-Aurora-2,37,Site17,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99.11,679.35,,,,3726757.515
Site17-Aurora-2,37,Site17,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,87.44,1314.6,,,,10914276.55
Site17-Aurora-2,37,Site17,Aurora,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.93,386.72,,,,3747318.637
Site17-Aurora-2,37,Site17,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,42.85,93.55,,,,779385.7361
Site17-Aurora-2,37,Site17,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,44.35,192.75,,,,829530.1902
Site17-Aurora-2,37,Site17,Aurora,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,44.39,49.62,,,,862045.9488
Site17-Aurora-2,37,Site17,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,76.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,76.59,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,81.98,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,21.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,20.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,13.91,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,26.33,136.49,,,,3182115.718
Site17-Aurora-2,37,Site17,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,26.28,264.59,,,,4764041.191
Site17-Aurora-2,37,Site17,Aurora,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,27.75,87.97,,,,4592158.801
Site17-Aurora-2,37,Site17,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.67,1267.83,,,,3845434.87
Site17-Aurora-2,37,Site17,Aurora,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.76,533.03,,,,3724088.176
Site17-Aurora-2,37,Site17,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,94.21,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,90.94,394.22,,,,74522.3938
Site17-Aurora-2,37,Site17,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.76,281.54,,97381.0,30458.0,70148.42712
Site17-Aurora-2,37,Site17,Aurora,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.65,368.31,,102791.0,27548.0,74045.52194
Site17-Aurora-2,37,Site17,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.28,113.81,,,,30982.264
Site17-Aurora-2,37,Site17,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,20.3,155.93,,,,31641.38447
Site17-Aurora-2,37,Site17,Aurora,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.71,132.6,,,,30376.44944
Site17-Aurora-2,37,Site17,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,68.55,546.22,,,,111643.8439
Site17-Aurora-2,37,Site17,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62.38,479.12,,,,106025.2834
Site17-Aurora-2,37,Site17,Aurora,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.37,551.82,,,,110916.4777
Site17-Aurora-2,37,Site17,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.37,389.82,,,,10445471.05
Site17-Aurora-2,37,Site17,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.44,342.27,,,,9709002.245
Site17-Aurora-2,37,Site17,Aurora,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.2,398.4,,,,10410625.49
Site17-Aurora-2,37,Site17,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.86,1260.3,,,,3963607.214
Site17-Aurora-2,37,Site17,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.91,1107.79,,52836.0,13911.0,3811815.631
Site17-Aurora-2,37,Site17,Aurora,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.28,1253.84,,54906.0,13064.0,3961154.309
Site17-Aurora-2,37,Site17,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.25,143.36,,,,1128296.824
Site17-Aurora-2,37,Site17,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.8,123.61,,,,1133566.242
Site17-Aurora-2,37,Site17,Aurora,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.31,139.64,,,,1211724.694
Site17-Aurora-2,37,Site17,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,55.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,68.63,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,66.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,32.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,32.28,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.3,106,,,,10007764.48
Site17-Aurora-2,37,Site17,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.76,105.72,,,,9352880.346
Site17-Aurora-2,37,Site17,Aurora,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.44,121.88,,,,10309811.93
Site17-Aurora-2,37,Site17,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,95.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,96.66,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.56,392.68,,,,72750.3322
Site17-Aurora-2,37,Site17,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.99,268.2,,,,68530.52047
Site17-Aurora-2,37,Site17,Aurora,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,86.62,359.89,,,,72629.31336
Site17-Aurora-2,37,Site17,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.35,116.45,,,,29581.18277
Site17-Aurora-2,37,Site17,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,20.44,159.77,,,,30345.47438
Site17-Aurora-2,37,Site17,Aurora,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.96,132.73,,,,29040.19974
Site17-Aurora-2,37,Site17,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,67.38,546.71,,,,111643.8439
Site17-Aurora-2,37,Site17,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.13,477.87,,,,107740.7696
Site17-Aurora-2,37,Site17,Aurora,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,65.22,542.38,,,,112777.4372
Site17-Aurora-2,37,Site17,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.66,391.77,,,,10572974.12
Site17-Aurora-2,37,Site17,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,71.8,343.11,,,,9822567.089
Site17-Aurora-2,37,Site17,Aurora,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.56,393.54,,,,30445198.39
Site17-Aurora-2,37,Site17,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.88,1273.12,,,,3946509.018
Site17-Aurora-2,37,Site17,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.85,1121.07,,,,3791326.653
Site17-Aurora-2,37,Site17,Aurora,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,98.2,1264.75,,,,3947230.461
Site17-Aurora-2,37,Site17,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.02,142.23,,,,1114659.945
Site17-Aurora-2,37,Site17,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.75,123.07,,,,1132557.321
Site17-Aurora-2,37,Site17,Aurora,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,24.97,135.44,,,,4215928.561
Site17-Aurora-2,37,Site17,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,69.73,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,65.75,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,35.23,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,27.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,32.11,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.92,112.9,,,,10191447.07
Site17-Aurora-2,37,Site17,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.39,112.47,,,,9163660.534
Site17-Aurora-2,37,Site17,Aurora,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.25,118.54,,,,2956890.517
Site17-Aurora-2,37,Site17,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,96.09,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.64,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.47,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.16,390.37,,,,72862.70684
Site17-Aurora-2,37,Site17,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.21,282.57,,,,68184.75235
Site17-Aurora-2,37,Site17,Aurora,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,88.2,363.73,,,,72635.07616
Site17-Aurora-2,37,Site17,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.08,108.2,,,,29025.07238
Site17-Aurora-2,37,Site17,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,18,128.05,,,,28515.06441
Site17-Aurora-2,37,Site17,Aurora,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,15.81,124.09,,,,29179.94769
Site17-Aurora-2,37,Site17,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,69.1,530.95,,,,110267.3377
Site17-Aurora-2,37,Site17,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,66.28,471.43,,,,106913.2191
Site17-Aurora-2,37,Site17,Aurora,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,67.83,532.43,,,,111682.2708
Site17-Aurora-2,37,Site17,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,71.78,381.13,,,,10511281.64
Site17-Aurora-2,37,Site17,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,72.03,339.56,,,,9804352.365
Site17-Aurora-2,37,Site17,Aurora,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,72.48,385.91,,,,10499679.65
Site17-Aurora-2,37,Site17,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.62,1242.28,,,,4042749.499
Site17-Aurora-2,37,Site17,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.5,1075.45,,,,3864192.385
Site17-Aurora-2,37,Site17,Aurora,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,97.63,1226.55,,,,4036400.802
Site17-Aurora-2,37,Site17,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,26.35,139.92,,,,11133313.5
Site17-Aurora-2,37,Site17,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.94,122.31,,,,1120335.124
Site17-Aurora-2,37,Site17,Aurora,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,25.51,135.83,,,,1193514.773
Site17-Aurora-2,37,Site17,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.86,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,66.14,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,64,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,35.64,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.45,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,33.62,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.84,98.65,,,,10079842.46
Site17-Aurora-2,37,Site17,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.72,83.34,,,,7089634.528
Site17-Aurora-2,37,Site17,Aurora,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,12.84,100.77,,,,9842064.43
Site17-Aurora-2,37,Site17,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.25,863.73,,,,3983519.038
Site17-Aurora-2,37,Site17,Aurora,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.5,598.77,,,,4017066.132
Site17-Aurora-2,37,Site17,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.15,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.02,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,84.15,214.95,,,,87585.22513
Site17-Aurora-2,37,Site17,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,86.32,235.45,,,,88608.12247
Site17-Aurora-2,37,Site17,Aurora,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.41,312.92,,,,91510.41361
Site17-Aurora-2,37,Site17,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.12,5.67,,,,32199.65591
Site17-Aurora-2,37,Site17,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.11,84.72,,,,31410.15204
Site17-Aurora-2,37,Site17,Aurora,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.9,96.69,,,,33044.62675
Site17-Aurora-2,37,Site17,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.66,314.74,,,,1109149.265
Site17-Aurora-2,37,Site17,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,62,472.75,,,,91471.09821
Site17-Aurora-2,37,Site17,Aurora,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,60.87,540.16,,,,94788.16239
Site17-Aurora-2,37,Site17,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,66.79,210.21,,,,10320185.43
Site17-Aurora-2,37,Site17,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,67.2,317.68,,,,9907423.945
Site17-Aurora-2,37,Site17,Aurora,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,65.33,352.91,,,,10174428.04
Site17-Aurora-2,37,Site17,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.21,765.18,,,,4224985.972
Site17-Aurora-2,37,Site17,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.48,1027.68,,,,4006100.2
Site17-Aurora-2,37,Site17,Aurora,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.23,1232.54,,,,4161282.565
Site17-Aurora-2,37,Site17,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27.74,87.3,,,,1109149.265
Site17-Aurora-2,37,Site17,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.5,130.02,,,,937024.1079
Site17-Aurora-2,37,Site17,Aurora,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,29.31,158.32,,,,1023029.112
Site17-Aurora-2,37,Site17,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.37,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,76.76,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,70.95,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,32.85,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.97,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.05,84.67,,,,7993639.94
Site17-Aurora-2,37,Site17,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.54,110.89,,,,6660593.825
Site17-Aurora-2,37,Site17,Aurora,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.93,132.48,,,,8480095.732
Site17-Aurora-2,37,Site17,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,92.69,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,92.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,95.12,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.48,209.78,,,,85829.01123
Site17-Aurora-2,37,Site17,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.05,226.29,,,,87464.92664
Site17-Aurora-2,37,Site17,Aurora,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,87.81,299.19,,,,90302.38625
Site17-Aurora-2,37,Site17,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.29,52.89,,,,31091.75723
Site17-Aurora-2,37,Site17,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.33,76.95,,,,30439.84026
Site17-Aurora-2,37,Site17,Aurora,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,10.21,88.26,,,,30993.7896
Site17-Aurora-2,37,Site17,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.18,299.15,,,,96874.19365
Site17-Aurora-2,37,Site17,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,60.64,451.9,,,,92986.21565
Site17-Aurora-2,37,Site17,Aurora,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,59.73,516.23,,,,96190.74393
Site17-Aurora-2,37,Site17,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,69.34,207.45,,,,10421079.16
Site17-Aurora-2,37,Site17,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,69.3,313.15,,,,10014257.26
Site17-Aurora-2,37,Site17,Aurora,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,67.48,348.37,,,,10278410.36
Site17-Aurora-2,37,Site17,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.13,771.47,,,,4199519.038
Site17-Aurora-2,37,Site17,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.64,1032.98,,,,2350028.056
Site17-Aurora-2,37,Site17,Aurora,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,96.96,1249.27,,,,4134444.89
Site17-Aurora-2,37,Site17,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25.76,77.07,,,,1093527.444
Site17-Aurora-2,37,Site17,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25.92,117.14,,,,914356.2924
Site17-Aurora-2,37,Site17,Aurora,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,27.17,140.25,,,,995311.2098
Site17-Aurora-2,37,Site17,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,66.65,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,72.14,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,69.18,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,30.39,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,25.17,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,27.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.55,79.97,,,,7717598.622
Site17-Aurora-2,37,Site17,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.14,105.4,,,,6389794.053
Site17-Aurora-2,37,Site17,Aurora,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,14.62,126.35,,,,8236216.003
Site17-Aurora-2,37,Site17,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,91.42,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,91.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,94.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,88.78,211.96,,,,85933.46202
Site17-Aurora-2,37,Site17,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.73,232.18,,,,87568.65707
Site17-Aurora-2,37,Site17,Aurora,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,89.14,309.73,,,,90427.00684
Site17-Aurora-2,37,Site17,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10,48.57,,,,31076.62988
Site17-Aurora-2,37,Site17,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.08,72.3,,,,30334.66913
Site17-Aurora-2,37,Site17,Aurora,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,9.91,81.67,,,,30523.40089
Site17-Aurora-2,37,Site17,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,62.03,301.42,,,,95879.21163
Site17-Aurora-2,37,Site17,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63.26,453.94,,,,92129.84493
Site17-Aurora-2,37,Site17,Aurora,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,62.4,514.35,,,,95769.42051
Site17-Aurora-2,37,Site17,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,68.12,205.34,,,,10393044.33
Site17-Aurora-2,37,Site17,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.16,309.41,,,,9997626.426
Site17-Aurora-2,37,Site17,Aurora,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,66.63,342.71,,,,102936473.7
Site17-Aurora-2,37,Site17,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,97.71,748.92,,,,4279671.343
Site17-Aurora-2,37,Site17,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.22,1005.82,,,,4070020.04
Site17-Aurora-2,37,Site17,Aurora,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,95.85,1206.25,,,,4224192.385
Site17-Aurora-2,37,Site17,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27.5,82.89,,,,1083317.605
Site17-Aurora-2,37,Site17,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.46,124.67,,,,909646.1682
Site17-Aurora-2,37,Site17,Aurora,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,28.84,148.32,,,,996775.2414
Site17-Aurora-2,37,Site17,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,71.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,68.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,31.88,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,26.31,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,28.81,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.98,67.95,,,,7294431.139
Site17-Aurora-2,37,Site17,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.15,94.34,,,,6167660.02
Site17-Aurora-2,37,Site17,Aurora,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,13.62,112.25,,,,7994419.452
Site17-Aurora-2,37,Site17,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.7,698.23,,,,4169795.591
Site17-Aurora-2,37,Site17,Aurora,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.46,732.2,,,,4274332.665
Site17-Aurora-2,37,Site17,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,226.77,,,,6662380.762
Site17-Aurora-2,37,Site17,Aurora,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,257.03,,,,6338020.04
Site17-Aurora-2,37,Site17,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.41,35.23,,,,131297.5186
Site17-Aurora-2,37,Site17,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,80.33,39.27,,,,123858.4617
Site17-Aurora-2,37,Site17,Aurora,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,77.68,30.24,,,,34491.09004
Site17-Aurora-2,37,Site17,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.47,28.59,,,,40188.34012
Site17-Aurora-2,37,Site17,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.29,28.56,,,,35546.40314
Site17-Aurora-2,37,Site17,Aurora,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.73,24.23,,,,120771.0405
Site17-Aurora-2,37,Site17,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.98,142.21,,,,130931.3987
Site17-Aurora-2,37,Site17,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.79,143.51,,,,146734.4578
Site17-Aurora-2,37,Site17,Aurora,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,72.11,127.19,,,,159230.0596
Site17-Aurora-2,37,Site17,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.5,91.73,,,,28085282.91
Site17-Aurora-2,37,Site17,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.88,91.67,,,,27978568.39
Site17-Aurora-2,37,Site17,Aurora,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.79,81.14,,,,24900636.41
Site17-Aurora-2,37,Site17,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,242.94,,,,4201178.357
Site17-Aurora-2,37,Site17,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,250.98,,,,4180977.956
Site17-Aurora-2,37,Site17,Aurora,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,217.58,,,,3845002.004
Site17-Aurora-2,37,Site17,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.73,49.39,,,,2569704.503
Site17-Aurora-2,37,Site17,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.36,50.75,,,,2475381.386
Site17-Aurora-2,37,Site17,Aurora,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,45.2,,,,2279584.977
Site17-Aurora-2,37,Site17,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,81.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.65,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,81.07,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.48,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,17.89,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.45,24.6,,,,126388.4587
Site17-Aurora-2,37,Site17,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,12.4,24.8,,,,133000.8707
Site17-Aurora-2,37,Site17,Aurora,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.31,21.71,,,,107223.2161
Site17-Aurora-2,37,Site17,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.77,34.77,,,,119991.6216
Site17-Aurora-2,37,Site17,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,76.81,39.47,,,,113220.3293
Site17-Aurora-2,37,Site17,Aurora,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,72.38,30.47,,,,110290.6648
Site17-Aurora-2,37,Site17,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.47,28.63,,,,35096.18424
Site17-Aurora-2,37,Site17,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.25,28.46,,,,30844.6771
Site17-Aurora-2,37,Site17,Aurora,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.68,24.23,,,,29898.85723
Site17-Aurora-2,37,Site17,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,72.09,142.64,,,,136486.8293
Site17-Aurora-2,37,Site17,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.84,143.47,,,,152892.3672
Site17-Aurora-2,37,Site17,Aurora,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,72.45,128.36,,,,165356.404
Site17-Aurora-2,37,Site17,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.05,92.79,,,,29694237
Site17-Aurora-2,37,Site17,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,64.33,92.3,,,,29565862.79
Site17-Aurora-2,37,Site17,Aurora,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.94,82.07,,,,26327166.08
Site17-Aurora-2,37,Site17,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,244.46,,,,4172897.796
Site17-Aurora-2,37,Site17,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,253.53,,,,4141226.453
Site17-Aurora-2,37,Site17,Aurora,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,221.32,,,,4002925.852
Site17-Aurora-2,37,Site17,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.9,49.79,,,,2618083.346
Site17-Aurora-2,37,Site17,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,35.58,51.05,,,,2521457.258
Site17-Aurora-2,37,Site17,Aurora,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,35.98,46.19,,,,2314211.792
Site17-Aurora-2,37,Site17,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,80.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,78.77,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.83,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,20.27,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.03,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.59,24.92,,,,129009.2318
Site17-Aurora-2,37,Site17,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,11.59,23.15,,,,139519.2036
Site17-Aurora-2,37,Site17,Aurora,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.42,22,,,,109884.3087
Site17-Aurora-2,37,Site17,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.34,35.33,,,,35096.18424
Site17-Aurora-2,37,Site17,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,78.7,39.37,,,,123541.5076
Site17-Aurora-2,37,Site17,Aurora,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,73.55,30.85,,,,120390.6956
Site17-Aurora-2,37,Site17,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.48,28.52,,,,119991.6216
Site17-Aurora-2,37,Site17,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,14.28,28.43,,,,34791.47609
Site17-Aurora-2,37,Site17,Aurora,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,13.71,24.1,,,,33795.95205
Site17-Aurora-2,37,Site17,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,71.68,141.17,,,,131429.5759
Site17-Aurora-2,37,Site17,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,71.69,142.77,,,,147426.1419
Site17-Aurora-2,37,Site17,Aurora,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,72.33,127.14,,,,159799.601
Site17-Aurora-2,37,Site17,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.27,90.73,,,,28160042.47
Site17-Aurora-2,37,Site17,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,63.48,90.63,,,,28073403.74
Site17-Aurora-2,37,Site17,Aurora,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,63.65,80.93,,,,24952904.75
Site17-Aurora-2,37,Site17,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,242.99,,,,4380240.481
Site17-Aurora-2,37,Site17,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,251.02,,,,4355783.567
Site17-Aurora-2,37,Site17,Aurora,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,218.53,,,,4002925.852
Site17-Aurora-2,37,Site17,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.57,48.8,,,,2539765.878
Site17-Aurora-2,37,Site17,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,34.42,49.14,,,,2445179.565
Site17-Aurora-2,37,Site17,Aurora,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,36.03,45.81,,,,2242030.098
Site17-Aurora-2,37,Site17,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,81.05,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,79.34,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,80.44,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.33,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,19.93,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,19.19,Not reportable,Not reportable,Not reportable,Not reportable,
Site17-Aurora-2,37,Site17,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,12.5,24.61,,,,126926.0532
Site17-Aurora-2,37,Site17,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,12.33,24.57,,,,134358.2967
Site17-Aurora-2,37,Site17,Aurora,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,12.28,21.59,,,,107895.2091
Site18-CytoflexS,38,Site18,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.2,8302,601,123914.0,63350.0,27200
Site18-CytoflexS,38,Site18,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,91.1,10358,916,92675.0,35932.0,29400
Site18-CytoflexS,38,Site18,CytoflexS,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.1,4280,310,36248.0,14226.0,183000
Site18-CytoflexS,38,Site18,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.8,4190,370,32089.0,13470.0,192000
Site18-CytoflexS,38,Site18,CytoflexS,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,68.4,18953,1372,61312.0,24663.0,504
Site18-CytoflexS,38,Site18,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,59.8,16938,1497,54754.0,22191.0,628
Site18-CytoflexS,38,Site18,CytoflexS,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,49.5,9375,679,137966.0,32975.0,8930000
Site18-CytoflexS,38,Site18,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,43.1,8188,724,134658.0,33492.0,8980000
Site18-CytoflexS,38,Site18,CytoflexS,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.8,47597,3446,52192.0,17347.0,1810000
Site18-CytoflexS,38,Site18,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.8,47395,4190,46627.0,15618.0,1880000
Site18-CytoflexS,38,Site18,CytoflexS,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,43.8,8295,601,148903.0,72442.0,138
Site18-CytoflexS,38,Site18,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,48.3,7298,645,121366.0,65964.0,146
Site18-CytoflexS,38,Site18,CytoflexS,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15,4888,354,39593.0,61500.0,9040
Site18-CytoflexS,38,Site18,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.6,4143,366,21595.0,39072.0,8860
Site18-CytoflexS,38,Site18,CytoflexS,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,82.4,8110,580,126955.0,61079.0,43900
Site18-CytoflexS,38,Site18,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.3,10094,892,93640.0,34587.0,419000
Site18-CytoflexS,38,Site18,CytoflexS,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.2,4691,336,36743.0,15142.0,133000
Site18-CytoflexS,38,Site18,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,16.5,4743,419,33305.0,16071.0,152000
Site18-CytoflexS,38,Site18,CytoflexS,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,59.3,19607,1403,62160.0,24782.0,39700
Site18-CytoflexS,38,Site18,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,59.7,17125,1513,55509.0,22381.0,41300
Site18-CytoflexS,38,Site18,CytoflexS,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,47.9,9398,672,138925.0,32904.0,446000
Site18-CytoflexS,38,Site18,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,47.5,8130,718,135126.0,33549.0,449000
Site18-CytoflexS,38,Site18,CytoflexS,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99,48666,3482,53275.0,17719.0,12900
Site18-CytoflexS,38,Site18,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.2,47924,4233,47591.0,15842.0,12700
Site18-CytoflexS,38,Site18,CytoflexS,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44.1,8656,619,148903.0,72556.0,36100
Site18-CytoflexS,38,Site18,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,42.7,7316,646,121787.0,64451.0,38900
Site18-CytoflexS,38,Site18,CytoflexS,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,20.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15,8110,580,42526.0,62868.0,67200
Site18-CytoflexS,38,Site18,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.5,4164,368,23552.0,40092.0,83200
Site18-CytoflexS,38,Site18,CytoflexS,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,89.4,6981,577,126955.0,61275.0,175
Site18-CytoflexS,38,Site18,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.9,7924,997,93964.0,34490.0,104
Site18-CytoflexS,38,Site18,CytoflexS,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,13.7,3408,282,36248.0,14740.0,0.0901
Site18-CytoflexS,38,Site18,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.7,2964,373,32197.0,14186.0,0.0537
Site18-CytoflexS,38,Site18,CytoflexS,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,58.2,17892,1479,61523.0,24680.0,2110
Site18-CytoflexS,38,Site18,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,59.5,14490,1823,54942.0,22269.0,0.263
Site18-CytoflexS,38,Site18,CytoflexS,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,49.4,8155,674,137966.0,32975.0,12.1
Site18-CytoflexS,38,Site18,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,48.6,6683,841,134192.0,33492.0,0.0109
Site18-CytoflexS,38,Site18,CytoflexS,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,99,43320,3582,53093.0,17050.0,494
Site18-CytoflexS,38,Site18,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.1,38005,4782,47429.0,15573.0,494
Site18-CytoflexS,38,Site18,CytoflexS,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44.2,8272,684,148387.0,73695.0,508000
Site18-CytoflexS,38,Site18,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,43.7,6598,830,120528.0,67349.0,3430
Site18-CytoflexS,38,Site18,CytoflexS,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,68.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.3,4070,337,40685.0,62483.0,249
Site18-CytoflexS,38,Site18,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,14.7,3559,448,22476.0,39740.0,0.107
Site18-CytoflexS,38,Site18,CytoflexS,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.3,8203,3446,67501.0,20549.0,12900
Site18-CytoflexS,38,Site18,CytoflexS,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.9,8533,4190,69145.0,20000.0,12900
Site18-CytoflexS,38,Site18,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.3,8736,931,106044.0,31143.0,27200
Site18-CytoflexS,38,Site18,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,94.7,10084,4700,89222.0,24041.0,29400
Site18-CytoflexS,38,Site18,CytoflexS,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.4,6179,658,37754.0,12894.0,209000
Site18-CytoflexS,38,Site18,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.9,3784,1764,36619.0,12414.0,222000
Site18-CytoflexS,38,Site18,CytoflexS,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75,26310,2802,81289.0,30756.0,669
Site18-CytoflexS,38,Site18,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.3,14257,1671,79352.0,29310.0,998
Site18-CytoflexS,38,Site18,CytoflexS,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.9,19452,2072,146851.0,29123.0,9570000
Site18-CytoflexS,38,Site18,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.7,10507,4897,148387.0,30269.0,9650000
Site18-CytoflexS,38,Site18,CytoflexS,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.5,48312,5146,54380.0,13104.0,2400000
Site18-CytoflexS,38,Site18,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.8,33655,3944,53458.0,14652.0,0.259
Site18-CytoflexS,38,Site18,CytoflexS,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.7,6493,692,152563.0,48210.0,136
Site18-CytoflexS,38,Site18,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.7,3522,1642,141846.0,45714.0,153
Site18-CytoflexS,38,Site18,CytoflexS,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.84,2138,228,57052.0,69694.0,9220
Site18-CytoflexS,38,Site18,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.1,1419,661,53825.0,62943.0,9380
Site18-CytoflexS,38,Site18,CytoflexS,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,99.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,93,8973,956,106412.0,30506.0,46000
Site18-CytoflexS,38,Site18,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,96.1,10000,1177,89222.0,25593.0,5860
Site18-CytoflexS,38,Site18,CytoflexS,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.7,6271,668,37883.0,13292.0,93400
Site18-CytoflexS,38,Site18,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.4,4033,475,37119.0,13424.0,118000
Site18-CytoflexS,38,Site18,CytoflexS,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.2,26271,2800,81852.0,30971.0,52700
Site18-CytoflexS,38,Site18,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.2,14292,1682,79626.0,29229.0,47800
Site18-CytoflexS,38,Site18,CytoflexS,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.9,19431,2071,147361.0,29537.0,480000
Site18-CytoflexS,38,Site18,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.6,10552,1242,148903.0,30691.0,463000
Site18-CytoflexS,38,Site18,CytoflexS,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.5,48645,5184,54942.0,13360.0,0.0141
Site18-CytoflexS,38,Site18,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,65.8,33837,3982,54195.0,14910.0,12900
Site18-CytoflexS,38,Site18,CytoflexS,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.7,6493,692,152035.0,48599.0,36200
Site18-CytoflexS,38,Site18,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.6,3525,415,143155.0,46067.0,37400
Site18-CytoflexS,38,Site18,CytoflexS,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.18,2190,233,62803.0,75279.0,88400
Site18-CytoflexS,38,Site18,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.63,1517,179,58638.0,66216.0,59200
Site18-CytoflexS,38,Site18,CytoflexS,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.3,7489,912,106412.0,30378.0,175
Site18-CytoflexS,38,Site18,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,94.6,6608,1352,89531.0,23562.0,175
Site18-CytoflexS,38,Site18,CytoflexS,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,17.5,4920,599,37754.0,13025.0,0.0901
Site18-CytoflexS,38,Site18,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.1,2481,508,36743.0,12629.0,0.0901
Site18-CytoflexS,38,Site18,CytoflexS,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,74.7,22262,2711,81570.0,30958.0,2110
Site18-CytoflexS,38,Site18,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70.9,9817,2008,79352.0,29219.0,2110
Site18-CytoflexS,38,Site18,CytoflexS,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.9,16344,1990,146343.0,29331.0,12.1
Site18-CytoflexS,38,Site18,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.7,7195,1472,148387.0,30269.0,12.1
Site18-CytoflexS,38,Site18,CytoflexS,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.9,42044,5120,54754.0,13217.0,494
Site18-CytoflexS,38,Site18,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.2,23777,4864,54009.0,14657.0,494
Site18-CytoflexS,38,Site18,CytoflexS,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.8,5589,681,152035.0,48405.0,-508000
Site18-CytoflexS,38,Site18,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.8,2459,503,141355.0,45891.0,494
Site18-CytoflexS,38,Site18,CytoflexS,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,72.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.17,1721,210,62373.0,75994.0,0.0231
Site18-CytoflexS,38,Site18,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.48,969,198,56662.0,66413.0,0.263
Site18-CytoflexS,38,Site18,CytoflexS,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,99.1,8675,5146,72307.0,21311.0,13200
Site18-CytoflexS,38,Site18,CytoflexS,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,98.6,8410,3944,69622.0,21536.0,13200
Site18-CytoflexS,38,Site18,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.4,11271,1077,101384.0,34878.0,14300
Site18-CytoflexS,38,Site18,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.9,10835,1238,88304.0,28094.0,27800
Site18-CytoflexS,38,Site18,CytoflexS,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11,3264,312,38271.0,14552.0,200000
Site18-CytoflexS,38,Site18,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.4,3212,367,36125.0,13750.0,206000
Site18-CytoflexS,38,Site18,CytoflexS,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,73.8,21847,2088,69622.0,26418.0,160
Site18-CytoflexS,38,Site18,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.8,20775,2373,67733.0,25446.0,539
Site18-CytoflexS,38,Site18,CytoflexS,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,68.4,14938,1428,139892.0,33837.0,7780000
Site18-CytoflexS,38,Site18,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.4,14253,1628,139408.0,33719.0,9260000
Site18-CytoflexS,38,Site18,CytoflexS,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.3,48028,4590,51132.0,15604.0,-1850000
Site18-CytoflexS,38,Site18,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97,46918,5360,50094.0,15174.0,-2160000
Site18-CytoflexS,38,Site18,CytoflexS,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28.2,6171,590,132804.0,68143.0,146
Site18-CytoflexS,38,Site18,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,27.9,5805,663,128727.0,64200.0,151
Site18-CytoflexS,38,Site18,CytoflexS,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.47,2507,240,37883.0,57352.0,9090
Site18-CytoflexS,38,Site18,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.51,2396,274,27387.0,50180.0,9010
Site18-CytoflexS,38,Site18,CytoflexS,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,97.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.2,11156,1075,102087.0,33227.0,
Site18-CytoflexS,38,Site18,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.6,11156,1274,88915.0,27166.0,
Site18-CytoflexS,38,Site18,CytoflexS,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12,3617,349,38926.0,15865.0,
Site18-CytoflexS,38,Site18,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.6,3617,413,37119.0,15389.0,
Site18-CytoflexS,38,Site18,CytoflexS,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,73.6,22214,2141,70103.0,26443.0,
Site18-CytoflexS,38,Site18,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.3,20958,2393,68201.0,25468.0,
Site18-CytoflexS,38,Site18,CytoflexS,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,67.4,14983,1444,140387.0,34074.0,
Site18-CytoflexS,38,Site18,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,67.9,14983,1711,139892.0,33644.0,
Site18-CytoflexS,38,Site18,CytoflexS,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.6,48337,4658,52014.0,15750.0,
Site18-CytoflexS,38,Site18,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.5,47262,5396,50784.0,15379.0,
Site18-CytoflexS,38,Site18,CytoflexS,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28.7,6376,614,134192.0,69339.0,
Site18-CytoflexS,38,Site18,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.1,6376,728,129622.0,64630.0,
Site18-CytoflexS,38,Site18,CytoflexS,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,62.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,25,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.85,2668,257,43552.0,61650.0,
Site18-CytoflexS,38,Site18,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.71,2668,305,31551.0,54330.0,
Site18-CytoflexS,38,Site18,CytoflexS,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,96.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.7,8093,1035,102441.0,33112.0,
Site18-CytoflexS,38,Site18,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.3,4604,1409,89222.0,27366.0,
Site18-CytoflexS,38,Site18,CytoflexS,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,11.4,2208,282,38271.0,15202.0,
Site18-CytoflexS,38,Site18,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.9,1035,317,36371.0,14249.0,
Site18-CytoflexS,38,Site18,CytoflexS,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,73.5,16725,2140,69622.0,26259.0,
Site18-CytoflexS,38,Site18,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,73.5,7463,2284,67733.0,25369.0,
Site18-CytoflexS,38,Site18,CytoflexS,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,68.5,11072,1417,139892.0,33837.0,
Site18-CytoflexS,38,Site18,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.7,5057,1548,139408.0,33719.0,
Site18-CytoflexS,38,Site18,CytoflexS,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,98.8,37502,4798,51836.0,15567.0,
Site18-CytoflexS,38,Site18,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,97.6,17649,5401,50610.0,15201.0,
Site18-CytoflexS,38,Site18,CytoflexS,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,28.5,5035,644,132804.0,68975.0,
Site18-CytoflexS,38,Site18,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.2,2147,657,128727.0,65458.0,
Site18-CytoflexS,38,Site18,CytoflexS,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,61.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,59.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,24.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.9,1725,221,42237.0,61955.0,
Site18-CytoflexS,38,Site18,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.81,728,223,29692.0,53471.0,
Site18-CytoflexS,38,Site18,CytoflexS,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,98.4,8571,4590,68671.0,19951.0,-1850000
Site18-CytoflexS,38,Site18,CytoflexS,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,99.8,8682,5360,71811.0,21328.0,-1850000
Site18-CytoflexS,38,Site18,CytoflexS,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,20093,1873.585176,105314.0,50041.0,21300
Site18-CytoflexS,38,Site18,CytoflexS,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.6,26203,2107,29393.0,6559.0,43100
Site18-CytoflexS,38,Site18,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.1,6955,559,32525.0,2984.0,29300
Site18-CytoflexS,38,Site18,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.5,12654,1017,137488.0,47269.0,142000
Site18-CytoflexS,38,Site18,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.1,8106,652,217436.0,30240.0,1350000
Site18-CytoflexS,38,Site18,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,23076,,60269.0,31140.0,21300
Site18-CytoflexS,38,Site18,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.4,4477,360,420000.0,32140.0,102000
Site18-CytoflexS,38,Site18,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,22.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,14,3629,292,483.0,364.0,1670
Site18-CytoflexS,38,Site18,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,80.8,5274,425,29393.0,6559.0,175
Site18-CytoflexS,38,Site18,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,15.1,2702,218,32416.0,2963.0,0.0901
Site18-CytoflexS,38,Site18,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.6,12667,1020,137966.0,47009.0,2110
Site18-CytoflexS,38,Site18,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,64.1,8106,653,218194.0,30346.0,12.1
Site18-CytoflexS,38,Site18,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,21783,,61312.0,30976.0,707
Site18-CytoflexS,38,Site18,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,35.3,4468,360,419000.0,31353.0,494
Site18-CytoflexS,38,Site18,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,22.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,28.9,5191,418,424.0,323.0,0.0226
Site18-CytoflexS,38,Site18,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.1,4234,41.6,29393.0,6582.0,104
Site18-CytoflexS,38,Site18,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.9,2704,26.6,32746.0,2994.0,0.0286
Site18-CytoflexS,38,Site18,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.3,17873,175.5,137488.0,47269.0,0.263
Site18-CytoflexS,38,Site18,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.4,8085,79.4,216682.0,30567.0,0.0109
Site18-CytoflexS,38,Site18,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,23362,,60684.0,30976.0,494
Site18-CytoflexS,38,Site18,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.8,4468,43.9,420000.0,32140.0,0.0226
Site18-CytoflexS,38,Site18,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-CytoflexS,38,Site18,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.2,399,32.23422761,278.0,298.0,0.0109
Site18-CytoflexS,38,Site18,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site18-CytoflexS,38,Site18,CytoflexS,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,86.5,7119,648,159619.0,78195.0,27200
Site18-NorthernL,39,Site18,NorthernL,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,88.9,38076,1017,181688.0,83969.0,29400
Site18-NorthernL,39,Site18,NorthernL,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,3448,314,52451.0,20628.0,183000
Site18-NorthernL,39,Site18,NorthernL,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.9,3010,379,53035.0,21604.0,192000
Site18-NorthernL,39,Site18,NorthernL,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,63,17640,1605,83989.0,33063.0,504
Site18-NorthernL,39,Site18,NorthernL,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,61.2,14219,1789,87366.0,34536.0,628
Site18-NorthernL,39,Site18,NorthernL,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,46.7,8239,750,149877.0,36517.0,8930000
Site18-NorthernL,39,Site18,NorthernL,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,43.5,6739,848,150777.0,36057.0,8980000
Site18-NorthernL,39,Site18,NorthernL,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,86.5,43421,3591,62356.0,20152.0,12900
Site18-NorthernL,39,Site18,NorthernL,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,84.2,38076,4790,61313.0,19660.0,1880000
Site18-NorthernL,39,Site18,NorthernL,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,44,7760,706,104377.0,54326.0,138
Site18-NorthernL,39,Site18,NorthernL,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,47.4,6181,778,112673.0,58157.0,146
Site18-NorthernL,39,Site18,NorthernL,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,64.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,61.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.2,4252,387,119529.0,189259.0,9040
Site18-NorthernL,39,Site18,NorthernL,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,16,3713,467,148093.0,228947.0,8860
Site18-NorthernL,39,Site18,NorthernL,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,87.8,7193,586,161548.0,76974.0,73800
Site18-NorthernL,39,Site18,NorthernL,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,89.8,8106,988,183342.0,83223.0,74600
Site18-NorthernL,39,Site18,NorthernL,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.6,3554,289,52596.0,21015.0,227000
Site18-NorthernL,39,Site18,NorthernL,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,13.2,37654,377,53182.0,21825.0,257000
Site18-NorthernL,39,Site18,NorthernL,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,61.7,17432,1420,84140.0,32804.0,1810000
Site18-NorthernL,39,Site18,NorthernL,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,59.9,37654,1712,87366.0,34266.0,1880000
Site18-NorthernL,39,Site18,NorthernL,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,47.4,8265,673,151683.0,36979.0,8930000
Site18-NorthernL,39,Site18,NorthernL,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,48.2,37654,825,152595.0,36512.0,8980000
Site18-NorthernL,39,Site18,NorthernL,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,82,42901,3494,62709.0,19689.0,9040
Site18-NorthernL,39,Site18,NorthernL,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,79.9,37654,4590,61486.0,19382.0,8860
Site18-NorthernL,39,Site18,NorthernL,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,42.9,7484,610,104377.0,51982.0,27200
Site18-NorthernL,39,Site18,NorthernL,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,42.2,37654,722,112673.0,55331.0,29400
Site18-NorthernL,39,Site18,NorthernL,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,65.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,62.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,24,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,15.1,42901,346,122032.0,192936.0,504
Site18-NorthernL,39,Site18,NorthernL,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.9,3730,455,152139.0,232809.0,628
Site18-NorthernL,39,Site18,NorthernL,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,85.1,6981,577,162035.0,75571.0,104
Site18-NorthernL,39,Site18,NorthernL,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,87.5,7924,997,184453.0,80992.0,104
Site18-NorthernL,39,Site18,NorthernL,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,12.3,3408,282,52451.0,20758.0,0.0537
Site18-NorthernL,39,Site18,NorthernL,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,12.9,2964,373,52888.0,21472.0,0.0537
Site18-NorthernL,39,Site18,NorthernL,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,64.7,17892,1479,84140.0,36803.0,46.4
Site18-NorthernL,39,Site18,NorthernL,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,63,14490,1823,87874.0,34725.0,494
Site18-NorthernL,39,Site18,NorthernL,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,45.6,8155,674,151683.0,36803.0,0.61
Site18-NorthernL,39,Site18,NorthernL,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,46.1,6683,841,152595.0,36512.0,0.61
Site18-NorthernL,39,Site18,NorthernL,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,82.8,43320,3473,62356.0,20094.0,707
Site18-NorthernL,39,Site18,NorthernL,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,80.6,38005,4208,61313.0,19660.0,707
Site18-NorthernL,39,Site18,NorthernL,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,46.2,8272,684,101066.0,58735.0,674000
Site18-NorthernL,39,Site18,NorthernL,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,45.5,6598,830,109402.0,62068.0,674000
Site18-NorthernL,39,Site18,NorthernL,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,63.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,23.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,14.7,4070,337,120953.0,190160.0,34000
Site18-NorthernL,39,Site18,NorthernL,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,15.5,3559,448,148982.0,228613.0,3430
Site18-NorthernL,39,Site18,NorthernL,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,89.6,3744,3591,78199.0,24016.0,12900
Site18-NorthernL,39,Site18,NorthernL,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,87.6,3797,4790,83459.0,24710.0,12900
Site18-NorthernL,39,Site18,NorthernL,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,94.6,7373,885,111681.0,28582.0,27200
Site18-NorthernL,39,Site18,NorthernL,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,95.2,6603,1061,130653.0,33038.0,29400
Site18-NorthernL,39,Site18,NorthernL,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.6,5088,611,54982.0,18785.0,209000
Site18-NorthernL,39,Site18,NorthernL,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.5,2494,401,57167.0,19527.0,222000
Site18-NorthernL,39,Site18,NorthernL,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.3,22803,2738,111352.0,40927.0,669
Site18-NorthernL,39,Site18,NorthernL,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,72.3,9865,1585,115024.0,41889.0,998
Site18-NorthernL,39,Site18,NorthernL,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.3,16714,2007,161064.0,32950.0,9570000
Site18-NorthernL,39,Site18,NorthernL,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.5,7244,1164,162522.0,33563.0,9650000
Site18-NorthernL,39,Site18,NorthernL,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,88.5,41996,5043,63778.0,15279.0,2400000
Site18-NorthernL,39,Site18,NorthernL,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,70.9,23761,3817,64685.0,17668.0,460000
Site18-NorthernL,39,Site18,NorthernL,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25,5698,684,104684.0,34900.0,136
Site18-NorthernL,39,Site18,NorthernL,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.8,2446,393,113674.0,37627.0,153
Site18-NorthernL,39,Site18,NorthernL,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,71.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,56.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,29.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,6.16,1948,234,157241.0,220017.0,9220
Site18-NorthernL,39,Site18,NorthernL,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.52,1027,165,235153.0,273779.0,9380
Site18-NorthernL,39,Site18,NorthernL,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,94.6,7590,896,112011.0,28761.0,77300
Site18-NorthernL,39,Site18,NorthernL,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,94.7,6711,1057,131433.0,32675.0,62700
Site18-NorthernL,39,Site18,NorthernL,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.8,5016,592,55135.0,18892.0,157000
Site18-NorthernL,39,Site18,NorthernL,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,19.7,2526,398,57327.0,19856.0,175000
Site18-NorthernL,39,Site18,NorthernL,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.5,22545,2660,111681.0,40818.0,0.0231
Site18-NorthernL,39,Site18,NorthernL,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,70,9916,1561,114685.0,41889.0,0.0179
Site18-NorthernL,39,Site18,NorthernL,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.5,16574,1956,162522.0,33065.0,9570000
Site18-NorthernL,39,Site18,NorthernL,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.8,7292,1148,163995.0,34185.0,7780000
Site18-NorthernL,39,Site18,NorthernL,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87,41901,4944,63958.0,15191.0,9570000
Site18-NorthernL,39,Site18,NorthernL,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,98.1,23531,3705,65052.0,17385.0,9090
Site18-NorthernL,39,Site18,NorthernL,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,24.8,5593,660,104377.0,34366.0,27200
Site18-NorthernL,39,Site18,NorthernL,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,24.7,2437,384,112673.0,37159.0,14300
Site18-NorthernL,39,Site18,NorthernL,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,71.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,60.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,19.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,31.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.98,1837,217,162035.0,219638.0,669
Site18-NorthernL,39,Site18,NorthernL,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.42,1057,166,241697.0,276570.0,160
Site18-NorthernL,39,Site18,NorthernL,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,98.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,94.5,7489,912,112341.0,27942.0,104
Site18-NorthernL,39,Site18,NorthernL,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,95.2,6608,1352,131433.0,32573.0,104
Site18-NorthernL,39,Site18,NorthernL,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,16.6,4920,599,54982.0,18581.0,0.0537
Site18-NorthernL,39,Site18,NorthernL,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,18.3,2481,508,57167.0,19743.0,0.0537
Site18-NorthernL,39,Site18,NorthernL,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.1,22262,2711,111681.0,40709.0,52.2
Site18-NorthernL,39,Site18,NorthernL,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,71.8,9817,2008,114685.0,41758.0,59200
Site18-NorthernL,39,Site18,NorthernL,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,73.3,16344,1990,163012.0,32868.0,0.61
Site18-NorthernL,39,Site18,NorthernL,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,73.3,7195,1472,163995.0,33987.0,0.61
Site18-NorthernL,39,Site18,NorthernL,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,87.5,42044,5173,63778.0,15279.0,707
Site18-NorthernL,39,Site18,NorthernL,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,66.5,23777,3942,64868.0,17603.0,707
Site18-NorthernL,39,Site18,NorthernL,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,25.2,5589,681,104377.0,34791.0,669
Site18-NorthernL,39,Site18,NorthernL,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,25,2459,503,112673.0,38197.0,59200
Site18-NorthernL,39,Site18,NorthernL,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,69.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,58.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,18.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,5.69,1721,210,162522.0,219435.0,0.0372
Site18-NorthernL,39,Site18,NorthernL,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.92,969,198,238766.0,276111.0,0.0372
Site18-NorthernL,39,Site18,NorthernL,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,91.1,3944,5043,83975.0,24565.0,9220
Site18-NorthernL,39,Site18,NorthernL,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,88.8,3744,3817,80203.0,25391.0,9220
Site18-NorthernL,39,Site18,NorthernL,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.5,8198,1054,140756.0,45492.0,14300
Site18-NorthernL,39,Site18,NorthernL,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.5,4665,1419,130265.0,40565.0,27800
Site18-NorthernL,39,Site18,NorthernL,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.2,2234,287,57008.0,21894.0,200000
Site18-NorthernL,39,Site18,NorthernL,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.7,1051,320,55135.0,21268.0,206000
Site18-NorthernL,39,Site18,NorthernL,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.2,16751,2154,101066.0,37228.0,160
Site18-NorthernL,39,Site18,NorthernL,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,76.2,22883,6959,100476.0,36423.0,539
Site18-NorthernL,39,Site18,NorthernL,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,67,11213,1442,155365.0,36349.0,7780000
Site18-NorthernL,39,Site18,NorthernL,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,68.4,5093,1549,155365.0,37364.0,9260000
Site18-NorthernL,39,Site18,NorthernL,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,82.7,37597,4835,62709.0,18529.0,-1850000
Site18-NorthernL,39,Site18,NorthernL,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,84.7,17668,5373,62181.0,18675.0,-2160000
Site18-NorthernL,39,Site18,NorthernL,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,29.1,4870,626,108122.0,56399.0,146
Site18-NorthernL,39,Site18,NorthernL,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28,2078,632,106858.0,55847.0,151
Site18-NorthernL,39,Site18,NorthernL,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,57.5,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,54.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.56,1880,242,105301.0,198256.0,9090
Site18-NorthernL,39,Site18,NorthernL,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,8.12,792,241,118473.0,200262.0,9010
Site18-NorthernL,39,Site18,NorthernL,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,92.6,8306,1261,141599.0,44422.0,
Site18-NorthernL,39,Site18,NorthernL,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,92.4,4701,1572,130653.0,40307.0,
Site18-NorthernL,39,Site18,NorthernL,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10.7,2323,353,57008.0,22296.0,
Site18-NorthernL,39,Site18,NorthernL,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,11.1,1074,359,55751.0,21439.0,
Site18-NorthernL,39,Site18,NorthernL,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,75.6,16804,2550,101659.0,37032.0,
Site18-NorthernL,39,Site18,NorthernL,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,75.3,7446,2490,100770.0,36327.0,
Site18-NorthernL,39,Site18,NorthernL,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,68,11339,1721,157241.0,36809.0,
Site18-NorthernL,39,Site18,NorthernL,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,69.4,5135,1717,157241.0,37836.0,
Site18-NorthernL,39,Site18,NorthernL,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,78.2,37254,4662,63063.0,18146.0,
Site18-NorthernL,39,Site18,NorthernL,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,80.3,17473,5218,62532.0,18363.0,
Site18-NorthernL,39,Site18,NorthernL,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,27.9,726,110,108441.0,53308.0,
Site18-NorthernL,39,Site18,NorthernL,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,26.7,2005,671,106545.0,53168.0,
Site18-NorthernL,39,Site18,NorthernL,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,56.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,54.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,23.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.9,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.17,37254,288,112341.0,203140.0,
Site18-NorthernL,39,Site18,NorthernL,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.86,794,266,129879.0,209070.0,
Site18-NorthernL,39,Site18,NorthernL,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,97.8,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,98.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,91.4,8093,1035,141599.0,43868.0,
Site18-NorthernL,39,Site18,NorthernL,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,90.7,4604,1409,130265.0,39923.0,
Site18-NorthernL,39,Site18,NorthernL,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,10,2208,282,56849.0,22110.0,
Site18-NorthernL,39,Site18,NorthernL,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,10.4,1035,317,54982.0,21027.0,
Site18-NorthernL,39,Site18,NorthernL,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,76.9,16725,2140,101066.0,37326.0,
Site18-NorthernL,39,Site18,NorthernL,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,77.8,7463,2284,100476.0,36614.0,
Site18-NorthernL,39,Site18,NorthernL,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.9,11072,1417,156300.0,37326.0,
Site18-NorthernL,39,Site18,NorthernL,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,67.6,5057,1548,156770.0,37414.0,
Site18-NorthernL,39,Site18,NorthernL,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,78.8,37502,4640,62886.0,18529.0,
Site18-NorthernL,39,Site18,NorthernL,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,81.1,17649,5379,62181.0,18614.0,
Site18-NorthernL,39,Site18,NorthernL,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,30.3,5035,644,105301.0,58812.0,
Site18-NorthernL,39,Site18,NorthernL,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,28.9,2147,657,105610.0,57329.0,
Site18-NorthernL,39,Site18,NorthernL,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,59.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,54.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,22.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,28.2,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,8.4,1725,221,111681.0,204184.0,
Site18-NorthernL,39,Site18,NorthernL,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,7.63,728,223,118473.0,204426.0,
Site18-NorthernL,39,Site18,NorthernL,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,86.3,3750,4835,81418.0,23454.0,-1850000
Site18-NorthernL,39,Site18,NorthernL,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,91.6,3984,5373,83257.0,24420.0,-1850000
Site18-NorthernL,39,Site18,NorthernL,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,23601,2134,123850.0,60679.0,13900
Site18-NorthernL,39,Site18,NorthernL,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-NorthernL,39,Site18,NorthernL,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81,3678,306,35006.0,9318.0,72700
Site18-NorthernL,39,Site18,NorthernL,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.4,2846,237,51589.0,4663.0,49200
Site18-NorthernL,39,Site18,NorthernL,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.7,13977,1164,300373.0,101953.0,72700
Site18-NorthernL,39,Site18,NorthernL,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65,9082,756,454000.0,62713.0,27100000
Site18-NorthernL,39,Site18,NorthernL,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,23507,,103160.0,48912.0,13900
Site18-NorthernL,39,Site18,NorthernL,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-NorthernL,39,Site18,NorthernL,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site18-NorthernL,39,Site18,NorthernL,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.8,4723,393,294892.0,21187.0,76600
Site18-NorthernL,39,Site18,NorthernL,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,79.7,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.3,24813,218,2963.0,2058.0,12.4
Site18-NorthernL,39,Site18,NorthernL,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,79.9,3640,297,35098.0,9280.0,104
Site18-NorthernL,39,Site18,NorthernL,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,14.5,2755,225,51875.0,4498.0,0.0537
Site18-NorthernL,39,Site18,NorthernL,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,70.9,13689,1117,302224.0,101307.0,0.0372
Site18-NorthernL,39,Site18,NorthernL,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65,8821,720,460000.0,61428.0,0.61
Site18-NorthernL,39,Site18,NorthernL,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,22947,,96469.0,48782.0,707
Site18-NorthernL,39,Site18,NorthernL,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-NorthernL,39,Site18,NorthernL,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site18-NorthernL,39,Site18,NorthernL,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,34.1,4647,379,293988.0,20703.0,707
Site18-NorthernL,39,Site18,NorthernL,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,77.3,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,18.6,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.5,2590,211,2999.0,2043.0,0.0372
Site18-NorthernL,39,Site18,NorthernL,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,81.1,4251,281,35098.0,9178.0,0.0537
Site18-NorthernL,39,Site18,NorthernL,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,13.9,2710,179,51589.0,4470.0,0.0226
Site18-NorthernL,39,Site18,NorthernL,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,69.3,12668,928,300373.0,101473.0,0.0158
Site18-NorthernL,39,Site18,NorthernL,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,65.4,8125,537,457000.0,63933.0,0.000554
Site18-NorthernL,39,Site18,NorthernL,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,19847,,102557.0,50006.0,0.369
Site18-NorthernL,39,Site18,NorthernL,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site18-NorthernL,39,Site18,NorthernL,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site18-NorthernL,39,Site18,NorthernL,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,33.8,4477,296,293988.0,21187.0,43100
Site18-NorthernL,39,Site18,NorthernL,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site18-NorthernL,39,Site18,NorthernL,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,78.1,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,17.4,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site18-NorthernL,39,Site18,NorthernL,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,13.2,5173,342,3054.0,2053.0,14.5
Site18-NorthernL,39,Site18,NorthernL,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site18-NorthernL,39,Site18,NorthernL,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site19-Fusion-1,40,Site19,Fusion,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-1,40,Site19,Fusion,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-1,40,Site19,Fusion,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-1,40,Site19,Fusion,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-1,40,Site19,Fusion,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site19-Fusion-2,41,Site19,Fusion,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site19-Fusion-2,41,Site19,Fusion,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site19-Fusion-2,41,Site19,Fusion,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site19-Fusion-2,41,Site19,Fusion,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site19-Fusion-2,41,Site19,Fusion,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,1,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,11105,,33921.0,10435.0,
Site20-Fortessa,42,Site20,Fortessa,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,11495,,334830.0,10751.0,
Site20-Fortessa,42,Site20,Fortessa,2,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,11173,,34414.0,10645.0,
Site20-Fortessa,42,Site20,Fortessa,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,4788,,7844.0,2813.0,
Site20-Fortessa,42,Site20,Fortessa,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,4936,,7844.0,2897.0,
Site20-Fortessa,42,Site20,Fortessa,3,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,4845,,7949.0,2894.0,
Site20-Fortessa,42,Site20,Fortessa,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,17525,,5093.0,1936.0,
Site20-Fortessa,42,Site20,Fortessa,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,17566,,5093.0,1936.0,
Site20-Fortessa,42,Site20,Fortessa,4,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,17467,,5093.0,1929.0,
Site20-Fortessa,42,Site20,Fortessa,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,8673,,33597.0,8864.0,
Site20-Fortessa,42,Site20,Fortessa,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,8796,,34085.0,8891.0,
Site20-Fortessa,42,Site20,Fortessa,5,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,8674,,34331.0,8829.0,
Site20-Fortessa,42,Site20,Fortessa,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,34719,,19709.0,5364.0,
Site20-Fortessa,42,Site20,Fortessa,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,34931,,19642.0,5296.0,
Site20-Fortessa,42,Site20,Fortessa,6,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,34456,,19441.0,5307.0,
Site20-Fortessa,42,Site20,Fortessa,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,7668,,29659.0,12140.0,
Site20-Fortessa,42,Site20,Fortessa,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,7597,,30450.0,12291.0,
Site20-Fortessa,42,Site20,Fortessa,7,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,7660,,30160.0,12065.0,
Site20-Fortessa,42,Site20,Fortessa,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,8,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,9,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,3387,,34003.0,30862.0,
Site20-Fortessa,42,Site20,Fortessa,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,3160,,33840.0,30426.0,
Site20-Fortessa,42,Site20,Fortessa,10,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,2911,,32879.0,31812.0,
Site20-Fortessa,42,Site20,Fortessa,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,11,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,11458,,33759.0,10463.0,
Site20-Fortessa,42,Site20,Fortessa,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,11458,,34746.0,10861.0,
Site20-Fortessa,42,Site20,Fortessa,12,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,11493,,34331.0,10646.0,
Site20-Fortessa,42,Site20,Fortessa,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,5295,,8063.0,2560.0,
Site20-Fortessa,42,Site20,Fortessa,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,5452,,8099.0,2628.0,
Site20-Fortessa,42,Site20,Fortessa,13,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,5335,,8244.0,2629.0,
Site20-Fortessa,42,Site20,Fortessa,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,15583,,4841.0,1886.0,
Site20-Fortessa,42,Site20,Fortessa,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,4821,,4821.0,1871.0,
Site20-Fortessa,42,Site20,Fortessa,14,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,15149,,4821.0,1874.0,
Site20-Fortessa,42,Site20,Fortessa,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,8469,,32643.0,8713.0,
Site20-Fortessa,42,Site20,Fortessa,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,8495,,33116.0,8558.0,
Site20-Fortessa,42,Site20,Fortessa,15,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,8313,,33356.0,8682.0,
Site20-Fortessa,42,Site20,Fortessa,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,33369,,18982.0,5288.0,
Site20-Fortessa,42,Site20,Fortessa,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,32870,,18917.0,5162.0,
Site20-Fortessa,42,Site20,Fortessa,16,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,31947,,18724.0,5195.0,
Site20-Fortessa,42,Site20,Fortessa,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,5633,,23316.0,10733.0,
Site20-Fortessa,42,Site20,Fortessa,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,5520,,23989.0,11022.0,
Site20-Fortessa,42,Site20,Fortessa,17,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,5470,,23538.0,10791.0,
Site20-Fortessa,42,Site20,Fortessa,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,18,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,19,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,3511,,34830.0,30969.0,
Site20-Fortessa,42,Site20,Fortessa,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,3049,,34746.0,31956.0,
Site20-Fortessa,42,Site20,Fortessa,20,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,2829,,33840.0,32893.0,
Site20-Fortessa,42,Site20,Fortessa,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,21,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,11394,,37619.0,12051.0,
Site20-Fortessa,42,Site20,Fortessa,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,11758,,38537.0,12383.0,
Site20-Fortessa,42,Site20,Fortessa,22,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,11423,,37801.0,12141.0,
Site20-Fortessa,42,Site20,Fortessa,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,5329,,7886.0,2819.0,
Site20-Fortessa,42,Site20,Fortessa,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,5469,,7869.0,,
Site20-Fortessa,42,Site20,Fortessa,23,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,5372,,7957.0,2850.0,
Site20-Fortessa,42,Site20,Fortessa,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,22598,,5158.0,1920.0,
Site20-Fortessa,42,Site20,Fortessa,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,22526,,5114.0,1919.0,
Site20-Fortessa,42,Site20,Fortessa,24,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,22399,,5136.0,1913.0,
Site20-Fortessa,42,Site20,Fortessa,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,10265,,32879.0,8288.0,
Site20-Fortessa,42,Site20,Fortessa,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,10986,,33921.0,8712.0,
Site20-Fortessa,42,Site20,Fortessa,25,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,10270,,33678.0,8442.0,
Site20-Fortessa,42,Site20,Fortessa,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,42256,,19777.0,5403.0,
Site20-Fortessa,42,Site20,Fortessa,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,41862,,19777.0,5334.0,
Site20-Fortessa,42,Site20,Fortessa,26,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,41597,,19508.0,5345.0,
Site20-Fortessa,42,Site20,Fortessa,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,9961,,29801.0,11834.0,
Site20-Fortessa,42,Site20,Fortessa,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,9950,,30377.0,12049.0,
Site20-Fortessa,42,Site20,Fortessa,27,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,9985,,30377.0,11788.0,
Site20-Fortessa,42,Site20,Fortessa,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,28,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,29,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,2566,,24450.0,28660.0,
Site20-Fortessa,42,Site20,Fortessa,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,2113,,21462.0,28322.0,
Site20-Fortessa,42,Site20,Fortessa,30,Donor1,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,1905,,17988.0,27595.0,
Site20-Fortessa,42,Site20,Fortessa,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,31,Donor1,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,32,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,17551,,29027.0,7145.0,
Site20-Fortessa,42,Site20,Fortessa,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,17435,,29447.0,7234.0,
Site20-Fortessa,42,Site20,Fortessa,33,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,17654,,29447.0,7296.0,
Site20-Fortessa,42,Site20,Fortessa,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,6262,,7966.0,2779.0,
Site20-Fortessa,42,Site20,Fortessa,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,5927,,8144.0,2780.0,
Site20-Fortessa,42,Site20,Fortessa,34,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,6217,,8162.0,2767.0,
Site20-Fortessa,42,Site20,Fortessa,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,22467,,6851.0,2676.0,
Site20-Fortessa,42,Site20,Fortessa,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,22546,,6866.0,2665.0,
Site20-Fortessa,42,Site20,Fortessa,35,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,22514,,6866.0,2679.0,
Site20-Fortessa,42,Site20,Fortessa,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,16272,,36635.0,8368.0,
Site20-Fortessa,42,Site20,Fortessa,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,16362,,36901.0,8597.0,
Site20-Fortessa,42,Site20,Fortessa,36,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,16200,,37079.0,8409.0,
Site20-Fortessa,42,Site20,Fortessa,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,33876,,18408.0,4277.0,
Site20-Fortessa,42,Site20,Fortessa,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,33427,,18345.0,4285.0,
Site20-Fortessa,42,Site20,Fortessa,37,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,33980,,18345.0,4316.0,
Site20-Fortessa,42,Site20,Fortessa,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,5832,,31414.0,12215.0,
Site20-Fortessa,42,Site20,Fortessa,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,5720,,31114.0,12302.0,
Site20-Fortessa,42,Site20,Fortessa,38,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,5899,,32022.0,12302.0,
Site20-Fortessa,42,Site20,Fortessa,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,39,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,40,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,983,,46420.0,50356.0,
Site20-Fortessa,42,Site20,Fortessa,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,951,,53045.0,48918.0,
Site20-Fortessa,42,Site20,Fortessa,41,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,941,,45529.0,47823.0,
Site20-Fortessa,42,Site20,Fortessa,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,42,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,18070,,29027.0,7171.0,
Site20-Fortessa,42,Site20,Fortessa,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,17793,,29447.0,7286.0,
Site20-Fortessa,42,Site20,Fortessa,43,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,18198,,29377.0,7374.0,
Site20-Fortessa,42,Site20,Fortessa,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,8448,,8448.0,2616.0,
Site20-Fortessa,42,Site20,Fortessa,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,6501,,8581.0,2609.0,
Site20-Fortessa,42,Site20,Fortessa,44,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,6783,,8677.0,2607.0,
Site20-Fortessa,42,Site20,Fortessa,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,18414,,6363.0,2521.0,
Site20-Fortessa,42,Site20,Fortessa,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,18467,,6377.0,2535.0,
Site20-Fortessa,42,Site20,Fortessa,45,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,18171,,6377.0,2510.0,
Site20-Fortessa,42,Site20,Fortessa,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,13973,,35251.0,8215.0,
Site20-Fortessa,42,Site20,Fortessa,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,14007,,35678.0,8437.0,
Site20-Fortessa,42,Site20,Fortessa,46,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,13766,,35764.0,8239.0,
Site20-Fortessa,42,Site20,Fortessa,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,30407,,17912.0,4437.0,
Site20-Fortessa,42,Site20,Fortessa,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,30128,,17852.0,4526.0,
Site20-Fortessa,42,Site20,Fortessa,47,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,30026,,17852.0,4453.0,
Site20-Fortessa,42,Site20,Fortessa,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,4057,,24978.0,10658.0,
Site20-Fortessa,42,Site20,Fortessa,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,3991,,24624.0,11038.0,
Site20-Fortessa,42,Site20,Fortessa,48,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,3991,,25519.0,11077.0,
Site20-Fortessa,42,Site20,Fortessa,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,49,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,50,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,1010,,52916.0,51174.0,
Site20-Fortessa,42,Site20,Fortessa,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,971,,49319.0,49435.0,
Site20-Fortessa,42,Site20,Fortessa,51,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,940,,43800.0,50157.0,
Site20-Fortessa,42,Site20,Fortessa,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,52,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,17994,,31263.0,7994.0,
Site20-Fortessa,42,Site20,Fortessa,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,17911,,31565.0,8073.0,
Site20-Fortessa,42,Site20,Fortessa,53,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,18138,,31565.0,8149.0,
Site20-Fortessa,42,Site20,Fortessa,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,6914,,7992.0,2761.0,
Site20-Fortessa,42,Site20,Fortessa,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,6554,,8135.0,2783.0,
Site20-Fortessa,42,Site20,Fortessa,54,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,6817,,8208.0,2741.0,
Site20-Fortessa,42,Site20,Fortessa,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,30549,,6972.0,2664.0,
Site20-Fortessa,42,Site20,Fortessa,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,30607,,6987.0,2664.0,
Site20-Fortessa,42,Site20,Fortessa,55,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,30198,,7003.0,2678.0,
Site20-Fortessa,42,Site20,Fortessa,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,20169,,35937.0,7695.0,
Site20-Fortessa,42,Site20,Fortessa,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,20319,,36197.0,7913.0,
Site20-Fortessa,42,Site20,Fortessa,56,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,20244,,36547.0,7907.0,
Site20-Fortessa,42,Site20,Fortessa,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,43116,,18470.0,4157.0,
Site20-Fortessa,42,Site20,Fortessa,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,42365,,18408.0,4103.0,
Site20-Fortessa,42,Site20,Fortessa,57,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,42815,,18408.0,4157.0,
Site20-Fortessa,42,Site20,Fortessa,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,7672,,31263.0,11778.0,
Site20-Fortessa,42,Site20,Fortessa,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,7522,,31189.0,12041.0,
Site20-Fortessa,42,Site20,Fortessa,58,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,7589,,31945.0,12003.0,
Site20-Fortessa,42,Site20,Fortessa,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,59,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,60,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,558,,22770.0,41253.0,
Site20-Fortessa,42,Site20,Fortessa,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,519,,20042.0,42757.0,
Site20-Fortessa,42,Site20,Fortessa,61,Donor2,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,502,,14584.0,34291.0,
Site20-Fortessa,42,Site20,Fortessa,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,62,Donor2,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,63,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,13758,,33921.0,9243.0,
Site20-Fortessa,42,Site20,Fortessa,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,15417,,34414.0,9381.0,
Site20-Fortessa,42,Site20,Fortessa,64,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,15454,,34167.0,9298.0,
Site20-Fortessa,42,Site20,Fortessa,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,3735,,8894.0,3069.0,
Site20-Fortessa,42,Site20,Fortessa,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,4338,,8894.0,2988.0,
Site20-Fortessa,42,Site20,Fortessa,65,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,4276,,9012.0,3015.0,
Site20-Fortessa,42,Site20,Fortessa,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,19357,,6267.0,2408.0,
Site20-Fortessa,42,Site20,Fortessa,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,0,,,,
Site20-Fortessa,42,Site20,Fortessa,66,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,22284,,6186.0,2370.0,
Site20-Fortessa,42,Site20,Fortessa,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,12585,,37619.0,9685.0,
Site20-Fortessa,42,Site20,Fortessa,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,0,,,,
Site20-Fortessa,42,Site20,Fortessa,67,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,14386,,37710.0,9637.0,
Site20-Fortessa,42,Site20,Fortessa,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,29256,,19913.0,5495.0,
Site20-Fortessa,42,Site20,Fortessa,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,0,,,,
Site20-Fortessa,42,Site20,Fortessa,68,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,33704,,19913.0,5540.0,
Site20-Fortessa,42,Site20,Fortessa,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,5894,,32486.0,14321.0,
Site20-Fortessa,42,Site20,Fortessa,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,0,,,,
Site20-Fortessa,42,Site20,Fortessa,69,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,6909,,32331.0,14428.0,
Site20-Fortessa,42,Site20,Fortessa,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,70,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,71,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,892,,49680.0,38123.0,
Site20-Fortessa,42,Site20,Fortessa,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,0,,,,
Site20-Fortessa,42,Site20,Fortessa,72,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,951,,49559.0,39222.0,
Site20-Fortessa,42,Site20,Fortessa,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,73,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,14314,,33840.0,9330.0,
Site20-Fortessa,42,Site20,Fortessa,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,15952,,34331.0,9447.0,
Site20-Fortessa,42,Site20,Fortessa,74,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,15959,,34085.0,9364.0,
Site20-Fortessa,42,Site20,Fortessa,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,4278,,9364.0,2832.0,
Site20-Fortessa,42,Site20,Fortessa,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,4923,,9406.0,2758.0,
Site20-Fortessa,42,Site20,Fortessa,75,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,4863,,9470.0,2809.0,
Site20-Fortessa,42,Site20,Fortessa,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,15643,,5750.0,2287.0,
Site20-Fortessa,42,Site20,Fortessa,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,17594,,5688.0,2250.0,
Site20-Fortessa,42,Site20,Fortessa,76,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,17718,,5688.0,2257.0,
Site20-Fortessa,42,Site20,Fortessa,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,11387,,35850.0,9683.0,
Site20-Fortessa,42,Site20,Fortessa,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,12946,,36023.0,9666.0,
Site20-Fortessa,42,Site20,Fortessa,77,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,12888,,35937.0,9517.0,
Site20-Fortessa,42,Site20,Fortessa,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,25056,,18917.0,5204.0,
Site20-Fortessa,42,Site20,Fortessa,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,28057,,18982.0,5246.0,
Site20-Fortessa,42,Site20,Fortessa,78,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,28480,,18917.0,5223.0,
Site20-Fortessa,42,Site20,Fortessa,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,3330,,21871.0,11468.0,
Site20-Fortessa,42,Site20,Fortessa,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,3641,,22184.0,11630.0,
Site20-Fortessa,42,Site20,Fortessa,79,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,3786,,22027.0,11229.0,
Site20-Fortessa,42,Site20,Fortessa,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,80,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,81,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,781,,49800.0,44013.0,
Site20-Fortessa,42,Site20,Fortessa,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,759,,49200.0,44737.0,
Site20-Fortessa,42,Site20,Fortessa,82,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,794,,53045.0,42865.0,
Site20-Fortessa,42,Site20,Fortessa,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,83,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,"Aqua-, Annexin-","Aqua-, Annexin-",% of singlets (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),1,,15872,,36372.0,10312.0,
Site20-Fortessa,42,Site20,Fortessa,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),2,,15896,,36724.0,10420.0,
Site20-Fortessa,42,Site20,Fortessa,84,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med, CD14+",% monocytes (% parent),3,,15930,,36372.0,10244.0,
Site20-Fortessa,42,Site20,Fortessa,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),1,,4786,,8933.0,3038.0,
Site20-Fortessa,42,Site20,Fortessa,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),2,,4961,,8913.0,2958.0,
Site20-Fortessa,42,Site20,Fortessa,85,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD19+",% of lymphocytes and Not Dump Monocytes (% parent),3,,4911,,8993.0,2986.0,
Site20-Fortessa,42,Site20,Fortessa,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),1,,29065,,6349.0,2402.0,
Site20-Fortessa,42,Site20,Fortessa,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),2,,29417,,6294.0,2392.0,
Site20-Fortessa,42,Site20,Fortessa,86,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+",% of lymphocytes and Not Dump Monocytes (% parent),3,,29465,,6267.0,2384.0,
Site20-Fortessa,42,Site20,Fortessa,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,17268,,36990.0,9251.0,
Site20-Fortessa,42,Site20,Fortessa,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,17669,,37079.0,9373.0,
Site20-Fortessa,42,Site20,Fortessa,87,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,17523,,36990.0,9172.0,
Site20-Fortessa,42,Site20,Fortessa,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),1,,42401,,19981.0,5605.0,
Site20-Fortessa,42,Site20,Fortessa,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),2,,42937,,20118.0,5691.0,
Site20-Fortessa,42,Site20,Fortessa,88,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+",% Annexin-Aqua- cells (%parent),3,,43115,,20049.0,5625.0,
Site20-Fortessa,42,Site20,Fortessa,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,8932,,32564.0,14097.0,
Site20-Fortessa,42,Site20,Fortessa,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,8947,,33037.0,14167.0,
Site20-Fortessa,42,Site20,Fortessa,89,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,9024,,32409.0,14202.0,
Site20-Fortessa,42,Site20,Fortessa,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,90,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes and Not Dump Monocytes,"Aqua-, Annexin-, CD45+, FSClow, SSClow",% CD45+ cells (% grandparent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,91,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"Aqua-, Annexin-, CD45+, FSCmed, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),1,,415,,19484.0,30383.0,
Site20-Fortessa,42,Site20,Fortessa,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),2,,365,,,,
Site20-Fortessa,42,Site20,Fortessa,92,Donor3,SOP3-e1,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"Aqua-, Annexin-, CD45+, FSClow, SSClow, CD56+/CD16+",% of lymphocytes and Not Dump Monocytes (% parent),3,,372,,16458.0,29150.0,
Site20-Fortessa,42,Site20,Fortessa,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,93,Donor3,SOP3-e2,Doublet,SOP2 Comp matrix 1,No control,CD45+ Mononuclear cells,"Aqua-,Annexin-, CD45+","% of singlet, live cells (% parent)",2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,94,Trucytes,SOP3-e3,Doublet,SOP2 Comp matrix 1,No control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,95,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,96,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,97,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,98,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,99,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,100,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,101,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,102,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,103,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 1,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,104,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,105,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,106,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,107,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,108,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,109,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,110,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,111,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,112,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 2,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,113,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD14+ Monocytes,"CD45+, SSC med, CD14+",% monocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,114,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD19+ B cells,"CD45 bright, SSClow, CD19+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,115,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD3 T cells,"CD45 bright, SSClow, CD3+",% of lymphocytes (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,116,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD4 T cells,"CD45 bright, SSClow, CD3+, CD4+",% of CD3+ T cells (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,1,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,2,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,117,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD45+ mononuclear cells,CD45+ mononuclear cells,,3,Not reportable,,,,,
Site20-Fortessa,42,Site20,Fortessa,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,118,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,CD8 T cells,"CD45bright, SSClow, CD3+, CD8+",% of CD3+ T cells (% parent),3,,,,,,
Site20-Fortessa,42,Site20,Fortessa,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,119,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Lymphocytes,"CD45 bright, SSClow",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),1,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),2,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,120,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,Monocytes,"CD45+, SSC med",% CD45+ cells (% parent),3,,Not reportable,Not reportable,Not reportable,Not reportable,
Site20-Fortessa,42,Site20,Fortessa,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),1,,,,,,
Site20-Fortessa,42,Site20,Fortessa,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),2,,,,,,
Site20-Fortessa,42,Site20,Fortessa,121,Trucytes,SOP3-e4,Triplet,SOP2 Comp matrix 3,FMO control,NK cells,"CD45 bright, SSClow, CD56+/CD16+",% of lymphocytes (% parent),3,,,,,,